SINOPEC SHANGHAI PETROCHEMICAL CO LTD Form 20-F Filed 2023-04-26

SINOPEC SHANGHAI PETROCHEMICAL

COMPANY LIMITED

Date: April 26, 2023

/s/ DU JUN

Du Jun, Chief Financial Officer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

20-F

☐	REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☐	SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of event requiring this shell company report

For the transition period from

Commission file number

1-12158

中国石化上海石油化工股份有限公司

(Exact name of Registrant as specified in its charter)

Sinopec Shanghai Petrochemical Company Limited

(Translation of Registrant’s name into English)

The People’s Republic of China

(Jurisdiction of incorporation or organization)

No. 48 Jinyi Road, Jinshan District, Shanghai, PRC

200540

(Address of principal executive offices)

Mr. Wan Tao

No. 48 Jinyi Road, Jinshan District, Shanghai,

200540

The People’s Republic of China

Tel: +86 (21) 57943143

Fax: +86 (21)

57940050

(Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act.


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	None	None

Securities registered or to be registered pursuant to Section 12(g) of the Act.

None

(Title of Class)

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

American Depositary Shares, each representing 100 H Shares, par value RMB1.00 per Share

(Title of Class)

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

3,495,000,000 H Shares, par value RMB1.00 per Share

7,328,813,500 A Shares, par value RMB1.00 per Share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or (15) (d) of the Securities Exchange Act of 1934. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation

S-T

(§232,405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.


Large Accelerated Filer	☒	Accelerated F iler	☐	Non-Accelerated F iler	☐

				Emerging growth company	☐

If an emerging growth company that prepares its financial statements in accordance with U.S.GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ☐

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to

§240.10D-1(b). ☐

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:


U.S. GAAP ☐	International Financial Reporting Standards as issued		Other ☐
	by the International Accounting Standards Board	☒

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

Item

17 ☐ Item

18 ☐

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☐ No ☒

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. * Yes ☐ No ☐

*	This requirement does not apply to the registrant in respect of this filing.

Table of Contents



CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS			1

EXCHANGE RATES			1

CERTAIN TERMS AND CONVENTIONS			2

PART I			2

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS			2

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE			2

ITEM 3. KEY INFORMATION			2

ITEM 4. INFORMATION ON THE COMPANY			16

ITEM 4A. UNRESOLVED STAFF COMMENTS			41

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS			41

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES			51

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS			60

ITEM 8. FINANCIAL INFORMATION			64

ITEM 9. THE OFFER AND LISTING			64

ITEM 10. ADDITIONAL INFORMATION			65

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK			79

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES			81

PART II			82

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES			82

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS			82

ITEM 15. CONTROLS AND PROCEDURES			83

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT			83

ITEM 16B. CODE OF ETHICS			83

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES			84

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES			84

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS			84

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT			84

ITEM 16G. CORPORATE GOVERNANCE			84

ITEM 16H. MINE SAFETY DISCLOSURE			84

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS			85

PART III			85

ITEM 17. FINANCIAL STATEMENTS			85

ITEM 18. FINANCIAL STATEMENTS			85

ITEM 19. EXHIBITS			85

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This annual report includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this annual report that address activities, events or developments which we expect or anticipate will or may occur in the future are hereby identified as forward-looking statements for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words such as “believe,” “intend,” “expect,” “anticipate,” “project,” “estimate,” “predict,” “plan” and similar expressions are also intended to identify forward-looking statements. These forward-looking statements address, among others, such issues as:

•

amount and nature of future development;

•

future prices of and demand for our products;

•

future earnings and cash flow;

•

capital expansion programs;

•

future plans and capital expenditures;

•

expansion and other development trends of the petrochemical industry;

•

expected production or processing capacities, including expected Rated Capacities and primary distillation capacities, of units or facilities not yet in operation;

•

expansion and growth of our business and operations; and

•

our prospective operational and financial information.

These statements are based on assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate in particular circumstances. However, whether actual results and developments will meet our expectations and predictions depends on a number of risks and uncertainties which could cause actual results to differ materially from our expectations, including the risks set forth in “Item 3. Key Information — Risk Factors” and the following:

•

fluctuations in crude oil and natural gas prices;

•

fluctuations in prices of our products;

•

failures or delays in achieving production from development projects;

•

potential acquisitions and other business opportunities;

•

continued availability of capital and financing;

•

changes to environmental and economic regulations;

•

general economic, market and business conditions, including volatility in interest rates, changes in foreign exchange rates and volatility in commodity markets; and

•

other risks and factors beyond our control.

Consequently, all of the forward-looking statements made in this annual report are qualified by these cautionary statements and readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements should be considered in light of the various important factors set forth above and elsewhere in this annual report, including the risks set forth in “Item 3. Key Information – Risk Factors.” In addition, we cannot assure you that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected effect on us or our business or operations.

EXCHANGE RATES

Unless otherwise specified, references in this annual report to “U.S. Dollars” or “U.S.$” are to United States Dollars, references to “HK Dollars” or “HK$” are to Hong Kong Dollars and references to “Renminbi” or “RMB” are to Renminbi yuan, the legal currency of the PRC.

We publish our financial statements in Renminbi. Unless otherwise indicated, all translations from Renminbi to U.S. Dollars have been made at a rate of RMB 6.8972 to U.S. $1.00, the noon buying rate on December 30, 2022 as set forth in the H.10 statistical release of the U.S. Federal Reserve Board. We do not represent that Renminbi or U.S. Dollar amounts could be converted into U.S. Dollars or Renminbi, as the case may be, at any particular rate.

CERTAIN TERMS AND CONVENTIONS

References to “we” or “us” or “Company” or “Group” are references to Sinopec Shanghai Petrochemical Company Limited and our subsidiaries, unless the context requires otherwise. Before our formation, these references relate to the petrochemical businesses carried on by the Complex.

References to “Sinopec Corp.” are references to China Petroleum & Chemical Corporation, the controlling shareholder of the Company.

References to the “Sinopec Group” or “Sinopec” are references to China Petrochemical Corporation, the controlling company of Sinopec Corp.

References to the “Complex” are references to Shanghai Petrochemical Complex, our predecessor founded in 1972.

References to “ADSs” are references to our American Depositary Shares. Each ADS represents 100 H Shares.

References to our “A Shares” are references to 7,328,813,500 A Shares of the Company, par value RMB1.00 per share, which are ordinary shares held by Chinese investors.

References to our “H Shares” are references to our overseas-listed foreign ordinary shares, par value RMB1.00 per share, which are listed and traded on The Stock Exchange of Hong Kong Limited (“HKSE”) under the number “338.”

“Rated Capacity” is the output capacity of a given production plant or, where appropriate, the throughput capacity, calculated by estimating the number of days in a year that the production plant is expected to operate, including downtime for regular maintenance, and multiplying that number by an amount equal to the plant optimal daily output or throughput, as the case may be.

All references to “tons” are references to metric tons.

Unless otherwise noted, references to sales volume are to sales to entities other than us or our divisions and subsidiaries.

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS.

Not applicable.

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE.

Not applicable.

ITEM 3. KEY INFORMATION.

Reserved

Capitalization and Indebtedness.

Not applicable.

Reasons for the Offer and Use of Proceeds.

Not applicable.

Risk Factors.

An investment in our ADSs involves significant risks. The risks and uncertainties described below are not the only ones we face. You should consider carefully all of the information in this annual report, including the risks and uncertainties described below and our consolidated financial statements and related notes, before making an investment in our ADSs. Any of the following risks could have a material adverse effect on our business, financial condition and results of operations. In any such case, the market price of our ADSs could decline, and you may lose all or part of your investment.

Risks Related to Doing Business in China

The PRC government has significant authority to intervene or influence our operations at any time. If the PRC government exerts more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers and we were to be subject to such oversight and control, it may result in a material adverse change to our business operations, significantly limit or completely hinder our ability to offer or continue to offer securities to investors, and cause our ADSs to significantly decline or loss in value.

Our business, prospects, financial condition, and results of operations may be influenced to a significant degree by political, economic, and social conditions in China generally, which could result in a material adverse change to our operations and the value of our securities.

Furthermore, given recent statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas, although we are currently not required to obtain permission from the PRC government and have not received any denial to list on a U.S. exchange, it is uncertain whether or when we might be required to obtain permission from the PRC government to issue securities, to maintain our listing or to list additional securities on a U.S. exchange in the future. Even if such permission is obtained, it is uncertain whether it will be later denied or rescinded, which could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors in the United States and result in a material adverse change to our business operations, and damage our reputation, and therefore causing the value of our ADSs to significantly decline or lose their value.

Changes in government regulations and legislation may limit our activities and affect our business operations and the price of our ADSs, and result in risks that affect our future financing plans and securities offerings, the liquidity of our investors, and the enforcement of court judgments and shareholders’ rights.

We are a joint stock limited company incorporated in China, and our controlling shareholder is China Petroleum & Chemical Corporation (a.k.a., Sinopec Corp.), which is in turn controlled by China Petrochemical Corporation. The controlling shareholder of China Petrochemical Corporation is Sinopec Group, which is in turn controlled by the State-owned Assets Supervision and Administration Commission of the State Council of China. Our management makes decisions with respect to our business strategies and operations in accordance with applicable laws and regulations, listing rules, and industrial policies based on procedures stipulated in our articles of association and other corporate governance documents and polices. All major corporate matters relating to our business operations are (i) submitted for the approval of our board of directors, which is required to review and approve certain operational matters, to convene general meetings of shareholders and to present certain matters to the shareholders for their approval, in each case in accordance with our articles of association, (ii) approved by resolutions adopted by our board of directors and/or shareholders, as appropriate, and (iii) carried out under the supervision of our board of supervisors. Because our business strategies are formulated, and our business operations are conducted, based on and pursuant to applicable laws and regulations and industrial policies, any changes thereto that bear on our business operations will likely have an impact on our business and our results of operations.

In addition, the PRC government may continue to make and adopt changes to its existing macroeconomic and industry policies for the petroleum and petrochemical industry, including further reforming and improvement of the pricing mechanisms of refined oil products and natural gas, which could impact the development of the petroleum and petrochemical industry in China and the production and operations of the market players in such industry. Our board of directors and management, when developing and formulating our business plan and operating strategies, are required to take into consideration of those control mechanisms and industry policies, some of which may impose constraints and limitations on our business planning and strategy-making, and we cannot assure you there will not be material adverse effects on our operations and profitability. The Special Administrative Measures for Foreign Investment Access (Negative List) (2021 Version) currently in effect (the “Negative List”), while requiring enterprises incorporated in China and operating in industries that are subject to a foreign investment prohibition to obtain approval from relevant competent government authorities for their overseas securities offerings and listings, does not prohibit or impose restrictions on foreign investments in the petroleum and petrochemical industries. However, we cannot rule out the possibility that the PRC government may in the future amend and revise PRC laws and regulations in this area to advance new energy security policies.

In addition, the Measures for the Security Review of Foreign Investments (“Security Review Measures”), which were issued by the PRC government and came into effect on January 18, 2021, provide that a foreign investor must seek the approval of the competent PRC regulatory authorities prior to investing in key energy and resources sectors that have national security implications where such investment will result in such investor obtaining actual control over the invested enterprises. The Security Review Measures also provide that PRC regulatory authorities should enact implementing rules applicable to the acquisition by foreign investors of publicly-traded securities of listed companies that have or may have national security consequences, and pending the enactment of such implementing rules, there are uncertainties as to whether there are restrictions on open-market purchases of our ADSs by foreign investors under those measures. Given that Sinopec Corp., our controlling shareholder, and its concert parties currently hold approximately 50.55% of our outstanding shares, we do not expect any foreign investor will be able to obtain control over us by investing in our publicly-traded H shares or ADSs.

The PRC government imposes controls on the convertibility of the Renminbi into foreign currencies and, in certain cases, the remittance of currency out of China. We receive substantially all of our revenues in Renminbi. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, can be made in foreign currencies without prior approval of the State Administration of Foreign Exchange (“SAFE”) by complying with certain procedural requirements. Specifically, under the existing exchange restrictions, without prior approval of SAFE, cash generated from the operations of our PRC subsidiaries in China may be used to pay dividends to our company. However, approval from or registration with appropriate government authorities is required where Renminbi is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of loans denominated in

foreign currencies. As a result, we need to obtain SAFE approval to use cash generated from the operations of our PRC subsidiaries to pay off their respective debt in a currency other than Renminbi (if any) owed to entities outside China, or to make other capital expenditure payments outside China in a currency other than Renminbi.

Meanwhile, other than approvals and filing processes required under prevailing PRC laws and regulations, our ability to transfer money or other assets out of China or enter into business transactions with non-Chinese parties in the ordinary course of our business have not been substantively affected by the Security Review Measures. If the PRC government, in keeping with its national security policy, promulgates new laws and regulations in the future to regulate and restrict our ability to enter into cross-border transactions or obtain foreign investments, we may be required to make adjustments to our operating and financing plans, which may in turn affect our business operations and financial position, and have material impacts on the value of our ADSs. If, in the future, foreign investments in petroleum and/or petrochemical industries in China become prohibited or restricted, investors in our ADSs may need to seek exit for their investments in accordance with applicable laws and regulations, which may result in a significant decline in the price of our ADSs and materially and adversely affect the value of the investments made in our ADSs by foreign investors.

In addition, on February 17, 2023, the China Securities Regulatory Commission issued the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (“Trial Measures”). In an effort to reform the regulatory regime for offshore listings, the Trial Measures establish a filing-based administration system for overseas listings of domestic enterprises, enhancing support for domestic companies that wish to go public overseas. If we fail to obtain any requisite approvals or filings with respect to future offerings of our equity securities to foreign investors, or if we inadvertently conclude that such approvals or filings are not required, our ability to execute our financing and equity offering plans may be significantly limited or completely hindered. Any measures taken by the PRC authorities to regulate or exert more control over securities offerings conducted overseas and foreign investments in China-based issuers may limit or hinder our ability to offer or continue to offer securities to investors outside China, and the price of our ADSs may decline significantly, leading to a material adverse effect on the value of investments in our ADSs by investors.

In light of the dynamic nature of the Chinese economy and the continuing development of the PRC legal system, the PRC authorities may promulgate new laws and regulations regulating the petroleum and petrochemical industry, or overall investment and market activities in general. Certain legislative changes are required by law to go through review and comment procedures open to certain market participants or the general public, and to the extent that such changes are made to regulate our business operation, we may have the opportunity to participate in such review and comment procedures during the policy and rule-making process. However, we cannot assure you that the rules or policies finally adopted will not adversely affect our business operations. The new regulations and policies or the amendment of current ones may at times only afford a short period for transition or adjustment, and may influence the implementation of our established business plans and operation strategies. They may also subject us to enhanced compliance scrutiny, result in more compliance costs and expenses, or otherwise adversely affect our business by requiring adjustments to our business plans and operations. For example, the PRC government has recently adopted, and may further adopt, stricter laws and regulations with respect to environmental protection and carbon emissions, which may lead to higher operating costs and expenses, and a prolonged project development timetable. As a result of those new or amended rules and policies, we may not have control over the timing or outcome of approvals of certain of our planned projects, and may encounter significant constraints on our ability to implement our business strategies, to develop or expand our business operations or to maximize our profitability, which could in turn adversely affect our operations by raising our operating costs and lowering our profits or otherwise impeding our efforts to improve our operational efficiency and profitability, and further adversely affect the market expectations of our business operations. Depending on the extent to which our operations are so affected, there may be a material change in our operations and the value of our ADSs.

Specifically, the PRC government has recently taken various legislative initiatives in the area of data security and to address market monopoly concerns.

•

With respect to data security protection, the revised Measures for Cybersecurity Review (the “Measures”) took effect on February 15, 2022 and provide that critical information infrastructure operators, must evaluate potential risks that the deployment of any products and services will have on national security prior to the procurement of such products and services, and must apply for a cybersecurity review if such products and services affect or may affect national security. “Online platform operators” must apply for a cybersecurity review if any of their data processing activities affects or may affect national security. If an “online platform operator” that is in possession of personal data of more than one million users intends to list its securities on a foreign stock exchange, it must apply for a cybersecurity review. However, the Measures have not clarified if any follow-on offering of ADSs by us will be regulated as a “listing shares on a foreign stock exchange” or whether public companies already listed overseas would be subject to regular cybersecurity reviews. During the reporting period of this annual report, we have not received from the CAC, the Ministry of Public Security or its local counterparts, or any industrial regulatory authorities, any notices imposing administrative penalties against us or demanding any remedial actions be taken in relation to data security matters.

•

With respect to anti-monopoly laws and regulations, the PRC Anti-monopoly Law prohibits monopolistic activities by market participants such as the entering into monopoly agreements, the abuse of dominant market position and anti-competitive activities that have or may have an effect of eliminate or reduce competition. In addition, the National Development and Reform Commission (the “NDRC”), the State Administration of Market Regulation (the “SAMR”) and the Cyberspace Administration of China (the “CAC”), among others, jointly issued the Several Opinions on Promotion of the Standardized, Sound and Sustainable Development of Platform Economy (the “Platform Economy Opinions”), which embody legislative and regulatory anti-monopoly initiatives in relation to the “platform economy.” The Platform Economy Opinions focus on the following aspects of the platform economy: formulation and promulgation of regulations on the prohibition of unfair online anti-competitive activities; future issuance of detailed rules applicable to data processing activities conducted by online platform enterprises; the formulation of regulations on pricing; the investigation on monopoly and unfair competition activities; and the enforcement against monopolistic agreements, abuse of dominant market position and unlawful market concentration.

We do not believe the abovementioned rules currently have a material impact on our capacity to operate our business in the ordinary course, obtain foreign investment, or maintain our listing overseas, however that could change in the future.

Recent greater oversight by the Cyberspace Administration of China (“CAC”) over data security, particularly for companies seeking to list on a foreign exchange, could adversely impact our business.

The PRC government has recently taken various legislative initiatives in the area of data security and to address market monopoly concerns. On December 28, 2021, the CAC and other relevant PRC governmental authorities jointly promulgated the Cybersecurity Review Measures (the “CAC Revised Measures”) to replace the original Cybersecurity Review Measures. The CAC Revised Measures took effect on February 15, 2022 and provide that (i) critical information infrastructures operators, or CIIOs, must evaluate potential risks that the deployment of any products and services will have on national security prior to the procurement of such products and services, and must apply for a cybersecurity review if such products and services affect or may affect national security, and “online platform operators” must apply for a cybersecurity review if any of their data processing activities affects or may affect national security, and (ii) if an “online platform operator” that is in possession of personal data of more than one million users intends to list its securities on a foreign stock exchange, it must apply for a cybersecurity review. However, the measures have not clarified if any follow-on offering of ADSs by us will be regulated as a “listing shares on a foreign stock exchange” or whether public companies already listed overseas would be subject to regular cybersecurity reviews. In addition, the NDRC, the SAMR and the CAC, among others, jointly issued the Platform Economy Opinions, which embodies legislative and regulatory anti-monopoly initiatives in relation to the “platform economy.” The Platform Economy Opinions focus on the following aspects of the platform economy: formulation and promulgation of regulations on the prohibition of unfair online anti- competitive activities; future issuance of detailed rules applicable to data processing activities conducted by online platform enterprises; the formulation of regulations on pricing; the investigation on monopoly and unfair competition activities; and the enforcement against monopolistic agreements, abuse of dominant market position and unlawful market concentration. During the reporting period of this annual report, we have not received from the CAC, the Ministry of Public Security or its local counterparts, or any industrial regulatory authorities, any notices imposing administrative penalties against us or demanding any remedial actions be taken in relation to data security matters. We do not believe the abovementioned rules currently have a material impact on our capacity to operate our business in the ordinary course, obtain foreign investment, or maintain our listing overseas, they could in the future. To the extent any current regulation or policy promulgated by the CAC applies to us, we believe we are in full compliance. Up to now, we have not received any notices from the CAC, the Ministry of Public Security or its local counterparts that the company is a critical information infrastructures operator. Based on the advice of counsel provided by Beijing Haiwen Law Firm upon which we have relied, we do not believe that we are subject to the review of, nor require the approval of, the CAC at this time. We can provide no assurance, however, that the CAC will not take a different position, or other regulations and policies that may be issued in the future and their implementation may further require the company to comply with stricter compliance conditions, adjust the company’s business operation mode and business plan, or have a significant impact on our ability to accept foreign investment or maintain its listing in the United States or other overseas markets.

Interpretation and enforcement of Chinese laws and regulations is uncertain and may change quickly, which could result in a material and negative impact our business operation, decrease the value of our ordinary shares and limit the legal protections available to us.

The Chinese legal system is based on statutory law. Under this system, prior court decisions may be cited as persuasive authority, but do not have the binding effect of precedents. Since 1979, the Chinese government has been developing a comprehensive system of commercial laws and considerable progress has been made in the promulgation of laws and regulations dealing with economic matters, such as corporate organization and governance, foreign investment, commerce, taxation and trade. Because these laws, regulations and legal requirements are relatively new and prior court decisions have little precedential value, the interpretation and enforcement of these laws, regulations and legal requirements may change quickly and involve greater uncertainty than in other jurisdictions.

From time to time, we may have to resort to administrative and court proceedings to enforce our legal rights. Since PRC administrative and court authorities have discretion in interpreting and implementing statutory and contractual terms, it may be difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy. Such uncertainties, including uncertainty over the scope and effect of our contractual, property (including intellectual property) and procedural rights, could materially and adversely affect our business and impede our ability to continue our operations.

Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business and results of operations.

Substantially all of our operations are conducted in China. Accordingly, our business, prospects, financial condition and results of operations may be influenced to a significant degree by political, economic and social conditions in China generally and by continued economic growth in China as a whole.

The Chinese economy differs from the economies of most developed countries in many respects, including the amount of government involvement, level of development, growth rate, control of foreign exchange and allocation of resources. See “Governmental control of currency conversion may limit our ability to utilize our revenues effectively and affect the value of your investment” for information about the PRC foreign exchange regulations. Although the Chinese government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets and the establishment of improved corporate governance in business enterprises, a substantial portion of productive assets in China are still owned by the government. In addition, the Chinese government continues to play a significant role in regulating industry development by imposing industrial policies. The Chinese government also exercises significant influence over China’s economic growth through allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy, and providing preferential treatment to particular industries or companies.

While the Chinese economy has experienced significant growth over the past decades, growth has been uneven, both geographically and among various sectors of the economy. The Chinese government has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures may benefit the overall Chinese economy, but may have a negative effect on us. Our financial condition and results of operations may be adversely affected by government control over capital investments or changes in tax regulations that are applicable to us. In addition, the Chinese government has implemented in the past certain measures, including interest rate increases, to control the pace of economic growth. These measures may cause decreased economic activity in China and the rate of China’s economic growth has slowed down. Any continued slowdown in the Chinese economy may reduce the demand for our products and services and materially and adversely affect our business and results of operations.

Governmental control of currency conversion may limit our ability to utilize our revenues effectively and affect the value of your investment.

Since 2016, the PRC government has imposed more restrictive foreign exchange policies and stepped up scrutiny of major outbound capital movement including overseas direct investment. More restrictions and substantial vetting processes are put in place by SAFE to regulate cross-border transactions falling under the capital account. If any of our shareholders regulated by such policies fail to satisfy the applicable overseas direct investment filing or approval requirement timely or at all, it may be subject to penalties from the relevant PRC authorities. The PRC government may at its discretion further restrict access in the future to foreign currencies for current account transactions. If the foreign exchange control system prevents us from obtaining sufficient foreign currencies to satisfy our foreign currency demands, we may not be able to pay dividends in foreign currencies to our shareholders, including holders of our ADSs.

Certain judgments obtained against our directors and/or officers by our shareholders may not be enforceable.

We are a joint stock limited company incorporated under the laws of China. The majority of our directors and other members of management reside within China or Hong Kong. As a result, your ability to bring an action against us or against these individuals in the U.S. in the event that you believe your rights have been infringed under the U.S. federal securities laws or otherwise, or the procedures in relation thereto, may be subject to uncertainties. Even if you are successful in bringing an action of this kind, it may be diffcult for you to enforce judgments against us or these individuals in U.S. courts.

In addition, there is uncertainty as to whether the courts of the PRC would recognize or enforce judgments of U.S. courts. Courts in China may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based on treaties between China and the country where the judgment is made or on reciprocity between jurisdictions. China does not have any treaties or other arrangements that provide for the reciprocal recognition and enforcement of foreign judgments with the United States. In addition, according to the PRC Civil Procedures Law, courts in the PRC will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates basic principles of PRC law or national sovereignty, security, or the public interest. These policies may make it even more difficult to enforce any judgments obtained from foreign courts against such persons compared to other jurisdictions.

Business and Operational Risk Factors

The coronavirus pandemic has and could continue to materially and adversely affect our business.

In 2022, the global pandemic of COVID-19 continues to spread. With the spread and dominance of the highly contagious Omicron strains, the Company has been affected by multiple rounds of clustered and large-scale infections, which have had an impact on the procurement of raw and auxiliary materials, production and operation, as well as demand for our end products. Our work arrangements, business operations, financial conditions, and business performance have all been negatively affected to varying degrees, and there have been infection cases among our employees. There remains uncertainty as to the future impact of the virus. The extent to which the COVID-19 pandemic impacts our long-term results will depend on future developments which are highly uncertain, unpredictable and beyond our control, including the appearance of new variants, the effectiveness of efforts to contain or treat cases, and future actions that may be taken in response to these developments. Consequently, the COVID-19 pandemic may continue to materially and adversely affect our business, financial condition and results of operations in the current and future years. We are closely monitoring the impacts of COVID-19 pandemic on us.

Our operations may be adversely affected by the cyclical nature of the petroleum and petrochemical markets and by the volatility of prices of crude oil and petrochemical products.

Most of our revenues are attributable to the sale of refined oil and petrochemical products, which have historically been cyclical and sensitive to the availability and price of raw materials and general economic conditions. Markets for many of our products are sensitive to changes in industry capacity and output levels, changes in regional and global economic conditions, the price and availability of substitute products and changes in consumer demand, which from time to time have had a significant impact on our product prices in the regional and global markets. Due to the recent extreme volatility in crude oil prices, the decrease in tariff charges, the removal of other restrictions on importation and the Chinese government’s gradual relaxation of its control of the allocation of products and pricing, many of our products have become increasingly vulnerable to the cyclical nature of regional and global petroleum and petrochemical markets, which may adversely affect our operations.

We consume large amounts of crude oil to manufacture our products of which more than 95% is typically imported. In 2022, crude oil costs accounted for RMB 47.14 billion, or 61.81% of our consolidated annual cost of sales (73.34% of parent company annual cost of sales). As a result, changes in crude oil prices can affect our profitability. In recent years, due to various reasons, the price of crude oil has fluctuated significantly. The volatility of crude oil prices, as well as in the price of other energy products, has increased significantly as a result of the pending conflict between Russia and Ukraine. Russia is a major supplier of crude oil and natural gas to global markets. The sanctions imposed on Russia by numerous countries may result in a material reduction in oil and gas exports from Russia, which could increase price volatility for such products. We expect that the volatility and uncertainty of the prices of crude oil and petrochemical products will continue, and that increasing crude oil prices and declines in prices of petrochemical products may adversely affect our business and results of operations and financial condition.

Some of our major products are subject to government price controls, and we are not able to pass on all cost increases from rising crude oil prices through higher product prices.

We consume large amounts of crude oil to manufacture our products of which more than 95% is typically imported. We attempt to mitigate the effect of increased costs due to rising crude oil prices. However, our ability to pass on these increased costs to our customers is dependent on market conditions and government regulations. Given that the increase of the sales prices of our products may lag behind the increase of crude oil costs, we may fail to completely cover the increased costs by increasing our sales prices, particularly where government regulations restrict the prices of certain of our fuel products. In particular, gasoline, diesel and jet fuel, and liquefied petroleum gas are subject to government price controls at present. In 2020, 2021 and 2022 approximately 43.64%, 47.01%, and 51.40% respectively, of our net sales were from such products subject to price controls. Although the current price-setting mechanism for refined petroleum products in China allows the Chinese government to adjust price in the PRC market when the average international crude oil price fluctuates beyond certain levels within a certain time period (see Item 4. Information on the Company – B. Business Overview – Product Pricing), the Chinese government still retains discretion as to whether or when to adjust the prices of the refined oil products. The Chinese government generally exercises certain price control over refined oil products once international crude oil prices experience a sustained rise or become significantly volatile. For instance, some of our fuel products are required to be sold to designated distributors (such as the subsidiaries of Sinopec Corp.). Because we cannot freely sell our fuel products to take advantage of possible opportunities for higher prices, we may not be able to fully cover increases in crude oil prices by increasing the sale prices of our products, which has had and will possibly continue to have a material adverse effect on our financial condition, results of operations and cash flows.

Our development and operation plans have significant capital expenditure and financing requirements, which are subject to a number of risks and uncertainties.

The petrochemical business is a capital intensive business. Our ability to maintain and increase our revenues, net profit and cash flows depends upon continued capital spending. Our current business strategy contemplates capital expenditure for 2023 of approximately RMB 3,700.00 million (U.S. $531.26 million), which will be provided through financing activities and use of our own capital. Our actual capital expenditures may vary significantly from these planned amounts, subject to our ability to generate sufficient cash flows from operations, investments and other factors that may be beyond our control. In addition, there can be no assurance as to whether, or at what cost, our capital projects will be completed or the success of these projects if completed.

As of March 31, 2023, we had an aggregate outstanding indebtedness of approximately RMB 5,048.00 million (U.S.$ 836.47 million). Most of our borrowings are with state-controlled banks in China and structured as short term debt obligations with payment due in one year or less. These banks have generally been willing to provide new short term loans while we pay off existing loans. Sinopec Finance Company Limited (“Sinopec Finance”), provided a loan of RMB 700.00 million (US $ 100.51 million) for our debt for the year ended December 31, 2022 and for the three months ended March 31, 2023.

Our ability to obtain external financing in the future and our ability to make timely repayments of our debt obligations are subject to a variety of uncertainties, including: our future results of operations, financial condition and cash flows; the condition of the economy in China and the condition of markets for our products; the cost of financing and the condition of financial markets; the issuance of relevant government approvals and other project risks associated with the development of infrastructure in China; and the continuing willingness of banks to provide new loans as we pay down existing debt.

While we anticipate that we will rely less on borrowings to finance capital expenditures and operations, our business, results of operations and financial condition could be adversely affected if we fail to obtain sufficient funding for our operations or development plans.

Our operations are exposed to risks relating to operating hazards and production safety and we have limited insurance coverage for resulting losses.

Our operations involve the handling and storage of explosives and other hazardous articles. In addition, our operations involve the use of heavy machinery, which involves inherent risks that cannot be entirely eliminated through our preventive efforts. As a result, we may encounter fires, explosions and other unexpected incidents during our operations, which may cause personal injuries or death, property damage, environmental damage, interruption of operations and reputational damages to us. Each of such incidents could have a material adverse impact on our financial condition and results of operations.

We maintain a package of insurance coverage plan through Sinopec Group on our property, facilities and inventory. In addition, we maintain insurance policies for such assets as vehicles and products in transit with third-party commercial insurance companies. Sinopec Group carries out unified insurance for safety production liability insurance and environmental liability insurance. We also insured a safety production liability insurance for one year in August 2022. The annual cumulative compensation caps is RMB 135 million and the compensation caps for each accident is RMB 67.5 million.

We are controlled by Sinopec Corp., whose interests may not be aligned with yours.

As of March 31, 2023, Sinopec Corp. owned 50.55% of our shares. Accordingly, it has voting and management control over us, and its interests may be different from the interests of our other shareholders. Subject to our Articles of Association and applicable laws and regulations, Sinopec Corp. will be in a position to cause us to declare dividends, determine the outcome of corporate actions requiring shareholder approval or effect corporate transactions without the approval of the holders of the H Shares and ADSs. Any such increase in our dividend payout would reduce funds available for reinvestment in our business and any such actions or transactions could adversely affect us or our minority shareholders. Sinopec Corp. may also experience changes in its own business strategy and policies. Although we are not currently aware of any specific changes, they could, in turn, lead Sinopec Corp. to change its policies or practices toward us in ways that we cannot predict, with corresponding unpredictable consequences for our business. Additionally, Sinopec Corp. may leverage its controlling shareholder position to influence our decisions with regard to the manufacturing and operation, allocation of financial resources and appointment and removal of senior management members, which could adversely affect us or our minority shareholders.

We have also engaged from time to time and will continue to engage in a variety of transactions with Sinopec Corp., Sinopec Group, the controlling company of Sinopec Corp., and their various subsidiaries or affiliates which provide a number of services to us, including the supply of raw materials, product distribution and sales agency, project design and installment service, petrochemical industry related insurance and financial services. We also sell oil and petrochemical products to Sinopec Corp. and its affiliates. Our transactions with these companies are governed by a Mutual Product Supply and Sales Services Framework Agreement with Sinopec Corp. and a Comprehensive Services Framework Agreement with Sinopec Group, the terms of which were negotiated on an arm’s-length basis. See Item 7. Major Shareholders and Related Party Transactions – B. Related Party Transactions. Our business and results of operations could be adversely affected if either Sinopec Corp. or Sinopec Group refuses to engage in such transactions or if one of them seeks to amend the contracts with us in a way adverse to us. In addition, Sinopec Corp. has interests in businesses that compete or are likely to compete, either directly or indirectly, with our businesses. Because Sinopec Corp. is our controlling shareholder and its interests may conflict with our own interests, Sinopec Corp. may take actions that favor itself over our interests.

We could face increasing competition in China.

Our principal market, Eastern China, which is comprised of Shanghai, Shandong, Jiangsu, Anhui, Zhejiang, Jiangxi and Fujian, has enjoyed stronger economic growth and a higher demand for petrochemical products than other regions of China. As a result, we believe that our competitors will try to expand their sales and build up their distribution networks in our principal market. We believe this will have an adverse impact on the production and sale of our major products. Moreover, Chinese private enterprises have gradually overcome technological and funding barriers to extend their business from the downstream processing sector to the upstream petrochemical field. These enterprises have advantages in many areas such as flexibility in operation costs, preferential policy treatments and regional presence, and may use these advantages to compete with us in our target market.

We face increasing foreign competition in our lines of business.

China joined the WTO on December 11, 2001 and committed to eliminate some tariff and non-tariff barriers to foreign competition in the domestic petrochemical industry that benefited us in the past. In particular, China:

•

has reduced tariffs on imported petrochemicals products that compete with ours;

•

increased levels of permitted foreign investment in the domestic petrochemicals industry, allowing foreign investors to own 100% of a domestic petrochemicals company from December 11, 2004;

•

has gradually relaxed restrictions on the import of crude oil by non-state-owned companies;

•

has granted foreign-owned companies the right to import petrochemical products; and

•

has permitted foreign-owned companies to distribute and market fuel products in both retail and wholesale markets in China.

As a result of these measures, we face increasing competition from foreign companies and imports. In addition, competition for our products has increased, as many overseas companies have switched their focus to sales in China. Furthermore, tariff reductions could reduce our profit margins or otherwise negatively impact our revenue from certain products, including a small number of significant products. The Chinese government may also reduce the tariffs imposed on production equipment that we may import in the future.

Cyber attacks and security breaches may threaten the integrity of our intellectual property and other sensitive information and disrupt our business operations, which could adversely affect our reputation, business and financial position.

We face numerous and evolving global cybersecurity threats, which may range from uncoordinated individual attempts to sophisticated and targeted measures directed at us. Cyber attacks and security breaches may include, but are not limited to, attempts to disrupt our operations including our information technology systems and data, gain access to confidential information, insertion of computer viruses, denial of service and other electronic security breaches, whether internal or external through third parties with whom we conduct business. In recent years, a number of major oil and petrochemical companies have been the subject of cyber attacks.

Although we have not experienced any material cybersecurity incidents in the past, we cannot assure you that we will not experience them in the future. Due to the evolving nature of cybersecurity threats, the scope and impact of any future incident cannot be predicted. While we continually work to safeguard our systems and mitigate potential risks, there is no assurance that such actions will be sufficient to prevent cyber attacks or security breaches that manipulate or improperly use our systems or networks, compromise confidential or otherwise protected information, destroy or corrupt data, or otherwise disrupt our operations. The occurrence of such events could disrupt our operations, cause physical harm to people or the environment, damage or destroy assets, compromise business systems, result in proprietary information, including information of our employees, customers, partners and other third parties, being altered, lost, stolen or compromised or otherwise disrupt our business operations. We could incur significant costs to remedy the effects of such a cybersecurity disruption as well as in connection with any resulting regulatory actions and litigation. In addition, a material cybersecurity incident could negatively impact our reputation and our competitive position, which could have an adverse effect on our financial condition and results of operations.

Risks associated with climate change.

In recent years, the petrochemical industry is facing more and more severe challenges as a result of concerns about global climate change. A series of international, domestic and regional agreements to limit greenhouse gas emissions have been signed and come into force. The Paris climate change agreement adopted in December 2015 included binding commitments by countries that have ratified the agreement since November 2016, which may lead to stricter national and regional measures in the near future. Compliance with these measures may lead to higher capital expenditures, tax expenditures, operating costs and other increased costs, resulting in reduced profits and income. Strategic investment may also be adversely affected.

Legal, Regulatory or Political Risk Factors

Our business operations may be adversely affected by present or future environmental regulations.

We are subject to extensive environmental protection laws and regulations in China. These laws and regulations permit:

•

the imposition of environmental protection tax for the discharge of waste substances;

•

the levy of payments and fines for damages for serious environmental offenses;

•

the government to close down or suspend any facility which has caused or may cause environmental damages and require it to correct or stop operations causing environmental damages; and

•

lawsuits and liabilities arising from pollutions and damages to the environment and public interests.

Our production operations produce substantial amounts of waste materials (i.e., waste water, waste gas and waste residue). In addition, our production and operations require environmental-related permits that are subject to renewal, modification and revocation. We were subject to various administrative penalties for violations of the relevant PRC environmental laws and regulations in the past years. See Item 4. Information of the Company – B. Business Overview – Environmental Protection. We have established a system to treat waste materials to prevent and reduce pollution. The Chinese government (including the local governments), however, has moved, and may move further, toward the adoption of more regulations and more stringent environmental standards. On May 31, 2021, the Ministry of ecology and environment issued the guidance on strengthening the prevention and control of the source of ecological environment of high energy consumption and high emission construction projects, strictly approving the environmental impact assessment of “two high” projects such as petrochemical and modern coal chemical industry, and resolutely curbing the blind development of “two high” projects. Chinese national or local authorities may also apply more rigorous enforcement of such regulations which would require us to incur additional expenditures on environmental matters. More stringent environmental requirements or a more rigorous enforcement program could impose significant additional costs on us, and may require us to undertake capital investments to conform with the new requirements. We cannot quantify such additional costs at this time.

If the Chinese government changes current regulations that allow us to make payments in foreign currencies, we may be unable to obtain the foreign currency necessary for our business.

The Renminbi currently is not a freely convertible currency. We receive most of our revenue in Renminbi. A portion of our Renminbi revenue must be converted into other currencies to meet our foreign currency needs, which include, among other things:

•

debt service costs on foreign currency-denominated debt;

•

purchases of imported equipment;

•

payment of any cash dividends declared in respect of the H Shares and the ADSs; and

•

import of crude oil and other materials.

Under existing foreign exchange regulations in China, we may undertake current account foreign exchange transactions, including the payment of dividends, without prior approval from the State Administration of Foreign Exchange (“SAFE”) by producing commercial documents evidencing the foreign exchange transactions, provided that they are processed through Chinese banks licensed to engage in foreign exchange transactions. Foreign exchange transactions under the capital account (international revenues and expenditures that increase or decrease debt or equity, including principal payments in respect of foreign currency-denominated obligations) continue to be subject to limitations and require the prior approval of SAFE. These limitations could affect our ability to obtain foreign exchange through debt financing, or to make capital expenditures in foreign currency. The Chinese government has stated publicly that it intends to eventually make the Renminbi freely convertible in the future. However, we cannot predict whether the PRC government will continue its existing foreign exchange policy and when the PRC government will allow free conversion of Renminbi.

If the Chinese government restricts our ability to make payments in foreign currency, we may be unable to obtain the foreign currency necessary for our business. In that case, our business may be materially adversely affected, and we may default on our obligations.

Changes in the monetary policy and fluctuations in the value of Renminbi may have an adverse impact on Sinopec Group’s business and operating results

The exchange rate of the Renminbi against the US Dollar and other foreign currencies may fluctuate and is subject to alterations due to changes on the Chinese political and economic situations. In July 2005, the PRC government overhauled its policy of pegging the value of the Renminbi to the US dollar by permitting the Renminbi to fluctuate within a certain band against a basket of foreign currencies. Since the adoption of this new policy, the value of the Renminbi against the US dollar fluctuates daily. In addition, the PRC government has been under international pressure to further ease its exchange rate policy, and may as a result further change its currency policy. Early in 2020, the Renminbi had weakened against the US dollar to levels not seen since 2008, but steadily rebounded at the end of the year.

A small portion of our cash and cash equivalents is denominated in foreign currencies (mainly the U.S. Dollar). As of December 31, 2022, our bank deposits denominated in foreign currencies were equivalent to RMB 195.59 million. Any increase in the value of Renminbi against other currencies, including the U.S. dollar, may decrease the Renminbi value of our cash and cash equivalents that are denominated in foreign currencies.

Although most of our revenue is denominated in Renminbi, most of our procurement of crude oil, certain equipment and certain debt repayments are denominated in foreign currencies. Any depreciation of the Renminbi in the future would increase our costs and adversely affect profitability. In addition, any depreciation of the Renminbi could adversely affect the value of the dividends of our H Shares and ADSs, which we declare in Renminbi and pay in foreign currencies.

Our business may be limited or adversely affected by government regulations.

The Chinese central and local governments continue to exercise a certain degree of control over the petrochemical industry in China by, among other things:

•

mandating distribution channels for our fuel products;

•

setting the allocations and pricing of certain resources, products and services;

•

assessing taxes and fees payable;

•

setting import and export quotas and procedures; and

•

setting safety, environmental and quality standards.

As a result, we may face significant constraints on our flexibility and ability to expand our business operations or to maximize our profitability. In the past, we have benefited from favorable regulatory policies. Existing policies that favor our industry may change in the future and our business could be adversely affected by any such changes.

Our development plans may require regulatory approval.

We are currently engaged in a number of construction and expansion projects. Most of our projects are subject to governmental review and approval. The timing and cost of completion of these projects will depend on numerous factors, including approvals from relevant government authorities and general economic conditions in China.

While in general we attempt to obtain governmental approval as far in advance as practicable, we are unable to predict the timing and outcome of these governmental reviews and approvals. If any of our important projects required for our future growth are not approved, or not approved on a timely basis, our results of operations and financial condition could be adversely affected.

Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on our business and results of operations.

The Chinese economy differs from the economies of most developed countries in many respects, including the amount of government involvement, level of development, growth rate, control of foreign exchange and allocation of resources. Although the Chinese government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets and the establishment of improved corporate governance in business enterprises, a substantial portion of productive assets in China is still owned by the government. In addition, the Chinese government continues to play a significant role in regulating industry development by imposing industrial policies. The Chinese government also exercises significant control over China’s economic growth through allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy, and providing preferential treatment to particular industries or companies.

While the Chinese economy has experienced significant growth over the past decades, growth has been uneven, both geographically and among various sectors of the economy. The Chinese government has implemented various measures to encourage economic growth and guide the allocation of resources. Some of these measures may benefit the overall Chinese economy, but may have a negative effect on us. Our financial condition and results of operations may be adversely affected by government control over capital investments or changes in tax regulations that are applicable to us. In addition, the Chinese government has implemented in the past certain measures, including interest rate increases, to control the pace of economic growth. These measures may cause decreased economic activity in China, and since 2012, the rate of China’s economic growth has slowed down. Any prolonged slowdown in the Chinese economy may reduce the demand for our products and services and materially and adversely affect our business and results of operations.

Interpretation and enforcement of Chinese laws and regulations is uncertain.

The Chinese legal system is based on statutory law. Under this system, prior court decisions may be cited as persuasive authority, but do not have the binding effect of precedents. Since 1979, the Chinese government has been developing a comprehensive system of commercial laws and considerable progress has been made in the promulgation of laws and regulations dealing with economic matters, such as corporate organization and governance, foreign investment, commerce, taxation and trade. Because these laws, regulations and legal requirements are relatively new or otherwise undeveloped and not all accessible to the public and because prior court decisions have little precedential value, the interpretation and enforcement of these laws, regulations and legal requirements involve greater uncertainty than in other jurisdictions.

You may not enjoy shareholders’ protections that you would be entitled to in other jurisdictions.

As most of our business is conducted in China, our operations are governed principally by the laws of China. Despite the continuing improvement of the PRC Company Law and Securities Law, Chinese legal provisions for the protection of shareholders’ rights and access to information are different from those applicable to companies formed in the United States, Hong Kong, the United Kingdom and other developed countries or regions. You may not enjoy shareholders’ protections under Chinese law that you would be entitled to in other jurisdictions. We are a foreign private issuer, and therefore exempt from certain rules under the Exchange Act that are applicable to U.S. domestic public companies, such as rules relating to the having a majority of independent directors; independent audit committee members, compensation committee members and nominating committee members; obtaining shareholder approval for certain issuances of securities; or certain reporting requirements and certifications. Because of these exemptions, shareholders may be afforded fewer protections than they otherwise would under corporate governance requirements applicable to U.S. domestic issuers, or shareholders may not be afforded the same information generally available to shareholders holding shares in public companies organized in the United States that are not foreign private issuers.

Our Articles of Association require you to submit your disputes with us and other persons defined by our Articles of Association regarding the Company’s affairs to arbitration. You will have no legal right to a court proceeding with respect to such disputes.

Our Articles of Association require holders of our H Shares or ADSs having a claim against, or a dispute with, us, our directors, supervisors, executive officers or a holder of our A Shares relating to any rights or obligations conferred or imposed by our Articles of Association, the PRC Company Law or other relevant Chinese laws or regulations relating to our affairs, to submit such claim or dispute to arbitration with the China International Economic and Trade Arbitration Commission or to the Hong Kong International Arbitration Center. Our Articles of Association further provide that any arbitration decisions with respect to such disputes or claims shall be final and binding on all parties. As a result, you will have no legal right to a court proceeding with respect to such disputes.

If remedial measures are imposed on the “big four” PRC-based accounting firms, including our predecessor independent registered public accounting firm and successor independent registered public accounting firm, we might not be able to timely file future financial statements in compliance with the requirements of the Exchange Act.

Starting in 2011, the Chinese affiliates of the “big four” accounting firms, including our predecessor independent registered public accounting firm and successor independent registered public accounting firm, were affected by a conflict between the United States and Chinese law. Specifically, for certain United States listed companies operating and audited in China, the SEC and the PCAOB sought to obtain from the Chinese accounting firms access to their audit work papers and related documents. The firms were, however, advised and directed that under Chinese law they could not respond directly to the United States regulators on those requests, and that requests by foreign regulators for access to such papers in China had to be channeled through the CSRC.

In late 2012, this impasse led the SEC to commence administrative proceedings under Rule 102(e) of its Rules of Practice and also under the Sarbanes-Oxley Act of 2002 against the PRC-based accounting firms, including predecessor independent registered public accounting firm and successor independent registered public accounting firm. In January 2014, an administrative law judge reached an initial decision to impose penalties on the firms including a temporary suspension of their right to practice before the SEC. The accounting firms filed a petition for review of the initial decision. On February 6, 2015, before a review by the Commissioners of the SEC had taken place, the firms reached a settlement with the SEC. Under the settlement, the SEC accepts that future requests by the SEC for the production of documents will normally be made to the CSRC. The firms will receive matching requests, and are required to abide by a detailed set of procedures with respect to such requests, which in substance require them to facilitate production via the CSRC. If they fail to meet specified criteria, the SEC retains authority to impose a variety of additional remedial measures on the firms depending on the nature of the failure. Remedies for any future noncompliance could include, as appropriate, an automatic six-month bar on a single firm’s performance of certain audit work, commencement of a new proceeding against a firm, or in extreme cases the resumption of the current proceeding against all four firms. Under the terms of the settlement, the underlying proceeding against the four PRC-based accounting firms was deemed dismissed with prejudice four years after entry of the settlement. The four-year mark occurred on February 6, 2019.

In the event that the SEC brings new administrative proceedings, listed companies in the United States with major PRC operations may find it difficult or impossible to retain auditors in respect of their operations in the PRC, which could result in financial statements being determined to not be in compliance with the requirements of the Exchange Act. Moreover, any negative news about any such future proceedings against these audit firms may cause investor uncertainty regarding PRC-based, United States listed companies and the market price of the ADSs may be adversely affected.

We may be or become a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. investors.

Generally, if, for any taxable year, at least 75% of our gross income is passive income, or at least 50% of the value of our assets is attributable to assets that produce passive income or are held for the production of passive income, we would be characterized as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes. Since PFIC status depends on the composition of our income and the composition and value of our assets from time to time, there can be no assurance that we are not currently a PFIC or that we will not be considered a PFIC for the current year, or for any future taxable year. If we are characterized as a PFIC, U.S. investors may suffer adverse tax consequences, including increased U.S. tax liabilities and reporting requirements. For further discussion of the adverse U.S. federal income tax consequences of our possible classification as a PFIC, see Item 10. Additional Information – E. Taxation – U.S. Taxation.

We could be sanctioned or otherwise penalized under relevant U.S. laws if we engage in business with certain entities in Iran or Russia and such transactions are determined by the U.S. governmental authorities to violate U.S. laws.

We have in the past sourced a small portion of crude oil from Iran. The United States has adopted a number of measures since 1996 that provide for the possible imposition of sanctions against non-U.S. companies engaged in certain activities in and with Iran in the energy and other sectors, including, the Iran Threat Reduction and Syria Human Rights Act of 2012 (“ITRSHRA”) enacted August 10, 2012 and the Iran Freedom and Counter-Proliferation Act (“IFCA”) enacted January 2, 2013, Section 1245 of the National Defense Authorization Act of 2012 (“NDAA”) enacted December 31, 2011, and Executive Order 13846 of August 6, 2018 that was issued in connection with the termination of the participation by the United States in the Joint Comprehensive Plan of Action, or JCPOA, that became effective January 16, 2016, and resulted in the waiver of certain U.S. sanctions against non-U.S. persons engaging in certain transactions with Iran. The withdrawal was effected in two stages that resulted on November 5, 2018, in the complete re-imposition of the U.S. sanctions that were waived under the JCPOA. On November 5, 2018, the United States also granted a 180-day waiver (that is potentially renewable) under Section 1245 of the NDAA to China (and seven other countries) allowing for the purchase of petroleum from Iran under specified conditions. The NDAA waiver does not authorize transactions that remain prohibited under other U.S. sanctions laws. On April 22, 2019, the U.S. Secretary of State announced that the United States would not grant any further waivers under the NDAA. In February 2021, U.S. President announced that the U.S. would not lift economic sanctions on Iran until Iran complies with the terms of the JCPOA.

The sanctionable activities include certain investments, the provision of goods, services, technology, or support that could contribute to the development of petroleum and petrochemical resources or the production of refined petroleum products in Iran, the exportation of refined petroleum products to Iran, the transportation of crude oil from Iran, or the engagement in a significant transaction for the purchase or acquisition of petroleum or petroleum products from Iran, and the engagement in transactions with certain Iranian specially designated nationals and blocked persons (“SDNs”) as identified and published by U.S. Department of the Treasury’s Office of Foreign Assets Control, or OFAC, the agency primarily responsible for administering U.S. sanctions and embargoes.

We have sourced a small portion of our crude oil from Iran in the past through Sinopec Corp., our current controlling shareholder, and independent third parties, and Iran may continue to be the ultimate source of a small portion of our crude oil. In addition, Sinopec Corp. and Sinopec Group, the controlling shareholder of Sinopec Corp., have engaged in operations in or purchasing crude oil sourced from Iran and may continue to do so in the future. We have no control over the activities of Sinopec Group or Sinopec Corp. in connection with any activities that they may conduct in Iran.

If our purchases of crude oil from Iran and transactions related thereto are determined to be sanctionable activities by the U.S. President and/or the relevant U.S. governmental authorities, we may be subject to five or more of the twelve sanctions options available under the Iran Sanctions Act of 1996 (as amended) (“ISA”) and the ITRSHRA, which include restrictions on bank financing, outright blocking of the Company’s property within any U.S. jurisdiction, under the control of U.S. persons anywhere in the world, and prohibition of U.S. persons from investing or purchasing a significant amount of equity or debt instruments of the Company. Similar sanctions may also be imposed under Executive Order 13846, the IFCA, and other U.S. laws. In addition, many states in the United States have adopted legislation requiring state pension funds to divest themselves of securities in any company with active business operations in Iran. We cannot assure that we or any of our affiliates will not be sanctioned by the U.S. President and/or the relevant U.S. governmental authorities in light of the activities by us or our affiliates in Iran. The imposition of any such sanctions on us or our affiliates will have a negative impact on our business, reputation or stock price. In addition, purchase of crude oil by Sinopec Corp. subsidiaries that supply us with raw materials may from time to time be sourced from National Iranian Oil Company. This entity has been identified by the U.S. government as an SDN and sanctioned under various laws, including for assisting the government of Iran to avoid sanction and for engaging in activities related to nuclear proliferation. Under Executive Order 13846, the U.S. President can sanction non-U.S. companies that engage in transactions with SDNs such as the National Iranian Oil Company. To the extent we indirectly (or directly) purchase raw materials from this entity, we risk potential U.S. government sanctions. Even absent any U.S. government sanctions, we risk adverse publicity in the world markets, which may impair our reputation and business.

In addition, the conflict between Russia and Ukraine has resulted in the imposition of new sanctions on the Russian energy sector and greater scrutiny of pre-existing sanctions. The continuation of the conflict may result in the imposition of additional or more severe sanctions, and may also generate a higher level of sanctions enforcement activity. The International Emergency Economic Powers Act currently prohibits dealings with designated Russian persons and entities if the transaction involves a nexus to the U.S., such as payment in U.S. dollars. Under U.S. law, penalties could be imposed upon us even if we purchase crude oil or natural gas through a third party, and we are not aware that the purchase was made from an entity subject to U.S. sanctions. The sanctions regime relating to the Russian energy sector is continuing to evolve, and no assurance can be given that the United States or other jurisdictions will not seek to impose penalties upon us if they believed that we had engaged in sanctionable activities. If we were to become involved in sanctions proceedings, our business reputation could be harmed and we could incur substantial costs in order to defend the proceedings or pay any resulting penalties.

Sinopec Group, the controlling shareholder of Sinopec Corp. which is our current controlling shareholder, or its affiliates’ current or future activities in certain countries are the subject of economic sanctions under relevant U.S. laws and could result in negative media and investor attention to us and possible imposition of sanctions on Sinopec Group, which could materially and adversely affect our shareholders.

Sinopec Group undertakes, from time to time and without our involvement, overseas investments and operations in the oil and gas industry, including the exploration and production of oil and gas, refining and Liquefied Natural Gas, or LNG, projects. Sinopec Group’s overseas asset portfolio includes oil and gas development projects in Iran, Sudan and Syria, countries subject to U.S. sanctions and embargoes. We cannot predict the interpretation or implementation of government policy at the U.S. federal, state or local levels with respect to any current or future activities by Sinopec Group or its affiliates in countries or with individuals or entities that are the subject of U.S. sanctions. Similarly, we cannot predict whether U.S. sanctions will be further tightened, or the impact that such actions may have on Sinopec Group. It is possible that the United States could subject Sinopec Group to sanctions due to these activities. Certain U.S. state and local governments and colleges have restrictions on the investment of public funds or endowment funds, respectively, in companies that are members of corporate groups with activities in certain countries that are the subject of U.S. sanctions. These investors may not wish to invest, and may divest their investment, in us because of our relationship with Sinopec Group and its investments and activities in those U.S. government sanctioned countries. It is possible that, as a result of activities by Sinopec Group or its affiliates in countries that are the subject of U.S. sanctions, we may be subject to negative media or investor attention, which may distract management, consume internal resources and affect investors’ perception of our company.

Further, the ISA authorizes the imposition of sanctions on companies that engage in certain activities in and with Iran, especially in Iran’s energy sector. It is possible that Sinopec Group or its affiliates engage in activities that are targeted for sanction purposes by the ISA or other U.S. laws. If the U.S. President determines that Sinopec Group or one of its affiliates in fact engaged in the targeted activities, he would be required under the ISA to impose on Sinopec Group or its affiliates at least five sanctions from among twelve sanctions options available under the ISA, which range from restrictions on U.S. exports or bank financing to outright blocking of Sinopec Group or its affiliate’s property within the United States or in the possession or control of U.S. persons anywhere in the world. In addition, the IFCA requires the U.S. President to block the property of persons and entities within U.S. jurisdiction or control of U.S. persons if he determines that, among other things, such persons or entities are engaged in certain transactions involving the energy, shipping or shipbuilding sectors of Iran or with certain SDNs. It also requires the U.S. President to impose five or more sanctions under the ISA on a person that he determines has knowingly, on or after July 1, 2013, sold, supplied or transferred to or from Iran precious metals or certain other materials (including graphite, aluminum, steel, coal and certain software) if used for specified purposes. If the U.S. President determines that Sinopec Group, or an entity it owns or controls engages in any such activities and if the most extreme sanction under the ISA or other U.S. sanctions laws, blocking, were applied to Sinopec Group’s property, including controlled subsidiaries, Sinopec Group could be prohibited from engaging in business activities in the United States or with U.S. individuals or entities, and U.S. transactions in our securities and distributions to U.S. individuals and entities with respect to our securities could also be prohibited.

In addition, pursuant to the IFCA, Executive Order 13846 and other U.S. laws, the U.S. government can sanction financial institutions anywhere in the world that engage in certain Iran-related transactions. Such sanctions include prohibiting the financial institution from opening, or imposing strict conditions on maintaining, a correspondent or payable through account in the United States. The potential for financial institutions to be sanctioned for Iran related activities may impact our ability to engage in financial transactions related to Iran transactions.

Risks Related to our ADSs

The trading prices of our ADSs and H Shares have been volatile and may continue to be volatile regardless of our operating performance.

The trading prices of our ADSs and H Shares have been and may continue to be subject to wide fluctuations. The market price for our ADSs may continue to be volatile and subject to wide fluctuations in response to factors including the following:

•

actual or anticipated fluctuations in our quarterly results of operations;

•

changes in financial estimates by securities research analysts;

•

conditions in petroleum and petrochemical markets;

•

changes in the operating performance or market valuations of other petroleum and petrochemical companies;

•

announcements by us or our competitors of new products, acquisitions, strategic partnerships, joint ventures or capital commitments;

•

fluctuations of exchange rates between RMB and the U.S. Dollar; and

•

general economic or political conditions in China or elsewhere in the world.

In addition, the stock market in general, and the market prices for companies with operations in China in particular, have experienced volatility that often has been unrelated to the operating performance of such companies. The securities of some PRC-based companies that have listed their securities in the United States have experienced significant volatility since their initial public offerings in recent years, including, in some cases, substantial declines in the trading prices of their securities. The trading performances of these companies’ securities after their offerings may affect the attitudes of investors towards Chinese companies listed in the United States in general, which consequently may impact the trading performance of our ADSs, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, corporate structure or other matters of other Chinese companies may also negatively affect the attitudes of investors towards Chinese companies in general, including us, regardless of whether we have engaged in any inappropriate activities. In particular, the global financial crisis and the ensuing economic recessions in many countries have contributed and may continue to contribute to extreme volatility in the global stock markets. These broad market and industry fluctuations may adversely affect the market price of our ADSs.

We delisted our ADSs from the New York Stock Exchange (“NYSE”) and terminated our depositary agreement with The Bank of New York Mellon, the depositary of the ADSs, which may create difficulties for holders of our ADSs.

On September 6, 2022, we voluntarily delisted our ADSs from the NYSE when the Form 25 Notification of Delisting we filed with the SEC on August 26, 2022 became effective. On March 15, 2023, we terminated the depositary agreement and our ADS program. The depositary, through its custodian, was the record holder of the shares underlying the ADSs. Therefore, only the depositary can exercise shareholder rights relating to the deposited shares. ADS holders, in their capacity, are not able to directly bring a derivative action, examine our accounting books and records and exercise appraisal rights. The depositary also exercised voting and other rights associated with shares underlying ADSs in accordance with the instructions given by ADS holders, and paid to ADS holders dividends and distributions collected from us.

Current holders of ADSs have one year from the termination date of the depositary agreement to exchange their ADSs for the underlying H Shares. During that time, the depositary will continue to act on behalf of the holders of ADSs. After such time, any remaining ADSs holders will not be able to use the depositary to exchange their ADSs but will be entitled, upon surrender of their ADSs, to receive the net proceeds of the depositary’s sale of the underlying H Shares. The termination of the ADS program may significantly limit the liquidity of the market for our ADSs.

Additionally, our H Shares, which underly our ADSs are quoted on the OTC Pink Sheets under the symbol “SPTJF”. The OTC Pink Sheets is a significantly more limited market than the NYSE. The quotation of our H Shares on the OTC Pink Sheets may result in a less liquid market available for existing and potential stockholders to trade our H Shares, could depress the trading price of our H Shares and could have a long-term adverse impact on our ability to raise capital in the future.

Our ADSs may be prohibited from trading in the United States under the Holding Foreign Companies Accountable Act (the “HFCAA”) in the future if the PCAOB is unable to inspect or investigate completely auditors located in China.

On December 16, 2021, the PCAOB issued a report to notify the SEC of its determination that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong and our auditor was subject to that determination. In May 2022, the SEC conclusively listed us as a Commission-Identified Issuer under the HFCAA following the filing of our annual report on Form 20-F for the fiscal year ended December 31, 2021. On December 15, 2022, the PCAOB removed mainland China and Hong Kong from the list of jurisdictions where it is unable to inspect or investigate completely registered public accounting firms. For this reason, we do not expect to be identified as a Commission-Identified Issuer under the HFCAA after we file this annual report on Form 20-F for the fiscal year ended December 31, 2022.

Each year, the PCAOB will determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other jurisdictions. If the PCAOB determines in the future that it no longer has full access to inspect and investigate completely accounting firms in mainland China and Hong Kong and we use an accounting firm headquartered in one of these jurisdictions to issue an audit report on our financial statements filed with the Securities and Exchange Commission, we would be identified as a Commission-Identified Issuer following the filing of the annual report on Form 20-F for the relevant fiscal year. In accordance with the HFCAA, our securities would be prohibited from being traded on a national securities exchange or on the over-the-counter trading market in the United States if we are identified as a Commission-Identified Issuer for two consecutive years in the future. If our shares and ADSs are prohibited from trading in the United States, there is no certainty that we will be able to list on a non-U.S. exchange or that a market for our shares will develop outside of the United States. A prohibition of being able to trade in the United States would substantially impair your ability to sell or purchase our ADSs when you wish to do so. Also, such a prohibition would significantly affect our ability to raise capital on terms acceptable to us, or at all, which would have a material adverse impact on our business, financial condition, and prospects.

ITEM 4. INFORMATION ON THE COMPANY.

A. History and Development of the Company

General Information

We were established in the People’s Republic of China as a joint stock limited company under the PRC Company Law on June 29, 1993 as Shanghai Petrochemical Company Limited. On October 12, 2000, we changed our name to Sinopec Shanghai Petrochemical Company Limited. Our registered office is at No. 48 Jinyi Road, Jinshan District, Shanghai, China 200540. Our telephone number there is (86-21) 5794-1941. Our company website is www.spc.com.cn. The SEC maintains an Internet site at www.sec.gov that contains reports, proxy and information statements, and our other information that file electronically with the SEC.

Our Predecessor

Our predecessor, the Complex, was founded in 1972 as one of the first large scale Chinese petrochemical enterprises using advanced imported technology and equipment. Prior to June 29, 1993, the Complex was wholly-owned by Sinopec Group, at the time a ministerial level enterprise (before its restructuring in 1998). The Complex’s location was chosen because of accessibility by water and land transportation to Shanghai, a major industrial city of China, and the availability of reclaimable land. The Complex was initially under the administration of the Ministry of Textile Industry and in 1983 was placed under the administration of Sinopec.

Construction Projects

The Complex and we, as its successor, have completed six major stages of construction. The first stage of construction (1972-1976) included reclamation of land and the installation of 18 production units. The second stage of construction (1980-1986) increased the Complex’s capacity for processing crude oil and doubled its capacity for synthetic fiber production. The third stage of construction (1987-1992) primarily consisted of the installation of a 300,000 ton Rated Capacity ethylene unit, an additional crude oil refining unit and other units for the production of petrochemical products. The third stage of construction completed our transition from a synthetic fiber producer to a highly integrated producer of a wide variety of petrochemical products. The fourth stage of construction (2000-2002) mainly included the 700,000 ton Ethylene Expansion Project and Coal-Fired Power Plant Expansion Project. The fifth stage of construction (2003-2009) was mainly designed to optimize our structure and realize sustainable development, and mainly included 3,300,000t/a diesel hydrogenation unit, 1,200,000t/a delayed coking unit and other projects implemented for removing “bottlenecks” in refinery, the building of new 600,000t/a paraxylene hydrocarbon complex unit, 150,000t/a C5 segregation unit, 380,000t/a ethane unit, etc..

The Company commenced the sixth stage of construction in 2010 (the “Phase 6 Project”) and completed the project in December 2012. The key component of the Phase 6 Project was the refinery revamping and expansion project. The Phase 6 Project also included the technology development and fine chemicals projects. The purpose of the Phase 6 Project was to improve the Company’s overall industrial structure, core competitiveness and the capability of maintaining sustainable developments. The Phase 6 Project was focused on the objective to achieve intensive utilization of natural resources and the build-up of a complete set of facilities, in accordance with the fundamental industrial model of integrating oil refining and petrochemical production. Through this project, the Company further enhanced its oil refining process and strengthened and expanded the Company’s core businesses while continuing to explore the development of fine chemicals and products with high value added.

Over the past four decades, the Company has built up an infrastructure system to support its production needs. The Company has its own facilities to supply water, electricity, steam and other utilities and to treat waste water, as well as ocean and inland waterway wharfs and railroad and road transportation facilities.

Our Initial Public Offering and Listing

We were established as a subsidiary of Sinopec on June 29, 1993. In preparation for our initial public offering of ordinary shares, all assets and liabilities of the Complex were transferred either to us or to Sinopec Shanghai Jinshan Industrial Company (“JI”), a separate subsidiary of Sinopec. The Complex’s non-core businesses and assets, such as housing, stores, schools, transportation and medical services, were transferred to JI. The Complex’s core business and assets were transferred to us. The Complex then ceased to exist as a legal entity. In 1998, Sinopec was restructured into a limited liability company under the name of China Petrochemical Corporation (“Sinopec Group”). On February 25, 2000, Sinopec Group transferred its interest in us to its subsidiary, Sinopec Corp. In 1997, JI was restructured and its subsidiaries were either transferred to Sinopec or Shanghai Jinshan District.

Our H Shares commenced listing on the HKSE on July 26, 1993. Our ADSs, each representing 100 H Shares, were listed on the NYSE. The last day of trading of the ADSs on the NYSE was September 6, 2022. Our A Shares are listed on the Shanghai Stock Exchange. We were the first Chinese joint stock limited company to have securities concurrently traded in Hong Kong, the United States and China. On November 8, 1993, our A Shares were included in the Shanghai Stock Exchange Stock Index.

A Share Reform

Pursuant to regulations issued by the CSRC, we were required to obtain shareholder approval for and implement certain share reform. As a result of such share reform, all non-publicly tradable A Shares of the Company would be converted into publicly tradable A Shares and may be sold publicly on the Shanghai Stock Exchange subject to any applicable lock-up period.

In connection with the share reform, the Distribution Proposal regarding 2013 Interim Distribution of Cash Dividend and the Conversion of Capital Fund and Surplus Reserve into Shares of the Company (“Proposal”) was approved at the Company’s 2013 First Extraordinary General Meeting, 2013 First A Shareholders Class Meeting and 2013 First H Shareholders Class Meeting held on October 22, 2013. According to the Proposal, based on the Company’s total share capital of 7,200,000,000 shares as of June 30, 2013, RMB2,421 million of the capital surplus of the Company from its share premium account was used to fund the issue of 3.36 new bonus shares with respect to every 10 issued and outstanding shares, the surplus reserve was used to fund the issue of 1.64 new bonus shares with respect to every 10 issued and outstanding shares, and an interim cash dividend of RMB0.50 (tax included) for every 10 issued and outstanding shares was distributed to all shareholders.

In addition, Sinopec Corp. undertakes under the Proposal that it shall not, within 12 months from the date on which Sinopec Corp. becomes entitled to trade, deal in or transfer its non-publicly tradable shares of the Company in the market (meaning the first trading day after the implementation of the Proposal), trade such shares in the market. Also, after the expiration of the aforesaid 12-month term, the amount of existing non-publicly tradable shares to be disposed of by Sinopec Corp. through trading on the stock exchange shall not represent more than 5% of the total number of our shares held by Sinopec Corp. within the next 12 months, and not more than 10% within the next 24 months.

Immediately upon completion of the conversion of capital surplus and surplus reserve into new shares of the Company, the total number of A Shares of the Company reached, as of December 4, 2013, 7,305,000,000, and the total amount of H Shares of the Company reached 3,495,000,000. Therefore, the Company’s total share capital consists of 10,800,000,000 shares. Sinopec Corp., being the controlling shareholder of the Company, holds 5,460,000,000 A Shares, representing 50.56% of the total share capital of the Company.

The share certificates of new H Shares issued in connection with the share reform were dispatched and the cash dividend was paid to the holders of H Shares on December 4, 2013. The dealings in the new H Shares commenced on December 5, 2013.

The Company exercised its Share Option Incentive Scheme for the first time in August 2017, and the second time in January 2018, and the total number of shares of the Company increased by 14,176, 600 shares and 9,636,900 shares, respectively, upon exercise. Immediately upon completion of the exercise of Share Option Incentive Scheme on February 14, 2018, the total number of A Shares of the Company reached, as of December 4, 2013, 7,328,813,500, and the total amount of H Shares of the Company reached 3,495,000,000.

On February 17, 2023, the Company canceled 24,528,000 H shares repurchased from the Stock Exchange of Hong Kong during the reporting period. With this cancellation, the total number of shares issued by the Company has been reduced to 10,799,285,500, including 7,328,813,500 A shares and 3,470,472,000 H shares.

Description of Principal Capital Expenditures and Divestitures

For a description of capital expansion projects related to our facilities, see Item 4. Information on the Company – D. Property, Plant and Equipment – Capital Expansion Program.

B. Business Overview

We are one of the major petrochemical companies in China based on 2022 net sales and ethylene production. Our highly integrated petrochemical complex processes crude oil into a broad range of products in four major product areas:

•

synthetic fibers,

•

resins and plastics,

•

intermediate petrochemicals, and

•

petroleum products.

Based on 2022 sales volumes, we are a leading Chinese producer of synthetic fibers and resins and plastic products. We believe that we are also a leading competitor in sales of petroleum products and intermediate petrochemicals in our regional markets.

Our net sales by business lines as a percentage of total net sales in each of 2020, 2021 and 2022 are summarized as follows:

Net Sales of RMB61,560.9 million in 2020


Synthetic fibers	2.39	%
Resins and plastics	15.30	%
Intermediate petrochemicals	13.33	%
Petroleum products	48.96	%
Trading of petrochemical products	18.81	%
Others	1.21	%

Total	100.00	%

Net Sales of RMB75,888.8 million in 2021


Synthetic fibers	1.81	%
Resins and plastics	13.13	%
Intermediate petrochemicals	14.21	%
Petroleum products	55.19	%
Trading of petrochemical products	14.56	%
Others	1.10	%

Total	100.00	%

Net Sales of RMB72,654.6 million in 2022


Synthetic fibers	0.57	%
Resins and plastics	10.08	%
Intermediate petrochemicals	14.50	%
Petroleum products	57.04	%
Trading of petrochemical products	16.53	%
Others	1.28	%

Total	100.00	%

We derive a substantial portion of our revenues from customers in Eastern China (principally Shanghai and its six neighboring provinces), an area that has experienced economic growth above the national average in recent years. Shown by geographic region and exports, our net sales by business lines as a percentage of total net sales for each of 2020, 2021 and 2022 are as follows:

2020 Net Sales by Region (%)


	Eastern China		Other parts of China		Exports
Synthetic fibers		89.85		10.15		0.00
Resins and plastics		91.93		8.07		0.00
Intermediate petrochemicals		94.72		4.06		1.22
Petroleum products		91.35		0.24		8.41
Trading of petrochemical products		61.08		5.61		33.31
Total net sales		86.92		2.64		10.45

2021 Net Sales by Region (%)


	Eastern China		Other parts of China		Exports
Synthetic fibers		91.68		8.32		0.00
Resins and plastics		94.99		5.01		0.00
Intermediate petrochemicals		97.12		1.18		1.70
Petroleum products		91.80		0.39		7.81
Trading of petrochemical products		64.54		3.11		32.35
Total net sales		89.28		1.43		9.29

2022 Net Sales by Region (%)


	Eastern China		Other parts of China		Exports
Synthetic fibers		98.34		1.66		0.00
Resins and plastics		97.45		2.55		0.00
Intermediate petrochemicals		97.44		0.68		1.88
Petroleum products		87.03		0.44		12.54
Trading of petrochemical products		68.77		27.19		4.04
Total net sales		87.18		1.18		11.64

Doing Business in China

As an integrated petroleum and petrochemical company operating in China, our business operations may be directly affected by new laws and regulations covering our industries that are enacted by the PRC government or the exercise of its supervisory power over our industries. The PRC government continues to exercise certain controls over the petroleum and petrochemical industry in China. These control mechanisms include periodically setting the upper limit of the retail prices for gasoline and diesel, collecting special oil income levies, deciding import and export quotas and procedures, setting safety, environmental and quality standards, and formulating policies to save energy and reduce emission. In addition, the PRC government may continue to make and adopt changes to its existing macroeconomic and industry policies for the petroleum and petrochemical industry, including further reform and improvement of pricing mechanisms of refined oil products and natural gas, which could impact the development of the petroleum and petrochemical industry in China and the production and operations of the market players in such industry. Our board of directors and management, when developing and formulating our business plan and operating strategies, are required to take into consideration those control mechanisms and industry policies, some of which may impose constraints and limitations on our business planning and strategy. We cannot assure you that these control mechanisms will not have a material adverse effect on our operations and profitability.

The Negative List, while requiring enterprises incorporated in China and operating in industries that are subject to foreign investment prohibition to obtain approval from relevant competent government authorities for their overseas securities offerings and listings, does not prohibit or impose restrictions on foreign investments in the petroleum and petrochemical industries. However, we cannot rule out the possibility that the PRC government may in the future amend and revise PRC laws and regulations in this area to advance new energy security policies. In addition, the Security Review Measures provide that a foreign investor must seek the approval of the competent PRC regulatory authorities prior to investing in key energy and resources sectors that have national security implications where such investment will result in such investor obtaining actual control over the invested enterprises. The Security Review Measures also provides that PRC regulatory authorities should enact implementing rules applicable to the acquisition by foreign investors of publicly-traded securities of listed companies that have or may have national security consequences, and pending the enactment of such implementing rules, there are uncertainties as to whether there are restrictions on open-market purchase of our publicly-traded ADSs by foreign investors under said measures. Given that Sinopec Corp., our controlling shareholder, and its concert parties currently hold approximately 50.55% of our outstanding shares, we do not expect any foreign investor will be able to obtain control over us by investing in our publicly traded H shares or ADSs.

Meanwhile, other than approvals and filing processes required under prevailing PRC laws and regulations, our ability to transfer money or other assets out of China or enter into business transactions with non-Chinese parties in the ordinary course of our business has not been substantively affected by the Security Review Measures. If the PRC government, in keeping with its national security policy, promulgates new laws and regulations in the future to regulate and restrict our ability to enter into cross-border transactions or obtain foreign investments, we may be required to make adjustments to our operating and financing plans, which may in turn affect our business operations and financial position, and have material impacts on the value of our ADSs. If, in the future, foreign investments in petroleum and/or petrochemical industries in China become prohibited or restricted, investors in our ADSs may need to seek exit for their investments in accordance with applicable laws and regulations, which may result in a significant decline in the price of our ADSs and materially and adversely affect the value of the investments made by such foreign investors.

Our business, prospects, financial condition, and results of operations may be influenced to a significant degree by political, economic, and social conditions in China generally. The PRC government has significant authority to intervene or influence our operations at any time, which could result in a material adverse change to our operations and the value of our securities.

Furthermore, given recent statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas, although we are currently not required to obtain permission from the PRC government and have not received any denial to list on a U.S. exchange, it is uncertain whether or when we might be required to obtain permission from the PRC government to maintain our current listing or list additional securities on U.S. exchanges in the future. Even if such permission is obtained, it is uncertain whether it will be later denied or rescinded, which could significantly limit or completely hinder our ability to offer or continue to offer our securities to investors in the United States and result in a material adverse change to our business operations, and damage our reputation, and therefore causing the value of our ADSs to significantly decline or lose their value.

The PRC government has recently taken various legislative initiatives in the area of data security and to address market monopoly concerns. On December 28, 2021, the CAC and other relevant PRC governmental authorities jointly promulgated the Cybersecurity Review Measures (the “CAC Revised Measures”) to replace the original Cybersecurity Review Measures. The CAC Revised Measures took effect on February 15, 2022 and provide that (i) critical information infrastructures operators, or CIIOs, must evaluate potential risks that the deployment of any products and services will have on national security prior to the procurement of such products and services, and must apply for a cybersecurity review if such products and services affect or may affect national security, and “online platform operators” must apply for a cybersecurity review if any of their data processing activities affects or may affect national security, and (ii) if an “online platform operator” that is in possession of personal data of more than one million users intends to list its securities on a foreign stock exchange, it must apply for a cybersecurity review. However, the measures have not clarified if any follow-on offering of ADSs by us will be regulated as a “listing shares on a foreign stock exchange” or whether public companies already listed overseas would be subject to regular cybersecurity reviews. In addition, the NDRC, the SAMR and the CAC, among others, jointly issued the Platform Economy Opinions, which embodies legislative and regulatory anti-monopoly initiatives in relation to the “platform economy.” The Platform Economy Opinions focuses on the following aspects of the platform economy: formulation and promulgation of regulations on the prohibition of unfair online anti- competitive activities; future issuance of detailed rules applicable to data processing activities conducted by online platform enterprises; the formulation of regulations on pricing; the investigation on monopoly and unfair competition activities; and the enforcement against monopolistic agreements, abuse of dominant market position and unlawful market concentration. During the reporting period of this annual report, we have not received from the CAC, the Ministry of Public Security or its local counterparts, or any industrial regulatory authorities, any notices imposing administrative penalties against us or demanding any remedial actions be taken in relation to data security matters. We do not believe the abovementioned rules have a material impact on our capacity to operate our business in the ordinary course, obtain foreign investment, or maintain our listing overseas. To the extent any current regulation or policy promulgated by the CAC applies to us, we believe we are in full compliance. Up to now, we have not received any notices from the CAC, the Ministry of Public Security or its local counterparts that the company is a critical information infrastructures operator. Based on the advice of counsel provided by Beijing Haiwen Law Firm upon which we have relied, we do not believe that we are subject to the review of, nor require the approval of, the CAC at this time. We can provide no assurance, however, that the CAC will not take a different position, or other regulations and policies that may be issued in the future and their implementation may further require the company to comply with stricter compliance conditions, adjust the company’s business operation mode and business plan, or have a significant impact on our ability to accept foreign investment or maintain its listing in the United States or other overseas markets.

The occurrence of any, some or all of the legal and operational risks described above and discussed under the heading “Risks Related to Doing Business in China” under Item 3.C of this Annual Report could cause the value of our securities to significantly decline or lose their value.

The Holding Foreign Companies Accountable Act

Pursuant to the HFCAA, if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been subject to inspections by the PCAOB for two consecutive years, the SEC will prohibit our shares or the ADSs from being traded on a national securities exchange or on the over-the-counter trading market in the United States. On December 16, 2021, the PCAOB issued a report to notify the SEC of its determination that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong, including our auditor. In May 2022, the SEC conclusively listed us as a Commission-Identified Issuer under the HFCAA following the filing of our annual report on Form 20-F for the fiscal year ended December 31, 2021. On December 15, 2022, the PCAOB issued a report that vacated its December 16, 2021 determination and removed mainland China and Hong Kong from the list of jurisdictions where it is unable to inspect or investigate completely registered public accounting firms. For this reason, we do not expect to be identified as a Commission-Identified Issuer under the HFCAA after we file this annual report on Form 20-F. Each year, the PCAOB will determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other jurisdictions. If PCAOB determines in the future that it no longer has full access to inspect and investigate completely accounting firms in mainland China and Hong Kong and we continue to use an accounting firm headquartered in one of these jurisdictions to issue an audit report on our financial statements filed with the SEC, we would be identified as a Commission-Identified Issuer following the filing of the annual report on Form 20-F for the relevant fiscal year. There can be no assurance that we would not be identified as a Commission-Identified Issuer for any future fiscal year, and if we were so identified for two consecutive years, we would become subject to the prohibition on trading under the HFCAA. See “Item 3. Key Information-D. Risk Factors- Risks Related to our ADSs—“Our ADSs may be prohibited from trading in the United States under the HFCAA in the future if the PCAOB is unable to inspect or investigate completely auditors located in China.”

Transfer of Cash through Our Organization

Sinopec Shanghai Petrochemical Co Ltd, is a joint stock limited company incorporated in China, and operates its business in China in accordance with the scope of business as set forth in its articles of association. The Company directly and indirectly owns equity interests in its PRC subsidiaries, and there is no variable interest entity within the Group. All cash flows among the Company, the parent company and the subsidiaries represent equity contributions, dividends and distributions, loans and other cash flow items underlying business activities made during the ordinary course of their business.

The Company is not a holding company established solely to hold equity interest in its operating subsidiaries but an operating company and independently generates revenue from its business operations. The Company is not solely relying on dividends and distributions declared and paid by its subsidiaries to satisfy its needs of funding. Having considered the status of its business operation and financial management, the Company has established a centralized treasury system within the group with the aim to effectively coordinate the fund and budget management at group level based on consolidated funding and budgeting regime, for the purpose of maintaining a sufficient cash reserve for the Company while optimizing funding management efficiently. As of December 31, 2022, the Company directly owns more than 90% of total consolidated assets and more than 75% of the consolidated cash and cash equivalents of the group. For the year ended December 31, 2022, the Company directly generated more than 80% of the total consolidated revenue of the group. Therefore, the Company can continue to generate sufficient funding for its business operations. On the other hand, the day-to-day sales from the Company’s business include inter-segment sales in the ordinary course of business, which are eliminated during the preparation of its consolidated financial statements and therefore will not be reflected under the line items of its consolidated revenues. As a result, the Company believes the preparation of cash flow and transfer of assets between the company and its subsidiaries is not meaningful to investors.

Our parent company, China Petroleum & Chemical Corporation (“Sinopec Corp.”) is the largest integrated petroleum company in China. Any cash flow and transfer of assets between our company and our parent company mainly involves (1) distribution of dividends based on shareholding and (2) funds transfer in the normal course of business. As disclosed on page 8 of the Form 20-F, our parent company has from time to time provided a variety of services to us, including the supply of raw materials, product distribution and sales agency, project design and installment service, petrochemical industry related insurance and financial services. We also sell oil and petrochemical products to Sinopec Corp. and its affiliates. These businesses are carried out on normal commercial terms and are in compliance with the relevant regulatory requirements in all material respects, and therefore the corresponding fund flows are not subject to any additional restrictions. Transactions between the Group and Sinopec Corp., its subsidiaries and joint ventures have been separately disclosed in Note 32 Related-party transactions of Item 17. Financial Statements.

The current foreign exchange regulations have significantly reduced the government’s foreign exchange control over transactions under the current account, including trade, services and dividend payments involving foreign exchange transactions. Foreign exchange transactions under capital account (including payment of principal of foreign currency debt) are still subject to strict foreign exchange control and need to be approved by the State Administration of foreign exchange. Such restrictions may affect the company’s ability to obtain foreign exchange through debt or equity financing. The Chinese government has publicly announced its plan for the free convertibility of RMB in the future. However, the company cannot predict whether the government will continue to adopt the current foreign exchange management system and when it will allow the free convertibility of RMB. The company’s income denominated in foreign currency and the exchange of RMB to foreign currency are the main sources of the company’s foreign currency funds. Up to now, the company’s currency exchange has not been significantly restricted, and the company’s ability to carry out daily operations, dividend payment and investment plans has not been significantly affected; The foreign currency currently held by the company is also sufficient to meet the needs of performing the financial obligations denominated in foreign currency. If the company is subject to more stringent foreign exchange control measures in the future, and therefore cannot obtain the required foreign currency through exchange in time, the company’s ability to pay financial obligations denominated in foreign currency according to the business plan may be significantly affected. In the case that the company cannot further obtain sufficient foreign currency funds, the company may therefore breach some foreign-related agreements and fail to pay dividends according to the plan, or unable to further carry out overseas business and investment activities.

Dividend Distribution Policy

According to the articles of association, our board of directors will determine the payment of dividends, if any, with respect to our shares on a per share basis. Any final dividend for a financial year shall be subject to shareholders’ approval. The board may declare interim and special dividends at any time under general authorization by a shareholders’ ordinary resolution. A decision to declare or to pay any dividends in the future and the amount of any dividends will depend on our results of operations, cash flows, financial condition, the payment by our subsidiaries of cash dividends to us, future prospects and other factors which our directors may determine to be important.

For holders of our H shares, cash dividend payments, if any, shall be declared by our board of directors in Renminbi and paid in Hong Kong dollars. The depositary will convert the Hong Kong dollar dividend payments and distribute them to holders of ADSs in US dollars, less expenses of conversion.

The Company may distribute dividends in the following forms: cash, shares or other forms provided by laws, administrative rules, regulations of competent authorities and regulatory provisions in the place where the Company’s shares are listed. The Company shall give priority to the distribution of dividends in cash. The Company may make interim dividends distribution. The Company shall distribute cash dividends when the Company’s net profit and retained earnings, in separate financial statement, are positive and the Company has adequate cash inflows over the requirements of cash outflows of operation and sustainable development. The cash dividends per annum should not be less than thirty percent of the net profit of the Company in the current year. Dividends in the form of shares will be distributed to the depositary and, except as otherwise described in the Deposit Agreement, will be distributed by the depositary in the form of additional ADSs, to holders of ADSs. The Company will be required to, pursuant to applicable PRC laws and regulations, withhold 10-20% dividend tax (based on the status of the shareholder) for dividends paid to holders of H shares (including ADSs representing such H shares), and make filing pursuant to applicable foreign exchange control procedures for the payment of such dividends. In addition, ADS holders will be required to pay applicable service fees in relation to the distribution of cash dividends pursuant to the Deposit Agreement for the Company’s American Depositary Shares.

In addition, foreign exchange transactions under the capital account, including principal payments in respect of foreign currency-denominated obligations, continue to be subject to significant foreign exchange controls and require the approval of SAFE. While we have not been denied of our applications for foreign exchange for the payment of our dividends, we cannot rule out the possibility that such control and limitation could affect our ability to obtain foreign exchange to pay cash dividends declared on our H shares (including ADSs representing our H shares). Consequently, we cannot assure that foreign investors’ investment will not be subject to foreign exchange payment risks as a result of these foreign exchange control measures. See “Legal, Regulatory or Political Risk Factors—If the Chinese government changes current regulations that allow us to make payments in foreign currencies, we may be unable to obtain the foreign currency necessary for our business.”

Since the Company’s shares were listed in Hong Kong and the U.S. in 1993, the Company has distributed dividends to its shareholders over 25 times, and has never experienced any restrictions.

During the reporting period of this annual report, the company used its own funds to distribute a final dividend of RMB 0.1 per share (tax included). For the financial year ended December 31, 2021, dividends of RMB 0.1 per share (tax included) were distributed throughout the year. For H-share holders, cash dividends are declared in Renminbi and paid in Hong Kong dollars. After receiving dividends in Hong Kong dollars, the depositary bank converts them into US dollars for distribution to holders of ADS.

According to the relevant laws and regulations of China, the company shall withhold and pay 10% of the dividend tax when distributing dividends to the ADS holders who are paid through the depositary bank. In addition, the ADS holders shall bear the service fees related to cash dividend distribution in accordance with the deposit agreement. In 2021, each ADR (equal to 100 H shares) received a dividend of US $1.56. After deducting the 10% dividend tax withheld and the deposit bank’s distribution fee of US $0.21/ADS for each dividend, the ADS holders actually received US $1.35/ADS. In 2021, the aggregate dividend paid to the ADS holders through the depositary bank was about US $436.32m.

Permits and Approvals

We are required to obtain permits and approvals for the operation of our business pursuant to applicable PRC laws, regulation and industrial policies. The following chart sets forth our current licenses, allowing us to operate our business in certain places and industries:


License	Underlying Business/Activities	Competent/Approving Authority
Port Operation License	Providing wharf facilities, storage, etc. for ships	Authorities of transportation

Newspaper Publishing License	Newspaper publishing	Authorities of press and publication

Power Business License	Engaging in power business	Authorities of energy management

Water-taking License	Using water resource	Authorities of water management

Radiation Safety License	Using specific radioactive sources	Authorities of environment protection management

Pollutant discharge License	Discharging pollutants into the environment	Authorities of ecological environment management

Work Safety License	Safe production activities	Authorities of Work Safe Regulation and Supervision (Ministry of Emergency Management and its counterparts)

Safety Production License for Hazardous Chemicals	Production of hazardous chemicals	Authorities of Work Safe Regulation and Supervision (Ministry of Emergency Management and its counterparts)

National Industrial Product Production License	Industrial product production	Authorities of quality and technology management

Mobile Pressure Vessel Filling License	Low pressure liquefied gas filling	Authorities of Work Safe Regulation and Supervision (Ministry of Emergency Management and its counterparts)

Shanghai Port Shoreline use License	Using shoreline	Authorities of port management

We have obtained all approvals and permits that are material for our business operations under the PRC laws and regulations, and we have not been subject to any material administrative penalties from the PRC regulatory authorities nor have any permissions or approvals ever been denied. However, we cannot rule out the possibility of new requirements for approvals and permits in the future. If we fail to obtain relevant approvals and permits in time, our business operations of may be adversely affected. In addition, pursuant to the Special Regulations of the State Council concerning Offering and Listing of Shares Overseas by Companies Limited by Shares promulgated in 1994, currently in effect, as a PRC company with equity securities listed in the PRC and the U.S., we are required to obtain the prior approval of the China Securities Regulatory Commission (the “CSRC”) for any public offering of equity securities to foreign investors. In addition, we may be subject to legal liabilities under the PRC Securities Law if our offering or the trading of our securities overseas is deemed to “disrupt the order of PRC domestic market and harm legitimate rights and interests of PRC domestic investors”. We have received from the CSRC the approval for our public offerings of equity securities in the past. We are required to continue to comply with the provisions of the PRC Securities Law and we remain subject to the supervision of the PRC regulatory authorities. However, we cannot assure you that we can timely receive such approval if we wish to make any new equity offerings in the future.

If we fail to obtain any requisite approvals with respect to future offerings of our equity securities to foreign investors, or if we inadvertently conclude that such approvals are not required, our ability to execute our financing and equity offering plans may be significantly limited or completely hindered. In the absence of alternative sources of financing, this could impede our efforts to improve our liquidity or expand our business operation, and we cannot assure you that there will not be material negative impacts on our financial condition and result of operations, or a significant decline in the value of our ADSs. Furthermore, we cannot assure you that PRC authorities will not promulgate new laws to further regulate the listing of our ADSs, or impose new compliance obligations for us to maintain the listing of our ADSs. Certain of our actions in relation to our overseas listing may also constitute a violation of PRC Securities Law or other relevant laws, and as a consequence, subject us to penalties, including without limitation fines, limitations on our ability of financing activities, or the suspension or termination of certain aspects of our business operations, which may in turn result in substantial difficulty for us to maintain our listing overseas.

Business Strategies

Our development objectives are to evolve itself into a “leading domestically, first-class globally” energy and chemical and new material enterprise. The key components of the Company’s development strategy are as follows: to take into account both low cost and differentiation, and to focus on both scale and refinement. The Company focuses on value and market orientation, creativity, talents as the backbone of the Company, the emphasis of environment and low carbon emissions and integrated development, to realize low cost and large scale of the upstream, and high value-added and refinement of the downstream. The Company will give full play to its advantages of a wide product chain, diversified products and close monitoring of the market to enhance competitiveness. Under the guidance of the above development strategy, according to the requirements of North-South Transformation Policy raised by Shanghai Government, the Company will (a) actively promote the transition from oil refining to chemical industry, the transition from chemical industry to materials, the transition from materials to high-end products, and the transition from parks to ecology, (b) carry out comprehensive technological transformation and quality upgrades, and (c) further optimize refining product structure to better meet the market needs. The Company will seek to strengthen the core industries of mid-to-high-end new materials such as carbon fiber, and take polyester, polyolefin, elastomer, and C-5 downstream fine chemical new materials as breakthrough and extension for the mid-to-high-end new materials which should help the North-South transformation and the construction of Carbon Valley Green Bay and local industrial parks in Jinshan District. The Company will seek to develop wind, light, fire, and biological integrated power generation and green hydrogen production technology, with a view towards realizing the energy structure transformation from fossil energy to fossil energy combined with renewable energy to achieve energy saving. Through diversified industrial linkage development and cluster agglomeration, the Company plans to build an industrial base with green energy, fine chemical, and high-end material on the north bank of Hangzhou Bay with world-scale and first-class competitiveness.

In 2023, the Company will, adhering to the principle of prioritizing stability while pursuing progress, integrate into the new development landscape and coordinate development and safety in a better way, to lay a solid foundation for its high-quality development on all fronts. In 2023, the Company plans to process a total of 13.6 million tons of crude oil, produce a total of 8.001 million tons of refined oil products, 756,000 tons of ethylene, 680,000 tons of xylene, and 698,700 tons of new synthetic resin products and special materials annually. In order to achieve the business objectives for 2023, the Group will focus on the following five areas of work:

•

Strengthen safety and environmental protection and improve the level of intrinsic safety

Learning from the accidents, we exercise full and strict management over the Company, and strengthen the fulfillment of responsibilities. We strictly control risks and ensure safety and environmental protection. We strengthen the control over contractors, promote the review of contractors’ QHSE system, and strengthen the supervision over direct work safety. While enhancing the basic skills training, we optimize the training mode and process. We push forward the effective operation of the HSE management system, improve environmental protection KPI indicators, and meet basic emission standards. In addition, we strictly implement the principles of solid waste reduction, recycling and harmlessness, and advance the construction of waste-free factories.

•

Strengthen efficiency and reduce costs to improve production and operation

We implement the target of efficiency improvement and cost reduction throughout production and operation. We put equal emphasis on both process and equipment, to ensure the stable and efficient operation of equipment. We optimize crude oil procurement, transportation and distribution, production operation and maintenance, energy saving and “three new business” (new energy, new materials and new economy), strictly control costs and expenses, and improve cost control. These efforts aim to maximize the overall efficiency of the Company.

•

Strengthen management to improve efficiency and enhance endogenous momentum

We keep optimizing the management system and mechanism, further optimize the organizational setup, and improve management efficiency and level. We strengthen organizational performance management by improving assessment, incentives and constraints, and refining the internal management market-oriented working mechanism.

•

Focus on transformation and development and promote the development of key projects

We accelerate transformation and upgrading. We go all out to create a more resilient and higher-value integrated industrial chain, and build an industrial base featuring green energy, fine chemical and high-end materials. We speed up the breakthroughs in core technologies in key fields and the implementation of key projects. During the year, the first phase of 48K large-tow carbon fiber went into commercial operation. We carried out the second phase of equipment construction, made available 100-ton test devices for high-performance carbon fiber and pilot plants for aeronautical composite materials, and accelerated the construction of 250,000 tons/year thermoplastic elastomer projects. We strengthen the construction of platforms of sci-tech innovation and our innovation capability. We promote the application of new technologies and processes in production units. Furthermore, we strengthen the operation and management of joint laboratories with universities to integrate production, learning, research and application.

•

Strengthen team building and consolidate the foundation for corporate development

We enhance cadres’ ability to perform their duties and continuously promote the construction of cadre management system. We also further better the talent system. Specifically, we provide the basic skills training for skilled operators, and continue with the business competition themed “big drills and big game”. We refine the plan for training and introducing talents, and improve the management plus assessment and incentive of cutting-edge and urgently-needed talents. These efforts will enable us to maintain the personal interests, long-term interests and fundamental interests of the employees, and enhance the satisfaction and sense of gain of the grass-roots employees.

Principal Products

We produce four principal types of products with different specifications, including synthetic fibers, resins and plastics, intermediate petrochemicals and petroleum products. We use many of the important petroleum products and intermediate petrochemicals we produce in producing our own downstream products.

The following table shows a comparison of the production volume and sales volume in 2022 and 2021 by our major products.


Product	Production							Sales
Product	2022 (10,000 tons)		2021 (10,000 tons)		Year-on-year change			2022 (10,000 tons)		2021 (10,000 tons)		Year-on-year change
Diesel^Note1		252.02		338.80		-25.61	%		251.84		338.10		-25.51	%
Gasoline		257.08		339.64		-24.31	%		255.84		340.23		-24.80	%
Jet Fuel^Note1		81.70		118.45		-31.03	%		66.24		99.57		-33.47	%
Paraxylene		58.59		49.63		18.05	%		58.54		46.53		25.81	%
Benzene^Note2		30.32		30.67		-1.14	%		29.70		29.99		-0.97	%
Ethylene Glycol		9.57		15.07		-36.50	%		6.24		4.14		50.72	%
Ethylene Oxide		19.67		33.56		-41.39	%		19.23		32.78		-41.34	%
Ethylene^Note2		59.81		71.28		-16.09	%		—		—		—
Polyethylene		39.12		49.62		-21.16	%		38.28		49.63		-22.87	%
Polypropylene		39.70		45.59		-12.92	%		37.07		42.26		-12.28	%
Polyester Pellet^Note2		10.75		34.34		-68.70	%		10.89		30.24		-63.99	%
Acrylic		1.96		7.10		-72.39	%		2.06		7.32		-71.86	%
Polyester Staple		0		2.62		-100.00	%		0		2.73		-100.00	%

Notes: 1. Excludes sales volume of proceeds on order.

2. The difference between production and sales are internal sales.

The above-mentioned sales volume does not include the trading of our petrochemical products.

The following table shows our 2022 net sales by major products as a percentage of total net sales together with the typical uses of these products.


Product	% of net sales	Typical Use
SYNTHETIC FIBERS
Polyester staple fiber	0.00	Textiles and apparel
Acrylic staple fiber	0.45	Cotton type fabrics, wool type fabrics
Others	0.12
Sub-total	0.57
RESINS AND PLASTICS
Polyester chips	0.95	Polyester fibers, films and containers
Polypropylene pellets	4.16	Films, ground sheeting, wire and
cable compound and other injection molding products such as housewares and toys
Polyethylene pellets	4.57	Films or sheets, injection molding
products such as housewares, toys and household electrical appliances and automobile parts Polyvinyl alcohol (“PVA”)	0.00	PVA fibers, building coating materials and textile starch
Others	0.39
Sub-total	10.08
INTERMEDIATE PETROCHEMICALS
Ethylene	0.00	Feedstock for polyethylene, ethylene glycol, polyvinyl chloride and other
intermediate petrochemicals which can be further processed into resins, plastics and synthetic fiber.
Ethylene oxide	1.73	Intermediate products for the chemical and pharmaceutical
industry, including dyes, detergents and adjuvant..
Benzene	2.82	Intermediate petrochemical products, styrene, plastics, explosives, dyes, detergents, epoxies and polyamide fiber
Paraxylene	5.97	Intermediate petrochemicals and polyester
Butadiene	0.76	Synthetic rubber and plastics
Ethylene glycol	0.35	Fine chemicals
Others	2.87
Sub-total	14.50
PETROLEUM PRODUCTS
Gasoline	23.50	Transportation fuels
Diesel	20.05	Transportation fuels and agricultural machinery fuels
Jet Fuel	5.90	Transportation fuels
Others	7.59
Sub-total	57.04
Trading of petrochemical products	16.53	Import and export trade of petrochemical products (purchased from domestic and overseas suppliers)
Others	1.28
Total	100.00

The following table provides a detailed description of our major products by industry segment, primary upstream raw materials, transport and storage method, primary downstream application fields and key price-influencing factors:


Product	Industry segment	Primary upstream raw material	Transport/storage method	Primary downstream application fields	Key price-influencing factors
Diesel	Petroleum products	Petroleum	Pipeline transportation and shipping/ storage tank	Transportation fuel, agricultural machinery fuel	International crude oil price, government control
Gasoline	Petroleum products	Petroleum	Pipeline transportation and shipping/ storage tank	Transportation fuel	International crude oil price, government control
Jet Fuel	Petroleum products	Petroleum	Pipeline transportation and shipping/ storage tank	Transportation fuel	International crude oil price, supply- demand balance
Paraxylene	Intermediate petrochemicals	Naphtha	Road transportation/ storage tank	Intermediate petrochemical products and polyester	Raw material price, supply-demand balance


Product	Industry segment	Primary upstream raw material	Transport/storage method	Primary downstream application fields	Key price- influencing factors
Benzene	Intermediate petrochemicals	Naphtha	Road transportation, shipping, rail transportation/ storage tank	Intermediate petrochemical products, styrene, plastic, explosive, dye, detergent, epoxy resin, chinlon	International crude oil price, market supply- demand condition
Ethylene Glycol	Intermediate petrochemicals	Naphtha	Road transportation/ storage tank	Fine Chemicals engineering	International crude oil price, market supply- demand condition
Ethylene Oxide	Intermediate petrochemicals	Naphtha	Road transportation, pipeline transportation/ storage tank	Chemical and medical industry intermediate products, including dyes, detergents and auxiliary	International crude oil price, market supply- demand condition
Ethylene	Intermediate petrochemicals	Naphtha	Road transportation, pipeline transportation, shipping/storage tank	PE, EG, PVC and other raw material for further processing of intermediate petrochemical products such as resins, plastics and synthetic fibres	International crude oil price, supply- demand balance
Polyethylene	Resins and plastics	Ethylene	Road transportation, shipping and rail transportation/ warehousing	Film, mulching film, cable insulation material and housewares, toys injection moulding products	Raw material price and market supply- demand condition
Polypropylene	Resins and plastics	Propylene	Road transportation, shipping and rail transportation/ warehousing	Film, mulching film, housewares, toys, household appliances and auto parts injection moulding products	Raw material price and market supply- demand condition
Polyester chips	Resins and plastics	PTA, EG	Road transportation, shipping and rail transportation/ warehousing	Polyester fibre or film, container	Raw material price and market supply- demand condition
Acrylics	Synthetic fibres	Acrylonitrile	Road transportation, shipping and rail transportation/ warehousing	Simple spinning or blend with other material for texture or acrylic top	Raw material price and market supply- demand condition
Polyester	Synthetic fibres	Polyester	Road transportation, shipping and rail transportation/warehousing	Texture, apparel	Raw material price and market supply- demand condition

Production Processes

The key component of the vertically integrated production facility of the Company is the ethylene facility producing ethylene and propylene and aromatics facility mainly producing paraxylene and benzene. Ethylene is the main raw material for the production of polyethylene and ethylene glycol, while ethylene glycol and PTA polymerization produces polyester. Propylene is the main raw material for the production of acrylics and polypropylene. The above-mentioned products all use crude oil as raw material and are processed through a series of petrochemical facilities. The chart below illustrates in brief the production processes of the Company.

LOGO

Intermediate Petrochemicals

Ethylene – Ethylene is either directly processed into polypropylene resins or processed into other intermediate petrochemicals. The most important of these is MEG. MEG is a key ingredient in polyester. It is produced by oxidizing ethylene in the ethylene oxide /ethylene glycol unit. Ethylene is also used to produce vinyl acetate which is processed into PVA.

Propylene – Propylene is either processed directly into polypropylene resins or is further processed into other intermediate petrochemicals such as acrylonitrile, acetonitrile, hydroxyl acetonitrile and sodium cyanide. Acrylonitrile is used in producing acrylics.

Vacuum gas oil – VGO is passed through the hydrocracker, and the resulting heavy naphtha is fed into the aromatics plants to produce paraxylene and benzene. Paraxylene is processed into PTA, one of the principal raw materials in producing polyester.

Resins and Plastics and Synthetic Fibers

We process our intermediate petrochemical products into five kinds of synthetic fiber raw materials: (1) polyester, (2) acrylonitrile, (3) polypropylene, (4) polyethylene, and (5) PVA. Each of these five products has its own production line or lines. We further process polyester and acrylonitrile into various types of synthetic fibers.

Polyester – MEG and PTA are fed into a polymerization unit which produces polyester chips and polyester melt. Both chips and melt are used as raw materials in the production of polyester staple and filaments. Some chips are also sold to third parties.

Polyester staple fiber is a multi-strand fiber cut into short lengths which can be spun into fabric on its own or blended with cotton, wool or flax to produce textiles. Polyester filaments are a class of more highly processed polyester materials which have been drawn and oriented to produce a long thread-like fiber.

Acrylonitrile – We produce polyacrylonitrile by feeding acrylonitrile into a polymerization unit. By passing the polyacrylonitrile through the fiber unit, acrylic fiber and acrylic staple fiber are produced, including cotton and wool type staple fibers. Wool acrylic staple fiber can be processed into acrylic wool strips.

Polypropylene – We produce polypropylene resins by feeding propylene into a polymerization unit. Our fiber grade polypropylene resin is the main ingredient for polypropylene fiber production.

Polyethylene – We have three sets of units producing polypropylene, two of which produce low-density polyethylene (“LDPE”) using the kettle type process, and the other unit produces all density polypropylene products using the Borstar bimodal process.

PVA – PVA granules are produced from vinyl acetate, derived from ethylene.

Raw Materials

In 2022, we continued to strengthen our advantages in refining and chemical integration and leverage the strong adaptability of our refining plants to process more high-sulfur crude oil; we used a Process Industry Modeling System to determine the cost performance of crude oil to further improve the cost control of crude oil purchases; and the total volume of the top ten main types of oil purchased in the whole year of 2022 accounted for 88.54% of the total purchase of crude oil.

To enhance the overall profitability, we optimized our ethylene cracking stocks, adjusted and improved our natural gas and fuel gas structure, optimized our hydrogen system, reduced the emission and increased the efficiency of flare gas, increased the outputs of gasoline and aviation kerosene, and optimized naphtha, residual oil and wax oil processing lines. We further optimized the structure of our finished oil products, achieving a diesel to gasoline ratio of 0.98:1 for 2022. We strengthened our tracking of the margin contribution of our units, and continuously carried out daily profitability measurement for each product so as to promptly detect changes in profitability, quickly adjust the load and running schedule of our production units and afford priority to the production of products with high profitability and market demand.

Crude Oil

Crude oil is our primary raw material and the most significant raw material we purchase from outside sources. In 2022, crude oil accounted for approximately 61.81% of our consolidated annual cost of sales (73.34% of parent company annual cost of sales). Accordingly, the supply and price of crude oil are key factors in determining our profitability.

Supply and Transportation – The crude oil required by us is purchased through Sinopec Corp., as an agent, from foreign sources and Shanghai Nanguang Petrochemical Co., Ltd., as an agent, from domestic sources. During 2022 we did not experience any significant problems in obtaining sufficient crude oil to meet our production needs.

Sinopec Group is responsible for preparing an annual plan on demand and supply for crude oil and petroleum products that forms the basis of the Chinese government’s annual “balancing plan” which effectively dictates our planned volume of crude oil processing in each year. Likewise, under the “balancing plan,” some of our petroleum products are designated for sale to the subsidiaries of Sinopec Group or other designated customers at market prices and we must consult Sinopec Group to sell elsewhere.

We have received confirmation from Sinopec Corp. that it will purchase on our behalf 13.60 million tons of imported crude oil in 2023. Sinopec Corp. has further confirmed that, subject to China’s national crude oil policy and our actual production needs, it will continue to purchase on our behalf sufficient quantities and appropriate types of crude oil, including domestic offshore and imported crude oil, to satisfy our anticipated annual needs. We anticipate that we will fully utilize our supply of crude oil in 2023. We believe that the mix of crude oil feedstock currently available is satisfactory for our 2023 production capacity and targets. Additionally, as part of China’s commitment at its accession into WTO, certain non-state-owned enterprises have been granted an increasing amount of quota to import crude oil. Although we do not expect to obtain crude oil through this channel in the foreseeable future due to the current crude oil supply system, this may provide us with an alternative source of crude oil supply.

Crude Oil Mix – Our refining equipment is designed to process certain grades of crude oil. Therefore, the origin and quality of the crude oil available can be important to our business. We believe that as we have been significantly increasing usage of imported crude oil, we will continue to be able to obtain from the market such imported crude oil that is compatible with our refining equipment. The overall mix of foreign versus domestic crude oil we process in 2023 will depend on a variety of factors, including the amount of future supply of domestic offshore crude oil and the availability, price, quality, processing profitability and compatibility with our refining capabilities of imported crude oil. Provided there are no significant modifications to the existing channels of crude oil supply, we believe that sufficient supplies of crude oil will be available on the domestic or international markets for our 2023 production capacity and goals.

In 2022, our crude oil was sourced as follows:


Domestic offshore crude oil	1.02	%
Imported crude oil	98.98	%

Total:	100.00	%

We expect that we will continue to rely principally on foreign sources for our crude oil supply. However, we believe that we will be able to maintain our processing efficiency through technological adjustments of our equipment and quality control and that increased use of imported oil will not materially adversely impact our business and results of operations.

Foreign and domestic offshore crude oil is supplied by tanker and pipeline to our oil terminal wharf and oil storage tank. See Item 4.D. Property, Plants and Equipment -Wharfs.

In the past, we have not experienced disruption in our crude oil supply. The crude oil for our atmosphere vacuum distillation facility is mainly supplied from the Ningbo-Shanghai-Nanjing oil pipeline. Due to our ability to obtain crude oil from multiple sources, we are able to meet our normal requirements for crude oil.

Pricing – The price of domestic crude oil shall apply the market –adjusted rate and the imported crude oil is generally sold to us at prevailing international market prices. The average cost of imported crude oil and domestic offshore crude oil in 2022 was RMB 4,675.66 (U.S.$ 695.70) per ton and RMB 5,318.94 (U.S.$ 791.41) per ton, respectively. In 2022, we processed 10,338,313 tons of imported crude oil and 107,022 tons of domestic offshore crude oil (including 378,279 tons of crude oil processed on a sub-contract basis).

Until March 2001 the Chinese government implemented a unified pricing system for crude oil. Each month, the National Development and Reform Commission (“NDRC”) established an indicative price for each grade of domestic onshore crude oil based on comparable international market prices, inclusive of any duties that would have been imposed had the oil been imported. The actual price for domestic onshore oil would be such indicative price plus a surcharge. This surcharge was determined by China National Petroleum Corporation and Sinopec Group to reflect any transportation and other miscellaneous costs that would have been incurred in having the oil delivered to various refineries. Beginning March 2001, NDRC ceased publishing an indicative price. Instead, the indicative price for domestic onshore oil has been calculated and determined directly by China National Petroleum Corporation and Sinopec Group based on the principles and methods formerly applied by NDRC.

On January 13, 2016, NDRC issued the Circular on Several Issues on Further Improving the Pricing Mechanism of Refined Oil (Fa Gai Jia Ge [2016] No. 64) to adjust the existing refined oil pricing mechanism, which include, among other things, (i) setting a price floor of U.S.$40 for the downward adjustment of the crude refined oil. When the international crude oil price drops to U.S.$40 per barrel or below, i.e., the adjustment price floor, the refined oil price in China shall no longer be adjusted downwards; and (ii) creating a reserve for risks associated with the adjustment and control of oil prices. When the international crude oil price drops to U.S.$40 per barrel or below, all unadjusted amount shall be allocated to the reserve above mentioned for use for the purpose of energy saving or reduction of emission, improving the oil quality and securing a safe supply of oil.

We purchase crude oil through Sinopec Corp. and its affiliates from the sources selected and in the quantities confirmed by the Company at market prices. On this basis, we believe that changes in crude oil prices should not have a material effect on our competitiveness with other domestic producers. Nevertheless, any increase in the price of crude oil could have an adverse impact on our profitability to the extent that we are unable to pass cost increases on to our customers.

As of December 31, 2022, the Group had processed a total of 10.4453 million tons of crude oil, indicating a year-on-year decrease of 24.11%, mainly due to the implementation of the largest overhaul in the Company’s history this year. The cost of crude oil processing for the whole year of 2022 was RMB4682.50 /ton, representing an increase of RMB1450.21 /ton or 44.87% from the same period last year. The annual crude oil processing total cost increased by RMB3.96 billion from the same period last year or 9.16%, accounting for 61.81% of the total cost of sales.

Coal

Most of the coal used for electricity generation is purchased through a unified system of procurement by Sinopec Corp.. Coal is transported by rail from the mines to Qinhuangdao port and shipped by barge to Jinshanwei where it is delivered to the plant via a company-owned wharf and conveyer system. Our cost is primarily dependent on coal price and transportation charges.

We expect that our total requirement for coal to generate electricity in 2023 will be approximately 1.90 million tons. In 2022, we consumed approximately 1.7352 million tons of coal, a decrease of 16,900 tons from 2021 of 1.7521 million tons.

Other Raw Materials

We produce most of the raw materials used as feedstock for our operations. If any of these raw materials, other than ethylene, becomes unavailable from internal production, we believe that there are sufficient alternative sources at reasonable prices and the unavailability of raw materials from internal sources will not have a significant effect on our operations and profitability.

We purchase some ancillary raw materials from outside sources. These raw materials include natural gas, methanol, ammonia, sodium hydroxide, sulfur, acetone, acrylonitrile, PTA, propylene and a variety of catalytic agents. In 2022, the total cost of these materials accounted for approximately 12.05 % of our total cost of sales. We do not expect any difficulties in obtaining a supply of any of these ancillary raw materials in amounts sufficient to meet our needs in the foreseeable future.

Sales and Marketing

Distribution

The distribution of our fuel products is subject to government regulations. We are required to sell certain refined products to the subsidiaries of Sinopec Group or customers designated by Sinopec Group. Since the second half of 2005, Sinopec Group has executed reforms to its system of selling petrochemical products and implemented what it refers to as a “Five Consolidations” strategy featuring “consolidated marketing strategy, consolidated promotion, consolidated logistics optimization, consolidated sales and consolidated branding.” As a result, the sales of our major petrochemical products are now conducted in a consolidated manner by sales agents designated by Sinopec Group. However, we have the autonomy to decide on the distribution method of our other products in accordance with market conditions. The products we sold in 2022 that were subject to planned distribution by Sinopec Group, sales by agents and sales based on our own discretion accounted for 65.31%, 29.09% and 5.60%, respectively, of the total sales volume in 2022.

We generally sell our products to larger trading companies and industrial users with whom we have long-standing relationships, including Sinopec Group or customers designated by Sinopec Group. We believe that the transition to sales of major petrochemical products by agents designated by Sinopec Group will increase our distribution efficiency, reduce horizontal competition and enhance our overall bargaining power, by allowing us to benefit from Sinopec Group’s extensive and highly specialized sales network. It will also allow us to focus more of our resources on reducing production costs and enhancing our technical support.

We use long term contracts to sell most of our products. We did not experience significant write-offs or defaults on our accounts receivable or other trading accounts in 2022. In general we managed to maintain a stable correlation between production and sales in 2022.

Product breakdown

Synthetic Fibers – In 2022, 11.85% of our synthetic fiber products were purchased by provincial and municipal government trading companies that act as intermediaries between us and end-users. List of customers each accounting for more than 25% of the sales in this segment. List of customers each accounting for more than 10% of the sales in this segment: Shanghai Dunshan Textile Co., Ltd. (上海盾杉纺织品有限公司): 21.77%; Jiangsu Zhonghuai Textile New Materials Co., Ltd. (江苏中淮纺织新材料有限公司): 13.85%

Resins and Plastics – In 2022, approximately 52% of our resins and plastics sales were to provincial and municipal government trading companies and approximately 48% were sold to industrial users. No single customer accounted for more than 5% of our sales of resins and plastics in 2022.

Intermediate Petrochemicals – We sell a variety of intermediate petrochemical products, among which the sale volume of petroleum benzene and paraxylene was relatively high in 2022. Shanghai SECCO Petrochemical Company Limited (“SECCO”) is the principal outside consumer of our petroleum benzene. In 2022, we sold 0.1685 million tons of petroleum benzene to SECCO, representing 56.71% of our total 2022 production of such product. List of customers each accounting for more than 10% of sales in this segment: SECCO: 56.71%; SINOPEC Shanghai Gaoqiao Petroleum Chemical Co., Ltd.: 18.61%; Zhejiang Baling Hengyi Caprolactam Co., Ltd.: 9.86%.

Jiaxing Petrochemical Company Limited, Oriental Petrochemical (Shanghai) Corporation and Zhejiang Dushan Energy Co., Ltd. are the outside consumers of our paraxylene. In 2022, we sold 0.2264 million tons, 0.0419 million and 0.3172 million tons of paraxylene, representing 38.16%, 7.06% and 53.47% of our total 2022 production of such product, to Jiaxing Petrochemical Company Limited, Oriental Petrochemical (Shanghai) Corporation respectively and Zhejiang Dushan Energy Co., Ltd., at prices mutually agreed upon by the relevant parties.

Petroleum Products – In 2022, our primary gasoline and diesel customer was East China Branch of Sinopec Sales Company Limited (“SINOPEC East China Company”).

Trading of Petrochemical Products – In 2022, our largest trading customer for petrochemical products was Sinopec Chemical Commercial Holding Company Limited.

Major Suppliers and Customers

The Group’s top five suppliers in 2022 were China International United Petroleum & Chemical Co., Ltd., East China Branch of Sinopec Sales Company Limited, Materials and Equipment Department of China Petroleum and Chemical Corporation, SECCO, and Shanghai Gas Co., Ltd.. Total procurement costs involving these five suppliers, which amounted to RMB 53,719.8 million, accounted for 74.29 % of the total procurement costs of the Group for the year. Among the top five suppliers, the purchase amount of related parties was RMB 52,304.9 million, accounting for 72.33% of the total annual purchase amount. The procurement from the largest supplier amounted to RMB 45,666.4 million, representing 63.15 % of the total costs of purchases by the Group for the year.

The Group’s top five customers in 2022 were SINOPEC East China Company, China International United Petroleum & Chemical Co., Ltd., Sinopec Sales Company Limited, SECCO and Zhejiang Dushan Energy Co., Ltd.. Total sales to these five customers amounted to RMB 54,719.9 million, representing 66.37% of the Group’s total turnover for the year. Among the sales of the top five customers, the sales of related parties was RMB 52,363.1 million, accounting for 63.51% of the total annual sales. Sales to Sinopec Group’s largest customer amounted to RMB 40,337.00 million, representing 48.93% of Sinopec Group’s total turnover for the year.

To the knowledge of the Board, among the suppliers and customers listed above, Shareholders and Directors of the Company and their close associates have no interest in Shanghai Gas Co., Ltd. and Zhejiang Dushan Energy Co., Ltd.; SECCO is an associate of the Company; China International United Petroleum & Chemical Co., Ltd., SINOPEC East China Company, Materials and Equipment Department of China Petroleum and Chemical Corporation and East China Branch of Sinopec Sales Company Limited and Sinopec Sales Company Limited are subsidiaries of Sinopec Corp., the controlling shareholder of the Company.

Product Pricing

Most of our products are permitted to be sold at market prices. However, four types of petroleum products (gasoline, diesel and jet fuel, and liquefied petroleum gas) that we sell are subject to varying degrees of government pricing control and are, accordingly, sold at prices set by the Chinese government. In 2020, 2021 and 2022, approximately 43.64%, 47.01% and 51.40% of our net sales, respectively, were from products subject to price controls. Price controls may apply to these products in various ways. Such price controls are sometimes applied exclusively to our products, exclusively to our competitors’ products or sometimes applied to neither our products nor our competitors’ products. The Chinese government has adopted changes to the pricing mechanism for domestic refined oil to be indirectly aligned with international crude oil prices in a controlled manner through use of certain formula(s).

For products that are not subject to price controls, we set our prices with reference to prices in the major Chinese chemical commodities markets in Shanghai and other parts of China. We also monitor pricing developments in major international commodities markets, particularly in Southeast Asia. In most cases, we revise product prices each month, or more frequently during periods of price volatility. Due to our economies of scale, brand recognition and high quality of products, we believe that we can continue to price our products competitively.

Competition

We compete principally in the Chinese domestic market where 88.36% of our products in volume were sold in 2022. In addition, we believe the limitation in transportation infrastructure in China and the difficulties involved in transporting petrochemical products force petrochemical companies in China, including us, to compete primarily on a regional basis. In 2022, 87.18% of our net sales were made to customers in Eastern China.

Our Competitive Advantages

We believe our primary competitive advantages are quality of product, pricing, brand recognition, geographic location and vertical integration. We have received many prizes and awards from both central and local government authorities for high product quality. Furthermore, our location on the outskirts of the densely populated and highly industrialized Shanghai area places us in close proximity to many of our customers. This location also gives us convenient access to ocean transport and inland waterways, which results in a competitive advantage in terms of transportation cost and reliability and punctuality of product delivery.

We believe that our vertical integration in business model represents a significant competitive advantage over non-integrated competitors in China, both in terms of reliability in delivery and price. For most downstream products, our vertical integration results in significant savings on transportation and storage costs which would be incurred by less vertically integrated facilities.

The Domestic Competitive Environment

Prior to 1993, because distribution and pricing of our products were determined in accordance with the state plan, we did not operate in a competitive environment. With the liberalization of control over pricing and product allocation by the Chinese government, competition in the domestic market has been gradually increasing. At the same time, Chinese private enterprises have gradually overcome technological and funding barriers to extend their business from the downstream processing sector to the upstream petrochemical field. These enterprises have advantages in many areas such as flexibility in operation costs, preferential policy treatment and regional presence, and may use these advantages to compete with us in markets for our products.

Foreign Competition and the World Trade Organization

China joined the WTO on December 11, 2001. As part of its membership commitments, China agreed to eliminate certain tariff and non-tariff barriers to foreign competition in the domestic petrochemical industry that benefited us in the past. In accordance with its WTO commitments, China:

•

has reduced tariffs on imported petrochemicals products that compete with ours;

•

increased levels of permitted foreign investment in the domestic petrochemicals industry, allowing foreign investors to own 100% of a domestic petrochemicals company from December 11, 2004;

•

has gradually relaxed restrictions on the import of crude oil by non-state owned companies;

•

has granted foreign-owned companies the right to import petrochemical products; and

•

has permitted foreign-owned companies to distribute and market fuel products in both retail and wholesale markets in China.

As a result of these measures, we are facing increasing competition from foreign companies and imports. On the other hand, we think that China’s WTO entry and increasing foreign investments in China have contributed and will continue to contribute to the growth of investment and business in China, resulting in an increase in sales opportunities for us.

Our Competitive Position

In the following discussion, internal consumption of resins and intermediate petrochemicals produced by integrated manufacturers in the production of downstream products are treated as sales.

Synthetic Fibers

In 2022, we had an approximate 0.05% share of total domestic polyester and acrylic consumption while imports had an approximate 0.52% share.

The following table summarizes the competitive position of our principal synthetic fibers according to domestic sales in 2022.


Product	Our share of domestic consumption		Our competitive ranking		Location of principal domestic competitor	Principal domestic competitor’s share of consumption		Imports’ share of consumption
	(%)					(%)		(%)
Acrylic		3.37		8	Jilin Province		55.02		7.84

Sources: Zhuochuang Information (www.chem99.com).

Resins and Plastics

In 2022, we had an approximate 1.01% share of total domestic resins and plastics consumption while imports had an approximate 18.84% share. The following table summarizes the competitive position of our principal resins and plastics products according to domestic sales in 2022.


Product	Our share of domestic consumption		Our competitive ranking		Location of principal domestic competitor	Principal Domestic competitor’s Share of consumption		Imports’ share of consumption
(%)						(%)		(%)
Polyester chips		0.54		4	Jiangsu Province		4.68		1.80
Polyethylene		1.05		29	Guangdong Province		1.59		36.27
Polypropylene		1.24		24	Zhejiang Province		3.42		9.19

Sources: Zhuochuang Information (www.chem99.com).

Intermediate Petrochemicals

In 2022, we were one of the largest sellers of intermediate petrochemicals in China, holding an approximate 1.14% share of total domestic consumption, while imports had an approximate 14.50% share of domestic consumption. Ethylene glycol, paraxylene, benzene and butadiene are our major intermediate petrochemical products. In 2022, we were a major producer of ethylene, paraxylene and benzene in China. The following table summarizes the competitive position of our principal intermediate petrochemicals according to domestic sales in 2022.


Product	Our share of domestic consumption		Our competitive ranking		Location of principal domestic competitor	Principal Domestic competitor’s Share of consumption		Imports’ share of consumption
	(%)					(%)		(%)
Ethylene glycol		0.46		11	Zhejiang Province		5.62		35.89
Paraxylene		1.71		16	Zhejiang Province		19.16		30.82
Benzene		1.60		8	Zhejiang Province		11.59		17.57
Butadiene		1.86		28	Jiangsu Province		1.91		4.07

Sources: Zhuochuang Information (www.chem99.com).

Petroleum Products

In 2022, we had an approximate 1.70% share of total domestic petroleum products market while imports had an approximate 7.33% share. Although we have one of the largest refining capabilities in China, we use most of our refining capacity to produce feedstock for our own downstream processing of petrochemical products.

The domestic markets for each of our major petroleum products are geographically concentrated because these markets tend to be highly localized with individual producers controlling a large share of the markets in their locality. In 2022, we sold approximately 88.08% of our petroleum products in Eastern China.

Research and Development, Patents and Licenses, etc.

We have a number of technology development units, including Advanced Materials Innovation Research Institute, the Petrochemical Research Institute, the Plastics Research Institute, and the Environmental Protection Research Institute. These units are charged with various research and development tasks with respect to new technology, new products, new production processes and equipment and environmental protection. Our research and development expenditures in 2020, 2021 and 2022 were RMB 110.6 million, RMB 94.3 million and RMB 130.5 million, respectively. The increase was mainly due to the increase in material cost for research and development of technology in equipment and products.

We are not, in any material aspect, dependent on any patents, licenses, industrial, commercial or financial contracts, or new production processes.

Investments

We established SECCO, a Sino-foreign equity joint venture, in late 2001 with BP Chemicals East China Investments Limited (“BP”) and Sinopec Corp., primarily to build and operate a 900,000 ton Rated Capacity ethylene petrochemical manufacturing facility. SECCO completed construction and commenced its manufacturing operations in 2005. In 2009, SECCO had expanded the capacity of certain facilities to 1,090,000 tons of ethylene per annum. We own 20% of the equity interest of SECCO, while BP and Sinopec Corp. own 50% and 30% interests in SECCO, respectively. In October 2017, BP transferred its 50% equity interests in SECCO to a subsidiary of Sinopec Corp., Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd. As a result of equity transfer, we, Sinopec Corp. and Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd. own 20%, 30% and 50% interests in SECCO, respectively, and SECCO was converted into a PRC domestic company. The registered capital of SECCO is RMB7,800,811,272.00, all of which had been fully contributed by the shareholders in accordance with their equity percentages in SECCO as of October 18, 2017. In July 2021, SECCO’s paid in capital has reduced from RMB 7,800,811,272 to RMB 500,000,000 and all shareers of SECCO has reduced their capital in proportion to their shareholding ratios. In August 2022, the registered capital of SECCO increased from RMB 500,000,000 to RMB 3,115,180,000 through transfer from surplus reserve. Sinopec Corp., Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd. and we increased the registered capital according to the original shareholding ratios. In December 2022, Sinopec Corp. transferred 15% of its equity to INEOS, and Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd. transferred 35% of its equity to INEOS. As at December 31, 2022, INEOS, Sinopec Corp., Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd. and we owned 50%,15%,15% and 20% interests in SECCO, respectively.

In 2022, SECCO achieved a sales revenue of RMB 24.10 billion (U.S.$ 3.59 billion), representing a decrease of 18.91% from its sales revenue of RMB 29.72 billion (U.S.$ 4.61 billion) in 2021. SECCO produced 171,535 tons of ethylene in 2022, representing a decrease of 98,029 tons over the previous year. SECCO had a net loss of RMB 1.95 billion (U.S.$ 290.14 million) in 2022, representing a decrease of RMB 5.08 billion (U.S.$ 775.61 million) over the previous year.

Environmental Protection

We are subject to national and local environmental protection regulations, which currently impose a graduated schedule of fees for the discharge of waste substances, require the payment of fines for pollution and provide for the forced closure of any facility that fails to comply with orders requiring it to cease or cure certain environmentally damaging practices. We have established environmental protection systems which consist of pollution control facilities to treat certain of our waste materials and to safeguard against accidents. Because of the nature of our business, however, we store a significant amount of waste substances in the plants and discharge them into the environment after making such waste substances meet the discharge standards. In 2022, the Company paid a total of RMB 12.68 million in environmental taxes, a decrease of 10.74% compared with 2021.

We were subject to various administrative penalties for its violations of the relevant PRC environmental laws and regulations in the past three years. In 2022, we were subject to no administrative penalty for violations of the relevant PRC environmental laws and regulations.

We believe our environmental protection facilities and systems are adequate for the existing national and local environmental protection regulations. In 2022, we continued to carry out various energy-saving and emissions reduction measures in accordance with the relevant domestic energy conservation and emissions reduction requirements, and achieved all energy-saving and emissions reduction goals set by the Chinese government during the year.

As compared with 2021, the emissions of ammonia nitrogen, sulfur dioxide and nitrogen oxide decreased by 57.64%, 23.90%, 10.56%, respectively, and COD emissions increased by 7.19%. The Company achieved a 100% comprehensive standard rate of effluents, a 99.99% standard rate of controlled exhaust gas discharge, and a 100% rate of proper disposal of hazardous waste. The Company continued to progress the LDAR related work. In 2022, we tested a total of 2,902,476 sealing points of production units, detected 8,374 leak points and repaired 8,245 points, with a repair rate of 98.50%.

Insurance

We currently participate in a package of insurance coverage plan through Sinopec Group as its controlled subsidiary, which, as of December 31, 2022, was approximately RMB 46.2429 billion (U.S.$ 6.7046 billion) on our property and facilities and approximately RMB 1,639.23 million (U.S.$ 237.67 million) on our inventory. In addition, we maintain insurance policies for such assets as vehicles and products in transit with third-party’s commercial insurance company. The Sinopec Group insurance coverage is compulsory and applies to all enterprises controlled by Sinopec Group, pursuant to guidelines of Sinopec Group which may not be legally enforceable against Sinopec Group. Thus, there are uncertainties under Chinese law as to what percentage insurance claims we may demand against Sinopec Group.

Cyber Security

We have implemented policies and procedures intended to prevent cyber incidents and to identify and respond to unauthorized intrusions. With respect to our internal internet policies on cybersecurity, we have established an information safety management system and issued internal regulations on cybersecurity, internal hardware and data safety systems and we are gradually implementing measures relating to the office environment information safety management, information system access control, protection from any malicious software, and internal review and audit of information safety risks, in order to prevent loss of information due to cybersecurity incidents, network outages or hardware incidents. In 2022, we did not experience any material cybersecurity incidents or related losses.

Government Regulations

Following the development of several major oil fields and a growth in demand for petroleum and petrochemical products in China in the early 1970s, the Chinese government organized petroleum refining and petrochemical production and processing plants into large complexes that would permit integrated production of petroleum products, intermediate petrochemicals, resins and plastics, and synthetic fibers.

Although the Chinese government is liberalizing its control over the petroleum and petrochemical industries in China, significant government regulations that limit the business strategies available to us remain. Central government agencies and their local or provincial level counterparts do not own or directly control our production plants. However, they exercise significant control over the petrochemical industry in areas such as pricing, production quotas, quality standards, allocation of raw materials and finished products, allocation of foreign exchange and Renminbi loans for capital construction projects. The Chinese government’s intentions with respect to the development objectives and policies for the petrochemical industry are stated as part of the Five Year Plans for National Economic and Social Development formulated every five years. These plans at both the national and Shanghai municipality level have identified the petrochemical industry as a “development industry.”

Historically, we were supervised by Sinopec, a ministry-level enterprise under the direct supervision of the State Council, China’s highest administrative body. As a result of a governmental restructuring in 1998, we became subject to the administration of the State Bureau of Petroleum and Chemical Industry. After its functions were terminated in March 2001, we became subject to the administration of the State Economic and Trade Commission. The State Economic and Trade Commission was dissolved in March 2003 and its function in directing the reform and management of state-owned enterprises was assumed by the State-owned Assets Supervision and Administration Commission, its function in industry planning and policy making was assumed by NDRC, and its functions in administering domestic trade, coordinating and implementing import and export plans of critical industrial products and raw materials were assumed by the Ministry of Commerce. Since then, we have been subject to the industrial oversight of these three governmental agencies at the national level.

As part of this restructuring, Sinopec was also restructured in July 1998. The succeeding entity, Sinopec Group, was authorized to conduct petrochemical business and to control the exploration of crude oil and natural gas and crude oil refining, mainly in the southern and eastern regions of China. China Petroleum and Natural Gas Corporation, another major state-owned petrochemical company, was also restructured, renamed China National Petroleum Corporation and authorized to conduct the same type of business, mainly in the northern and western regions of China. On December 31, 1999, Sinopec Group completed a reorganization pursuant to which certain of its core oil and gas and chemical operations and businesses and related assets and liabilities were transferred to its subsidiary, Sinopec Corp., currently our controlling shareholder.

Business Operations Relating to Iran and other U.S. Sanctioned Countries

In 2022, we sourced no crude oil from Iran.

In addition, based on feedback to our inquiries to Sinopec Corp., in 2022, it did not source any of its refinery throughputs of crude oil from Iran. Based on Sinopec Corp.’s internal reports and statistics, Sinopec Corp. recorded no revenue or net profit from its trading activities with Iranian companies.

In addition, based on feedback to our inquiries to Sinopec Group, the controlling shareholder of Sinopec Corp., Sinopec Group engaged in a small amount of business activities in Iran such as providing engineering services and designs. Sales revenue and profits from these business activities accounted for 0.02% and 0.13% of its total unaudited sales revenue and profits respectively.

We have no performance obligations under any contract to continue to purchase crude oil sourced from Iran in 2023.

C. Organizational Structure.

Our Subsidiaries

As of December 31, 2022, our significant subsidiaries are listed below. All of the subsidiaries named below are incorporated in China.


Subsidiary Name	Our ownership interest (%)		Our voting power (%)
Shanghai Petrochemical Investment Development Company Limited		100.00		100.00
China Jinshan Associated Trading Corporation		67.33		67.33
Shanghai Jinchang Engineering Plastics Company Limited		74.25		71.43
Shanghai Golden Phillips Petrochemical Company Limited		100.00		100.00
Shanghai Jinshan Trading Corporation		67.33		67.33
Zhejiang Jinlian Petrochemical Storage and Transportation Company Limited		100.00		100.00

Sinopec Corp.

We are a member of a group (defined as a parent and all its subsidiaries) for purposes of the disclosure rules of the SEC. The parent company of this group is Sinopec Corp., our controlling shareholder. Sinopec Corp. is operated by separate management and from time to time uses its interest as a shareholder to direct our policies and management.

Sinopec Corp. is the largest integrated petroleum and petrochemical company in China and one of the largest in Asia in terms of operating revenues. Sinopec Corp. is one of the largest refiners, distributors and marketers of gasoline, diesel, jet fuel and most other major refined products in China and Asia with principal markets in the eastern and southern regions of China. Sinopec Corp. is also a producer and distributor of petrochemicals in China and additionally explores, develops and produces crude oil and natural gas principally to supply its refining and chemical operations.

Subsidiaries

Details of Sinopec Corp.’s principal subsidiaries are given in the table below. Except for Sinopec Kantons Holdings Limited and Sinopec Overseas Investment Holding Limited, which are incorporated in Bermuda and Hong Kong respectively, all of the below principal subsidiaries are incorporated in China.

Name of Company

Particulars
of issued
capital

Type of legal
entity

Percentage of
equity held by
Sinopec Corp.
and its
subsidiary

Principal activities

(millions)

(%)

Sinopec International Petroleum Exploration and Production Company Limited

RMB8,250

Limited company

100.00

Investment in exploration, development, production, sales of petroleum and natural gas and other areas

Sinopec Great Wall Energy and Chemical Company Limited

RMB22,761

Limited company

100.00

Coal chemical industry investment management, production and sale of coal chemical products

Sinopec Yangzi Petrochemical Company Limited

RMB15,651

Limited company

100.00

Manufacturing of intermediate petrochemical products and petroleum products

Sinopec Yizheng Chemical Fiber Limited Liability Company

RMB4,000

Limited company

100.00

Production and sale of polyester chips and polyester fibers

Sinopec Lubricant Company Limited

RMB3,374

Limited company

100.00

Production and sale of lubricant products, lubricant base oil, and petrochemical materials

Sinopec Qingdao Petrochemical Company Limited

RMB1,595

Limited company

100.00

Manufacturing of intermediate petrochemical products and petroleum products

Sinopec Chemical Sales Company Limited

RMB1,000

Limited company

100.00

Marketing and distribution of petrochemical products

China International United Petroleum & Chemical Company Limited

RMB5,000

Limited company

100.00

Trading of crude oil and petrochemical products

Sinopec Overseas Investment Holding Limited

U.S.$3,423

Limited company

100.00

Investment of overseas business and equity interests management

Sinopec Catalyst Company Limited

RMB1,500

Limited company

100.00

Production and sale of catalyst products

China Petrochemical International Company Limited

RMB1,400

Limited company

100.00

Trading of petrochemical products

Sinopec Beihai Refining and Chemical Limited Liability Company

RMB5,294

Limited company

98.98

Import and processing of crude oil, production, storage and sales of petroleum and petrochemical products

Sinopec Qingdao Refining and Chemical Company Limited

RMB5,000

Limited company

85.00

Manufacturing of intermediate petrochemical products and petroleum products

Sinopec Hainan Refining & Chemical Company
Limited

RMB9,606

Limited company

100.00

Manufacturing of intermediate petrochemical products and petroleum products

Sinopec Marketing Co.

RMB28,403

Limited company

70.42

Marketing and distribution of refined petroleum products

Sinopec-SK (Wuhan) Petrochemical Company Ltd.

RMB7,193

Limited company

59.00

Production, sale, research and development of petroleum

products, petrochemical products, ethylene and downstream derivatives

Sinopec Kantons Holdings Limited

HK$248

Limited company

60.33

Provision of crude oil jetty services and natural gas

pipeline transmission services

Sinopec Shanghai Gaoqiao Petrochemical Company Limited

RMB10,000

Limited company

55.00

Manufacturing of intermediate petrochemical products

and petroleum products

Sinopec Shanghai Petrochemical Company Limited

RMB10,824

Limited company

50.55

Manufacturing of synthetic fibers, Resin and plastics,

intermediate petrochemical products and petroleum products

Fujian Petrochemical Company Limited

RMB10,492

Limited company

50.00

Manufacturing of plastics, intermediate petrochemical products and petroleum products

Zhongke (Guangdong) Refining & Chemical Co., Ltd.

RMB 6,397

Limited company

90.30

Crude oil processing and petroleum product manufacturing

Sinopec Baling Petrochemical Co., Ltd.

RMB 3,000

Limited company

55.00

Crude oil processing and petroleum product manufacturing

D. Property, Plant and Equipment.

Real Property

Our corporate headquarters and production facilities, occupying an area of approximately 7.03 square kilometers, are located in Jinshanwei, approximately 75 kilometers from downtown Shanghai. The total gross floor area of all our production and other facilities is approximately 2 million square meters. We own all of the buildings and facilities located at the site. We have the right to use the land upon which our buildings and facilities are located for a term of 50 years beginning in 1993 without the payment of any rent or usage fees other than land use taxes. We also have the right to transfer our land use rights to third parties without any payment to the Chinese government, so long as the use of the land remains the same as when the land use right was granted to us and the terms of the land use right we received will be applicable to any transferees.

Plants and Facilities

The following tables set forth the Rated Capacities of our principal production units. The actual production capacity of a production unit can exceed the Rated Capacity and may be further increased without increasing the Rated Capacity through technical improvements or expansion of such unit. The utilization rate of a production unit is based upon the Rated Capacity rather than actual production capacity and may vary with technical enhancements, changes in production management and scheduling of maintenance.

The following table sets forth the Rated Capacities and weighted average utilization rates of our principal production units for petroleum products and intermediate petrochemicals in 2022:


Key production facilities (number of sets)	Designed capacity (tons)		Capacity Utilization (%)
Crude oil distillation facility (2)		14,000,000		89.52
Hydrocracking facility (2)		3,000,000		88.88
Ethylene facility		700,000		97.06
* Aromatics facility (2)		835,000		96.86
PTA facility		400,000		—
Ethylene oxide/Ethylene glycol facility (2)		525,000		77.48
Catalytic cracking		3,500,000		92.19
Delayed coking (2)		2,200,000		88.60
** Diesel hydrogenation (2)		3,850,000		83.31
** Acrylonitrile facility		650,000		100.35
C-5 Separation (2)		185,000		123.25
*** Polyester facility (3)		550,000		87.31
**** Polyester staple fibre facility (2)		158,000		—
**** Polyester filament facility		21,000		—
***** Acrylics staple fibre facility (3)		140,800		93.03
Polyethylene facility (3)		408,000		93.33
Polypropylene facility (3)		400,000		95.13
Vinyl acetate facility		86,100		104.41

*	No.1 PX facility (235,000 tons/year) was suspended for the whole year.

**	No.2 Diesel hydrogenation facility (1,200,000 tons/year) was revamped into acrylonitrile facility by the end of 2016. Annual production is 650,000 tons/year.

***	No.2 polyester fibre facility (300,000 tons/year) and No.3 polyester fibre facility (100,000 tons/year) were suspended for the whole year.

****	Polyester staple fibre facility and polyester filament facility were suspended for the whole year.

*****

Acrylic south unit (46,800 tons/year) and the Acrylic south unit (66,000 tons/year) were suspended for the whole year.

Our two crude oil distillation units were designed and built in China. In 2022, the actual quantity of crude oil we processed was approximately 10.45 million tons. Our hydrocracker uses technology from United Oil Products Corporation of the United States. Our second ethylene unit uses technology from ABB Lummus Global Inc. of the United States. The aromatics unit uses technology from Universal Oil Products Corporation of the United States. The PTA unit uses technology from Mitsui Petrochemical Corporation of Japan. The ethylene oxide / ethylene glycol unit was constructed using technology from Scientific Design Corporation of the United States.

Our polyester units use technology from Kanebo Corporation of Japan and E.I. Dupont DeNemours & Co. Inc. of the United States. The polyester staple units use technology from Teijin of Japan and Jima of Germany as well as Chinese technology. The polyester filament units use technology from Murata Manufacturing Company Limited and Teijin Corporation of Japan, Barmag AG of Germany and E.I. Dupont DeNemours & Co. Inc. We produce polyethylene in three units; two LDPE units which use technology from Mitsubishi Petrochemical Corporation of Japan and BASF LDPE of Germany; and one high-density polypropylene unit uses the Borstar bimodal polyethylene technology from Northern European Chemical Engineering Company.

The acrylic fiber units were built domestically, based on a design of equipment which had been imported into China in the 1960s and that we substantially improved. In 1996, we acquired two additional acrylic fiber units which use technology from the Kawasaki Corporation of Japan. We produce polypropylene in three identical units using technology from Himont Corporation of Italy. The PVA unit uses technology acquired from Kuraray Corporation of Japan.

Power Facilities

Our electricity requirements are currently supplied by our own 425 megawatt coal-fired power plant and petroleum coke power plant. These power plants are designed to provide sufficient power supply needed by our facilities. We are connected to the Eastern China electricity grid, which provides a back-up source of power in case of a shortfall in our self-generated power supply.

Other Facilities

We also have facilities to produce industrial water, steam, hydrogen, oxygen and nitrogen which we use in our production facilities.

Maintenance

We engage in production stoppages for facility maintenance and repairs and implement our routine monthly maintenance and repair plans according to the needs of our production facilities, our requirements for product quality, and our commitment to security and environmental protection. The technicians in our facility management department have responsibility for the daily management of maintenance and repair work. We also outsource facility maintenance and repair projects to qualified contractors.

In 2022, the Group focused on building up and implementing stable production as its top priority in production management, and implemented and consolidated its foundation in production operation while cementing safety management. The Company seeks to implement the HSSE management system and put into practice process safety management, and further enhance its ensure equipment integrity assurance regime. We did not encounter serious accidents involving production safety, environmental pollution or occupational poisoning in 2022 except the No.1 ethylene glycol plant explosion accident, which occurred on June 28, 2022 due to a fire broke out in No.1 ethylene glycol plant of the intermediate petrochemicals segment of the Company, causing a fire on surrounding individual pipelines. Net losses due to the fire include (a) writing off of damaged fixed assets and inventories in the amount of RMB7,676 thousand and RMB819 thousand respectively, and (b) compensation to casualties in the amount of RMB1,010 thousand.

Transportation-Related Fixtures

Crude oil, our principal raw material, is transported by pipeline and oil tanker to a crude oil terminal wharf and storage tanks. Our products leave the factory by water, rail, road and pipeline. In 2022, approximately 88.08% of our products by sales volume were picked up by customers from our premises, and the others were delivered by us. Our major ethylene customer is supplied via a pipeline. And some of the products were transported using our facilities.

Wharfs

We own one chemical wharf at Jinshan with five berths of 3,000, 5,000, 10,000, 10,000 and 30,000 tons. We also own a connecting pipeline capable of loading up to approximately 4.6 million tons of chemical products annually onto ocean-going barges and ships. In 2022, products representing 39.07% of total sales volume were shipped from the wharf. We also have a facility to load ships and barges which use the region’s inland waterways. In 2022, products representing 1.08% of total sales volume were shipped from these facilities. We believe that we have a competitive advantage because a greater proportion of our products are shipped by water as opposed to rail and truck, which is subject to capacity constraints on China’s rail and highway networks. Additionally, we own facilities for receiving crude oil and coal at docks that we own and transporting such materials by pipeline or conveyor to our production facilities.

Rail

We own a railroad loading depot with an annual capacity of 500,000 tons. The depot provides access via a spur line to the national Chinese railway system. In 2022, products representing 0.13% of total sales volume were transported from the factory by rail.

Capital Expansion Program

We have planned or started a number of other principal capital expansion projects. In 2020, 2021 and 2022, we invested RMB 2.1 billion, RMB 3.533 billion and RMB 3.452 billion, respectively, in capital expansion projects. We expect that total investment in the projects described below will be approximately RMB 3.7 billion in 2023.

Increasing Quality of Oil Products

In 2016, we launched No. 2 Diesel Hydrogenation Unit Reconstruction and Diesel Quality Upgrading Project so as to further improve the quality of oil products and perfect oil product structure. In 2017, we launched an oil cleaning project with 400,000 tons/year clean gasoline components units, which was completed and put into operation in 2020.

Expansion of New and Existing Downstream Petrochemical Products

As a large-scale integrated petrochemical enterprise, we produce a wide range of intermediate and downstream petrochemical products. In order to adapt to the changes in the world’s energy market and the development trends in the oil and chemical products market in China, we will seek to further integrate the existing refining, olefin and aromatic processing chains, and further develop our chemical business.

To take advantage of our specialty in producing acrylics fiber and to improve our industrial structure and upgrade certain products, we plan to construct a carbon fiber project with a capacity of 1,500 tons/year. Sinopec Corp. approved the basic design for this project in December 2010; pile foundation construction was commenced in December 2010; civil engineering was commenced in February 2011 and one series of facilities under phase I were launched for trial operation in 2012. Subject to the market conditions, we commenced the construction of Phase II of the Project in April 2019, and completed the mid-term delivery of it in March 2021. We commenced raw silks (24,000 ton/year) and 48K large-tow carbon fiber (12,000 ton/year) project in November 2020, and completed Phase I mid-term delivery of them in August 2022.

Upgrading Environmental Protection Facilities Projects

To enhance our capacity for sustainable development and response to the government requirements of environmental protection, we intend to increase our capital expenditures on a series of environmental projects, mainly including 400,000 tons/year clean gasoline components units, transformation project for “ultra clean discharge” work in cogeneration unit, transformation of No. 2 olefin cracking burner, and Thermoelectric Department’s renovation project involving furnaces Nos. 3 and 4 meeting emission standards. All the projects were completed in 2020.

ITEM 4A.

UNRESOLVED STAFF COMMENTS.

None.

ITEM 5.

OPERATING AND FINANCIAL REVIEW AND PROSPECTS.

General

You should read the following discussion and analysis in conjunction with our audited financial statements, in each case, together with the accompanying notes included elsewhere in this annual report. Our audited financial statements have been prepared in accordance with IFRS, as issued by the International Accounting Standards Board.

Critical Accounting Estimates

We prepare our consolidated financial statements in accordance with IFRS, as issued by the IASB. In doing so, we have to make estimates and assumptions. Our critical accounting estimates are those estimates that involve a significant level of uncertainty at the time the estimate was made, and changes in them have had or are reasonably likely to have a material effect on our financial condition or results of operations. Accordingly, actual results could differ materially from our estimates. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis.

Classification of Financial Assets

The classification depends on the Company’s business model for managing the financial assets and the contractual terms of the cash flows. The Company determines the business model for managing financial assets at the level of the financial asset portfolio. The factors considered include the way to evaluate and report the performance of financial assets to key management personnel, the risks affecting the performance of financial assets and their management methods, and the way for relevant business management personnel to obtain remuneration, etc.

When evaluating whether the contractual cash flow of financial assets is consistent with the basic lending arrangements, the Company has the following main judgments: whether the time distribution or amount of the principal may change in the duration due to prepayment and other reasons; whether the interest only includes the time value of money, credit risk, other basic lending risks and the consideration of cost and profit. For example, does the amount of prepayment only reflect the outstanding principal and the interest based on the outstanding principal, as well as the reasonable compensation paid for the early termination of the contract.

Net realizable value (“NRV”) of inventories

Inventories are valued at the lower of cost and net realizable value. The net realizable value is determined based on the estimated selling prices in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale. These estimates are based on the current market condition and historical experience of selling products of similar nature. It could change significantly as a result of competitor actions in response to changes in market conditions.

Management reassesses these estimations at the end of each reporting period to ensure inventory is measured at the lower of cost and net realizable value.

Impairments for non-current assets

At the end of each reporting period, if any indication of impairment exists, the Company estimates the recoverable amount of an asset or a cash-generating unit (“CGU”) (a portion of which related to certain production facilities), at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses. If circumstances indicate that the carrying amount of the asset or CGU may not be recoverable, the asset or CGU may be considered “impaired”, and an impairment loss may be recognized.

The recoverable amount of assets or CGUs is the higher of the fair value less costs of disposal and value in use. As the fair value of certain assets or CGUs may not be publicly available, the Company uses all readily available information in determining an amount that is a reasonable approximation of recoverable amount, including estimates based on reasonable and supportable assumptions for projections of product sales and operating costs and discount rate. In particular, in determining the value in use of the Company’s specific CGUs, significant judgements are required on the accounting estimates which are based on the assumptions relating to product sales growth rates, related costs growth rates and discount rate applied.

Useful life and residual value of property, plant and equipment

Property, plant and equipment, are depreciated on a straight-line basis over the estimated useful lives of the assets, after taking into account the estimated residual value. Management reviews the estimated useful lives and estimated residual value of the assets annually in order to determine the amount of depreciation expense to be recorded during any reporting period. The useful lives are based on the Company’s historical experience with similar assets, taking into account anticipated technological changes. The depreciation expense for future periods is adjusted if there are significant changes from previous estimates.

A. Operating Results

The following discussion covers the years ended December 31, 2021 and 2022. For the discussion covering the year ended December 31, 2020, please refer to Item 5A of the Company’s Form 20-F for the year ended December 31, 2021 filed with the SEC on April 28, 2022.

Government Policies

The impact of government economic, fiscal, and monetary policies can materially affect our financial condition, results of operations, and cash flows (see Item 3. Key Information—D. Risk Factors).

In particular, we consume large amounts of crude oil to manufacture our products of which more than 95% is typically imported. We attempt to mitigate the effect of increased costs due to rising crude oil prices. However, our ability to pass on these increased costs to our customers is dependent on government regulations, among other factors. Given that the increase of the sales prices of our products can lag behind the increase of crude oil costs, we sometimes fail to completely cover the increased costs by increasing our sales prices, particularly where government regulations restrict the prices of certain of our fuel products such as gasoline, diesel and jet fuel, and liquefied petroleum gas. In 2020, 2021 and 2022, approximately 43.64%, 47.01% and 51.40% of our net sales were from such products subject to price controls. Although the current price-setting mechanism for refined petroleum products in China allows the Chinese government to adjust price in the PRC market when the average international crude oil price fluctuates beyond certain levels within a certain time period (see Item 4. Information on the Company – B. Business Overview – Product Pricing), the Chinese government still retains discretion as to whether or when to adjust the prices of the refined oil products. The Chinese government generally exercises certain price control over refined oil products once international crude oil prices experience a sustained rise or become significantly volatile. Moreover, the Chinese government controls the distribution of many fuel products in China. For instance, some of our fuel products are required to be sold to designated distributors (such as the subsidiaries of Sinopec Corp.). Because we cannot freely sell our fuel products to take advantage of opportunities for higher prices, we may not be able to fully cover increases in crude oil prices by increases in the sale prices of our products, which has had and will continue to have a material adverse effect on our financial condition, results of operations and cash flows.

In addition, the exchange rates between the Renminbi and the U.S. Dollar or other foreign currencies are affected by Chinese government policies. In particular, the value of the Renminbi is only permitted to fluctuate within a narrow and managed band against a basket of certain foreign currencies. The Chinese government continues to receive significant international pressure to liberalize its currency policy. Most of our revenue is denominated in Renminbi, and most of our purchase of crude oil and some equipment and repayment of certain borrowings are made in foreign currencies. Historically, the trend for appreciation of the Renminbi was helpful to us since our imported crude oil purchases constitute such a large portion of our total costs. However, the recent depreciation of the Renminbi increased our costs and affected our capacity of making profits. In addition, any depreciation of the Renminbi could adversely affect the value of the dividends of our H Shares and ADSs, which we pay in foreign currencies.

Further appreciation in the value of Renminbi against foreign currencies (including the U.S. Dollar) may cause a decrease in the value of our cash and cash equivalents that are denominated in foreign currencies.

Summary

In 2022, China’s GDP saw growth of 3%, and such rate of growth is expected to accelerate in 2023.

In 2022, the Company actively responded to the complex and severe domestic and international economic and industry situations. At the same time as pandemic prevention, Sinopec Group focused its attention on resolving main contradictions, system optimization, and pandemic prevention to transform potential crisis into opportunities and to achieve a level of operation results with the joint efforts of all staff.

The following table sets forth our sales volumes and net sales for the years indicated:


	Year ended December 31,
	2020						2021						2022
	Sales Volume (‘000 tons)		Net Sales (RMB million)		% of Total Net Sales		Sales Volume (‘000 tons)		Net Sales (RMB million)		% of Total Net Sales		Sales Volume (‘000 tons)		Net Sales (RMB million)		% of Total Net Sales
Synthetic fibers		151.4		1,472.4		2.4		101.9		1,374.8		1.8		22.4		412.5		0.6
Resins and plastics		1,365.4		9,419.7		15.3		1,254.9		9,962.7		13.1		889.3		7,321.2		10.1
Intermediate petrochemicals		2,168.0		8,205.8		13.3		1,989.1		10,780.5		14.2		1,544.2		10,537.7		14.5
Petroleum products		10,347.7		30,139.6		49.0		10,065.0		41,884.4		55.2		7,211.4		41,444.7		57.0
Trading of petrochemical products		—		11,577.3		18.8		—		11,051.4		14.6		—		12,007.6		16.5
Others		—		746.1		1.2		—		835.0		1.1		—		930.9		1.3
Total		14,032.5		61,560.9		100.0		13,410.9		75,888.8		100.0		9,667.3		72,654.6		100.0

The following table sets forth a summary statement of our consolidated statements of operations for the years indicated:


	Year ended December 31,
	2020						2021						2022
	RMB million			% of Net sales			RMB million			% of Net sales			RMB million			% of Net sales
Synthetic fibers
Net sales		1,472.4			2.4			1,374.8			1.8			412.5			0.6
Operating expenses		(1,836.6	)		(3.0	)		(2,228.9	)		(2.9	)		(1,427.8	)		(2.0	)
Segment loss		(364.2	)		(0.6	)		(854.1	)		(1.1	)		(1,015.3	)		(1.4	)


	Year ended December 31,
	2020						2021						2022
	RMB million			% of Net sales			RMB million			% of Net sales			RMB million			% of Net sales
Resins and plastics
Net sales		9,419.7			15.3			9,962.7			13.1			7,321.2			10.1
Operating expenses		(8,157.6	)		(13.3	)		(9,910.5	)		(13.1	)		(8,573.7	)		(11.8	)
Segment profit/(loss)		1,262.1			2.0			52.2			0.1			(1,252.5	)		(1.7	)
Intermediate petrochemicals
Net sales		8,205.8			13.3			10,780.5			14.2			10,537.7			14.5
Operating expenses		(7,624.2	)		(12.4	)		(11,415.6	)		(15.0	)		(11,994.3	)		(16.5	)
Segment profit/(loss)		581.6			0.9			(635.1	)		(0.8	)		(1,456.6	)		(2.0	)
Petroleum products
Net sales		30,139.6			49.0			41,884.4			55.2			41,444.7			57.0
Operating expenses		(32,338.3	)		(52.5	)		(38,917.4	)		(51.3	)		(41,443.7	)		(57.0	)
Segment (loss)/profit		(2,198.7	)		(3.5	)		2,967.0			3.9			1.0			0.0
Trading of petrochemical products
Net sales		11,577.3			18.8			11,051.4			14.6			12,007.6			16.5
Operating expenses		(11,535.3	)		(18.7	)		(11,007.7	)		(14.5	)		(11,994.8	)		(16.5	)
Segment profit		42.0			0.1			43.7			0.1			12.8			0.0
Others
Net sales		746.1			1.2			835.0			1.1			930.9			1.3
Operating expenses		(535.1	)		(0.9	)		(976.5	)		(1.3	)		(1,063.7	)		(1.5	)
Segment profit/(loss)		211.0			0.3			(141.5	)		(0.2	)		(132.8	)		(0.2	)
Total
Net sales		61,560.9			100.0			75,888.8			100.0			72,654.6			100.0
Operating expenses		(62,027.1	)		(100.8	)		(74,456.6	)		(98.1	)		(76,498.0	)		(105.3	)
(Loss)/profit from operations		(466.2	)		(0.8	)		1,432.2			1.9			(3,843.4	)		(5.3	)
Net finance income		332.3			0.5			414.6			0.5			443.3			0.6
Share of profits/(losses) of associates and jointly controlled entities		724.7			1.2			874.3			1.2			(173.6	)		(0.2	)
Profit/(loss) before income tax		590.8			0.9			2,721.1			3.6			(3,573.7	)		(4.9	)
Income tax		65.6			0.1			(644.5	)		(0.9	)		731.4			1.0
Net profit/(loss)		656.4			1.0			2,076.6			2.7			(2,842.3	)		(3.9	)
Attributable to:
Equity shareholders of the Company		645.1			1.0			2,073.4			2.7			(2,846.2	)		(3.9	)
Non-controlling interests		11.3			0.0			3.2			0.0			3.9			0.0
Net profit/(loss)		656.4			1.0			2,076.6			2.7			(2,842.3	)		(3.9	)

Net sales represent sales revenue of the respective segments after sales taxes and surcharges. Operating expenses here represent cost of sales, selling and administrative expenses and other operating expenses /income, as allocated to respective segments.

Year ended December 31, 2022 compared with year ended December 31, 2021

Net sales

In 2022, net sales of the Company amounted to RMB72,654.6 million, a decrease of 4.26% from the previous year’s RMB75,888.8 million. As of December 31, 2022, the weighted average prices (excluding tax) of synthetic fibers, resins and plastics, intermediate petrochemical products and petroleum products of the Company increased by 36.31%, 3.58%, 13.97% and 31.94% year-on-year respectively. The total volume of our products was 9.71 million tons in 2022, representing a decrease of 27.81% over the previous year. Our production/sales ratio was 99.83%, and the trade receivables recovery rate was 100%. Our total amount of sales from export was RMB 9.6 billion, an increase of 17.07% compared with 2021.

(i) Synthetic fibers

In 2022, the Company’s net sales of synthetic fiber products amounted to RMB412.5 million, representing a decrease of 70.00% from the previous year’s RMB1,374.8 million, which was mainly due to the price hike of main raw materials and perennial loss of acrylic fiber, and the lower sales during the Reporting Period resulted from the decrease of sales of synthetic fiber products. Sales volume of synthetic fibers decreased by 78.02% year-on-year, while the weighted average sales price increased by 36.31%. Meanwhile, the sales volume of acrylic fibers, the main product of the synthetic fibers segment, decreased by 71.92% year-on-year. Net sales of acrylic fibers and other products accounted for 78.47% and 21.53% of the total sales of synthetic fibers segment respectively.

Net sales of synthetic fibers accounted for 0.60% of the Company’s net sales in the current year, representing a decrease of 1.2 percentage points from the previous year.

(ii) Resins and plastics

In 2022, the Company’s net sales of resins and plastics products amounted to RMB7,321.2 million, a decrease of 26.51% from the previous year’s RMB9,962.7 million, which was mainly due to the decrease in production resulting from the downturn in the domestic market and the shutdown of production during the Reporting Period. The weighted average sales price of resins and plastics increased by 3.58%, while the sales volume of resins and plastics products decreased by 29.13% year-on-year. Meanwhile, the weighted average sales price of polyethylene and polypropylene decreased by 0.11% and 5.48%, and the weighted average sales price of polyester chips increased by 14.17% year-on-year. The sales of polyethylene, polypropylene, polyester chips and other products accounted for 45.36%, 41.31%, 9.47% and 3.86% of the total sales of resins and plastics segment respectively.

The net sales of resins and plastics accounted for 10.08% of the Company’s net sales in the current year, a decrease of 3 percentage points from the previous year.

(iii) Intermediate petrochemicals

In 2022, the Company’s net sales of intermediate petrochemical products amounted to RMB10,537.7 million, a decrease of 2.25% from the previous year’s RMB10,780.5 million, which was mainly due to the rise in unit price of intermediate petrochemical products driven by the sharp rise in international crude oil prices and due to the decrease in the sales volume resulting from the stagnant market. The weighted average sales price of major intermediate petrochemical products increased by 13.97% year-on-year, and its sales volume decreased by 11.43% year-on-year. The sales of p-xylene, ethylene oxide, pure benzene, ethylene glycol and other products accounted for 41.16%, 11.93%, 19.44%, 2.44% and 25.03% of the total sales of intermediate petrochemical products respectively.

The net sales of intermediate petrochemical products accounted for 14.50% of the Company’s net sales in the current year, an increase of 0.3 percentage points from the previous year.

(iv) Petroleum products

In 2022, the Company’s net sales of petroleum products amounted to RMB41,444.7 million, a decrease of 1.05% from the previous year’s RMB41,884.4 million, which was mainly due to the rise in the price of petroleum products resulted from the hike in international crude oil prices and decrease of sales volume resulted from the downturn in the domestic market. The weighted average sales price of petroleum products increased by 31.94% year-on-year, and sales volume decreased by 30.06%.

The net sales of petroleum products accounted for 57.04% of the Company’s net sales in the current year, an increase of 1.8 percentage points from the previous year.

(v) Trading of petrochemical products

In 2022, the Company’s net sales of trading of petrochemical products amounted to RMB12,007.6 million, an increase of 8.65% from the previous year’s RMB11,051.4 million. This was mainly due to the increase in sales of our second-level subsidiary, Shanghai Jinshan Trading Corporation, by RMB1,439 million.

The net sales of trading of petrochemical products accounted for 16.53% of the Company’s net sales in the current year, an increase of 1.9 percentage points from the previous year.

(vi) Others

In 2022, the Company’s net sales of other products amounted to RMB930.9 million, an increase of 11.48% from the previous year’s RMB835.0 million.

The net sales of other products accounted for 1.28% of the Company’s net sales in the current year, an increase of 0.2 percentage points from the previous year.

Cost of sales and operating expenses

Cost of sales and operating expense consist of cost of sales, sales and administrative expenses, other operating expenses and other operating income, etc.

In 2022, the Company’s cost of sales and expenses amounted to RMB76,498.0 million, an increase of 2.74% from RMB74,456.6 million in 2021. Cost of sales and expenses of synthetic fibers, resins and plastics, intermediate petrochemical products, petroleum products, petrochemical products and other products amounted to RMB1,427.8 million, RMB8,573.7 million, RMB 11,994.3 million, RMB41,443.7 million, RMB11,994.8 million and RMB1,063.7 million respectively, representing a decrease of 35.94%, a decrease of 13.49%, an increase of 5.07%, an increase of 6.49%, an increase of 8.97% and an increase of 8.93% year-on-year respectively.

Compared with the last year, the cost of sales and expenses of intermediate petrochemical products, petroleum products, trading of petrochemical products and others increased this year, which was mainly due to the sharp increase in crude oil prices and thus the increase in corresponding costs.

•

Cost of sales

In 2022, the Company’s cost of sales amounted to RMB76,265.9 million, an increase of 2.65% from previous year’s RMB74,298.0 million, which was mainly due to the increase in cost resulting from the rise in crude oil prices as well as accrual of inventories impairment in cost of sales. Cost of sales accounted for 104.97% of the net sales this year.

•

Selling and administrative expenses

In 2022, the Company’s sales and administrative expenses amounted to RMB288.7 million, a decrease of 21.59% from the previous year’s RMB368.2 million. This was primarily due to the overall sales volume drop in the year.

•

Other operating income

In 2022, the Company’s other operating income amounted to RMB110.6 million, a decrease of 11.73% from previous year’s RMB125.3 million. This was mainly due to the drop in rental income.

•

Other operating expenses

In 2022, the Company’s other operating expenses amounted to RMB25.8 million, a decrease of 42.28% from previous year’s RMB44.7 million. This was primarily due to the decrease of RMB23.2 million for the purchases of rights of carbon emission during the year.

Loss from operations

In 2022, the Company’s operating loss amounted to RMB3,843.4, and the operating profit amounted to RMB1,432.2 million in the previous year. In 2022, the Company’s operating loss was mainly due to the rising cost resulting from higher crude oil prices, the increase in the selling price of products not as high as the rising cost, and a sluggish domestic market.

(i) Synthetic fibers

In 2022, the operating loss of synthetic fibers amounted to RMB1,015.3 million, an increase of RMB161.2 million from the operating loss of RMB854.1 million in the previous year. The increase was mainly due to the weak market demand of the textile industry which is the downstream market of the synthetic fibers segment, together with temporary plant shutdown. Due to a part of production facilities being idle or obsolete the provision for impairment of long-term assets of RMB49.2 million was made for the synthetic fiber segment.

(ii) Resins and plastics

In 2022, the operating loss of resins and plastics amounted to RMB1,252.5million, and the operating profit amounted to RMB52.2 million in the previous year. The decrease in operating profit in the year was mainly because the rise in international crude oil prices resulted in the sharp rise in costs while the demand in the downstream market was weak, and thus the increase in sales price was lower than that in cost price.

(iii) Intermediate petrochemicals

In 2022, the operating loss of intermediate petrochemical products amounted to RMB1,456.6 million, an increase of RMB821.5 million from the operating loss of RMB635.1 million in the previous year. The increase in operating loss of petrochemical products as compared with the previous period was mainly because the rise in international crude oil prices resulted in the sharp rise in costs while the demand in the downstream market was weak, and thus the increase in sales price was lower than that in cost price. In 2022, provision for impairment of long-term assets of RMB212.4 million was made for some devices as increasing production and operation cost is not expected to be covered by the estimated selling price of the products due to deteriorating market conditions.

(iv) Petroleum products

In 2022, the operating profit of petroleum products amounted to RMB1.0 million, a decrease of RMB2,966.0 million from the operating profit of RMB2,967.0 million in the previous year. The decrease in operating profit in the year was mainly due to the rise in international crude oil prices resulted in the sharp rise in costs, and thus the increase in sales price was lower than that in cost price.

(v) Trading of petrochemical products

In 2022, the operating profit of the trading of petrochemical products amounted to RMB12.8 million, a decrease of RMB30.9 million from the operating profit of RMB43.7 million in the previous year, which was mainly due to the decrease in the gross profit from trading of petrochemical products during the period.

(vi) Others

In 2022, the Company’s other operating loss amounted to RMB132.8 million, a decrease of RMB8.7 million from the other operating loss of RMB141.5 million in the previous year, which was no significant change compared with the previous year.

Net finance income

In 2022, the Company’s net financial income amounted to RMB443.3 million, an increase of RMB28.7 million from the net financial income of RMB414.6 million in the previous year, mainly due to an increase in interest income from time deposits during the Reporting Period, resulting in an increase of our interest income by RMB33 million from RMB508.8 million in 2021 to RMB541.8 million in 2022.

Loss before taxation

In 2022, the Company’s loss before taxation amounted to RMB3,573.7 million, and the profit before taxation amounted to RMB2,721.1 million in the previous year.

Income tax

The income tax benefit of the Company amounted to RMB731.4 million in 2022 and the income tax expense amounted to RMB644.5 million in 2021. This was primarily due to the recognition of deferred income tax assets as a result of the Company’s loss for the year. In accordance with The Enterprise Income Tax Law of the PRC (amended in 2018), the income tax rate applicable to the Company in 2022 is 25% (2021: 25%).

The effective rate for income tax was 20.47% in 2022, as compared to 23.68% in 2021.

Loss for the year

In 2022, the Company’s loss after tax amounted to RMB2,842.3 million, a decrease of RMB4,918.9 million from the profit after tax of RMB2,076.6 million in the previous year.

B. Liquidity and Capital Resources.

We strive to always have sufficient liquidity to meet our liabilities when due, preparing for both normal and stressed conditions, without incurring unacceptable losses or risking damage to our reputation.

Our primary sources of funding have been cash provided by our operating activities and short term and long term borrowings. Our primary uses of cash have been for cost of sales, other operating expenses and capital expenditures. We prepare monthly cash flow budgets to ensure that we will always have sufficient liquidity to meet our financial obligations as they become due. We arrange and negotiate financing with financial institutions and maintain a certain level of standby credit facilities to reduce liquidity risk. We believe that our current cash on hand, expected cash flows from operations and available standby credit facilities from financial institutions will be sufficient to meet our working capital requirements and repay our short term borrowings and obligations when they become due. In addition, we will continue to optimize our fund raising strategy from short and long term perspectives to take advantage of low interest rates by issuing corporate bonds or debts with low financing costs.

The following table sets forth a condensed summary of our consolidated statement of cash flows for the years ended December 31, 2020, 2021 and 2022.


	Year Ended December 31,
	2020			2021			2022

	(RMB million)
Net cash generated from / (used in) operating activities		1,679.8			3,950.0			(7,459.4	)
Net cash (used in) / generated from investing activities		(3,887.5	)		(2,359.4	)		4,390.4
Net cash generated from / (used in) financing activities		1,681.8			(3,393.1	)		(1,168.9	)
Net decrease in cash and cash equivalents		(525.9	)		(1,802.5	)		(4,237.9	)

Net cash generated from operating activities

The net cash used in operating activities amounted to RMB 7,459.4 million in 2022, representing and the net cash inflows amounted to RMB 3,950.0 million in 2021. During the reporting period, with the operating loss, the Company’s cash outflows used in operating activities in 2022 amounted to RMB 6,960.7 million, and the cash inflows generated from operating activities amounted to RMB 4,411.7 million in 2021. The income tax paid in 2022 amounted to RMB 376.8 million, an increase of RMB 25.2 million from the income tax paid of RMB 351.6 million in the previous year.

The net cash generated from operating activities amounted to RMB 3,950.0 million in 2021, representing an increase in cash inflows of RMB 2,270.1 million as compared to the net cash inflows of RMB 1,679.9 million in 2020. During the reporting period, with profitability in operating, the Company’s cash inflows generated from operating activities in 2021 amounted to RMB 4,411.7 million, an increase of RMB 2,416.6 million from the cash inflows generated from operating activities of RMB 1,995.1 million in 2020. The income tax paid in 2021 amounted to RMB 351.6 million, an increase of RMB 107.7 million from the income tax paid of RMB 243.9 million in the previous year.

Net cash used in investing activities

The net cash inflows amounted to RMB4,390.4 million in 2022, and the net cash outflows amounted to RMB2,359.4 million in 2021. This was primarily due to the net cash inflow of time deposits increased in the year as compared with the previous year. .

Our net cash used in investing activities decreased from RMB 3,997.5 million in 2020 to RMB 2,359.4 million in 2021. This was primarily due to the proceeds from capital reduction of an associate. According to the resolution of the Board of Directors on 9 July 2021, the Company, Sinopec Corp., and Sinopec Shanghai Gaoqiao Petrochemical Company Limited approved to reduce their paid-in capital in SECCO, an associate of the Company, by a total amount of RMB 7,300.8 million in proportion to their shareholding ratios of 20%, 30% and 50% respectively. Among them, the Company reduced its investment cost in SECCO by approximately RMB 1,460.3 million and the Company has received the amount of the capital reduction in December 2021.

Net cash used in financing activities

Our net cash used in financing activities was RMB 1,168.9 million in 2022 as compared to RMB 3,393.1 million in 2021. The decrease of net cash outflows was primary because the net cash outflow from the acquisition and repayment of short-term bonds decreased by RMB3,001 million and the net cash outflow from the acquisition and repayment of loans increased by RMB722 million as compared with the previous year.

Our net cash used in financing activities was RMB 3,393.1 million in 2021 as compared to net cash generated from financing activities was RMB 1,681.8million in 2020. The decrease was mainly due to net cash outflow resulted from repayment of short-term bonds and issuance of short-term bonds.

Borrowings and banking facilities

Our total borrowings at the end of 2022 amounted to RMB2,250 million, representing a decrease of RMB 9.8 million as compared to RMB 2,259.8 million at the end of the previous year. See Item 11 Quantitative and Qualitative Disclosures about Market Risk – Interest Rate Risk for more information on the maturity and the interest rate of the borrowings. We have been able to arrange short term loans with several PRC financial institutions as and when needed. The debt obligations as of December 31, 2021 and 2022 were as follows.


Debt instruments	As of December 31,
	2021		2022

	(RMB million)
Short term bank loans (1)		1,559.8		1,550.0
Long term bank loans		700.0		700.0

		2,259.8		2,250.0

(1)

As of December 31, 2022, no borrowings were secured by the way of property, plant and equipment. We obtained a credit rating of AAA- for financing loans, assessed by Shanghai Huajie Credit Rating & Investors Service Co., Ltd., a credit rating agency authorized by the Shanghai Branch of the People’s Bank of China. As of December 31, 2022, the current assets exceeded current liabilities by RMB 1,767.5 million. The liquidity of the Company is primarily dependent on the ability to maintain adequate cash inflow from operations, the renewal of its short-term bank loans and on its ability to obtain adequate external financing to support its working capital and meet its debt obligation when they become due. We assessed that all the facilities could be renewed upon their expiration dates. We have carried out a detailed review of the cash flow forecast for the 12 months ending December 31, 2022. Based on such forecast, we believe that we will be able to renew these facilities when they expire based on our well-established relationships with various lenders and adequate sources of liquidity exist to fund our working capital and capital expenditure requirements.

In light of our good credit standing and various financing channels, we believe that we will not experience any difficulty in obtaining sufficient financing for our operations.

We managed to maintain our gearing ratio at a safe level by enhancing controls over both liabilities (including borrowings) and financing risks. We generally do not experience any seasonality in borrowings. However, due to the nature of the capital expenditures plan, long term bank loans can be arranged in advance of expenditures while short term borrowings are used to meet operational needs. The terms of our existing borrowings do not restrict our ability to pay dividends on our shares.

Gearing ratio

As of December 31, 2022, our gearing ratio was 35.93%, while as of December 31, 2021, our gearing ratio was 35.26%. The ratio is calculated using this formula: total liabilities divided by total assets.

Capital expenditure

In 2022, our capital expenditure amounted to RMB 3,452 million, representing a decrease of 2.29% as compared to RMB 3,533 million in capital expenditure in 2021. Major projects include the following:


Major Project	Total amount of project investment RMB million		Amount of project Investment in 2022 RMB million		Project progress as of December 31, 2022
Shanghai Jinshan baling New Material Co., Ltd		400,000		200,000	Paid in RMB200 million
Sinopec Shanghai 24000 T/A precursor fiber and 12000 T/A 48K large tow carbon fiber project		3,489,638		1,099,999	Under construction
100 ton high performance carbon fiber test plant		566,183		326,739	Under construction
Improvement transformation project of clean water and sewage separation of Sinopec Shanghai		155,293		80,000	Under construction
Third circuit 220kV incoming power line project of Sinopec Shanghai		507,120		75,000	Under construction
The compliance transformation project plus the hidden danger rectification project of the control system in the control room of 1#, 2#, 3#, 4# refining combined unit of oil refining department		97,689		70,000	Interim delivery
Compliance transformation project of control room of the synthetic resin department (the former plastics department)		121,991		60,000	Under construction
Compliance transformation project of energy consumption of 2xCC100 Turbine (No.5 and No.6) for coal power units		93,260		53,000	Put into operation

Note: In addition to the major capital expenditure items disclosed in the above table, the total capital expenditure of other projects of the Company is RMB1,487 million.

The Company’s capital expenditures for 2023 are estimated at approximately RMB3,700 million.

Proposed Dividend Distribution

The Board did not recommend the distribution of profit for the year nor Capital Reserve Capitalization. The proposal remains to be approved at our 2022 Annual General Meeting.

C. Research and Development, Patents and Licenses, etc.

We have a number of technology development units, including the Petrochemical Research Institute, the Plastics Research Institute, the Polyester Fiber Research Institute, the Acrylic Fiber Research Institute and the Environmental Protection Research Institute. These units are charged with various research and development tasks with respect to new technology, new products, new production processes and equipment and environmental protection. Our research and development expenditures in 2020, 2021 and 2022 were RMB 110.6 million, RMB 94.30 million and RMB 130.5 million, respectively. The increase was mainly due to the increase in material cost for research and development of technology in equipment and products.

We are not, in any material aspect, dependent on any patents, licenses, industrial, commercial or financial contracts, or new production processes.

D. Trend Information

The International Monetary Fund advised in its April 2023 edition of World Economic Outlook that the global economy grew 3.4 percent in 2022 and is projected to have a continued moderate recovery of about 2.8 percent in 2023 and 3.0 percent in 2024. The global economic recovery is still clouded by the following challenges: rising energy costs, higher than anticipated inflation, prolonged pandemic disruptions due to more variants, supply chain disruptions, geo-political tensions such as the Russia-Ukraine conflict and related sanctions, and ongoing climate emergencies and natural disasters.

The domestic petrochemical industry is currently facing the challenge of a downward economic cycle. During the “14th Five-Year Plan” period, China’s refining and chemical industry is set to enter a full phase of new release in capacity and fierce competition. Industry integration, transformation and upgrading are also phasing in. Oversupply is further seen in the refined oil market. The transformation of chemical products towards the higher end and the more environmentally friendly will become a new trend. Driven by new energy, new materials, and the new economy, clean, digital, and diversified developments are now the key trends in developments upon the phasing in of a new energy regime in social development. These new developments will impact the energy supply from petrochemical companies, which will put severe pressure on petrochemical companies’ profitability.

E. Critical Accounting Estimates

Please refer to discussion on Critical Accounting Estimates in general section of Item 5.

F. Other Information

Purchase, Sale and Investment

Except as disclosed in this report, during the year ended December 31, 2022, we engaged in no material purchase or sale of our subsidiaries or associated companies or any other material investments.

Pledge of Assets

As of December 31, 2022, we did not pledge any of our property or equipment.

ITEM 6.

DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES.

A. Directors and Senior Management.

The following table sets forth certain information concerning our directors, executive officers and members of our supervisory committee (“Supervisory Committee”). The current term for our directors, executive officers and members of our Supervisory Committee is three years, which term will end in June 2023.


Name	Age		Position
Directors
Wan Tao		55	Executive Director, Chairman of the Board of Directors, Chairman of Strategy Committee, and Member of Nomination Committee
Guan Zemin		59	Executive Director, Vice-Chairman of the Board of Directors, Vice-Chairman of Strategy Committee, and President
Du Jun		52	Executive Director, Vice President and Chief Finance Officer
Huang Xiangyu		55	Executive Director and Vice President
Xie Zhenglin		58	Non-executive Director and Member of Strategy Committee
Peng Kun		57	Non-executive Director
Li Yuanqin		50	Independent Director, and Chairman of Audit Committee
Tang Song		43	Independent Director, and Member of Audit Committee
Chen Haifeng		49	Independent Director, Member of Audit Committee and Member of Nomination Committee
Yang Jun		67	Independent Director, Chairman of Remuneration and Appraisal Committee and Chairman of Nomination Committee
Gao Song		53	Independent Director, Member of Remuneration and Appraisal Committee and Member of Strategy Committee
Supervisory Committee
Ma Yanhui		52	Chairman of the Supervisory Committee
Zhang Feng		54	Employee Supervisor
Chen Hongjun		52	Employee Supervisor
Zhang Xiaofeng		53	Supervisor
Zheng Yunrui		58	Independent Supervisor
Choi Tingki		69	Independent Supervisor
Senior Management
Jin Qiang*		58	Vice President
Jin Wenmin*		58	Vice President
Zhou Jijun*			Vice President
Huang Fei*		46	Vice President
Liu Gang		51	Secretary of the Board of Directors
Wu Haijun*		61	Former Executive Director, Chairman of the Board of Directors, Chairman of Strategy Committee, and Member of Nomination Committee

On February 15, 2022, Mr. Jin Qiang, Mr. Jin Wenmin and Mr. Huang Fei proposed request to the board of directors that they would no longer serve as executive directors and directors due to job change. Mr. Jin Qiang’s, Mr. Jin Wenmin’s and Mr. Huang Fei’s resignations took effect when the resignation reports were delivered to the board of directors of the Company on February 15, 2022. Mr. Zhou Jijun was appointed as the Vice President of the Company by the board of directors of the Company on January 18, 2023. On September 8, 2022, Mr. Wu Haijun proposed to the board of directors that he would no longer serve as Executive Director and Chairman due to job change. Mr. Wu Haijun’s resignation took effect when the resignation report was delivered to the board of directors of the Company on September 8, 2022.

Directors

Wan Tao, born in January 1968, currently serves as the Company’s Chairman, Executive Director, Chairman of the Strategy Committee and member of the Nomination Committee, Director of Shanghai SECCO and Chairman of Shanghai Chemical Industry Park Development Co., Ltd. From August 2012 to January 2017, he served as deputy director of the Chemical Department of China Petroleum & Chemical Corporation. From March 2013 to January 2017, he served as supervisor of Sinopec Catalyst Co., Ltd. From March 2014 to January 2017, he served as director of Sinopec Great Wall Energy & Chemical (Guizhou) Co. Ltd. From January 2017 to December 2019, he served as general manager of Sinopec Yizheng Chemical Fibre Limited Liability Company and general manager of Yizheng Branch at Sinopec Assets Management Co, Ltd. From January 2017 to January 2018, he served as deputy secretary of the CPC Committee of Sinopec Yizheng Chemical Fibre Limited Liability Company. From January 2018 to July 2022, he served as executive director and secretary of the CPC Committee of Sinopec Yizheng Chemical Fibre Limited Liability Company. In July 2022, he was appointed as secretary of the CPC Committee of the Company and director of Shanghai SECCO. In September 2022, he was appointed as Chairman, Executive Director, Chairman of the Strategy Committee and member of the Nomination Committee of the Company. In October 2022, he was appointed as Chairman of Shanghai Chemical Industry Park Development Co., Ltd. Mr. Wan graduated from Tianjin University in 1992 with an engineering master’s degree in chemical engineering. He is a senior engineer.

Guan Zemin, born in December 1964, is serving as Vice Chairman, Executive Director, Vice Chairman of the Strategy Committee and President of the Company. Mr. Guan started to work in 1990, and he has successively served as Section Manager of Technology Development Section, Technology Development Department, and Deputy Chief Engineer of Wuhan Petrochemical Works, and Director of Catalyzing Workshop, Deputy Director and Director of Production Scheduling Department, and Deputy Chief Engineer of the Wuhan branch of Sinopec Corp. (“Wuhan Branch”). From December 2012 to December 2018, he served as Deputy General Manager of Wuhan Branch. From May 2016 to December 2019, he served as General Manager and Director of Sinopec-SK (Wuhan) Petrochemical Company Limited. From December 2018 to December 2019, he served as the Director and Deputy Party Secretary and General Manager of Wuhan Branch. In December 2019, he was appointed as Deputy Secretary of the Company. From February 2020, he served as the President of the Company. From June 2020, he served as the Executive Director, Vice Chairman and Vice Chairman of the Strategy Committee of the Company. Mr. Guan graduated from the Fine Chemical Major of School of Chemical Engineering, East China University of Science and Technology with a Master’s degree in Engineering in July 1990. He is a senior engineer by professional title.

Du Jun, born in March 1970, is currently the Executive Director, member of the Strategy Committee, Vice President and Chief Financial Officer of the Company, chairman of Jinshan Associated Trading, and director of Shanghai Chemical Industry Park Development Co., Ltd. Mr. Du stared the work in 1990 and successively served as the chief of the second section of the Secretary of the general manager’s office of Yangzi Petrochemical Co., Ltd., the deputy director of the finance department and the deputy director of the Finance Department of Yangzi Petrochemical Co., Ltd. From August 2004 to July 2007, he served as the director of the Finance Department of Yangzi Petrochemical Co., Ltd. From July 2007 to August 2012, he served as the director of the Finance Department of Yangzi Petrochemical Co., Ltd. From August 2012 to August 2016, he served as the chief accountant of Yangzi Petrochemical Co., Ltd. From December 2015 to September 2020, he served as the supervisor of Yangzi Petrochemical BASF Co., Ltd. From June 2016 to September 2020, he served as a director of Yangzi Petrochemical Co., Ltd. From August 2016 to September 2020, he served as the chief accountant of Yangzi Petrochemical Co., Ltd. From September 2020, he served as the deputy general manager and chief financial officer of the Company. He has been the chairman of Jinshan Associated Trading since December 2020. He has been a director of Shanghai Chemical Industry Park Development Co., Ltd. since December 2020. He has been an Executive Director of the Company since June 2021. He has been a member of the Company’s Strategy Committee since March 2022. Mr. Du graduated from Southeast University in 1990, majoring in industrial enterprise management, and obtained a master’s degree in Business Administration from Southeast University in 2004. He has the title of senior accountant.

Huang Xiangyu, born in March 1968, is the Executive Director and Vice President of the Company. Mr. Huang started his career in 1990 and joined Shanghai Petrochemical Complex in 1992. He served as the Deputy Director of the chemical workshop of Shanghai Jinyang Acrylic Plant, Deputy Director of Jinyang Equipment, Director and Deputy Director of Jinyang Acrylic Equipment of Acrylic Business Unit and Chief Engineer of Acrylic Business Unit. From July 2011 to January 2020, he served as the Director of the Acrylic Fiber Research Institute. From November 2011 to January 2020, he served as the Chief Engineer of the Acrylic Fiber Department. From February 2019 to January 2020, he served as Deputy Chief Engineer of the Company. From February 2020, he served as the Vice President of the Company. He has been an Executive Director of the Company since June 2020. Mr. Huang graduated from the Organic Chemical Major of the School of Chemical Engineering, East China University of Science and Technology with a Bachelor’s degree in Engineering in July 1990. He obtained a Master’s degree in Engineering from Donghua University in May 2004. He graduated from Polymeric Chemistry and Physics Major of Fudan University with a doctor’s degree in Science in June 2013. He is a professorate senior engineer by title.

Xie Zhenglin, born in February 1965, is a Non-Executive Director, member of the Strategy Committee, Vice President of Chemical Service Department of the Sinopec Corp., General Manager of Sinopec Group Assets Management Co., Ltd., a director of Chongqing Yangzijiang Acetyl Chemical Co., Ltd., Chairman of Tianjin Jinpuli Environmental Protection Technology Co., Ltd., and a director of Sinopec Shanghai Gaoqiao Petrochemical Co. Ltd.. Mr. Xie started his work in 1989, served as Principal Staff Member of State Price Control Bureau and State Development Planning Commission. After joined Sinopec Group in September 1995, he successively served as Deputy Director of the Comprehensive Division of the Finance Department, Deputy Director of Capital Management Department, Director of the Capital Management Division of the Finance and Assets Department, Director of the Capital Management Division of the Financial Planning Department, Deputy Director of the Financial Planning Department of Sinopec Corp., Deputy Director of General Accounting Department of Sinopec Assets Management (presided over the work), Deputy Director of Assets Management Department of Sinopec Corp., Deputy General Manager of Sinopec Assets Management, Acting Director of Assets Management Department of Sinopec Corp., and Deputy Executive Director and Deputy General Manager of Sinopec Assets Management. From April 2014 to October 2020, he served as the Vice Chairman and director of China Merchants Energy Shipping Co., Ltd. (listed on the Shanghai Stock Exchange, Stock Code: 601872). From April 2014 to December 2019, Mr. Xie served as Director of Assets Management Department of Sinopec Corp., and Executive Director and General Manager of Sinopec Assets Management. He has been the Deputy President of Chemical Service Department of Sinopec Corp. and General Manager of Sinopec Assets Management since December 2019. From June 2020, he served as the Executive Director and a member of the Strategy Committee of the Company. Mr. Xie obtained a Master’s degree in Economics from Graduate School of Chinese Academy of Social Science in August 1989. He obtained a Master’s degree in Business Administration from University of Houston in May 2007. He is a Senior Accountant by professional title.

Peng Kun, born in December 1966, is currently a Non-Executive Director, the General Manager of Human Resource Department, Minister of Party Committee Organization Department, Director of the CPC United Front Work Department and Director of the Office of Veteran Cadres of the Company. Mr. Peng joined the Shanghai Petrochemical Complex in 1986 and served as Deputy Director of General Affairs Office, Department of Chemical Engineering, General Research Institute, assistant manager of the life logistics subsidiary of Easy-Art Design, section manager of Coordination Section of Chemical Engineering Institute, section manager of Administration Department, Secretary of Party General Branch and Deputy Director of Quality Center, Deputy Party Secretary and Secretary of Commission for Discipline Inspection of Quality Management Center, Director of Labor Union, and Chairman, Secretary of the Communist Party Committee and Deputy Manager of Labor Union. He served as Director of Human Resources Department of the Company from February 2016 to April 2018, the Head of Human Resources Division of the Company from April 2018 to May 2019, and the Head of Organization and Personnel Division of the Company from May 2019 to March 2020. He was appointed as Director of CPC United Front Work Department and Director of Retired Cadres Office in May 2019, and General Manager of Human Resources Department and Director of CPC Organization Department of the Company from March 2020. From June 2020, he served as the Non-Executive Director of the Company. Mr. Peng graduated from East China University of Science and Technology in Engineering Management Major in July 2004 and obtained senior professional and technical title.

Li Yuanqin, born in July 1973, is an Independent Non-Executive Director, Chairman of the Audit Committee of the Company, Professor of the School of Management and the associate head of the Department of Accountancy at Shanghai University. Ms. Li has been served as an Independent Non-Executive Director of the Company since August 2017. She is currently the independent director of Yunsai Zhilian Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 600602, 900901) and Hengtian Kaima Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 900953). Ms. Li served as an independent director of Shanghai New World Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 600628) from June 2014 to December 2021. From April 2000 to March 2003, Ms. Li served at the Settlement Department of the ICBC headquarters. From June 2006 to September 2009, she was a lecturer of the School of Management of Shanghai University. From September 2009 to March 2020, she was the associate professor of the School of Management of Shanghai University. She has been the professor of the School of Management of Shanghai University since March 2019, and she has been the associate head of the Department of Accountancy of Shanghai University since May 2011. During that period, she was also a visiting scholar at Foster School of Business, University of Washington in the United States between February 2012 and February 2013. She also serves as a member of the eighth and ninth session of the Shanghai Baoshan Committee of the Chinese People’s Political Consultative Conference and a non-practicing member of the Chinese Institute of Certified Public Accountants. She received a PhD in Management from Antai College of Economics and Management (ACEM) at Shanghai Jiao Tong University.

Tang Song, born in December 1980, is the Independent Non-executive Director and a member of the Audit Committee and Remuneration and Appraisal Committee of the Company, Dean Assistant of School of Accountancy, Shanghai University of Finance and Economics, Professor and PH. D supervisor. Mr. Tang obtained a bachelor’s degree in management (accountancy) in June 2003 from the School of Accountancy of the Shanghai University of Finance and Economics, and obtained a doctor’s degree from a successive postgraduate and doctoral program in management (accountancy) in June 2008. Mr. Tang worked in the School of Accounting and Finance, Hong Kong Polytechnic University for collaborative research from August 2008 to August 2009. He worked in China Europe International Business School for collaborative research from August 2009 to June 2010. Mr. Tang served as a lecturer of School of Accountancy, Shanghai University of Finance and Economics from June 2010 to July 2012. He served as associate professor of the School of Accountancy, Shanghai University of Finance and Economics from August 2012 to June 2019. He served as Dean Assistant of Shanghai University of Finance and Economics from January 2019, and as a Professor of the School of Accountancy of the University since August 2019. Mr. Tang served as an independent director of the Shanghai Qifan Cable Co. Ltd. (listed on the Shanghai Stock Exchange, stock code: 605222) from July 2019 to July 2022, served as an independent director of Tibet Dongcai Fund Management Co., Ltd since August 2019, and as an Independent Director for the Shanghai Universal Biotech Co., Ltd. (listed on the Shenzhen Stock Exchange, stock code: 301166) since April 2020. He served as the Independent Non-executive Director, member of the Audit Committee and the Strategy Committee of the Company since June 2020. He served as an independent director for Wuxi Commercial Mansion Grand Orient Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 600327) since November 2020. He served as an independent director for Shanghai Shine-Link International Logistics Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 603648) since November 2022.

Chen Haifeng, born in January 1974, is an Independent Non-Executive Director, member of the Audit Committee and the Nomination committee of the Company, and a Senior Director of the Shanghai MindMotion Microelectronics Co., Ltd. Mr. Chen graduated from Fudan University with a Bachelor’s degree in applied physics in July 1997. He served as clerk, project supervisor, and project manager of Investment Banking Department of CITIC Securities from July 1997 to August 2001. Mr. Chen served as a senior manager of the strategic investment department of SVT Group from September 2002 to February 2006. He served as a senior manager of investment banking department of Orient Securities from August 2006 to March 2008. Mr. Chen served as senior vice president and sponsor deputy of investment banking department of China Jianyin Investment Securities from April 2008 to May 2012. He served as the CEO and sponsor deputy of investment banking department of Caida Securities from June 2012 to June 2015. Mr. Chen served as an independent director of Cnnc Hua Yuan Titanium Dioxide Company Limited (listed on Shenzhen Stock Exchange, stock code: 002145) from February 2015 to October 2018. He served as the CEO and sponsor deputy of investment banking department of Dongxing Securities from July 2015 to September 2017. Mr. Chen has been a non-independent director of Zhejiang Yueling Wheels Corporation from October 2017 to December 2020 (listed on the Shenzhen Stock Exchange, Stock Code: 002725). He served as an Independent Non-executive Director, member of the Audit Committee and member of the Nomination Committee of the Company since June 2020. He served as a senior director of Shanghai MindMotion Microelectronics Co., Ltd. since January 2021.

Yang Jun, born in August 1957, is an Independent Non-executive Director, Chairman of the Nomination Committee and the Remuneration and Appraisal Committee of the Company, a director (vice president level) of Gansu Gangtai Holding (Group) Co., Ltd., and the chief supervisor of Shanghai Aoqi Science and Technology Development Foundation. Mr. Yang graduated from East China University of Political Science and Law with a degree in Law in September 1979 and from Peking University with a Master’s degree in Civil Law in July 1991. He worked in Shanghai Intermediate Court and Supreme Court from July 1983 to July 2005. He served as an assistant to the president and general legal officer of Shanghai United Assets and Equity Exchange, general manager of Beijing headquarters of Central Enterprise Equity Exchange, operation director of Equity Exchange and general manager of Financial Equity Exchange from July 2005 to September 2017. He served as an arbitrator of China International Economic and Trade Arbitration Commission from March 2007 to March 2015 and served as an arbitrator of Shanghai International Economic and Trade Arbitration Commission and Shanghai Arbitration Commission since March 2007. He served as an independent non-executive Director of China Merchants Securities Co., Ltd. (listed on the Hong Kong stock exchange, stock code: 06099) from June 2011 to January 2018. He has served as an independent director of Shanghai Zhenhua Heavy Industries Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 600320) from April 2015 to March 2021 and a director (vice president level) of Gansu Gangtai Holding (Group) Co., Ltd. since September 2017. He has served as an Independent Non-executive Director, Chairman of the Nomination Committee and Chairman of the Remuneration and Assessment Committee of the Company since June 2020. He served as the chief supervisor of Shanghai Aoqi Science and Technology Development Foundation since January 2022.

Gao Song, born in June 1970, is an Independent Director, member of Remuneration and Appraisal Committee and Strategy Committee of the Company, Professor of Business School of East China University of Science and Technology and Director of China’s Institute for action learning. Mr. Gao graduated from Shandong University with a degree in Computer Software in 1992, from the School of Management of Fudan University with a Master’s degree in Corporate Management in 1998 and from the Antai College of Economics & Management of Shanghai Jiao Tong University with a doctorate in Corporate Management in 2006. He served as a director of marketing department of Shanghai Guanshengyuan Group Co., Ltd. from March 1998 to May 2002 and the general manager of Shanghai Aichu Food Co., Ltd. from May 2002 to March 2007. He has served as a professor of the Business School of East China University of Science and Technology and a director of China’s Institute for Action Learning since May 2009. He was a visiting scholar at the University of Illinois at Urbana-Champaign from 2014 to 2015. From June 2020, he served as the Independent Non-executive Director, Chairman of the Remuneration and Appraisal Committee and a member of the Strategy Committee of the Company.

Supervisors

Ma Yanhui, born in February 1971, is a Supervisor, the Chairman of Supervisory Committee, Secretary of the Communist Party Discipline Supervisory Committee and Chairman of the Labour Union of the Company. Mr. Ma started his career in 1996. He served as the secretary of Office of Yanhua Refinery, office secretary and deputy director of Yanhua Branch of Great Wall Lubricant Oil, supervisor and acting director and deputy director of Integrated Corporate Reform Department of China Petrochemical Corporation, and deputy director and director of Structure Reform Sector, Corporate Reform Department of Sinopec Assets Management Co., Ltd., etc. From June 2008 to August 2017, Mr. Ma was the director of Integrated Corporate Reform Department of China Petrochemical Corporation (Sinopec Group). From August 2017, Mr. Ma was the Deputy Secretary of the Communist Party Committee and Secretary of the Communist Party Discipline Supervisory Committee of the Company. He was appointed as the Supervisor, Chairman of Supervisory Committee and Chairman of the Labour Union of the Company in October 2017. Mr. Ma graduated from East China University of Science and Technology in July 1996, majoring in petroleum processing, and obtained a Bachelor’s degree in engineering. In June 2006, he obtained a Master’s degree in corporate management from Renmin University of China. Mr. Ma is a senior economist by professional title.

Zhang Feng, born in June 1969, is currently a Supervisor and the Auditing Director of the Company. Mr. Zhang started his career in Shanghai Petrochemical Complex in 1991. He served as Assistant of Chief and Deputy Chief of Finance Section of Polyester II Factory, Deputy Chief of Finance Section of Polyester Department, Deputy Chief and Chief of Cost Section of Finance Division of Polyester Department, Deputy Chief and Chief of Finance Division, Director Assistant, Deputy Director, Deputy Director (Hosting Work), Director of Finance Department, and Chief of Finance Division, etc. He worked as Auditing Director of the Company from December 2018 to March 2020, and as Supervisor in October 2019. From March 2020, he worked as the Auditing Director of the Company. Mr. Zhang graduated from Shanghai University of Finance and Economics in 1991, majoring in accounting, and obtained a Bachelor’s degree in Economics. Mr. Zhang is a senior accountant by professional title.

Chen Hongjun, born in January 1971, is currently a Supervisor, Vice-President of Labour Union, Director of the Public Affairs Department, and Vice-President of the Association of Science and Technology of the Company. Mr. Chen started his career in Shanghai Petrochemical Complex in 1996. He served as Vice Party Branch Secretary of Fibre Polymer Office, Deputy Director of Spinning Office, Director of Simulation Office, Section Manager of Scientific Research Management Department, Deputy Secretary and Secretary of Youth League Committee of the Company, Party Secretary and Deputy Director of the Chemical Engineering Department, Party Secretary and Assistant Manager of Fine Chemicals Department and Director of Public Affairs Department. Mr. Chen was appointed as Vice-President of Labour Union of the Company in November 2013. He was appointed as Vice President of the Association of Science and Technology in December 2017. He served as Director of the Public Affairs Department of the Company from April 2018 to March 2020, and he was elected as a Supervisor of the Company in October 2019. He was the Director of Public Affairs of the Company since March 2020. In November 2021, he served as the executive director, general manager and secretary of the general Party branch of Sinopec Shanghai Training Center, general manager of Shanghai Petrochemical training center, executive vice president of the Party school, general manager of Shanghai Convention Center and President of Jinshan Community College. In 1993, Mr. Chen graduated from Chengdu University of Science and Technology, majoring in Dyeing and Finishing Engineering, and obtained a Bachelor’s degree in engineering. In 1996, he obtained a Master’s degree in Chemical Fibre from Sichuan Unite University. Mr. Chen is a senior engineer by professional title.

Zhang Xiaofeng, born in March 1970, is currently an External Supervisor of the Company, deputy general manager of the Enterprise Reform and Legal Department of Sinopec Group. Mr. Zhang is currently a supervisor of Sinopec Insurance Limited, Sinopec Oilfield Equipment Corporation, Sinopec Petroleum Reserve Company Limited and a director of Sinopec International Energy Investment Co., Ltd. Starting his career in 1995, Mr. Zhang has served as deputy chief of the Office Management Division of the Legal Department of Sinopec Group, deputy chief and chief of the Contract Project Division, chief of the Dispute Management Division, and chief of the General Management Division of Legal Department of Sinopec Group. He served as the deputy director of Legal Department of Sinopec Group from January 2018 to December 2019. He served as the supervisor of Sinopec Insurance Limited from June 2019 to May 2021. He has also served as the deputy general manager of the Enterprise Reform and Legal Department of Sinopec Group since December 2019. In June 2021, he served as a director of Sinopec International Energy Investment Co., Ltd. Mr. Zhang, majoring in international economic law, graduated from China University of Political Science and Law with a Bachelor’s degree in law in July 1995. Mr. Zhang is a senior economist by professional title and the lawyer of the Company.

Zheng Yunrui, born in December 1965, is an Independent Supervisor of the Company, a professor in civil and commercial law at the Faculty of Law of the East China University of Political Science. He has served as the Company’s Independent Supervisor since December 2014. He is currently an independent director of Fuxin Dare Automotive Parts Co, Ltd. (listed on the Shenzhen Stock Exchange, stock code: 300473) and Wuxi New Hongtai Electrical Technology Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 603016). Mr. Zheng graduated from the Shangrao Normal University in Jiangxi Province, majoring in English. Mr. Zheng obtained a Master’s degree in law and a doctorate’s degree in law from the Faculty of Law of Peking University in July 1993 and July 1998, respectively. Mr. Zheng previously worked at the Education Bureau of Shangrao County, Jiangxi Province, Hainan Airport Limited, China Township Enterprise Investment and Development Company Limited and the Legal Affairs Office of the Shanghai Municipal People’s Government. He has been teaching at East China University of Political Science and Law since August 2001. He was a visiting scholar at the Faculty of Law of National University of Singapore between July 2002 and December 2002. From April 2013 to May 2019, he served as independent director of Hangzhou Xianfeng Electronic Technology Co., Ltd. (listed on Shenzhen Stock Exchange, stock code: 002767). From 2019 to February 2021, he served as the external supervisor of Zhejiang Weihai Construction Group Co., Ltd. (listed on Shenzhen Stock Exchange, stock code: 002586). From December 2015 to June 2021, he was an independent director of Jiangxi Xinyu Guoke Technology Co., Ltd. (listed on Shenzhen Stock Exchange, stock code: 300722). From April 2019 to March 2022, he served as an independent director of Dalian Electric Porcelain Group Co., Ltd. (listed on Shenzhen Stock Exchange, stock code: 002606). In November 2019, he served as a member of the second Shareholding Exercise Expert Committee of China Securities Small and Medium Investors Service Center. In September 2020, he was appointed as a legal consultant of Wuxi Intermediate People’s Court. Mr. Zheng has been engaged in trials, teaching and research relating to civil law, property law, contract law, company law, insurance law, social insurance law and government procurement law. He is experienced in the legal affairs on corporate governance and has great academic achievements. He is also an arbitrator at the Arbitration Commission of Shenzhen, Xuzhou, Wuxi and Suzhou. Mr. Zheng was appointed as an advisory expert on civil and administrative cases of the Supreme People’s Procuratorate and the Zhejiang People’s Procuratorate, a member of the second shareholding exercise Committee of CSI small and medium-sized investment service center, a news, public opinion and legal advisory expert of Wuxi intermediate people’s court, a member of the expert advisory Committee of Shanghai Yangpu District People’s Procuratorate and a mediator of Shanghai Second Intermediate People’s court.

Choi Ting Ki, born September 1954, is an Independent Supervisor of the Company and a Fellow of the Hong Kong Institute of Certified Public Accountants. He joined the Company in June 2011. Mr. Choi served as Independent Non-Executive Director of the Company from June 2011 to June 2017 and has been Independent Supervisor of the Company since June 2017. Mr. Choi has been an independent non-executive director of Yangtzekiang Garment Limited (listed on the Main Board of the Hong Kong Stock Exchange, stock code: 00294) and YGM Trading Limited (listed on the Main Board of the Hong Kong Stock Exchange, stock code: 00375) since December 2012. Mr. Choi graduated from the Department of Accounting, Hong Kong Polytechnic in 1978 and joined KPMG in the same year. He has held various positions, including the Partner of the Audit Department of KPMG Hong Kong Office, Executive Partner of KPMG Shanghai Office, Senior Partner of KPMG Huazhen Shanghai Office, as well as Senior Partner of KPMG Huazhen in Eastern and Western China. Mr. Choi retired from KPMG Huazhen in April 2010.

Senior Management

Jin Qiang, born in May 1965, is the Vice President of the Company. Mr. Jin joined Zhenhai General Petrochemical Works in 1986 and has held various positions, including deputy chief of the Utilities Department, deputy director and director of the Machinery and Power Division of Sinopec Zhenhai Refining & Chemical Co., Ltd., and director of the Machinery and Power Division of Sinopec Zhenhai Refining & Chemical Co., Ltd. Mr. Jin was the deputy chief engineer of Sinopec Zhenhai Refining & Chemical Co., Ltd. from March 2007 to October 2011, and was appointed as the Vice President of the Company in October 2011. From June 2014 to February 2022, Mr. Jin served as an Executive Director of the Company. Mr. Jin graduated from the East China Institute of Chemical Technology in 1986 majoring in chemical machinery and graduated from the Graduate School of Central Party School in 2007 majoring in economic management. He is a professorate senior engineer by title.

Jin Wenmin, born in February 1965, is the Vice President of the Company. Mr. Jin joined Shanghai Petrochemical Complex in 1985 and served as the Secretary of the Communist Party Committee of the Company’s No.1 Oil Refining Device of Refining Unit, Head of Butadiene Device, Manager of the Storage and Transportation Branch, Manager and Deputy Secretary of the Communist Party Committee of Storage and Transportation Department, Manager and Deputy Secretary of the Communist Party Committee of Oil Refining Department etc. From April 2013 to February 2017, Mr. Jin was appointed as the Head of Production Department of the Company. From May 2013 to August 2016, Mr. Jin was appointed as the Assistant to the General Manager of the Company and was appointed as the Vice President of the Company in September 2016. He served as the Executive Director of the Company from June 2018 to February 2022. Mr. Jin graduated from the Shanghai Second Polytechnic University in July 2003. He is a senior engineer by professional title.

Zhou Jijun, born in May 1965, is the Vice President of the Company. Mr. Zhou stated his career in 1987 and served as the deputy director, chief engineer and director of Olefins Department of Sinopec Zhenhai Refining & Chemical Co., Ltd. From January 2015 to 8, 2016, he served as the deputy chief engineer and director of Olefins Department and secretary of Party General Branch of Sinopec Zhenhai Refining & Chemical Co., Ltd. From August 2016 to January 2019, he served as the deputy general manager and member of the Party Committee of Shanghai Gaoqiao Petrochemical Co., Ltd. From January 2019 to November 2022, he served as the vice general manager and member of the Party Committee of Shanghai SECCO Petrochemical Co., Ltd. From February 2023, he served as the Vice President of the Company. Zhou Jijun graduated from Zhejiang Institute of Technology in 1987, majoring in inorganic chemical engineering, and obtained a master’s degree in engineering from East China University of Science and Technology in 1998. He is a senior engineer by professional title.

Huang Fei, born in January 1977, is the Deputy President of the Company. Mr. Huang joined Sinopec Shanghai Petrochemical in 2000, and he has successively served as Polyolefin Plant Deputy Director of Plastic Business Unit and Manager Assistant and Polyolefin Plant Director of Plastic Department. From August 2012 to June 2014, he served as Deputy Manager of the Plastic Department. From June 2014 to February 2017, he served as Director of Statistical Center and Vice Party Secretary. From February 2017 to December 2018, he served as Manager of Olefin Department and Deputy Party Secretary. From December 2018 to January 2019, he served as President’s Assistant and the Director of Production Department. From January 2019 to December 2019, Mr. Huang served as President’s Assistant and Manager of Production Department of Shanghai SECCO. From February 2020, he served as the Vice President of the Company. From June 2020 to April 2021, he served as the Secretary to the Board and Joint Company Secretary. From June 2020 to February 2022, he served as the Executive Director and member of the Strategy Committee of the Company. Mr. Huang graduated from the polymer materials and engineering major of East China University of Science and Technology with a bachelor’s degree of engineering in July 2000. He graduated from chemical engineering major of East China University of Science and Technology with a master’s degree in April 2008. He is a senior engineer by professional title.

Liu Gang, born in September 1972, is currently the Secretary to the Board, the Joint Company Secretary, the Assistant to the General Manager, the General Counsel, and the general manager of the Capital Operation Department and Shanghai Petrochemical Investment Development Co., Ltd. Mr. Liu Gang joined the work in 1995 and successively served as the deputy director and director of the supply management department of the Company’s material supply company and the business operation manager of the Commercial Department of Shanghai SECCO. From November 2015 to August 2018, he served as the Deputy Director of the Company’s Material Procurement Center. From August 2018 to April 2019, he served as the Deputy Director (presiding over the work) of the Company’s Material Procurement Center. From April 2019 to January 2021, he served as the General Manager of the Material Procurement Center of the Company. He has been the Assistant to the General Manager of the Company since December 2019. He has been the General Counsel of the Company since March 2021. He has been the Secretary of the Board and Joint Company Secretary of the Company since April 2021. He has been the General Manager of the Company’s Capital Operation Department and Shanghai Petrochemical Investment Development Co., Ltd. since August 2021. Mr. Liu Gang graduated from China Textile University in 1995, majoring in mechatronics, and obtained a master’s degree in power engineering from East China University of technology in 2007, with the title of senior economist.

B. Compensation.

The aggregate amount of cash compensation we paid to our directors, supervisors and executive officers during the year ended December 31, 2022 was approximately RMB 14.31 million. In addition, directors and supervisors who are also officers or employees receive certain other benefits-in-kind, such as subsidized or free health care services, housing and transportation, which large Chinese enterprises customarily provide to their employees. No benefits are payable to members of the board or the Supervisory Committee or the executive officers upon termination of their relationship with us.


Name	Position with the Company	Salaries and other benefits		Retirement scheme contributions*		Discretionary bonus		Fees		Total Remuneration in 2022 (excluding share options)
		(RMB’000)		(RMB’000)		(RMB’000)		(RMB’000)		(RMB’000)
		(before tax)		(before tax)		(before tax)		(before tax)		(before tax)
Wan Tao	Chairman & Executive Director		177		24		90		—		291
Guan Zemin	Executive Director, Vice Chairman & President		412		55		992		—		1,459
Du Jun	Executive Director Vice President & Chief Financial Officer		373		55		894		—		1,322
Huang Xiangyu	Executive Director & Vice President		250		54		817		—		1,121
Xie Zhenglin	Independent Director		—		—		—		—		—
Peng Kun	Independent Director		193		52		641		—		886
Li Yuanqin	Independent Director		—		—		—		150		150
Tang Song	Independent Director		—		—		—		150		150
Chen Haifeng	Independent Director		—		—		—		150		150
Yang Jun	Independent Director		—		—		—		150		150
Gao Song	Independent Director		—		—		—		150		150
Ma Yanhui	Chairman of Supervisory Committee		343		55		899		—		1,297
Zhang Feng	Supervisor		174		46		560		—		780
Chen Hongjun	Supervisor		184		47		603		—		834
Zhang Xiaofeng	Supervisor		—		—		—		—		—
Zheng Yunrui	Independent Supervisor		100		—		—		—		100
Choi Tingki	Independent Supervisor		100		—		—		—		100
Jin Qiang*	Vice President		372		55		907		—		1,334
Jin Wenmin*	Vice President		259		55		812		—		1,126
Zhou Jijun*	Vice President		—		—		—		—		—
Huang Fei*	Vice President		247		52		811		—		1109
Liu Gang	Secretary of the Board of Directors		204		55		662		—		921
Wu Haijun*	Former Executive Director, Chairman of the Board of Directors, Chairman of Strategy Committee, and Member of Nomination Committee		207		35		634		—		876

On 15 February 2022, Mr. Jin Qiang, Mr. Jin Wenmin and Mr. Huang Fei proposed request to the board of directors that they would no longer serve as executive directors and directors due to job change. Mr. Jin Qiang’s, Mr. Jin Wenmin’s and Mr. Huang Fei’s resignations took effect when the resignation reports were delivered to the board of directors of the Company on 15 February 2022. Mr. Zhou Jijun was appointed as the Vice President of the Company by the board of directors of the Company on 18 January 2023. On 8 September 2022, Mr. Wu Haijun proposed request to the board of directors that he would no longer serve as Executive Director and Chairman due to job change. Mr. Wu Haijun’s resignation took effect when the resignation report was delivered to the board of directors of the Company on 8 September 2022.

Board Practices.

Board of Directors

Our Board of Directors consists of eleven members. Our Directors are elected at meetings of our shareholders, and, unless they resign at an earlier date, are deceased or removed, will serve three-year terms. The Directors shall be eligible for reelection upon expiry of their terms of office; however, the combined tenure of an Independent Non-executive Director may not exceed a total of six years. The term of our current Board of Directors will expire in June 2023. None of our Directors have entered into any service contracts with us or any of our subsidiaries providing for benefits upon termination of appointment or employment (with the exception of compensation required by Chinese labor law).

Independent Board Committee

We formed an Independent Board Committee on June 18, 2020, which consists of five Independent Non-executive Directors. The current members are Ms. Li Yuanqin, Mr. Tang Song, Mr. Chen Haifeng, Mr. Yang Jun and Mr. Gao Song. The Independent Board Committee advised our shareholders other than Sinopec Corp. and its associates in respect of the terms of the continuing connected transactions under the renewed Mutual Product Supply and Sale Services Framework Agreement with Sinopec Group and Sinopec Corp. and the renewed Comprehensive Services Framework Agreement with Sinopec Group and the proposed caps on annual transaction values thereof for the three years ending December 31, 2022.

Remuneration and Appraisal Committee

We formed a remuneration and appraisal committee on December 25, 2001 which consists of three Directors. As of December 31, 2022, the members of the remuneration committee are Mr. Yang Jun (Chairman of the Committee), Mr. Tang Song and Mr. Gao Song. The key responsibility of the Remuneration Committee is to formulate and review the remuneration policy and plan for the Directors and executive officers, formulate the standards for evaluation of the Directors and executive officers and conduct such evaluations. The members of the remuneration and appraisal committee will hold office for the same term as their directorships which will expire in June 2023.

Audit Committee

We formed an audit committee on June 15, 1999 which consists of three Directors. As of December 31, 2022, the members are Ms. Li Yuanqin (Chairman of the Committee), Mr. Tang Song and Mr. Chen Haifeng. The key responsibility of the Audit Committee is to advise the Board on the appointment, dismissal, remuneration and terms of engagement of external auditors, review and supervise our financial reporting process, internal controls and risk management systems, and review our connected transactions. The members of the audit committee will hold office for the same term as their directorships which will expire in June 2023.

Nomination Committee

We formed a nomination committee on June 27, 2012 which consists of three Directors. As of December 31, 2022, the members are Mr. Yang Jun (Chairman of the Committee), Mr. Chen Haifeng and Mr. Wan Tao. The key responsibility of the Nomination Committee is to review the Board composition, make recommendations to the Board on the procedures and criteria for the selection and appointment of Directors and senior management and assess the independence of Independent Non-executive Directors. The members of the audit committee will hold office for the same term as their directorships which will expire in June 2023.

Strategy Committee

We formed a strategy committee on June 15, 2017 which consists of three Executive Directors, one Non-executive Directors and one Independent Non-executive Director. As of December 31, 2022, the members are Mr. Wan Tao (Chairman of the Committee), Mr. Guan Zemin (Vice-Chairman of the Committee), Mr. Du Jun, Mr. Huang Xiangyu, Mr. Xie Zhenglin, and Mr. Gao Song.] The key responsibility of the Strategy Committee is to conduct researches and give recommendations to the Board on major investment decisions, projects and major issues that affect our development, and monitor our long-term development strategic plan. The members of the audit committee will hold office for the same term as their directorships which will expire in June 2023.

D. Employees.

As of December 31, 2022, we had 8,007 employees.

The following table shows the approximate number of employees we had at the end of the last three years by the principal business function they performed:


	December 31,
	2020		2021		2022
Management		1066		1044		1008
Engineers, technicians and factory personnel		5094		5070		5077
Accounting, marketing and others		2306		2116		1922

Total		8466		8230		8007

Approximately32.17% of our work force are graduates with a bachelor’s degree or higher. In addition, we offer our employees opportunities for education and training based upon our development plans and requirements and the individual performance of each employee.

A system of labor contracts has been adopted in our Company. The contract system imposes discipline, provides incentives to adopt better work habits and gives us greater management control over our work force. We believe that by linking remuneration to productivity, the contract system has also improved employee morale. As of December 31, 2022, almost all of the work force was employed pursuant to labor contracts which specify the employee’s position, responsibilities, remuneration and grounds for termination. The contracts generally have short terms of one to five years and may be renewed with the agreement of both parties. The remaining personnel are employed for an indefinite term.

We have a labor union that protects employees’ rights, aims to assist in the fulfillment of our economic objectives, encourages employee participation in management decisions and assists in mediating disputes between us and union members. We have not been subject to any strikes or other labor disturbances which have interfered with our operations, and we believe that our relations with our employees are good.

Total remuneration of our employees includes salary and bonuses. Employees also receive certain benefits in terms of housing, education and health services that we subsidize, and other miscellaneous subsidies. In 2022, we incurred RMB 3,545.72 million in employment costs.

In compliance with Shanghai regulations, we and our employees participate in a defined contribution government pension scheme under which all employees upon retirement are entitled to receive pensions. In order to safeguard and properly enhance the living level of retired employees and improve the medium and long term incentive system, the Company established an enterprise annuity plan. According to the plan, to the extent that the employees volunteer for the related payments and have been with the Company for one year or more, such employees are entitled to participate in the enterprise annuity plan. We will make payments to match the payments made by the employees after giving considerations to our profitability, the employee’s work responsibilities, contributions, and treatments post retirement based on the principle of universal benefits. We have 19454 retired employees under the above retirement insurance plans.

In addition to the pension benefits, pursuant to the relevant laws and regulations of the PRC, we and our employees participate in defined social security contributions for employees, such as a housing fund, basic medical insurance, supplementary medical insurance, unemployment insurance, injury insurance and maternity insurance.

E. Share Ownership.

The table below sets forth information regarding the beneficial ownership of our shares held by our directors, supervisors and executive officers as of March 31, 2023:

Name

Position held

Number of Shares held
(shares)

Percentage of total issued
shares of the Company (%)

Percentage of total
issued A shares (%)

Jin Qiang*

Vice President

301,000 A shares (L)

0.002781

0.00411

Jin Wenmin*

Vice President

175,000 A shares (L)

0.001617

0.00239

Huang Xiangyu

Executive Director and Vice President

140,000 A shares (L)

0.001293

0.001910

Zhang Feng

Supervisor

10,000 A shares (L)

0.000092

0.00014

Chen Hongjun

Supervisor

31,400 A shares (L)

0.000290

0.00043

(L):	Long position

Jin Qiang and Jin Wenmin resigned as executive directors on February 15, 2022.

Share Option Incentive Scheme

The Share Option Incentive Scheme of the Company took effect from 23 December 2014, with a validity period of 10 years until 22 December 2024. The first grant of A-share share options under the Share Option Incentive Scheme was on 6 January 2015. For details, please refer to the relevant announcements uploaded on the websites of Shanghai Stock Exchange, Hong Kong Stock Exchange and the Company on 6 January 2015. All the exercise periods of the first grant have ended on 28 December 2018. For details, please refer to the relevant announcements uploaded on the websites of Shanghai Stock Exchange, Hong Kong Stock Exchange and the Company on 28 December 2018. At present, the Company has no other granting scheme.

During 2022, the Company did not grant A-share share options under the Share Option Incentive Scheme, nor did the grantees exercise any A-share share options, and no A-share share options were cancelled or lapsed.

ITEM 7.

MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS.

A. Major Shareholders.

Sinopec Corp. owns 50.55% of our share capital and is able to exercise all the rights of a controlling shareholder, including the election of directors and voting on amendments to our Articles of Association.

The diagram below sets forth the information on the ownership and controlling relationship between our Company, Sinopec Corp., and Sinopec Group.

LOGO

*Including 767,916,000 H shares in in Sinopec Group held by Sinopec Century Bright Capital Investment Limited, an overseas wholly-owned subsidiary of Sinopec Group, through HKSCC (Nominees) Limited.

The table below sets forth information regarding ownership of our shares as of March 31, 2023 by all persons who we know own more than five percent of our A shares and our H Shares. Our major shareholders listed below do not have voting rights different from those of our other shareholders.


Name of shareholders	Interests held (shares)	Percentage of total issued shares of the Company (%)			Percentage of total issued shares for this category (%)
Sinopec Corp.	5,459,455,000 A Shares(L) Shares of legal person		50.55	(L)		74.549	(L)
The Bank of New York Mellon Corporation	201,171,367 H Shares (L) 174,382,000 H Shares (S) 26,776,667 H Shares (P)		1.86 1.61 0.25			5.76 4.99 0.77
Corn Capital Company Ltd	211,008,000 H Shares (L) 200,020,000 H Shares (S)		1.95 1.85			6.04 5.72
Hung Hin Fai	211,008,000 H Shares (L) 200,020,000 H Shares (S)		1.95 1.85			6.04 5.72
Yardley Finance Limited	200,020,000 H Shares (L)		1.85			5.72
Chan Kin Sun	200,020,000 H Shares (L)		1.85			5.72

(L)	: Long position; (S): Short position; (P): Lending Pool

Notes:

(1)

Based on the information obtained by the Directors from the website of the Hong Kong Stock Exchange and as far as the Directors are aware, Sinopec Group directly and indirectly owned 67.84% of the issued share capital of Sinopec Corp. as at 31 March 2023. By virtue of such relationship, Sinopec Group is deemed to have an interest in the 5,459,455,000 A shares of the Company directly owned by Sinopec Corp.

(2)

All the 201,171,367 H shares (L) and 174,382,000 H shares (S) are deemed to be held by The Bank of New York Mellon Corporation, due to control of multiple companies (among which 174,382,000 H shares (S) are held through physical settlement unlisted derivatives). Below are the companies indirectly or wholly owned by The Bank of New York Mellon Corporation:

(2.1)

All the 3,000 H shares (L) are held by BNY Mellon, National Association. Since BNY Mellon, National Association is wholly owned by The Bank of New York Mellon Corporation, The Bank of New York Mellon Corporation is deemed to have an interest in the 3,000 H shares (L) of the Company held by BNY Mellon, National Association.

(2.2)

All the 9,700 H shares (L) is directly held by BNY Mellon Corporate Trustee Services Limited. Since BNY Mellon Corporate Trustee Services Limited is wholly owned by BNY International Financing Corporation, BNY International Financing Corporation is wholly owned by The Bank of New York Mellon, and The Bank of New York Mellon is wholly owned by The Bank of New York Mellon Corporation. The Bank of New York Mellon Corporation is deemed to have an interest in the 9,700 H shares (L) of the Company held by BNY Mellon Corporate Trustee Services Limited.

(2.3)

All the 201,158,667 H shares (L) and 174,382,000 H shares (S) are directly or indirectly held by The Bank of New York Mellon. Since The Bank of New York Mellon is wholly owned by The Bank of New York Mellon Corporation, The Bank of New York Mellon Corporation is deemed to have an interest in the 201,158,667 H shares (L) and 174,382,000 H shares (S) of the Company held by The Bank of New York Mellon.

(3)

These shares were held by Corn Capital Company Limited. Hung Hin Fai held 100% interests in Corn Capital Company Limited. Pursuant to the SFO, Hung Hin Fai was deemed to be interested in the shares held by Corn Capital Company Limited.

(4)

These shares were held by Yardley Finance Limited. Chan Kin Sun held 100% interests in Yardley Finance Limited. Pursuant to the SFO, Chan Kin Sun was deemed to be interested in the shares held by Yardley Finance Limited.

Save as disclosed above, as at 31 March 2023, the Directors have not been notified by any person (other than the Directors, chief executive and Supervisors) who had interests or short positions in the shares and underlying shares of the Company which would fall to be disclosed to the Company pursuant to Divisions 2 and 3 of Part XV of the SFO or as recorded in the register of interests required to be kept by the Company under section 336 of the SFO.

As of March 31, 2023, a total of 3,470,472,000 H Shares were outstanding, and a total of 7,328,813,500 A Shares were outstanding.

To the best of our knowledge, except as disclosed above, we are not directly or indirectly controlled by another corporation, any foreign government, or any other natural or legal person, severally or jointly.

We are not aware of any arrangement that may at a subsequent date result in a change of control of our company.

B. Related Party Transactions.

Intercompany service agreements and business-related dealings

The Company entered into the Mutual Product Supply and Sales Services Framework Agreement and Comprehensive Services Framework Agreement (the “Framework Agreement”) with Sinopec Corp., the controlling shareholder of the Company, and Sinopec Group, the actual controller of the Company on 23 October 2019. Pursuant to the Framework Agreement, the Company conducted a series of continuing connected transactions related to daily operation with Sinopec Group, Sinopec Corp. and their associates. The Framework Agreement was valid for three years and expired on 31 December 2022. The Company’s Board of Directors considered and approved on 10 November 2022, the signing of a new Mutual Product Supply and Sales Services Framework Agreement and a new Comprehensive Services Framework Agreement between the Company and Sinopec Group and Sinopec Corp., which are valid for three years until the expiry of 31 December 2025; and the Financial Services Framework Agreement signed with Sinopec Group is valid for one year until the expiry of 31 December 2023. The Company has disclosed the three agreements and each of the continuing connected transactions under the agreements in the announcement dated 10 November 2022, and considered and approved the new Mutual Product Supply and Sales Services Framework Agreement, the new Comprehensive Services Framework Agreement and each of the continuing connected transactions under the agreements, as well as the annual cap for the years 2023 to 2025 at the third extraordinary general meeting of the Company in 2022. For details, please refer to the 6-K of the Company filed with the Commission dated 20 January 2023.

The Company entered into a storage service agreement with Sinopec Commercial Reserve Co., Ltd., a wholly-owned subsidiary of Sinopec Group, the actual controller of the Company, and its subsidiary Baishawan branch (“Baishawan branch”) on 31 December 2020. Accordingly, Baishawan branch provides storage services to the Company, with the service period from 1 January 2021 to 31 December 2023, and the maximum annual storage service fee is RMB114 million (including value-added tax). For details, please refer to the 6-K of the company filed with the Commission dated 8 December 2020.

The Company entered into the Technology Development Contract with Sinopec Corp. on 15 December 2022, pursuant to which Sinopec Corp. entrusted the Company to research and develop the 100 ton level high-performance carbon fiber related devices. The consideration for the Technology Development Contract is RMB44,400,000, of which RMB5,010,000 and RMB39,390,000 shall be paid by Sinopec Corp. in 2022 and 2023, respectively. Sinopec Corp. is the controlling shareholder of the Company and is therefore a connected person of the Company. Related announcements were published on the official websites of the Shanghai Stock Exchange and Hong Kong Stock Exchange on 20 December 2022 and 19 December 2022, respectively.

The purchases by us of crude oil and related materials from, and sales of petroleum products by us to, Sinopec Corp. and its associates were conducted in accordance with the State’s relevant policy and applicable State tariffs or State guidance prices. As long as the State does not lift its control over purchases of crude oil, sales of petroleum products and pricing thereof, such connected transactions will continue to occur. We sell petrochemicals to Sinopec Corp. and its associates and Sinopec Corp. and its associates act as agents for the sales of petrochemicals in order to reduce our inventories, expand their trading, distribution and sales networks and improve our bargaining power with our customers. We lease part of the properties to Sinopec Corp. and its associates in consideration of their good financial background and credit standing. We accept construction and installation, engineering design, insurance agency and financial services relating to the petrochemical industry from Sinopec Group and its associates in order to secure steady and reliable services at reasonable prices.

The prices of the continuing connected (i.e., related-party) transactions conducted between the Company and Sinopec Group, Sinopec Corp. and its associates are determined by the parties involved after consultation pursuant to (1) the fixed price of the state; or (2) the guiding price of the state; or (3) market prices, and the conclusion of agreements for the connected transactions are in compliance with the needs of the Company’s production and operation. Therefore the above continuing connected transactions do not cause a material impact on the Company’s independence.

The table below sets forth certain relevant information regarding our continuing connected transactions with Sinopec Corp. and Sinopec Group under the Mutual Product Supply and Sales Services Framework Agreement and the Comprehensive Services Framework Agreement in 2022.


Type of major transactions	Connected parties	Annual cap for 2022		Transaction Amount during the reporting Period		Unit: RMB’000 Percentage Of the total Amount of the same type of transaction (%)
Mutual Product Supply and Sales Services Framework Agreement
Purchases of raw materials	Sinopec Corp., Sinopec Group and their associates		78,591,000		58,502,366		80.89	%
Sales of petroleum and petrochemical products	Sinopec Group, Sinopec Corp. and their associates		71,274,000		51,288,425		67.66	%
Property leasing	Sinopec Group, Sinopec Corp. and their associates		37,000		33,866		45.06	%
Agency sales of petrochemical products	Sinopec Corp. and its associates		169,000		90,341		100.00	%
Comprehensive Services Framework Agreement
Construction, installation and engineering design services	Sinopec Group, Sinopec Corp. and their associates		1,074,000		812,516		48.79	%
Petrochemical industry insurance services	Sinopec Group and its associates		130,000		109,597		100.00	%
Financial services	Associate of Sinopec Group (Sinopec Finance)		200,000		2,917		0.54	%
Storage services agreement
Storage services	Associate of Sinopec Group (Baishawan Branch)		114,000		114,000		83.28	%

The prices of continuing connected transactions between the Company and Sinopec Group, Sinopec Corp. and their associates are based on: 1) national pricing; or 2) national guidance price; or 3) the market price is determined by both parties through negotiation, and the conclusion of the related party transaction agreement is based on the needs of the Company’s production and operation. Therefore, the above continuing connected transactions do not have a significant impact on the independence of the Company.

The independent non-executive director of the Company has reviewed the continuing connected transactions of the Company and confirmed that: the above continuing connected transactions 1) are entered into in the daily business of the Company; 2) generally or better; 3) according to the agreement on the transaction, the terms are fair and reasonable and in line with the overall interests of the shareholders of the Company; and 4) the transaction amount in the Reporting Period was within the annual maximum limit.

HKSE connected transactions rules

We are required by HKSE listing rules to obtain advance shareholder approval for certain transactions with related parties such as Sinopec Group, Sinopec Corp., or its associates. We comply with such HKSE listing rules by obtaining advance shareholder approval at least every three years for the renewal of our framework agreements (e.g., the Mutual Product Supply and Sales Services Framework Agreement and the Comprehensive Services Framework Agreement) with Sinopec Corp. and Sinopec Group for setting maximum aggregated annual values spent on the supply of products and services under these agreements. The independent non-executive directors will need to confirm each year, upon reviewing our continuing connected transaction, that these transactions are conducted in the ordinary and usual course of our business, on normal commercial terms and in accordance with the terms of these agreements.

C. Interests of Experts and Counsel.

Not applicable.

ITEM 8.

FINANCIAL INFORMATION.

A. Consolidated Statements and Other Financial Information.

Please see Item 18. Financial Statements for our audited consolidated financial statements filed as part of this annual report.

Litigation

Neither we nor any of our subsidiaries is a party to, nor is any of our or their property the subject of any legal or arbitration proceedings which may have significant effects on our financial position or profitability or cash flows. We are not aware of any litigation or arbitration proceedings in which any of our directors, any member of our senior management or any of our affiliates is an adverse party or has a material adverse interest.

Dividend Policy

Our Board of Directors may propose dividend distributions subject to the approval of the shareholders. The Articles of Association also provide that, the aggregate profits distributed in cash in the recent three years shall not be less than 30% of the average annual distributable profits within such three-year period. Shareholders receive dividends in proportion to their shareholdings.

The Articles of Association require that cash dividends and other distributions in respect of H Shares be declared in Renminbi and paid by us in Hong Kong Dollars while cash dividends and other distributions in respect of our A Shares be paid in Renminbi. If we record no profit for the year, we may not distribute dividends in such year.

We expect to continue to pay dividends, although there can be no assurance as to the particular amounts that might be paid from year to year. Payment of future dividends will depend upon our revenue, financial condition, future earnings and other factors. See Item 5. Operating and Financial Review and Prospects.

B. Significant Changes.

No significant change has occurred since the date of the financial statements included in this annual report.

ITEM 9.

THE OFFER AND LISTING.

A. Offer and Listing Details

The principal trading market for our H Shares is the HKSE. We have also listed our A Shares on the Shanghai Stock Exchange. Prior to our initial public offering on July 26, 1993 and subsequent listings on the HKSE, there was no market for our H Shares. Public trading in our A Shares commenced on November 8, 1993.

B. Plan of Distribution

Not applicable.

C. Markets

Our H Shares are listed for trading on the HKSE (Code: 00338), and our A Shares are listed for trading on the Shanghai Stock Exchange (Code: 600688).

D. Selling Shareholders

Not applicable.

E. Dilution

Not applicable.

F. Expenses of the Issuer

Not applicable.

ITEM 10.

ADDITIONAL INFORMATION.

A. Share Capital

Not applicable.

B. Memorandum and Articles of Association.

We are a joint stock limited company established in accordance with the PRC Company Law and certain other laws and regulations of the PRC. We are registered with the Shanghai Administration for Market Regulation with business license number 91310000132212291W.

The following is a summary based upon provisions of our Articles of Association as currently in effect, the PRC Company Law and other selected laws and regulations applicable to us. You should refer to the text of the Articles of Association and to the texts of applicable laws and regulations for further information.

Our Articles of Association provide, at article 12, that our purpose is:

•

to build and operate a diversified industrial company which will be one of the world’s leading petrochemical companies;

•

to promote the development of the petrochemical industry in China through the production of a broad variety of outstanding products; and

•

to practice advanced, scientific management and apply flexible business principles, and to develop overseas markets for our products so that we and our shareholders receive reasonable economic benefits.

Our scope of business is limited to matters approved by Chinese authorities. Article 13 provides that our primary business scope includes:

Refining crude oil, petroleum products, petrochemical products, synthetic fibers and monomers, plastic products, raw materials for knitting and textile products, preparation of catalysts and recover waste catalysts, power, heat, water and gas supply, water treatment, railway cargo loading and unloading, inland water transport, wharf operation, warehousing, design, research and development, technology development, transfer, consultancy and other services, property management, lease of self-owned premises, internal staff training, design and fabrication of various advertisements, release of advertisements on self-owned media and quality technology services (administrative license should be obtained when required). We may adjust these subject to approval by governmental authorities.

The following discussion primarily concerns our shares and the rights of our shareholders. Holders of our ADSs will not be treated as our shareholders and will be required to surrender their ADSs for cancellation and withdrawal from the depositary facility in which the H Shares are held in order to exercise shareholder rights in respect of H Shares.

A Shares and overseas-listed foreign invested H Shares are both ordinary shares in our share capital. A Shares are shares we issue to domestic Chinese investors for subscription in Renminbi, while H Shares are shares we issue for subscription in other currencies to investors from Hong Kong, Macau, Taiwan and outside of China.

Sources of Shareholders’ Rights

China’s legal system is based on written statutes and is a system in which decided legal cases have little precedent value. China’s legal system is similar to civil law systems in this regard. In 1979, China began the process of developing its legal system by undertaking to promulgate a comprehensive system of laws. In December 1993, the Standing Committee of the 8th National People’s Congress adopted the PRC Company Law. Although the PRC Company Law is expected to serve as the core of a body of regulatory measures, which will impose a uniform standard of corporate behavior on companies and their directors and shareholders, only a limited portion of this body of regulatory measures has so far been promulgated.

Currently, the primary sources of shareholder rights are the Articles of Association, the PRC Company Law and the HKSE listing rules, which, among other things, impose standards of conduct, fairness and disclosure on us, our directors and our controlling shareholder. To facilitate the offering and listing of shares of Chinese companies overseas, and to regulate the behavior of companies whose shares are listed overseas, the former State Council Securities Committee and the former State Commission for Restructuring the Economic System issued the Mandatory Provisions for articles of association of Companies Listing Overseas on August 27, 1994. These provisions have been incorporated into our Articles of Association and any amendment to those provisions will only become effective after approval by the companies approval department authorized by the State.

In addition, upon the listing of and for so long as the H Shares are listed on the HKSE, we will be subject to those relevant ordinances, rules and regulations applicable to companies listed on the HKSE, the Securities and Futures Ordinance and the Codes on Takeovers and Mergers and Share Repurchases.

Unless otherwise specified, all rights, obligations and protections discussed below derive from our Articles of Association and/or the PRC Company Law.

Enforceability of Shareholders’ Rights

There has not been any public disclosure in relation to the enforcement by holders of H Shares of their rights under the charter documents of joint stock limited companies or the PRC Company Law or in the application or interpretation of the Chinese or Hong Kong regulatory provisions applicable to Chinese joint stock limited companies.

In most states of the United States, shareholders may sue a corporation “derivatively.” A derivative suit involves the commencement by a shareholder of a corporate cause of action against persons who have allegedly wronged the corporation, where the corporation itself has failed to enforce the claims directly. This would include suits against corporate officers, directors, or the controlling shareholder. This type of action is brought based upon a primary right of the corporation, but is asserted by a shareholder on behalf of the corporation. In accordance with the PRC Company Law, if a company incurs losses due to the violation of any provision of laws, administrative regulations or the Company’s articles of association by any of its directors, supervisors and officers during his/her discharge of duties entrusted by the Company, or due to any other person’s infringement of the Company’s legal rights or interests, the shareholders of the Company may take legal action before a court under the PRC Company Law.

Our Articles of Association provide that all differences or claims

•

between a holder of H Shares and us;

•

between a holder of H Shares and any of our directors, supervisors, manager or other senior officers; or

•

between a holder of H Shares and a holder of A Shares,

involving any right or obligation provided in the Articles of Association, the PRC Company Law or any other relevant law or administrative regulation which concerns our affairs must, with certain exceptions, be referred to arbitration at either the China International Economic and Trade Arbitration Commission in China or the Hong Kong International Arbitration Center. Our Articles of Association also provide that the arbitration will be final and conclusive. On June 21, 1999, an arrangement was made between Hong Kong and China for the summary mutual enforcement of each other’s arbitration awards in a manner consistent with the United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards and practices that occurred before the handover of Hong Kong to China. This arrangement was approved by the Supreme Court of China and the Hong Kong Legislative Council, and became effective on February 1, 2000.

All of our directors and officers reside outside the United States (principally in China) and substantially all of our assets and of those persons are located outside the United States. Therefore, you may not be able to effect service of process within the United States against any of those persons. In addition, China does not have treaties providing for the reciprocal recognition and enforcement of judgments of courts within the United States or most other countries that are members of the Organization for Economic Cooperation and Development. This means that administrative actions brought by regulatory authorities such as the SEC, and other actions which result in foreign court judgments could only be enforced in China if the judgments or rulings do not violate the basic principles of the law of China or the sovereignty, security and social public interest of the society of China, as determined by a People’s Court of China which has jurisdiction for recognition and enforcement of judgments. We have been advised by our Chinese counsel, Haiwen & Partners, that there is doubt as to the enforceability in China of any actions to enforce judgments of United States courts arising out of or based on the ownership of our H Shares or ADSs, including judgments arising out of or based on the civil liability provisions of United States federal or state securities laws.

Restrictions on Transferability and the Share Register

All fully paid up H Shares will be freely transferable in accordance with the Articles of Association unless otherwise prescribed by law and/or administrative regulations. Under current laws and regulations, H Shares may be traded only among investors who are not Chinese persons, and may not be sold to Chinese investors. Consequences under Chinese law of a purported transfer of H Shares to Chinese investors are unclear.

As provided in our Articles of Association, we may refuse to register a transfer of H Shares without providing any reason unless:

•

all relevant transfer fees and stamp duties are paid;

•

the instrument of transfer is accompanied by the share certificates to which it relates and any other evidence reasonably required by our board to prove the transferor’s right to make the transfer;

•

there are no more than four joint holders as transferees; and

•

the H Shares are free from any lien of ours.

Additionally, no transfers of shares may be registered within the 30 days prior to a shareholders’ general meeting or within five days before we decide on the distribution of dividends.

We are required to keep a register of our shareholders which shall be comprised of various parts, including one part which is to be maintained in Hong Kong in relation to H Shares listed on the HKSE. Shareholders have the right to inspect the share register. For a reasonable fee, shareholders may copy any part of the share register, obtain background information regarding our directors, supervisors, manager and other senior officers, minutes of shareholder general meetings and reports regarding our share capital and any share repurchases in the prior year.

Dividends

Upon approval by ordinary resolution at a shareholders’ meeting, our Board of Directors may propose dividend distribution at any time. The Articles of Association permits dividends issued in the form of cash or shares. Special resolution of the shareholders’ general meeting is required for dividends issued in the form of shares.

Dividends may only be distributed, however, after allowance has been made for:

•

recovery of losses, if any;

•

allocations to the statutory common reserve fund; and

•

allocations to a discretionary common reserve fund.

The Articles of Association require us to appoint on behalf of the holders of H Shares a receiving agent which is registered as a trust corporation under the Trustee Ordinance of Hong Kong to receive dividends we declare in respect of the H Shares on behalf of the H shareholders. The Articles of Association require that cash dividends and other distributions in respect of H Shares be declared in Renminbi and paid by us in Hong Kong Dollars while cash dividends and other distributions of the A Shares shall be paid in Renminbi.

If we record no profit for the year, we may not normally distribute dividends for the year.

Dividend payments may be subject to Chinese withholding tax. See Item 10. Additional Information – E. Taxation.

Voting Rights and Shareholders’ Meetings

Our Board of Directors must convene a shareholders’ annual general meeting once every year within six months from the end of the preceding financial year. Our board must convene an extraordinary general meeting within two months of the occurrence of any one of the following events:

•

where the number of directors is less than five as required by the PRC Company Law or two-thirds of the number specified in our Articles of Association;

•

where our unrecovered losses reach one-third of the total amount of our share capital;

•

where shareholder(s) holding 10% or more of our issued and outstanding voting shares request(s) in writing; or

•

whenever our board deems necessary or our Supervisory Committee so requests.

Meetings of a special class of shareholders must be called in specified situations when the rights of the holders of that class of shares may be varied or abrogated, as discussed below. The Board of Directors, the Supervisory Committee, and shareholders individually or collectively holding 3% or more of our total voting shares are entitled to make written proposals to a shareholders’ meeting. Shareholders individually or collectively holding more than 3% of our total shares may submit written interim proposals to the convener of a shareholders’ meeting ten days before the meeting.

All shareholders’ meetings must be convened by our board by notice given to shareholders by personal service, mail or announcement in the newspaper not less than 45 days before the meeting. Based on the written replies we receive 20 days before a shareholders’ meeting, we will calculate the number of voting shares represented by shareholders who have indicated that they intend to attend the meeting. We can convene the shareholders’ general meeting if the number of voting shares represented by those shareholders is more than one-half of our total voting shares. Otherwise, we shall, within five days, inform the shareholders again of the motions to be considered and the date and venue of the meeting by way of public announcement. After the announcement is made, the shareholders’ meeting may be convened. Our accidental omission to give notice of a meeting to, or the non-receipt of notice of a meeting by, a shareholder will not invalidate the proceedings at that shareholders’ meeting. However, an extraordinary shareholders meeting cannot conduct any business not contained in the notice of meeting.

Shareholders at meetings have the power, among other things, to decide on our operational policies and investment plans, to approve or reject our proposed annual budget, approve our profit distribution plans, an increase or decrease in share capital, the issuance of debentures, our merger or liquidation and any amendment to our Articles of Association. Shareholders also have the right to review any proposals by a shareholder owning 3% or more of our shares.

In general, holders of H Shares and A Shares vote together as a single class at all meetings and on all matters. However, the rights of a class of shareholders may not be varied or abrogated, unless approved by both a special resolution of all shareholders at a general shareholders’ meeting and by a special resolution of shareholders of that class of shares at a separate meeting. Our Articles of Association specify, without limitation, that the following amendments would be deemed to be a variation or abrogation of the rights of a class of shareholders:

•

increasing or decreasing the number of shares of a class or of a class having voting or distribution rights or privileges equal or superior to that class;

•

removing or reducing rights to receive dividends in a particular currency;

•

creating shares with voting or distribution rights superior to shares of that class;

•

restricting or adding restrictions to the transfer of ownership of shares of that class;

•

allotting and issuing rights to subscribe for, or to convert into, shares of that class or another class;

•

increasing the rights or privileges of any other class; or

•

modifying the provision of our Articles of Association that specifies which amendments would be deemed a variation or abrogation of the rights of a class of shareholder.

For votes on any of these matters, or any other matter that would vary or abrogate the rights of the A Shares or H Shares, the holders of A Shares and H Shares are deemed to be separate classes and vote separately. However, “Interested Shareholders” are not entitled to vote at class meetings. The meaning of “Interested Shareholder” depends on the proposal to be voted on at the class meeting:

If the proposal is for us to repurchase our shares either from all shareholders proportionately or by purchasing share on a stock exchange, an “Interested Shareholder” is our controlling shareholder;

•

If the proposal is for us to repurchase our shares from a shareholder by a private contract, an “Interested Shareholder” is the shareholder whose shares would be repurchased;

•

If the proposal is for our restructuring, an “Interested Shareholder” is any shareholder that has an interest in the restructuring different from the other shareholders of the class or who bears a burden under the proposed restructuring that is less than proportionate to his shareholdings of the class.

Our Articles of Association specifically provide that an issue of up to 20% of A and H Shares would not be a variation or abrogation of the rights of A shareholders or H shareholders, therefore, separate approval of the A shareholders or H Shareholders would not be required.

Each share is entitled to one vote on all matters submitted to a vote of our shareholders at all shareholders’ meetings, except for meetings of a special class of shareholders where only holders of shares of the affected class are entitled to vote on the basis of one vote per share of the affected class.

Shareholders are entitled to attend and vote at meetings either in person or by proxy. Proxy authorization forms must be in writing and deposited at our company’s principal offices, or at such other place specified in the notice of shareholders meeting not less than 24 hours before the time that such meeting will be held or the time appointed for passing upon the relevant resolutions. If a proxy authorization form is signed by a third party on behalf of the relevant shareholder, then such proxy authorization form must be accompanied by the signature authorization letter or other such document authorizing such third party to sign on behalf of the shareholder.

Except for those actions discussed below, which require supermajority votes, or special resolutions, resolutions of the shareholders are passed by a simple majority of the voting shares held by shareholders who are present in person or by proxy. Special resolutions must be passed by more than two-thirds of the voting rights represented by shareholders who are present in person or by proxy.

The following decisions must be adopted by special resolution:

•

an increase or reduction of our share capital or the issue of shares of any class, warrants and other similar securities;

•

the issue of our debentures;

•

our division, merger, dissolution and liquidation;

•

amendments to our Articles of Association;

•

significant acquisition or disposal of material assets or provision of guarantees conducted within the period of one year with a value exceeding 30% of our latest audited total assets;

•

share incentive schemes; and

•

any other matters considered by the shareholders in a general meeting and which they have resolved by way of an ordinary resolution to be material and should be adopted by special resolution.

All other actions taken by the shareholders, including the appointment and removal of our directors and independent auditors and the declaration of normal dividend payments, will be decided by an ordinary resolution of the shareholders.

Our listing agreement with the HKSE provides that we may not permit amendments to certain sections of our Articles of Association that are subject to the Mandatory Provisions. These sections include provisions relating to (i) varying the rights of existing classes of shares, (ii) voting rights, (iii) our ability to purchase our own shares, (iv) rights of minority shareholders and (v) procedures on liquidation. In addition, certain amendments to the Articles of Association require the approval and assent of Chinese authorities.

Board of Directors

Our Articles of Association authorize 11 to 15 directors. Directors are elected by shareholders at a general meeting for a three year term from among candidates nominated by the Board of Directors or by shareholders holding 3% or more of our shares (Independent Directors may be nominated by shareholders each holding 1% or more of our shares). Because our directors do not serve staggered terms, the entire Board of Directors will stand for election, and could be replaced, every three years. Our directors are not required to hold any shares in us, and there is no age limit requirement for the retirement or non- retirement of our directors.

In addition to obligations imposed by laws, administrative regulations or the listing rules of the stock exchanges on which our shares are listed, the Articles of Association place on each of our directors, supervisors, manager and any other senior officers a duty to each shareholder, in the exercise of our functions and powers entrusted to them:

•

not to cause us to exceed the scope of business stipulated in our business license;

•

to act honestly in what he considers our best interests;

•

not to expropriate our assets in any way, including (without limitation) usurpation of opportunities which may benefit us; and

•

not to expropriate the individual rights of shareholders, including (without limitation) rights to distributions and voting rights, except according to a restructuring which has been submitted to the shareholders for their approval in accordance with the Articles of Association.

Our Articles of Association further place on each of our directors, supervisors, manager and other senior officers:

•

a duty, in the exercise of their powers and discharge of their duties, to exercise the care, diligence and skill that a reasonably prudent person would exercise in comparable circumstances;

•

a fiduciary obligation, in the discharge of his duties, not to place himself or herself in a position where his or her interests may conflict with his or her duty to us; and

•

a duty not to cause a person or an organization related or connected to him or her in specified relationships to do what they are prohibited from doing.

We pay all expenses that our directors incur for their services as directors. Directors also receive compensation for their services under service contracts that are negotiated by the Board of Directors and approved by the shareholders.

Subject to the stipulations of relevant laws and regulations, the shareholders in a general meeting may by ordinary resolution remove any director before the expiration of his term of office. Except for the restrictions placed on the controlling shareholder, discussed below, our shareholders in general meeting have the power to relieve a director or supervisor from liability for specific breaches of duty.

Cumulative voting is required for a meeting of shareholders held for the election of two or more of our directors or supervisors as long as more than 30% of our outstanding shares are held by a single shareholder. Cumulative voting allows shareholders to cast a number of votes for a candidate equal to the number of shares held multiplied by the number of directors being elected at the shareholders’ meeting. If a shareholder attempts to cast more votes than he is entitled to under this system, all of the shareholder’s votes will be invalid and will be deemed an abstention.

More than one third of our directors of board must be independent from our shareholders and not hold any office with us (each, “Independent Director”). At least one Independent Director must be an accounting professional and all Independent Directors must possess a basic knowledge of the operations of a listed company and be familiar with relevant laws and rules and have at least five years working experience in law, economics or other area required for the fulfillment of responsibilities as an Independent Director. Independent Directors may not serve for terms exceeding six years. In addition, there are specific persons who are disqualified from acting as Independent Director. These include:

•

immediate family members of persons who work for us or our associated entities;

•

persons or their immediate family who hold one percent or more of our shares or are among our ten largest shareholders;

•

any persons that satisfied the foregoing conditions within the past one year;

•

persons providing financial, legal, consultation or other services to us or our associated entities;

•

persons who already serve as Independent Director for five other listed companies; and

•

anyone identified by the CSRC as unsuitable for serving as an Independent Director.

If the resignation of an Independent Director would cause our Board of Directors to have less than one third Independent Directors, the resignation will only become effective after a new Independent Director has been appointed.

Our Board will be required to meet at least four times each year. Directors who miss two consecutive Board meetings without appointing an alternate director to attend on their behalf will be proposed for removal at the next shareholders’ meeting, provided that Independent Directors may miss three consecutive meetings in person before being proposed for removal.

Directors may not vote on any matter in which he has a material interest, nor will he be counted for purposes of forming a quorum on such a matter.

Board resolutions are passed by a simple majority of the Directors except for the following matters which require the consent of more than two thirds of the Directors:

•

proposals for our financial policies;

•

the increase or reduction of our registered capital;

•

the issue of securities of any kind and their listing;

•

any repurchase of our shares;

•

significant acquisitions or disposals;

•

our merger, division or dissolution; and

•

any amendment to our Articles of Association.

Our Board of Directors or Supervisory Committee may nominate candidates for our Board of Directors and Supervisory Committee. In addition, shareholders holding one percent or more of our shares have the right to nominate candidates for Independent Director or Independent Supervisor and shareholders holding three percent or more of our shares have the right to nominate other candidates for Director or Supervisor. For candidates for Director, the nominator and candidates will be responsible for providing truthful and complete information about the candidate for disclosure. Candidates for Independent Director must publicly declare that there does not exist any relationship between himself and us that may influence his independent, objective judgment. The CSRC may veto any candidate for Independent Director.

Any material connected transactions are subject to prior approval by our Independent Directors. Connected transactions are those defined by the HKSE and by Chinese rules and regulations, but would generally include transactions with any of the following:

•

any company that, directly or indirectly, controls us or is under common control with us;

•

any shareholders owning 5% or more of our shares;

•

our directors, supervisors and other senior management;

•

any of our key technical personnel or key technology suppliers; and

•

any close relative or associate of any of the above.

Our Independent Directors can also propose to the Board of Directors the appointment or removal of our auditors, the convening of a Board meeting, independently appoint external auditors, solicit votes from shareholders and report circumstances directly to shareholders, Chinese securities regulatory authorities or other government departments. Two or more may request that the Board convene an extraordinary meeting of shareholders.

Our Independent Directors will have to express their opinion on specified matters to the Board or to the shareholders at a shareholders’ meeting, either by a single unanimous statement or individually. These matters are:

•

the nomination, removal and remuneration of directors or senior management;

•

any major loans or financial transactions with our shareholders or related enterprises and whether we have taken adequate steps to ensure repayment;

•

matters that the Independent Director believes may harm the rights and interests of minority shareholders; and

•

any other matter that they are required to opine on by applicable law or rules.

These opinions must be expressed as either, agree, qualified agreement, opposition or unable to form an opinion. All but agreement must also be accompanied by a supporting explanation. If public disclosure of the matter is required, we must also disclose the opinions of our Independent Directors.

Any Independent Director may engage independent institutions to provide independent opinions as the basis of their decision. We must arrange the engagement and bear any costs.

Supervisory Committee

The Supervisory Committee is responsible for supervising our directors and senior officers and preventing them from abusing their positions and powers or infringing upon the rights and interests of our company or those of our shareholders and employees. The Supervisory Committee has no power over the decisions or actions of our directors or officers except for requesting the directors or officers to correct any acts that are harmful to our interests. The Supervisory Committee is composed of six members appointed for a three year term. It has the right to:

•

attend the meetings of our Board of Directors;

•

inspect our financial affairs;

•

supervise and evaluate the conduct of our directors, general manager and other senior officers in order to determine whether they violate any laws, regulations or the Articles of Association in performing their duties;

•

require our directors, general manager or other senior officers to correct any act harmful to our interests and those of our shareholders and employees;

•

verify financial reports, accounting reports, business reports, profit distribution plans and other financial information proposed to be tabled at the shareholders’ general meeting, and entrust registered accountants and practicing accountants to re-review such documents upon its discovery of any problems;

•

require the Board of Directors to convene an extraordinary general meeting of shareholders;

•

represent us in negotiations with directors or in initiating legal proceedings against a director on our company’s behalf;

•

conduct investigation into any identified irregularities in our operations, and where necessary, to engage accountants, legal advisers or other professionals to assist in the investigation; and

•

any other matters authorized by the Articles of Association.

One third of our Supervisory Committee members must be employee representatives appointed by our employees. The remaining members are appointed by the shareholders in a general meeting, provided that our directors, general manager and senior officers are not eligible to serve as supervisors. The Supervisory Committee must meet at least four times a year. Decisions of the Supervisory Committee can be passed by the consents of over two thirds of all the supervisors. We will pay all reasonable expenses incurred by the Supervisory Committee in appointing professional advisors, such as lawyers, accountants or auditors.

Liquidation Rights

In the event of our liquidation, payment of borrowings out of our remaining assets will be made in the order of priority prescribed by applicable laws and regulations. After payment of borrowings, we will distribute the remaining property to shareholders according to the class and proportion of their shareholdings. For this purpose, the H Shares will rank equally with the A Shares.

Obligation of Shareholders

Shareholders are not obligated to make any further contributions to our share capital other than as agreed by the subscriber of the relevant shares on subscription. This provision means that holders of ADSs will also not be obligated to make further contributions to our share capital.

Duration

We are organized as a stock limited company of indefinite duration.

Increase in Share Capital

The Articles of Association require that approval by a resolution of the shareholders be obtained prior to issuing new shares. New issues of shares must also be approved by the relevant Chinese authorities.

Reduction of Share Capital and Purchase by Us of Our Shares

We may reduce our registered share capital only upon obtaining the approval of the shareholders and, when applicable, relevant Chinese authorities. Repurchases may be made either by way of a general offer to all shareholders in proportion to their shareholdings, by purchasing our shares on a stock exchange or by an off-market contract with shareholders.

Restrictions on Large or Controlling Shareholders

Our Articles of Association provide that, in addition to any obligation imposed by laws and administrative regulations or required by the listing rules of the stock exchanges on which our shares are listed, a controlling shareholder cannot exercise voting rights in a manner prejudicial to the interests of the shareholders generally or of some part of the shareholders:

•

to relieve a director or supervisor from his or her duty to act honestly in our best interest;

•

to approve the expropriation by a director or supervisor (for his or her own benefit or for the benefit of another person) of our assets in any way, including, without limitation, opportunities which may benefit us; or

•

to approve the expropriation by a director or supervisor (for his or her own benefit or for the benefit of another person) of the individual rights of other shareholders, including, without limitation, rights to distributions and voting rights (but not according to a restructuring of our company which has been submitted for approval by the shareholders in a general meeting in accordance with our Articles of Association).

A controlling shareholder, however, will not be precluded by our Articles of Association or any laws and administrative regulations or the listing rules of the stock exchanges on which our shares are listed from voting on these matters.

A controlling shareholder is defined by our Articles of Association as any person who, acting alone or together with others:

•

has the power to elect more than one-half of the Board of Directors;

•

has the power to exercise, or to control the exercise of, 30% or more of our voting rights;

•

holds 30% or more of our issued and outstanding shares; or

•

has de facto control of us in any other way.

Minutes, Accounts and Annual Report

Our shareholders may inspect copies of the minutes of the shareholders’ general meetings during our business hours free of charge. Shareholders are also entitled to receive copies of these minutes within seven days of receipt of the reasonable charges we may require.

Our fiscal year is the calendar year ending December 31. Each fiscal year, we must mail our financial report to shareholders not less than 21 days before the date of the shareholders’ annual general meeting. These and any interim financial statements must be prepared in accordance with Chinese accounting standards and, for so long as H Shares are listed on the HKSE, must also be prepared in accordance with or reconciled to either Hong Kong accounting standards or international accounting standards. The financial statements must be approved by an ordinary resolution of the shareholders at the annual general meeting.

Independent auditors are appointed each year by the shareholders at the annual meeting.

C. Material Contracts.

We have not entered into any material contracts in the last two years other than in the ordinary course of business and other than those described in Item 4. Information on the Company or elsewhere in this annual report on Form 20-F.

D. Exchange Controls.

Our Articles of Association require that cash dividends on our H Shares be declared in Renminbi and paid in HK Dollars. The Articles of Association further stipulate that unless otherwise provided in law and administrative regulations, such dividends must be converted to HK Dollars at a rate equal to the average of the closing exchange rates for HK Dollars as announced by the Chinese Foreign Exchange Trading Center for the calendar week preceding the date on which the dividends are declared.

The Renminbi currently is not a freely convertible currency. SAFE, under supervision of the People’s Bank of China (“PBOC”), controls the conversion of Renminbi into foreign currency. Chinese governmental policies were introduced in 1996 to reduce restrictions on the convertibility of Renminbi into foreign currency for current account items. In recent years, the Chinese government has gradually simplified and improved the foreign exchange administration policies in relation to capital items, such as the cancellation of foreign exchange registration and approval for domestic and overseas foreign direct investment. However, foreign exchange control over the capital items is not completely abolished. The limitations on foreign exchange could affect our ability to obtain foreign exchange through borrowings or equity financing, or to obtain foreign exchange for capital expenditures.

On July 21, 2005, the Chinese government changed its policy of pegging the Renminbi to the U.S. Dollar. Under the new policy, the Renminbi is permitted to fluctuate within a narrow and managed band against a basket of certain foreign currencies. Since the adoption of this new policy, the value of the Renminbi has fluctuated daily within a narrow band, but overall has appreciated against the U.S. Dollar. Nevertheless, the Chinese government continues to receive significant international pressure to further liberalize its currency policy which could result in a further and more significant appreciation in the value of the Renminbi against the U.S. Dollar. While the impact of the foregoing developments is not entirely clear, it appears that the trend in the Chinese government’s foreign exchange policy is toward easier convertibility of the Renminbi.

The holders of the ADSs will receive the HK Dollar dividend payments in U.S. Dollars at conversion rates related to market rates and subject to fees as set forth in our Deposit Agreement with The Bank of New York Mellon, as Depositary. The HK Dollar is currently linked to and trades within a narrow band against the U.S. Dollar at a rate that does not deviate significantly from HK$7.80 = U.S.$1.00. The Hong Kong government has stated its intention to maintain such link, although there can be no guarantee that such link will be maintained.

E. Taxation

PRC Taxation

The following is a summary of those taxes, including withholding provisions, to which United States security holders are subject under existing Chinese laws and regulations. The summary is subject to changes in Chinese law, including changes that could have retroactive effect. The summary does not take into account or discuss the tax laws of any country other than China, nor does it take into account the individual circumstances of a security holder. This summary does not purport to be a complete technical analysis or an examination of all potential tax effects under such laws and regulations.

Tax on Dividends

For an Individual Investor

According to the Individual Income Tax Law of the People’s Republic of China, as amended on August 31, 2018 and effective on January 1, 2019 (the “Individual Income Tax Law”) dividends paid by Chinese companies to individual investors are subject to Chinese withholding tax at a flat rate of 20%. As for a foreign individual investor that neither has a domicile nor resides in China, or that has no domicile and has resided in China for no more than one year, the dividends received by such an investor in China are generally subject to a withholding tax at a flat rate of 20% under the individual income tax law, subject to exemption or reduction by an applicable income tax treaty. According to the State Administration of Taxation’s tax treatments with regard to the dividends of H Shares paid by onshore non-foreign invested enterprises listed on the HKSE, we will withhold and pay the individual income tax at the tax rate of 10% for individual shareholders who are residents of Hong Kong, Macau, or countries which have entered into tax treaties with China, which provide for a 10% dividends tax rate, and we will temporarily withhold and pay the individual income tax at the tax rate of 10% for individual shareholders who are residents of countries which have entered into tax treaties with China, which provide for a less than 10% dividends tax rate. Shareholders of H Shares may directly or through our Company apply to the in-charge tax authority for the preferential treatments provided by the relevant tax treaties.

Upon the approval by the in-charge tax authority, the excessive amount being paid will be refunded. For individual shareholders who are residents of countries which have entered into tax treaties with China providing for a more than 10% but less than 20% dividends tax rate, we will withhold and pay the individual income tax at the specific tax rate required therein. We will withhold and pay the individual income tax at the dividends tax rate of 20% for individual shareholders who are residents of countries which have not entered into any forms of tax treaties with China or in circumstances other than above described.

For a Corporation

According to the Enterprise Income Tax Law of the People’s Republic of China (“Enterprise Income Tax Law”) and its implementation rules, as amended on December 29, 2018, dividends by Chinese resident enterprises to non-resident enterprises are ordinarily subject to a Chinese withholding tax levied at a flat rate of 10%. For purposes of the Enterprise Income Tax Law, a “Chinese resident enterprise” is an enterprise which is either (i) set up in China in accordance with PRC laws or (ii) set up in accordance with the laws of a foreign country (region) but whose actual administrative headquarters is in China. For purposes of the Enterprise Income Tax Law, a “non-resident enterprise” is an enterprise which is set up in accordance with the laws of a foreign country (region) and whose actual administrative headquarters is located outside China but which has either (i) set up a legal presence in China or (ii) has income originating from China despite not having formally set up a legal presence in China. The State Administration of Taxation issued a Circular on Issues Relating to the Withholding of Enterprise Income Tax for Dividends Distributed by Resident Enterprises in China to Non-resident Enterprises Holding H-shares of the Enterprises (Guo Shui Han [2008] No. 897) on November 6, 2008, which further clarifies that Chinese resident enterprises should, in distributing dividends for 2008 or any year hereafter to non-resident enterprises holding H-shares of the Chinese resident enterprise, withhold enterprise income tax for such dividends at a tax rate of 10%. After receiving dividends, non-resident enterprises holding H-shares of any Chinese resident enterprise can, on their own or through an agent, file an application to the relevant taxation authorities for such dividends to be covered by any applicable tax treaty (or other arrangement). The relevant taxation authorities should, upon reviewing and verifying the application and supporting materials to be correct, refund the difference between the tax levied and the tax payable calculated at a tax rate specified by the applicable tax treaty (or other arrangement).

Capital Gains Tax

For an Individual Investor

So far as we are aware, in practice, capital gains derived by a foreign individual investor from the sale of overseas-listed shares are temporarily exempted from individual income tax.

For a Corporation

According to the Enterprise Income Tax Law and its implementation rules, a non-resident enterprise is subject to a 10% withholding tax for capital gains derived from the disposal of overseas-listed shares unless such payment is exempted or deducted pursuant to applicable double taxation treaties or otherwise. According to the Circular issued by the State Administration of Taxation on Issues regarding Income Tax Payable by Foreign Invested Enterprises, Foreign Enterprises and Individuals for Capital Gains Derived from the Disposal of Shares (Equity Interests) and Dividends (Guoshuifa [1993] No. 45), capital gains derived by a non-resident enterprise from the disposal of overseas-listed shares are temporarily exempted from withholding tax in China. However, this circular has been revoked in 2011. Therefore, technically, PRC withholding tax should be applied to non-resident enterprises on capital gains derived from the disposal of overseas-listed shares unless it is tax exempted under the applicable double tax treaty. So far as we are aware, practically, there is no consistent enforcement of the collection of such withholding tax in China at current stage. However, we are aware of cases where the PRC tax authorities try to levy PRC withholding tax when they became aware of the disposal of the overseas- listed shares that the profits from the disposal of shares are derived from China.

Tax Treaties

China has an income tax treaty with the United States that currently limits the rate of Chinese withholding tax to 10% for dividends paid to individuals and corporations that qualify for treaty benefits. However, this treaty does not offer reduced tax rates for capital gains.

However, if certain conditions under the double tax treaty are satisfied (e.g., the shareholding in H-shares is less than 25% and the H-share company is not ‘land rich’), the capital gains may be exempted from the 10% PRC withholding tax.

Stamp Tax

While no express exemption exists for the imposition of Chinese stamp tax on transfers of Overseas Shares pursuant to the Provisional Regulations of the People’s Republic of China Concerning Stamp Tax, as amended on January 8, 2011, we are not aware of any circumstance under which Chinese stamp tax has actually been imposed on the transfer of Overseas Shares.

Estate or Gift Tax

China does not currently impose any estate or gift tax.

U.S. Taxation

The following is a summary of the material U.S. federal income tax consequences of the ownership and disposition of H Shares or ADSs to U.S. Holders (as defined below). The following discussion is not exhaustive of all possible tax considerations. This summary is based upon the Internal Revenue Code of 1986, as amended (the “Code”), regulations promulgated under the Code by the U.S. Treasury Department (including proposed and temporary regulations), rulings, current administrative interpretations and official pronouncements of the Internal Revenue Service (“IRS”), and judicial decisions, all as currently available and all of which are subject to differing interpretations or to change, possibly with retroactive effect. Such change could materially and adversely affect the tax consequences described below. No assurance can be given that the IRS will not assert, or that a court will not sustain, a position contrary to any of the tax consequences described below.

This discussion does not address state, local, or foreign tax consequences, or the net investment income tax consequences, of the ownership and disposition of H Shares or ADSs. (See “PRC Taxation” above).

This summary is for general information only and does not address all aspects of U.S. federal income taxation that may be important to a particular holder in light of its investment or tax circumstances or to holders subject to special tax rules, such as: banks; financial institutions; insurance companies; dealers in stocks, securities, or currencies; entities treated as partnerships for U.S. federal income taxes or partners therein; traders in securities that elect to use a mark-to-market method of accounting for their securities holdings; tax-exempt organizations; real estate investment trusts; regulated investment companies; qualified retirement plans, individual retirement accounts, and other tax-deferred accounts; expatriates of the United States; individuals subject to the alternative minimum tax; persons holding H Shares or ADSs as part of a straddle, hedge, conversion transaction, or other integrated transaction; persons who acquired H Shares or ADSs pursuant to the exercise of any employee stock option or otherwise as compensation for services; persons actually or constructively holding 10% or more of the voting power or value of our stock; U.S. Holders (as defined below) whose functional currency is other than the U.S. Dollar; and persons holding our H Shares or ADSs in connection with a trade or business conducted outside the United States.

This discussion is not a comprehensive description of all of the U.S. federal tax consequences that may be relevant with respect to the ownership and disposition of H Shares or ADSs. We urge you to consult your own tax advisor regarding your particular circumstances and the U.S. federal income and estate tax consequences to you of owning and disposing of H Shares or ADSs, as well as any tax consequences arising under the laws of any state, local, or foreign or other tax jurisdiction and the possible effects of changes in U.S. federal or other tax laws.

This summary is directed solely to U.S. Holders (defined below) who hold their H Shares or ADSs as capital assets within the meaning of Section 1221 of the Code, which generally means as property held for investment. For purposes of this discussion, the term “U.S. Holder” means a beneficial owner of H Shares or ADSs that is any of the following:

•

a citizen or resident of the United States or someone treated as a U.S. citizen or resident for U.S. federal income tax purposes;

•

a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia; or

•

a trust or estate, the income of which is subject to U.S. federal income taxation regardless of its source.

ADSs

Generally, a holder of ADSs will be treated as the owner of the underlying H Shares represented by those ADSs for U.S. federal income tax purposes. Accordingly, no gain or loss will be recognized if the holder exchanges ADSs for the underlying H Shares represented by those ADSs. The holder’s adjusted tax basis in the H Shares will be the same as the adjusted tax basis of the ADSs surrendered in exchange therefor, and the holding period for the H Shares will include the holding period for the surrendered ADSs.

TAXATION OF U.S. HOLDERS

The discussion in “Distributions on H Shares or ADSs” and “Dispositions of H Shares or ADSs” below is based on the assumption that we will not be treated as a PFIC for U.S. federal income tax purposes. For a discussion of the rules that apply if we are treated as a PFIC, see the discussion in “Passive Foreign Investment Company” below.

Distributions on H Shares or ADSs

General. Subject to the discussion in “Passive Foreign Investment Company” below, if you actually or constructively receive a distribution on H Shares or ADSs, you must include the distribution in gross income as a taxable dividend on the date of your (or in the case of ADSs, the depositary’s) receipt of the distribution, but only to the extent of our current or accumulated earnings and profits, as calculated under U.S. federal income tax principles. Such amount must be included without reduction for any foreign taxes withheld. Dividends paid by us will not be eligible for the dividends received deduction allowed to corporations with respect to dividends received from certain domestic corporations. Dividends paid by us may or may not be eligible for preferential rates applicable to qualified dividend income, as described below.

To the extent a distribution exceeds our current and accumulated earnings and profits, it will be treated first as a non-taxable return of capital to the extent of your adjusted tax basis in the H Shares or ADSs, and thereafter as capital gain. Preferential tax rates for long term capital gain may be applicable to non-corporate U.S. Holders.

We do not intend to calculate our earnings and profits under U.S. federal income tax principles. Therefore, you should expect that a distribution generally will be reported as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above.

Qualified Dividend Income. With respect to non-corporate U.S. Holders (i.e., individuals, trusts, and estates), dividends that are treated as qualified dividend income (“QDI”) are taxable at a maximum tax rate of 20%. Among other requirements, dividends generally will be treated as QDI if either (i) our H Shares or ADSs are readily tradable on an established securities market in the United States, or (ii) we are eligible for the benefits of a comprehensive income tax treaty with the United States which includes an information exchange program and which is determined to be satisfactory by the U.S. Treasury. It is expected that our ADSs will be “readily tradable” as a result of being listed on the NYSE.

In addition, for dividends to be treated as QDI, we must not be a PFIC (as discussed below) for either the taxable year in which the dividend was paid or the preceding taxable year. Please see the discussion under “Passive Foreign Investment Company” below. Additionally, in order to qualify for QDI treatment, you generally must have held the H Shares or ADSs for more than 60 days during the 121-day period beginning 60 days prior to the ex-dividend date. However, your holding period will be reduced for any period during which the risk of loss is diminished.

Moreover, a dividend will not be treated as QDI to the extent you are under an obligation (whether pursuant to a short sale or otherwise) to make related payments with respect to positions in substantially similar or related property. Since the QDI rules are complex, you should consult your own tax advisor regarding the availability of the preferential tax rates for dividends paid on H Shares or ADSs.

Foreign Currency Distributions. A dividend paid in foreign currency (e.g., Hong Kong Dollars or Chinese Renminbi) must be included in your income as a U.S. Dollar amount based on the exchange rate in effect on the date such dividend is received, regardless of whether the payment is in fact converted to U.S. Dollars. If the dividend is converted to U.S. Dollars on the date of receipt, you generally will not recognize a foreign currency gain or loss. However, if you convert the foreign currency to U.S. Dollars on a later date, you must include in income any gain or loss resulting from any exchange rate fluctuations. The gain or loss will be equal to the difference between (i) the U.S. Dollar value of the amount you included in income when the dividend was received and (ii) the amount that you receive on the conversion of the foreign currency to U.S. Dollars. Such gain or loss generally will be ordinary income or loss and U.S. source for U.S. foreign tax credit purposes.

Foreign Tax Credits. Subject to certain conditions and limitations, any foreign taxes paid on or withheld from distributions from us and not refundable to you may be credited against your U.S. federal income tax liability or, alternatively, may be deducted from your taxable income. This election is made on a year-by-year basis and applies to all foreign taxes paid by you or withheld from you that year.

Distributions will constitute foreign source income for foreign tax credit limitation purposes. The foreign tax credit limitation is calculated separately with respect to specific classes of income. For this purpose, distributions characterized as dividends distributed by us generally will constitute “passive category income” or, in the case of certain U.S. Holders, “general category income.” Special limitations may apply if a dividend is treated as QDI (as defined above).

Since the rules governing foreign tax credits are complex, you should consult your own tax advisor regarding the availability of foreign tax credits in your particular circumstances.

Dispositions of H Shares or ADSs

Subject to the discussion in “Passive Foreign Investment Company” below, you generally will recognize taxable gain or loss realized on the sale or other taxable disposition of H Shares or ADSs equal to the difference between the U.S. Dollar value of (i) the amount realized on the disposition (i.e., the amount of cash plus the fair market value of any property received), and (ii) your adjusted tax basis in the H Shares or ADSs. Such gain or loss will be a capital gain or loss. Capital gain from the sale or other taxable disposition of H Shares or ADSs held by certain non-corporate U.S. Holders will be taxed at preferential rates if such H Shares or ADSs have been held for more than one year and certain other requirements are met. The deductibility of capital losses is subject to limitations. Any gain or loss recognized generally will be treated as gain or loss from sources within the United States for U.S. foreign tax credit limitation purposes.

If you receive currency other than U.S. Dollars upon the disposition of H Shares or ADSs, the tax consequences will generally be as described under “—Foreign Currency Distributions” above.

Passive Foreign Investment Company

Generally, if, for any taxable year, at least 75% of our gross income is passive income, or at least 50% of the value of our assets is attributable to assets that produce passive income or are held for the production of passive income, we would be characterized as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes. Since PFIC status depends on the composition of our income and the composition and value of our assets from time to time, there can be no assurance that we will not be considered a PFIC for the current year until its close, or for any future taxable year. If we are characterized as a PFIC, U.S. investors may suffer adverse tax consequences, including increased U.S. tax liabilities and reporting requirements. For further discussion of the adverse U.S. federal income tax consequences of our possible classification as a PFIC, see Item 10. Additional Information – E. Taxation – U.S. Taxation.

Certain “look through” rules apply for purposes of the income and asset tests described above. If we own, directly or indirectly, 25% or more of the total value of the outstanding shares of another corporation, we generally will be treated as if we (a) held directly a proportionate share of the other corporation’s assets, and (b) received directly a proportionate share of the other corporation’s income. In addition, passive income does not include any interest, dividends, rents, or royalties that are received or accrued by us from a “related person” (as defined in Section 954(d)(3) of the Code), to the extent such items are properly allocable to income of such related person that is not passive income.

Under the income and asset tests, our PFIC status must be determined annually at the end of each year based upon the composition of our income and the composition and valuation of our assets, all of which are subject to change. In determining whether we are a PFIC, we rely on a current valuation of our assets including goodwill, not reflected in our financial statements, and our projection of our income for the current year. We determine the value of our assets in large part by reference to the market value of our ordinary shares at the end of each quarter. We believe this valuation approach is reasonable. However, the IRS may successfully challenge our valuation of our assets, and the market price of our ordinary shares may fluctuate.

Because the PFIC determination is highly fact intensive and made at the end of each taxable year, there can be no assurance that we will not be a PFIC for the current or any future taxable year or that the IRS will not challenge our determination concerning our PFIC status.

Default PFIC Rules under Section 1291 of the Code. If we are treated as a PFIC with respect to a U.S. Holder, the U.S. federal income tax consequences to the U.S. Holder of the ownership and disposition of ordinary shares will depend on whether such U.S. Holder makes an election to treat us as a qualified electing fund (“QEF”) under Section 1295 of the Code (a “QEF Election”) or a mark-to-market election under Section 1296 of the Code (a “Mark-to-Market Election”). A U.S. Holder owning ordinary shares while we were or are a PFIC that has not made either a QEF Election or a Mark-to-Market Election will be referred to in this summary as a “Non-Electing U.S. Holder.”

If you are a Non-Electing U.S. Holder, you will be subject to the default tax rules of Section 1291 of the Code with respect to:

•

any “excess distribution” paid on ordinary shares, which means the excess (if any) of the total distributions received by you during the current taxable year over 125% of the average distributions received by you during the three preceding taxable years (or during the portion of your holding period for the ordinary shares prior to the current taxable year, if shorter); and

•

any gain recognized on the sale or other taxable disposition (including a pledge) of ordinary shares.

Under these default tax rules:

•

any excess distribution or gain will be allocated ratably over your holding period for the ordinary shares,

•

the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC will be treated as ordinary income in the current year,

•

the amount allocated to each of the other years will be treated as ordinary income and taxed at the highest applicable tax rate in effect for that year, and

•

the resulting tax liability from any such prior years will be subject to the interest charge applicable to underpayments of tax.

In addition, notwithstanding any election you may make, dividends that you receive from us will not be eligible for the preferential tax rates applicable to QDI (as discussed above in “Distributions on H Shares or ADSs”) if we are a PFIC either in the taxable year of the distribution or the preceding taxable year, but will instead be taxable at rates applicable to ordinary income.

Special rules for Non-Electing U.S. Holders will apply to determine U.S. foreign tax credits with respect to foreign taxes imposed on distributions on H Shares or ADSs.

If we are a PFIC for any taxable year during which you hold H Shares or ADSs, we will continue to be treated as a PFIC with respect to you for all succeeding years during which you hold H Shares or ADSs, regardless of whether we actually continue to be a PFIC.

If we are treated as a PFIC in any year with respect to you, you will be required to file an annual return on IRS Form 8621 regarding distributions received on H Shares or ADSs and any gain realized on the disposition of H Shares or ADSs.

QEF Election. We currently do not intend to prepare or provide you with certain tax information that would permit you to make a QEF Election to mitigate the adverse tax consequences associated with owning PFIC stock.

Mark-to-Market Election. U.S. Holders may make a Mark-to-Market Election, but only if the H Shares or ADSs are marketable stock. The mark- to-market election is available only for “marketable stock,” which is stock that is traded in other than de minimis quantities on at least 15 days during each calendar quarter on a qualified exchange or other market, as defined in the applicable U.S. Treasury regulations. There can be no assurances, however, that our H Shares or ADSs will be treated, or continue to be treated, as marketable stock.

If you own (or owned) H Shares or ADSs while we are (or were) a PFIC and you make a Mark-to-Market Election, you generally will not be subject to the default rules of Section 1291 of the Code discussed above. Rather, you generally will be required to recognize ordinary income for any increase in the fair market value of the H Shares or ADSs for each taxable year that we are a PFIC. You will also be allowed to deduct as an ordinary loss any decrease in the fair market value to the extent of net marked-to-market gain previously included in prior years. Your adjusted tax basis in the H Shares or ADSs will be adjusted to reflect the amount included or deducted.

The Mark-to-Market Election will be effective for the taxable year for which the election is made and all subsequent taxable years, unless the H Shares or ADSs cease to be marketable stock or the IRS consents to the revocation of the election. You should consult your own tax advisor regarding the availability of, and procedure for making, a Mark-to-Market Election.

Since the PFIC rules are complex, you should consult your own tax advisor regarding them and how they may affect the U.S. federal income tax consequences of the ownership and disposition of H Shares or ADSs.

Information reporting regarding specified foreign financial assets

Certain U.S. Holders who are individuals (and under proposed regulations, certain entities) may be required to report information relating to an interest in our H Shares or ADSs, subject to certain exceptions (including an exception for shares held in accounts maintained by U.S. financial institutions). U.S. Holders are urged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our H Shares or ADSs. In the event a U.S. Holder does not file such required reports, the statute of limitations on the assessment and collection of U.S. federal income taxes of such U.S. holder for the related tax year will not close before such report is filed.

If you are a U.S. Holder, you are urged to consult with your own tax advisor regarding the application of the specified foreign financial assets information reporting requirements and related statute of limitations tolling provisions with respect to our H Shares and ADSs.

Information Reporting and Backup Withholding

Generally, information reporting requirements will apply to distributions on H Shares or ADSs or proceeds from the disposition of H Shares or ADSs paid within the United States (and, in certain cases, outside the United States) to a U.S. Holder unless such U.S. Holder is an exempt recipient, such as a corporation. Furthermore, backup withholding (currently at 24%) may apply to such amounts unless such U.S. Holder (i) is an exempt recipient that, if required, establishes its right to an exemption, or (ii) provides its taxpayer identification number, certifies that it is not currently subject to backup withholding, and complies with other applicable requirements.

A U.S. Holder may generally avoid backup withholding by furnishing a properly completed IRS Form W-9.

Backup withholding is not an additional tax. Rather, amounts withheld under the backup withholding rules may be credited against your U.S. federal income tax liability. Furthermore, you may obtain a refund of any excess amounts withheld by filing an appropriate claim for refund with the IRS and furnishing any required information in a timely manner.

F. Dividends and Paying Agents.

Not applicable.

G. Statement by Experts.

Not applicable.

H. Documents on Display.

We are subject to the periodic reporting and other informational requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Under the Exchange Act, we are required to file reports and other information with the SEC. Specifically, we are required to file annually a Form 20-F no later than four months after the close of each fiscal year, which is December 31 of each year. The SEC also maintains a Web site at www.sec.gov that contains reports, proxy and information statements, and other information regarding registrants that make electronic filings with the SEC using its EDGAR system. As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the furnishing and content of quarterly reports and proxy statements, and officers, directors and principal shareholders are exempt from the reporting and short- swing profit recovery provisions contained in Section 16 of the Exchange Act.

I. Subsidiary Information.

Not applicable.

ITEM 11.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Our market risk exposures primarily consist of fluctuations in oil and gas prices, exchange rates and interest rates.

Commodity Price Risk

We are exposed to commodity price risk related to price volatility of crude oil and refined oil products.

In 2022, the price of international crude oil market fluctuated and rose. The Company carried out crude oil (lending and return) hedging business in August and December 2021 respectively, and bought 2.15 million barrels of DUBAI SWAP; and positions were closed at the end of May and October 2022. In July, September, November 2021, and February and March 2022, the Company conducted crude oil (high sulfur price difference) hedging business, selling 2.7 million barrels of DTD SWAP and buying 2.7 million barrels of DUBAI SWAP. The position was closed at the end of the second quarter of 2022. The Company is engaged in the hedging business of refined oil products (crack spread of refined oil products), selling 1.653 million barrels of Gasoil 10 ppm Sin and buying 1.653 million barrels of DUBAI SWAP by the end of December; selling 604,000 barrels of Kerosene Sin and buying 604,000 barrels of DUBAI SWAP; and all positions were closed by the end of the fourth quarter. The commodity derivative business carried out belongs to hedging business. The implementation of the above businesses has no risk exposure, and the maximum amount of possible loss is RMB50,000 thousand. In 2022, the Company delivered USD57,876,800 in commodity financial derivatives, equivalent to RMB397,868,000, and the position at the end of the year was USD0. The combination of financial derivatives is matched by the hedged project as a whole, played the role of hedging real price risk.

See Item 3. Key Information – D. Risk Factors—Our operations may be adversely affected by the cyclical nature of the petroleum and petrochemical markets and by the volatility of prices of crude oil and petrochemical products.

Interest Rate Risk

We are subject to risk resulting from fluctuations in interest rates. Our borrowings are fixed and variable rate bank and other borrowings, with original maturities ranging from 1 to 5 years. Accordingly, fluctuations in interest rates can lead to significant fluctuations in the fair value of such debt instruments. We had no program of interest rate hedging activities and did not engage in any such activities in 2021 or 2022.

The following table provides information, by maturity date, regarding our interest rate sensitive financial instruments, which consist of fixed and variable rate short term and long term debt obligations, as of December 31, 2022 and 2021.


	As of December 31, 2022
	2023			2024			2025		2026		2027		Total Recorded Amount			Fair Value
	(RMB equivalent in thousands, except interest rates)
Fixed rate bank and other loans
In U.S. Dollars		—			—			—		—		—		—			—
Average interest rate		—			—			—		—		—		—			—
In RMB		1,550,000			—			—		—		—		1,550,000			1,550,000
Average interest rate⁽¹⁾		2.15	%		—			—		—		—		2.15	%		2.15	%
Variable rate bank and other loans
In U.S. Dollars		—			—			—		—		—		—			—
Average interest rate⁽¹⁾		—			—			—		—		—		—			—
In RMB		—			700,000			—		—		—		700,000			700,000
Average interest rate⁽¹⁾		—			1.08	%		—		—		—		1.08	%		1.08	%

(1)	The average interest rates for variable rate bank and other loans are calculated based on the year end indices.


	As of December 31, 2021
	2022			2023		2024			2025		2026		Total Recorded Amount			Fair Value
	(RMB equivalent in thousands, except interest rates)
Fixed rate bank and other loans
In U.S. Dollars		—			—		—			—		—		—			—
Average interest rate		—			—		—			—		—		—			—
In RMB		1,500,000			—									1,500,000			1,500,000
Average interest rate⁽¹⁾		2.70	%		—		—			—		—		2.70	%		2.70	%
Variable rate bank and other loans
In U.S. Dollars		—			—		—			—		—		—			—
Average interest rate⁽¹⁾		—			—		—			—		—		—			—
In RMB		59,800			—		700,000			—		—		759,800			759,800
Average interest rate⁽¹⁾		3.70	%		—		1.08	%		—		—		1.29	%		1.29	%

(1)	The average interest rates for variable rate bank and other loans are calculated based on the year end indices.

Exchange Rate Risk

We are also exposed to foreign currency exchange rate risk as a result of our foreign currency denominated short term borrowing and, to a limited extent, cash and cash equivalents denominated in foreign currencies. The following table provides information, by maturity date, regarding our foreign currency exchange rate sensitive financial instruments, which consist of cash and cash equivalents, short term debt obligations as of December 31, 2022 and 2021.


	As of December 31, 2022
	2023		2024		2025		2026		2027		Thereafter		Total Recorded Amount		Fair Value
	(RMB equivalent in thousands, except interest rates)
On-balance sheet financial instruments
Cash and cash equivalents:
In Hong Kong Dollars		—		—		—		—		—		—		—		—
In U.S. Dollars		195,594		—		—		—		—		—		195,594		195,594
In Euro		—		—		—		—		—		—		—		—
In Japanese Yen		—		—		—		—		—		—		—		—
In Swiss Frank		—		—		—		—		—		—		—		—
Debt:
Fixed rate bank and other loans in U.S. Dollars		—		—		—		—		—		—		—		—
Average interest rate(1)		—		—		—		—		—		—		—		—


	As of December 31, 2022
	2023		2024		2025		2026		2027		Thereafter		Total Recorded Amount		Fair Value
	(RMB equivalent in thousands, except interest rates)
Variable rate bank and other loans in U.S. Dollars		—		—		—		—		—		—		—		—
Average interest rate(1)		—		—		—		—		—		—		—		—

(1)	The average interest rates for variable rate bank and other loans are calculated based on the year end indices.


	As of December 31, 2021
	2022		2023		2024		2025		2026		Thereafter		Total Recorded Amount		Fair Value
	(RMB equivalent in thousands, except interest rates)
On-balance sheet financial instruments
Cash and cash equivalents:
In Hong Kong Dollars		—		—		—		—		—		—		—		—
In U.S. Dollars		165,864		—		—		—		—		—		165,864		165,864
In Euro		—		—		—		—		—		—		—		—
In Japanese Yen		—		—		—		—		—		—		—		—
In Swiss Frank		—		—		—		—		—		—		—		—
Debt:
Fixed rate bank and other loans in U.S. Dollars		—		—		—		—		—		—		—		—
Average interest rate(1)		—		—		—		—		—		—		—		—
Variable rate bank and other loans in U.S. Dollars		—		—		—		—		—		—		—		—
Average interest rate(1)		—		—		—		—		—		—		—		—

(1)	The average interest rates for variable rate bank and other loans are calculated based on the year end indices.

ITEM 12.

DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.

A. Debt Securities.

Not applicable.

B. Warrants and Rights.

Not applicable.

C. Other Securities.

Not applicable.

D. American Depositary Shares.

In connection with our ADR program, a holder of our ADSs may have to pay, either directly or indirectly, certain fees and charges, as described in Item 12.D.3. In addition, we receive fees and other direct and indirect payments from The Bank of New York Mellon that are related to our ADS as described in Item 12.D.4.

On March 15, 2023, we terminated the Restated Deposit Agreement, thereby terminating our ADR program. For one year after such date the Bank of New York Mellon will continue to act as depositary on behalf of the holders of our ADSs to facilitate the exchange of ADSs for underlying H Shares.

12.D.3 Fees and Charges that a holder of our ADSs May Have to Pay

The Bank of New York Mellon collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The Bank of New York Mellon also collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The Bank of New York Mellon may collect its annual fee for depositary services by deductions from cash distributions.


Persons depositing or withdrawing shares must pay:		For:

$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)		Issuance and withdrawal of ADSs, including issuances resulting from a distribution of shares or rights or other property

A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs		Distribution of securities distributed to holders of deposited securities which are distributed by The Bank of New York Mellon to ADS registered holders

A fee of $.05 (or less) per ADS (or portion thereof) Registration or transfer fees		Any cash distribution made pursuant to the Deposit Agreement Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares

Expenses of The Bank of New York Mellon		Cable, telex and facsimile transmissions (when expressly provided in the Deposit Agreement); Converting foreign currency to U.S. Dollars

Taxes and other governmental charges The Bank of New York Mellon or the custodian have to pay on any ADS or share underlying an ADS, for example, stock transfer taxes, stamp duty or withholding taxes		As necessary

Any charges incurred by The Bank of New York Mellon or its agents for servicing the deposited securities		As necessary

12.D.4 Fees and Other Payments Made by the Bank of New York Mellon

From January 1, 2022 through March 31, 2023, a total of U.S.$ 0 was paid by the Bank of New York Mellon on our behalf for our ADSs program.

The standard out-of-pocket maintenance costs for our ADSs program were U.S.$ 140,106.94, which have been waived by the Bank of New York Mellon.

PART II

ITEM 13.

DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES.

None.

ITEM 14.

MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS.

On May 11, 2011, we entered into an Amended and Restated Deposit Agreement (the “Restated Deposit Agreement”) with The Bank of New York Mellon, as depositary (the “Depositary”) and updated the form of American Depositary Receipt (“ADR”) evidencing the ADSs issued under the terms of the Restated Deposit Agreement. The Restated Deposit Agreement restates our original deposit agreement with The Bank of New York (the predecessor of The Bank of New York Mellon), dated as of July 23, 1993 (as amended, the “1993 Deposit Agreement”), in its entirety.

We and The Bank of New York Mellon entered into the Restated Deposit Agreement to modify the ADSs voting process and to bring our arrangements with The Bank of New York Mellon in line with the current customary market practice regarding depositary arrangements.

By the Restated Deposit Agreement, subject to the Depositary’s obligation to notify the owner of ADSs of any meeting of holders of our shares or other deposited securities, and subject further to certain exceptions as provided therein, to the extent that no instructions are received by the Depositary from an owner of ADSs on or before the date established by the Depositary, the Depositary may deem instructions by the owner of the ADS have been given to give a discretionary proxy to a person designated by us to exercise voting rights in the meeting of holders of our shares or other deposited securities.

In addition, the Restated Deposit Agreement amends the 1993 Deposit Agreement, among other things, to (i) provide the American Depositary Shares may be uncertificated securities or certificated securities evidenced by ADRs, and (ii) change the fees and charges of the Depositary, see Item 12D.3 Fees and Charges that a holder of our ADSs May Have to Pay.

The foregoing descriptions of the Restated Deposit Agreement and ADR do not purport to be complete and are qualified in their entirety by reference to the complete Restated Deposit Agreement and ADR which are incorporated herein by reference to Exhibit 2 and the forms filed on Form F-6 (File number 033-65616) on May 4, 2011.

ITEM 15.

CONTROLS AND PROCEDURES.

(a). Disclosure Controls And Procedures.

The term “disclosure controls and procedures” is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. These rules refer to the controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported within required time periods. This includes controls and procedures designed to ensure that information required to be disclosed is accumulated and communicated to our management, including our principal executive officer or officers and principal financial officer or officers, to allow timely decisions regarding required disclosure.

We maintain a written policy adopted by our Board of Directors that governs the collection, coordination and disclosure of information to our shareholders, the public and to governmental and other regulatory bodies. All such disclosures are coordinated by the Secretary to our Board of Directors and subject to execution by either the Chairman of our Board of Directors or, for disclosures by our Supervisory Committee, the Chairman of the Supervisory Committee. Under the policy, all material issues must be disclosed and our disclosures must be true, accurate, complete and timely without any false or misleading statements. Each of our departments and subsidiaries has their own supplemental policies which may be both written and unwritten.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) as of the end of the fiscal year covered by this annual report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the fiscal year covered by this annual report, our disclosure controls and procedures were effective to ensure that information required to be disclosed in the reports we file under the Exchange Act is accumulated and communicated to the management to allow timely decisions to be made regarding required disclosures, and is recorded, processed, summarized and reported as and when required.

(b). Management’s

Report on Internal Control over Financial Reporting.

Our management is accountable for establishing and maintaining effective internal control over financial reporting (as defined in Rules 13a-15(f) of the Securities Exchange Act of 1934). The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives and may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become ineffective because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management assessed the effectiveness of our internal control over financial reporting based upon the criteria established in Internal Control- Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) as of December 31, 2022. Based on that evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2022 based on these criteria.

KPMG Huazhen LLP, an independent registered public accounting firm, has audited the consolidated financial statements for the year ended December 31, 2022 included in this annual report on Form 20-F and, as part of the audit, has issued a report, included herein, on the effectiveness of our internal control over financial reporting.

(c). Report of Independent Registered Public Accounting Firm.

Our independent auditors have issued an audit report on the effectiveness of our internal control over financial reporting. This report appears on page F-2.

(d). Changes

in Internal Control over Financial Reporting.

For the year ended December 31, 2022, there have been no changes to our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

ITEM 16A.

AUDIT COMMITTEE FINANCIAL EXPERT.

Our Board of Directors has determined that Ms. Li Yuanqin who is currently serving on our audit committee, is an audit committee financial expert and is an Independent Director (under the standards set forth in the NYSE rules and Rule 10A-3 of the Exchange Act).

ITEM 16B.

CODE OF ETHICS.

Sinopec Group, the controlling shareholder of Sinopec Corp., adopted a Staff Code in 2014 to provide disciplines and requirements for its staff’s conducts, including legal and ethical matters as well as the sensitivities involved in reporting illegal and unethical matters. The Staff Code covers such areas as health, safety and environment, conflict of interests, anti-corruption, protection and proper use of our assets and properties, as well as reporting requirements. The Staff Code also applies to all directors, officers and employees of each subsidiary of Sinopec Group, including us. We have provided all our directors and senior officers with a copy of the Staff Code and required them to comply with in it order to ensure our operations are proper and lawful. We have posted the Staff Code on the following website: http://www.sinopec.com/listco/en/Resource/Pdf/ygsz2014b.pdf.

ITEM 16C.

PRINCIPAL ACCOUNTANT FEES AND SERVICES.

The following table summarizes the fees charged by KPMG Huazhen LLP, our principal accountant, for services rendered to us during 2021 and 2022 respectively.


	For the year ended December 31,
	(in thousands of RMB)
	2021		2022
Audit fees (1)		6,837		6,837
Audit-Related fees (2)		—		—
Tax fees (3)		—		129
All other fees (4)		—		—
Total		6,837		6,966

(1)	“Audit fees” means the aggregate fees billed in each of the fiscal years listed for professional services rendered by our principal auditors for the audit of our annual financial statements.

(2)	“Audit-Related fees” means the aggregate fees billed in each of the fiscal years listed for assurance and related services by the principal accountant that are reasonably related to the performance of the audit or review of our financial statements and are not reported under audit fees.

(3)	“Tax fees” means the aggregate fees billed in each of the fiscal years listed for professional services rendered by the principal accountant for tax compliance, and tax advice.

(4)	“All other fees” means the aggregate fees billed in each of the fiscal years listed for products and services provided by our principal accountant, other than the services reported under audit fees, audit-related fees and tax fees.

Audit Committee Pre-approval Policies and Procedures

Our audit committee has adopted procedures which set forth the manner in which the committee will review and approve all audit and non-audit services to be provided by KPMG Huazhen LLP. The pre-approval procedures are as follows:

•

Any audit or non-audit service to be provided to us by the independent accountant must be (i) pre-approved by the audit committee; or (ii) pre-approved by one or several committee members designated by the committee and rectified by the audit committee.

In 2022, 100% of the services and fees described above were approved by the audit committee, pursuant to its pre-approval policy.

ITEM 16D.

EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES.

Not applicable.

ITEM 16E.

PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS.

None.

ITEM 16F.

CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT.

Not applicable.

ITEM 16G.

CORPORATE GOVERNANCE.

Not applicable.

ITEM 16H.

MINE SAFETY DISCLOSURE.

Not applicable.

ITEM 16I.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

On December 16, 2021, the PCAOB issued a report to notify the SEC of its determination that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong, and our auditor was subject to that determination. In May 2022, we were conclusively listed by the SEC as a Commission-Identified Issuer under the HFCAA following the filing of our annual report on Form 20-F for the fiscal year ended December 31, 2021. On December 15, 2022, the PCAOB issued a report that vacated its December 16, 2021 determination and removed mainland China and Hong Kong from the list of jurisdictions where it is unable to inspect or investigate completely registered public accounting firms. For this reason, we do not expect to be identified as a Commission-Identified Issuer under the HFCAA after we file this annual report on Form 20-F.

As of the date of this annual report and to our best knowledge:

(i)

Sinopec Corp., our controlling shareholder, and its concert parties currently hold approximately 50.55% of our outstanding shares. Sinopec Corp. is controlled by China Petrochemical Corporation. The controlling shareholder of China Petrochemical Corporation is Sinopec Group Company, which is in turn controlled by the State-owned Assets Supervision and Administration Commission of the State Council of China. See “Item 4. Information on the Company-C. Organizational Structure.” Sinopec Corp. is operated by separate management and from time to time uses its interest as a shareholder to direct our policies and management;

(ii)

none of the members of our Board of Directors is an official of the Chinese Communist Party (the “Party”); and

(iii)

the following articles in the Articles of Association of Sinopec Shanghai Petrochemical Company Limited, as currently in effect, contain charters of the Party:

(a)

Article 11: In accordance with the Company Law and the Constitution of the Communist Party of China (the “Party”), the Company hereby set up Party organizations. The Party organizations play the role of political core in the Company. The Company shall set up related Party working organs and maintain an adequate level of staffing to handle Party affairs as well as sufficient funding necessary for the activities of the Party organizations; and

(b)

Article 126: If any matters to be resolved by the Board involve significant matters such as direction of reform and development, key objectives, and priority operational arrangements of the Company, the board of directors should seek advice from the Party committee. When the board of directors appoints the management personnel of the Company, the Party committee shall consider and provide comments on the candidates for management positions nominated by the board of directors or the president, or recommend candidates to the board of directors and/or president.

PART III

ITEM 17.

FINANCIAL STATEMENTS.

SECCO was deemed a significant equity investee for the fiscal years ended December 31, 2020 and a non-significant equity investee for the fiscal years ended December 31, 2021 and December 31, 2022 under Rule 3-09 of Regulation S-X. As such, the financial statements of SECCO required by Rule 3-09 of Regulation S-X are provided as Exhibit 99.1 to this Annual Report on Form 20-F.

ITEM 18.

FINANCIAL STATEMENTS.

See pages F-1 to F-119.

ITEM 19.

EXHIBITS.


No.		Exhibit

1.1		Translation of the amended and restated Articles of Association of Sinopec Shanghai Petrochemical Company Limited as approved in the annual general meeting of the Company held on 16 June 2021 (incorporated by reference to our Form 6-K (File No.001-12158) filed with the Commission on June 21, 2021).

2.		Amended and Restated Deposit Agreement between Sinopec Shanghai Petrochemical Company Limited and The Bank of New York Mellon dated May 11, 2011(incorporated by reference to Exhibit 2 of our annual report on Form 20-F (File No. 001-12158) filed with the Commission on April 30, 2012).

4.1		Translation of the renewed Product Supply and Sales Services Framework Agreement among Sinopec Shanghai Petrochemical Company Limited, China Petroleum & Chemical Corporation and China Petrochemical Corporation as approved in the First Extraordinary General Meeting of Sinopec Shanghai Petrochemical Company Limited for 2016 on October 18, 2016 (incorporated by reference to Exhibit 4.1 of our annual report on Form 20-F Amendment No.1 (File No.001-12158) filed with the Commission on September 14, 2017).

4.2		Translation of the renewed Comprehensive Services Framework Agreement between Sinopec Shanghai Petrochemical Company Limited and China Petrochemical Corporation as approved in the First Extraordinary General Meeting of Sinopec Shanghai Petrochemical Company Limited for 2016 on October 18, 2016 (incorporated by reference to Exhibit 4.2 of our annual report on Form 20-F Amendment No.1 (File No.001-12158) filed with the Commission on September 14, 2017).


No.		Exhibit

4.3		Translation of the Property Right Transaction Agreement with Sinopec Sales Company Limited as approved in the eighteenth meeting of the seventh session of the board of directors of Sinopec Shanghai Petrochemical Company Limited on December 5, 2013 (incorporated by reference to Exhibit 4.3 of our annual report on Form 20-F (File No.001-12158) filed with the Commission on April 30, 2014).

4.4		English summary of principal terms of the Share Option Scheme as adopted at the second meeting of the eighth session of the board of directors of Sinopec Shanghai Petrochemical Company Limited on August 15, 2014 (incorporated by reference to Appendix I of our Form 6-K (File No.001-12158) filed with the Commission on November 6, 2014).

8*		A list of subsidiaries of Sinopec Shanghai Petrochemical Company Limited.

12.1*		Certification of President Required by Rule 13a-14(a).

12.2*		Certification of Chief Financial Officer Required by Rule 13a-14(a).

13.1*		Certification of President Required by Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

13.2*		Certification of Chief Financial Officer Required by Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

99.1*		Financial statements of SECCO

101.INS*		Inline XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH*		Inline XBRL Taxonomy Extension Schema Document

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF *		Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*		Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)

*	Filed with this annual report on Form 20-F

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form 20-F on its behalf.

Index to the Financial Statements


	Page
Report of independent registered public accounting firm (KPMG Huazhen LLP, Shanghai, China, Auditor Firm ID: 1186)		F - 2
Report of independent registered public accounting firm (PCAOB ID 1424)		F - 5
Consolidated statements of profit or loss		F - 6
Consolidated statements of profit or loss and other comprehensive income		F - 8
Consolidated statements of financial position		F - 9
Consolidated statements of changes in equity		F - 12
Consolidated cash flow statements		F - 15
Notes to the consolidated financial statements		F - 17

F-1

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors

Sinopec Shanghai Petrochemical Company Limited:

Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting

We have audited the accompanying consolidated statements of financial position of Sinopec Shanghai Petrochemical Company Limited and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of profit or loss, consolidated statements of profit or loss and other comprehensive income, consolidated statements of changes in equity, and consolidated cash flow statements for the years then ended, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by COSO.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

F-2

Table of Contents

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Assessment of net realizable value of raw materials, work in progress and finished goods

As discussed in Notes 2.14, 4.2(a) and 21 to the consolidated financial statements, as of December 31, 2022, the gross carrying amount of raw materials, work in progress and finished goods, and provision for diminution in value were RMB 7,552,845 thousand and RMB 446,485 thousand, respectively. Inventories are valued at the lower of cost and net realizable value. The net realizable value is determined based on the estimated selling prices in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale.

We identified the assessment of net realizable value of raw materials, work in progress and finished goods as a critical audit matter. Evaluation of estimated selling prices of inventories, estimated costs to completion, and other costs necessary to make the sale involved a high degree of auditor judgement.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the process of determination of net realizable value of raw materials, work in progress and finished goods, including controls related to the determination of estimated selling prices, estimated costs to completion, and other costs necessary to make the sale; we evaluated the estimated selling prices at the reporting date for a sample of inventory items by comparison of the estimated selling price to the price from publicly available market data and the actual prices of sales transactions subsequent to the reporting date if available; and we evaluated the estimated costs to completion and other costs necessary to make the sale by comparing with the historical costs to completion and other costs necessary to make the sale for the same type of inventories on a sample basis.

F-3

Table of Contents

Assessment of value in use of certain production facilities

As discussed in Notes 2.12 (b), 4.2(b) and 16 to the consolidated financial statements, the carrying amount of property, plant and equipment was RMB 12,179,504 thousand as of December 31, 2022. During the year ended December 31, 2022, the Company recognized impairment loss on property, plant and equipment in relation to certain production facilities under the intermediate petrochemicals segment of RMB 212,410 thousand. At the end of each reporting period, if any indication of impairment exists, the Company estimates the recoverable amount of an asset, or a cash-generating unit, at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses. The Company’s estimated value in use includes assumptions on product sales growth rates, related costs growth rates (“forecasted growth rates”) and discount rate.

We identified the assessment of value in use of certain production facilities as a critical audit matter. A high degree of subjectivity and auditor judgment was involved to evaluate the forecasted growth rates and the discount rate used to estimate value in use of these assets. The forecasted growth rates and the discount rate were challenging to test as minor changes to those assumptions would have a significant effect on the Company’s assessment of value in use of these assets. In addition, specialized skills and knowledge were required to assess the discount rate used to estimate value in use of these assets.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s process in assessing the value in use of certain production facilities, including controls related to the determination of the forecasted growth rates and the discount rate; we assessed the forecasted growth rates adopted in the Company’s value in use assessment by comparing them with historical results, future operation plans and external market data; we performed sensitivity analysis over the forecasted growth rates and the discount rate assumptions to assess their impact on the Company’s impairment assessment. In addition, we involved valuation professionals with specialized skills and knowledge, who assisted in evaluating the discount rate used by comparing it against discount rate that was independently developed using publicly available industry data.

/s/ KPMG Huazhen LLP

We have served as the Company’s auditor since 2021.

Shanghai, China

April 26, 2023

F-4

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Sinopec Shanghai Petrochemical Company Limited

Opinion on the Financial Statements

We have audited the consolidated statements of profit or loss, of profit or loss and other comprehensive income, of changes in equity and consolidated cash flow statement of Sinopec Shanghai Petrochemical Company Limited and its subsidiaries (the “Company”) for the year ended December 31, 2020, including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the results of operations and cash flows of the Company for the year ended December 31, 2020 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/PricewaterhouseCoopers Zhong Tian LLP

Shanghai, the People’s Republic of China

April 28,

2021

We served as the Company’s auditor from 2013 to 2021.

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated statement

s o

f profit or loss

for the years ended 31 December 2020, 2021 and 2022


			Years ended 31 December
			2020			2021			2022
	Note		RMB’000			RMB’000			RMB’000
Revenue		5		74,623,575			89,198,492			82,443,156
Taxes and surcharges				(13,062,710	)		(13,309,688	)		(9,788,593	)

Net sales				61,560,865			75,888,804			72,654,563
Cost of sales		10		(61,901,114	)		(74,298,048	)		(76,265,940	)

Gross (loss)/profit				(340,249	)		1,590,756			(3,611,377	)
Selling and administrative expenses		10		(486,323	)		(368,243	)		(288,701	)
Reversal/(provision) of impairment losses on financial assets		3.1 (c)		120,916			(1,355	)		(5,366	)
Other operating income		6		148,676			125,305			110,641
Other operating expenses		7		(24,686	)		(44,712	)		(25,775	)
Other gains/(losses) - net		8		115,430			130,481			(22,788	)

(Loss) / profit from operations				(466,236	)		1,432,232			(3,843,366	)

Finance income		9		431,228			508,755			541,830
Finance expenses		9		(98,954	)		(94,186	)		(98,502	)

Finance income – net				332,274			414,569			443,328

Share of net profits/(losses) of associates and joint ventures accounted for using the equity method		20		724,740			874,285			(173,616	)

Profit/(loss) before taxation				590,778			2,721,086			(3,573,654	)
Income tax benefits/(expenses)		12		65,620			(644,480	)		731,354

Profit/(loss) for the year				656,398			2,076,606			(2,842,300	)

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated statements of profit or loss

for the years ended 31 December 2020, 2021 and 2022 (continued)

Years ended 31 December

Note

2020

RMB’000

2021

RMB’000

2022

RMB’000

Profit/(loss) attributable to:

– Equity shareholders of the Company

645,072

2,073,431

(2,846,156

)

–

Non-controlling

interests

11,326

3,175

3,856

Profit/(loss) for the year

656,398

2,076,606

(2,842,300

)

Earnings/(losses) per share attributable to equity shareholders of the Company for the year (expressed in RMB per share)

Basic earnings/(losses) per share

13(a)

RMB 0.060

RMB 0.192

RMB (0.263)

Diluted earnings/(losses) per share

13(b)

RMB 0.060

RMB 0.192

RMB (0.263)

The notes on pages F-17 to F-119 form part of these financial statements.

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated statements of profit or loss and other comprehensive income

for the years ended 31 December 2020, 2021 and 2022


			Years ended 31 December
	Note		2020 RMB’000			2021 RMB’000		2022 RMB’000
Profit/(loss) for the year				656,398			2,076,606		(2,842,300	)

Other comprehensive income
Items that are or may be reclassified subsequently to profit or loss:
Share of other comprehensive income of associates accounted for using the equity method		3 1		(11,512	)		16,639		(23,771	)
Cash flow hedges: net movement in hedging reserve		3 1		—			125,159		201,519

Other comprehensive income for the year, net of tax				(11,512	)		141,798		177,748

Total comprehensive income for the year				644,886			2,218,404		(2,664,552	)

Attributable to:
– Equity shareholders of the Company				633,560			2,215,229		(2,668,408	)
– Non-controlling interests				11,326			3,175		3,856

Total comprehensive income for the year				644,886			2,218,404		(2,664,552	)

The notes on pages F-17 to F-119 form part of these financial statements.

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements as at 31 December 2021 and 2022

Consolidated statements of financial position

as at 31 December 2021 and 2022


			As at 31 December
			2021		2022
	Note		RMB’000		RMB’000
Non-current assets
Property, plant and equipment		16		11,310,032		12,179,504
Right-of-use assets		15		385,643		379,805
Investment properties		17		352,188		336,863
Construction in progress		18		3,293,177		3,748,461
Investments accounted for using the equity method		20		4,088,888		3,504,393
Financial assets at fair value through other comprehensive income		25		5,000		5,000
Time deposits with banks		24		5,581,435		3,389,559
Deferred tax assets		12		184,143		991,850
Other non-current assets		14		787,807		835,400

				25,988,313		25,370,835

Current assets
Inventories		21		5,923,525		7,294,060
Financial assets at fair value through other comprehensive income		25		1,047,690		582,354
Derivative financial instruments		3.1 (a)		81,405		—
Trade receivables		22		77,425		69,351
Other receivables		22		47,597		107,507
Prepayments				30,364		17,832
Value added tax recoverable				13,322		1,057,463
Amounts due from related parties		22		1,212,331		2,638,983
Cash and cash equivalents		23		5,112,010		889,413
Time deposits with banks		24		7,386,607		3,108,919

				20,932,276		15,765,882

Total assets				46,920,589		41,136,717

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements as at 31 December 2021 and 2022

Consolidated statements of financial position

as at 31 December 2021 and 2022 (continued)


			As at 31 December
			2021		2022
	Note		RMB’000		RMB’000
Equity and liabilities
Equity attributable to equity shareholders of the Company
Share capital		3 0		10,823,814		10,823,814
Reserves		3 1		19,418,325		15,403,868

				30,242,139		26,227,682
Non-controlling interests				135,259		127,681

Total equity				30,377,398		26,355,363

Liabilities
Non-current liabilities
Borrowings		26		700,000		700,000
Lease liabilities		15		1,384		7,513
Deferred tax liabilities		12		33,344		30,895
Deferred income		2 9		12,720		44,608

				747,448		783,016

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements as at 31 December 2021 and 2022

Consolidated statements of financial position

as at 31 December 2021 and 2022 (continued)


			As at 31 December
			2021		2022
	Note		RMB’000		RMB’000
Current liabilities
Borrowings		26		1,559,800		1,550,000
Lease liabilities		15		3,229		8,738
Derivative financial instruments		3.1 (a)		23,804		—
Contract liabilities		2 8		424,607		372,760
Trade and other payables		2 7		3,095,694		2,926,534
Amounts due to related parties		2 7		6,304,816		7,887,809
Current tax liabilities				3,865,231		931,852
Staff salaries and welfares payable				260,096		317,891
Income tax payable		12		258,466		2,754

				15,795,743		13,998,338

Total liabilities				16,543,191		14,781,354

Total equity and liabilities				46,920,589		41,136,717

Approved and authorized for issue by the Board of Directors on 26 April 2023.




Wan Tao

		Directors

Du Jun

The notes on pages F-17 to F-119 form part of these financial statements.

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated statements of changes in equity

for the years ended 31 December 2020, 2021 and 2022


			Attributable to equity shareholders of the Company
			Share capital		Other reserves			Retained earnings						Non-controlling			Total
			RMB’000		RMB’000			RMB’000			Total			interests			equity
	Note		(note 30)		(note 31)			(note 31)			RMB’000			RMB’000			RMB’000
Balance at 1 January 2020				10,823,814		4,369,391			14,670,083			29,863,288			130,560			29,993,848

Changes in equity for 2020:
Profit for the year				—		—			645,072			645,072			11,326			656,398
Other comprehensive income		3 1		—		(11,512	)		—			(11,512	)		—			(11,512	)

Total comprehensive income for the year				—		(11,512	)		645,072			633,560			11,326			644,886

Dividends proposed and approved		3 3		—		—			(1,298,858	)		(1,298,858	)		—			(1,298,858	)
Dividend paid by subsidiaries to non-controlling interests				—		—			—			—			(4,901	)		(4,901	)
Appropriation of safety production fund		3 1		—		88,460			(88,460	)		—			—			—

Balance at 31 December 2020				10,823,814		4,446,339			13,927,837			29,197,990			136,985			29,334,975

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated statements of changes in equity

for the years ended 31 December 2020, 2021 and 2022 (continued)


		Attributable to equity shareholders of the Company
	Note	Share capital RMB’000 (note 30)		Other reserves RMB’000 (note 31)			Retained earnings RMB’000 (note 31)			Total RMB’000			Non-controlling interests RMB’000			Total equity RMB’000
Balance at 1 January 2021			10,823,814		4,446,339			13,927,837			29,197,990			136,985			29,334,975

Changes in equity for 2021
Profit for the year			—		—			2,073,431			2,073,431			3,175			2,076,606
Other comprehensive income	3 1		—		141,798			—			141,798			—			141,798

Total comprehensive income for the year			—		141,798			2,073,431			2,215,229			3,175			2,218,404

Transfer to other reserves			—		2,498,808			(2,498,808	)		—			—			—
Amounts transferred from hedging reserve to initial carrying amount of hedged items			—		(88,699	)		—			(88,699	)		—			(88,699	)
Dividends proposed and approved	3 3		—		—			(1,082,381	)		(1,082,381	)		—			(1,082,381	)
Dividends paid by subsidiaries to non-controlling interests			—		—			—			—			(4,901	)		(4,901	)
Appropriation of safety production fund	3 1		—		40,729			(40,729	)		—			—			—

Balance at 31 December 2021			10,823,814		7,038,975			12,379,350			30,242,139			135,259			30,377,398

The notes on pages F-17 to F-119 form part of these financial statements.

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated statements of changes in equity

for the years ended 31 December 2020, 2021 and 2022 (continued)


			Attributable to equity shareholders of the Company											Non-controlling interests RMB’000			Total equity RMB’000
	Note		Share capital RMB’000 (note 30)		Other reserves RMB’000 (note 31)			Retained earnings RMB’000 (note 31)			Total RMB’000			Non-controlling interests RMB’000			Total equity RMB’000
Balance at 1 January 2022				10,823,814		7,038,975			12,379,350			30,242,139			135,259			30,377,398

Changes in equity for 2022
(Loss)/profit for the year				—		—			(2,846,156	)		(2,846,156	)		3,856			(2,842,300	)
Other comprehensive income		3 1		—		177,748			—			177,748			—			177,748

Total comprehensive income for the year				—		177,748			(2,846,156	)		(2,668,408	)		3,856			(2,664,552	)

Amounts transferred from hedging reserve to initial carrying amount of hedged items		3.1a(iii)		—		(237,979	)		—			(237,979	)		—			(237,979	)
Dividends proposed and approved		3 3		—		—			(1,082,381	)		(1,082,381	)		—			(1,082,381	)
Dividends paid by subsidiaries to non-controlling interests				—		—			—			—			(11,434	)		(11,434	)
Purchase of own shares		30(ii)		—		(25,689	)		—			(25,689	)		—			(25,689	)
Appropriation of safety production fund		3 1		—		54,092			(54,092	)		—			—			—

Balance at 31 December 2022				10,823,814		7,007,147			8,396,721			26,227,682			127,681			26,355,363

The notes on pages F-17 to F-119 form part of these financial statements.

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated cash flow statements

for the years ended 31 December 2020, 2021 and 2022


			Years ended 31 December
			2020			2021			2022
	Note		RMB’000			RMB’000			RMB’000
Operating activities
Cash generated from / (used in) operations		23 (b)		1,995,087			4,411,653			(6,960,734	)
Interest paid				(71,369	)		(110,070	)		(121,876	)
Income tax paid				(243,870	)		(351,627	)		(376,765	)

Net cash generated from / (used in) operating activities				1,679,848			3,949,956			(7,459,375	)

Cash flows from investing activities
Dividends received from joint ventures and associates				561,755			777,220			683,780
Interest received from entrusted loans				—			—			2,704
Interest received from structured deposits				132,690			97,921			11,124
Interest received from related parties				2,088			—			—
Interest received from banks excluded structured deposits				275,626			398,937			330,216
(Payments)/proceeds from settlement of derivative financial instruments				(912	)		5,674			(14,679	)
Payment for the purchase of property, plant and equipment and construction in progress				(1,840,986	)		(3,224,000	)		(2,836,912	)
Net proceeds from disposal of property, plant and equipment				59,642			55,254			13,937
Cash received from time deposits with maturity less than one year				500,000			3,800,000			7,350,000
Cash received from time deposits with maturity more than one year				—			—			1,800,000
Cash received from maturity of structured deposits				10,900,000			8,150,000			1,000,000
Cash payment for investment in structured deposits				(7,600,000	)		(8,150,000	)		(1,000,000	)
Cash payment for investment in entrusted loans				—			—			(150,000	)
Cash received from investment in entrusted loans				—			—			150,000
Cash payment for investment deposits				—			—			(50,000	)
Payment for investment in associates and a joint venture		20		—			—			(296,672	)
Cash payment for investment in time deposits with maturity less than one year				(3,000,000	)		(3,650,000	)		—
Cash payment for investment in time deposits with maturity more than one year				(3,500,000	)		(2,000,000	)		(2,600,000	)
Acquisition of a subsidiary, net of cash acquired				(340,315	)		—			—
Payment for set up of an associate		20		(27,603	)		(26,000	)		—
Payment for set up of a joint venture		20		—			(50,000	)		—
Proceeds from capital reduction of an associate				—			1,460,258			—
Payment for sales of financial assets at fair value through other comprehensive income				(9,513	)		(4,685	)		(3,148	)

Net cash (used in) / generated from investing activities				(3,887,528	)		(2,359,421	)		4,390,350

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Financial statements for the years ended 31 December 2020, 2021 and 2022

Consolidated cash flow statements

for the years ended 31 December 2020, 2021 and 2022 (continued)


				Years ended 31 December
				2020			2021			2022
	Note			RMB’000			RMB’000			RMB’000
Financing activities
Proceeds from borrowings		23	(c)		3,458,100			14,163,132			19,485,000
Proceeds from short-term bonds		23	(c)		2,998,469			5,998,899			5,000,000
Repayments of borrowings		23	(c)		(3,460,556	)		(13,451,332	)		(19,494,800	)
Repayments of short-term bonds		23	(c)		—			(9,000,000	)		(5,000,000	)
Principal elements of lease payments					(15,586	)		(17,544	)		(13,069	)
Dividends paid by subsidiaries to non-controlling interests					(4,901	)		(4,901	)		(11,434	)
Dividends paid to the Company’s shareholders					(1,293,736	)		(1,081,326	)		(1,081,327	)
Payment for repurchase of shares					—			—			(53,262	)
Net cash generated from / (used in) financing activities					1,681,790			(3,393,072	)		(1,168,892	)
Net decrease in cash and cash equivalents					(525,890	)		(1,802,537	)		(4,237,917	)
Cash and cash equivalents at the beginning of the year		23			7,449,699			6,916,408			5,112,010
Exchange (losses) / gains on cash and cash equivalents					(7,401	)		(1,861	)		15,320

Cash and cash equivalents at the end of the year		23			6,916,408			5,112,010			889,413

The notes on pages F-17 to F-119 form part of these financial statements.

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Notes to the consolidated financial statements

(Expressed in Renminbi Yuan unless otherwise indicated)

1	General Information

Sinopec Shanghai Petrochemical Company Limited (“the Company”), formerly Shanghai Petrochemical Company Limited, was established in the People’s Republic of China (“the PRC”) on 29 June 1993 with registered capital of RMB

4,000,000

thousand, invested by its holding company-China National Petrochemical Corporation (“Sinopec Group”); these shares were converted from assets of former Shanghai Petrochemical Complex.

H shares were listed on the Hong Kong Stock Exchange on 26 July 1993, and listed on the New York Stock Exchange in the form of American Depositary Shares at the same time; the A shares were listed on the Shanghai Stock Exchange on 8 November 1993.

Sinopec Group completed its reorganization on 25 February 2000. After the reorganization, China Petroleum & Chemical Corporation (“Sinopec Corp.”) was established. As part of the reorganization, Sinopec Group transferred its

4,000,000,000

of the Company’s state-owned legal shares, which represented

55.56

percent of the issued share capital of the Company, to Sinopec Corp. Sinopec Corp. became the largest shareholder of the Company.

The Company changed its name to Sinopec Shanghai Petrochemical Company Limited on 12 October 2000.

Ordinary A shares of RMB14,177 thousand and RMB9,637 thousand were registered on 27 September 2017 and 12 January 2018.

As at 31 December 2022, total share capital of the Company were RMB10,823,814 thousand , 1 Yuan per share. Detailed changes to share capital refers to note 30. The Company and its subsidiaries (“the Group”) is a highly integrated entity which processes crude oil into synthetic fibres, resins and plastics, intermediate petrochemicals and petroleum products.

Details of the Company’s principal subsidiaries are set out in note 19.

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies

The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

2.1	Statement of compliance and basis of preparation

(a)	Statement of compliance

These financial statements have been prepared in accordance with all applicable International Financial Reporting Standards (IFRSs), which collective term includes all applicable individual International Financial Reporting Standards, International Accounting Standards (IASs) and related Interpretations, promulgated by the International Accounting Standards Board (IASB) Significant accounting policies adopted by the Group are disclosed below.

The IASB has issued certain amendments to IFRSs that are first effective or available for early adoption for the current accounting period of the Group. Note 2.1 (c) provides information on any changes in accounting policies resulting from initial application of these developments to the extent that they are relevant to the Group for the current accounting period reflected in these financial statements.

(b)	Basis of preparation

The consolidated financial statements for the year ended 31 December 2022 comprise the Company and its subsidiaries (together referred to as the “Group”) and the Group’s interest in associates and a joint ventures.

The measurement basis used in the preparation of the financial statements is the historical cost basis except for certain financial assets and liabilities measured at fair value, including:

•

derivative financial instruments (see note 2.13); and

•

investment in debt and equity securities (see note 2.11).

The preparation of financial statements in conformity with IFRSs requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements made by management in the application of IFRSs that have significant effect on the financial statements and major sources of estimation uncertainty are discussed in note 4.

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.1	Statement of compliance and basis of preparation (continued)

(c)	Changes in accounting policies

The Group has applied the following amendments to IFRSs issued by the IASB to these financial statements for the current accounting period:

•

Amendments to IAS 16, Property, plant and equipment: Proceeds before intended use

•

Amendments to IAS 37, Provisions, contingent liabilities and contingent assets: Onerous contracts —

cost of fulfilling a contract

•

Amendments to IFRSs, Annual Improvements to IFRS Standards 2018-2020

•

Amendments to IFRS 3, Reference to the Conceptual Framework

None of these developments have had a material effect on how the Group’s results and financial position for the current or prior periods have been prepared or presented. The Group has not applied any new standard or interpretation that is not yet effective for the current accounting period.

2.2	Subsidiaries

2.2.1

Consolidation

Subsidiaries are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.

Inter-company transactions, balances and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group.

Non-controlling

interests in the results and equity of subsidiaries are shown separately in the consolidated statements of financial position, consolidated statements of profit or loss, statements of comprehensive income and changes in equity respectively.

(a)	Business combinations

The acquisition method of accounting is used to account for all business combinations by the Group, regardless of whether equity instruments or other assets are acquired. The consideration transferred for the acquisition of a subsidiary comprises the:

•

fair values of the assets transferred;

•

liabilities incurred to the former owners of the acquired business;

•

equity interests issued by the Group;

•

fair value of any asset or liability resulting from a contingent consideration arrangement, and

•

fair value of any

pre-existing

equity interest in the subsidiary.

Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date. The Group recognizes any

non-controlling

interest in the acquired entity on an

acquisition-by-acquisition

basis either at fair value or at the

non-controlling

interest’s proportionate share of the acquired entity’s net identifiable assets.

Acquisition-related costs are expensed as incurred.

The excess of the:

•

consideration transferred

•

amount of any

non-controlling

interest in the acquired entity, and

•

acquisition-date fair value of any previous equity interest in the acquired entity

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.2	Subsidiaries (continued)

2.2.1

Consolidation (continued)

(a)	Business combinations (continued)

Over the fair value of the net identifiable assets acquired is recorded as goodwill. If those amounts are less than the fair value of the net identifiable assets of the business acquired, the difference is recognized directly in the statements of profit or loss as a bargain purchase.

Where settlement of any part of cash consideration is deferred, the amounts payable in the future are discounted to their present value as at the date of exchange. The discount rate used is the Group’s incremental borrowing rate, being the rate at which a similar borrowing could be obtained from an independent financier under comparable terms and conditions.

If the business combination is achieved in stages, the acquirer’s previously held equity interest in the acquiree is remeasured to fair value at the acquisition date. Any gains or losses arising from such remeasurement are recognized in the statements of profit or loss.

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.2	Subsidiaries (continued)

2.2.1

Consolidation (continued)

(b)	Changes in ownership interests

The Group treats transactions with

non-controlling

interests that do not result in loss of control as transactions with equity

owners

of the Group. A change in ownership interest results in an adjustment between the carrying amounts of the controlling and

non-controlling

interests to reflect their relative interests in the subsidiary. Any difference between the amount of the adjustment to

non-controlling

interests and any consideration paid or received is recognized in a separate reserve within equity attributable to owners of the Group.

When the Group ceases to consolidate or equity account for an investment because of a loss of control, joint control or significant influence, any retained interest in the entity is remeasured to its fair value, with the change in carrying amount recognized in the statements of profit or loss. This fair value becomes the initial carrying amount for the purposes of subsequently accounting for the retained interest as an associate, joint venture or financial asset. In addition, any amounts previously recognized in other comprehensive income in respect of that entity are accounted for as if the Group had directly disposed of the related assets or liabilities. This means that amounts previously recognized in other comprehensive income are reclassified to profit or loss.

2.2.2

Separate financial statements

Investments in subsidiaries are accounted for at cost less impairment. Cost includes direct attributable costs of investment. The results of subsidiaries are accounted for by the Company on the basis of dividend received and receivable.

Investments in joint ventures and associates are accounted for using the equity method of accounting.

F-21

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.3	Associates

Associates are all entities over which the Group has significant

influence

but not control or joint control. Investments in associates are accounted for using the equity method of accounting. Under the equity method, the investment is initially recognized at cost, and the carrying amount is increased or decreased to recognize the investor’s share of the profit or loss of the investee after the date of acquisition. The Group’s investments in associates include goodwill identified on acquisition. Upon the acquisition of the ownership interest in an associate, any difference between the cost of the associate and the Group’s share of the net fair value of the associate’s identifiable assets and liabilities is accounted for as goodwill.

The Group’s share of post-acquisition profit or loss is recognized in the statements of profit or loss, and its share of post-acquisition movements in other comprehensive income is recognized in other comprehensive income with a corresponding adjustment to the carrying amount of the investment. When the Group’s share of losses in an associate equals or exceeds its interest in the associate, including any other unsecured receivables, the Group does not recognize further losses, unless it has incurred legal or constructive obligations or made payments on behalf of the associate.

The Group determines at each reporting date whether there is any objective evidence that the investment in the associate is impaired. If this is the case, the Group calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value and recognizes the amount in the statements of profit or loss.

Profits and losses resulting from upstream and downstream transactions between the Group and its associates are recognized in the Group’s financial statements only to the extent of unrelated investor’s interests in the associates. Unrealized losses are eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of associates have been changed where necessary to ensure consistency with the policies adopted by the Group.

Gain or loss on dilution of equity interest in associates are recognized in the statements of profit or

loss

F-2

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.4	Joint arrangements

Under IFRS 11 ‘Joint Arrangements’ investments in joint arrangements are classified as either joint operations or joint ventures. The classification depends on the contractual rights and obligations of each investor, rather than the legal structure of the joint arrangement. The Group has assessed the nature of its joint arrangements and determined them to be joint ventures. Joint ventures are accounted for using the equity method.

Under the equity method of accounting, interests in joint ventures are initially recognized at cost and adjusted thereafter to recognize the Group’s share of the post-acquisition profits or losses and movements in other comprehensive income. The Group’s investments in joint ventures include goodwill identified on acquisition. Upon the acquisition of the ownership interest in a joint venture, any difference between the cost of the joint venture and the Group’s share of the net fair value of the joint venture’s identifiable assets and liabilities is accounted for as goodwill. When the Group’s share of losses in a joint venture equals or exceeds its interests in the joint ventures, including any other unsecured receivables, the Group does not recognize further losses, unless it has incurred obligations or made payments on behalf of the joint ventures.

Unrealized gains on transactions between the Group and its joint ventures are eliminated to the extent of the Group’s interest in the joint ventures. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of the joint ventures have been changed where necessary to ensure consistency with the policies adopted by the Group.

The carrying amount of equity-accounted investments is tested for impairment in accordance with the policy described in note 2.12.

2.5	Segment reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Board of Directors that makes strategic decisions.

F-2

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.6	Foreign currency translation

(a)

Functional and presentation currency

Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic environment in which the entity operates (“the functional currency”).

The consolidated financial statements are presented in RMB, which is the Company’s functional and the Group’s presentation currency.

(b) Transactions and balances

Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates, are generally recognized in the statements of profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges and qualifying net investment hedges.

2.7	Property, plant and equipment

Property, plant and equipment is stated at historical cost less depreciation and impairment losses. Historical cost includes expenditure that is directly attributable to the acquisition of the items.

Items may be produced while bringing an item of property, plant and equipment to the location and condition necessary for it to be capable of operating in the manner intended by management. The proceeds from selling any such items and the related costs are recognized in profit or loss.

Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statements of profit or loss during the financial period in which they are incurred.

Depreciation on property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:


- Buildings			12 to 40 years
- Plant and machinery			5 to 20 years
- Vehicles and other equipment			4 to 20 years

The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.

An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount (note 2.12 (b)).

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized within Other gains/(losses) - net in the statements of profit or loss.

F-2

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.8	Construction in progress

Construction in progress represents buildings, various plant and equipment under construction and pending installation, and is stated at cost less government grants that compensate the Company for the cost of construction, and impairment losses. Cost comprises direct costs of construction as well as interest charges, and foreign exchange differences on related borrowed funds to the extent that they are regarded as an adjustment to interest charges, during the period of construction. Construction in progress is transferred to property, plant and equipment when the asset is substantially ready for its intended use. No depreciation is provided in respect of construction in progress.

2.9	Investment properties

Investment properties are properties which are owned either to earn rental income and/or for capital appreciation.

Investment properties are stated in the statements of financial position at cost less accumulated depreciation and impairment losses (note 2.12(b)). Depreciation is provided over their estimated useful lives on a straight-line basis, after taking into account their estimated residual values.

Estimated useful lives of the Group’s investment properties are

30-40

years.

2.10	Other non-current assets

Other non-current assets mainly represent intangible assets and long-term prepaid expense, which are amortized on a straight-line basis over the following periods:


Intangible assets - patents			2 to 28 years
Long-term prepaid expense - catalyst			1.5 to 10 years
Long-term prepaid expense - leasehold improvement			3 to 27 years

2.11	Other investments in debt and equity securities

The Group’s policies for investments in debt and equity securities, other than investments in subsidiaries, associates and joint ventures, are set out below.

Investments in debt and equity securities are recognized/derecognized on the date the Group commits to purchase/sell the investment. The investments are initially stated at fair value plus directly attributable transaction costs, except for those investments measured at fair value through profit or loss (FVPL) for which transaction costs are recognized directly in profit or loss. For an explanation of how the Group determines fair value of financial instruments, see note 3.3. These investments are subsequently accounted for as follows, depending on their classification.

F-2

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.11	Other investments in debt and equity securities (continued)

(a)	Investments other than equity investments

Non-equity

investments held by the Group are classified into one of the following measurement categories:

•

amortized cost, if the investment is held for the collection of contractual cash flows which represent solely payments of principal and interest. Interest income from the investment is calculated using the effective interest method (see note 2.27).

•

fair value through other comprehensive income (FVOCI) - recycling, if the contractual cash flows of the investment comprise solely payments of principal and interest and the investment is held within a business model whose objective is achieved by both the collection of contractual cash flows and sale. Changes in fair value are recognized in other comprehensive income, except for the recognition in profit or loss of expected credit losses, interest income (calculated using the effective interest method) and foreign exchange gains and losses. When the investment is derecognized, the amount accumulated in other

comprehensive

income is recycled from equity to profit or loss.

•

fair value through profit or loss (FVPL) if the investment does not meet the criteria for being measured at amortized cost or FVOCI (recycling). Changes in the fair value of the investment (including interest) are recognized in profit or loss.

(b)	Equity investments

An investment in equity securities is classified as FVPL unless the equity investment is not held for trading purposes and on initial recognition of the investment the Group makes an irrevocable election to designate the investment at FVOCI

(non-recycling)

such that subsequent changes in fair value are recognized in other comprehensive income. Such elections are made on an

instrument-by-instrument

basis, but may only be made if the investment meets the definition of equity from the issuer’s perspective. Where such an election is made, the amount accumulated in other comprehensive income remains in the fair value reserve

(non-recycling)

until the investment is disposed of. At the time of disposal, the amount accumulated in the fair value reserve

(non-recycling)

is transferred to retained earnings. It is not recycled through profit or loss. Dividends from an investment in equity securities, irrespective of whether classified as at FVPL or FVOCI, are recognized in profit or loss as other income in accordance with the policy set out in note 2.28.

2.12	Credit losses and impairment of assets

(a)	Credit losses from financial instruments

The Group recognizes a loss allowance for expected credit losses (ECLs) on the following items:

•

financial assets measured at amortized cost (including cash and cash equivalents, time deposits with banks, trade receivables and other receivables); and

•

debt securities measured at FVOCI (recycling);

F-2

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.12	Credit losses and impairment of assets (continued)

(a)	Credit losses from financial instruments (continued)

Other financial assets measured at fair value, including equity securities designated at FVOCI

(non-recycling)

and derivative financial assets, are not subject to the ECL assessment.

Measurement of ECLs

ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of all expected cash shortfalls (i.e. the difference between the cash flows due to the Group in accordance with the contract and the cash flows that the Group expects to receive).

The expected cash shortfalls are discounted using the following discount rates where the effect of discounting is material:

•

fixed-rate financial assets, trade and other receivables: effective interest rate determined at initial recognition or an approximation thereof;

•

variable-rate financial assets: current effective interest rate.

The maximum period considered when estimating ECLs is the maximum contractual period over which the Group is exposed to credit risk. In measuring ECLs, the Group takes into account reasonable and supportable information that is available without undue cost or effort. This includes information about past events, current conditions and forecasts of future economic conditions.

ECLs are measured on either of the following bases:

•

12-month

ECLs: these are losses that are expected to result from possible default events within the 12 months after the reporting date; and

•

lifetime ECLs: these are losses that are expected to result from all possible default events over the expected lives of the items to which the ECL model applies.

Loss allowances for trade receivables are always measured at an amount equal to lifetime ECLs. ECLs on these financial assets are estimated using a provision matrix based on the Group’s historical credit loss experience, adjusted for factors that are specific to the debtors and an assessment of both the current and forecast general economic conditions at the reporting date.

For all other financial instruments, the Group recognizes a loss allowance equal to

12-month

ECLs unless there has been a significant increase in credit risk of the financial instrument since initial recognition, in which case the loss allowance is measured at an amount equal to lifetime ECLs.

F-27

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.12	Credit losses and impairment of assets (continued)

(a)	Credit losses from financial instruments (continued)

Significant increases in credit risk

In assessing whether the credit risk of a financial instrument has increased significantly

since

initial recognition, the Group compares the risk of default occurring on the financial instrument assessed at the reporting date with that assessed at the date of initial recognition.

In making this reassessment, the Group considers that a default event occurs when (i) the borrower is unlikely to pay its credit obligations to the Group in full, without recourse by the Group to actions such as realizing security (if any is held); or (ii) the financial asset is 90 days past due.

The Group considers both quantitative and qualitative information that is reasonable and supportable, including historical experience and forward-looking information that is available without undue cost or effort.

In particular, the following information is taken into account when assessing whether credit risk has increased significantly since initial recognition:

•

failure to make payments of principal or interest on their contractually due dates;

•

an actual or expected significant deterioration in a financial instrument’s external or internal credit rating (if available);

•

an actual or expected significant deterioration in the operating results of the debtor; and

•

existing or forecast changes in the technological, market, economic or legal environment that have a significant adverse effect on the debtor’s ability to meet its obligation to the Group.

Depending on the nature of the financial instruments, the assessment of a significant increase in credit risk is performed on either an individual basis or a collective basis. When the assessment is performed on a collective basis, the financial instruments are grouped based on shared credit risk characteristics, such as past due status and credit risk ratings.

ECLs are remeasured at each reporting date to reflect changes in the financial instrument’s credit risk since initial recognition. Any change in the ECL amount is recognized as an impairment gain or loss in profit or loss. The Group recognizes an impairment gain or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for investments in debt securities that are measured at FVOCI (recycling), for which the loss allowance is recognized in other comprehensive income and accumulated in the fair value reserve (recycling).

F-28

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.12	Credit losses and impairment of assets (continued)

(a)	Credit losses from financial instruments (continued)

Basis of calculation of interest income

Interest income recognized in accordance with note 2.27 is calculated based on the gross carrying amount of the financial asset unless the financial asset is credit-impaired, in which case interest income is calculated based on the amortized cost (i.e. the gross carrying amount less loss allowance) of the financial asset.

At each reporting date, the Group assesses whether a financial asset is credit-impaired. A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred.

Evidence that a financial asset is credit-impaired includes the following observable events:

•

significant financial difficulties of the debtor;

•

a breach of contract, such as a default or past due event;

•

it is becoming probable that the borrower will enter into bankruptcy or other financial reorganization;

•

significant changes in the technological, market, economic or legal environment that have an adverse effect on the debtor; or

•

the disappearance of an active market for a security because of financial difficulties of the issuer.

Write-off

policy

The gross carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. This is generally the case when the Group determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the

write-off.

Subsequent recoveries of an asset that was previously written off are recognized as a reversal of impairment in profit or loss in the period in which the recovery occurs.

F-29

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.12	Credit losses and impairment of assets (continued)

(b)	Impairment of other non-current assets

Internal and external sources of information are reviewed at the end of each reporting period to identify indications

that

the following assets may be impaired or, except in the case of goodwill, an impairment loss previously recognized no longer exists or may have decreased:

•

property, plant and equipment;

•

right-of-use

assets;

•

investment properties;

•

construction in progress

•

other

non-current

assets; and

•

investments in subsidiaries, associates and joint ventures in the Company’s statements of financial position.

At the end of each reporting period, if any indication of impairment exists, the Company estimates the recoverable amount of an asset, or a cash- generating unit, at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses.

•

Calculation of recoverable amount

The recoverable amount of an asset is the greater of its fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash fl ows are discounted to their present value using a

pre-tax

discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. Where an asset does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the smallest group of assets that generates cash inflows independently (i.e. a cash-generating unit). A portion of the carrying amount of a corporate asset (for example, head office building) is allocated to an individual cash-generating unit if the allocation can be done on a reasonable and consistent basis, or to the smallest group of cash-generating units if otherwise.

•

Recognition of impairment losses

An impairment loss is recognized in profit or loss if the carrying amount of an asset, or the cash-generating unit to which it belongs, exceeds its recoverable amount. Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to the cash-generating unit (or group of units) and then, to reduce the carrying amount of the other assets in the unit (or group of units) on a pro rata basis, except that the carrying value of an asset will not be reduced below its individual fair value less costs of disposal (if measurable) or value in use (if determinable).

•

Reversals of impairment losses

An impairment loss is reversed if there has been a favourable change in the estimates used to determine the recoverable amount.

A reversal of an impairment loss is limited to the asset’s carrying amount that would have been determined had no impairment loss been recognized in prior years.

F-30

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.12	Credit losses and impairment of assets (continued)

Reversals of impairment losses are credited to profit or loss in the year in which the reversals are recognized.

2.13	Derivative and hedging activities

Derivatives are initially recognized at fair value on the date a derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. The accounting for subsequent changes in fair value depends on whether the derivative is designated as a hedging instrument and, if so, the nature of the item being hedged. The Group designates certain derivatives as hedges of a particular risk associated with the cash flows of recognized assets and liabilities and highly probable forecast transactions (cash flow hedges).

At inception of the hedge relationship, the Group documents the economic relationship between hedging instruments and hedged items, including whether changes in the cash flows of the hedging instruments are expected to offset changes in the cash flows of hedged items. The Group documents its risk management objective and strategy for undertaking its hedge transactions.

The fair values of derivative financial instruments designated in hedge relationships are disclosed in note 3.1(a). Movements in the hedging reserve in shareholders’ equity are shown in note 3

. The full fair value of a hedging derivative is classified as a

non-current

asset or liability when the remaining maturity of the hedged item is more than 12 months; it is classified as a current asset or liability when the remaining maturity of the hedged item is less than 12 months. Trading derivatives are classified as a current asset or liability.

Cash flow hedges that qualify for hedge accounting

The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in the cash flow hedge reserve within equity. The gain or loss relating to the ineffective portion is recognized immediately in the statements of profit or loss, within Other gains/(losses) – net.

When swap contracts are used to hedge forecast transactions the Group may designate the full change in fair value of the swap contract as the hedging instrument. The gains or losses relating to the effective portion of the change in fair value of the entire swap contract are recognized in the cash flow hedge reserve within equity.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.13	Derivative and hedging activities (continued)

Amounts accumulated in equity are reclassified in the periods when the hedged item affects the statements of profit or loss as follows:

Where the hedged item subsequently results in the recognition of a

non-financial

asset (such as inventory), the deferred hedging gains and losses are included within the initial cost of the asset. The deferred amounts are ultimately recognized in the statements of profit or loss as the hedged item affects profit or loss (for example through cost of sales).

When a hedging instrument expires, or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative deferred gain or loss and deferred costs of hedging in equity at that time remains in equity until the forecast transaction occurs, resulting in the recognition of a

non-financial

asset such as inventory. When the forecast transaction is no longer expected to occur, the cumulative gain or loss and deferred costs of hedging that were reported in equity are immediately reclassified to Other gains/(losses) - net.

Derivatives that do not qualify for hedge accounting

Certain derivative instruments do not qualify for hedge accounting. Changes in the fair value of any derivative instrument that does not qualify for hedge accounting are recognized immediately in the statements of profit or loss and are included in Other gains/(losses) - net.

2.14	Inventories

Inventories are valued at the lower of cost and net realizable value. Cost is determined using the weighted average cost method. The cost of finished goods and work in progress comprises raw materials, direct labor, other direct costs and related production overheads (based on normal operating capacity). It excludes borrowing costs. The net realizable value is determined based on the estimated selling price in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale.

2.15	Contract liabilities

A contract liability is recognized when the customer pays

non-refundable

consideration before the Group recognizes the related revenue (see note 2.26). A contract liability would also be recognized if the Group has an unconditional right to receive

non-refundable

consideration before the Group recognizes the related revenue. In such cases, a corresponding receivable would also be recognized (see note 2.16).

When the contract includes a significant financing component, the contract balance includes interest accrued under the effective interest method (see note 2.27).

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.16	Trade and other receivables

A receivable is recognized when the Group has an unconditional right to receive consideration. A right to receive consideration is unconditional if only the passage of time is required before payment of that consideration is due. If revenue has been recognized before the Group has an unconditional right to receive consideration, the amount is presented as a contract asset.

Trade receivables that do not contain a significant financing component are initially measured at their transaction price.

Receivables are subsequently stated at amortized cost using the effective interest method less allowance for credit losses (see note 2.12(a)).

2.17	Cash and cash equivalents

In the consolidated cash flow statements, cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value, and bank overdrafts. Bank overdrafts are presented within borrowings in current liabilities in the statements of financial position. Cash and cash equivalents are assessed for expected credit losses (ECL) in accordance with the policy set out in note 2.12(a).

2.18	Share capital

Ordinary shares are classified as equity.

Incremental costs directly attributable to the issue of new shares are shown in equity as a deduction, net of tax, from the proceeds.

2.19	Safety production fund

Under China’s law and regulation, the Group is required to accrue safety production fund at a certain percentage of the sales of dangerous goods. The fund is earmarked for improving the safety of production. The fund is accrued from retained earnings to other reserves and converted back to retained earnings when used.

2.20	Trade and other payables

Trade and other payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade and other payables are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as

non-current

liabilities.

Trade and other payables generally are financial liabilities and are recognized initially at fair value plus transaction costs and subsequently measured at amortized cost unless the effect of discounting would be immaterial, in which case they are stated at invoice amounts.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.21	Borrowings

Borrowings are initially recognized at fair value, net of transaction costs incurred. Borrowings are subsequently measured at amortized cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognized in the statements of profit or loss over the period of the borrowings using the effective interest method.

Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalized as a

pre-payment

for liquidity services and amortized over the period of the facility to which it relates.

Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the end of the reporting period.

2.22	Borrowings costs

General and specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.

Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalization.

Other borrowing costs are expensed in the period in which they are incurred.

2.23	Current and deferred income tax

The tax expense for the period comprises current and deferred tax. Tax is recognized in the statements of profit or loss, except to the extent that it relates to items recognized in other comprehensive income or directly in equity. In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively.

(a)	Current income tax

The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the statements of financial position date in the countries where the Company’s subsidiaries, associates and joint ventures operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.23	Current and deferred income tax (continued)

(b)	Deferred income tax

Inside basis differences

Deferred income tax is recognized, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. However, deferred tax liabilities are not recognized if they arise from the initial recognition of goodwill, the deferred income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the statements of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled.

Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.

Outside basis differences

Deferred income tax liabilities are provided on taxable temporary differences arising from investments in subsidiaries, associates and joint arrangements, except for deferred income tax liability where the timing of the reversal of the temporary difference is controlled by the Group and it is probable that the temporary difference will not reverse in the foreseeable future. Generally, the Group is unable to control the reversal of the temporary difference for associates. Only when there is an agreement in place that gives the Group the ability to control the reversal of the temporary difference in the foreseeable future, deferred tax liability in relation to taxable temporary differences arising from the associate’s undistributed profits is not recognized.

Deferred income tax assets are recognized on deductible temporary differences arising from investments in subsidiaries, associates and joint arrangements only to the extent that it is probable the temporary difference will reverse in the future and there is sufficient taxable profit available against which the temporary difference can be utilized.

(c)	Offsetting

Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities and when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.24	Employee benefits

(a)	Short-term employee benefits

Salaries, annual bonuses, paid annual leave and the cost of

non-monetary

benefits are accrued in the year in which the associated services are rendered by employees. Where payment or settlement is deferred and the effect would be material, these amounts are stated at their present values.

(b)	Pension obligations

The PRC employees of the Group are covered by various PRC government-sponsored defined-contribution pension plans under which the employees are entitled to a monthly pension based on certain formulas. The relevant government agencies are responsible for the pension liability to these employees when they retire. The Group contributes on a monthly basis to these pension plans for the employees which are determined at a certain percentage of their salaries. Under these plans, the Group has no obligation for post-retirement benefits beyond the contribution made. Contributions to these plans are expensed as incurred and contributions paid to the defined contribution pension plans for a staff are not available to reduce the Group’s future obligations to such defined-contribution pension plans even if the staff leaves the Group.

(c)	Termination benefits

Termination benefits are payable when employment is terminated by the Group before the normal retirement date, or whenever an employee accepts voluntary redundancy in exchange for these benefits. The Group recognizes termination benefits at the earlier of the following dates: (a) when the Group can no longer withdraw the offer of those benefits; and (b) when the entity recognizes costs for a restructuring that is within the scope of IAS 37 and involves the payment of terminations benefits. In the case of an offer made to encourage voluntary redundancy, the termination benefits are measured based on the number of employees expected to accept the offer. Benefits falling due more than 12 months after the end of the reporting period are discounted to present value.

2.25	Provisions and contingent liabilities

Provisions for environmental restoration, restructuring costs and legal claims are recognized when: the Group has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount has been reliably estimated. Restructuring provisions comprise lease termination penalties and employee termination payments. Provisions are not recognized for future operating losses.

Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. A provision is recognized even if the likelihood of an outflow with respect to any one item included in the same class of obligations may be small.

Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a

pre-tax

rate that reflects current market assessments of the time value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognized as interest expense.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.25	Provisions and contingent liabilities (continued)

Where it is not probable that an outflow of economic benefits will be required, or the amount cannot be estimated reliably, the obligation is disclosed as a contingent liability, unless the probability of outflow of economic benefits is remote. Possible obligations, whose existence will only be confirmed by the occurrence or

non-occurrence

of one or more future events are also disclosed as contingent liabilities unless the probability of outflow of economic benefits is remote.

2.26	Revenue recognition

(a)	Sales of petroleum and chemical products

The Group manufactures and sells petroleum and chemical products. Sales are recognized when control of the products has transferred, being when the products are delivered to or accepted by the customer. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the customer, and either the customer has accepted the products in accordance with the sales contract, or the Group has objective evidence that all criteria for acceptance have been satisfied. Advance from customers but goods not yet delivered is recorded as contract liabilities and is recognized as revenue when a customer obtains control over the relevant goods.

Revenue excludes value added tax and is after deduction of any estimated trade discounts.

The Group has elected to apply the practical expedient that contract costs incurred related to contracts with an amortization period of less than one year have been expensed as incurred. The Group also applies the practical expedient in paragraph 121 of IFRS 15 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

(b)	Overseas shipping services

The Group arranges overseas shipping services for the customer and revenue is recognized over time and based on the actual shipping service provided to the end of the reporting period as a proportion of the total services to be provided, because the customer receives and uses the benefits simultaneously. This is determined based on the actual passages of time (days) relative to the total expected shipping days.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.27	Interest income

Interest income from financial assets at FVPL is included in Other gains/(losses) - net, see note 8 below. Interest income on financial assets at amortized cost and financial assets at FVOCI calculated using the effective interest method is recognized in the consolidated statements of profit or loss as part of other income.

Interest income is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for financial assets that subsequently become credit-impaired. For credit-impaired financial assets the effective interest rate is applied to the net carrying amount of the financial asset (after deduction of the loss allowance).

Interest income is presented as Finance income where it is earned from financial assets that are held for cash management purposes, see note 9 below.

2.28	Dividend income

Dividend income is recognized when the right to receive payment is established.

2.29	Government grants

Grants from the government are recognized at their fair value where there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions.

Government grants relating to costs are deferred and recognized in the statements of profit or loss over the period necessary to match them with the costs that they are intended to compensate.

Grants that compensate the Group for the cost of an asset are deducted from the carrying amount of the asset and consequently are effectively recognized in the statements of profit or loss over the useful life of the asset by way of reduced depreciation expense.

2.30

Leases

The Group leases various land, buildings, equipment, vehicles and others. Rental contracts of buildings, equipment, vehicles and others are typically made for fixed periods of 1 to 30 years. Rental contracts of land use rights are typically made for fixed periods of 30 to 50 years. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions.

Leases are recognized as a

right-of-use

asset and a corresponding liability at the date at which the leased asset is available for use by the Group.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.30	Leases (continued)

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments:

•

fixed payments (including

in-substance

fixed payments), less any lease incentives receivable,

•

variable lease payment that are based on an index or a rate, initially measured using the index or rate as at the commencement date,

•

amounts expected to be payable by the Group under residual value guarantees,

•

the exercise price of a purchase option if the Group is reasonably certain to exercise that option, and

•

payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option.

The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the Group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the

right-of-use

asset in a similar economic environment with similar terms, security and conditions.

To determine the incremental borrowing rate, the Group:

•

where possible, uses recent third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing conditions since third party financing was received

•

uses a

build-up

approach that starts with a risk-free interest rate adjusted for credit risk for leases held by the Group, which does not have recent third party financing, and

•

makes adjustments specific to the lease, e.g., term, country, currency and security.

Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.

Right-of-use

assets are measured at cost comprising the following:

•

the amount of the initial measurement of lease liability,

•

any lease payments made at or before the commencement date less any lease incentives received,

•

any initial direct costs, and

•

restoration costs.

F-3

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.30	Leases (continued)

Right-of-use

assets are generally depreciated over the shorter of the asset’s useful life and the lease term on a straight - line basis, as follows:


Land use rights			20 - 50 years
Buildings			2 - 8 years
Equipment			2 - 3 years
Others			2 - 4 years

Payments associated with short-term leases of equipment and vehicles are recognized on a straight-line basis as an expense in the statements of profit or loss. Short-term leases are leases with a lease term of 12 months or less. A single discount rate was applied to the portfolio of the leases with reasonably similar characteristics.

Lease income from operating leases where the Group is a lessor is recognized as income on a straight-line basis over the lease term. Initial direct costs incurred in obtaining an operating lease are added to the carrying amount of the underlying asset and recognized as expense over the lease term on the same basis as lease income. The respective leased assets are included in the statement

of financial position based on their nature.

2.31	Dividend distribution

Dividend distribution to the Company’s shareholders is recognized as a liability in the Group’s financial statements in the period in which the dividends are approved by the Company’s shareholders.

2.32	Research and development costs

Research and development costs comprise all costs that are directly attributable to research and development activities or that can be allocated on a reasonable basis to such activities. Research and development costs are recognized as intangible assets when the following criteria are met:

•

it is technically feasible to complete the research and development project so that it will be available for use or sale;

•

management intends to complete the research and development project, and use or sell it;

•

it can be demonstrated how the research and development project will generate economic benefits;

•

there are adequate technical, financial and other resources to complete the development and the ability to use or sell the research and development project; and

•

the expenditure attributable to the research and development project during its development phase can be reliably measured.

Other research and development expenditures that do not meet these criteria are recognized as an expense as incurred. Research and development costs previously recognized as an expense are not recognized as an asset in a subsequent period.

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

2	Significant accounting policies (continued)

2.33	Related parties

(a)	A person, or a close member of that person’s family, is related to the Group if that person:

(i)

has control or joint control over the Group;

(ii)

has significant influence over the Group; or

(iii)

is a member of the key management personnel of the Group or the Group’s parent.

(b)	An entity is related to the Group if any of the following conditions applies:

(iv)

The entity and the Group are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others).

(v)

One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member).

(vi)

Both entities are joint ventures of the same third party.

(vii)

One entity is a joint venture of a third entity and the other entity is an associate of the third entity.

(viii)

The entity is a post-employment benefit plan for the benefit of employees of either the Group or an entity related to the Group. (ix) The entity is controlled or jointly controlled by a person identified in (i).

(x)

A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity).

(xi)

The entity, or any member of a Group of which it is a part, provides key management personnel services to the Group or to the Group’s parent.

Close members of the family of a person are those family members who may be expected to influence, or be influenced by, that person in their dealings with the entity.

2.34	Rounding of amounts

All amounts disclosed in the consolidated financial statements and notes have been rounded off to the nearest thousand currency units unless otherwise stated.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management

3.1	Financial risk factors

The Group’s activities exposed it to a variety of financial risks: market risk (including foreign exchange risk,

cash

flow and fair value interest rate risk and commodity price risk), credit risk and liquidity risk. The Group’s overall risk management programmer focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Group’s financial performance.

Where all relevant criteria are met, hedge accounting is applied to remove the accounting mismatch between the hedging instrument and the hedged item.

(a)	Derivatives

The Group has the following derivative financial instruments in the following line items in the statements of financial position:


	As at 31 December
	2021			2022
	RMB’000			RMB’000
Current derivative financial instrument assets
Commodity swaps contracts applied hedge accounting		48,614			—
Commodity swaps contracts at fair value through profit or loss		32,791			—

Total derivative financial assets		81,405			—

Current derivative financial instrument liabilities
Commodity swaps contracts at fair value through profit or loss		(23,804	)		—

Total derivative financial liabilities		(23,804	)		—

(i)

Classification of derivatives

Derivatives are only used for economic hedging purposes and not as speculative investments. However, where derivatives do not meet the hedge accounting criteria, they are classified as ‘held for trading’ for accounting purposes and are accounted for at fair value through profit or loss. They are presented as current assets or liabilities to the extent they are expected to be settled within 12 months after the end of the reporting period.

The Group’s accounting policy for its cash flow hedges is set out in note 2.13.

(ii)

Fair value measurement

For information about the methods and assumptions used in determining the fair value of derivatives refer to note 3.3.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(a)	Derivatives (continued)

(iii)

Hedging reserves

The following table provides a reconciliation of the hedging reserve in respect of commodity price risk and shows the effectiveness of the hedging relationships:


	Pre-tax			Tax effect			Post-tax
	amount RMB’000			RMB’000			amount RMB’000
Balance at 1 January 2022		48,613			(12,153	)		36,460
Effective portion of the cash flow hedge recognized in other comprehensive income		375,701			(93,925	)		281,776
Amounts reclassified to profit or loss		(107,009	)		26,752			(80,257	)
Reclassified to inventory		(317,305	)		79,326			(237,979	)

Balance at 31 December 2022		—			—			—

(iv)

Amounts recognized in the consolidated statements of profit or loss

In addition to the amounts disclosed in the reconciliation of hedging reserves above, the following amounts were recognized in the consolidated statements of profit or loss in relation to derivatives:


	2021			2022
	RMB’000			RMB’000
Net gains/(losses) on commodity swaps contracts not qualifying as hedges included in other gains / (losses) - net		18,997			(35,434	)
Net gains on foreign exchange forward contracts not qualifying as hedges included in other gains / (losses) - net		—			7,583
Net losses on foreign exchange option contracts not qualifying as hedges included in other gains / (losses) - net		(151	)		—

Total		18,846			(27,851	)

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(a)	Derivatives (continued)

(iv)

Amounts recognized in the consolidated statements of profit or loss (continued)

Hedge effectiveness

Hedge effectiveness is determined at the inception of the hedge relationship, and through periodic prospective effectiveness assessments, to ensure that an economic relationship exists between the hedged item and hedging instrument.

The Group enters into commodity swaps contracts that have similar critical terms as the hedged item, such as reference rate, payment dates, transaction price, oil variety and oil quantity.

Hedge ineffectiveness for commodity swaps contracts may occur due to the changes in the timing of the hedged transactions. There was no recognized ineffectiveness during the year ended 31 December 2022 in relation to the commodity swaps.

As at 31 December 2022, the Group did not have commodity contracts of oil designed as qualified cash flow hedges. As at 31 December 2021, the Group had certain commodity contracts of crude oil designed as qualified cash flow hedges, which will be matured over the next 10 months. The fair value of such cash flow hedges is RMB48,614 thousand recognized as derivative financial assets in the consolidated statement

of financial position.

(b)	Market risk

(i)

Foreign exchange risk

The Group’s major operational activities are carried out in Mainland China and a majority of the transactions are denominated in RMB. Nevertheless, the Group is exposed to foreign exchange risk arising from the recognized assets and liabilities, and future transactions denominated in foreign currencies, primarily with respect to US dollar. The Group’s finance department at its headquarter is responsible for monitoring the amount of assets and liabilities, and transactions denominated in foreign currencies to minimize the foreign exchange risk. For the years ended 31 December 2021 and 31 December 2022, the Group used foreign exchange forward contracts and foreign exchange option contracts to mitigate its exposure to foreign exchange risk respect to US dollar.

As at 31 December 2022, there were no foreign exchange forward contract and foreign exchange option contract that had not been matured (31 December 2021: Nil).

As at 31 December 2022, if US dollar and HK dollar had weakened/strengthened by 5% against RMB with all other variables held constant, the Group’s net loss for the year ended 31 December 2022 would decrease/increase by RMB 1,751 thousand (31 December 2021: net profit would decrease/increase by RMB 2,292 thousand) before considering the impact of forward and option contracts as a result of foreign exchange gains/losses which is mainly resulted from the translation of US dollar denominated trade receivables and payables.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(b)	Market risk (continued)

The aggregate net foreign exchange (losses) / gains recognized in the consolidated statements of profit or loss were:


	2021			2022
	RMB’000			RMB’000
Net foreign exchange (losses)/gains included in Other gains/(losses) - net (note 8)		(1,861	)		21,969

(ii)

Cash flow and fair value interest rate risk

The Group’s interest rate risk arises from interest-bearing borrowings and short-term bonds. Borrowings obtained at variable rates expose the Group to cash flow interest rate risk. Borrowings obtained at fixed rates expose the Group to fair value interest rate risk. The Group determines the relative proportions of its fixed rate and floating rate contracts depending on the prevailing market conditions.

The Group’s finance department at its headquarter continuously monitors the interest rate position of the Group. Increases in interest rates will increase the cost of new borrowing and the interest expenses with respect to the Group’s outstanding floating rate borrowings, and therefore could have a material adverse effect on the Group’s financial position. The Group makes adjustments timely with reference to the latest market conditions and may enter into interest rate swap agreements to mitigate its exposure to interest rate risk. For the years ended 31 December 2021 and 31 December 2022, the Group did not enter into any interest rate swap agreements.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(b)	Market risk (continued)

At the reporting date, the interest rate profile of the Group’s interest-bearing financial instruments was as follows.


	2021			2022
	RMB’000			RMB’000
Fixed rate:
Time deposits with maturity less than one year		7,350,000			3,000,000
Time deposits with maturity more than one year		5,500,000			3,300,000
Borrowings		(1,500,000	)		(1,550,000	)
Lease liabilities		(4,613	)		(16,251	)

		11,345,387			4,733,749

Variable rate:
Cash and cash equivalents		5,112,010			889,413
Borrowings		(759,800	)		(700,000	)

		4,352,210			189,413

As at 31 December 2022, if interest rates on the floating rate financial instruments had risen/fallen by 50 basis points while all other variables had been held constant, the Group’s net loss would have decreased / increased by approximately RMB 730 thousand (2021: RMB 16,252 thousand increased / decreased in net profit), mainly as a result of higher/lower interest interest on floating rate cash and cash equivalents.

(iii)

Commodity price risk

The Group principally engages in processing crude oil into synthetic fibers, resins and plastics, intermediate petrochemicals and petroleum products. The selling price of petroleum products is periodically adjusted by the government department based on the market price adjustment mechanism, and generally in connection with the crude oil price. The fluctuations in prices of crude oil, refined oil products and intermediate petrochemicals and petroleum products could have significant impact on the Group. The Group uses commodity swaps contracts to manage a portion of this risk.

As at 31 December 2021, the Group had certain unexpired commodity contracts of crude oil and refined oil designated as qualified cash flow hedges balances of which have been disclosed in note 3.1 (a). As at 31 December 2022, the Group had no

unexpired

commodity contracts of crude oil and refined oil designated as qualified cash flow hedges.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(c)	Credit risk

(i)

Risk management

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in a financial loss to the Group. Credit risk is managed on group basis. It mainly arises from cash and cash equivalents, time deposits with banks, bills receivable, derivative financial assets, trade receivables measured at amortized cost and FVOCI, other receivables etc.

The Group expects that there is no significant credit risk associated with cash at bank (including time deposits and structured deposits), bills receivable and derivative financial assets because the counterparties are banks and financial institutions with a relatively higher credit rating, which the Group considers to represent low credit risk. Management does not expect that there will be any significant losses from

non-performance

by these counterparties.

In addition, the Group has policies to limit the credit exposure on trade receivables, other receivables. The Group assesses the credit quality of and sets credit limits on its customers by taking into account their financial position, the availability of guarantee from third parties, their credit history and other factors such as current market conditions. The credit history of the customers is regularly monitored by the Group. In respect of customers with a poor credit history, the Group will use written payment reminders, or shorten or cancel credit periods, to ensure the overall credit risk of the Group is limited to a controllable extent.

The Group considers the probability of default upon initial recognition of a financial asset and whether there has been a significant increase in credit risk on an ongoing basis throughout each reporting period. To assess whether there is a significant increase in credit risk, the Group compares the risk of a default occurring on the asset as at the reporting date with the risk of default as at the date of initial recognition. It considers available reasonable and supportive forward-looking information. Especially the following indicators are incorporated:

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(c)	Credit risk (continued)

(i)

Risk management (continued)

•

internal credit rating;

•

external credit rating (as far as available);

•

actual or expected significant adverse changes in business, financial or economic conditions that are expected to cause a significant change to the debtors’ ability to meet its obligations;

•

actual or expected significant changes in the operating results of the debtors;

•

significant increases in credit risk on other financial instruments of the same debtors;

•

significant changes in the value of the collateral supporting the obligation or in the quality of third-party guarantees or credit enhancements;

•

significant changes in the expected performance and behaviour of the debtors, including changes in the payment status of debtors, etc.

Regardless of the analysis above, a significant increase in credit risk is presumed if a debtor is more than 30 days past due in making a contractual payment.

It has other monitoring procedures to ensure that

follow-up

action is taken to recover overdue debts. In addition, the Group reviews regularly the recoverable amount of each individual trade receivables to ensure that adequate impairment losses are made for irrecoverable amounts. Significant concentrations of credit risk primarily arise when the Group has significant exposure to individual customers. As at 31 December 2022, 95.57% and 97.65% of the total trade receivables were due from the Group’s largest customer and the five largest customers respectively within the Group (31 December 2021: 93.20% and 94.70%).

For other receivables, management makes periodic collective assessment as well as individual assessment on the recoverability of other receivables based on historical settlement records and forward-looking information. The management believes that there is no material credit risk inherent in the Group’s outstanding balance of other receivable.

(ii)

Impairment of financial assets

The Group has three types of financial assets that are subject to the expected credit loss model:

•

Trade receivables for sales of goods and from the providing services,

•

Other financial assets carried at amortized cost, and

•

Debt instruments carried at FVOCI.

While cash and cash equivalents, time deposits with banks and bills receivable are also subject to the impairment requirements of IFRS 9, the identified impairment loss was immaterial.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(c)	Credit risk (continued)

(ii)

Impairment of financial assets (continued)

Trade receivables

The Group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables (including trade receivables with related parties) and financial assets at fair value through other comprehensive income.

To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due.

The expected credit loss rates are based on the payment profiles of sales over a period of 36 months before 31 December 2021 and 31 December 2022 respectively and the corresponding historical credit losses experienced within this period. The historical loss rates are adjusted to reflect current and forward-looking information on macroeconomic factors affecting the ability of the customers to settle the receivables

Impairment losses on trade receivables are presented as provision of impairment losses on financial assets within operating (loss) / profit. Subsequent recoveries of amounts previously written off are credited against the same line item.

Other financial assets at amortized cost

Other financial assets at amortized cost include other receivables.

As at 31 December 2021 and 31 December 2022, the internal credit rating of other receivables was all performing. The Group has assessed that the expected credit losses for these receivables are not material under the 12 months expected losses method.

Management considered that there was no significant increase in credit risk for other receivables including receivables from related parties by taking into account of their past history of making payments when due and current ability to pay, and thus the impairment provision recognized during the period was limited to 12 months expected losses.

The (reversal)/provision for loss allowance was recognized in the statements of profit or loss in reversal/(provision) of impairment losses on financial assets.

Trade and other receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan with the Group, and a failure to make contractual payments for a period of greater than 120 days past due.

Impairment losses on trade and other receivables are presented as (provision)/ reversal of impairment losses within operating profit. Subsequent recoveries of amounts previously written off are credited against the same line item.

F-4

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(c)	Credit risk (continued)

(ii)

Impairment of financial assets (continued)

Debt instruments carried at FVOCI

Debt instruments carried at FVOCI include trade receivables and bills receivable with a business model which is achieved both by collecting contractual cash flows and selling of these assets. The loss allowance for debt instruments is recognized in the statements of profit or loss and reduces the fair value loss otherwise recognized in OCI.

As at 31 December 2021 and 31 December 2022, no loss allowance was provided for financial assets at FVOCI.

(iii)

Provision of impairment losses on financial assets recognized in the consolidated statements of profit or loss

During the year, the following (losses) /recoveries were recognized in provision of impairment losses on financial assets in relation to impaired financial assets:


	2021 RMB’000			2022 RMB’000
Impairment losses
- provision in loss allowance for trade receivables		(1,354	)		(778	)
- provision in loss allowance for other receivables		(1	)		(4,727	)
Impairment losses reversed		—			139

Provision of impairment losses on financial assets		(1,355	)		(5,366	)

(iv)

Financial assets at fair value through profit or loss

The Group is also exposed to credit risk in relation to investments such as derivative financial instruments, which are measured at fair value through profit or loss. The maximum exposure at the end of the reporting period is the carrying amount of these investments.

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(d)	Liquidity risk

Cash flow forecast is performed by the operating entities of the Group and aggregated by Group finance. Group finance monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities from major financial institutions so that the Group does not breach borrowing limits or covenants on any of its borrowing facilities to meet the short-term and long-term liquidity requirements.

The liquidity of the Group is primarily dependent on its ability to maintain adequate cash inflow from operations, the renewal of its short-term bank loans and its ability to obtain adequate external financing to support its working capital and meet its debt obligation when they become due. As at 31 December 2022, the Group had credit facilities with several PRC financial institutions which provided the Group to draw down to RMB 9,200,000 thousand, within which amounted to RMB 6,950,000 thousand were unused. Management assessed that all the facilities could be renewed upon the expiration dates.

Surplus cash held by the operating entities over and above balance required for working capital management is transferred to the Group treasury. As at 31 December 2022, the Group held cash and cash equivalents of RMB 889,413 thousand (31 December 2021: RMB 5,112,010 thousand) (note 23), time deposits with banks - current of RMB 3,108,919 thousand (31 December 2021: RMB 7,386,607 thousand) (note 24) and trade receivables (including trade receivables with related parties and those carried at fair value through other comprehensive income (“FVOCI”) of RMB 2,957,771 thousand (31 December 2021: RMB 1,568,800 thousand), that are expected to readily generate cash inflows for managing liquidity risk.

The table below analyzes the Group’s financial liabilities into relevant maturity groupings based on the remaining period at the consolidated statements of financial position date to the contractual maturity date. The amounts disclosed in the table are the contractual undiscounted cash flows.


	As at 31 December 2021
	Contractual maturities of financial liabilities
	Less than 1 year RMB’000		Between 1 and 2 years RMB’000		Between 2 and 5 years RMB’000		Over 5 years RMB’000		Total RMB’000		Carrying amount
Non-derivatives
Borrowings		1,578,817		7,665		704,914		—		2,291,396		2,259,800
Lease liabilities		3,814		730		814		—		5,358		4,613
Bills payables		562,593		—		—		—		562,593		562,593
Trade payables		1,527,706		—		—		—		1,527,706		1,527,706
Other payables		1,003,860		—		—		—		1,003,860		1,003,860
Amounts due to related parties excluded non-financial liabilities		4,910,255		—		—		—		4,910,255		4,910,255

		9,587,045		8,395		705,728		—		10,301,168		10,268,827

Derivatives
Derivative financial liabilities		23,804		—		—		—		23,804		23,804

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.1	Financial risk factors (continued)

(d)	Liquidity risk (continued)


	As at 31 December 2022
	Contractual maturities of financial liabilities
	Less than 1 year		Between 1 and 2 years		Between 2 and 5 years		Over 5 years		Total		Carrying amount
	RMB’000		RMB’000		RMB’000		RMB’000		RMB’000		Carrying amount
Non-derivatives
Borrowings		1,570,282		704,914		—		—		2,275,196		2,250,000
Lease liabilities		9,395		7,531		655		—		17,581		16,251
Bills payables		24,951		—		—		—		24,951		24,951
Trade payables		1,818,453		—		—		—		1,818,453		1,818,453
Other payables		1,083,130		—		—		—		1,083,130		1,083,130
Amounts due to related parties excluded non-financial liabilities		7,877,323		—		—		—		7,877,323		7,877,323

		12,383,534		712,445		655		—		13,096,634		13,070,108

Derivatives
Derivative financial liabilities		—		—		—		—		—		—

3.2	Capital management

The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern, so that it can continue to provide returns for shareholders and benefits for other stakeholders, by pricing products and services commensurately with the level of risk and by securing access to finance at a reasonable cost.

The Group actively and regularly reviews and manages its capital structure to maintain a balance between the higher shareholder returns that might be possible with higher levels of borrowings and the advantages and security afforded by a sound capital position, and makes adjustments to the capital structure in light of changes in economic conditions.

The Group monitors its capital structure on the basis of an adjusted net

debt-to-capital

ratio. For this purpose, adjusted net debt is defined as total debt (which includes interest-bearing loans and borrowings, and lease liabilities) plus unaccrued proposed dividends, less cash and cash equivalents. Adjusted capital comprises all components of equity, other than amounts recognized in equity relating to cash flow hedges,less unaccrued proposed dividends.

The Group’s adjusted net

debt-to-capital

ratio at 31 December 2022 was as follows:


	Note		2022 RMB’000
Current liabilities:
Borrowings		26		1,550,000
Lease liabilities		15		8,738

				1,558,738
Non-current liabilities:
Borrowings		26		700,000
Lease liabilities		15		7,513

Total Debt				2,266,251
Less: Cash and cash equivalents		23		(889,413	)

Adjusted net debt				1,376,838

Total equity				26,355,363
Less: Hedging reserve				—

Adjusted capital				26,355,363

Adjusted net debt-to-capital ratio				5	%

As cash and cash equivalents exceed total borrowings and short-term bonds, which was resulted primarily from profitability, there was no net debt as at 31 December 2021.

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.3	Fair value estimation

The table below analyzes the Group’s financial instruments carried at fair value as at 31 December 2021 and 2022 by the level of the inputs to valuation techniques used to measure fair value. Such inputs are categorized into three levels within a fair value hierarchy as follows:

•

The fair value of financial instruments traded in active markets (such as publicly traded derivatives and equity securities) is based on quoted market prices at the end of the reporting period. The quoted market price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.

•

The fair value of financial instruments that are not traded in an active market (for example, over–the–counter derivatives) is determined using valuation techniques that maximize the use of observable market data and rely as little as possible on entity- specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is in

cluded in level 2.

•

If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. This is the case for unlisted equity securities.


	As at 31 December 2021
	Note		Level 1		Level 2		Level 3		Total
			RMB’000		RMB’000		RMB’000		RMB’000
Recurring fair value measurements
Financial assets
Financial assets measured at fair value through profit or loss
- Commodity swaps contracts		3.1(a)		—		32,791		—		32,791
Financial assets at fair value through other comprehensive income
- Trade and bills receivable		25		—		1,072,690		—		1,072,690
- Equity investments		25		—		—		5,000		5,000
- Commodity swaps contracts		3.1(a)		—		48,614		—		48,614

				—		1,154,095		5,000		1,159,095

Financial liabilities
Financial liabilities measured at fair value through profit or loss
- Commodity swaps contracts				—		23,804		—		23,804

				—		23,804		—		23,804

Amounts due to related parties – measured at fair value through profit or loss (FVPL)				—		1,388,286		—		1,388,286


			As at 31 December 2022
	Note		Level 1		Level 2		Level 3		Total
			RMB’000		RMB’000		RMB’000		RMB’000
Recurring fair value measurements
Financial assets
Financial assets measured at fair value through other comprehensive income
- Trade and bills receivable		25		—		582,354		—		582,354
- Equity investments		25		—		—		5,000		5,000

				—		582,354		5,000		587,354

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

3	Financial risk management (continued)

3.3	Fair value estimation (continued)

Valuation techniques and inputs used in Level 2 fair value measurements

The fair value of commodity swaps contract is the estimated amount that the Group would receive or pay to terminate the swap at the end of the reporting period, taking into account the current interest rates and the current creditworthiness of the swap counterparties.

The fair value of trade and bills receivable is estimated as the present value of the future cash flows, discounted at the market interest rates at the balance sheet date.

The fair value of amounts due to related parties is the estimated amount that the Group would settle the liability by returning certain quantity of crude oil at the end of the reporting period, referring to market price of the related crude oil. As at 31 December 2022, if market price of crude oil had risen/fallen by 10% while all other variables had been held constant, the Group’s net loss would have increased / decreased by approximately RMB nil (2021: RMB 89,787 thousand decreased / increased in net profit ).

During the year ended 31 December 2022, there were no transfers between Level 1 and Level 2, or transfers into or out of Level 3. The Group’s policy is to recognize transfers between levels of fair value hierarchy as at the end of the reporting period in which they occur.

Financial assets and financial liabilities not measured at fair value mainly represent trade receivables, other receivables, amounts due from related parties excluded prepayments, trade payables, amounts due to related parties, other payables (except for the staff salaries and welfare payables and taxes payables), borrowings and short-term bonds. The carrying amounts of these financial assets and liabilities not measured at fair value are a reasonable approximation of their fair value.

The following table presents the changes in level 3 items for the year ended 31 December 2022:


	Equity investments RMB’000		Structured deposits RMB’000			Total RMB’000
As at 31 December 2020		5,000		—			5,000
Acquisitions		—		8,150,000			8,150,000
Disposals		—		(8,247,921	)		(8,247,921	)
Fair value change		—		97,921			97,921

As at 31 December 2021		5,000		—			5,000

Acquisitions		—		1,000,000			1,000,000
Disposals		—		(1,011,124	)		(1,011,124	)
Fair value change		—		11,124			11,124

As at 31 December 2022		5,000		—			5,000

4	Critical accounting judgement and estimates

4.1	Critical accounting judgements in applying the Group’s accounting policies

In the process of applying the Group’s accounting policies, management has made the following accounting judgement:

(a)	Classification of financial assets

The classification depends on the Group’s business model for managing the financial assets and the contractual terms of the cash flows. The Group determines the business model for managing financial assets at the level of the financial asset portfolio. The factors considered include the way to evaluate and report the performance of financial assets to key management personnel, the risks affecting the performance of financial assets and their management methods, and the way for relevant business management personnel to obtain remuneration, etc.

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

4	Critical accounting judgement and estimates (continued)

4.1	Critical accounting judgements in applying the Group’s accounting policies (continued)

(a)	Classification of financial assets (continued)

When evaluating whether the contractual cash flow of financial assets is consistent with the basic lending arrangements, the Group has the following main judgments: whether the time distribution or amount of the principal may change in the duration due to prepayment and other reasons; whether the interest only includes the time value of money, credit risk, other basic lending risks and the consideration of cost and profit. For example, does the amount of prepayment only reflect the outstanding principal and the interest based on the outstanding principal, as well as the reasonable compensation paid for the early termination of the contract.

4.2	Sources of estimation uncertainty

Significant sources of estimation uncertainty are as follows:

(a)	Net realizable value (“NRV”) of inventories

As described in note 2.14, inventories are valued at the lower of cost and net realizable value. The net realizable value is determined based on the estimated selling prices in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale. These estimates are based on the current market condition and historical experience of selling products of similar nature. It could change significantly as a result of competitor actions in response to changes in market conditions.

Management reassesses these estimations at the end of each reporting period to ensure inventory is measured at the lower of cost and net realizable value.

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

4	Critical accounting judgement and estimates (continued)

4.2	Sources of estimation uncertainty (continued)

(b)	Impairments for non-current assets

As discussed in note 2.12, at the end of each reporting period, the Group estimates the recoverable amount of an asset or a cash-generating unit (“CGU”) (a portion of which related to certain production facilities), at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses. If circumstances indicate that the carrying amount of the asset or CGU may not be recoverable, the asset or CGU may be considered “impaired”, and an impairment loss may be recognized.

The recoverable amount of assets or CGUs is the higher of the fair value less costs of disposal and value in use. As the fair value of certain assets or CGUs may not be publicly available, the Group uses all readily available information in determining an amount that is a reasonable approximation of recoverable amount, including estimates based on reasonable and supportable assumptions for projections of product sales and operating costs and discount rate. In particular, in determining the value in use of the Group’s specific CGUs, significant judgements are required on the accounting estimates which are based on the assumptions relating to product sales growth rates, related costs growth rates and discount rate applied.

(c)	Useful life and residual value of property, plant and equipment

Property, plant and equipment, are depreciated on a straight-line basis over the estimated useful lives of the assets, after taking into account the estimated residual value. Management reviews the estimated useful lives and estimated residual value of the assets annually in order to determine the amount of depreciation expense to be recorded during any reporting period. The useful lives are based on the Group’s historical experience with similar assets, taking into account anticipated technological changes. The depreciation expense for future periods is adjusted if there are significant changes from previous estimates.

5	Segment information and revenue

5.1	Segment information

The Group manages its business by divisions, which are organized by business lines. In view of the fact that the Company and its subsidiaries operate substantially all in the PRC, no geographical segment information is presented.

In a manner consistent with the way in which information is reported internally to the Group’s chief operating decision maker, Board of Directors, for the purposes of resource allocation and performance assessment, the Group has identified the following five reportable segments. No operating segments have been aggregated to form the following reportable segments.

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)

Segment results, assets and liabilities include items directly attributable to a segment as well as those that can be allocated on a reasonable basis. Unallocated items mainly comprise interests in associates and joint ventures, deferred tax assets, cash and cash equivalents, time deposits, and incomes relating to these assets (such as share of net profits/(losses) of associates and joint ventures accounted for using the equity method and interest income), derivative financial assets, borrowings, short-term bonds and interest expenses, derivative financial liabilities, and deferred tax liabilities.

The Group principally operates in five operating segments: synthetic fibres, resins and plastics, intermediate petrochemicals, petroleum products and trading of petrochemical products. Synthetic fibres, resins and plastics, intermediate petrochemicals and petroleum products are produced through intermediate steps from the principal raw material of crude oil. The specific products of each segment are as follows:

(i)

The petroleum products segment is equipped with crude oil refinery facilities used to produce qualified refined gasoline, fuel, diesel oil, heavy oil and liquefied petroleum gas, and provide raw materials for the Group’s downstream petrochemical processing facilities.

(ii)

The intermediate petrochemicals segment primarily produces

p-xylene,

benzene and ethylene oxide. The intermediate petrochemicals produced by the Group are both served as raw materials in the production of other petrochemicals, resins, plastics and synthetic fibres, and sold to external customers.

(iii)

The resins and plastics segment produces primarily polyester chips, polyethylene resins, polypropylene resins and PVA granules. The polyester chips are used to produce polyester fibres, coating and containers. Polyethylene resins and plastics are used to produce insulated cable, mulching films and moulded products such as housewares and toys. Polypropylene resins are used for films, sheets and moulded products such as housewares, toys, consumer electronics and automobile parts.

(iv)

The synthetic fibres segment produces primarily polyester, acrylic fibres and carbon fibres, which are mainly used in the textile and apparel industries.

(v)

The trading of petrochemical products segment is primarily engaged in importing and exporting of petrochemical products. The products are sourced from international and domestic suppliers.

(vi)

Other operating segments represent the operating segments that do not meet the quantitative threshold for determining reportable segments. These include investment property leasing, service provision and a variety of other commercial activities.

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)


2020	Petroleum products RMB’000			Intermediate petrochemicals RMB’000			Resins and plastics RMB’000			Synthetic fibres RMB’000			Trading of petrochemical products RMB’000			Others RMB’000			Total RMB’000
Total segment revenue		49,711,547			19,777,574			9,576,944			1,480,576			12,023,744			1,583,236			94,153,621
Inter segment revenue		(6,631,343	)		(11,526,322	)		(101,057	)		—			(438,634	)		(832,690	)		(19,530,046	)

Revenue from external customers		43,080,204			8,251,252			9,475,887			1,480,576			11,585,110			750,546			74,623,575

Timing of revenue recognition
- At a point in time		43,080,204			8,251,252			9,475,887			1,480,576			11,583,709			750,546			74,622,174
- Over time		—			—			—			—			1,401			—			1,401

		43,080,204			8,251,252			9,475,887			1,480,576			11,585,110			750,546			74,623,575

Segment result – (loss)/profit from operations		(2,198,705	)		581,597			1,262,029			(364,211	)		42,039			211,015			(466,236	)

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)


2021	Petroleum products RMB’000			Intermediate petrochemicals RMB’000			Resins and plastics RMB’000			Synthetic fibres RMB’000			Trading of petrochemical products RMB’000			Others RMB’000			Total RMB’000
Total segment revenue		65,528,687			26,454,844			10,176,285			1,381,443			12,972,922			1,625,705			118,139,886
Inter segment revenue		(10,454,529	)		(15,619,770	)		(170,255	)		(445	)		(1,912,789	)		(783,606	)		(28,941,394	)

Revenue from external customers		55,074,158			10,835,074			10,006,030			1,380,998			11,060,133			842,099			89,198,492

Timing of revenue recognition
- At a point in time		55,074,158			10,835,074			10,006,030			1,380,998			11,020,323			842,099			89,158,682
- Over time		—			—			—			—			39,810			—			39,810

		55,074,158			10,835,074			10,006,030			1,380,998			11,060,133			842,099			89,198,492

Segment result – profit/(loss) from operations		2,967,030			(635,155	)		52,215			(854,077	)		43,729			(141,510	)		1,432,232

F-5

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)


2022	Petroleum products RMB’000			Intermediate petrochemicals RMB’000			Resins and plastics RMB’000			Synthetic fibres RMB’000			Trading of petrochemical products RMB’000			Others RMB’000			Total RMB’000
Total segment revenue		62,729,318			26,112,700			7,416,830			413,981			12,938,663			1,641,243			111,252,735
Inter segment revenue		(11,575,451	)		(15,536,795	)		(71,778	)		(98	)		(922,077	)		(703,380	)		(28,809,579	)

Revenue from external customers		51,153,867			10,575,905			7,345,052			413,883			12,016,586			937,863			82,443,156

Timing of revenue recognition
- At a point in time		51,153,867			10,575,905			7,345,052			413,883			11,917,827			937,863			82,344,397
- Over time		—			—			—			—			98,759			—			98,759

		51,153,867			10,575,905			7,345,052			413,883			12,016,586			937,863			82,443,156

Segment result – profit/(loss) from operations		972			(1,456,647	)		(1,252,524	)		(1,015,255	)		12,838			(132,750	)		(3,843,366	)

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)


	2020 RMB’000			2021 RMB’000			2022 RMB’000
Segment result – (loss)/profit from operations
Petroleum products		(2,198,705	)		2,967,030			972
Intermediate petrochemicals		581,597			(635,155	)		(1,456,647	)
Resins and plastics		1,262,029			52,215			(1,252,524	)
Synthetic fibres		(364,211	)		(854,077	)		(1,015,255	)
Trading of petrochemical products		42,039			43,729			12,838
Others		211,015			(141,510	)		(132,750	)

(Loss)/profit from operations		(466,236	)		1,432,232			(3,843,366	)
Finance income – net		332,274			414,569			443,328
Share of profit/(loss) of investments accounted for using the equity method		724,740			874,285			(173,616	)

Profit/(loss) before taxation		590,778			2,721,086			(3,573,654	)

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)

Other profit and loss disclosures


	2020									2021									2022
	Depreciation and amortization			Impairment loss and credit loss			Inventory write-down			Depreciation and amortization			Impairment loss and credit loss			Inventory write-down			Depreciation and amortization			Impairment loss and credit loss			Inventory write-down
	RMB’000			RMB’000			RMB’000			RMB’000			RMB’000			RMB’000			RMB’000			RMB’000			RMB’000
Petroleum products		(917,637	)		—			(138,537	)		(975,492	)		(94,420	)		(782	)		(928,687	)		—			(37,900	)
Intermediate petrochemicals		(465,425	)		(55,204	)		(15,418	)		(523,484	)		(297,632	)		(136,694	)		(414,999	)		(215,355	)		(248,518	)
Resins and plastics		(138,204	)		—			(26,382	)		(86,183	)		(61,242	)		(168	)		(106,845	)		(25,102	)		(134,138	)
Synthetic fibres		(78,030	)		88,550			(39,657	)		(132,091	)		(135,683	)		(13,239	)		(140,885	)		(51,160	)		(104,713	)
Trading of petrochemical products		(19,938	)		—			(788	)		(39,125	)		—			—			(35,345	)		—			—
Others		(207,905	)		—			(106	)		(209,333	)		(28,392	)		—			(186,537	)		(9	)		—


		(1,827,139	)		33,346			(220,888	)		(1,965,708	)		(617,369	)		(150,883	)		(1,813,298	)		(291,626	)		(525,269	)

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)


	As at 31 December
	2021 Total assets RMB’000		2022 Total assets RMB’000
Allocated assets
Petroleum products		13,317,338		16,021,111
Intermediate petrochemicals		3,781,785		3,803,989
Resins and plastics		1,395,867		1,359,796
Synthetic fibres		1,919,194		2,734,193
Trading of petrochemical products		1,348,751		1,391,104
Others		2,700,327		2,765,693


Allocated assets		24,463,262		28,075,886


Unallocated assets
Investments accounted for using the equity method		4,088,888		3,504,393
Cash and cash equivalents		5,112,010		889,413
Time deposits with banks		12,968,042		6,498,478
Deferred tax assets		184,143		991,850
Derivative financial assets		81,405		—
Value added tax recoverable		13,322		1,057,463
Others		9,517		119,234
Unallocated assets		22,457,327		13,060,831


Total assets		46,920,589		41,136,717

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.1	Segment information (continued)


	As at 31 December
	2021 Total liabilities RMB’000		2022 Total liabilities RMB’000
Allocated liabilities
Petroleum products		9,749,806		8,159,960
Intermediate petrochemicals		1,257,436		801,787
Resins and plastics		1,327,587		1,309,344
Synthetic fibres		490,211		531,455
Trading of petrochemical products		1,257,750		1,370,346
Others		112,876		251,328

Allocated liabilities		14,195,666		12,424,220

Unallocated liabilities
Borrowings		2,259,800		2,250,000
Deferred tax liabilities		33,344		30,895
Derivative financial liabilities		23,804		—
Others		30,577		76,239

Unallocated liabilities		2,347,525		2,357,134

Total liabilities		16,543,191		14,781,354


	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Additions to property, plant and equipment, construction in progress, right-of-use assets, other non-current assets
Petroleum products		779,392		708,342		544,806
Intermediate petrochemicals		278,788		1,306,813		1,029,771
Resins and plastics		139,212		44,495		54,220
Synthetic fibres		496,125		1,748,868		1,573,781
Trading of petrochemical products		378,292		71,917		16,603
Others		222,080		234,023		235,406

		2,293,889		4,114,458		3,454,587

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

5	Segment information and revenue (continued)

5.2

Revenue

The Group’s revenue from external customers are substantially all within Mainland China in 2020, 2021 and 2022. As at 31 December 2021 and 31 December 2022, assets are also substantially all within Mainland China.

Revenue of approximately RMB 52,190,120

thousand (2020: RMB38,651,385 thousand, 2021: RMB

59,766,489 thousand) are derived from a single customer. These revenues are attributable to the petroleum products and other segments .

Details of concentrations of credit risk arising from these customers are set out in note 3.1(c).

6	Other operating income


	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Government grants (a)		61,296		35,944		33,055
Rental income from investment properties (note 17)		81,608		81,923		75,159
Others		5,772		7,438		2,427

		148,676		125,305		110,641

(a)	Government grants

Grants related to R&D, other tax refund and subsidies are included in the government grants line item. There are no unfulfilled conditions or other contingencies attaching to these grants.

7	Other operating expenses


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Cost related to lease of investment properties		(15,625	)		(13,439	)		(12,037	)
Others		(9,061	)		(31,273	)		(13,738	)

		(24,686	)		(44,712	)		(25,775	)

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company

Limited

8	Other gains/(losses) – net


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Net (losses) / gains on disposal of property, plant and equipment and other long-term assets		(1,212	)		48,671			(26,767	)
Gains from structured deposits (note a)		114,283			97,921			11,124
Net losses on foreign exchange option contracts		(376	)		(151	)		—
Net gains on foreign exchange forward contracts		—			—			7,583
Net gains/(losses) on commodity swaps contracts not qualified for hedging accounting		—			18,997			(35,434	)
Losses from disposal of a subsidiary		—			—			—
Impairment losses for investment in an associate		—			(28,392	)		—
Net foreign exchange gains / (losses)		12,248			(1,861	)		21,969
Losses on sale of FVOCI		(9,513	)		(4,685	)		(3,148	)
Gains from entrusted loan receivables		—			—			2,704
Net losses on disposal of inventories		—			(19	)		(819	)

		115,430			130,481			(22,788	)

(a)	Gains from structured deposits

Structured deposits are financial products issued by banks, return of which are linked to the performance of the embedded index, like foreign exchange rate, interest rate and etc..

(b)	The effect of “6.18” No.1 ethylene glycol plant explosion accident

On 18 June 2022, a fire broke out in No.1 ethylene glycol plant of the intermediate petrochemicals segment of the Company, causing a fire on surrounding individual pipelines. Net losses due to the fire, including writing off of damaged fixed assets and inventories in the amount of RMB7,676 thousand and RMB819

thousand respectively, have been recorded in Other

gains/(losses)

- net, and compensation to casualties in the amount of RMB

1,010

thousand have been recorded in other operating expenses (2020 and 2021:

Nil).

9	Finance income and expenses


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Interest income from time deposits with maturity more than 3 months		339,595			424,696			410,652
Interest income from time deposits with maturity less than 3 months		83,812			71,402			124,468
Others		7,821			12,657			6,710

Finance income		431,228			508,755			541,830

Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss		(101,732	)		(106,827	)		(122,638	)
Less: interest expense capitalized into construction in progress		8,292			12,641			24,136

Net interest expenses		(93,440	)		(94,186	)		(98,502	)
Net foreign exchange losses		(5,514	)		—			—

Finance expenses		(98,954	)		(94,186	)		(98,502	)

Finance income – net		332,274			414,569			443,328

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

10	Expense by nature


	2020		2021			2022
	RMB’000		RMB’000			RMB’000
Cost of raw materials		42,082,307		54,457,558			55,997,717
Cost of trading products		11,467,420		10,929,127			11,910,488
Employee benefit expenses (note 11)		3,143,219		3,456,765			3,545,720
Depreciation and amortization:
Property, plant and equipment (note 16)		1,553,039		1,621,459			1,494,176
Investment properties (note 17)		15,184		15,325			15,323
Other non-current assets (note 14)		226,263		294,617			270,881
Right-of-use assets (note 15)		32,653		34,307			32,918
Repairs and maintenance expenses		1,060,624		1,587,955			1,513,812
Changes of work in progress and finished goods		862,652		(235,402	)		(78,255	)
Transportation costs		274,002		238,405			193,144
Inventory write-down (note 21)		220,888		150,883			525,269
External processing fee		215,467		213,691			192,288
Commission expense (note 3 2 )		104,598		110,552			90,341
Impairment loss of property, plant and equipment (note 16)		87,570		587,622			286,260
Impairment loss of investments accounted for using equity method (note 20)		—		28,392			—
Auditors’ remuneration – audit services		7,800		6,837			6,837
Auditors’ remuneration – non-audit services		—		129			129
Expenses relating to short - term leases		3,731		6,938			14,774

11	Employee benefit expenses


	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Wages and salaries		2,009,645		2,142,959		2,139,472
Social welfare costs		714,484		861,375		921,971
Others		419,090		452,431		484,277

Total employee benefit expense		3,143,219		3,456,765		3,545,720

(a)

Employees of the Group’s subsidiaries in the PRC are required to participate in a defined contribution retirement scheme administered and operated by the local municipal government. The Group’s subsidiaries in the PRC contribute funds which are calculated on certain percentages of the average employee salary as stipulated by the local municipal government to the scheme to fund the retirement benefits of the employees.

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

11	Employee benefit expenses (continued)

In addition, the Group provides a supplementary retirement plan for its staff at rates not exceeding 8% of the salaries. The Group has no other material obligation for the payment of pension benefits associated with these plans beyond the annual contributions described above.

For the year ended 31 December 2022, the Group’s total contributions to defined contribution retirement plans was RMB 463,204 thousand.

(2020: RMB 342,073 thousand, 2021: RMB

431,818 thousand)

(c)	As at 31 December 2020, 31 December 2021 and 31 December 2022, there was no material outstanding contribution to the above defined contribution retirement plans.

12	Income tax benefits /(expenses)


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Current income tax		(37,027	)		(590,668	)		(66,649	)
Deferred taxation		102,647			(53,812	)		798,003

Income tax benefits / (expenses)		65,620			(644,480	)		731,354

A reconciliation of the expected income tax calculated at the applicable tax rate and profit / (loss) before taxation, with the actual income tax is as follows:


	Years ended 31 December
	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Profit / (loss) before income tax		590,778			2,721,086			(3,573,654	)

Expected PRC income tax at the statutory tax rate of 25%		(147,695	)		(680,272	)		893,414
Tax effect of share of net profits / (losses) of investments accounted for using the equity method		178,685			214,750			(46,787	)
Tax effect of other non-taxable income		54,379			10,782			9,890
Tax effect of additional deductions for R&D expenses		11,863			12,168			17,779
Tax effect of non-deductible loss, expenses and costs		(51,543	)		(185,945	)		(67,330	)
True up for final settlement of enterprise income taxes in respect of previous years		9,188			—			(54,017	)
Tax losses for which no deferred income tax asset was recognized		(2,821	)		(21,225	)		(24,948	)
Utilization of previously unrecognized tax losses		13,564			157			3,353
Tax effect of additional deduction for purchasing environmental protection equipment		—			12,446			—
Derecognition of previously recognized tax losses		—			(7,341	)		—

Actual income tax benefits / (expenses)		65,620			(644,480	)		731,354

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

12	Income tax benefits /(expenses) (continued)

The provision for PRC income tax is calculated at the rate of

% (2020 and 2021:

%) on the estimated taxable income of the year ended
31 December 2022 determined in accordance with relevant income tax rules and

regul

ations. The Group did

not car

ry out business overseas and therefore does not incur overseas income taxes.

(a)	Current taxation in the consolidated statements of financial position represents:


	2021 RMB’000			2022 RMB’000
At the beginning of the year		19,425			258,466
Provision for current income tax for the year		590,668			66,649
Payment during the year		(351,627	)		(376,765	)

At the end of the year		258,466			(51,650	)
Representing
Income tax		258,466			2,754
-Payable		—			(54,404	)
-Prepaid		258,466			(51,650	)

(b)	Movements in deferred tax assets and liabilities are as follows:


	Balance as at 1 January 2021 RMB’000			Credited/ (Charged) to profit or loss RMB’000			Credited/ (Charged) to reserves RMB’000			Balance as at 31 December 2021 RMB’000
Deferred tax assets:
Impairment for bad and doubtful debts and provision for inventories		57,326			(977	)		—			56,349
Provision for impairment losses in property, plant and equipment and construction in progress		226,435			131,776			—			358,211
Tax losses		87,799			(87,799	)		—			—
Accruals and others		130,986			(48,808	)		—			82,178

		502,546			(5,808	)		—			496,738

Deferred tax liabilities:
Difference in depreciation		(283,739	)		(46,332	)		—			(330,071	)
Capitalization of borrowing costs		(2,043	)		575			—			(1,468	)
Derivative financial instruments		—			(2,247	)		(12,153	)		(14,400	)

		(285,782	)		(48,004	)		(12,153	)		(345,939	)

Deferred tax assets – net		252,121			(55,825	)		(12,153	)		184,143
Deferred tax liabilities – net		(35,357	)		2,013			—			(33,344	)

F-6

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

12	Income tax benefits /(expenses) (continued)

(b)	Movements in deferred tax assets and liabilities are as follows (continued):


	Balance as at 1 January 2022 RMB’000			Credited/ (Charged) to profit or loss RMB’000			Credited/ (Charged) to reserves RMB’000		Balance as at 31 December 2022 RMB’000
Deferred tax assets:
Impairment for bad and doubtful debts and provision for inventories		56,349			71,761			—		128,110
Provision for impairment losses in property, plant and equipment and construction in progress		358,211			70,499			—		428,710
Tax losses		—			872,648			—		872,648
Accruals and others		82,178			(55,873	)		—		26,305

		496,738			959,035			—		1,455,773

Deferred tax liabilities:
Difference in depreciation		(330,071	)		(163,492	)		—		(493,563	)
Capitalization of borrowing costs		(1,468	)		213			—		(1,255	)
Derivative financial instruments		(14,400	)		2,247			12,153		—

		(345,939	)		(161,032	)		12,153		(494,818	)

Deferred tax assets – net		184,143			795,554			12,153		991,850
Deferred tax liabilities – net		(33,344	)		2,449			—		(30,895	)

The Group recognizes deferred tax assets only to the extent that it is probable that future taxable income will be available against which the assets can be utilized. Based on the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets will be utilized, management believes that it is probable the Group will realize the benefits of these temporary differences for which deferred tax assets have been recognized.

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

12	Income tax benefits /(expenses) (continued)

(c)	Deferred tax assets not recognized:

As at 31 December 2022, certain subsidiaries of the Company did not recognize the deferred tax assets in respect of the impairment losses

property, plant and equipment amounting to RMB29,856 thousand (31 December 2021: RMB29,969 thousand), because it was not probable that the related tax benefit would be realized.

As at 31 December 2022, certain subsidiaries of the Company did not recognize the deferred tax assets in respect of tax losses of RMB 393,896 thousand (31 December 2021: RMB350,574 thousand) carried forward for PRC income tax purpose because it was not probable that the related tax benefit would be realized.

Tax losses carried

forw

ard that are not recognized as deferred tax assets will expire in the following years:


	2021		2022
	RMB’000		RMB’000
2022		65,331		—
2023		66,965		65,585
2024		91,901		91,901
2025		41,475		41,475
2026		84,902		95,144
2027		—		99,791

		350,574		393,896

13	Earnings/(losses) per share

(a)	Basic earnings/(losses) per share

Basic earnings/(losses) per share is calculated by dividing the profit/(loss) attributable to equity shareholders of the Company by the weighted average number of ordinary shares in issue during the year.


	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Net profit/(loss) attributable to equity shareholders of the Company		645,072		2,073,431		(2,846,156	)
Weighted average number of ordinary shares in issue (thousand of shares)		10,823,814		10,823,814		10,819,622
Basic earnings/(losses) per share (RMB per share)		RMB 0.060		RMB 0.192		RMB(0.263	)

Weighted average number of ordinary shares (thousand of shares)


	2020		2021		2022
Issued ordinary shares at 1 January		10,823,814		10,823,814		10,823,814
Effect of shares repurchased (note 30)		—		—		(4,192	)

Weighted average number of ordinary shares at 31 December		10,823,814		10,823,814		10,819,622

(b)	Diluted earnings/(losses) per share

There were no dilutive potential ordinary shares for the years ended 31 December 2020, 2021 and 2022, therefore diluted earnings/(losses) per share is the same as basic earnings/(losses) per share.

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

14	Other non-current assets


	Intangible assets			Long-term prepaid expense			Investment deposits		Total
	RMB’000			RMB’000			RMB’000		RMB’000
As at 1 January 2021
Cost		85,908			1,069,157			—		1,155,065
Accumulated amortization		(71,139	)		(658,967	)		—		(730,106	)

Net book amount		14,769			410,190			—		424,959

Year ended 31 December 2021
Opening net book amount		14,769			410,190			—		424,959
Additions		—			657,465			—		657,465
Charge for the year		(2,925	)		(291,692	)		—		(294,617	)

Closing net book amount		11,844			775,963			—		787,807

As at 31 December 2021
Cost		85,908			1,726,622			—		1,812,530
Accumulated amortization		(74,064	)		(950,659	)		—		(1,024,723	)

Net book amount		11,844			775,963			—		787,807

Year ended 31 December 2022
Opening net book amount		11,844			775,963			—		787,807
Additions		—			268,474			50,000		318,474
Charge for the year		(2,924	)		(267,957	)		—		(270,881	)

Closing net book amount		8,920			776,480			50,000		835,400

As at 31 December 2022
Cost		85,908			1,995,096			50,000		2,131,004
Accumulated amortization		(76,988	)		(1,218,616	)		—		(1,295,604	)

Net book amount		8,920			776,480			50,000		835,400

For the year ended 31 December 2022, the amortization of intangible assets and long-term prepaid expense of RMB 270,881

thousand (2020: RMB226,263 thousand, 2021:

RMB294,617 thousand) has been charged in Cost of sales.

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Leases

(a)	Amounts recognized in the consolidated statements of financial position

The consolidated statements of financial position shows the following amounts relating to leases:


	As at 31 December
	202 1		202 2
	RMB’000		RMB’000
Right-of-use assets
Land use rights		380,764		363,720
Buildings		3,288		14,540
Equipment		625		373
Others		966		1,172

		385,643		379,805

Lease liabilities
Current		3,229		8,738
Non-current		1,384		7,513

		4,613		16,251

For the year ended 31 December 2022, additions to the

right-of-use

assets were RMB27,275

thousand (2020: RMB 109,238 thousand, including 102,283 thousand generated by the acquisition of a subsidiary, 2021: RMB

9,534 thousand). At 31 December 2022, the lease liabilities were repayable as follows:


	2022
	RMB’000
Within 1 year		8,738
After 1 year but within 2 years		6,945
After 2 years but within 5 years		568

		16,251

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

15	Leases (continued)

(b)	Amounts recognized in the consolidated statement s of profit or loss

The consolidated statements of profit or loss shows the following amounts relating to leases:


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Depreciation charge of right-of-use assets
Land use rights		(15,965	)		(17,044	)		(17,044	)
Buildings		(15,481	)		(15,677	)		(14,089	)
Equipment		(449	)		(399	)		(547	)
Others		(758	)		(1,187	)		(1,238	)

		(32,653	)		(34,307	)		(32,918	)

Interest expense (included in Finance expenses)		(887	)		(537	)		(1,039	)
Expense relating to short-term leases (included in Cost of sales)		(3,731	)		(6,938	)		(14,774	)

The total cash outflow for leases in 2022 was RMB27,843

thousand (2020: RMB20,204 thousand, 2021: RMB

24,482 thousand).

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

16	Property, plant and equipment


	Buildings			Plant and machinery			Vehicles and other equipment			Total
	RMB’000			RMB’000			RMB’000			RMB’000
Cost:
At 1 January 2021		3,481,210			42,742,330			1,958,220			48,181,760
Additions		—			161,118			15,646			176,764
Transferred from construction in progress (note 18)		130,947			1,476,065			92,962			1,699,974
Reclassification		267,662			(275,880	)		8,218			—
Disposals		(4,717	)		(737,634	)		(62,782	)		(805,133	)
Transferred from investment properties (note 17)		1,164			—			—			1,164
Transferred to construction in progress (note 18)		(2,091	)		(1,260	)		(15,404	)		(18,755	)
Transferred to investment properties (note 17)		(83	)		(7	)		—			(90	)

At 31 December 2021 and 1 January 2022		3,874,092			43,364,732			1,996,860			49,235,684
Additions		132			187,460			39,934			227,526
Transferred from construction in progress (note 18)		609,303			1,768,395			90,219			2,467,917
Reclassification		9,088			(47,399	)		38,311			—
Disposals		(2,596	)		(393,686	)		(51,813	)		(448,095	)
Transferred from investment properties (note 17)		47			—			—			47
Others		1,208			—			—			1,208

At 31 December 2022		4,491,274			44,879,502			2,113,511			51,484,287

Accumulated depreciation:
At 1 January 2021		(2,396,564	)		(31,700,912	)		(1,457,854	)		(35,555,330	)
Charge for the year		(88,234	)		(1,419,669	)		(113,556	)		(1,621,459	)
Reclassification		(214,041	)		216,706			(2,665	)		—
Written back on disposals		3,652			626,865			55,709			686,226
Transferred from investment properties (note 17)		(1,088	)		—			—			(1,088	)
Transfer to construction in progress (note 18)		46			735			5,642			6,423
Transferred to investment properties (note 17)		80			7			—			87

At 31 December 2021 and 1 January 2022		(2,696,149	)		(32,276,268	)		(1,512,724	)		(36,485,141	)
Charge for the year		(95,661	)		(1,270,423	)		(128,092	)		(1,494,176	)
Reclassification		(787	)		6,340			(5,553	)		—
Written back on disposals		2,469			344,469			50,036			396,974
Transferred from investment properties (note 17)		(45	)		—			—			(45	)

At 31 December 2022		(2,790,173	)		(33,195,882	)		(1,596,333	)		(37,582,388	)

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

16	Property, plant and equipment (continued)


	Buildings			Plant and machinery			Vehicles and other equipment			Total
	RMB’000			RMB’000			RMB’000			RMB’000
Impairment losses:
At 1 January 2021		(53,792	)		(850,967	)		(8,649	)		(913,408	)
Charge for the year		(793	)		(586,147	)		(682	)		(587,622	)
Written back on disposals		—			60,018			501			60,519
Reclassification		(26,133	)		26,270			(137	)		—

At 31 December 2021 and 1 January 2022		(80,718	)		(1,350,826	)		(8,967	)		(1,440,511	)
Charge for the year		(984	)		(283,624	)		(1,652	)		(286,260	)
Written back on disposals		—			4,264			112			4,376
Reclassification		(2,146	)		2,202			(56	)		—

At 31 December 2022		(83,848	)		(1,627,984	)		(10,563	)		(1,722,395	)

Net book value:
At 31 December 2022		1,617,253			10,055,636			506,615			12,179,504

At 31 December 2021		1,097,225			9,737,638			475,169			11,310,032

(i)

The Group recognized impairment loss on property, plant and equipment in relation to certain production facilities of RMB 212,410 thousand for the year ended 31 December 2022. Due to deteriorating market conditions, the increasing production cost is not expected to be covered by the estimated selling price of the products, the Group identified an impairment indicator for property, plant and equipment in relation to certain production facilities, including No.1 ethylene glycol plant and No.2 ethylene glycol plant under intermediate petrochemicals segment, and performed an impairment assessment of these assets based on their estimated recoverable amounts, as a result the carrying amount of these assets were written down to their recoverable amount of RMB 265,377 thousand.

The recoverable amounts of above production facilities are estimated using the present value of future cash flows based on the financial budgets approved by management covering a five-year period. Forecasted cash flows are developed using several key assumptions, including the product sales growth rates, related costs growth rates (“forecasted growth rates”) and discount rate. The forecasted growth rates are based on past business performance and market participants’ expectations for market development, which are consistent with the forecasts included in industry reports. The discount rate used is a

pre-tax

ratio of 9% and reflects specific risks relating to the Group.

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

16	Property, plant and equipment (continued)

(ii)

During the year ended 31 December 2022, a number of production facilities were idle or obsolete. The Group does not expect to have future economic benefits recoverable from the use of those production facilities. There is no alternative use of those production facilities which is specifically designed. The recoverable amounts of property, plant and equipment related to those production facilities are estimated to be their residual value. As a result, impairment loss of RMB49,230 thousand under synthetic fibres segment and RMB24,620 thousand under resins and plastics segment was made against the carrying amounts of those assets.

As a result of these assessments, an impairment loss of RMB286,260 thousand on property, plant and equipment was recognized in “cost of sales” for the year ended 31 December 2022.

For the year ended 31 December 2021, impairment loss of RMB 587,622 thousand on property, plant and equipment was recognized in Cost of sales for the excess of carrying amount over its recoverable amount.

For the year ended 31 December 2020, impairment loss of RMB 87,570 thousands has been recognized in Cost of sales for the excess of carrying amount over its recoverable amount.

17	Investment properties


	RMB’000
Cost:
As at 1 January 2021		627,488
Transferred from property plant and equipment (note 16)		90
Transferred to property plant and equipment (note 16)		(1,164	)

At 31 December 2021 and 1 January 2022		626,414

Transferred to property plant and equipment (note 16)		(47	)

At 31 December 2022		626,367

Accumulated depreciation:
At 1 January 2021		(259,902	)
Charge for the year		(15,325	)
Transferred from property plant and equipment (note 16)		(87	)
Transferred to property plant and equipment (note 16)		1,088

At 31 December 2021 and 1 January 2022		(274,226	)

Charge for the year		(15,323	)
Transferred from property plant and equipment (note 16)		—
Transferred to property plant and equipment (note 16)		45

At 31 December 2022		(289,504	)

Net book value:
At 31 December 2022		336,863

At 31 December 2021		352,188

As at 31 December 2022, the Group has no contractual obligations for future repairs and maintenance (31 December 2020 and 31 December 2021: Nil).

Investment properties represent certain floors of an office building leased to other entities including related parties.

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

17	Investment properties (continued)

The fair value of the investment properties of the Group as at 31 December 2022 was estimated by the directors to be approximately RMB 1,236,686 thousand by reference to market values of similar properties in the nearby area (31 December 2021: RMB 1,217,987 thousand). This fair value estimation was at level 3 of fair value hierarchy by using market observable inputs. The investment properties have not been valued by external independent appraisers.

Rental income of RMB

75,159

thousand was recognized in other operating income by the Group for the year ended 31 December 2022 (2020: RMB81,608 thousand, 2021: RMB

81,923

thousand).

Leasing arrangements

The investment properties are leased out under operating leases. The leases typically run for an initial period of 1 to 3 years, with an option to renew the lease after that date at which time all terms are renegotiated. Lease payments are usually renegotiated every year to reflect market rentals.

Undiscounted lease payments under

non-cancellable

operating leases in place at the reporting date will be receivable by the Group in future periods as follows :


	2021		2022
	RMB’000		RMB’000
Within 1 year		49,420		52,138
Between 1 and 2 years		39,137		6,638
Above 2 years		—		6,522

		88,557		65,298

18	Construction in progress


	202 1			202 2
	RMB’000			RMB’000
As at 1 January		1,710,124			3,293,177
Additions		3,270,695			2,927,950
Disposal		—			(4,749	)
Transferred to property plant and equipment (note 16)		(1,699,974	)		(2,467,917	)
Transferred from property plant and equipment (note 16)		12,332			—

As at 31 December		3,293,177			3,748,461

As at 31 December 2022, the impairment loss in construction in progress was RMB24,486

thousand (31 December 2020: RMB24,486 thousand, 31 December 2021: RMB

24,486 thousand).

For the year ended 31 December 2022, the group had no impairment write-off due to the disposal of construction in progress (2020: RMB 10,175 thousand, 2021: Nil).

For the year ended 31 December 2022, the Group capitalized borrowing costs amounting to RMB24,136

thousand (2021: RMB

12,641 thousand) on qualifying assets. Borrowing costs were capitalized at the weighted average rate of its borrowings of 1.78

% (2020: 2.79%, 2021:

2.85%).

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

19	Subsidiaries

The following list contains only the particulars of subsidiaries which principally affected the results, assets or liabilities of the Group. The class of shares held is ordinary unless otherwise stated.

Proportion of ownership interest

Name of company

Place of
incorporation
and business

Particulars of paid-
up capital ’000

Group’s
effective
interest

Held by
the Company

Held by a
subsidiary

Principal activity

Shanghai Petrochemical Investment Development Company Limited
(“Toufa”)

Mainland
China

RMB1,000,000

100.00

—

Investment
management

China Jinshan Associated Trading Corporation (“Jinmao”)

Mainland
China

RMB 25,000

67.33

—

Import and
export of
petrochemical
products and
equipment

Shanghai Jinchang Engineering Plastics Company Limited (“Jinchang”)

Mainland
China

USD 9,154

74.25

—

74.25

Production of
polypropylene
compound
products

Shanghai Golden Phillips Petrochemical Company Limited (“Jinfei”)

Mainland
China

RMB 415,623

100.00

—

100.00

Production of
polyethylene
products

Shanghai Jinshan Trading Corporation (“JMGJ”)

Mainland
China

RMB 100,000

67.33

—

67.33

Import and
export of
petrochemical
products

Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd.
(“Jinlian”)

Mainland
China

RMB 400,000

100.00

—

100.00

Trading of
petrochemical
products

F-7

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

19	Subsidiaries (continued)

a. On 30 June 2020, one of the Company’s subsidiaries, Toufa acquired

100

% share of Zhejiang Zhonghang Oil Petrochemical Storage and Transportation Co., Ltd., renamed as Jinlian, from China Aviation Oil Group Logistics Co., Ltd., with the total purchase consideration of RMB

340,369

thousand.

20	Investments accounted for using the equity method

The amounts recognized in the consolidated statements of financial position are as follows:


	As at 31 December
	2021		2022
	RMB’000		RMB’000
Associates
– Share of net assets		3,812,845		3,027,632
Joint ventures
– Share of net assets		276,043		476,761

As at 31 December		4,088,888		3,504,393

The amounts recognized in the share of net profits / (losses) of associates and joint ventures accounted for using the equity method are as follows:


	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Associates		678,077		825,132		(188,549	)
Joint ventures		46,663		49,153		14,933

		724,740		874,285		(173,616	)

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates


	2021			2022
	RMB’000			RMB’000
As at 1 January		5,146,160			3,812,845
Additions (note i)		26,000			96,672
Decrease caused by associate’s capital reduction (note ii)		(1,460,258	)		—
Share of net profits / (losses)		825,132			(188,549	)
Other comprehensive income		16,639			(23,771	)
Cash dividends distribution		(712,436	)		(669,565	)
Impairment (note iii)		(28,392	)		—

As at 31 December		3,812,845			3,027,632

Set out below are the material associates of the Group as at 31 December 2022. The associates as

listed

below have share capital consisting solely of ordinary shares, which are held directly by the Group; the country of incorporation or registration is also their principal place of business.

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)

The following list contains only the particulars of material associates, all of which

are

unlisted

corporate

entities whose quoted market price is not available:


						Proportion of ownership interest
Name of company	Form of business structure		Place of incorporation and business	Particulars of paid- up capital ‘000		Group’s effective interest			Held by the Company			Held by a subsidiary			Principal activity
Shanghai Secco Petrochemical Company Limited (“Shanghai Secco”) (note ii)		Incorporated	Mainland China		RMB 3,115,180		20.00	%		20.00	%		—		Manufacturing and distribution of chemical products
Shanghai Chemical Industry Park Development Company Limited (“Chemical Industry”)		Incorporated	Mainland China		RMB 2,372,439		38.26	%		38.26	%		—		Planning, development and operation of the Chemical Industry Park in Shanghai, PRC
Shanghai Jinsen Hydrocarbon Resins Company Limited (“Jinsen”)		Incorporated	Mainland China		RMB 193,695		40.00	%		—			40.00	%	Production of resins products
Shanghai Azbil Automation Company Limited (“Azbil”)		Incorporated	Mainland China		RMB 24,440		40.00	%		—			40.00	%	Service and maintenance of building automation systems and products
Shanghai Shidian Energy Company Limited (“Shidian Energy”) (note i)		Incorporated	Mainland China		RMB 1,000,000		40.00	%		—			40.00	%	Electric power supply

There are no contingent liabilities relating to the Group’s

interest

in the associates.

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)

Pursuant to the articles of association of Shidian Energy in August 2019, Toufa agreed to make a capital contribution of

RMB

400,000 thousand to acquire 40% share of Shidian Energy. In 2022, Toufa contributed RMB80,000 thousand to Shidian Energy and the total investment amounted to RMB 400,000

thousand as at 31 December 2022 (31 December 202

: RMB 320,000 thousand, 31 December 2021:

RMB

320,000 thousand).

ii.

According to the resolution of the Board of Directors on 9 July 2021, the Company, Sinopec Corp., and Sinopec Shanghai Gaoqiao Petrochemical Company Limited (“Gaoqiao Company”) approved to reduce their

paid-in

capital in Shanghai Secco, an associate of the Company, by a total amount of RMB 7,300,811,000 in proportion to their shareholding ratios of 20%, 30% and 50% respectively. Among them, the Company reduced its investment cost in Shanghai Secco by approximately RMB 1,460,258 thousand and the Company has received the amount of the capital reduction in December 2021.

iii.

During the year ended 31 December 2021, the directors of the Company reviewed the carrying value of the Group’s associate and joint ventures. The entire carrying amount of the interests in an associate is tested for impairment in accordance with IAS 36 Impairment of Assets as a single asset by comparing its recoverable amount with its carrying amount. Since the recoverable amount of investment in an associate Jinsen is lower when compared with its carrying amount, impairment loss of RMB 28,392 thousand is recognized during the year ended 31 December 2021. The recoverable amount of the investment in an associate was based on its fair value less costs to sell. The fair value was estimated with reference to the transaction price of a recent share transaction of the associate.

All of the above associates are accounted for using the equity method in the consolidated financial statements.

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)

Summarized financial information of the material associates, adjusted for any differences in accounting policies, and reconciled to the carrying amounts in the consolidated financial statements, are disclosed below:

Summarized financial information for material associates

Set out below are the summarized financial information for the above associates.

Summarized statements of financial position for material associates


As at 31 December 2021	Shanghai Secco RMB’000			Chemical Industry RMB’000			Jinsen RMB’000			Azbil RMB’000			Shidian Energy RMB’000
Current
– Current assets		6,066,119			4,133,397			63,192			274,697			804,470
– Current liabilities		(5,433,872	)		(1,789,223	)		(10,476	)		(111,472	)		(34,565	)
Non-current
– Non-current assets		5,735,360			4,431,463			58,737			15,698			121,051
– Non-current liabilities		(66	)		(619,306	)		—			(7,506	)		(15,827	)

Net assets		6,367,541			6,156,331			111,453			171,417			875,129

Group’s effective interest		20.00	%		38.26	%		40.00	%		40.00	%		40.00	%
Group’s share of net assets		1,273,508			2,355,412			44,581			68,567			350,052
Unrealized upstream and downstream transaction		(3,157	)		—			—			—			(15,979	)
Unentitled portion (note i)		—			(331,826	)		—			—			—
Impairment loss		—			—			(28,392	)		—			—

Carrying value		1,270,351			2,023,586			16,189			68,567			334,073

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)

Summarized statements of financial position for material associates (continued)


As at 31 December 2022	Shanghai Secco RMB’000			Chemical Industry RMB’000			Jinsen RMB’000			Azbil RMB’000			Shidian Energy RMB’000
Current
– Current assets		4,941,394			4,327,622			49,810			276,707			950,614
– Current liabilities		(8,977,030	)		(1,765,771	)		(17,905	)		(125,216	)		(38,133	)
Non-current
– Non-current assets		5,683,409			4,480,448			50,360			12,338			166,068
– Non-current liabilities		(1	)		(651,729	)		—			(5,518	)		(35,355	)

Net assets		1,647,772			6,390,570			82,265			158,311			1,043,194

Group’s effective interest		20.00	%		38.26	%		40.00	%		40.00	%		40.00	%
Group’s share of net assets		329,554			2,445,032			32,906			63,324			417,278
Unrealized upstream and downstream transaction		4,342			—			—			—			(12,615	)
Unentitled portion (note i)		—			(329,890	)		—			—			—
Impairment loss		—			—			(28,392	)		—			—

Carrying value		333,896			2,115,142			4,514			63,324			404,663

Note i: Unentitled portion represented the earnings from sales of the lands injected by Government in Chemical Industry that cannot be shared by other shareholders.

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)

Summarized statements of comprehensive income for material

associates


	Shanghai Secco		Chemical Industry			Jinsen			Azbil		Shidian Energy
2020	RMB’000		RMB’000			RMB’000			RMB’000		RMB’000
Revenue		21,626,059		1,683,096			187,580			340,905		472,640
Post-tax profit/(loss) from continuing operations		2,412,802		404,117			(8,232	)		48,264		36,696
Other comprehensive income		—		(30,089	)		—			—		—

Total comprehensive income		2,412,802		374,028			(8,232	)		48,264		36,696

Dividend received from the associate		473,600		32,522			—			9,200		—

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)


2021	Shanghai Secco			Chemical Industry			Jinsen			Azbil		Shidian Energy
	RMB’000			RMB’000			RMB’000			RMB’000		RMB’000
Revenue		29,723,223			1,709,110			165,499			427,378		489,490
Post-tax profit/(loss) from continuing operations		3,125,904			396,761			(16,657	)		61,711		33,269
Other comprehensive income		—			43,488			—			—		—

Total comprehensive income		3,125,904			440,249			(16,657	)		61,711		33,269

Dividend received from the associate		634,341			52,225			—			19,200		—


2022	Shanghai Secco			Chemical Industry			Jinsen			Azbil		Shidian Energy
	RMB’000			RMB’000			RMB’000			RMB’000		RMB’000
Revenue		24,096,829			1,806,888			119,098			384,655		508,704
Post-tax (loss)/profit from continuing operations		(1,947,579	)		441,369			(29,188	)		46,894		28,065
Other comprehensive income		—			(62,130	)		—			—		—

Total comprehensive income		(1,947,579	)		379,239			(29,188	)		46,894		28,065

Dividend received from the associate		554,438			55,477			—			24,000		24,000

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(a)	Investment in associates (continued)

Aggregate information of associates that are not individually material:


	2021		2022
	RMB’000		RMB’000
Aggregate carrying value of investments at 31 December		100,079		106,093
Aggregate amounts of the Group’s share of those associates:
Profit for the year		5,655		876

Total comprehensive income		5,655		876

Dividend received from the associate		6,670		11,650

(b)	Investment in joint ventures


	2021			2022
	RMB’000			RMB’000
As at 1 January		241,674			276,043
Addition (note i)		50,000			200,000
Share of profit		49,153			14,933
Cash dividends distribution		(64,784	)		(14,215	)

As at 31 December		276,043			476,761

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(b)	Investment in joint ventures (continued)

Details of the Group’s interest in the joint venture, which is accounted for using the equity method in the consolidated financial statements, are as follows:

The following list contains only the particulars of material joint ventures, all of the Group’s joint ventures are unlisted corporate entities whose quoted market price is not available:

Name of joint venture

Form of
business

structure

Place of
incorporation

and business

Particulars of

paid-up

capital ’000

Proportion of ownership interest

Principal activity

Group’s
effective
interest

Held by

the
Company

Held by a
subsidiary

Linde-SPC

Gases Company Limited (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)

Incorporated

Mainland China

USD 32,000

50.00

—

50.00

Production and sales
of industrial gases

Shanghai Petrochemical Pressure Vessel Testing Center (“JYJC”)

Incorporated

Mainland China

RMB 10,000

50.00

—

50.00

Providing
inspection and
testing service

Shanghai Petrochemical Yangu Gas
Development Company Limited
(“Yangu Gas”)

Incorporated

Mainland China

USD 10,560

50.00

—

50.00

Production and sales
of industrial gases

Shanghai Jinshan Baling New Materials
Co., Ltd. (“Baling Materials”) (note i)
(“Linde”), formerly known as
“BOC-SPC Gases Company Limited”)

Incorporated

Mainland China

RMB 500,000

50.00

—

50.00

Production and sales
of new styrene
thermoplastic
elastomer materials

F-8

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(b)	Investment in joint ventures (continued)

In September 2021, Sinopec Baling Petrochemical Co., Ltd and the Company jointly established Baling

Materials

, the Company agreed to make cash contribution of RMB 400,000 thousand to acquire 50% share of Baling Materials. In 2022, the Group made new investment of RMB 200,000 thousand into Barling Materials. As at 31 December 2022, the Company has made a

paid-up

capital contribution of RMB 250,000 thousand.

Summarized financial information for joint ventures

Set out below are the summarized financial information for joint ventures which are accounted for using the equity method.

Summarized statements of financial position for joint ventures

As at 31 December 2021


	Linde RMB’000			JYJC RMB’000			Yangu Gas RMB’000			Baling Materials RMB’000
Current
Cash and cash equivalents		226,860			16,914			72,916			6,062
Other current assets (excluding cash)		74,652			5,065			11,149			28,418

Total current assets		301,512			21,979			84,065			34,480
Total current liabilities		(62,356	)		(3,356	)		(3,262	)		—

Non-current
Total non-current assets		109,366			1,577			19,034			65,520
Total non-current liabilities		(16,303	)		—			—			—

Net assets		332,219			20,200			99,837			100,000

Group’s effective interest		50%			50%			50%			50%
Interest in joint ventures		166,110			10,100			49,919			50,000
Unrealized downstream transactions		(86	)		—			—			—

Carrying value		166,024			10,100			49,919			50,000

As at 31 December 2022


	Linde			JYJC			Yangu Gas			Baling Materials
	RMB’000			RMB’000			RMB’000			RMB’000
Current
Cash and cash equivalents		237,902			11,482			62,639			13,948
Other current assets (excluding cash)		73,026			9,167			6,423			60,243

Total current assets		310,928			20,649			69,062			74,191
Total current liabilities		(32,670	)		(2,437	)		(2,392	)		(153,952	)

Non-current
Total non-current assets		92,325			1,478			13,765			626,761
Total non-current liabilities		(17,016	)		—			—			(47,000	)

Net assets		353,567			19,690			80,435			500,000

Group’s effective interest		50%			50%			50%			50%
Interest in joint ventures		176,784			9,845			40,218			250,000
Unrealized downstream transactions		(86	)		—			—			—

Carrying value		176,698			9,845			40,218			250,000

F-

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(b)	Investment in joint ventures (continued)

Summarized statements of comprehensive income for joint ventures

The information above reflects the amounts presented in the financial statements of the joint ventures (and not the Group’s share of those amounts) adjusted for differences in accounting policies between the Group and the joint ventures.

2020


	Linde			JYJC			Yangu Gas
	RMB’000			RMB’000			RMB’000
Revenue		420,160			21,674			58,463
Depreciation and amortization		(45,756	)		(350	)		(8,313	)
Interest income		2,246			304			1,483
Interest expense		—			—			—
Profit from continuing operations		108,677			2,279			1,830
Income tax expenses		(26,290	)		(177	)		—
Post-tax profit from continuing operations		82,387			2,102			1,830
Other comprehensive income		—			—			—

Total comprehensive income		82,387			2,102			1,830

Dividend received from joint venture		38,234			1,049			1,000

2021


	Linde			JYJC			Yangu Gas			Baling Materials
	RMB’000			RMB’000			RMB’000			RMB’000
Revenue		428,971			27,190			60,222			—
Depreciation and amortization		(44,307	)		(386	)		(5,162	)		—
Interest income		3,489			304			1,516			—
Profit from continuing operations		116,768			2,250			4,144			—
Income tax (expenses)/benefits		(29,316	)		1,125			—			—
Post-tax profit from continuing operations		87,452			3,375			4,144			—
Other comprehensive income		—			—			—			—

Total comprehensive income		87,452			3,375			4,144			—

Dividend received from joint venture		63,044			940			800			—

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

20	Investments accounted for using the equity method (continued)

(b)	Investment in joint ventures (continued)

Summarized statements of comprehensive income for joint

ventures

(continued)

2022


	Linde			JYJC			Yangu Gas			Baling Materials
	RMB’000			RMB’000			RMB’000			RMB’000
Revenue		375,795			25,129			26,091			—
Depreciation and amortization		(20,902	)		(341	)		(8,061	)		—
Interest income		4,799			351			1,029			—
Profit/ (loss) from continuing operations		58,338			1,996			(15,802	)		—
Income tax expenses		(14,590	)		(76	)		—			—
Post-tax profit/ (loss) from continuing operations		43,748			1,920			(15,802	)		—
Other comprehensive income		—			—			—			—

Total comprehensive income		43,748			1,920			(15,802	)		—

Dividend received from joint venture		11,200			1,215			1,800			—

(c)

For the year ended December 31, 2022, equity method investments held by the Company in aggregate have met the significance criteria as defined under Rule 4-08(g) of Regulation S-X. Shanghai Secco was deemed a significant equity investee for the fiscal years ended December 31, 2020 and a non-significant equity investee for the fiscal years ended December 31, 2021 and December 31, 2022 under Rule 3-09 of Regulation S-X. As such, the financial statements of Shanghai Secco required by Rule 3-09 of Regulation S-X are provided as Exhibit 99.1 to this Annual Report on Form 20-F. Financial information for the Company’s equity method investments other than Shanghai Secco are summarized as a group as follow:


	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Revenue		4,548,574		4,863,742		3,759,076
Gross profit		825,799		828,183		670,678
Profit from continuing operations		753,799		798,867		670,678
Profit after taxation		593,211		586,612		512,758
Profit after taxation attributable to the Group		243,953		240,882		208,401


	As of 31 December 2022
	2021			2022
	RMB’000			RMB’ 000
Current assets		6,083,530			6,436,238
Non-current assets		5,000,852			5,909,304
Current liabilities		(2,086,793	)		(2,185,434	)
Non-current liabilities		(707,374	)		(978,325	)
Non-controlling interests		1,508,175			1,578,714

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

21	Inventories

(a)	Inventories in the consolidated statements of financial position comprise:


	As at 31 December 2021							As at 31 December 2022
	Gross carrying amount		Provision for diminution in value of inventories			Carrying amount		Gross carrying amount		Provision for diminution in value of inventories			Carrying amount
	RMB’000		RMB’000			RMB’000		RMB’000		RMB’000			RMB’000
Raw materials		4,391,555		(13,406	)		4,378,149		5,700,215		(26,491	)		5,673,724
Work in progress		795,791		(105,450	)		690,341		756,007		(237,959	)		518,048
Finished goods		709,990		(45,950	)		664,040		1,096,623		(182,035	)		914,588
Spare parts and consumables		249,456		(58,461	)		190,995		246,161		(58,461	)		187,700

		6,146,792		(223,267	)		5,923,525		7,799,006		(504,946	)		7,294,060

(b)	The analysis of the amount of inventories recognized as expenses and included in profit or loss is as follows:

The cost of inventories recognized in Cost of sales amounted to RMB72,419,098

thousand for the year ended 31 December 2022 (2020: RMB53,622,798 thousand, 2021: RMB

70,704,868 thousand) which excluded an inventory provision of RMB 525,269

thousand (2020: RMB220,888 thousand, 2021: RMB

150,883 thousand).

For the year ended 31 December 2022, the Group sold certain finished goods and utilized certain spare parts and consumables which were previously provided for. The related provision of RMB243,590

thousand was reversed and included in cost of sales in the consolidated statement of profit or loss (2020: RMB147,817 thousand, 2021: RMB

156,149 thousand).

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

22	Trade and other receivables


	As at 31 December 2021			As at 31 December 2022
	RMB’000			RMB’000

Trade receivables		79,413			72,110
Less: loss allowance		(1,988	)		(2,759	)

		77,425			69,351
Amounts due from related parties excluded prepayments and bills receivable (*)		1,153,111			2,583,289
Less: loss allowance (*)		—			(2,802	)

Total trade receivables		1,230,536			2,649,838

Other receivables		47,737			109,440
Less: loss allowance		(140	)		(1,933	)

		47,597			107,507

Financial assets measured at amortized cost		1,278,133			2,757,345

Amounts due from related parties - prepayments (*)		34,220			58,496
Amounts due from related parties - bills receivables (*) (note 25)		25,000			—

		1,337,353			2,815,841

Amounts due from related parties (summary of *)		1,212,331			2,638,983

All of the trade and other receivables are expected to be recovered or recognized as expenses within one year.

Amounts due from related parties mainly represent trade-related balances, unsecured in nature and bear no interest.

The aging analysis based on invoice date of trade receivables and amounts due from related parties excluded prepayments and bills receivable (net of allowance for doubtful debts) is as follows:


	As at 31 December 2021		As at 31 December 2022
	RMB’000		RMB’000

Within one year		1,230,360		2,649,673
Over one year but within two years		27		165
Over two years		149		—

		1,230,536		2,649,838

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

22	Trade and other receivables (continued)

Movements in the loss allowance account in respect of trade and other receivables during the period is as follows:


	Years ended 31 December
	2021		2022
	RMB’000		RMB’000
Balance at 1 January		773		2,128
Impairment losses recognized during the year		1,355		5,366

Balance at 31 December		2,128		7,494

As at 31 December 2021 and 31 December 2022, no trade receivable was pledged as collateral.

Sale to third parties is generally on cash basis or on letter of credit. Subject to negotiation, credit is generally only available for major customers

with well-established trading records.

23	Cash and cash equivalents

(a)	Cash and cash equivalents comprise:


	As at		As at
	31 December 2021		31 December 2022
	RMB’000		RMB’000
Cash deposits with a related party (note i)		3,243		—
Cash at bank and on hand		5,108,767		889,413

Cash and cash equivalents in the consolidated statements of financial position		5,112,010		889,413

Cash deposits with a related party were cash deposits at Sinopec Finance Company Limited (“Sinopec Finance”).

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

23	Cash and cash equivalents (continued)

(b)	Cash generated from / (used in) cash

Reconciliation of profit/(loss)

before

taxation to cash generated from

operations


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Profit/(loss) before taxation		590,778			2,721,086			(3,573,654	)
Adjustments items:
Interest income from time deposits with maturity more than 3 months		(339,505	)		(424,696	)		(410,652	)
Share of (profits)/losses of investments accounted for using the equity method		(724,740	)		(874,285	)		173,616
Net losses/(gains) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges		376			(18,846	)		27,851
Gains from structured deposits		(114,283	)		(97,921	)		(11,124	)
Gains from entrusted loan receivables		—			—			(2,704	)
Losses on sale of FVOCI		9,513			4,685			3,148
Interest expense		64,169			94,186			98,502
Foreign exchange losses/(gains)		5,514			1,861			(15,320	)
Depreciation of property, plant and equipment		1,553,039			1,621,459			1,494,176
Depreciation of investment property		15,184			15,325			15,323
Depreciation of right-of-use assets		32,653			34,307			32,918
Amortization of other non-current assets		226,263			294,617			270,881
Impairment loss on property, plant and equipment		87,570			587,622			286,260
Impairment loss on investment accounted for using the equity method		—			28,392			—

Losses / (gains) on disposal of property, plant and equipment and other long-term assets-net		1,212			(48,671	)		26,767

Profit/(loss) on operation before change of working capital		1,407,743			3,939,121			(1,584,012	)
Decrease/(increase) in inventories		2,865,687			(2,034,779	)		(1,370,535	)
Decrease in operation receivables		308,333			49,586			511,325
Decrease in operation payables		(1,008,800	)		(70,235	)		(4,673,853	)
(Decrease)/increase in balances to related parties – net		(1,577,876	)		2,527,960			156,341

Cash generated from/(used in) operations		1,995,087			4,411,653			(6,960,734	)

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

23	Cash and cash equivalents (continued)

(c)	Reconciliation of liabilities arising from financing activities


	Borrowings			Lease liabilities			Short-term bonds			Total
	RMB’000			RMB’000			RMB’000			RMB’000
As at 31 December 2020 and 1 January 2021		1,548,000			12,471			3,017,811			4,578,282
Changes from financing cash flows:
Proceeds from new bank loans		14,163,132			—			—			14,163,132
Repayment of bank loans		(13,451,332	)		—			—			(13,451,332	)
Proceeds from short-term bonds		—			—			5,998,899			5,998,899
Repayments of short-term bonds		—			—			(9,000,000	)		(9,000,000	)
Principal elements of lease payments		—			(17,544	)		—			(17,544	)

Total changes from financing cash flows		711,800			(17,544	)		(3,001,101	)		(2,306,845	)
Other changes:
Addition of lease liabilities		—			9,686			—			9,686
Issuance costs on short-term bonds		—			—			1,101			1,101
Interest expense		—			—			28,340			28,340
Others		—			—			(46,151	)		(46,151	)

Total other changes		—			9,686			(16,710	)		(7,024	)
As at 31 December 2021 and 1 January 2022		2,259,800			4,613			—			2,264,413

Changes from financing cash flows:
Proceeds from new bank loans		19,485,000			—			—			19,485,000
Repayment of bank loans		(19,494,800	)		—			—			(19,494,800	)
Proceeds from short-term bonds		—			—			5,000,000			5,000,000
Repayments of short-term bonds		—			—			(5,000,000	)		(5,000,000	)
Principal elements of lease payments		—			(13,069	)		—			(13,069	)

Total changes from financing cash flows		(9,800	)		(13,069	)		—			(22,869	)

Other changes:
Addition of lease liabilities		—			24,707			—			24,707

Total other changes		—			24,707			—			24,707

As at 31 December 2022		2,250,000			16,251			—			2,266,251

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

23	Cash and cash equivalents (continued)

(d)	Total cash outflow for leases

Amounts included in the consolidated statements of cash flows for leases comprise the following:


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Within operating cash flows		(4,618	)		(6,938	)		(14,774	)
Within financing cash flows		(15,586	)		(17,544	)		(13,069	)

		(20,204	)		(24,482	)		(27,843	)

These amounts relate to the following:


	2020			2021			2022
	RMB’000			RMB’000			RMB’000
Lease rentals paid		(20,204	)		(24,482	)		(27,843	)

24	Time deposits with banks


	As at 31 December
	2021		2022
	RMB’000		RMB’000
T ime deposits with maturity less than one year		7,386,607		3,108,919
Time deposits with maturity more than one year		5,581,435		3,389,559

		12,968,042		6,498,478

As at 31 December 2022, interest rates of time deposits with maturity less than one year ranged from 3.85% to 4.13% per annum (31 December 2021: 3.40% to 3.50% per annum), which were presented as current assets. Time deposits with maturity of more than one year were time deposits of three or five years with the interest rates from 3.55% to 4.20% per annum, which were presented as

non-current

assets in the consolidated statement of financial position (31 December 2021: 3.45% to 4.20% per annum).

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

25	Financial assets at fair value through other comprehensive income


	As at 31 December
	2021		2022
	RMB’000		RMB’000
Trade and bills receivable (i)
- Amounts due from related parties (note 22)		25,000		—
- Others		1,047,690		582,354

		1,072,690		582,354
Equity investments		5,000		5,000

		1,077,690		587,354

(i)

As at 31 December 2021 and 2022, certain trade receivables and bills receivable were classified as

financial

assets at FVOCI, as the Group’s business model is achieved both by collecting contractual cash flows and selling of these assets.

(ii)

As at 31 December 2022, the Group discounted certain bank acceptance bills to banks for cash proceeds and endorsed certain bank acceptance bills to suppliers on a full recourse basis for settling trade payables of the same amount. The Group has derecognized these bills receivable and the payables to suppliers in their entirety. These derecognized bank acceptance bills had a maturity date less than twelve months from the end of the reporting period. In the opinion of the directors, the Group has transferred substantially all the risks and rewards of ownership of these bills to its suppliers, and the Group has limited exposure in respect of the settlement obligation of these bills receivable under the relevant PRC rules and regulations should the issuing banks fail to settle the bills on maturity date. The Group considered the issuing banks of the bills are of good credit rating and the

non-settlement

of these bills by the issuing banks on maturity is not probable.

As at 31 December 2022, the Group’s maximum exposure to loss and undiscounted cash outflow, which is the same as the amounts payable by the Group to banks or suppliers in respect of the discounted bills and endorsed bills, should the issuing banks fail to settle the bills on maturity date, amounted to RMB 196,667 thousand and RMB 178,369 thousand respectively.

F-9

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

26	Borrowings


	As at 31 December 2021		As at 31 December 2022
	RMB’000		RMB’000
Credit loans due within one year
- Short term bank loan		1,559,800		1,550,000

Credit loans due over one year but within three years
- Long-term borrowing from a related party (note 3 2 (c))		700,000		700,000

		2,259,800		2,250,000

(a)	The analysis of the repayment schedule of borrowings are as follows:


	2021		2022
	RMB’000		RMB’000
Within 1 year or on demand		1,559,800		1,550,000

Over one year but within two years		—		700,000
Over two years but within three years		700,000		—

		2,259,800		2,250,000

The weighted average interest rate for the Group’s short-term bank loan was 2.35

% as at 31 December 2022 (2020: 2.79%, 2021:

2.74%). The interest rate of the Group’s long-term borrowings was 1.08

% as at 31 December 2022 (2020: Nil, 2021:

1.08%).

As at 31 December 2021 and 31 December 2022, no borrowings were secured by property, plant and equipment .

F-

100

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

27	Trade and other payables


	As at 31 December
	2021		2022
	RMB’000		RMB’000
Trade payables		1,527,706		1,818,453
Bills payable		562,593		24,951
Amounts due to related parties exclude advances received (*)		4,910,255		7,877,323

		7,000,554		9,720,727

Dividends payable		30,577		31,631
Construction payable		487,283		831,422
Accrued expenses		400,391		143,299
Other liabilities		87,144		76,778

		1,005,395		1,083,130

Financial liabilities measured at amortized cost		8,005,949		10,803,857
Amounts due to related parties – advances received (*)		6,275		10,486
Amounts due to related parties – measured at fair value through profit or loss (FVPL) (*) (note i)		1,388,286		—

		9,400,510		10,814,343

Total amount due to related parties (summary of *)		6,304,816		7,887,809

All trade and other payables (including amounts due to related parties) are expected to be

settled

or recognized as income within one year or are repayable on demand.

(i) Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.

As at 31 December 2021 and 31 December 2022, all trade and other payables of the Group were

non-interest

bearing, and their fair value, approximated their carrying amounts due to their short maturities.

Majority of amount due to related parties were trade payable for purchasing crude oil from related parties .

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

27	Trade and other payables (continued)

As at 31 December 2021 and 31 December 2022, the ageing analysis of the trade payables (including amounts due to related parties of trading in nature) and bills payable based on invoice date were as follows:


	As at 31 December
	2021		2022
	RMB’000		RMB’000
Within one year		6,990,653		9,708,441
Over one year within two years		9,527		2,524
Over two years		374		9,762

		7,000,554		9,720,727

28	Contract liabilities


	As at 31 December
	2021		2022
	RMB’000		RMB’000
Contract liabilities		424,607		372,760

The contract liabilities of the Group are advance for goods from customers. Related performance obligations are expected to be satisfied and revenue is recognized within one year. Revenue amounted to RMB

424,607

thousand has been recognized in the current year relates to carried-forward contract liabilities (2020: RMB 579,750 thousand, 2021: RMB

495,404

thousand).

29	Deferred income


	2021			2022
	RMB’000			RMB’000
As at 1 January		13,433			12,720
Additions		—			34,623
Amortization		(713	)		(2,735	)

As at 31 December		12,720			44,608

30	Share capital

(i)	Issued share captial


	Number of shares		Amount
	’000		RMB’000
As at 31 December 2021, 1 January 2022 and 31 December 2022
Registered, issued and fully paid:
Ordinary A shares listed in PRC		7,328,814		7,328,814
Foreign invested H shares listed overseas		3,495,000		3,495,000

Total		10,823,814		10,823,814

(ii)	Purchase of own shares

During the year, the Company repurchased its own ordinary shares on the Stock Exchange of Hong Kong Limited as follows:


Month/year	Number of shares repurchased		Highest price paid per share		Lowest price paid per share		Aggregate price paid
			HKD		HKD		RMB’000

October 2022		4,956,000		1.10		1.03		4,883
November 2022		15,866,000		1.26		1.04		16,299
December 2022		3,706,000		1.39		1.25		4,507

		24,528,000						25,689

The Company repurchased 24,528,000 H shares for an aggregate consideration of RMB 25,689 thousand. In February 2023, the Company has completed the cancellation procedures for all the repurchased own shares.

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

Reserves


	Legal surplus		Capital surplus		Surplus reserve		Other reserve			Hedging reserve			Share premium		Safety production fund		Treasury shares			Retained earnings			Total
	(note(a))		(note(b))		(note(c))		(note(d))			(note 3.1(a))			(note(e))		(note(f))		(note 30(ii))			(note(g))
	RMB’000		RMB’000		RMB’000		RMB’000			RMB’000			RMB’000		RMB’000		RMB’000			RMB’000			RMB’000
Balance at 1 January 2021		4,072,476		13,739		101,355		6,326			—			106,846		145,597		—			13,927,837			18,374,176
Total comprehensive income for the year attributable to shareholders of the Company		—		—		—		16,639			125,159			—		—		—			2,073,431			2,215,229
Amounts transferred from hedging reserve to initial carrying amount of hedged items		—		—		—		—			(88,699	)		—		—		—			—			(88,699	)
Dividends declared and approved in respect of previous year		—		—		—		—			—			—		—		—			(1,082,381	)		(1,082,381	)
Transfer to legal surplus		2,498,808		—		—		—			—			—		—		—			(2,498,808	)		—
Appropriation of safety production fund		—		—		—		—			—			—		40,729		—			(40,729)			—
Balance at 31 December 2021 and 1 January 2022		6,571,284		13,739		101,355		22,965			36,460			106,846		186,326		—			12,379,350			19,418,325

Total comprehensive income for the year attributable to shareholders of the Company		—		—		—		(23,771	)		201,519			—		—		—			(2,846,156	)		(2,668,408	)
Amounts transferred from hedging reserve to initial carrying amount of hedged items		—		—		—		—			(237,979	)		—		—		—			—			(237,979	)
Dividends declared and approved in respect of previous year		—		—		—		—			—			—		—		—			(1,082,381	)		(1,082,381	)
Purchase of own shares		—		—		—		—			—			—		—		(25,689	)		—			(25,689	)
Appropriation of safety production fund		—		—		—		—			—			—		54,092		—			(54,092	)		—

Balance at 31 December 2022		6,571,284		13,739		101,355		(806	)		—			106,846		240,418		(25,689	)		8,396,721			15,403,868

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

31	Reserves (continued)

Notes:

(a) Under PRC rules and regulations, the Company and its PRC subsidiaries are required to set aside 10% of the net income determined in accordance with the PRC accounting rules and regulations to a legal surplus reserve. The transfer to this reserve must be made before distribution of any dividend to shareholders.

The legal surplus reserve is

non-distributable

other than in liquidation and can be used to make good of previous years’ losses, if any, and may be utilized for business expansion or converted into ordinary shares by the issuance of new shares to shareholders in proportion to

their

existing shareholdings or by increasing the par value of the shares currently held by the shareholders, provided that the balance after such issuance is not less than 25% of the registered capital.

In accordance with PRC rules and regulations, the Company has set aside RMB6,571,284 thousand of legal surplus as of 31 December 2022.

(b) This reserve represents gifts or grants received from China Petrochemical Corporation, the ultimate parent company and which are required to be included in this reserve fund by PRC regulations.

(c) The transfer to this reserve from the retained profits is subject to the approval by shareholders at general meetings. Its usage is similar to that of the legal surplus reserve.

(d) Other reserve comprises share of post-acquisition movements in other comprehensive income from associates and joint ventures using the equity methods of accounting with a corresponding adjustment to the carrying amount of the investment.

(e) The application of the share premium account is governed by Sections 167 and 168 of the PRC Company Law.

(f) According to the relevant PRC regulations, the Group is required to transfer an amount to specific reserve for the safety production fund based on the turnover of certain refining and chemicals products. This reserve represents unutilized safety production fund.

(g) According to the Company’s Articles of Association, the reserve available for distribution is the lower of the amount determined under China Accounting Standards for Business Enterprises and the amount determined under IFRS.

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions

The following is a list of the Group’s major related parties:


		Names of related parties		Relationship with the Company
		China International United Petroleum & Chemicals Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Chemical Sales Company Limited		Subsidiary of the ultimate parent company
		Sinopec Chemical Commercial Holding Company Limited		Subsidiary of the ultimate parent company
		Petro-cyberworks Information Technology Co., Ltd.		Subsidiary of the ultimate parent company
		Lianhua (Ningbo) International Logistics Co., Ltd.		Subsidiary of the ultimate parent company
		Zhongke (Guangdong) Refining & Chemical Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Marketing Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Fuel Oil Sales Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Lubricant Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Yangzi Petrochemical Co., Ltd.		Subsidiary of the ultimate parent company
		China Petrochemical International (Beijing) Company Limited		Subsidiary of the ultimate parent company
		Sinopec Catalysts Co., Ltd.		Subsidiary of the ultimate parent company
		China Petrochemical International (Shanghai) Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Beijing Research Institute of Chemical Industry		Subsidiary of the ultimate parent company
		China Petrochemical International (Ningbo) Co., Ltd.		Subsidiary of the ultimate parent company
		Zhoushan Shihua Crude Oil Terminal Co., Ltd.		Subsidiary of the ultimate parent company
		Dalian Sinopec Material Equip Company		Subsidiary of the ultimate parent company
		Sinopec Material & Equipment (East China) Co., Ltd.		Subsidiary of the ultimate parent company
		China Petrochemical International (Nanjing) Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Honeywell (Tianjin) Company Limited		Subsidiary of the ultimate parent company
		China Petrochemical International (Wuhan) Co., Ltd.		Subsidiary of the ultimate parent company
		China Petrochemical International Co., Ltd.		Subsidiary of the ultimate parent company
		China Petrochemical Refinery Sales Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd.		Subsidiary of the ultimate parent company
		China Petrochemical International (Tianjin) Co., Ltd.		Subsidiary of the ultimate parent company
		Ningbo East sea Line fan Technology Company Limited		Subsidiary of the ultimate parent company
		Sinopec Petroleum & Chemical Scientific Research Institute Dadi Company		Subsidiary of the ultimate parent company
		Sinopec Shanghai Research Institute of Petrochemical Technology		Subsidiary of the ultimate parent company
		Sinopec Lubricating Oil Shanghai Research Institute Company Limited		Subsidiary of the ultimate parent company
		Dalian Furuipu Technology Co., Ltd.		Subsidiary of the ultimate parent company
		Nantong Donghai Petrochemical Co., Ltd.		Subsidiary of the ultimate parent company
		China Petroleum and Chemical Corporation Qingdao Security Engineering Research Institute		Subsidiary of the ultimate parent company
		Sinopec (Shanghai) Energy Trade Co., Ltd.		Subsidiary of the ultimate parent company
		Storage and Transportation Installation Company of Ningbo Engineering Company Limited		Subsidiary of the ultimate parent company
		Sinopec Chemical Commercial Holding (Hong Kong) Company Limited		Subsidiary of the ultimate parent company
		Sinopec Yizheng Chemical Fibre Limited Liability Company		Subsidiary of the ultimate parent company
		Fujian Gulei Petrochemical Company Limited		Subsidiary of the ultimate parent company
		Sinopec China East Chemical Sales Co., Ltd.		Subsidiary of the ultimate parent company

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)


		Names of related parties		Relationship with the Company
		Unipec Singapore		Subsidiary of the ultimate parent company
		China Yanshan United Foreign Trade Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Chemical Commercial Holding (Wuhan) Company Limited		Subsidiary of the ultimate parent company
		Nanjing Yangzi Petrol-chemical Industry Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Baling Petrochemical Co., Ltd.		Subsidiary of the ultimate parent company
		Shengli Oil Field Exploration and Development Research Institute		Subsidiary of the ultimate parent company
		Shanghai Lide Catalyst Co., Ltd.		Subsidiary of the ultimate parent company
		Ypc-gpro (Nanjing) Rubber Co., Ltd.		Subsidiary of the ultimate parent company
		Fujian Refining & Petrochemical Company Limited		Subsidiary of the ultimate parent company
		Sinopec Dalian (Fushun) Research Institute of Petroleum and Petrochemicals		Subsidiary of the ultimate parent company
		Sinopec Jianghan Salt Chemical Hubei Co., Ltd.		Subsidiary of the ultimate parent company
		Yipaike Business Factoring Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Great Wall Energy and Chemical (Ningxia) Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec (Shenzhen) E-Commerce Company Limited		Subsidiary of the ultimate parent company
		Sinopec Research Institute of Safety Engineering		Subsidiary of the ultimate parent company
		Ningbo Minggang Gas Company Limited		Subsidiary of the ultimate parent company
		Sinopec Zhongyuan Petrol-Chemical Industry Co., Ltd.		Subsidiary of the ultimate parent company
		Epec E-commerce Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Oil Refining and Marketing (Shanghai) Co., Ltd.		Subsidiary of the ultimate parent company
		Sinopec Chemical Sales (Guangdong) Co., Ltd.		Subsidiary of the ultimate parent company
		Unipec (Qingdao) International Logistics Company Limited		Subsidiary of the ultimate parent company

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)


		Names of related parties		Relationship with the Company
		Qingdao Zhonghua Sunshine Management System Certification Center		Subsidiary of the ultimate parent company
		Zhejiang Baling Hengyi Caprolactam Limited Company		Joint venture of the ultimate parent company
		Shanghai Sinopec Mitsui Chemicals, Co., Ltd .		Joint venture of the ultimate parent company
		Basf-ypc Company Limited		Joint venture of the ultimate parent company
		Shanghai Changshi Shipping Co., Ltd.		Associate of the ultimate parent company
		Shanghai KSD Bulk Solids Engineering Co., Ltd.		Associate of the ultimate parent company
		Basf Gao-Qiao Performance Chemicals (Shanghai) Company Limited		Associate of the ultimate parent company
		Sinopec Chemical Commercial Holding (Singapore) Pte. Ltd .		Subsidiary of the immediate parent company
		Sinopec Finance Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Chemical Commercial Holding Company Limited		Subsidiary of the immediate parent company
		Sinopec Nanjing Chemical Research Institute Co., Ltd.		Subsidiary of the immediate parent company
		China Economy Phulishing House Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Publishing House Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec International Travel Service Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Assets Management Co., Ltd.		Subsidiary of the immediate parent company
		Ningbo Engineering Company of Sinopec		Subsidiary of the immediate parent company
		Sinopec Shared Service Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Petroleum Engineering Geophysics Ltd.		Subsidiary of the immediate parent company
		Sinopec Baichuan Economic and Trade Company		Subsidiary of the immediate parent company
		Sinopec Group Jiangsu Petroleum Exploration Bureau Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Newspaper Office		Subsidiary of the immediate parent company
		Sinopec Energy Saving Technology Service Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Group Economic and Technology Research Institute Co., Ltd.		Subsidiary of the immediate parent company

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)


		Names of related parties		Relationship with the Company
		Beijing Petro-Chemical Construction Consulting Co., Ltd.		Subsidiary of the immediate parent company
		China Economicbooks Co., Ltd.		Subsidiary of the immediate parent company
		Petrol-Chemical Industry Management Cadre College		Subsidiary of the immediate parent company
		Sinopec Engineering Quality Supervision Terminal		Subsidiary of the immediate parent company
		Sinopec Group Shanghai Training Center Ltd.		Subsidiary of the immediate parent company
		Sinopec Beijing Yanshan Petrochemical Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Zhongyuan Petroleum Exploration Bureau Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Shengli Petroleum Administration Co., Ltd.		Subsidiary of the immediate parent company
		The Fourth Construction Company of Sinopec		Subsidiary of the immediate parent company
		Sinopec Tending Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Shanghai Engineering Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Engineering Incorporation		Subsidiary of the immediate parent company
		Sinopec Engineering Quality Monitoring Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Engineering(Group)Co.,Ltd.		Subsidiary of the immediate parent company
		National Petrochemical Project Risk Assessment Technology Center		Subsidiary of the immediate parent company
		The Tenth Construction Company of Sinopec		Subsidiary of the immediate parent company
		The Fifth Construction Company of Sinopec		Subsidiary of the immediate parent company
		Shanghai Petrochemical Machinery Manufacturing Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Nanjing Engineering Company Limited		Subsidiary of the immediate parent company
		Sinopec Luoyang Engineering Company Limited		Subsidiary of the immediate parent company
		Jiangsu Jinling Opta Polymer Company Limited		Subsidiary of the immediate parent company
		Shanghai Petro-Chemical Haidi Administration Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec Sichuan Uinylon Works		Subsidiary of the immediate parent company
		China Petrochemical Corp. Nanjing Chemistry Industrial Co., Ltd.		Subsidiary of the immediate parent company

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)


		Names of related parties		Relationship with the Company
		Sinopec Group International Petroleum Exploration And Production Limited		Subsidiary of the immediate parent company
		Sinopec Consulting Company Limited		Subsidiary of the immediate parent company
		China Petrochemical Corp. Engineering Ration Management Station		Subsidiary of the immediate parent company
		Beijing Victory Hotel Company Limited		Subsidiary of the immediate parent company
		Maoming Shihua Dongcheng Chemical Co., Ltd.		Subsidiary of the immediate parent company
		Yihua Tory Polyester Film Company Limited		Joint venture of the immediate parent company
		China Sinopec Pipeline Storage and Transportation Co., Ltd.		Associate of the immediate parent
		Yihua Bonar Yarns and Fabrics Co., Ltd.		Associate of the immediate parent
		Unipec Singapore		Subsidiary of the immediate parent company
		Unipec America, Inc		Subsidiary of the immediate parent company
		Sinopec Japan Company Limited		Subsidiary of the immediate parent company
		Rizhao Shihua Crude Oil Terminal Co., Ltd.		Joint venture of the ultimate parent company
		Sinopec Europe Company Limited		Subsidiary of the immediate parent company
		Sinopec Chemical Commercial Holding (North America), Inc.		Subsidiary of the immediate parent company
		Sinopec International (Australia) Pty. Ltd.		Subsidiary of the immediate parent company
		Sinopec Easy Joy sales CO., Ltd.		Subsidiary of the immediate parent company
		Sinopec National Petrochemical Project Risk Assessment Technology Center Co., Ltd.		Subsidiary of the immediate parent company
		Sinopec International (Russia) Pty. Ltd.		Subsidiary of the immediate parent company
		Sinopec Jianghan Petroleum Administration Co., Ltd.		Subsidiary of the ulitimate parent company
		Sinopec America Company Limited		Subsidiary of the ulitimate parent company
		Sinopec (Beijing) Chemical Research Institute Co., Ltd.		Subsidiary of the ulitimate parent company
		Sinopec-Sk(Wuhan)Petrochemical Co., Ltd.		Subsidiary of the ulitimate parent company
		Shanghai Petroleum&Natural Gas General Co., Ltd.		Associate of the ultimate parent company
		Beijing Heyuan Jingyi Hotel Co., Ltd.		Subsidiary of the ulitimate parent company
		Sinopec Henan Oilfield Training Center		Subsidiary of the ulitimate parent company
		Sinopec Jiangsu Petroleum Exploration Bureau Co., Ltd. Training Center		Subsidiary of the ulitimate parent company
		Sinopec Capital Co., Ltd.		Subsidiary of the ulitimate parent company

The following is a summary of significant balances and transactions between the Group and its related

parties

except for the dividends payable as disclosed in note 33.

F-10

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)

(a)	Most of the transactions undertaken by the Group during the year ended 31 December 2022 have been affected on such terms as determined by Sinopec Corp. and relevant PRC authorities.

Sinopec Corp. negotiates and agrees with the terms of crude oil supply with suppliers on a group basis, which is then allocated among its subsidiaries, including the Group, on a discretionary basis. Sinopec Corp. also owns a widespread petroleum products sales network and possesses a fairly high market share in the domestic petroleum products market, which is subject to extensive regulation by the PRC government.

The Group has entered into a mutual product supply and sales services framework agreement with Sinopec Corp. Pursuant to the agreement, Sinopec Corp. provides the Company with crude oil, other petrochemical raw materials and agent services. On the other hand, the Group provides Sinopec Corp. with petroleum products, petrochemical products and property leasing services.

The pricing policy for these services and products provided under the agreement is as follows:

•

if there are applicable State (central and local government) tariffs, the pricing shall follow the State tariffs;

•

if there are no State tariffs, but there are applicable State guidance prices, the pricing shall follow the State’s guidance prices; or

•

if there are no State tariffs or State’s guidance prices, the pricing shall be determined in accordance with the prevailing market prices (including any bidding prices).

Transactions between the Group and Sinopec Corp, its subsidiaries and joint ventures during the years ended 31 December 2020, 2021 and 2022 were as follows :


	2020 RMB’000		2021 RMB’000		2022 RMB’000
Sales of petroleum products		39,879,549		47,201,755		44,392,225
Sales other than petroleum products		6,790,568		9,439,546		8,194,827
Purchases of crude oil		27,934,926		35,371,820		46,790,433
Purchases other than crude oil		9,937,862		9,008,147		7,544,094
Commission expense		104,598		110,552		90,341
Rental income		32,829		34,475		34,088

F-1

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)

(b)	Other transactions between the Group and Sinopec Group and its subsidiaries, associates and joint ventures of the Group during the years ended 31 December 2020, 2021 and 2022 were as follows:


	2020 RMB’000		2021 RMB’000		2022 RMB’000
Sales of goods and service fee income
- Sinopec Group and its subsidiaries		14,870		36,683		19,450
- Associates and joint ventures of the Group		2,019,997		4,248,658		3,171,835

		2,034,867		4,285,341		3,191,285

Purchases
- Sinopec Group and its subsidiaries		832,617		2,830,256		1,870,287
- Associates and joint ventures of the Group		3,648,664		4,425,698		2,411,552

		4,481,281		7,255,954		4,281,839

Insurance premium expenses
- Sinopec Group and its subsidiaries		107,495		108,850		109,597

Addition to right-of-use assets
- Sinopec Group and its subsidiaries		2,267		1,388		20,023

Interest expense of lease liabilities
- Sinopec Group and its subsidiaries		205		247		787
- Joint ventures of the Group		8		24		17

		213		271		804

Interest expens e
- Sinopec Finance		—		2,835		7,665

Interest income
- Sinopec Finance		2,088		824		213
- Joint ventures of the Group		—		—		2,704

		2,088		824		2,917

Construction and installation cost
- Sinopec Group and its subsidiaries		233,591		785,216		812,516

Rental income
- Associates and joint ventures of the Group		15,577		14,930		14,032
- Sinopec Group and its subsidiaries		464		464		427

		16,041		15,394		14,459

Long-term borrowings
- Sinopec Finance		—		700,000		—

The directors of the Company are of the opinion that the transactions with Sinopec Corp., its subsidiaries and joint ventures, Sinopec Group and its subsidiaries, associates and joint ventures of the Group as disclosed in notes 3

(a) and 3

(b) were conducted in the ordinary course of business, on normal commercial terms and in accordance with the agreements governing such transactions.

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)

(c)	The relevant amounts due from/to Sinopec Corp., its subsidiaries and joint ventures, Sinopec Group and its subsidiaries, associates and joint ventures of the Group, arising from purchases, sales and other transactions as disclosed in notes 3 2 (a) and 3 2 (b), are summarized as follows:


	As at 31 December 2021		As at 31 December 2022
	RMB’000		RMB’000
Amounts due from related parties
- Sinopec Corp., its subsidiaries and joint ventures		1,184,117		2,593,908
- Associates and joint ventures of the Group		28,214		45,075

		1,212,331		2,638,983

Amounts due to related parties
- Sinopec Corp., its subsidiaries and joint ventures		4,475,992		6,569,219
- Sinopec Group and its subsidiaries		1,672,439		1,232,589
- Associates and joint ventures of the Group		156,385		86,001

		6,304,816		7,887,809

Lease liabilities
- Sinopec Group and its subsidiaries		992		12,714
- Joint ventures of the Group		435		290

		1,427		13,004

Cash deposits, maturing within three months
- Sinopec Finance (note d)		3,243		—

Long-term borrowings
- Sinopec Finance		700,000		700,000

(d)	As at 31 December 2021, cash deposits at Sinopec Finance were charged at an interest rate of 0.35 % per annum.

Except for cash deposits at Sinopec Finance and long-term borrowings from Sinopec Finance, the balances with related parties as above are unsecured, interest-free and repayable on demand.

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)

(e)	Key management personnel compensation, post-employment benefit plans and share options

Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the Group, directly or indirectly, including directors and supervisors of the Group. The key personnel compensations are as follows:


	Years ended 31 December
	2020		2021		2022
	RMB’000		RMB’000		RMB’000
Short-term employee benefits		9,859		11,866		13,667
Post-employment benefits		441		551		639

		10,300		12,417		14,306

(f)	Transactions with other state-owned entities in the PRC

The Group is a state-controlled enterprise and operates in an economic regime currently dominated by entities directly or indirectly

controlled

by the PRC government (collectively referred to as “state-controlled entities”) through its government authorities, agencies, affiliations and other organizations.

Apart from transactions with related parties, the Group has transactions with other state-controlled entities which include, but are not limited to, the following:

•

sales and purchases of goods and ancillary materials;

•

rendering and receiving services;

•

lease of assets, purchase of property, plant and equipment;

•

placing deposits and obtaining finance; and

•

use of public utilities

These transactions are conducted in the ordinary course of the Group’s business on terms comparable to those with other entities that are not state controlled. The Group has established its procurement policies, pricing strategy and approval process for purchases and sales of products and services which do not depend on whether the counterparties are state-controlled entities or not.

(g)	Commitments with related parties

(i)	Construction and installation cost


	As at 31 December 2021 RMB’000		As at 31 December 2022 RMB’000
Sinopec Group and its subsidiaries		775,007		930,665

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

32	Related-party transactions (continued)

(h)	Investment commitments with related parties


	As at 31 December 2021 RMB’000		As at 31 December 2022 RMB’000
Capital contribution to Shanghai Secco (i)		111,263		111,263
Capital contribution to Shanghai Shidian Energy Company
Limited (“Shidian Energy”) (ii)		80,000		—
Capital contribution to Baling Materials (iii)		350,000		150,000

		541,263		261,263

(i)

Pursuant to the resolution of the 18th meeting of the 7th term of Board of Directors on 5 December 2013, the Group was approved to make a capital contribution of USD 30,017,000 (RMB 182,804 thousand equivalent) to Shanghai Secco, an associate of the Group. As at 31 December 2022, the Company has contributed RMB 71,541 thousand to Shanghai Secco.

According to the approval by Shanghai Municipal Commission of Commerce as issued on 19 October 2015, the rest of the capital contribution to Shanghai Secco should be within 50 years starting from its registration date.

(ii)	Pursuant to the articles of association of Shidian Energy in August 2019 , Toufa agreed to make a capital contribution of RMB 400,000 thousand to acquire 40% share of Shidian Energy. As at 31 December 2022, Toufa has fully contributed RMB 400,000 thousand to Shidian Energy.

(iii)

Sinopec Baling Petrochemical Co., Ltd and the Company jointly established Baling Materials on 7 September 2021, each with a cash contribution of RMB 400,000 thousand. As at 31 December 2022, the Company has made a

paid-up

capital contribution of RMB 250,000 thousand.

Except for the above disclosed in notes 32 (g) and 32 (h), the Group had no other material commitments with related parties as at 31 December 2022, which are contracted, but not included in the financial statements.

Dividend

(a)	Dividends payable to equity shareholders of the Company attributable to the year:


	2021 RMB’000		2022 RMB’000
No final dividend proposed after the end of the reporting period (2021: RMB 0.10 per ordinary share)		1,082,381		—

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

33	Dividend (continued)

The final dividend proposed after the end of the reporting period has not been recognized as a liability at the end of the reporting period.

(b)	Dividends payable to equity shareholders of the Company attributable to the previous financial year, approved and paid during the year


	2021 RMB’000		2022 RMB’000
Final dividend in respect of the previous financial year, approved and paid during the year, of RMB 0.10 per share (2021: RMB 0.10)		1,082,381		1,082,381

34	Commitments

Capital commitments outstanding at 31 December 2022 not provided for in the financial statements were as follows:


	As at 31 December 2021 RMB’000		As at 31 December 2022 RMB’000
Property, plant and equipment contracted for		1,176,168		1,783,781

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

35	Statements of financial position and equity movement of the Company


	As at 31 December 2021		As at 31 December 2022
	RMB’000		RMB’000

Non-current assets
Property, plant and equipment		10,914,990		11,823,562
Investment properties		381,540		365,147
Right-of-use assets		275,924		274,926
Construction in progress		3,201,111		3,647,200
Investments in subsidiaries		2,048,328		2,048,328
Investments accounted for using the equity method		3,299,050		2,654,151
Time deposits with banks		5,381,149		3,139,559
Deferred tax assets		178,084		986,830
Other non-current assets		769,492		821,397

		26,449,668		25,761,100

Current assets
Derivative financial instruments		81,405		—
Inventories		5,726,264		7,043,613
Trade receivables		149		—
Other receivables		8,276		88,839
Amounts due from related parties		1,116,553		2,526,598
Prepayments		13,790		10,711
Value added tax recoverable		—		1,045,002
Financial assets at fair value through other comprehensive income (FVOCI)		615,689		127,558
Time deposits with banks		7,386,605		3,108,916
Cash and cash equivalents		4,927,519		671,538

		19,876,250		14,622,775

Current liabilities
Trade and other payables		2,389,508		2,217,580
Contract liabilities		376,834		289,407
Amounts due to related parties		7,423,883		8,809,690
Staff salaries and welfares payable		253,800		307,190
Borrowings		1,500,000		1,500,000
Lease liabilities		1,604		7,172
Derivative financial instruments		23,804		—
Income tax payable		249,332		—
Current tax liabilities		3,843,541		913,231

		16,062,306		14,044,270

Net current assets		3,813,944		578,505

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

35	Statements of financial position and equity movement of the Company (continued)


	As at 31 December 2021		As at 31 December 2022
	RMB’000		RMB’000
Total assets less current liabilities		30,263,612		26,339,605

Non-current liabilities
Interest-bearing borrowings		700,000		700,000
Lease liabilities		399		6,481
Deferred income		12,720		44,494

		713,119		750,975



NET ASSETS		29,550,493		25,588,630

CAPITAL AND RESERVES
Share capital		10,823,814		10,823,814
Reserves		18,726,679		14,764,816

TOTAL EQUITY		29,550,493		25,588,630

Approved and authorized for issue by the Board of Directors on 26 April 2023.


	)
	)
Wan Tao	)
	)
	)	Directors
	)
Du Jun	)
	)
	)

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

35	Statements of financial position and equity moveme nt of the Company (continued)

(a)	Movements in components of equity of the Company


	Share capital RMB’000		Legal surplus RMB’000		Capital surplus RMB’000		Surplus reserve RMB’000		Other reserve RMB’000			Hedging reserve RMB’000			Share premium RMB’000		Safety production fund RMB’000		Treasury reserve RMB’000			Retained earnings RMB’000			Total RMB’000
Balance at 1 January 2021		10,823,814		4,072,476		4,180		101,355		6,326			—			106,846		145,597		—			13,260,897			28,521,491
Total comprehensive income for the year		—		—		—		—		16,639			125,159			—		—		—			2,058,284			2,200,082
Amounts transferred from hedging reserve to initial carrying amount of hedged items		—		—		—		—		—			(88,699	)		—		—		—			—			(88,699	)
Dividends declared and approved in respect of previous year		—		—		—		—		—			—			—		—		—			(1,082,381	)		(1,082,381	)
Transfer to legal surplus		—		2,498,808		—		—		—			—			—		—		—			(2,498,808	)		—
Appropriation of safety production fund		—		—		—		—		—			—			—		32,310		—			(32,310	)		—

Balance at 31 December 2021 and 1 January 2022		10,823,814		6,571,284		4,180		101,355		22,965			36,460			106,846		177,907		—			11,705,682			29,550,493

Total comprehensive income for the year		—		—		—		—		(23,771	)		201,519			—		—		—			(2,793,562	)		(2,615,814	)
Amounts transferred from hedging reserve to initial carrying amount of hedged items		—		—		—		—		—			(237,979	)		—		—		—			—			(237,979	)
Dividends declared and approved in respect of previous year		—		—		—		—		—			—			—		—		—			(1,082,381	)		(1,082,381	)
Purchase of own shares		—		—		—		—		—			—			—		—		(25,689	)		—			(25,689	)
Appropriation of safety production fund		—		—		—		—		—			—			—		61,782		—			(61,782	)		—

Balance at 31 December 2022		10,823,814		6,571,284		4,180		101,355		(806	)		—			106,846		239,689		(25,689	)		7,767,957			25,588,630

F-11

Table of Contents

Sinopec Shanghai Petrochemical Company Limited

36	Comparative figures

Certain comparative figures, as disclosed below, have been adjusted to conform to current year’s presentation. Value added tax recoverable in the amount of RMB

13,322

thousand as of December 31, 2021, which was previously included in prepayments, and has been reclassified as value added tax recoverable and separately presented on the consolidated balance sheet as of December 31, 2021.

37	Possible impact of amendments, new standards and interpretations issued but not yet effective for the year ended 31 December 2022

Up to the date of issue of these financial statements, the IASB has issued a number of amendments, new standards and interpretations, which are not yet effective for the year ended 31 December 2022 and which have not been adopted in these financial statements. These developments include the following which may be relevant to the Group.


	Effective for accounting periods beginning on or after
IFRS 17, Insurance contracts		1 January 2023
Amendments to IAS 1, Presentation of financial statements: Classification of liabilities as current or non-current		1 January 2023
Amendments to IAS 1, Presentation of financial statements and IFRS Practice Statement 2, Making materiality judgements: Disclosure of accounting policies		1 January 2023
Amendments to IAS 8, Accounting policies, changes in accounting estimates and errors: Definition of accounting estimates		1 January 2023
Amendments to IAS 12, Income taxes: Deferred tax related to assets and liabilities arising from a single transaction		1 January 2023

The Group is in the process of making an assessment of what the impact of these amendments, new standards and interpretations are expected to be in the period of initial application. So far, the Group has concluded that the adoption of them is unlikely to have a significant impact on the consolidated financial statements.

F-1

Exhibit 8

List of Principal Subsidiaries of Sinopec Shanghai Petrochemical Company Limited


Subsidiary Name	Place of Incorporation		Our ownership interest (%)
Shanghai Petrochemical Investment Development Company Limited		PRC		100.00
China Jinshan Associated Trading Corporation		PRC		67.33
Shanghai Jinchang Engineering Plastics Company Limited		PRC		71.43
Shanghai Golden Phillips Petrochemical Company Limited		PRC		100.00
Shanghai Jinshan Trading Corporation		PRC		67.33
Zhejiang Jinlian Petrochemical Storage and Transportation Company Limited		PRC		100.00

Exhibit 12.1

CERTIFICATION

I, Guan Zemin, certify that:

1. I have reviewed this annual report on Form 20-F of Sinopec Shanghai Petrochemical Company Limited.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report.

4. The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting.

5. The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date: April 26, 2023



By:		/s/ Guan Zemin
		Guan Zemin
		President

Exhibit 12.2

CERTIFICATION

I, Du Jun, certify that:

1. I have reviewed this annual report on Form 20-F of Sinopec Shanghai Petrochemical Company Limited.

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date: April 26, 2023



By:		/s/ Du Jun
		Du Jun
		Chief Financial Officer

Exhibit 13.1

906 CERTIFICATION

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Ladies and Gentlemen:

In connection with the Annual Report of Sinopec Shanghai Petrochemical Company Limited (the “Company”) on Form 20-F for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Guan Zemin, the President of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed “filed” with the Securities and Exchange Commission.

Date: April 26, 2023



By:		/s/ Guan Zemin
Name:		Guan Zemin
Title:		President

Exhibit 13.2

906 CERTIFICATION

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Ladies and Gentlemen:

In connection with the Annual Report of Sinopec Shanghai Petrochemical Company Limited (the “Company”) on Form 20-F for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (the “Report”), I, Du Jun, the Chief Financial Officer of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed “filed” with the Securities and Exchange Commission.

Date: April 26, 2023



By:		/s/ Du Jun
Name:		Du Jun
Title:		Chief Financial Officer

Exhibit 99.1


Report of independent registered public accounting firm (PCAOB ID 1424)			2

Financial statements of SECCO			3

Report of Independent Registered Public Accounting Firm

To the Board of Directors of Shanghai Secco Petrochemical Company Limited

We have audited the accompanying income statement statements of changes in owners’ equity and cash flows of Shanghai Secco Petrochemical Company Limited (the “Company”) for the year ended December 31, 2020.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the requirements of Accounting Standards for Business Enterprises in the People’s Republic of China; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

Auditors’ Responsibility

Our responsibility is to express an opinion on the financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the Company’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the financial statements referred to above present fairly, in all material respects, the results of operations and cash flows of the Company for the year ended December 31, 2020 in accordance with the requirements of Accounting Standards for Business Enterprises in the People’s Republic of China.

Other Matter

The accompanying balance sheets of the Company as of December 31, 2022 and 2021, and the related income statements, statements of changes in owners’ equity and cash flows for the years then ended are presented for purposes of complying with Rule 3-09 of SEC Regulation S-X; however, Rule 3-09 does not require the 2022 and 2021 financial statements to be audited and they are therefore not covered by this report.

/s/PricewaterhouseCoopers Zhong Tian LLP

Shanghai, the People’s Republic of China

April 28, 2021

Shanghai Secco Petrochemical Company Limited

Balance sheets as at 31 December 2021* and 2022*

(Expressed in Renminbi Yuan)


	Note	31 December 2021^*		31 December 2022^*
Assets
Current assets
Cash at bank and on hand	6		3,282,751,042		1,322,431,469
Accounts receivable	7		251,529,912		224,931,881
Financial assets at fair value through other comprehensive income	8		260,065,209		212,655,800
Advances to suppliers	9		22,771,842		55,368,985
Other receivables	10		41,376,432		501,424,701
Inventories	11		2,205,453,196		2,290,713,659
Current portion of non-current assets			—		—
Other current assets	12		2,171,547		333,867,951

Total current assets			6,066,119,180		4,941,394,446

Non-current assets
Fixed assets	13		3,166,903,848		2,800,316,384
Construction in progress	14		203,497,772		421,906,466
Right-of-use assets	15		367,711		53,685
Intangible assets	16		627,505,136		590,916,001
Long term prepaid expenses	17		135,014,349		102,709,387
Deferred tax assets	18		48,291,526		698,726,289
Other non-current assets	19		1,553,779,369		1,068,780,880

Total non-current assets			5,735,359,711		5,683,409,092

Total assets			11,801,478,891		10,624,803,538

Liabilities and owner’s equity
Current liabilities
Short-term borrowings	20		—		6,608,867,012
Accounts payable			1,787,137,217		1,424,493,816
Contract liabilities	21		415,450,821		434,327,898
Employee benefits payable	22		105,573,340		101,102,098
Taxes payable	5(3)		316,126,213		73,406,011
Other payables	23		2,755,463,900		278,305,641
Non-current liabilities maturing within one year	24		111,639		65,123
Other current liabilities	25		54,008,607		56,462,627

Total current liabilities			5,433,871,737		8,977,030,226

Non-current liabilities
Lease liabilities	26		65,747		1,809
Deferred tax liabilities			—		—

Total non-current liabilities			65,747		1,809

Total liabilities			5,433,937,484		8,977,032,035

Owners’ equity
Paid-in capital	27		500,000,000		3,115,180,000
Capital surplus	28		1,454,646		1,454,646
Specific reserve	29		—		—
Surplus reserve	30		3,052,773,285		437,593,285
Undistributed profits/(accumulated losses)			2,813,313,476		(1,906,456,428	)

Total owners’ equity			6,367,541,407		1,647,771,503

Total liabilities and owners’ equity			11,801,478,891		10,624,803,538

*	Not covered by the independent auditor’s report included herein

The accompanying notes form an integral part of these financial statements.


Legal representative	Chief Executive Officer	Chief Finance Officer department	(Company stamp)
Wang Jingyi	Zhang Minglong	Zhang Bing

Shanghai Secco Petrochemical Company Limited

Income statements for the year ended 31 December 2020, 2021* and 2022*

(Expressed in Renminbi Yuan)


	Note		2020			2021^*			2022^*
Revenue		32		21,626,059,244			29,723,223,208			24,096,829,125

Less: Cost of sales				17,269,274,588			25,170,369,009			25,816,322,652
Taxes and surcharges		33		47,163,147			68,615,664			34,194,268
Selling and distribution expenses				545,058,651			171,618,022			99,155,273
General and administrative expenses				778,238,133			384,640,241			410,883,541
R&D expenses				10,829,389			15,954,174			12,557,414
Financial (income)/expense		34		(162,465,492	)		(228,367,775	)		28,453,641
Including: Interest expenses				6,019,753			2,682,042			134,233,247
Interest income				172,009,089			232,479,017			104,673,458
Add: Other income		35		10,958,322			16,387,830			8,459,157
Investment income		36		58,535,901			46,328,616			—
Net reversal of impairment losses on financial assets				1,040,393			—			—
Asset impairment losses		37		(6,787,522	)		(127,513,762	)		(289,308,464	)
Losses on disposal of assets				—			—			—

Operating Profit/(loss)				3,201,707,922			4,075,596,557			(2,585,586,971	)

Add: Non-operating income		38		15,062,370			4,305,837			1,148,819
Less: Non-operating expenses		38		8,546,265			13,581,464			13,478,436

Profi/(Loss) before taxation				3,208,224,027			4,066,320,930			(2,597,916,588	)

Less: Income tax expenses		39		795,424,371			940,417,068			(650,337,336	)

Net profit/(loss) for the year				2,412,799,656			3,125,903,862			(1,947,579,252	)

Including: Net profit/(loss) from continuing operations				2,412,799,656			3,125,903,862			(1,947,579,252	)
Net profit from discontinued operations				—			—			—

Other comprehensive income				—			—			—

Total comprehensive income				2,412,799,656			3,125,903,862			(1,947,579,252	)

*	Not covered by the independent auditor’s report included herein

The accompanying notes form an integral part of these financial statements.


Legal representative	Chief Executive Officer	Chief Finance Officer department	(Company stamp)
Wang Jingyi	Zhang Minglong	Zhang Bing

Shanghai Secco Petrochemical Company Limited

Cash flow statements for the year ended 31 December 2020, 2021* and 2022*

(Expressed in Renminbi Yuan)


	Note		2020			2021^*			2022^*
Cash flow generated from/(used in) operating activities:
Cash received from sales of goods or rendering of services				21,427,685,227			28,606,446,224			23,210,508,430
Refund of taxes and surcharges				53,504			374,419			208,526,868
Cash received from other operating activities				181,540,815			151,007,619			57,185,620

Sub-total of cash inflows				21,609,279,546			28,757,828,262			23,476,220,918

Cash paid for goods and services				(16,695,409,936	)		(22,606,453,710	)		(25,105,405,730	)
Cash paid to and on behalf of employees				(506,833,430	)		(577,421,410	)		(647,391,432	)
Payments of taxes and surcharges				(1,209,305,980	)		(2,035,109,503	)		(954,985,656	)
Cash paid to other operating activities				(78,693,377	)		(90,970,900	)		(86,639,796	)

Sub-total of cash outflows				(18,490,242,723	)		(25,309,955,523	)		(26,794,422,614	)

Net cash flow generated from/(used in) operating activities		41(1)		3,119,036,823			3,447,872,739			(3,318,201,696	)

Cash flow (used in)/generated from investing activities:
Cash received from entrusted loans				2,000,000,000			2,000,000,000			—
Cash received from returns on investments				62,048,056			49,108,333			—
Cash received from disposal of fixed assets				1,314,386			—			316,019
Cash received from other investing activities				120,834,086			1,252,602,486			1,020,280,522

Sub-total of cash inflows				2,184,196,528			3,301,710,819			1,020,596,541

Cash paid to acquire fixed assets, intangible assets and other long-term assets				(378,975,254	)		(318,538,272	)		(277,888,509	)
Cash paid for entrusted loans				(4,000,000,000	)		—			—
Cash paid to other investing activities				(2,140,000,000	)		(1,450,000,000	)		(34,823,000	)

Sub-total of cash outflows				(6,518,975,254	)		(1,768,538,272	)		(312,711,509	)

Net cash flows (used in)/generated from investing activities				(4,334,778,726	)		1,533,172,547			707,885,032

Cash flows (used in)/generated from financing activities:
Cash received from borrowings				—			—			7,009,867,012

Sub total of cash inflows				—			—			7,009,867,012

Cash repayments of borrowings				(500,000,000	)		—			(401,000,000	)
Cash payments for distribution of profits				(2,368,000,000	)		(3,171,706,061	)		(2,772,190,652	)
Payment for capital reduction				—			(4,650,645,401	)		(2,650,165,871	)
Cash payments for interest expenses				(5,222,150	)		—			(124,568,098	)
Cash paid to other financing activities				(6,378,698	)		(5,746,724	)		(98,730	)

Sub-total of cash outflows				(2,879,600,848	)		(7,828,098,186	)		(5,948,023,351	)

Net cash flows (used in)/generated from financing activities				(2,879,600,848	)		(7,828,098,186	)		1,061,843,661

Effect of foreign exchange rate changes on cash and cash equivalents				(2,504,130	)		(832,847	)		3,330,430

Net decrease in cash and cash equivalents		41(2)		(4,097,846,881	)		(2,847,885,747	)		(1,545,142,573	)
Add: Cash and cash equivalents at beginning of year				9,278,483,670			5,180,636,789			2,332,751,042

Cash and cash equivalents at end of year		41(3)		5,180,636,789			2,332,751,042			787,608,469

*	Not covered by the independent auditor’s report included herein

The accompanying notes form an integral part of these financial statements.


Legal representative	Chief Executive Officer	Chief Finance Officer	(Company stamp)
Wang Jingyi	Zhang Minglong	Zhang Bing

Shanghai Secco Petrochemical Company Limited

Statements of changes in owner’s equity for the years ended 31 December 2020, 2021* and 2022*

(Expressed in Renminbi Yuan)


	Note	Paid-in capital			Capital surplus		Specific reserve			Surplus reserve			Undistributed profits/ (accumulated losses)			Total owners’ equity
Balance at 1 January 2020			7,800,811,272			1,454,646		—			2,498,902,933			3,368,186,371			13,669,355,222
Movements for the year ended 31 December 2020

Net profit			—			—		—			—			2,412,799,656			2,412,799,656
Profit distribution
- Appropriation to surplus reserve			—			—		—			241,279,966			(241,279,966	)		—
- Distribution for owners			—			—		—			—			(2,368,000,000	)		(2,368,000,000	)
Specific reserve
- Accrued			—			—		39,036,294			—			—			39,036,294
- Utilized			—			—		(39,036,294	)		—			—			(39,036,294	)

Balance at 31 December 2020			7,800,811,272			1,454,646		—			2,740,182,899			3,171,706,061			13,714,154,878

Balance at 1 January 2021			7,800,811,272			1,454,646		—			2,740,182,899			3,171,706,061			13,714,154,878

Movements for the year ended 31 December 2021^*

Net profit						—		—			—			3,125,903,862			3,125,903,862
Owner’s contributions
- Capital reduction			(7,300,811,272	)		—		—			—			—			(7,300,811,272	)
Profit distribution	31
- Appropriation to surplus reserve			—			—		—			312,590,386			(312,590,386	)		—
- Distribution for owners			—			—		—			—			(3,171,706,061	)		(3,171,706,061	)
Specific reserve	29
- Accrued			—			—		28,523,706			—			—			28,523,706
- Utilized			—			—		(28,523,706	)		—			—			(28,523,706	)

Balance at 31 December 2021^*			500,000,000			1,454,646		—			3,052,773,285			2,813,313,476			6,367,541,407

Balance at 1 January 2022^*			500,000,000			1,454,646		—			3,052,773,285			2,813,313,476			6,367,541,407
Movements for the year ended 31 December 2022^*

Net loss			—			—		—			—			(1,947,579,252	)		(1,947,579,252	)
Owner’s contributions
- Capital reduction			—			—		—			—			—			—
Profit distribution	31
- Appropriation to surplus reserve			2,615,180,000			—		—			(2,615,180,000	)		—			—
- Distribution for owners			—			—		—			—			(2,772,190,652	)		(2,772,190,652	)
Specific reserve	29
- Accrued			—			—		41,419,862			—			—			41,419,862
- Utilized			—			—		(41,419,862	)		—			—			(41,419,862	)

Balance at 31 December 2022^*			3,115,180,000			1,454,646		—			437,593,285			(1,906,456,428	)		1,647,771,503

*	Not covered by the independent auditor’s report included herein

The accompanying notes form an integral part of these financial statements.


Legal representative	Chief Executive Officer	Chief Finance Officer	(Company stamp)
Wang Jingyi	Zhang Minglong	Zhang Bing

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

1	Company status

Shanghai Secco Petrochemical Company Limited (“the Company”) was a Sino-foreign equity joint venture established in Shanghai, the People’s Republic of China (“the PRC”) in 2001 by China Petroleum and Chemical Corporation (“Sinopec Corp.”), Sinopec Shanghai Petrochemical Company Limited (“SPC”) and BP Chemicals East China Investments Limited (“BPCECIL”). The original registered capital and paid-in capital of the Company both were USD 901,440,964. Sinopec Corp., SPC and BPCECIL held 30%, 20% and 50% equity interest in the Company, respectively. The Company commenced its active operation on 31 March 2005, and the approved period of operation is 50 years.

On 24 October 2013 and 25 November 2013, Sinopec Corp., SPC and BPCECIL amended the Equity Joint Venture Contract and Articles of Association to progressively increase the registered capital of the Company from USD 901,440,964 to USD 1,051,526,582. The total increased registered capital would be contributed by Sinopec Corp., SPC and BPCECIL in proportion to their respective shareholding in the Company by instalments. In 2013 and 2014, the Company received paid-in capital contributed by Sinopec Corp., SPC and BPCECIL in proportion to their respective shareholding in the Company by instalments, totalling to USD 58,430,374 (equivalent to RMB 357,226,095). The capital has been verified by PricewaterhouseCoopers Zhong Tian LLP and Shanghai Huayi Accountant Office Co., Ltd. with verification reports PricewaterhouseCoopers Zhongtian Yanzi (2013) No. 872 and Hua Yanzi (2014) No. 002 issued, respectively.

On 27 April 2017, Sinopec Corp. and Sinopec Shanghai Gaoqiao Petrochemical Company Limited (“Gaoqiao Petrochemical”) (subsidiary of Sinopec Corp.) entered into an agreement with BPCECIL, according to which Gaoqiao Petrochemical purchased 50% equity in the Company from BPCECIL. On 26 October 2017, the Company was transformed from a “Sino-foreign joint venture” to an “other limited liability corporation”.

According to the resolution of the Board of Directors on 12 July 2021, the Company’s paid-in capital has reduced from RMB 7,800,811,272 to RMB 500,000,000, all owners of the Company has reduced their capital in proportion to their shareholding ratios.

According to the resolution of the 15th Session of the first Shareholders’ Meeting on 30 August 2022, the registered capital of the Company increased from RMB 500,000,000 to RMB 3,115,180,000, and the registered capital increased by RMB 2,615,180,000 through transfer from surplus reserve. Sinopec, Gaoqiao Petrochemical and Shanghai Petrochemical increased the capital according to the original shareholding ratio.

According to the resolution of the 16th Session of the first Shareholders’ Meeting on 25 November 2022, Sinopec transferred 15% of its equity (original investment amount of RMB 467,277,000) to INEOS, and Gaoqiao Petrochemical transferred 35% of its equity (original investment amount of RMB 1,090,313,000) to INEOS. As at 31 December 2022, to INEOS, Sinopec, Gaoqiao Petrochemical and Shanghai Petrochemical held the registered and paid-up capital of the Company of RMB 1,557,590,000, RMB 467,277,000, RMB 467,277,000 and RMB 623,036,000, respectively. The stakes are 50%, 15%, 15% and 20%.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

The Company’s approved scope of business operations mainly comprises the production of ethylene, polyethylene, styrene, polystyrene, propylene, acrylonitrile, polypropylene, butadiene, aromatic hydrocarbons and by-products; sales of these products and purchased raw materials; as well as provision of related after-sales services and technical consultation with respect to such main petrochemical products and by-products; it is also engaged in polymers application development and providing ancillary utilities engineering services to suppliers and processors.

These financial statements were approved for issue by the Company’s responsible persons on 15 March 2022.

2	Basis of preparation

The financial statements are prepared in accordance with the Accounting Standards for Business Enterprises—Basic Standard, the specific accounting standards and other relevant regulations issued by the Ministry of Finance on 15 February 2006 and in subsequent periods (hereafter collectively referred to as “the Accounting Standards for Business Enterprises” or “CAS”).

The Company incurred net loss of RMB 1,947,579,252 during 2022. As at 31 December 2022, the Company’s current liabilities exceeded its current assets by RMB 4,035,635,780. The Company’s working capital position depends primarily on the Company’s ability to maintain sufficient net operating cash inflows and renew short-term borrowings, as well as access to sufficient external financing to maintain working capital and repay maturing debts. As at 31 December 2022, the management forecasted the Company’s cash flows for the period from 1 January 2023 to 31 December 2023, taking full account of current unused bank lines of credit, future capital expenditures and irrevocable capital commitments, and the ability to renew and refinance future bank borrowings as they mature. As at 31 December 2022, the Company’s unused bank line of credit was RMB 2,191,132,988. As at the issue date of the report, the Company has increased its bank line of credit by RMB 5,700,000,000. According to this forecast, the management believes that the Company has sufficient funds to meet its working capital, capital expenditure and debt repayment requirements for the period from 1 January 2023 to 31 December 2023. Accordingly, these financial statements have been prepared on a going concern basis.

The financial statements have been prepared on the going concern basis.

(1)	Statement of compliance

The financial statements have been prepared in accordance with the requirements of Accounting Standards for Business Enterprises or referred to as China Accounting Standards (“CAS”) issued by the Ministry of Finance (“MOF”). These financial statements present truly and completely the financial position of the Company as at 31 December 2022, and the financial performance and the cash flows of the Company for the year then ended.

(2)	Accounting year

The accounting year of the Company is from 1 January to 31 December.

(3)	Functional currency and presentation currency

The Company’s functional currency is Renminbi and these financial statements are presented in Renminbi.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

3	Significant accounting policies and accounting estimates

(1)	Translation of foreign currencies

When the Company receives capital in foreign currencies from investors, the capital is translated to Renminbi at the spot exchange rate at the date of the receipt. Other foreign currency transactions are, on initial recognition, translated to Renminbi at the spot exchange rates on the dates of the transactions.

Monetary items denominated in foreign currencies are translated to Renminbi at the spot exchange rate at the balance sheet date. The resulting exchange differences are generally recognized in profit or loss, unless they arise from the re-translation of the principal and interest of specific borrowings for the acquisition, construction or production of qualifying assets. Non-monetary items that are measured at historical cost in foreign currencies are translated to Renminbi using the exchange rate at the transaction date.

(2)	Cash and cash equivalents

Cash and cash equivalents comprise cash on hand, deposits that can be readily withdrawn on demand, and short-term, highly liquid investments that are readily convertible into known amounts of cash and are subject to an insignificant risk of change in value.

(3)	Inventories

Inventories include raw materials, work in progress and finished goods, and are measured at the lower of cost and net realizable value.

Cost is determined using the weighted average method. The cost of finished goods and semi-finished products comprise raw materials, direct labor and systematically allocated production overhead based on the normal production capacity. Turnover materials include low value consumables and packaging materials, and are expensed when issued.

Provision for decline in the value of inventories is determined at the excess amount of the carrying amounts of the inventories over their net realizable value. Net realizable value is determined based on the estimated selling price in the ordinary course of business, less the estimated costs to completion and estimated costs necessary to make the sale and related taxes.

The Company adopts the perpetual inventory system.

(4)	Fixed assets

Fixed assets comprise buildings, specialized machinery and equipment, general machinery and equipment, office and other equipment. Fixed assets purchased or constructed by the Company are initially measured at cost at the time of acquisition.

When an enterprise sells products or by-products produced before a fixed asset is available for its intended use, the proceeds and related cost are accounted for in accordance with CAS 14 - Revenue and CAS 1 - Inventories respectively, and recognised in profit or loss for the current period.

Subsequent expenditures incurred for a fixed asset are included in the cost of the fixed asset when it is probable that the associated economic benefits will flow to the Company and the related cost can be reliably measured. The carrying amount of the replaced part is derecognized. All the other subsequent expenditures are recognized in profit or loss for the period in which they are incurred.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Fixed assets are depreciated using the straight-line method to allocate the cost of the assets to their estimated residual values over their estimated useful lives. For the fixed assets that have been provided for asset impairment loss, the related depreciation charge is prospectively determined based upon the adjusted carrying amounts over their remaining useful lives.

The estimated useful lives, the estimated net residual values expressed as a percentage of cost and the annual depreciation rates of fixed assets are as follows:


	Estimated useful life	Residual value rate			Depreciation rate
Plant and buildings	12 to 40 years		3	%	2.43% to 8.08%
Specialized machinery and equipment	5 to 30 years		3	%	3.23% to 19.40%
General machinery and equipment	4 to 20 years		3	%	4.85% to 24.25%
Office and other equipment	5 years		0	%	20.00%
Motor vehicles	8 to 10 years		3	%	9.70% to 12.13%
Machinery and equipment	4 to 14 years		3	%	6.93% to 24.25%

The estimated useful life and the estimated net residual value of a fixed asset and the depreciation method applied to the asset are reviewed, and adjusted as appropriate at each year-end.

A fixed asset is derecognized on disposal or when no future economic benefits are expected from its use or disposal. The amount of proceeds from disposals on sale, transfer, retirement or damage of a fixed asset net of its carrying amount and related taxes and expenses is recognized in profit or loss for the current period.

(5)	Construction in progress

Construction in progress is measured at actual cost. Actual cost comprises construction costs, installation costs, borrowing costs that are eligible for capitalization and other costs necessary to bring the fixed assets ready for their intended use. Construction in progress is transferred to fixed assets when the assets are ready for their intended use, and depreciation is charged starting from the following month.

When an enterprise sells products or by-products produced before a fixed asset is available for its intended use, the proceeds and related cost are accounted for in accordance with CAS 14 – Revenue and CAS 1 – Inventories respectively, and recognised in profit or loss for the current period.

(6)

Leases

(a)

The Company as the lessee

The Company recognize the right-of-use assets at the beginning of the lease period and the lease liabilities at the present value of the outstanding lease payments. Lease payments include fixed payments and payments to be made if it is reasonably determined that the option to buy or to terminate the lease option will be exercized. The variable rent, which is determined by a certain percentage of sales, is not included in the lease payment and is recorded into the current profit and loss when it actually occurs. The Company will be paid from the balance sheet date within one year (including one year) of the lease liabilities, as a non-current liabilities due within one year.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

The right-of-use assets of the Company including leased houses and buildings, plant and machinery equipment, means of transport and others. The right-of-use assets are initially measured at cost, which includes the initial measurement of the lease liability, the lease payment paid on or before the lease period, the initial direct expenses, etc., and deducts the lease incentive received. Where the Company is able to reasonably determine the ownership of the leased assets upon the expiration of the lease term, depreciation of the leased assets shall be calculated and withdrawn within the remaining service life of the leased assets; If it is not reasonable to determine whether the ownership of the leased asset can be acquired at the end of the lease term, the depreciation shall be calculated within the shorter period between the lease term and the remaining useful life of the leased asset. When the recoverable amount is lower than the book value of the asset, the Company writes down the book value to the recoverable amount.

For short-term leases with a lease term of no more than 12 months, the Company chooses not to recognize the right-of-use assets and lease liabilities, and records the relevant rental expenses into the current profits and losses or related asset costs according to the straight-line.

(7)	Intangible assets

Intangible assets are stated in the balance sheet at cost less accumulated amortization (where the estimated useful life is finite) and impairment losses (see Note 3(11)(b)).

For an intangible asset with finite useful life, its cost less estimated residual value and accumulated asset impairment losses is amortized using the straight-line method over its estimated useful life. The respective amortization periods for such intangible assets are as follows:


	Amortization period
Land use rights		47 years
Patents		10 years
Software		2 to 10 years

Useful lives and amortization methods of intangible asset with finite useful life are reviewed at least at each year-end.

If the acquisition costs of the land use rights and the buildings located thereon cannot be reasonably allocated between the land use rights and the buildings, all of the acquisition costs are recognized as fixed assets.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(8)	Research and development

The expenditure on an internal research and development project is classified into expenditure on the research phase and expenditure on the development phase based on its nature and whether there is material uncertainty that the research and development activities can form an intangible asset at the end of the project.

Expenditure on the research phase is recognized in profit or loss in the period in which it is incurred. Expenditure on the development phase is capitalized only if all of the following conditions are satisfied:

•

it is technically feasible to complete the intangible asset so that it will be available for use or sale;

•

management intends to complete the intangible asset, and use or sell it;

•

it can be demonstrated how the intangible asset will generate economic benefits;

•

there are adequate technical, financial and other resources to complete the development and the ability to use or sell the intangible asset; and

•

the expenditure attributable to the intangible asset

Other development expenditures that do not meet the conditions above are recognized in profit or loss in the period in which they are incurred. Development costs previously recognized as expenses are not recognized as an asset in a subsequent period. Capitalized expenditure on the development phase is presented as development costs in the balance sheet and transferred to intangible assets at the date that the asset is ready for its intended use.

When an enterprise sells products or by-products produced in the course of research and development, the proceeds and related cost are accounted for in accordance with CAS 14 – Revenue and CAS 1 - Inventories respectively, and recognised in profit or loss for the current period.

(9)	Long-term deferred expenses

Long-term prepaid expenses mainly include the catalyst expenditures that have been incurred but should be recognized as expenses over more than one year in the current and subsequent periods. Long-term prepaid expenses are amortized on the straight-line basis over the expected beneficial period and are presented at actual expenditure net of accumulated amortization.

Catalysts are amortized on the straight-line basis over their useful lives of 1.5 to 10 years.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(10)	Financial instruments

Financial instruments include cash at bank and on hand, receivables, payables, paid-in capital and etc.

(a)

Recognition and initial measurement of financial assets and financial liabilities

A financial asset or financial liability is recognized in the balance sheet when the Company becomes a party to the contractual provisions of a financial instrument.

A financial asset or financial liability is measured initially at fair value. For financial assets and financial liabilities at fair value through profit or loss, any related directly attributable transaction costs are charged to profit or loss; for other categories of financial assets and financial liabilities, any related directly attributable transaction costs are included in their initial costs. A trade receivable, without significant financing component or practical expedient applied for one year or less contracts, is initially measured at the transaction price in accordance with Note 3(16).

(b)

Classification and subsequent measurement of financial assets

(i)

Classification of financial assets

The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. On initial recognition, a financial asset is classified as measured at amortized cost, at fair value through other comprehensive income (“FVOCI”), or at fair value through profit or loss (“FVTPL”).

Financial assets are not reclassified subsequent to their initial recognition unless the Company changes its business model for managing financial assets in which case all affected financial assets are reclassified on the first day of the first reporting period following the change in the business model.

A financial asset is measured at amortized cost if it meets both of the following conditions and is not designated as at FVTPL:

•

it is held within a business model whose objective is to hold assets to collect contractual cash flows; and

•

its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

A debt investment is measured at FVOCI if it meets both of the following conditions and is not designated as at FVTPL:

•

it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and

•

its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

On initial recognition of an equity investment that is not held for trading, the Company may irrevocably elect to present subsequent changes in the investment’s fair value in other comprehensive income. This election is made on an investment-by-investment basis. The instrument meets the definition of equity from the perspective of the issuer.

All financial assets not classified as measured at amortized cost or FVOCI as described above are measured at FVTPL. On initial recognition, the Company may irrevocably designate a financial asset that otherwise meets the requirements to be measured at amortized cost or at FVOCI as at FVTPL if doing so eliminates or significantly reduces an accounting mismatch that would otherwise arise.

The business model refers to how the Company manages its financial assets in order to generate cash flows. That is, the Company’s business model determines whether cash flows will result from collecting contractual cash flows, selling financial assets or both. The Company determines the business model for managing the financial assets according to the facts and based on the specific business objective for managing the financial assets determined by the Company’s key management personnel.

In assessing whether the contractual cash flows are solely payments of principal and interest, the Company considers the contractual terms of the instrument. For the purposes of this assessment, ‘principal’ is defined as the fair value of the financial asset on initial recognition. ‘Interest’ is defined as consideration for the time value of money and for the credit risk associated with the principal amount outstanding during a particular period of time and for other basic lending risks and costs, as well as a profit margin. The Company also assesses whether the financial asset contains a contractual term that could change the timing or amount of contractual cash flows such that it would not meet this condition.

(ii)

Subsequent measurement of financial assets

•

Financial assets at FVTPL

These financial assets are subsequently measured at fair value. Net gains and losses, including any interest or dividend income, are recognized in profit or loss unless the financial assets are part of a hedging relationship.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

•

Financial assets at amortized cost

These assets are subsequently measured at amortized cost using the effective interest method. A gain or loss on a financial asset that is measured at amortized cost and is not part of a hedging relationship shall be recognized in profit or loss when the financial asset is derecognized, reclassified, through the amortization process or in order to recognize impairment gains or losses.

•

Debt investments at FVOCI

These assets are subsequently measured at fair value. Interest income calculated using the effective interest method, impairment and foreign exchange gains and losses are recognized in profit or loss. Other net gains and losses are recognized in other comprehensive income. On derecognition, gains and losses accumulated in other comprehensive income are reclassified to profit or loss.

•

Equity investments at FVOCI

These assets are subsequently measured at fair value. Dividends are recognized as income in profit or loss. Other net gains and losses are recognized in other comprehensive income. On derecognition, gains and losses accumulated in other comprehensive income are reclassified to retained earnings.

(c)

Classification and subsequent measurement of financial liabilities

Financial liabilities are classified as measured at FVTPL or amortized cost.

•

Financial liabilities at FVTPL

A financial liability is classified as at FVTPL if it is classified as held-for-trading (including derivative financial liability) or it is designated as such on initial recognition.

Financial liabilities at FVTPL are subsequently measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss, unless the financial liabilities are part of a hedging relationship.

•

Financial liabilities at amortized cost

These financial liabilities are subsequently measured at amortized cost using the effective interest method.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(d)

Offsetting

Financial assets and financial liabilities are generally presented separately in the balance sheet, and are not offset. However, a financial asset and a financial liability are offset and the net amount is presented in the balance sheet when both of the following conditions are satisfied:

•

the Company currently has a legally enforceable right to set off the recognized amounts;

•

the Company intends either to settle on a net basis, or to realize the financial asset and settle the financial liability simultaneously.

(e)

Derecognition of financial assets and financial liabilities

Financial asset is derecognized when one of the following conditions is met:

•

the Company’s contractual rights to the cash flows from the financial asset expire;

•

the financial asset has been transferred and the Company transfers substantially all of the risks and rewards of ownership of the financial asset; or

•

the financial asset has been transferred, although the Company neither transfers nor retains substantially all of the risks and rewards of ownership of the financial asset, it does not retain control over the transferred asset.

Where a transfer of a financial asset in its entirety meets the criteria for derecognition, the difference between the two amounts below is recognized in profit or loss:

•

the carrying amount of the financial asset transferred measured at the date of derecognition;

•

the sum of the consideration received from the transfer and, when the transferred financial asset is a debt investment at FVOCI, any cumulative gain or loss that has been recognized directly in other comprehensive income for the part derecognized.

The Company derecognizes a financial liability (or part of it) only when its contractual obligation (or part of it) is extinguished.

(f)

Equity instrument

The consideration received from the issuance of equity instruments net of transaction costs is recognized in owners’ equity. Consideration and transaction costs paid by the Company for repurchasing self-issued equity instruments are deducted from owners’ equity.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(11)	Impairment of assets

Except for impairment of assets set out in Notes 3(3) and (15), impairment of assets is accounted for using the following principles:

(a)

Impairment of financial instruments

The Company recognizes loss allowances for expected credit loss (ECL) on:

•

financial assets measured at amortized cost;

•

debt investments measured at FVOCI.

Measurement of ECLs

ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of all cash shortfalls (i.e. the difference between the cash flows due to the entity in accordance with the contract and the cash flows that the Company expects to receive).

The maximum period considered when estimating ECLs is the maximum contractual period (including extension options) over which the Company is exposed to credit risk.

Lifetime ECLs are the ECLs that result from all possible default events over the expected life of a financial instrument.

12-month ECLs are the portion of ECLs that result from default events that are possible within the 12 months after the balance sheet date (or a shorter period if the expected life of the instrument is less than 12 months).

Loss allowances for trade receivables are always measured at an amount equal to lifetime ECL. ECLs on these financial assets are estimated using a provision matrix based on the Company’s historical credit loss experience, adjusted for factors that are specific to the debtors and an assessment of both the current and forecast general economic conditions at the balance sheet date.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Except for trade receivables, the Company measures loss allowance at an amount equal to 12-month ECL for the following financial instruments, and at an amount equal to lifetime ECL for all other financial instruments.

•

If the financial instrument is determined to have low credit risk at the balance sheet date;

•

If the credit risk on a financial instrument has not increased significantly since initial recognition.

Financial instruments that have low credit risk

The credit risk on a financial instrument is considered low if the financial instrument has a low risk of default, the borrower has a strong capacity to meet its contractual cash flow obligations in the near term and adverse changes in economic and business conditions in the longer term may, but will not necessarily, reduce the ability of the borrower to fulfil its contractual cash flow obligations.

Significant increases in credit risk

In assessing whether the credit risk of a financial instrument has increased significantly since initial recognition, the Company compares the risk of default occurring on the financial instrument assessed at the balance sheet date with that assessed at the date of initial recognition.

When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when estimating ECL, the Company considers reasonable and supportable information that is relevant and available without undue cost or effort, including forward-looking information. In particular, the following information is taken into account:

•

failure to make payments of principal or interest on their contractually due dates;

•

an actual or expected significant deterioration in a financial instrument’s external or internal credit rating (if available);

•

an actual or expected significant deterioration in the operating results of the debtor; and;

•

existing or forecast changes in the technological, market, economic or legal environment that have a significant adverse effect on the debtor’s ability to meet its obligation to the Company.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

The Company assumes that the credit risk on a financial asset has increased significantly if it is more than 30 days past due.

The Company considers a financial asset to be in default when:

•

the borrower is unlikely to pay its credit obligations to the Company in full, without recourse by the Company to actions such as realizing security (if any is held); or

•

the financial asset is more than 90 days past due.

Credit-impaired financial assets

At each balance sheet date, the Company assesses whether financial assets carried at amortized cost and debt investments at FVOCI are credit-impaired. A financial asset is ‘credit-impaired’ when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred. Evidence that a financial asset is credit-impaired includes the following observable data:

•

significant financial difficulty of the borrower or issuer;

•

a breach of contract, such as a default in interest or principal payments;

•

for economic or contractual reasons relating to the borrower’s financial difficulty, the Company having granted to the borrower a concession that would not otherwise consider;

•

it is probable that the borrower will enter bankruptcy or other financial reorganization; or

•

the disappearance of an active market for that financial asset because of financial difficulties.

Presentation of allowance for ECL

ECLs are remeasured at each balance sheet date to reflect changes in the financial instrument’s credit risk since initial recognition. Any change in the ECL amount is recognized as an impairment gain or loss in profit or loss. The Company recognizes an impairment gain or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for debt investments that are measured at FVOCI, for which the loss allowance is recognized in other comprehensive income.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Write-off

The gross carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. A write-off constitutes a derecognition event. This is generally the case when the Company determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the write-off. However, financial assets that are written off could still be subject to enforcement activities in order to comply with the Company’s procedures for recovery of amounts due.

Subsequent recoveries of an asset that was previously written off are recognized as a reversal of impairment in profit or loss in the period in which the recovery occurs.

(b)

Impairment of other assets

The carrying amounts of the following assets are reviewed at each balance sheet date based on internal and external sources of information to determine whether there is any indication of impairment:

•

fixed assets

•

construction in progress

•

right-of-use assets

•

intangible assets

•

long-term deferred expenses.

If any indication exists, the recoverable amount of the asset is estimated.

An asset group is composed of assets directly related to cash generation and is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or asset groups.

The recoverable amount of an asset (or asset group, set of asset groups) is the higher of its fair value (see Note 3(12)) less costs to sell and its present value of expected future cash flows.

The present value of expected future cash flows of an asset is determined by discounting the future cash flows, estimated to be derived from continuing use of the asset and from its ultimate disposal, to their present value using an appropriate pre-tax discount rate.

An impairment loss is recognized in profit or loss when the recoverable amount of an asset is less than its carrying amount. A provision for impairment of the asset is recognized accordingly. Impairment losses related to an asset group or a set of asset groups are to reduce the carrying amount of the other assets in the asset group or set of asset groups on a pro rata basis. However, such allocation would not reduce the carrying amount of an asset below the highest of its fair value less costs to sell (if measurable), its present value of expected future cash flows (if determinable) and zero.

Once an impairment loss is recognized, it is not reversed in a subsequent period.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(12)	Fair value measurement

Unless otherwise specified, the Company measures fair value as follows:

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

When measuring fair value, the Company takes into account the characteristics of the particular asset or liability (including the condition and location of the asset and restrictions, if any, on the sale or use of the asset) that market participants would consider when pricing the asset or liability at the measurement date, and uses valuation techniques that are appropriate in the circumstances and for which sufficient data and other information are available to measure fair value. Valuation techniques mainly include the market approach, the income approach and the cost approach.

(13)	Employee benefits

Employee benefits refer to all forms of consideration or compensation given by the Company in exchange for service rendered by employees or for termination of employment relationship, which include short-term employee benefits, post-employment benefits, termination benefits and other long-term employee benefits.

(a)

Short-term employee benefits

Short-term employee benefits include employee wages or salaries, bonus, allowances and subsidies, staff welfare, premiums or contributions on medical insurance, work injury insurance and maternity insurance, housing funds, union running costs and employee education costs. The short term employee benefits actually occurred are recognized as a liability in the accounting period in which the service is rendered by the employees, with a corresponding charge to the profit or loss for the current period or the cost of relevant assets. Non-monetary benefits are measured at fair value.

(b)

Post-employment benefits

The Company classifies post-employment benefit plans as either defined contribution plans or defined benefit plans. Defined contribution plans are post-employment benefit plans under which the Company pays fixed contributions into a separate fund and will have no obligation to pay further contributions; and defined benefit plans are post-employment benefit plans other than defined contribution plans. During the reporting period, the Company’s post-employment benefits mainly include the premiums or contributions on basic pensions and unemployment insurance, both of which belong to defined contribution plans.

Basic pensions

The Company’s employees participate in the basic pension plan set up and administered by local authorities of Ministry of Human Resource and Social Security. Monthly payments of premiums on the basic pensions are calculated according to prescribed bases and percentages by relevant local authorities. When employees retire, the relevant local authorities are obliged to pay the basic pensions to them. The amounts based on the above calculations are recognized as liabilities in the accounting period in which the service has been rendered by the employees, with a corresponding charge to the profit or loss for the current period or the cost of relevant assets.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(c)

Termination benefits

The Company provides compensation for terminating the employment relationship with employees before the end of the employment contracts or as an offer to encourage employees to accept voluntary redundancy before the end of the employment contracts. The Company recognizes a liability arising from compensation for termination of the employment relationship with employees, with a corresponding charge to profit or loss for the current period at the earlier of the following dates: 1) when the Company cannot unilaterally withdraw an employment termination plan or a curtailment proposal; 2) when the Company recognizes costs or expenses for a restructuring that involves the payment of termination benefits.

The termination benefits expected to be settled within one year since the balance sheet date are classified as current liabilities.

(14)	Provisions

Provisions for product warranties and onerous contracts, are recognized when the Company has a present obligation, it is probable that an outflow of economic benefits will be required to settle the obligation, and the amount of the obligation can be measured reliably.

A provision is initially measured at the best estimate of the expenditure required to settle the related present obligation. Factors surrounding a contingency, such as the risks, uncertainties and the time value of money, are taken into account as a whole in reaching the best estimate of a provision. Where the effect of the time value of money is material, the best estimate is determined by discounting the related future cash outflows. The increase in the discounted amount of the provision arising from passage of time is recognized as interest expense.

The carrying amount of provisions is reviewed at each balance sheet date and adjusted to reflect the current best estimate.

The provisions expected to be settled within one year since the balance sheet date are classified as current liabilities.

(15)	Income tax

Current tax and deferred tax are recognized in profit or loss.

Current tax is the expected tax payable calculated at the applicable tax rate on taxable income for the year, plus any adjustment to tax payable in respect of previous years.

At the balance sheet date, current tax assets and liabilities are offset only if the Company has a legally enforceable right to set them off and also intends either to settle on a net basis or to realise the asset and settle the liability simultaneously.

Deferred tax assets and liabilities arise from deductible and taxable temporary differences respectively, being the differences between the carrying amounts of assets and liabilities for financial reporting purposes and their tax bases, which include the deductible tax losses and

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

tax credits carried forward to subsequent periods. Deferred tax assets are recognized to the extent that it is probable that future taxable profits will be available against which deductible temporary differences can be utilized.

At the balance sheet date, deferred tax is measured based on the tax consequences that would follow from the expected manner of recovery or settlement of the carrying amount of the assets and liabilities, using tax rates enacted at the balance sheet date that are expected to be applied in the period when the asset is recovered or the liability is settled.

The carrying amount of a deferred tax asset is reviewed at each balance sheet date, and is reduced to the extent that it is no longer probable that the related tax benefits will be utilized. Such reduction is reversed to the extent that it becomes probable that sufficient taxable profits will be available.

At the balance sheet date, deferred tax assets and liabilities are offset if all of the following conditions are met:

•

the taxable entity has a legally enforceable right to offset current tax liabilities and assets, and

•

they relate to income taxes levied by the same tax authority on either:

•

the same taxable entity; or

•

different taxable entities which intend either to settle the current tax liabilities and assets on a net basis, or to realise the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered.

(16)	Revenue recognition

The Company shall, when the customer acquires control over the relevant goods or services, recognize the income at the amount of consideration to which it is expected to be entitled.

The following is the description of accounting policies regarding revenue from the Company’s principal activities:

(a)

Sales of goods

The Company manufactures and sells ethylene, polyethylene, styrene, polystyrene, propylene, acrylonitrile, polypropylene, butadiene, aromatic hydrocarbons and other chemical products and plastic raw materials to distributors. Sales are recognized when control of the products has transferred, being when the products are delivered to and accepted by the customer. The Company delivers the products to the specific location in accordance with the sales contract, and recognized as revenues when the customer confirms receipt of the products. Revenue excludes value added tax and is after deduction of any estimated trade discounts.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(17)	Government grants

Government grants refer to the monetary or non-monetary assets obtained by the Company from the government, including tax return and financial subsidy.

Government grants are recognized when the grants can be received and the Company can comply with all attached conditions. If a government grant is a monetary asset, it will be measured at the amount received or receivable. If a government grant is a non-monetary asset, it will be measured at its fair value. If it is unable to obtain its fair value reliably, it will be measured at its nominal amount.

Government grants related to assets refer to government grants which are obtained by the Company for the purposes of purchase, construction or acquisition of the long-term assets. Government grants related to income refer to the government grants other than those related to assets.

Government grants related to assets are either deducted against the carrying amount of the assets, or recorded as deferred income and recognized in profit or loss on a systemic basis over the useful lives of the assets. Government grants related to income that compensate the future costs, expenses or losses are recorded as deferred income and recognized in profit or loss, or deducted against related costs, expenses or losses in reporting the related expenses; government grants related to income that compensate the incurred costs, expenses or losses are recognized in profit or loss, or deducted against related costs, expenses or losses directly in current period. The Company applies the presentation method consistently to the similar government grants in the financial statements.

Government grants that are related to ordinary activities are included in operating profit, otherwise, they are recorded in non-operating income or expenses.

(18)	Safety production costs

The Company extracted safety production costs in accordance with the regulations, shall be charged in relevant costs or profit and loss, and in the specific reserve. When the Company use the specific reserve, safety production belong to expenses and directly offset the special reserves. If the costs formed into fixed assets, the special reserves shall be offset according to the cost forming into fixed assets, and recognize the same amount of accumulated depreciation. This fixed asset shall no longer accrue depreciation in the following period.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(19)	Profit distributions to owners

Distributions of profit proposed in the profit appropriation plan to be approved after the balance sheet date are not recognized as a liability at the balance sheet date but are disclosed in the notes separately.

(20)	Related parties

If a party has the power to control, jointly control or exercize significant influence over another party, or vice versa, or where two or more parties are subject to common control or joint control from another party, they are considered to be related parties. Related parties may be individuals or enterprises. Enterprises with which the Company is under common control only from the State and that have no other related party relationships are not regarded as related parties.

(21)	Significant accounting estimates and judgements

The Company continually evaluates the critical accounting estimates and key judgements applied based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

(a)

Critical judgments in applying the accounting policies

Classification of financial assets

The Company in determining the classification of financial assets involved in the major judgments including business model and contract cash flow characteristics of the analysis.

The Company determines the business model of managing financial assets at the level of financial asset portfolio, taking into account such factors as the way of evaluating and reporting the performance of financial assets to key managers, the risk and management methods that affect the performance of financial assets, and the ways in which relevant business managers are paid, etc.

When the Company evaluates whether the contract cash flow of financial assets is consistent with the basic loan arrangement, there are the following main judgments: whether the time distribution or amount of principal may change within the duration due to prepayment or other reasons; whether interest include only the time value of money, credit risk, other basic lending risks, and consideration of costs and profits. For example, whether the prepayment amount reflect only the principal outstanding and the interest based on the principal outstanding, as well as the reasonable compensation paid for the early termination of the contract.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(b)

Critical accounting estimates and key assumptions

The critical accounting estimates and key assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next accounting year are outlined below:

(i)

Estimated useful lives and net residual values of fixed assets and other long-term assets

The Company assessed the estimated useful lives of fixed assets and other long-term assets in line with historical experience based on the actual useful lives of assets with similar nature or function. If there are significant changes in estimated useful lives and net residual values, depreciation or amortization expenses for future periods are adjusted.

(ii)

Provision for decline in the value of inventories

Any excess of the cost over the net realizable value of each item of inventories is recognized as a provision for decline in the value of inventories. Net realizable value is determined based on the estimated selling price in the ordinary course of business, less the estimated costs to completion and estimated costs necessary to make the sale and related taxes. Management bases the estimates on all available information, including the current market prices of the finished goods and raw materials, costs to completion, costs necessary to make the sale and related taxes. If the actual selling prices are lower or the costs to completion are higher than estimated, the actual allowance for decline in the value of inventories would be higher than estimated.

(iii)

Income taxes

As there are some transactions and events for which the ultimate tax determination is uncertain during the ordinary course of business, significant judgement is required from the Company in determining the provision for income taxes. Where the final tax outcome of these matters is different from the amounts that were initially recorded, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.

(iv)

Impairments for non-current assets

At the end of each reporting period, the Company tests for impairment for non-current assets for which certain events or changes in circumstances indicate that the carrying amount may not be recoverable. If circumstances indicate that the carrying amount of non-current assets may not be recoverable, an impairment loss may be recognized in profit or loss for the excess of the carrying amounts over the recoverable amounts.

The recoverable amount of an asset or a cash-generating unit (“CGU”) (a portion of which related to certain production facilities) are the higher of the fair value less costs of disposal and value in use. In estimating the present value of future cash flows, significant judgments are required regarding the volume of production, selling price,

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

related operating costs and discount rate to be used in calculating the present value of the asset or CGUs. In estimating recoverable amounts, the Company uses all relevant information available, including projections of production volumes, selling prices and related operating costs based on reasonable and supportable assumptions.

4	Changes in accounting policies

In 2022, the Company has adopted the revised accounting requirements and guidance under CAS newly issued by the Ministry of Finance (“MOF”) as follows :

•

“Accounting for selling outputs that are produced before fixed assets are available for intended use or produced in the course of research and development” (“accounting for sales before intended use”) in CAS Bulletin No.15 (Caikuai [2021] No.35)

•

“Determining whether a contract is onerous” in CAS Bulletin No.15

•

Notice of Application Issues for Accounting Treatment of COVID-19-Related Rent Concessions (Caikuai [2022] No.13)

(1)	Accounting for sales before intended use

In accordance with CAS Bulletin No.15, the Company accounts for the proceeds and related cost arising from the sale of products or by-products produced before the fixed asset is available for its intended use and in the course of research and development (“sales before intended use”) in accordance with CAS 14 – Revenue and CAS 1 – Inventories respectively, and recognises them in profit or loss for the current period. The net amount of proceeds from such sales before intended use less related costs is no longer offset against the cost of the fixed asset or research and development expenditure.

These provisions are effective from 1 January 2022. The Company has made retrospective adjustments in accordance with these provisions for sales before intended use occurring between 1 January 2021 and the date of initial implementation.

The adoption of Bulletin No.15 does not have a significant effect on the financial position and financial performance of the Company.

(2)	“Determining whether a contract is onerous”

In accordance with CAS Bulletin No.15, when determining whether a contract is onerous, the Company includes in its estimated cost of fulfilling the contract the amount of the incremental cost of fulfilling the contract and the allocation of other costs directly attributable to fulfilling the contract.

The provisions in CAS Bulletin No. 15 on determining whether a contract is onerous are effective from 1 January 2022. The Company applied these provisions to contracts for which it has not yet fulfilled all its obligations as at 1 January 2022, and recognised the cumulative effect as an adjustment to the opening balance of retained earnings and other relevant financial statement items in the year of initial application. Comparative information is not restated.

The adoption of Bulletin No.15 does not have a significant effect on the financial position and financial performance of the Company.

(3)	Caikuai [2022] No.13

The Accounting Treatment of COVID-19-Related Rent Concessions (Caikuai [2020] No.10) provides a practical expedient under certain conditions for rent concessions occurring as a direct consequence of the COVID-19 pandemic. According to the provisions of Caikuai [2022] No.13, the practical expedient of Caikuai [2020] No.10 can continue to apply to eligible reduction in lease payments that are originally due after 30 June 2022.

The Company adopted the above regulation on 1 January 2022 with retrospective adjustments. The cumulative effects have been adjusted to the opening balance of retained earnings and other relevant line items in the financial statements for the year 2022. Comparative information is not restated.

The adoption of the above regulation does not have a significant effect on the financial position and financial performance of the Company.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Taxation

(1)	The types of taxes applicable to the Company’s include


Tax Name		Tax basis and applicable rate
Value added tax (“VAT”)		Output VAT is 6% or 9% or 13% of product sales and taxable services revenue, based on tax laws. The basis for VAT payable is to deduct input VAT from the output VAT for the period
City maintenance and construction tax		5% of VAT paid
Educational surcharge		3% of VAT paid
Local educational surcharge		2% of VAT paid

(2)	Income tax

The statutory income tax rate of the Company is 25%. The applicable income tax rate for the year is the statutory rate (2021: 25%).

Pursuant to the “Circular on Enterprise Income Tax Policy concerning Deductions for Equipment and Appliances”(Cai Shui [2018] 54) issued by the State Administration of Taxation, during the period from 1 January 2018 to 31 December 2020, the cost of newly purchased equipment with the original cost less than RMB 5 million can be fully deducted against taxable profit in the next month after the asset is put into use, instead of being depreciated annually for tax filing.

(3)	Taxes payable


	31 December 2021		31 December 2022
	RMB		RMB
Unpaid VAT		63,240,335		—
Enterprise income tax payable		173,463,260		—
Environmental tax payable		65,275,459		64,873,290
Educational surcharge payable		3,162,017		—
Individual income tax payable		5,008,019		4,309,517
City maintenance and construction tax payable		3,162,016		—
Unpaid stamp tax		2,065,124		1,980,181
Property tax payable		—		1,493,040
Unpaid land use tax		749,983		749,983

Total		316,126,213		73,406,011

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

6	Cash at bank and on hand AND


	31 December 2021		31 December 2022
	RMB		RMB
Deposits with banks
- RMB		3,246,711,253		1,282,704,723
- USD (translated into RMB)		36,039,789		39,726,746
Other cash balances		—		—

Total		3,282,751,042		1,322,431,469

Cash and cash equivalents listed in the cash flow statement:


	31 December 2021		31 December 2022
	RMB		RMB
Cash at bank		3,282,751,042		1,322,431,469
Less: Time deposit (a)		950,000,000		534,823,000

Cash and cash equivalents		2,332,751,042		787,608,469

(a)

As at 31 December 2022, time deposits represent time deposit at bank of one year to three years of maturity which will expire within one year, and the annual interest rate is 3.784% to 5.110% (31 December 2021: time deposit at bank of 18 months to three years of maturity which will expire within one year, and the annual interest rates are from 3.192% to 3.784%).

7	Accounts receivable

(1)	Accounts receivable by customer type:


	31 December 2021		31 December 2022
	RMB		RMB
Receivables due from related parties		33,850,641		57,609,762
Accounts receivable from third parties		225,436,156		175,079,004

Sub-total		259,286,797		232,688,766

Less: Provision for bad debts		7,756,885		7,756,885

Total		251,529,912		224,931,881

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(2)	The ageing analysis of accounts receivable is as follows:


	31 December 2021		31 December 2022
	RMB		RMB
Within 1 year (inclusive)		251,529,912		224,931,881
Over 1 year but within 2 years (inclusive)		—		—
Over 2 years but within 3 years (inclusive)		—		—
Over 3 years		7,756,885		7,756,885

Sub-total		259,286,797		232,688,766

Less: Provision for bad debts		7,756,885		7,756,885

Total		251,529,912		224,931,881

The ageing is counted starting from the date when accounts receivable are recognized.

(3)	Assessment of ECLs on accounts receivable:

For accounts receivables, regardless of whether exists the significant financing component, the Company measures the loss provision according to the lifetime expected credit losses.

(4)	Movements of provisions for bad debts:


	2020			2021		2022
	RMB			RMB		RMB
Balance at the beginning of the year		8,797,278			7,756,885		7,756,885
Additions during the year		—			—		—
Recoveries or reversals during the year		(1,040,393	)		—		—

Balance at the end of the year		7,756,885			7,756,885		7,756,885

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

8	Financial assets at fair value through other comprehensive income


	31 December 2021		31 December 2022
	RMB		RMB
Financial assets at fair value through other comprehensive income		260,065,209		212,655,800

(1)

Due to the requirement of cash management, the Company discounted and endorsed part of the bank acceptance notes. The business model of bank acceptance notes management is for the purpose of collecting cash flow of contracts and sales. Therefore, the Company classified all notes receivable to financial assets measured at fair value and whose changes are included in other comprehensive income.

(2)

The Company has no single provision for impairment of the bank acceptance notes, with all provision was accrued by their expected credit loss. As at 31 December 2022 and 31 December 2021, the Company considers that no bank acceptance notes has significant credit risk, and will not suffer significant loss due to the violation of banks.

(3)	As at 31 December 2022 and 31 December 2021, the Company had no unmatured notes receivable that have been endorsed or discounted.

9	Advances to suppliers


	31 December 2021		31 December 2022
	RMB		RMB
Advances to suppliers		22,771,842		55,368,985

As at 31 December 2022 and 31 December 2021, the Company’s prepayment mainly refers to the prepayment of goods purchase, the aging of which is within one year.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

10	Other receivables


	31 December 2021		31 December 2022
	RMB		RMB
Refund of consumption tax payable (a)		28,448,944		460,539,379
Property rental deposits		12,911,288		40,769,797
Others		16,200		115,525

Total		41,376,432		501,424,701

As at 31 December 2022 and 31 December 2021, all other receivables were aged within one year except for property rental deposits. No other receivables were past due but unimpaired. Provision for bad debts was not required as assessed by management of the Company.

(a)

According to regulations of the Interim Measures for Consumption Tax Refunding (Exempting) on Naphtha and Fuel Used in Production of Ethylene and Arene Chemical Products issued by the State Administration of Taxation, eligible enterprises, which use naphtha and fuel to produce ethylene and arene chemical products, can enjoy tax rebate for consumption tax. As at 31 December 2022, the Company could made a tax refund application to the local tax bureau and estimated that the consumption tax refund of RMB 460,539,379 would be received (31 December 2021: RMB 28,448,944 ).

11	Inventories

(1)	An analysis of inventories by category for the year is as follows:


	31 December 2021			31 December 2022
	RMB			RMB
Raw materials		1,321,363,602			1,378,708,801
Semi-finished products		555,997,481			483,437,116
Finished goods		333,877,632			502,732,687
Goods in transit		130,226,977			160,539,431

Sub-total		2,341,465,692			2,525,418,035

Less: Provision for decline in the value of inventories		(136,012,496	)		(234,704,376	)

Total		2,205,453,196			2,290,713,659

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(2)	An analysis of provision for decline in the value of inventories of the Company is as follows:


	Balance at 1 January 2020		Provision made for the year		Written back during the year Transferred out			Balance at 31 December 2020
	RMB		RMB		RMB			RMB
Raw materials		75,392,637		2,508,089		(5,600,250	)		72,300,476
Semi-finished products		4,834,979		2,752,574		(4,834,980	)		2,752,573
Finished goods		2,423,292		1,526,859		(2,423,291	)		1,526,860

Total		108,687,179		9,301,069		(35,337,340	)		82,650,908


	Balance at 1 January 2021		Provision made for the year		Written back during the year Transferred out			Balance at 31 December 2021
	RMB		RMB		RMB			RMB
Raw materials		72,300,476		26,762,508		(1,996,635	)		97,066,349
Semi-finished products		2,752,573		26,554,107		(2,752,574	)		26,554,106
Finished goods		1,526,860		12,392,039		(1,526,858	)		12,392,041

Total		76,579,909		65,708,654		(6,276,067	)		136,012,496


	Balance at 1 January 2022		Provision made for the year		Written back during the year Transferred out			Balance at 31 December 2022
	RMB		RMB		RMB			RMB
Raw materials		97,066,349		55,403,648		(44,068,193	)		108,401,804
Semi-finished products		26,554,106		112,266,867		(90,114,823	)		48,706,150
Finished goods		12,392,041		121,637,949		(56,433,568	)		77,596,422

Total		136,012,496		289,308,464		(190,616,584	)		234,704,376

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

12	Other current assets


	31 December 2021		31 December 2022
	RMB		RMB
Entrusted loans		—		—
Time deposits		—		—
Input tax to be deducted		—		333,711,035
Others		2,171,547		156,916

Total		2,171,547		333,867,951

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

13	Fixed assets


	Plant and buildings			Specialized machinery and equipment			General machinery and equipment			Office and other equipment			Motor vehicles			Machinery and equipment			Total
	RMB			RMB			RMB			RMB			RMB			RMB			RMB
Cost
Balance at 31 December 2020		1,362,400,848			19,928,699,797			—			—			11,598,267			250,758,393			21,553,457,305
Transfers from construction in progress (Note 14)		7,354,242			229,893,477			24,174,512			—			—			—			261,422,231
Other increases during the year		1,303,787			29,177,331			10,941,680			3,924,580			—			—			45,347,378
Reclassification during the year		104,437,291			(188,982,524	)		325,549,776			21,352,117			(11,598,267	)		(250,758,393	)		—
Disposals during the year		(991,050	)		(50,030,703	)		(7,908,577	)		(119,347	)		—			—			(59,049,677	)

Balance at 31 December 2021		1,474,505,118			19,948,757,378			352,757,391			25,157,350			—			—			21,801,177,237

Less: Accumulated depreciation
Balance at 31 December 2020		(969,634,784	)		(16,916,359,748	)		—			—			(4,208,383	)		(144,633,489	)		(18,034,836,404	)
Charge for the year		(45,718,875	)		(561,948,667	)		(33,774,586	)		(4,269,835	)		—			—			(645,711,963	)
Decrease during the year		329,819			38,258,737			7,569,715			116,707			—			—			46,274,978
Reclassification during the year		(77,210,951	)		127,193,874			(183,732,050	)		(15,092,745	)		4,208,383			144,633,489			—

Balance at 31 December 2021		(1,092,234,791	)		(17,312,855,804	)		(209,936,921	)		(19,245,873	)		—			—			(18,634,273,389	)

Carrying amounts
At 31 December 2021		382,270,327			2,635,901,574			142,820,470			5,911,477			—			—			3,166,903,848

At 31 December 2020		392,766,064			3,012,340,049			—			—			7,389,884			106,124,904			3,518,620,901


	Buildings			Specialized machinery and equipment			General machinery and equipment			Office and other equipment			Total
	RMB			RMB			RMB			RMB			RMB
Cost
Balance at 31 December 2021		1,474,505,118			19,948,757,378			352,757,391			25,157,350			21,801,177,237
Transfers from construction in progress (Note 14)		3,510,569			91,984,579			36,076,308			—			131,571,456
Other increases during the year		853,384			13,093,475			16,463,015			210,273			30,620,147
Reclassification during the year		—			(59,030	)		59,030			—			—
Disposals during the year		(914,921	)		(72,664,124	)		(5,876,258	)		(32,135	)		(79,487,438	)

Balance at 31 December 2022		1,477,954,150			19,981,112,278			399,479,486			25,335,488			21,883,881,402

Less: Accumulated depreciation
Balance at 31 December 2021		(1,092,234,791	)		(17,312,855,804	)		(209,936,921	)		(19,245,873	)		(19,083,565,018	)
Charge for the year		(42,791,317	)		(442,490,162	)		(37,548,490	)		(2,051,590	)		(524,881,559	)
Decrease during the year		347,247			69,534,840			5,687,388			20,455			75,589,930
Reclassification during the year		(4,176	)		4,176			(4,176	)		—			—

Balance at 31 December 2022		(1,134,678,861	)		(17,685,806,950	)		(241,802,199	)		(21,277,008	)		(18,034,836,404	)

Carrying amounts
At 31 December 2022		343,275,289			2,295,305,328			157,677,287			4,058,480			2,800,316,384

At 31 December 2021		382,270,327			2,635,901,574			142,820,470			5,911,477			3,166,903,848

In 2022, the amounts of depreciation expenses charged cost of sales, selling and distribution expenses, general and administrative expenses and research and development expenses were RMB 503,299,883, RMB 35,965, RMB 20,735,611 and RMB 810,100 (2021: RMB 625,441,687, RMB 235,451, RMB 19,521,193 and RMB 513,632 ), respectively.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

14	Construction in progress


	RMB
Cost
Balance at 1 January 2021		366,781,634
Additions during the year		220,463,538
Transferred to fixed assets (note 13)		(261,422,231	)
Decrease due to other reasons		(19,425,759	)
Transferred to intangible assets (note 16)		(41,094,302	)

Balance at 31 December 2021		265,302,880


Less: Provision for impairment
Balance at 1 January and 31 December 2020		—
Charge for the year		(61,805,108	)

Balance at 31 December 2021		(61,805,108	)

Carrying amounts
At 31 December 2021		203,497,772

At 31 December 2020		366,781,634


	RMB
Cost
Balance at 1 January 2022		265,302,880
Additions during the year		368,877,517
Transferred to fixed assets (note 13)		131,571,456
Decrease due to other reasons		—
Transferred to intangible assets (note 16)		18,897,367

Balance at 31 December 2022		483,711,574


Less: Provision for impairment
Balance at 1 January 2022 and 31 December 2021		(61,805,108	)
Charge for the year		—

Balance at 31 December 2022		(61,805,108	)

Carrying amounts
At 31 December 2022		421,906,466

At 31 December 2021		203,497,772

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

The construction in progress balance of the Company is mainly production and environmental protection equipment installation programs.

15	Right-of-use assets

(1)	As a lessee


	Buildings			Vehicles and other equipments			Total
	RMB			RMB			RMB
Cost
Balance at 1 January 2021		10,704,710			323,880			11,028,590
Decrease during the year		(5,994,638	)		(71,973	)		(6,066,611	)

Balance at 31 December 2021		4,710,072			251,907			4,961,979

Less: Accumulated depreciation
Balance at 1 January 2021		(5,138,260	)		(53,980	)		(5,192,240	)
Amortization during the year		(5,360,384	)		(108,255	)		(5,468,639	)
Decrease during the year		5,994,638			71,973			6,066,611

Balance at 31 December 2021		(4,504,006	)		(90,262	)		(4,594,268	)

Carrying amounts
At 31 December 2021		206,066			161,645			367,711

At 31 December 2020		5,566,450			269,900			5,836,350


	Buildings			Vehicles and other equipments			Total
	RMB			RMB			RMB
Cost
Balance at 1 January 2022		4,710,072			251,907			4,961,979
Decrease during the year		(4,710,072	)		—			(4,710,072	)

Balance at 31 December 2022		—			251,907			251,907

Less: Accumulated depreciation
Balance at 1 January 2022		(4,504,006	)		(90,262	)		(4,594,268	)
Amortization during the year		(206,066	)		(107,960	)		(314,026	)
Decrease during the year		4,710,072			—			4,710,072

Balance at 31 December 2022		—			(198,222	)		(198,222	)

Carrying amounts
At 31 December 2022		—			53,685			53,685

At 31 December 2021		206,066			161,645			367,711

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

16	Intangible assets


	Land use rights			Patents			Software			Total
	RMB			RMB			RMB			RMB
Cost
Balance at 31 December 2020		770,966,668			1,024,953,159			208,052,638			2,003,972,465
- Additions during the year		—			—			3,065,615			3,065,615
- Transferred from construction in progress (Note 14)		—			—			41,094,302			41,094,302

Balance at 31 December 2021		770,966,668			1,024,953,159			252,212,555			2,048,132,382

Less: Accumulated amortization
Balance at 31 December 2020		(261,641,497	)		(973,852,833	)		(131,696,368	)		(1,367,190,698	)
Provision during the year		(16,429,844	)		(11,201,198	)		(25,805,506	)		(53,436,548	)

Balance at 31 December 2021		(278,071,341	)		(985,054,031	)		(157,501,874	)		(1,420,627,246	)

Carrying amounts
At 31 December 2021		492,895,327			39,899,128			94,710,681			627,505,136

At 31 December 2020		509,325,171			51,100,326			76,356,270			636,781,767


	Land use rights			Patents			Software			Total
	RMB			RMB			RMB			RMB
Cost
Balance at 31 December 2021		770,966,668			1,024,953,159			252,212,555			2,048,132,382
- Additions during the year		—			—			871,550			871,550
- Transferred from construction in progress (Note 14)		—			—			18,897,367			18,897,367

Balance at 31 December 2022		770,966,668			1,024,953,159			271,981,472			2,067,901,299

Less: Accumulated amortization
Balance at 31 December 2021		(278,071,341	)		(985,054,031	)		(157,501,874	)		(1,420,627,246	)
Provision during the year		(16,429,846	)		(10,857,525	)		(29,070,681	)		(56,358,052	)

Balance at 31 December 2022		(294,501,187	)		(995,911,556	)		(186,572,555	)		(1,476,985,298	)

Carrying amounts
At 31 December 2022		476,465,481			29,041,603			85,408,917			590,916,001

At 31 December 2021		492,895,327			39,899,128			94,710,681			627,505,136

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

17	Long-term prepaid expenses


	Balance at 31 December 2020		Additions during the year		Amortization during the year			Balance at 31 December 2021
	RMB		RMB		RMB			RMB
Catalyst		170,066,390		18,596,307		(53,648,348	)		135,014,349
Improvements to fixed assets held under operating leases		1,038,509		—		(1,038,509	)		—

		171,104,899		18,596,307		(54,686,857	)		135,014,349


	Balance at 31 December 2021		Additions during the year		Amortization during the year			Balance at 31 December 2022
	RMB		RMB		RMB			RMB
Catalyst		135,014,349		17,903,167		(50,208,129	)		102,709,387

		135,014,349		17,903,167		(50,208,129	)		102,709,387

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

18	Deferred tax assets and liabilities


	Deferred tax assets/(liabilities)
	Balance at the beginning of 2021			Current year increase/ decrease charged to profit or loss			Balance at the end of 2021
	RMB			RMB			RMB
Provision for decline in the value of inventories		19,144,978			14,858,147			34,003,125
Provision for impairment of fixed assets and construction in progress		—			15,451,277			15,451,277
Bad debt provision for accounts receivables		1,939,221			—			1,939,221
Accrued environmental tax		15,909,685			—			15,909,685
Sales cut-off adjustments		9,540,273			(9,540,273	)		—
Difference in depreciation of fixed assets		3,289,597			66,809,389			70,098,986
Undeclared assets disposals		3,241,760			1,998,953			5,240,713
Differences in amortization of long - term prepaid expenses		1,549,097			(1,531,005	)		18,092
Difference in depreciation of fixed assets		(86,917,981	)		(7,451,592	)		(94,369,573	)

Total		(32,303,370	)		80,594,896			48,291,526


	Deferred tax assets/(liabilities)
	Balance at the beginning of 2022			Current year increase/ decrease charged to profit or loss			Balance at the end of 2022
	RMB			RMB			RMB
Provision for decline in the value of inventories		34,003,125			24,672,969			58,676,094
Provision for impairment of fixed assets and construction in progress		15,451,277			—			15,451,277
Bad debt provision for accounts receivables		1,939,221			—			1,939,221
Accrued environmental tax		15,909,685			—			15,909,685
Difference in depreciation of fixed assets (deferred tax assets)		70,098,986			(3,015,224	)		67,083,762
Undeclared assets disposals		5,240,713			53,145			5,293,858
Differences in amortization of long - term prepaid expenses		18,092			81,416			99,508
Deductible loss		—			648,529,795			648,529,795

Other assets		—			75,000			75,000
Difference in depreciation of fixed assets		(94,369,573	)		(19,962,338	)		(114,331,911	)
Total		48,291,526			650,434,763			698,726,289

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

At the balance sheet date, the deferred tax assets and liabilities on the balance sheet, after offsetting each other, were as follows:


	31 December 2021		31 December 2022
	RMB		RMB
Deferred tax assets, net		48,291,526		698,726,289
Deferred tax liabilities, net		—		—

Total		48,291,526		698,726,289

19	Other non-current assets


	31 December 2021		31 December 2022
	RMB		RMB
Bank deposits
- Agricultural bank of China (1)		500,000,000		—
Time deposits
- China Everbright Bank (2)		500,000,000		500,000,000
- China Industrial Bank (3)		500,000,000		500,000,000
Construction materials		34,874,025		—
Prepayment for machineries		18,905,344		68,780,880

Total		1,553,779,369		1,068,780,880

(1)	As at 31 December 2021, bank deposits included three year deposit of RMB 500,000,000 in Agricultural Bank of China, Shanghai Jinshan branch, with an annual interest rate of 3.784%, which will be due on 28 December 2023.

(2)	As at 31 December 2022, time deposits of RMB 500,000,000 (31 December 2021: RMB 500,000,000 ) was three-year deposit in China Everbright Bank, Shanghai Nanshi branch, with an annual interest rate of 3.700%, which will be due on 1 February 2024.

(3)	As at 31 December 2022, time deposits of RMB 500,000,000 (31 December 2021: RMB 500,000,000 ) was three-year deposit in China Industrial Bank, Shanghai branch, with an annual interest rate of 3.650%, which will be due on 5 January 2024.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

20.	Short-term borrowings


	2022		2021
	RMB		RMB
Credit loans		6,608,867,012		—

As at 31 December 2022,the interest rate of short-term borrowings is from 2.85% to 2.95% (31 December 2021: Nil).

As at 31 December 2022, the Company had no overdue short-term borrowings.

21	Contract liabilities


	31 December 2021		31 December 2022
	RMB		RMB
Advances from customers		415,450,821		434,327,898

22	Employee benefits payable


	Note		31 December 2021		31 December 2022
	Note		RMB		RMB
Short-term employee benefits		(1)		99,965,532		95,035,491
Defined contribution plans payable		(2)		5,607,808		6,066,607

Total				105,573,340		101,102,098

(1)	Short-term employee benefits


	Balance at 1 January 2021		Accrued during the year		Paid during the year			Balance at 31 December 2021
	RMB		RMB		RMB			RMB
Wages and salaries, bonus, allowances and subsidies		20,000,000		404,673,606		(404,673,606	)		20,000,000
Staff welfare		—		17,329,504		(17,329,504	)		—
Social security contributions		4,653,102		33,831,726		(35,632,799	)		2,852,029
- Medical insurance		3,695,473		29,375,245		(30,679,767	)		2,390,951
- Work injury insurance		421,434		2,027,544		(2,239,580	)		209,398
- Maternity insurance		536,195		2,428,937		(2,713,452	)		251,680
Housing fund		—		34,551,223		(34,551,223	)		—
Labour union fee		832,226		7,924,676		(7,927,121	)		829,781
Employee education funds		—		5,467,918		(5,467,918	)		—
Employees’ bonus and welfare fund		76,283,722		—		—			76,283,722
Termination benefits		—		501,130		(501,130	)		—

Total		101,769,050		504,279,783		(506,083,301	)		99,965,532

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)


	Balance at 1 January 2022		Accrued during the year		Paid during the year			Balance at 31 December 2022
	RMB		RMB		RMB			RMB
Wages and salaries, bonus, allowances and subsidies		20,000,000		450,222,847		(455,222,847	)		15,000,000
Staff welfare		—		15,779,913		(15,779,913	)		—
Social security contributions		2,852,029		39,066,877		(38,891,524	)		3,027,382
- Medical insurance		2,390,951		33,189,237		(33,064,822	)		2,515,366
- Work injury insurance		209,398		2,673,570		(2,650,438	)		232,530
- Maternity insurance		251,680		3,204,070		(3,176,264	)		279,486
Housing fund		—		38,486,039		(38,486,039	)		—
Labour union fee		829,781		9,046,777		(9,152,171	)		724,387
Employee education funds		—		3,272,558		(3,272,558	)		—
Employees’ bonus and welfare fund		76,283,722		—		—			76,283,722
Termination benefits		—		684,354		(684,354	)		—
Other		—		108,290		(108,290	)		—

Total		99,965,532		556,667,655		(561,597,696	)		95,035,491

(2)	Defined contribution plans payable


	Balance at 1 January 2021		Accrued during the year		Paid during the year			Balance at 31 December 2021
	RMB		RMB		RMB			RMB
Basic pensions		8,692,144		48,071,927		(52,737,206	)		4,026,865
Unemployment insurance		224,924		714,459		(813,543	)		125,840
Supplementary pensions		1,455,103		27,589,451		(27,589,451	)		1,455,103

Total		10,372,171		76,375,837		(81,140,200	)		5,607,808


	Balance at 1 January 2022		Accrued during the year		Paid during the year			Balance at 31 December 2022
	RMB		RMB		RMB			RMB
Basic pensions		4,026,865		51,431,431		(50,986,535	)		4,471,761
Unemployment insurance		125,840		1,609,543		(1,595,640	)		139,743
Supplementary pensions		1,455,103		30,392,732		(30,392,732	)		1,455,103

Total		5,607,808		83,433,706		(82,974,907	)		6,066,607

23	Other payables


	31 December 2021		31 December 2022
	RMB		RMB
Deposits		9,500,000		12,060,000
Capital reduction payable		2,650,165,871		—
Construction payable		92,861,068		254,245,705
Others		2,936,961		11,999,936

Total		2,755,463,900		278,305,641

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

24	Non-current liabilities maturing within one year


	Note	31 December 2021		31 December 2022
	Note	RMB		RMB
Lease liabilities maturing within one year	26		111,639		65,123

25	Other current liabilities


	31 December 2021		31 December 2022
	RMB		RMB
Output VAT to be recognized		54,008,607		56,462,627

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

26	Lease liabilities


	31 December 2021			31 December 2022
	RMB			RMB
Lease liabilities		177,386			66,932
Less: current portion of non-current liabilities (Note 24)		(111,639	)		(65,123	)

Total		65,747			1,809

As at 31 December 2022, the Company had no lease payments related to lease contracts which had been signed but not been executed (31 December 2021: Nil).

27	Paid-in capital

The Company’s paid-in capital and registered capital structure at 31 December is as follows:


	2021				2022
	Amount		%		Amount		%
	RMB				RMB
INEOS		—		—		1,557,590,000		50
Sinopec Corp		150,000,000		30		467,277,000		15
Gaoqiao Petrochemical		250,000,000		50		467,277,000		15
SPC		100,000,000		20		623,036,000		20

Total		500,000,000		100		3,115,180,000		100

According to the resolution of the first 15th Shareholders’ Meeting on 30 August 2022, the registered capital of the Company increased from RMB 500,000,000 to RMB 3,115,180,000, and the registered capital increased by RMB 2,615,180,000 through transfer from surplus reserve. Sinopec, Gaoqiao Petrochemical and Shanghai Petrochemical increased the capital according to the original shareholding ratio.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

28	Capital surplus


	31 December 2021 and 2022
	RMB
Other capital surplus
- Transferred from special payable		1,964,000
Foreign currency capital translation difference		(509,354	)

Total		1,454,646

29	Specific reserve


	2021			2022
	RMB			RMB
Balance at the beginning of the year		—			—
Increase during the year		28,523,706			41,419,862
Decrease during the year		(28,523,706	)		(41,419,862	)

Balance at the end of the year		—			—

30	Surplus reserve


	31 December 2020		Increase during the year		Decrease during the year		31 December 2021
	RMB		RMB		RMB		RMB
Reserve fund		133,718,997		—		—		133,718,997
Enterprise expansion fund		133,718,996		—		—		133,718,996
Statutory surplus reserve		1,422,522,825		312,590,386		—		1,735,113,211
Discretionary surplus reserve		1,050,222,081		—		—		1,050,222,081

		2,740,182,899		312,590,386		—		3,052,773,285


	31 December 2021		Increase during the year		Decrease during the year			31 December 2022
	RMB		RMB		RMB			RMB
Reserve fund		133,718,997		—		(133,718,997	)		—
Enterprise expansion fund		133,718,996		—		(133,718,996	)		—
Statutory surplus reserve		1,735,113,211		—		(1,297,519,926	)		437,593,285
Discretionary surplus reserve		1,050,222,081		—		(1,050,222,081	)		—

		3,052,773,285		—		(2,615,180,000	)		437,593,285

In accordance with the Company Law and the Company’s Articles of Association, the Company should appropriate 10% of net profit for the year to the statutory surplus reserve, and the Company can cease appropriation when the statutory surplus reserve accumulated to more than 50% of the registered capital. The statutory surplus reserve can be used to make up for the loss or increase the share capital after approval from the appropriate authorities. The Company didn’t appropriate the statutory surplus reserve in 2022 (2021: RMB 312,590,386 to the statutory surplus reserve).

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

31	Undistributed profits


	2021			2022
	RMB			RMB
Undistributed profits at beginning of year		3,171,706,061			2,813,313,476
Add: Net profit/(loss) for the current year		3,125,903,862			(1,947,579,252	)

Less: Profit distribution
Profit distribution to equity owners		(3,171,706,061	)		(2,772,190,652	)
Appropriation to free surplus reserves		(312,590,386	)		—

Undistributed profits/(accumulated losses) at end of year		2,813,313,476			(1,906,456,428	)

Pursuant to the resolution at the 32th Session of the first Meeting of the Board of Directors dated 28 February 2022, the Company made profit distribution to shareholders amounting to RMB 2,772,190,652 for the current year (2021: RMB 3,171,706,061, 2020: RMB 2,368,000,000).

32	Revenue and cost of sales


	2020					2021					2022
	Revenue		Cost of sales			Revenue		Cost of sales			Revenue		Cost of sales
Main operations
- Sales of olefin		5,098,976,996		(4,246,257,694	)		7,113,735,587		(6,326,093,477	)		6,295,589,765		(5,751,203,014	)
- Sales of polyethylene		4,994,277,463		(3,803,906,817	)		5,741,835,673		(5,429,556,673	)		5,190,012,918		(6,079,495,459	)
- Sales of acrylonitrile		4,418,734,626		(3,676,021,011	)		7,476,126,532		(5,536,514,979	)		4,514,576,652		(5,639,421,091	)
- Sales of styrene		2,394,141,160		(2,178,378,109	)		3,407,790,936		(2,933,607,175	)		2,983,565,129		(2,975,548,981	)
- Sales of polystyrene		2,382,513,536		(1,699,238,708	)		3,520,810,677		(2,740,722,490	)		2,783,826,139		(2,764,687,444	)
- Sales of polypropylene		2,186,126,691		(1,531,787,415	)		2,273,269,124		(2,067,997,433	)		2,149,281,286		(2,544,731,840	)

Other operations		151,288,772		(133,684,834	)		189,654,679		(135,876,782	)		179,977,236		(61,234,823	)

		21,626,059,244		(17,269,274,588	)		29,723,223,208		(25,170,369,009	)		24,096,829,125		(25,816,322,652	)

The Company’s revenue is recognized at a certain point of time.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

33	Taxes and surcharges


	2020		2021		2022
	RMB		RMB		RMB
Educational surcharge		20,293,244		30,855,712		4,796,425
Stamp tax		9,931,997		11,779,005		11,762,332
Environmental protection tax		9,877,785		9,253,559		8,356,953
City maintenance and construction tax		4,058,649		13,725,651		4,796,425
Urban land utilization tax		2,999,933		2,999,933		1,499,966
Property tax		—		—		2,980,363
Others		1,539		1,804		1,804

Total		47,163,147		68,615,664		34,194,268

34	Financial (income)/expense - net


	2020			2021			2022
	RMB			RMB			RMB
Interest expenses		6,019,753			2,682,042			134,233,247

Less: interest income		(172,009,089	)		(232,479,017	)		(104,673,458	)
Exchange losses/(gains) net		3,049,923			1,030,046			(1,359,689	)
Others		473,921			399,154			253,541

Total		(162,465,492	)		(228,367,775	)		28,453,641

35	Other income


	2020 RMB		2021 RMB		2022 RMB		Asset- related/ Income- related
Refund for unemployment insurance		—		3,195,900		12,000		Income-related
Government subsidies for port construction		1,769,194		118,083		—		Income-related
Government subsidies for chemical industry zone		6,142,800		12,600,000		4,125,300		Income-related
Government subsidies for R&D project		2,623,000		—		—		Income-related
Others		423,328		473,847		1,158,857		Income-related
Government subsidies for Shanghai high-tech		—		—		3,163,000		Income-related

Total		10,958,322		16,387,830		8,459,157

36	Investment income

2020

2021

2022

RMB

Income from entrusted loans

58,535,901

46,328,616

—

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

37	Asset impairment losses


	2020			2021			2022
	RMB			RMB			RMB
Losses on decline in the value of inventories		(6,787,522	)		(65,708,654	)		(289,308,464	)
Impairment loss of construction in progress		—			(61,805,108	)		—

Total		(6,787,522	)		(127,513,762	)		(289,308,464	)

38	Non-operating income and expenses

(1)	Non-operating income


	2020		2021		2022
	RMB		RMB		RMB
Long aging payables not to be paid		2,509,172		2,461,634		348,166
Suppliers penalty for breach of contracts		11,098,500		—		342,910
Gains on retirement of assets		—		281,442		432,743
Others		1,454,698		1,562,761		25,000

Total		15,062,370		4,305,837		1,148,819

(2)	Non-operating expenses


	2020		2021		2022
	RMB		RMB		RMB
Losses on retirement of assets		6,071,562		11,930,452		3,896,782
Donation expenses		2,016,652		200,000		300,000
Penalty expenses		450,000		—		—
Others		8,051		1,451,012		9,281,654

Total		8,546,265		13,581,464		13,478,436

39	Income tax expenses

(1)	Income tax expenses for the year represents


	2020		2021			2022
	RMB		RMB			RMB
Current tax expenses for the year		775,846,702		1,021,011,964			97,427
Changes in deferred tax assets/liabilities		19,577,669		(80,594,896	)		(650,434,763	)

Total		795,424,371		940,417,068			(650,337,336	)

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(2)	Reconciliation between income tax expense and accounting profit:


	2020			2021			2022
	RMB			RMB			RMB
Total profit/(losses)		3,208,224,027			4,066,320,930			(2,597,916,588	)
Income tax expenses calculated at applicable tax rates		802,056,007			1,016,580,232			(649,479,147	)
Costs, expenses and losses not deductible for tax purposes		2,114,316			2,114,316			2,179,756
Super deduction of R&D expenses		—			(3,890,000	)		(3,137,647	)
Identify discrepancies arising from unregulated deferred income tax assets in previous years		—			(74,148,775	)		—
Deductible temporary differences for which no deferred tax asset was recognized		(3,300,003	)		—			2,275
True up for final settlement of enterprise income tax in respect of previous year		(3,475,083	)		(238,705	)		97,427

Income tax expenses		795,424,371			940,417,068			(650,337,336	)

40	Supplement to income statement

The cost of sales, selling and administrative expenses, general and administrative expenses and R&D expenses in the income statements are listed as follows by nature:


	2020		2021			2022
	RMB		RMB			RMB
Changes in inventories of finished goods and semi-finished products		19,142,488		(195,053,026	)		(242,843,079	)
Consumed raw materials and low value consumables, etc.		16,117,811,082		23,345,177,320			24,227,388,996
Employee benefits		509,886,089		580,655,620			640,101,361
Depreciation and amortization expenses		726,861,191		759,304,007			631,761,766
Transportation costs		410,720,367		453,194,590			431,310,686
Repairs and maintenance expenses		385,416,604		405,370,162			221,878,212
Environment related cost		83,888,263		73,927,998			70,418,639
Commodity storage fees		33,037,958		34,245,243			30,830,561
Insurance expense		22,588,996		22,048,801			25,044,891
Vehicle usage fees		16,144,814		16,172,557			15,493,010
Others		277,902,909		247,538,174			287,533,837

		18,603,400,761		25,742,581,446			26,338,918,880

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

41	Supplement to cash flow statement

(1)	Reconciliation of net profit to cash flows from operating activities:


		2020			2021			2022
		RMB			RMB			RMB
Net profit/(loss)			2,412,799,656			3,125,903,862			(1,947,579,252	)
Add:	Losses on provision for decline in the value of inventories		6,787,522			65,708,654			289,308,464
	Impairment loss of construction in progress		—			61,805,108			—
	Net reversal of impairment losses on financial assets		(1,040,393	)		—			—
	Depreciation of fixed assets		624,149,178			645,711,963			524,881,559
	Amortization of intangible assets		53,691,786			53,436,548			56,358,052
	Amortization of long-term prepaid expenses		43,307,960			54,686,857			50,208,129
	Depreciation of right-of-use assets		5,712,267			5,468,639			314,026
	Losses on disposal of fixed assets		6,071,562			11,649,010			3,464,039
	Financial (income)/loss		(23,611,698	)		(111,432,469	)		56,687,415
	Investment income		(58,535,901	)		(46,328,616	)		—
	Increase in deferred tax assets		—			(48,291,526	)		(650,434,763	)
	Increase / (decrease) in deferred tax liabilities		19,577,669			(32,303,370	)		—
	Decrease / (increase) in inventories		91,046,499			(779,872,012	)		(374,568,927	)
	(Increase) / decrease in operating receivables		(117,243,028	)		440,884,928			(416,357,016	)
	Increase/(decrease) in operating payables		56,323,744			845,163			(910,483,422	)

Net cash flows generated from/(used in) operating activities			3,119,036,823			3,447,872,739			(3,318,201,696	)

(2)	Major investments and financing activities not involving cash payments:


	2021		2022
	RMB		RMB
Surplus reserve transferred to paid-in capital		—		2,615,180,000

(3)	Change in cash and cash equivalents:


	2020			2021			2022
	RMB			RMB			RMB
Cash and cash equivalents at the end of the year		5,180,636,789			2,332,751,042			787,608,469
Less: Cash and cash equivalents at the beginning of the year		(9,278,483,670	)		(5,180,636,789	)		(2,332,751,042	)

Net decrease in cash and cash equivalents		(4,097,846,881	)		(2,847,885,747	)		(1,545,142,573	)

(3)	Cash and cash equivalents held by the Company are as follows:


	2020		2021		2022
	RMB		RMB		RMB
(a) Cash at bank and on hand
- Bank deposits available on demand		5,180,636,789		2,332,751,042		787,608,469

(b) Closing balance of cash and cash equivalents available on demand		5,180,636,789		2,332,751,042		787,608,469

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

42	Risk analysis for financial instruments

Financial instruments and risks

The Company’s activities expose it to a variety of financial risks: market risk (primarily foreign exchange risk and interest rate risk), credit risk and liquidity risk. The Company’s overall risk management programme focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Company’s financial performance.

(1)	Market risk

(a)

Foreign exchange risk

The Company’s major operational activities are carried out in Mainland China. Sales transactions are mainly denominated in RMB while purchase transactions are mainly denominated in USD and RMB. The Company is exposed to foreign exchange risk arising from the recognized assets and liabilities, and future transactions denominated in foreign currencies, primarily with respect to US dollars. The Company’s finance department is responsible for monitoring the amount of assets and liabilities, and transactions denominated in foreign currencies to minimize the foreign exchange risk. Therefore, the Company may consider entering into forward exchange contracts or currency swap contracts to mitigate the foreign exchange risk. During 2021 and 2022, the Company did not enter into any forward exchange contracts or currency swap contracts.

The financial assets and the financial liabilities denominated in foreign currencies, which are held by the Company, whose recording currencies are RMB, are expressed in RMB as at 31 December 2021 and 2022 as follows:


	31 December 2021
	USD			EUR			Total
Financial assets denominated in foreign currency - Cash at bank and on hand		36,039,789			—			36,039,789
Financial liabilities denominated in foreign currency - Payables		(214,584,414	)		(724,528	)		(215,308,942	)

Net balance sheet exposure		(178,544,625	)		(724,528	)		(179,269,153	)


	31 December 2022
	USD			EUR			Total
Financial assets denominated in foreign currency - Cash at bank and on hand		39,726,746			—			39,726,746
Financial liabilities denominated in foreign currency - Payables		(280,801,289	)		(672,032	)		(281,473,321	)

Net balance sheet exposure		(241,074,543	)		(672,032	)		(241,746,575	)

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

As at 31 December 2022, if the RMB had strengthened/weakened by 10% against the USD while all other variables had been held constant, the Company’s net profit for the year would have been approximately RMB 18,080,591 (31 December 2021: approximately RMB 13,390,847 lower/higher) lower/higher for various financial assets and liabilities denominated in USD.

(b)

Interest rate risk

The interest rate risk of the Company is mainly generated by short-term loan. Financial liabilities with floating interest rate make the Company face interest rate risk of cash flow, while financial liabilities with fixed interest rate make the Company face interest rate risk of fair value. The Company determines the relative proportions of fixed and floating rate contracts in accordance with prevailing market conditions. As at 31 December 2022, the balance of short-term borrowings is RMB 6,608,867,012, all of which are fixed interest rate financial liabilities. (31 December 2021: Nil).

The financial department of the Company headquarters continuously monitors the interest rate level of the Company. Higher interest rates would increase the cost of the new interest-bearing debt and the Company has not yet been paid to the floating interest at a pre-determined rate of interest-bearing debt payments, and our Company’s financial performance have a significant adverse impact, management is on the basis of the latest market situation to adjust in time, the adjustment of interest rate swap arrangements may be carried out to reduce the interest rate risk. There is no interest rate swap arrangement for the Company in 2021 and 2022.

(2)	Credit risk

Credit risk is managed on the grouping basis. Credit risk mainly arises from cash at bank, accounts receivable, other receivables and notes receivable.

The Company expects that there is no significant credit risk associated with cash at bank since they are deposited at state-owned banks and other medium or large size listed banks. Management does not expect that there will be any significant losses from non-performance by these counterparties.

In addition, the Company has policies to limit the credit exposure on bills receivable, accounts receivable, receivables under financing and other receivables. The Company assesses the credit quality of and sets credit limits on its customers by taking into account their financial position, the availability of guarantee from third parties, their credit history and other factors such as current market conditions. The credit history of the customers is regularly monitored by the Company. In respect of customers with a poor credit history, the Company will use written payment reminders, or shorten or cancel credit periods, to ensure the overall credit risk of the Company is limited to a controllable extent.

As at 31 December 2021 and 2022, the Company has no collateral or other credit enhancement held as a result of a material debtor’s mortgage.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(3)	Liquidity risk

Cash flow forecasting is performed by the Company. The Company monitors the Company’s short-term and long-term liquidity requirements to ensure it has sufficient cash and securities that are readily convertible to cash to meet operational needs, while maintaining sufficient headroom on its undrawn committed borrowing facilities from major financial institutions so that the Company does not breach borrowing limits or covenants on any of its borrowing facilities to meet the short-term and long-term liquidity requirements.

The financial liabilities of the Company at the balance sheet date are analyzed by their maturity dates below at their undiscounted contractual cash flows:


	31 December 2021
	Within 1 year		1 to 2 years		1 to 2 years		Over 5 years		Total
	RMB		RMB		RMB		RMB		RMB
Accounts payable		1,787,137,217		—		—		—		1,787,137,217
Other payables		2,755,463,900		—		—		—		2,755,463,900
Lease liabilities		116,496		67,956		—		—		184,452

		4,542,717,613		67,956		—		—		4,542,785,569


	31 December 2022
	Within 1 year		1 to 2 years		1 to 2 years		Over 5 years		Total
	RMB		RMB		RMB		RMB		RMB
Short-term borrowings		6,684,482,143		—		—		—		6,684,482,143
Accounts payable		1,424,493,816		—		—		—		1,424,493,816
Other payables		278,305,641		—		—		—		278,305,641
Lease liabilities		66,119		1,837		—		—		67,956

		8,387,347,719		1,837		—		—		8,387,349,556

As at 31 December 2022, the Company had no lease payments related to lease contracts which had been signed but not been executed (as at 31 December 2021: Nil).

43	Fair value estimation

(1)	Assets and liabilities measured at fair value

The following table presents the fair value information and the fair value hierarchy, at the end of the current reporting period, of the Company’s assets and liabilities which are measured at fair value at each balance sheet date on a recurring or non-recurring basis. The level in which fair value measurement is categorized is determined by the level of the fair value hierarchy of the lowest level input that is significant to the entire fair value measurement. The levels of inputs are defined as follows:


Level 1 inputs:		unadjusted quoted prices in active markets that are observable at the measurement date for identical assets or liabilities;

Level 2 inputs:		inputs other than Level 1 inputs that are either directly or indirectly observable for underlying assets or liabilities;

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)


Level 3 inputs:		inputs that are unobservable for underlying assets or liabilities.

31 December 2021

Note

Level 1

fair value

measurements

Level 2

fair value

measurements

Level 3

fair value

measurements

Total

RMB

Financial assets

Financial assets at fair value through other comprehensive income-Notes receivable

—

260,065,209

—

260,065,209

31 December 2022

Note

Level 1

fair value

measurements

Level 2

fair value

measurements

Level 3

fair value

measurements

Total

RMB

Financial assets

Financial assets at fair value through other comprehensive income-Notes receivable

—

212,655,800

—

212,655,800

(2)	Fair value of other financial instruments (items not measured at fair value at the end of the year)

The Company’s financial assets and liabilities measured at amortized cost mainly include receivables, short-term borrowings and payables.

As at 31 December 2022 and 31 December 2021, the carrying amount of the financial assets and liabilities not measured at fair value is a reasonable approximation of their fair value.

44	Capital management

The Company’s capital management policies aim to safeguard the Company’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders, and to maintain an optimal capital structure to reduce the cost of capital.

In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends paid to shareholders, return capital to shareholders, or sell assets to reduce debts.

The Company’s total capital is calculated as ‘owners’ equity’ as shown in the balance sheet. The Company is not subject to external mandatory capital requirements, and monitors capital on the basis of gearing ratio.

As at 31 December 2021 and 2022, the gearing ratios of the Company were as follows:


	31 December 2021			31 December 2022
Gearing ratio		46.04	%		84.49	%

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

45	Commitments

As at 31 December, the capital commitments of the Company are summarized as follows:


Item	2021		2022
	RMB		RMB
Contracts for acquisition of fixed assets being or to be executed		47,874,261		113,103,648

46	Related parties and related party transactions

(1)	Information about the investor of the Company is listed as follows:


Investor name	Registered place	Business nature	31 December 2021 and 2022 Shareholding percentage
Sinopec Corp.	Beijing, the PRC	Oil and gas exploration, development, production and marketing, crude oil processing, oil products production, trading and distribution		15	%
Sinopec Shanghai Petrochemical Company Limited	Shanghai, the PRC	Crude oil processing, petroleum products, chemical products and synthetic fibres, etc.		20	%
Sinopec Shanghai Gaoqiao Petrochemical Company Limited	Shanghai, the PRC	Crude oil processing, petroleum products, chemical products and storage, etc.		15	%
INEOS	Shanghai, the PRC	Investment, technical services, consulting services, etc		50	%

(2)	Nature of related parties that do not control or are not controlled by the Company


Name of entity		Relationship with the Company
INEOS Europe AG		Subsidiary of INEOS
INEOS Styrolution Switzerland S.A.		Subsidiary of INEOS
Shanghai Dongfang Engineering Consultants Co., Ltd.		Subsidiary of Sinopec Corp.
Shanghai Sinopec Mitsui Elastomers, Co., Ltd.		Joint venture of Gaoqiao Petrochemical Corp
Shanghai Chemical Industry Park Logistics Company Limited		Associated Company of SPCL
Shanghai Huayi Information Technology Company Limited		Associated Company of Sinopec Corp.
Shanghai Petrochemical Machinery Manufacturing Company Limited		Subsidiary of Sinopec Corp.
Shanghai Leader Catalyst Company Limited		Subsidiary of Sinopec Corp.
Shanghai Jinshan Hotel Co., Ltd.		Subsidiary of SPCL
Shanghai Jinchang Engineering Plastics Company Limited		Subsidiary of SPCL
China International United Petroleum and Chemical Company Limited		Subsidiary of Sinopec Corp.
Sinopec Shanghai Petrochemical Company Limited		Subsidiary of Sinopec Corp.
Sinopec Shanghai Gaoqiao Petrochemical Company Limited		Subsidiary of Sinopec Corp.
Sinopec Catalyst Company Limited Shanghai Branch		Subsidiary of Sinopec Corp.
Sinopec Catalyst Company Limited Beijing AUDA Branch		Subsidiary of Sinopec Corp.
Sinopec Catalyst Company Limited Nanjing Branch		Subsidiary of Sinopec Corp.
China Petrochemical Press Co., Ltd		Subsidiary of Sinopec Corp.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)


Name of entity		Relationship with the Company
Sinopec Chemical Commercial Holding Company Limited Huadong Branch		Subsidiary of Sinopec Corp.
Sinopec Consulting Company Limited		Subsidiary of Sinopec Corp.
Sinopec Engineering Construction Company Limited		Subsidiary of Sinopec Corp.
Sinopec Hainan Petrochemical Company Limited		Subsidiary of Sinopec Corp.
Sinopec Lubricants Company Limited Huadong Branch		Subsidiary of Sinopec Corp.
Sinopec Fuel Oil Sales Company Limited. Shanghai Branch		Subsidiary of Sinopec Corp.
Sinopec Sales Company Limited. Shanghai Branch		Subsidiary of Sinopec Corp.
Sinopec Shared Services Company Limited		Subsidiary of Sinopec Corp.
Sinopec Tendering Company Limited		Subsidiary of Sinopec Corp.
Sinopec Qingdao Refining&Chemical Company Limited		Subsidiary of Sinopec Corp.
Shanghai Research Institute of Petrochemical Technology		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Beijing Research Institute of Chemical Industries		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Beijing Yanshan Branch		Branch of Sinopec Corp.
China Petroleum and Chemical Corporation Guangzhou Branch		Branch of Sinopec Corp.
China Petroleum and Chemical Corporation Jinling Branch		Branch of Sinopec Corp.
China Petroleum and Chemical Corporation Zhenhai Refining Branch		Branch of Sinopec Corp.
China Sinopec Corporation Qingdao Institute of Safety Engineering		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Co., Ltd., QILU Research Institute		Subsidiary of Sinopec Corp.
China Jinshan Associated Trading Corporation		Subsidiary of SPCL
Sinopec (Beijing) Chemical Research Institute Co. LTD		Subsidiary of Sinopec Corp.
Sinopec (Europe) Co., LTD		Subsidiary of Sinopec Corp.
Sinopec Shanghai Engineering Company Limited		Subsidiary of Sinopec Corp.
Sinopec Beijing Catalyst Company Limited		Subsidiary of Sinopec Corp.
Sinopec Nanjing Engineering Company Limited		Subsidiary of Sinopec Corp.
Sinopec Group Shared Services Co., Ltd. Nanjing Branch		Subsidiary of Sinopec Corp.
Sinopec International Business Ningbo Co., LTD		Subsidiary of Sinopec Corp.
Sinopec Ningbo Engineering Company Limited		Subsidiary of Sinopec Corp.
Sinopec Ningbo Engineering Company Limited Shanghai Branch		Subsidiary of Sinopec Corp.
Sinopec Ningbo Engineering Company Limited Shanghai Jinshan Branch		Branch of Sinopec Corp.
Information Technology Branch of Sinopec Refining and Chemical Engineering (Group) Co., Ltd.		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Limited Yanshan Branch of Beihua Institute		Subsidiary of Sinopec Corp.
Nanjing Yangzi Petrochemical Refining Company Limited		Subsidiary of Sinopec Corp.
Sinopec Qingdao Security Engineering Research Institute Co. LTD		Subsidiary of Sinopec Corp.
BASF Gaoqiao Specialty Chemicals (Shanghai) Company Limited		Associated Company of Gaoqiao Petrochemical Corp.
BASF-YPC. Shanghai Company Limited		Joint venture of Sinopec Corp.
Sinopec Yingke Information Technology Co., Ltd		Subsidiary of Sinopec Corp.
Petrochemical Engineering Quality Supervision Station		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Zhenhai Refining Branch		Branch of Sinopec Corp.
China International United Petroleum and Chemical Company Limited		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Jinling Branch		Branch of Sinopec Corp.
Sinopec Qingdao Refining&Chemical Company Limited		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Guangzhou Branch		Branch of Sinopec Corp.
China Jinshan Associated Trading Corporation		Subsidiary of SPC
Shanghai Jinshan Hotel Co., Ltd.		Subsidiary of SPCL
Sinopec Chemical Commercial Holding Company Limited Huadong Branch		Subsidiary of Sinopec Corp.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)


Name of entity		Relationship with the Company
Shanghai Leader Catalyst Company Limited		Subsidiary of Sinopec Corp.
Sinopec Catalyst Company Limited Shanghai Branch		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Beijing Yanshan Branch		Branch of Sinopec Corp.
Nanjing Yangzi Petrochemical Refining Company Limited		Subsidiary of Sinopec Corp.
Sinopec Catalyst Company Limited Beijing AUDA Branch		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Shanghai Petrol-Chemical Industry Institute		Subsidiary of Sinopec Corp.
BASF-YPC. Shanghai Company Limited		Joint venture of Gaoqiao Petrochemical
Petro-Cyber Works Information Technology Company Limited		Subsidiary of Sinopec Corp.
Sinopec Hainan Petrochemical Co., Ltd.		Subsidiary of Sinopec Corp.
Sinopec Catalyst Company Limited Nanjing Branch		Subsidiary of Sinopec Corp.
Sinopec Beijing Catalyst Company Limited		Subsidiary of Sinopec Corp.
BASF Gaoqiao Specialty Chemicals (Shanghai) Company Limited		Associated Company of Gaoqiao Petrochemical
Shanghai Sinopec Mitsui Elastomers Company Limited		Associated Company of Gaoqiao Petrochemical

(2)	Nature of related parties that do not control or are not controlled by the Company (continued)


Name of entity		Relationship with the Company
Sinopec Shanghai Sales Company Limited		Subsidiary of Sinopec Corp.
Shanghai Jinchang Engineering Plastics Company Limited		Subsidiary of SPC
China Petrochemical International Tianjin Company Limited		Subsidiary of Sinopec Corp.
Yihua Bona Fabric Company Limited		Joint venture of Sinopec Corp.
Petrochemical Engineering Quality Supervision Station		Subsidiary of Sinopec Corp.
Sinopec Ningbo Engineering Company Limited Shanghai Branch		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Co., Ltd., QILU Branch		Subsidiary of Sinopec Corp.
China Sinopec Corporation Qingdao Institute of Safety Engineering		Subsidiary of Sinopec Corp.
China Petroleum and Chemical Corporation Beijing Research Institute of Chemical Industries		Subsidiary of Sinopec Corp.
Information Technology Branch of Sinopec Refining and Chemical Engineering (Group) Co., Ltd.		Subsidiary of Sinopec Corp.
Sinopec Tendering Company Limited		Subsidiary of Sinopec Corp.
Sinopec Consulting Company Limited		Subsidiary of Sinopec Corp.
Shanghai Petrochemical Machinery Manufacturing Company Limited		Subsidiary of Sinopec Corp.
Sinopec Publishing House Co., Ltd.		Subsidiary of Sinopec Corp.
Sinopec Europa Gmbh		Subsidiary of Sinopec Corp.
China petrochemical International Enterprise Company Limited Ningbo Bidding Center		Subsidiary of Sinopec Corp.
Shanghai Chemical Industry Park Logistics Company Limited		Joint venture of SPC
Sinopec Nanjing Engineering Company Limited		Subsidiary of Sinopec Corp.
Shanghai Dongfang Engineering Consultants Co., Ltd.		Subsidiary of Sinopec Corp.
Shanghai Huayi Information Technology Company Limited		Joint venture of Sinopec Corp.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

(3)	Significant related party transactions

The Company’s pricing on products sold to related parties and raw materials purchased from related parties is negotiated by both parties.

(a)

Significant related party transactions

Sales of goods


	2020		2021		2022
	RMB		RMB		RMB
Sinopec Shanghai Petrochemical Company Limited		2,469,008,549		3,096,709,578		1,603,058,780
Sinopec Shanghai Gaoqiao Petrochemical Company Limited		1,609,838,063		2,344,682,615		2,302,251,861
Shanghai Sinopec Mitsui Elastomers Company Limited		313,324,007		542,433,412		484,362,580
China Jinshan Associated Trading Corporation		300,543,910		395,108,984		307,997,249
Sinopec Chemical Commercial Holding Company Limited Huadong Branch		137,036,739		104,461,770		118,193,894
Sinopec Shanghai Sales Company Limited		—		9,369,061		11,289,111
Shanghai Jinchang Engineering Plastics Company Limited		2,274,336		1,606,018		—
China Petrochemical International Tianjin Company Limited		11,467,671		—		—
Yihua Bona Fabric Company Limited		1,428,761		—		—

Total		4,844,922,036		6,494,371,438		4,827,153,475

Purchase of goods


	2020		2021		2022
	RMB		RMB		RMB
China Petroleum and Chemical Corporation Zhenhai Refining Branch		1,886,994,055		5,055,451,144		4,611,840,757
Sinopec Shanghai Gaoqiao Petrochemical Company Limited		2,416,640,786		3,500,853,274		4,914,204,373
Sinopec Shanghai Petrochemical Company Limited		1,214,059,295		2,806,216,204		1,763,524,192
Shanghai Jinshan Hotel Co., Ltd.		—		143,386		39,021
China International United Petroleum and Chemical Company Limited		1,789,430,831		1,774,208,796		1,931,024,604

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)


China Petroleum and Chemical Corporation Jinling Branch	1,350,625,256	1,605,310,945	1,460,215,574
Sinopec Qingdao Refining&Chemical Company Limited	576,192,296	1,133,704,017	1,069,735,977
China Petroleum and Chemical Corporation Guangzhou Branch	431,135,789	992,405,630	390,798,834
China Jinshan Associated Trading Corporation	511,087,351	745,813,800	664,592,297
Sinopec Chemical Commercial Holding Company Limited Huadong Branch	1,285,275,149	611,974,256	855,436,077
Shanghai Leader Catalyst Company Limited			18,964,712
Shanghai Leader Catalyst Company Limited	33,549,209	32,657,746	24,159,630
Sinopec Catalyst Company Limited Shanghai Branch	21,991,150	23,561,947	20,106,193
China Petroleum and Chemical Corporation Beijing Yanshan Branch	12,927,351	19,934,903	18,494,348
Nanjing Yangzi Petrochemical Refining Company Limited	13,123,737	13,593,346	6,588,114
Sinopec Catalyst Company Limited Beijing AUDA Branch	14,549,120	13,243,628	11,625,700
China Petroleum and Chemical Corporation Shanghai Petrol-Chemical Industry Institute	—	1,979,555	311,416
BASF-YPC. Shanghai Company Limited	—	1,506,970	7,679,153
Petro-Cyber Works Information Technology Company Limited	83,894	197,124	—
Sinopec Fuel Oil Sales Co., Ltd. Shanghai Branch.	—	—	227,912
Sinopec Lubricants Co., Ltd. East China Branch	—	—	199,326
Sinopec Sales Company Limited. Shanghai Branch	—	—	132,743
INEOS Europe AG	—	—	50,993,672
Sinopec Hainan Petrochemical Co., Ltd.	160,937,378	—	44,176,559
Sinopec Catalyst Company Limited Nanjing Branch	2,653,805	—	—
Sinopec Beijing Catalyst Company Limited	1,235,865	—	—
BASF Gaoqiao Specialty Chemicals (Shanghai) Company Limited	157,678	—	—
Shanghai Jinshan Trading Corporation

Total	11,722,649,995	18,332,756,671	17,865,071,184

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Purchasing engineering construction and maintenance services


	2020		2021		2022
	RMB		RMB		RMB
Sinopec Engineering Incorporation		3,481,030		30,735,660		6,701,600
Sinopec Shanghai Engineering Company Limited		3,614,528		8,913,236		50,258,150
Sinopec Shanghai Engineering Company Limited-headquarter		—		—		679,245
Sinopec Ningbo Engineering Company Limited		6,531,069		3,570,813		1,535,141
Sinopec Ningbo Engineering Company Limited Shanghai Jinshan Branch		5,231,665		3,150,482		—
Petrochemical Engineering Quality Supervision Station		499,900		280,300		—
Sinopec Ningbo Engineering Company Limited Shanghai Branch		—		244,268		594,785
China Petroleum and Chemical Co., Ltd., QILU Branch		—		216,981		—
INEOS Styrolution Switzerland S.A.		—		—		13,162,973
Sinopec International Business Ningbo Co., LTD		—		—		7,615,752
Shanghai Petrochemical Machinery Manufacturing Company Limited		—		—		27,217
Sinopec Qingdao Security Engineering Research Institute Co. LTD		—		—		3,264,211
Shanghai Chemical Industry Park Logistics Company Limited		2,293,009		—		—
Sinopec Nanjing Engineering Company Limited		441,742		—		—
Shanghai Dongfang Engineering Consultants Co., Ltd.		299,444		—		—
Sinopec Consulting Company Limited		—		—		—
Shanghai Petrochemical Machinery Manufacturing Company Limited		—		—		—

Total		22,392,387		47,111,740		83,839,074

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Rental expenses

2020

2021

2022

RMB

Sinopec Shanghai Petrochemical Company Limited

2,050,914

2,038,814

1,905,717

Issuing entrusted loan

2020

2021

2022

RMB

Sinopec Corp.

4,000,000,000

—

Recovering entrusted loan

2020

2021

2022

RMB

Sinopec Corp.

2,000,000,000

—

Interest income from entrusted loans

2020

2021

2022

RMB

Sinopec Corp.

58,535,901

46,328,616

—

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Consulting service fee


	2020		2021		2022
	RMB		RMB		RMB
Petro-Cyber Works Information Technology Company Limited		23,148,656		14,597,690		2,120,583
China Sinopec Corporation Qingdao Institute of Safety Engineering		3,468,491		2,076,967		—
China Petroleum and Chemical Corporation Beijing Research Institute of Chemical Industries		1,186,151		558,019		—
Information Technology Branch of Sinopec Refining and Chemical Engineering (Group) Co., Ltd.		—		138,867		—
Sinopec Tendering Company Limited		189,761		94,340		1,142,302
Sinopec Consulting Company Limited		—		87,264		87,264
Shanghai Petrochemical Machinery Manufacturing Company Limited		—		84,528		—
Sinopec Publishing House Co., Ltd.		—		45,871		—
Sinopec Europa Gmbh		576,088		17,369		11,854
China Petroleum and Chemical Corporation Limited Yanshan Branch of Beihua Institute		—		—		19,700
Sinopec Group Shared Services Co., Ltd. Nanjing Branch		—		—		73,585
Sinopec (Beijing) Chemical Research Institute Co., Ltd		—		—		318,000
Shanghai Chemical Industry Park Logistics Company Limited		1,309,586		—		—

Sinopec Ningbo Engineering Company Limited		188,679		—		—
China petrochemical International Enterprise Company Limited Ningbo Bidding Center		39,057		—		—
Shanghai Huayi Information Technology Company Limited		—		—		—

Total		30,106,469		17,700,915		3,773,288

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Transportation service fee

2020

2021

2022

RMB

Shanghai Chemical Industry Park Logistics Company Limited

114,227,900

115,224,861

114,642,946

The above transactions with related parties were conducted under normal commercial terms or relevant agreements.

(b)

The balances of transactions with related parties as at 31 December are set out as follows:

Accounts receivable


	2021		2022
	RMB		RMB
Shanghai Sinopec Mitsui Elastomers Company Limited		24,609,303		22,584,461
China Jinshan Associated Trading Corporation		5,663,355		2,625,886
Sinopec Chemical Commercial Holding Company Limited Huadong Branch		2,232,207		16,151,762
Sinopec Shanghai Sales Company Limited		1,345,776		1,319,312
Sinopec Shanghai Petrochemical Company Limited		—		14,928,341

Total		33,850,641		57,609,762

Financial assets at fair value through other comprehensive income


	2021		2022
	RMB		RMB
China Jinshan Associated Trading Corporation		24,480,000		16,000,000
Sinopec Chemical Commercial Holding Company Limited Huadong Branch		—		—

Total		24,480,000		16,000,000

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Advances to suppliers


	2021		2022
	RMB		RMB
Shanghai Petrochemical Machinery Company		—		1,052,726
China International Petrochemical Union Co. LTD		—		1,365,058
Sinopec Beijing Catalyst Company Limited		18,280,685		—

Total		18,280,685		2,417,784


Other current assets-entrusted loans

	2021		2022
	RMB		RMB
Sinopec Corp.		—		—

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

Contract Liabilities


	2021		2022
	RMB		RMB
China Jinshan Associated Trading Corporation		1,374,802		2,959,508
Yihua Bona Fabric Company Limited		—		—
Shanghai Jinchang Engineering Plastics Company Limited		—		—

Total		1,374,802		2,959,508

Accounts payable


	2021		2022
	RMB		RMB
China Petroleum and Chemical Corporation Zhenhai Refining Branch		410,286,919		216,979,815
China International United Petroleum and Chemical Company Limited		164,575,394		262,989,639
Sinopec Shanghai Gaoqiao Petrochemical Company Limited		130,646,973		84,211,976
Sinopec Qingdao Refining&Chemical Company Limited		74,953,420		73,655,716
Sinopec Shanghai Petrochemical Company Limited		22,363,326		461,341
Sinopec Catalyst Company Limited Shanghai Branch		17,258,591		981,821
Sinopec Chemical Commercial Holding Company Limited Huadong Branch		17,203,042		22,465,957
Shanghai Chemical Industry Park Logistics Company Limited		16,564,103		16,539,190
China Petroleum and Chemical Corporation Jinling Branch		8,361,978		4,532,191
Sinopec Catalyst Company Limited Beijing AUDA Branch		5,160,796		1,926,301
Shanghai Leader Catalyst Company Limited		3,515,961		2,987,309
Sinopec Engineering Incorporation		3,481,030		3,797,730
Sinopec Ningbo Engineering Company Limited		2,335,709		3,210,449
Sinopec Shanghai Engineering Company Limited		1,874,373		1,197,392
China Jinshan Associated Trading Corporation		1,585,234		35,465,721

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)


Petro-Cyber Works Information Technology Company Limited	1,518,474	2,951,356
Nanjing Yangzi Petrochemical Refining Company Limited	1,456,195	—
Sinopec Beijing Catalyst Company Limited	1,235,865	1,550,809
China Petroleum and Chemical Corporation Beijing Research Institute of Chemical Industries	591,000	591,000
BASF-YPC. Shanghai Company Limited	355,500	1,530,074
China Petroleum and Chemical Corporation Shanghai Petrol-Chemical Industry Insti Tute	349,904	—
Sinopec Ningbo Engineering Company Limited Shanghai Jinshan Branch	158,500	158,500
Sinopec Nanjing Engineering Company Limited	77,403	77,403
INEOS Europe AG	—	40,130
Sinopec Publishing House Co., Ltd.	45,871	—
China Petroleum and Chemical Corporation Guangzhou Branch	—	—
Sinopec Catalyst Company Limited Nanjing Branch	—	—
Shanghai Dongfang Engineering Consultants Co., Ltd.	—	—
China Sinopec Corporation Qingdao Institute of Safety Engineering	—	—
Shanghai Huayi Information Technology Company Limited	—	—
Basf Gaoqiao Specialty Chemicals (Shanghai) Company Limited	—	—
Petrochemical Engineering Quality Supervision Station	—	—
Sinopec Hainan Petrochemical Co., Ltd.	—	—
China Petroleum and Chemical Corporation Beijing Yanshan Branch	—	—

Total	885,955,561	738,301,820

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

48	Reconciliation to United States generally accepted accounting principles

The financial statements have been prepared in accordance with Accounting Standards for Business Enterprises in the People’s Republic of China (“CAS”), which differ in certain respects from accounting principles generally accepted in the United States of America (“U.S. GAAP”). The significant differences are described in the reconciliation tables below. Other differences do not have a significant effect on either net profit or owners’ equity. The effects of the significant adjustments to net profit for the years ended 31 December 2020, 2021 and 2022 which would be required if U.S. GAAP were to be applied instead of CAS are summarized as follows:


	2020			2021		2022
	RMB			RMB		RMB
Net profit / (loss) under CAS		2,412,799,656			3,125,903,862		(1,947,579,252	)
Adjustments:
Employees’ bonus and welfare fund (a)		(148,099	)		—		—

Net profit / (loss) under U.S. GAAP		2,412,651,557			3,125,903,862		(1,947,579,252	)

The effects of the significant adjustments to owners’ equity as at 31 December 2020 and 2021 which would be required if U.S. GAAP were to be applied instead of CAS are summarized as follows:


	2021		2022
	RMB		RMB
Owners’ equity under CAS		6,367,541,407		1,647,771,503
Adjustments:
Employees’ bonus and welfare fund (a)		76,283,722		76,283,722

Owners’ equity under U.S. GAAP		6,443,825,129		1,724,055,225

(a)	Employees’ bonus and welfare fund

In accordance with the Law of the PRC on Chinese-Foreign Equity Joint Ventures and the Company’s Articles of Association, the Company appropriated the employees’ bonus and welfare fund of net profit after setting off accumulated losses of previous years and before profit distributions to the investors.

SHANGHAI SECCO PETROCHEMICAL COMPANY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEARS ENDED 31 DECEMBER 2020, 2021 AND 2022 (AMOUNTS FOR THE YEAR ENDED 31 DECEMBER 2022 AND 31 DECEMBER 2021 ARE NOT COVERED BY THE INDEPENDENT AUDITOR’S REPORT INCLUDED HEREIN)

(EXPRESSED IN RENMINBI YUAN)

The employees’ bonus and welfare fund is restricted to fund payments of special bonus to employees and for the collective welfare of employees. None of it is allowed to be transferred to the Company in terms of cash dividends, loans or advances, nor can it be distributed except under liquidation.

Under CAS, appropriation of the employees’ bonus and welfare fund is a liability in nature and accounted for as a transfer from undistributed profits to employees’ bonus and welfare fund, a liability account. Subsequent payment is accounted for as a release of the Company’s liability.

Under U.S. GAAP, appropriation to the employees’ bonus and welfare fund is accounted for as a transfer from undistributed profits to the statutory reserves. Subsequent payment is accounted for as expenses or assets based on the usage of the payment, and proportionate undistributed profits and the statutory reserves are reversed concurrently.

v3.23.1

Cover Page - shares
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Document Information [Line Items]

Document Type 20-F

Amendment Flag false

Document Registration Statement false

Document Annual Report true

Document Period End Date Dec. 31, 2022

Current Fiscal Year End Date --12-31

Document Fiscal Year Focus 2022

Document Fiscal Period Focus FY

Document Transition Report false

Document Shell Company Report false

Entity Registrant Name Sinopec Shanghai Petrochemical Company Limited

Entity Central Index Key 0000908732

Entity Address, Country CN

Entity Address, Address Line One No. 48 Jinyi Road, Jinshan District, Shanghai, PRC 200540

Entity Address, City or Town Shanghai

Entity Address, Postal Zip Code 200540

Entity Well-known Seasoned Issuer Yes

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Interactive Data Current Yes

Entity Filer Category Large Accelerated Filer

Entity Emerging Growth Company false

ICFR Auditor Attestation Flag true

Document Accounting Standard International Financial Reporting Standards

Entity Shell Company false

Entity File Number 1-12158

Auditor Name KPMG Huazhen LLP PricewaterhouseCoopers Zhong Tian LLP

Auditor Firm ID 1186 1424

Auditor Location Shanghai, China Shanghai, the People’s Republic of China

Entity Incorporation, State or Country Code F4

Business Contact [Member]

Document Information [Line Items]

Entity Address, Country CN

Entity Address, Address Line One No. 48 Jinyi Road, Jinshan District, Shanghai, 200540

Entity Address, City or Town Shanghai

Entity Address, Postal Zip Code 200540

Contact Personnel Name Mr. Wan Tao

City Area Code +86

Local Phone Number 57943143

Contact Personnel Fax Number 57940050

American Depositary Shares [member]

Document Information [Line Items]

Title of 12(b) Security American Depositary Shares, each representing 100 H Shares, par value RMB1.00 per Share

No Trading Symbol Flag true

H shares [member]

Document Information [Line Items]

Entity Common Stock, Shares Outstanding 3,495,000,000

A shares [member]

Document Information [Line Items]

Entity Common Stock, Shares Outstanding 7,328,813,500

v3.23.1

Consolidated statements of profit or loss and other comprehensive income - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Statement of comprehensive income [abstract]

Revenue ¥ 82,443,156 ¥ 89,198,492 ¥ 74,623,575

Taxes and surcharges (9,788,593) (13,309,688) (13,062,710)

Net sales 72,654,563 75,888,804 61,560,865

Cost of sales (76,265,940) (74,298,048) (61,901,114)

Gross (loss)/profit (3,611,377) 1,590,756 (340,249)

Selling and administrative expenses (288,701) (368,243) (486,323)

Reversal/(provision) of impairment losses on financial assets (5,366) (1,355) 120,916

Other operating income 110,641 125,305 148,676

Other operating expenses (25,775) (44,712) (24,686)

Other gains/(losses) - net (22,788) 130,481 115,430

(Loss) / profit from operations (3,843,366) 1,432,232 (466,236)

Finance income 541,830 508,755 431,228

Finance expenses (98,502) (94,186) (98,954)

Finance income – net 443,328 414,569 332,274

Share of net profits/(losses) of associates and joint ventures accounted for using the equity method (173,616) 874,285 724,740

Profit/(loss) before taxation (3,573,654) 2,721,086 590,778

Income tax benefits/(expenses) 731,354 (644,480) 65,620

Profit/(loss) for the year (2,842,300) 2,076,606 656,398

Profit/(loss) attributable to:

Equity shareholders of the Company (2,846,156) 2,073,431 645,072

Non-controlling interests 3,856 3,175 11,326

Profit/(loss) for the year ¥ (2,842,300) ¥ 2,076,606 ¥ 656,398

Earnings/(losses) per share attributable to equity shareholders of the Company for the year (expressed in RMB per share)

Basic earnings/(losses) per share ¥ (0.263) ¥ 0.192 ¥ 0.06

Diluted earnings/(losses) per share ¥ (0.263) ¥ 0.192 ¥ 0.06

Profit/(loss) for the year ¥ (2,842,300) ¥ 2,076,606 ¥ 656,398

Other comprehensive income

Share of other comprehensive income of associates accounted for using the equity method (23,771) 16,639 (11,512)

Cash flow hedges: net movement in hedging reserve 201,519 125,159 0

Other comprehensive income for the year, net of tax 177,748 141,798 (11,512)

Total comprehensive income for the year (2,664,552) 2,218,404 644,886

Attributable to:

Equity shareholders of the Company (2,668,408) 2,215,229 633,560

Non-controlling interests 3,856 3,175 11,326

Total comprehensive income for the year ¥ (2,664,552) ¥ 2,218,404 ¥ 644,886

v3.23.1

Consolidated statements of financial position - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Non-current assets

Property, plant and equipment ¥ 12,179,504 ¥ 11,310,032

Right-of-use assets 379,805 385,643

Investment properties 336,863 352,188

Construction in progress 3,748,461 3,293,177

Investments accounted for using the equity method 3,504,393 4,088,888

Financial assets at fair value through other comprehensive income 5,000 5,000

Time deposits with banks 3,389,559 5,581,435

Deferred tax assets 991,850 184,143

Other non-current assets 835,400 787,807

Non-current assets 25,370,835 25,988,313

Current assets

Inventories 7,294,060 5,923,525

Financial assets at fair value through other comprehensive income 582,354 1,047,690

Derivative financial instruments 0 81,405

Trade receivables 69,351 77,425

Other receivables 107,507 47,597

Prepayments 17,832 30,364

Value added tax recoverable 1,057,463 13,322

Amounts due from related parties 2,638,983 1,212,331

Cash and cash equivalents 889,413 5,112,010

Time deposits with banks 3,108,919 7,386,607

Current assets 15,765,882 20,932,276

Total assets 41,136,717 46,920,589

Equity and liabilities

Share capital 10,823,814 10,823,814

Reserves 15,403,868 19,418,325

Equity attributable to owners of the Company 26,227,682 30,242,139

Non-controlling interests 127,681 135,259

Total equity 26,355,363 30,377,398

Non-current liabilities

Borrowings 700,000 700,000

Lease liabilities 7,513 1,384

Deferred tax liabilities 30,895 33,344

Deferred income 44,608 12,720

Non-current liabilities 783,016 747,448

Current liabilities

Borrowings 1,550,000 1,559,800

Lease liabilities 8,738 3,229

Derivative financial instruments 0 23,804

Contract liabilities 372,760 424,607

Trade and other payables 2,926,534 3,095,694

Amounts due to related parties ^[1] 7,887,809 6,304,816

Current tax liabilities 931,852 3,865,231

Staff salaries and welfares payable 317,891 260,096

Income tax payable 2,754 258,466

Current liabilities 13,998,338 15,795,743

Total liabilities 14,781,354 16,543,191

Total equity and liabilities ¥ 41,136,717 ¥ 46,920,589

[1] Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.

v3.23.1

Consolidated Statements of Changes in Equity - CNY (¥)
¥ in Thousands

Total

Share capital [member]

Other reserves [member]

Retained earnings [member]

Total [member]

Non-controlling interests [member]

Beginning Balance at Dec. 31, 2019 ¥ 29,993,848 ¥ 10,823,814 ¥ 4,369,391 ¥ 14,670,083 ¥ 29,863,288 ¥ 130,560

(Loss)/profit for the year 656,398 0 0 645,072 645,072 11,326

Other comprehensive income (11,512) 0 (11,512) 0 (11,512) 0

Total comprehensive income for the year 644,886 0 (11,512) 645,072 633,560 11,326

Dividends proposed and approved (1,298,858) 0 0 (1,298,858) (1,298,858) 0

Dividends paid by subsidiaries to non-controlling interests (4,901) 0 0 0 0 (4,901)

Appropriation of safety production fund 0 0 88,460 (88,460) 0 0

Ending Balance at Dec. 31, 2020 29,334,975 10,823,814 4,446,339 13,927,837 29,197,990 136,985

(Loss)/profit for the year 2,076,606 0 0 2,073,431 2,073,431 3,175

Other comprehensive income 141,798 0 141,798 0 141,798 0

Total comprehensive income for the year 2,218,404 0 141,798 2,073,431 2,215,229 3,175

Transfer to other reserves 0 0 2,498,808 (2,498,808) 0 0

Amounts transferred from hedging reserve to initial carrying amount of hedged items (88,699) 0 (88,699) 0 (88,699) 0

Dividends proposed and approved (1,082,381) 0 0 (1,082,381) (1,082,381) 0

Dividends paid by subsidiaries to non-controlling interests (4,901) 0 0 0 0 (4,901)

Appropriation of safety production fund 0 0 40,729 (40,729) 0 0

Ending Balance at Dec. 31, 2021 30,377,398 10,823,814 7,038,975 12,379,350 30,242,139 135,259

(Loss)/profit for the year (2,842,300) 0 0 (2,846,156) (2,846,156) 3,856

Other comprehensive income 177,748 0 177,748 0 177,748 0

Total comprehensive income for the year (2,664,552) 0 177,748 (2,846,156) (2,668,408) 3,856

Amounts transferred from hedging reserve to initial carrying amount of hedged items (237,979) 0 (237,979) 0 (237,979) 0

Dividends proposed and approved (1,082,381) 0 0 (1,082,381) (1,082,381) 0

Dividends paid by subsidiaries to non-controlling interests (11,434) 0 0 0 0 (11,434)

Purchase of own shares (25,689) 0 (25,689) 0 (25,689) 0

Appropriation of safety production fund 0 0 54,092 (54,092) 0 0

Ending Balance at Dec. 31, 2022 ¥ 26,355,363 ¥ 10,823,814 ¥ 7,007,147 ¥ 8,396,721 ¥ 26,227,682 ¥ 127,681

v3.23.1

Consolidated Statements of Cash Flow - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Cash flows from operating activities

Cash generated from / (used in) operations ¥ (6,960,734) ¥ 4,411,653 ¥ 1,995,087

Interest paid (121,876) (110,070) (71,369)

Income tax paid (376,765) (351,627) (243,870)

Net cash generated from / (used in) operating activities (7,459,375) 3,949,956 1,679,848

Cash flows from investing activities

Dividends received from joint ventures and associates 683,780 777,220 561,755

Interest received from entrusted loans 2,704 0 0

Interest received from structured deposits 11,124 97,921 132,690

Interest received from related parties 0 0 2,088

Interest received from banks excluded structured deposits 330,216 398,937 275,626

(Payments)/proceeds from settlement of derivative financial instruments (14,679) 5,674 (912)

Payment for the purchase of property, plant and equipment and construction in progress (2,836,912) (3,224,000) (1,840,986)

Net proceeds from disposal of property, plant and equipment 13,937 55,254 59,642

Cash received from time deposits with maturity less than one year 7,350,000 3,800,000 500,000

Cash received from time deposits with maturity more than one year 1,800,000 0 0

Cash received from maturity of structured deposits 1,000,000 8,150,000 10,900,000

Cash payment for investment in structured deposits (1,000,000) (8,150,000) (7,600,000)

Cash payment for investment in entrusted loans (150,000) 0 0

Cash received from investment in entrusted loans 150,000 0 0

Cash payment for investment deposits (50,000) 0 0

Payment for investment in associates and a joint venture (296,672) 0 0

Cash payment for investment in time deposits with maturity less than one year 0 (3,650,000) (3,000,000)

Cash payment for investment in time deposits with maturity more than one year (2,600,000) (2,000,000) (3,500,000)

Acquisition of a subsidiary, net of cash acquired 0 0 (340,315)

Payment for set up of an associate 0 (26,000) (27,603)

Payment for set up of a joint venture 0 (50,000) 0

Proceeds from capital reduction of an associate 0 1,460,258 0

Payment for sales of financial assets at fair value through other comprehensive income (3,148) (4,685) (9,513)

Net cash (used in) / generated from investing activities 4,390,350 (2,359,421) (3,887,528)

Cash flows from financing activities

Proceeds from borrowings 19,485,000 14,163,132 3,458,100

Proceeds from short-term bonds 5,000,000 5,998,899 2,998,469

Repayments of borrowings (19,494,800) (13,451,332) (3,460,556)

Repayments of short-term bonds (5,000,000) (9,000,000) 0

Principal elements of lease payments (13,069) (17,544) (15,586)

Dividends paid by subsidiaries to non-controlling interests (11,434) (4,901) (4,901)

Dividends paid to the Company's shareholders (1,081,327) (1,081,326) (1,293,736)

Payment for repurchase of shares (53,262) 0 0

Net cash generated from / (used in) financing activities (1,168,892) (3,393,072) 1,681,790

Net decrease in cash and cash equivalents (4,237,917) (1,802,537) (525,890)

Cash and cash equivalents at the beginning of the year 5,112,010 6,916,408 7,449,699

Exchange (losses) / gains on cash and cash equivalents 15,320 (1,861) (7,401)

Cash and cash equivalents at end of the year ¥ 889,413 ¥ 5,112,010 ¥ 6,916,408

v3.23.1

General Information
12 Months Ended

Dec. 31, 2022

General information [abstract]

General information

1

General Information

Sinopec Shanghai Petrochemical Company Limited (“the Company”), formerly Shanghai Petrochemical Company Limited, was established in the People’s Republic of China (“the PRC”) on 29 June 1993 with registered capital of RMB
4,000,000
thousand, invested by its holding company-China National Petrochemical Corporation (“Sinopec Group”); these shares were converted from assets of former Shanghai Petrochemical Complex.

H shares were listed on the Hong Kong Stock Exchange on 26 July 1993, and listed on the New York Stock Exchange in the form of American Depositary Shares at the same time; the A shares were listed on the Shanghai Stock Exchange on 8 November 1993.

Sinopec Group completed its reorganization on 25 February 2000. After the reorganization, China Petroleum & Chemical Corporation (“Sinopec Corp.”) was established. As part of the reorganization, Sinopec Group transferred its
4,000,000,000
of the Company’s state-owned legal shares, which represented
55.56
percent of the issued share capital of the Company, to Sinopec Corp. Sinopec Corp. became the largest shareholder of the Company.

The Company changed its name to Sinopec Shanghai Petrochemical Company Limited on 12 October 2000.

Ordinary A shares of RMB14,177 thousand and RMB9,637 thousand were registered on 27 September 2017 and 12 January 2018.

As at 31 December 2022, total share capital of the Company were RMB10,823,814 thousand , 1 Yuan per share. Detailed changes to share capital refers to note 30. The Company and its subsidiaries (“the Group”) is a highly integrated entity which processes crude oil into synthetic fibres, resins and plastics, intermediate petrochemicals and petroleum products.

Details of the Company’s principal subsidiaries are set out in note 19.

v3.23.1

Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2022

Summary of significant accounting policies [abstract]

Summary of significant accounting policies

2
Significant accounting policies

The principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

2.1
Statement of compliance and basis of preparation

(a)
Statement of compliance

These financial statements have been prepared in accordance with all applicable International Financial Reporting Standards (IFRSs), which collective term includes all applicable individual International Financial Reporting Standards, International Accounting Standards (IASs) and related Interpretations, promulgated by the International Accounting Standards Board (IASB) Significant accounting policies adopted by the Group are disclosed below.

The IASB has issued certain amendments to IFRSs that are first effective or available for early adoption for the current accounting period of the Group. Note 2.1 (c) provides information on any changes in accounting policies resulting from initial application of these developments to the extent that they are relevant to the Group for the current accounting period reflected in these financial statements.

(b)
Basis of preparation

The consolidated financial statements for the year ended 31 December 2022 comprise the Company and its subsidiaries (together referred to as the “Group”) and the Group’s interest in associates and a joint ventures.

The measurement basis used in the preparation of the financial statements is the historical cost basis except for certain financial assets and liabilities measured at fair value, including:

•
derivative financial instruments (see note 2.13); and

•
investment in debt and equity securities (see note 2.11).

The preparation of financial statements in conformity with IFRSs requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements made by management in the application of IFRSs that have significant effect on the financial statements and major sources of estimation uncertainty are discussed in note 4.

(c)

Changes in accounting policies
The Group has applied the following amendments to IFRSs issued by the IASB to these financial statements for the current accounting period:

•
Amendments to IAS 16, Property, plant and equipment: Proceeds before intended use

•
Amendments to IAS 37, Provisions, contingent liabilities and contingent assets: Onerous contracts —
cost of fulfilling a contract

•
Amendments to IFRSs, Annual Improvements to IFRS Standards 2018-2020

•
Amendments to IFRS 3, Reference to the Conceptual Framework
None of these developments have had a material effect on how the Group’s results and financial position for the current or prior periods have been prepared or presented. The Group has not applied any new standard or interpretation that is not yet effective for the current accounting period.

2.2
Subsidiaries

2.2.1
Consolidation
Subsidiaries are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Inter-company transactions, balances and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group.
Non-controlling
interests in the results and equity of subsidiaries are shown separately in the consolidated statements of financial position, consolidated statements of profit or loss, statements of comprehensive income and changes in equity respectively.

(a)

Business combinations
The acquisition method of accounting is used to account for all business combinations by the Group, regardless of whether equity instruments or other assets are acquired. The consideration transferred for the acquisition of a subsidiary comprises the:

•
fair values of the assets transferred;

•
liabilities incurred to the former owners of the acquired business;

•
equity interests issued by the Group;

•
fair value of any asset or liability resulting from a contingent consideration arrangement, and

•
fair value of any
pre-existing
equity interest in the subsidiary.
Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date. The Group recognizes any
non-controlling
interest in the acquired entity on an
acquisition-by-acquisition
basis either at fair value or at the
non-controlling
interest’s proportionate share of the acquired entity’s net identifiable assets.
Acquisition-related costs are expensed as incurred.
The excess of the:

•
consideration transferred

•
amount of any
non-controlling
interest in the acquired entity, and

•
acquisition-date fair value of any previous equity interest in the acquired entity

Over the fair value of the net identifiable assets acquired is recorded as goodwill. If those amounts are less than the fair value of the net identifiable assets of the business acquired, the difference is recognized directly in the statements of profit or loss as a bargain purchase.
Where settlement of any part of cash consideration is deferred, the amounts payable in the future are discounted to their present value as at the date of exchange. The discount rate used is the Group’s incremental borrowing rate, being the rate at which a similar borrowing could be obtained from an independent financier under comparable terms and conditions.
If the business combination is achieved in stages, the acquirer’s previously held equity interest in the acquiree is remeasured to fair value at the acquisition date. Any gains or losses arising from such remeasurement are recognized in the statements of profit or loss.

(b)
Changes in ownership interests
The Group treats transactions with
non-controlling
interests that do not result in loss of control as transactions with equity
owners
of the Group. A change in ownership interest results in an adjustment between the carrying amounts of the controlling and
non-controlling
interests to reflect their relative interests in the subsidiary. Any difference between the amount of the adjustment to
non-controlling
interests and any consideration paid or received is recognized in a separate reserve within equity attributable to owners of the Group.
When the Group ceases to consolidate or equity account for an investment because of a loss of control, joint control or significant influence, any retained interest in the entity is remeasured to its fair value, with the change in carrying amount recognized in the statements of profit or loss. This fair value becomes the initial carrying amount for the purposes of subsequently accounting for the retained interest as an associate, joint venture or financial asset. In addition, any amounts previously recognized in other comprehensive income in respect of that entity are accounted for as if the Group had directly disposed of the related assets or liabilities. This means that amounts previously recognized in other comprehensive income are reclassified to profit or loss.

2.2.2
Separate financial statements
Investments in subsidiaries are accounted for at cost less impairment. Cost includes direct attributable costs of investment. The results of subsidiaries are accounted for by the Company on the basis of dividend received and receivable.
Investments in joint ventures and associates are accounted for using the equity method of accounting.

2.3
Associates
Associates are all entities over which the Group has significant
influence
but not control or joint control. Investments in associates are accounted for using the equity method of accounting. Under the equity method, the investment is initially recognized at cost, and the carrying amount is increased or decreased to recognize the investor’s share of the profit or loss of the investee after the date of acquisition. The Group’s investments in associates include goodwill identified on acquisition. Upon the acquisition of the ownership interest in an associate, any difference between the cost of the associate and the Group’s share of the net fair value of the associate’s identifiable assets and liabilities is accounted for as goodwill.
The Group’s share of post-acquisition profit or loss is recognized in the statements of profit or loss, and its share of post-acquisition movements in other comprehensive income is recognized in other comprehensive income with a corresponding adjustment to the carrying amount of the investment. When the Group’s share of losses in an associate equals or exceeds its interest in the associate, including any other unsecured receivables, the Group does not recognize further losses, unless it has incurred legal or constructive obligations or made payments on behalf of the associate.
The Group determines at each reporting date whether there is any objective evidence that the investment in the associate is impaired. If this is the case, the Group calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value and recognizes the amount in the statements of profit or loss.
Profits and losses resulting from upstream and downstream transactions between the Group and its associates are recognized in the Group’s financial statements only to the extent of unrelated investor’s interests in the associates. Unrealized losses are eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of associates have been changed where necessary to ensure consistency with the policies adopted by the Group.
Gain or loss on dilution of equity interest in associates are recognized in the statements of profit or
loss
.

2.4
Joint arrangements
Under IFRS 11 ‘Joint Arrangements’ investments in joint arrangements are classified as either joint operations or joint ventures. The classification depends on the contractual rights and obligations of each investor, rather than the legal structure of the joint arrangement. The Group has assessed the nature of its joint arrangements and determined them to be joint ventures. Joint ventures are accounted for using the equity method.
Under the equity method of accounting, interests in joint ventures are initially recognized at cost and adjusted thereafter to recognize the Group’s share of the post-acquisition profits or losses and movements in other comprehensive income. The Group’s investments in joint ventures include goodwill identified on acquisition. Upon the acquisition of the ownership interest in a joint venture, any difference between the cost of the joint venture and the Group’s share of the net fair value of the joint venture’s identifiable assets and liabilities is accounted for as goodwill. When the Group’s share of losses in a joint venture equals or exceeds its interests in the joint ventures, including any other unsecured receivables, the Group does not recognize further losses, unless it has incurred obligations or made payments on behalf of the joint ventures.
Unrealized gains on transactions between the Group and its joint ventures are eliminated to the extent of the Group’s interest in the joint ventures. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of the joint ventures have been changed where necessary to ensure consistency with the policies adopted by the Group.
The carrying amount of equity-accounted investments is tested for impairment in accordance with the policy described in note 2.12.

2.5
Segment reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Board of Directors that makes strategic decisions.

2.6
Foreign currency translation
(a)

Functional and presentation currency
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic environment in which the entity operates (“the functional currency”).
The consolidated financial statements are presented in RMB, which is the Company’s functional and the Group’s presentation currency.
(b) Transactions and balances

Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates, are generally recognized in the statements of profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges and qualifying net investment hedges.

2.7
Property, plant and equipment
Property, plant and equipment is stated at historical cost less depreciation and impairment losses. Historical cost includes expenditure that is directly attributable to the acquisition of the items.

Items may be produced while bringing an item of property, plant and equipment to the location and condition necessary for it to be capable of operating in the manner intended by management. The proceeds from selling any such items and the related costs are recognized in profit or loss.
Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statements of profit or loss during the financial period in which they are incurred.

Depreciation on property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:

- Buildings
   12 to 40 years

- Plant and machinery
   5 to 20 years

- Vehicles and other equipment
   4 to 20 years

The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.
An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount (note 2.12 (b)).

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized within Other gains/(losses) - net in the statements of profit or loss.

2.8
Construction in progress

Construction in progress represents buildings, various plant and equipment under construction and pending installation, and is stated at cost less government grants that compensate the Company for the cost of construction, and impairment losses. Cost comprises direct costs of construction as well as interest charges, and foreign exchange differences on related borrowed funds to the extent that they are regarded as an adjustment to interest charges, during the period of construction. Construction in progress is transferred to property, plant and equipment when the asset is substantially ready for its intended use. No depreciation is provided in respect of construction in progress.

2.9
Investment properties

Investment properties are properties which are owned either to earn rental income and/or for capital appreciation.

Investment properties are stated in the statements of financial position at cost less accumulated depreciation and impairment losses (note 2.12(b)). Depreciation is provided over their estimated useful lives on a straight-line basis, after taking into account their estimated residual values.

Estimated useful lives of the Group’s investment properties are
30-40
years.

2.10
Other
non-current
assets

Other non-current assets mainly represent intangible assets and long-term prepaid expense, which are amortized on a straight-line basis over the following periods:

Intangible assets - patents
   2 to 28 years

Long-term prepaid expense - catalyst
   1.5 to 10 years

Long-term prepaid expense - leasehold improvement
   3 to 27 years

2.11
Other investments in debt and equity securities

The Group’s policies for investments in debt and equity securities, other than investments in subsidiaries, associates and joint ventures, are set out below.

Investments in debt and equity securities are recognized/derecognized on the date the Group commits to purchase/sell the investment. The investments are initially stated at fair value plus directly attributable transaction costs, except for those investments measured at fair value through profit or loss (FVPL) for which transaction costs are recognized directly in profit or loss. For an explanation of how the Group determines fair value of financial instruments, see note 3.3. These investments are subsequently accounted for as follows, depending on their classification.

(a)
Investments other than equity investments

Non-equity
investments held by the Group are classified into one of the following measurement categories:

•
amortized cost, if the investment is held for the collection of contractual cash flows which represent solely payments of principal and interest. Interest income from the investment is calculated using the effective interest method (see note 2.27).

•
fair value through other comprehensive income (FVOCI) - recycling, if the contractual cash flows of the investment comprise solely payments of principal and interest and the investment is held within a business model whose objective is achieved by both the collection of contractual cash flows and sale. Changes in fair value are recognized in other comprehensive income, except for the recognition in profit or loss of expected credit losses, interest income (calculated using the effective interest method) and foreign exchange gains and losses. When the investment is derecognized, the amount accumulated in other
comprehensive
income is recycled from equity to profit or loss.

•
fair value through profit or loss (FVPL) if the investment does not meet the criteria for being measured at amortized cost or FVOCI (recycling). Changes in the fair value of the investment (including interest) are recognized in profit or loss.

(b)
Equity investments

An investment in equity securities is classified as FVPL unless the equity investment is not held for trading purposes and on initial recognition of the investment the Group makes an irrevocable election to designate the investment at FVOCI
(non-recycling)
such that subsequent changes in fair value are recognized in other comprehensive income. Such elections are made on an
instrument-by-instrument
basis, but may only be made if the investment meets the definition of equity from the issuer’s perspective. Where such an election is made, the amount accumulated in other comprehensive income remains in the fair value reserve
(non-recycling)
until the investment is disposed of. At the time of disposal, the amount accumulated in the fair value reserve
(non-recycling)
is transferred to retained earnings. It is not recycled through profit or loss. Dividends from an investment in equity securities, irrespective of whether classified as at FVPL or FVOCI, are recognized in profit or loss as other income in accordance with the policy set out in note 2.28.

2.12
Credit losses and impairment of assets

(a)
Credit losses from financial instruments

The Group recognizes a loss allowance for expected credit losses (ECLs) on the following items:

•
financial assets measured at amortized cost (including cash and cash equivalents, time deposits with banks, trade receivables and other receivables); and

•
debt securities measured at FVOCI (recycling);

Other financial assets measured at fair value, including equity securities designated at FVOCI
(non-recycling)
and derivative financial assets, are not subject to the ECL assessment.
Measurement of ECLs
ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of all expected cash shortfalls (i.e. the difference between the cash flows due to the Group in accordance with the contract and the cash flows that the Group expects to receive).
The expected cash shortfalls are discounted using the following discount rates where the effect of discounting is material:

•
fixed-rate financial assets, trade and other receivables: effective interest rate determined at initial recognition or an approximation thereof;

•
variable-rate financial assets: current effective interest rate.
The maximum period considered when estimating ECLs is the maximum contractual period over which the Group is exposed to credit risk. In measuring ECLs, the Group takes into account reasonable and supportable information that is available without undue cost or effort. This includes information about past events, current conditions and forecasts of future economic conditions.
ECLs are measured on either of the following bases:

•
12-month
ECLs: these are losses that are expected to result from possible default events within the 12 months after the reporting date; and

•
lifetime ECLs: these are losses that are expected to result from all possible default events over the expected lives of the items to which the ECL model applies.
Loss allowances for trade receivables are always measured at an amount equal to lifetime ECLs. ECLs on these financial assets are estimated using a provision matrix based on the Group’s historical credit loss experience, adjusted for factors that are specific to the debtors and an assessment of both the current and forecast general economic conditions at the reporting date.
For all other financial instruments, the Group recognizes a loss allowance equal to
12-month
ECLs unless there has been a significant increase in credit risk of the financial instrument since initial recognition, in which case the loss allowance is measured at an amount equal to lifetime ECLs.

Significant increases in credit risk
In assessing whether the credit risk of a financial instrument has increased significantly
since
initial recognition, the Group compares the risk of default occurring on the financial instrument assessed at the reporting date with that assessed at the date of initial recognition.
In making this reassessment, the Group considers that a default event occurs when (i) the borrower is unlikely to pay its credit obligations to the Group in full, without recourse by the Group to actions such as realizing security (if any is held); or (ii) the financial asset is 90 days past due.
The Group considers both quantitative and qualitative information that is reasonable and supportable, including historical experience and forward-looking information that is available without undue cost or effort.
In particular, the following information is taken into account when assessing whether credit risk has increased significantly since initial recognition:

•
failure to make payments of principal or interest on their contractually due dates;

•
an actual or expected significant deterioration in a financial instrument’s external or internal credit rating (if available);

•
an actual or expected significant deterioration in the operating results of the debtor; and

•
existing or forecast changes in the technological, market, economic or legal environment that have a significant adverse effect on the debtor’s ability to meet its obligation to the Group.
Depending on the nature of the financial instruments, the assessment of a significant increase in credit risk is performed on either an individual basis or a collective basis. When the assessment is performed on a collective basis, the financial instruments are grouped based on shared credit risk characteristics, such as past due status and credit risk ratings.
ECLs are remeasured at each reporting date to reflect changes in the financial instrument’s credit risk since initial recognition. Any change in the ECL amount is recognized as an impairment gain or loss in profit or loss. The Group recognizes an impairment gain or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for investments in debt securities that are measured at FVOCI (recycling), for which the loss allowance is recognized in other comprehensive income and accumulated in the fair value reserve (recycling).

Basis of calculation of interest income
Interest income recognized in accordance with note 2.27 is calculated based on the gross carrying amount of the financial asset unless the financial asset is credit-impaired, in which case interest income is calculated based on the amortized cost (i.e. the gross carrying amount less loss allowance) of the financial asset.
At each reporting date, the Group assesses whether a financial asset is credit-impaired. A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred.
Evidence that a financial asset is credit-impaired includes the following observable events:

•
significant financial difficulties of the debtor;

•
a breach of contract, such as a default or past due event;

•
it is becoming probable that the borrower will enter into bankruptcy or other financial reorganization;

•
significant changes in the technological, market, economic or legal environment that have an adverse effect on the debtor; or

•
the disappearance of an active market for a security because of financial difficulties of the issuer.
Write-off
policy
The gross carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. This is generally the case when the Group determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the
write-off.

Subsequent recoveries of an asset that was previously written off are recognized as a reversal of impairment in profit or loss in the period in which the recovery occurs.

(b)
Impairment of other
non-current
assets

Internal and external sources of information are reviewed at the end of each reporting period to identify indications
that
the following assets may be impaired or, except in the case of goodwill, an impairment loss previously recognized no longer exists or may have decreased:

•
property, plant and equipment;

•
right-of-use
assets;

•
investment properties;

•
construction in progress

•
other
non-current
assets; and

•
investments in subsidiaries, associates and joint ventures in the Company’s statements of financial position.
At the end of each reporting period, if any indication of impairment exists, the Company estimates the recoverable amount of an asset, or a cash- generating unit, at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses.

•
Calculation of recoverable amount
The recoverable amount of an asset is the greater of its fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash fl ows are discounted to their present value using a
pre-tax
discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. Where an asset does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the smallest group of assets that generates cash inflows independently (i.e. a cash-generating unit). A portion of the carrying amount of a corporate asset (for example, head office building) is allocated to an individual cash-generating unit if the allocation can be done on a reasonable and consistent basis, or to the smallest group of cash-generating units if otherwise.

•
Recognition of impairment losses
An impairment loss is recognized in profit or loss if the carrying amount of an asset, or the cash-generating unit to which it belongs, exceeds its recoverable amount. Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to the cash-generating unit (or group of units) and then, to reduce the carrying amount of the other assets in the unit (or group of units) on a pro rata basis, except that the carrying value of an asset will not be reduced below its individual fair value less costs of disposal (if measurable) or value in use (if determinable).

•
Reversals of impairment losses
An impairment loss is reversed if there has been a favourable change in the estimates used to determine the recoverable amount.
A reversal of an impairment loss is limited to the asset’s carrying amount that would have been determined had no impairment loss been recognized in prior years.

Reversals of impairment losses are credited to profit or loss in the year in which the reversals are recognized.

2.13

Derivative and hedging activities
Derivatives are initially recognized at fair value on the date a derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. The accounting for subsequent changes in fair value depends on whether the derivative is designated as a hedging instrument and, if so, the nature of the item being hedged. The Group designates certain derivatives as hedges of a particular risk associated with the cash flows of recognized assets and liabilities and highly probable forecast transactions (cash flow hedges).
At inception of the hedge relationship, the Group documents the economic relationship between hedging instruments and hedged items, including whether changes in the cash flows of the hedging instruments are expected to offset changes in the cash flows of hedged items. The Group documents its risk management objective and strategy for undertaking its hedge transactions.
The fair values of derivative financial instruments designated in hedge relationships are disclosed in note 3.1(a). Movements in the hedging reserve in shareholders’ equity are shown in note 3
1
. The full fair value of a hedging derivative is classified as a
non-current
asset or liability when the remaining maturity of the hedged item is more than 12 months; it is classified as a current asset or liability when the remaining maturity of the hedged item is less than 12 months. Trading derivatives are classified as a current asset or liability.
Cash flow hedges that qualify for hedge accounting

The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in the cash flow hedge reserve within equity. The gain or loss relating to the ineffective portion is recognized immediately in the statements of profit or loss, within Other gains/(losses) – net.
When swap contracts are used to hedge forecast transactions the Group may designate the full change in fair value of the swap contract as the hedging instrument. The gains or losses relating to the effective portion of the change in fair value of the entire swap contract are recognized in the cash flow hedge reserve within equity.

Amounts accumulated in equity are reclassified in the periods when the hedged item affects the statements of profit or loss as follows:
Where the hedged item subsequently results in the recognition of a
non-financial
asset (such as inventory), the deferred hedging gains and losses are included within the initial cost of the asset. The deferred amounts are ultimately recognized in the statements of profit or loss as the hedged item affects profit or loss (for example through cost of sales).

When a hedging instrument expires, or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative deferred gain or loss and deferred costs of hedging in equity at that time remains in equity until the forecast transaction occurs, resulting in the recognition of a
non-financial
asset such as inventory. When the forecast transaction is no longer expected to occur, the cumulative gain or loss and deferred costs of hedging that were reported in equity are immediately reclassified to Other gains/(losses) - net.
Derivatives that do not qualify for hedge accounting

Certain derivative instruments do not qualify for hedge accounting. Changes in the fair value of any derivative instrument that does not qualify for hedge accounting are recognized immediately in the statements of profit or loss and are included in Other gains/(losses) - net.

2.14

Inventories
Inventories are valued at the lower of cost and net realizable value. Cost is determined using the weighted average cost method. The cost of finished goods and work in progress comprises raw materials, direct labor, other direct costs and related production overheads (based on normal operating capacity). It excludes borrowing costs. The net realizable value is determined based on the estimated selling price in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale.

2.15

Contract liabilities
A contract liability is recognized when the customer pays
non-refundable
consideration before the Group recognizes the related revenue (see note 2.26). A contract liability would also be recognized if the Group has an unconditional right to receive
non-refundable
consideration before the Group recognizes the related revenue. In such cases, a corresponding receivable would also be recognized (see note 2.16).
When the contract includes a significant financing component, the contract balance includes interest accrued under the effective interest method (see note 2.27).

2.16

Trade and other receivables
A receivable is recognized when the Group has an unconditional right to receive consideration. A right to receive consideration is unconditional if only the passage of time is required before payment of that consideration is due. If revenue has been recognized before the Group has an unconditional right to receive consideration, the amount is presented as a contract asset.
Trade receivables that do not contain a significant financing component are initially measured at their transaction price.
Receivables are subsequently stated at amortized cost using the effective interest method less allowance for credit losses (see note 2.12(a)).

2.17

Cash and cash equivalents
In the consolidated cash flow statements, cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value, and bank overdrafts. Bank overdrafts are presented within borrowings in current liabilities in the statements of financial position. Cash and cash equivalents are assessed for expected credit losses (ECL) in accordance with the policy set out in note 2.12(a).

2.18

Share capital
Ordinary shares are classified as equity.
Incremental costs directly attributable to the issue of new shares are shown in equity as a deduction, net of tax, from the proceeds.

2.19

Safety production fund
Under China’s law and regulation, the Group is required to accrue safety production fund at a certain percentage of the sales of dangerous goods. The fund is earmarked for improving the safety of production. The fund is accrued from retained earnings to other reserves and converted back to retained earnings when used.

2.20

Trade and other payables
Trade and other payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade and other payables are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as
non-current
liabilities.
Trade and other payables generally are financial liabilities and are recognized initially at fair value plus transaction costs and subsequently measured at amortized cost unless the effect of discounting would be immaterial, in which case they are stated at invoice amounts.

2.21

Borrowings
Borrowings are initially recognized at fair value, net of transaction costs incurred. Borrowings are subsequently measured at amortized cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognized in the statements of profit or loss over the period of the borrowings using the effective interest method.
Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalized as a
pre-payment
for liquidity services and amortized over the period of the facility to which it relates.
Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the end of the reporting period.

2.22

Borrowings costs
General and specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.
Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalization.
Other borrowing costs are expensed in the period in which they are incurred.

2.23

Current and deferred income tax
The tax expense for the period comprises current and deferred tax. Tax is recognized in the statements of profit or loss, except to the extent that it relates to items recognized in other comprehensive income or directly in equity. In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively.

(a)

Current income tax
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the statements of financial position date in the countries where the Company’s subsidiaries, associates and joint ventures operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.

(b)
Deferred income tax

Inside basis differences

Deferred income tax is recognized, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. However, deferred tax liabilities are not recognized if they arise from the initial recognition of goodwill, the deferred income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the statements of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled.

Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.

Outside basis differences

Deferred income tax liabilities are provided on taxable temporary differences arising from investments in subsidiaries, associates and joint arrangements, except for deferred income tax liability where the timing of the reversal of the temporary difference is controlled by the Group and it is probable that the temporary difference will not reverse in the foreseeable future. Generally, the Group is unable to control the reversal of the temporary difference for associates. Only when there is an agreement in place that gives the Group the ability to control the reversal of the temporary difference in the foreseeable future, deferred tax liability in relation to taxable temporary differences arising from the associate’s undistributed profits is not recognized.

Deferred income tax assets are recognized on deductible temporary differences arising from investments in subsidiaries, associates and joint arrangements only to the extent that it is probable the temporary difference will reverse in the future and there is sufficient taxable profit available against which the temporary difference can be utilized.

(c)

Offsetting

Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities and when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.

2.24

Employee benefits

(a)
Short-term employee benefits

Salaries, annual bonuses, paid annual leave and the cost of
non-monetary
benefits are accrued in the year in which the associated services are rendered by employees. Where payment or settlement is deferred and the effect would be material, these amounts are stated at their present values.

(b)
Pension obligations

The PRC employees of the Group are covered by various PRC government-sponsored defined-contribution pension plans under which the employees are entitled to a monthly pension based on certain formulas. The relevant government agencies are responsible for the pension liability to these employees when they retire. The Group contributes on a monthly basis to these pension plans for the employees which are determined at a certain percentage of their salaries. Under these plans, the Group has no obligation for post-retirement benefits beyond the contribution made. Contributions to these plans are expensed as incurred and contributions paid to the defined contribution pension plans for a staff are not available to reduce the Group’s future obligations to such defined-contribution pension plans even if the staff leaves the Group.

(c)

Termination benefits

Termination benefits are payable when employment is terminated by the Group before the normal retirement date, or whenever an employee accepts voluntary redundancy in exchange for these benefits. The Group recognizes termination benefits at the earlier of the following dates: (a) when the Group can no longer withdraw the offer of those benefits; and (b) when the entity recognizes costs for a restructuring that is within the scope of IAS 37 and involves the payment of terminations benefits. In the case of an offer made to encourage voluntary redundancy, the termination benefits are measured based on the number of employees expected to accept the offer. Benefits falling due more than 12 months after the end of the reporting period are discounted to present value.

2.25

Provisions and contingent liabilities

Provisions for environmental restoration, restructuring costs and legal claims are recognized when: the Group has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount has been reliably estimated. Restructuring provisions comprise lease termination penalties and employee termination payments. Provisions are not recognized for future operating losses.

Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. A provision is recognized even if the likelihood of an outflow with respect to any one item included in the same class of obligations may be small.

Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a
pre-tax
rate that reflects current market assessments of the time value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognized as interest expense.

Where it is not probable that an outflow of economic benefits will be required, or the amount cannot be estimated reliably, the obligation is disclosed as a contingent liability, unless the probability of outflow of economic benefits is remote. Possible obligations, whose existence will only be confirmed by the occurrence or
non-occurrence
of one or more future events are also disclosed as contingent liabilities unless the probability of outflow of economic benefits is remote.

2.26

Revenue recognition

(a)

Sales of petroleum and chemical products

The Group manufactures and sells petroleum and chemical products. Sales are recognized when control of the products has transferred, being when the products are delivered to or accepted by the customer. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the customer, and either the customer has accepted the products in accordance with the sales contract, or the Group has objective evidence that all criteria for acceptance have been satisfied. Advance from customers but goods not yet delivered is recorded as contract liabilities and is recognized as revenue when a customer obtains control over the relevant goods.

Revenue excludes value added tax and is after deduction of any estimated trade discounts.

The Group has elected to apply the practical expedient that contract costs incurred related to contracts with an amortization period of less than one year have been expensed as incurred. The Group also applies the practical expedient in paragraph 121 of IFRS 15 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

(b)
Overseas shipping services

The Group arranges overseas shipping services for the customer and revenue is recognized over time and based on the actual shipping service provided to the end of the reporting period as a proportion of the total services to be provided, because the customer receives and uses the benefits simultaneously. This is determined based on the actual passages of time (days) relative to the total expected shipping days.

2.27
Interest income

Interest income from financial assets at FVPL is included in Other gains/(losses) - net, see note 8 below. Interest income on financial assets at amortized cost and financial assets at FVOCI calculated using the effective interest method is recognized in the consolidated statements of profit or loss as part of other income.

Interest income is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for financial assets that subsequently become credit-impaired. For credit-impaired financial assets the effective interest rate is applied to the net carrying amount of the financial asset (after deduction of the loss allowance).

Interest income is presented as Finance income where it is earned from financial assets that are held for cash management purposes, see note 9 below.

2.28
Dividend income

Dividend income is recognized when the right to receive payment is established.

2.29
Government grants

Grants from the government are recognized at their fair value where there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions.

Government grants relating to costs are deferred and recognized in the statements of profit or loss over the period necessary to match them with the costs that they are intended to compensate.

Grants that compensate the Group for the cost of an asset are deducted from the carrying amount of the asset and consequently are effectively recognized in the statements of profit or loss over the useful life of the asset by way of reduced depreciation expense.

2.30
Leases

The Group leases various land, buildings, equipment, vehicles and others. Rental contracts of buildings, equipment, vehicles and others are typically made for fixed periods of 1 to 30 years. Rental contracts of land use rights are typically made for fixed periods of 30 to 50 years. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions.

Leases are recognized as a
right-of-use
asset and a corresponding liability at the date at which the leased asset is available for use by the Group.

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments:

•
fixed payments (including
in-substance
fixed payments), less any lease incentives receivable,

•
variable lease payment that are based on an index or a rate, initially measured using the index or rate as at the commencement date,

•
amounts expected to be payable by the Group under residual value guarantees,

•
the exercise price of a purchase option if the Group is reasonably certain to exercise that option, and

•
payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option.
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the Group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the
right-of-use
asset in a similar economic environment with similar terms, security and conditions.
To determine the incremental borrowing rate, the Group:

•
where possible, uses recent third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing conditions since third party financing was received

•
uses a
build-up
approach that starts with a risk-free interest rate adjusted for credit risk for leases held by the Group, which does not have recent third party financing, and

•
makes adjustments specific to the lease, e.g., term, country, currency and security.
Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.

Right-of-use
assets are measured at cost comprising the following:

•

the amount of the initial measurement of lease liability,

•

any lease payments made at or before the commencement date less any lease incentives received,

•

any initial direct costs, and

•

restoration costs.

Right-of-use
assets are generally depreciated over the shorter of the asset’s useful life and the lease term on a straight - line basis, as follows:

Land use rights

20 - 50 years

Buildings
   2 - 8 years

Equipment
   2 - 3 years

Others
   2 - 4 years

Payments associated with short-term leases of equipment and vehicles are recognized on a straight-line basis as an expense in the statements of profit or loss. Short-term leases are leases with a lease term of 12 months or less. A single discount rate was applied to the portfolio of the leases with reasonably similar characteristics.
Lease income from operating leases where the Group is a lessor is recognized as income on a straight-line basis over the lease term. Initial direct costs incurred in obtaining an operating lease are added to the carrying amount of the underlying asset and recognized as expense over the lease term on the same basis as lease income. The respective leased assets are included in the statement
s
of financial position based on their nature.

2.31
Dividend distribution
Dividend distribution to the Company’s shareholders is recognized as a liability in the Group’s financial statements in the period in which the dividends are approved by the Company’s shareholders.

2.32
Research and development costs
Research and development costs comprise all costs that are directly attributable to research and development activities or that can be allocated on a reasonable basis to such activities. Research and development costs are recognized as intangible assets when the following criteria are met:

•
it is technically feasible to complete the research and development project so that it will be available for use or sale;

•
management intends to complete the research and development project, and use or sell it;

•
it can be demonstrated how the research and development project will generate economic benefits;

•
there are adequate technical, financial and other resources to complete the development and the ability to use or sell the research and development project; and

•
the expenditure attributable to the research and development project during its development phase can be reliably measured.
Other research and development expenditures that do not meet these criteria are recognized as an expense as incurred. Research and development costs previously recognized as an expense are not recognized as an asset in a subsequent period.

2.33
Related parties

(a)
A person, or a close member of that person’s family, is related to the Group if that person:

(i)
has control or joint control over the Group;

(ii)
has significant influence over the Group; or

(iii)
is a member of the key management personnel of the Group or the Group’s parent.

(b)
An entity is related to the Group if any of the following conditions applies:

(iv)
The entity and the Group are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others).

(v)
One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member).

(vi)
Both entities are joint ventures of the same third party.

(vii)
One entity is a joint venture of a third entity and the other entity is an associate of the third entity.

(viii)
The entity is a post-employment benefit plan for the benefit of employees of either the Group or an entity related to the Group. (ix) The entity is controlled or jointly controlled by a person identified in (i).

(x)
A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity).

(xi)
The entity, or any member of a Group of which it is a part, provides key management personnel services to the Group or to the Group’s parent.

Close members of the family of a person are those family members who may be expected to influence, or be influenced by, that person in their dealings with the entity.

2.34
Rounding of amounts

All amounts disclosed in the consolidated financial statements and notes have been rounded off to the nearest thousand currency units unless otherwise stated.

v3.23.1

Financial Risk Management
12 Months Ended

Dec. 31, 2022

Disclosure of nature and extent of risks arising from financial instruments [abstract]

Financial risk management

3
Financial risk management

3.1
Financial risk factors

The Group’s activities exposed it to a variety of financial risks: market risk (including foreign exchange risk,
cash
flow and fair value interest rate risk and commodity price risk), credit risk and liquidity risk. The Group’s overall risk management programmer focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the Group’s financial performance.

Where all relevant criteria are met, hedge accounting is applied to remove the accounting mismatch between the hedging instrument and the hedged item.

(a)
Derivatives

The Group has the following derivative financial instruments in the following line items in the statements of financial position:

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Current derivative financial instrument assets


Commodity swaps contracts applied hedge accounting
   48,614    —

Commodity swaps contracts at fair value through profit or loss
   32,791    —





Total derivative financial assets
   81,405    —





Current derivative financial instrument liabilities


Commodity swaps contracts at fair value through profit or loss
   (23,804 )    —





Total derivative financial liabilities
   (23,804 )    —





(i)
Classification of derivatives

Derivatives are only used for economic hedging purposes and not as speculative investments. However, where derivatives do not meet the hedge accounting criteria, they are classified as ‘held for trading’ for accounting purposes and are accounted for at fair value through profit or loss. They are presented as current assets or liabilities to the extent they are expected to be settled within 12 months after the end of the reporting period.

The Group’s accounting policy for its cash flow hedges is set out in note 2.13.

(ii)
Fair value measurement

For information about the methods and assumptions used in determining the fair value of derivatives refer to note 3.3.

(iii)
Hedging reserves

The following table provides a reconciliation of the hedging reserve in respect of commodity price risk and shows the effectiveness of the hedging relationships:


Pre-tax
   Tax effect
Post-tax

   amount
RMB’000    RMB’000    amount
RMB’000

Balance at 1 January 2022
   48,613    (12,153 )    36,460

Effective portion of the cash flow hedge recognized in other comprehensive income
   375,701    (93,925 )    281,776

Amounts reclassified to profit or loss
   (107,009 )    26,752    (80,257 )

Reclassified to inventory
   (317,305 )    79,326    (237,979 )







Balance at 31 December 2022
   —      —      —







(iv)

Amounts recognized in the consolidated statements of profit or loss

In addition to the amounts disclosed in the reconciliation of hedging reserves above, the following amounts were recognized in the consolidated statements of profit or loss in relation to derivatives:

   2021    2022

   RMB’000    RMB’000

Net gains/(losses) on commodity swaps contracts not qualifying as hedges included in other gains / (losses) - net
   18,997    (35,434 )

Net gains on foreign exchange forward contracts not qualifying as hedges included in other gains / (losses) - net
   —      7,583

Net losses on foreign exchange option contracts not qualifying as hedges included in other gains / (losses) - net
   (151 )    —





Total
   18,846    (27,851 )





Hedge effectiveness

Hedge effectiveness is determined at the inception of the hedge relationship, and through periodic prospective effectiveness assessments, to ensure that an economic relationship exists between the hedged item and hedging instrument.

The Group enters into commodity swaps contracts that have similar critical terms as the hedged item, such as reference rate, payment dates, transaction price, oil variety and oil quantity.

Hedge ineffectiveness for commodity swaps contracts may occur due to the changes in the timing of the hedged transactions. There was no recognized ineffectiveness during the year ended 31 December 2022 in relation to the commodity swaps.

As at 31 December 2022, the Group did not have commodity contracts of oil designed as qualified cash flow hedges. As at 31 December 2021, the Group had certain commodity contracts of crude oil designed as qualified cash flow hedges, which will be matured over the next 10 months. The fair value of such cash flow hedges is RMB48,614 thousand recognized as derivative financial assets in the consolidated statement
s
of financial position.

(b)
Market risk

(i)
Foreign exchange risk

The Group’s major operational activities are carried out in Mainland China and a majority of the transactions are denominated in RMB. Nevertheless, the Group is exposed to foreign exchange risk arising from the recognized assets and liabilities, and future transactions denominated in foreign currencies, primarily with respect to US dollar. The Group’s finance department at its headquarter is responsible for monitoring the amount of assets and liabilities, and transactions denominated in foreign currencies to minimize the foreign exchange risk. For the years ended 31 December 2021 and 31 December 2022, the Group used foreign exchange forward contracts and foreign exchange option contracts to mitigate its exposure to foreign exchange risk respect to US dollar.

As at 31 December 2022, there were no foreign exchange forward contract and foreign exchange option contract that had not been matured (31 December 2021: Nil).

As at 31 December 2022, if US dollar and HK dollar had weakened/strengthened by 5% against RMB with all other variables held constant, the Group’s net loss for the year ended 31 December 2022 would decrease/increase by RMB 1,751 thousand (31 December 2021: net profit would decrease/increase by RMB 2,292 thousand) before considering the impact of forward and option contracts as a result of foreign exchange gains/losses which is mainly resulted from the translation of US dollar denominated trade receivables and payables.

The aggregate net foreign exchange (losses) / gains recognized in the consolidated statements of profit or loss were:

   2021    2022

   RMB’000    RMB’000

Net foreign exchange (losses)/gains included in Other gains/(losses) - net (note 8)
   (1,861 )    21,969

(ii)
Cash flow and fair value interest rate risk

The Group’s interest rate risk arises from interest-bearing borrowings and short-term bonds. Borrowings obtained at variable rates expose the Group to cash flow interest rate risk. Borrowings obtained at fixed rates expose the Group to fair value interest rate risk. The Group determines the relative proportions of its fixed rate and floating rate contracts depending on the prevailing market conditions.

The Group’s finance department at its headquarter continuously monitors the interest rate position of the Group. Increases in interest rates will increase the cost of new borrowing and the interest expenses with respect to the Group’s outstanding floating rate borrowings, and therefore could have a material adverse effect on the Group’s financial position. The Group makes adjustments timely with reference to the latest market conditions and may enter into interest rate swap agreements to mitigate its exposure to interest rate risk. For the years ended 31 December 2021 and 31 December 2022, the Group did not enter into any interest rate swap agreements.

At the reporting date, the interest rate profile of the Group’s interest-bearing financial instruments was as follows.



2021



2022



RMB’000



RMB’000

Fixed rate:


Time deposits with maturity less than one year
   7,350,000    3,000,000

Time deposits with maturity more than one year
   5,500,000    3,300,000

Borrowings
   (1,500,000 )    (1,550,000 )

Lease liabilities
   (4,613 )    (16,251 )





   11,345,387    4,733,749





Variable rate:


Cash and cash equivalents
   5,112,010    889,413

Borrowings
   (759,800 )    (700,000 )





   4,352,210    189,413





As at 31 December 2022, if interest rates on the floating rate financial instruments had risen/fallen by 50 basis points while all other variables had been held constant, the Group’s net loss would have decreased / increased by approximately RMB 730 thousand (2021: RMB 16,252 thousand increased / decreased in net profit), mainly as a result of higher/lower interest interest on floating rate cash and cash equivalents.

(iii)
Commodity price risk

The Group principally engages in processing crude oil into synthetic fibers, resins and plastics, intermediate petrochemicals and petroleum products. The selling price of petroleum products is periodically adjusted by the government department based on the market price adjustment mechanism, and generally in connection with the crude oil price. The fluctuations in prices of crude oil, refined oil products and intermediate petrochemicals and petroleum products could have significant impact on the Group. The Group uses commodity swaps contracts to manage a portion of this risk.

As at 31 December 2021, the Group had certain unexpired commodity contracts of crude oil and refined oil designated as qualified cash flow hedges balances of which have been disclosed in note 3.1 (a). As at 31 December 2022, the Group had no
unexpired
commodity contracts of crude oil and refined oil designated as qualified cash flow hedges.

(c)
Credit risk

(i)
Risk management
Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in a financial loss to the Group. Credit risk is managed on group basis. It mainly arises from cash and cash equivalents, time deposits with banks, bills receivable, derivative financial assets, trade receivables measured at amortized cost and FVOCI, other receivables etc.
The Group expects that there is no significant credit risk associated with cash at bank (including time deposits and structured deposits), bills receivable and derivative financial assets because the counterparties are banks and financial institutions with a relatively higher credit rating, which the Group considers to represent low credit risk. Management does not expect that there will be any significant losses from
non-performance
by these counterparties.
In addition, the Group has policies to limit the credit exposure on trade receivables, other receivables. The Group assesses the credit quality of and sets credit limits on its customers by taking into account their financial position, the availability of guarantee from third parties, their credit history and other factors such as current market conditions. The credit history of the customers is regularly monitored by the Group. In respect of customers with a poor credit history, the Group will use written payment reminders, or shorten or cancel credit periods, to ensure the overall credit risk of the Group is limited to a controllable extent.
The Group considers the probability of default upon initial recognition of a financial asset and whether there has been a significant increase in credit risk on an ongoing basis throughout each reporting period. To assess whether there is a significant increase in credit risk, the Group compares the risk of a default occurring on the asset as at the reporting date with the risk of default as at the date of initial recognition. It considers available reasonable and supportive forward-looking information. Especially the following indicators are incorporated:

•
internal credit rating;

•
external credit rating (as far as available);

•
actual or expected significant adverse changes in business, financial or economic conditions that are expected to cause a significant change to the debtors’ ability to meet its obligations;

•
actual or expected significant changes in the operating results of the debtors;

•
significant increases in credit risk on other financial instruments of the same debtors;

•
significant changes in the value of the collateral supporting the obligation or in the quality of third-party guarantees or credit enhancements;

•
significant changes in the expected performance and behaviour of the debtors, including changes in the payment status of debtors, etc.
Regardless of the analysis above, a significant increase in credit risk is presumed if a debtor is more than 30 days past due in making a contractual payment.
It has other monitoring procedures to ensure that
follow-up
action is taken to recover overdue debts. In addition, the Group reviews regularly the recoverable amount of each individual trade receivables to ensure that adequate impairment losses are made for irrecoverable amounts. Significant concentrations of credit risk primarily arise when the Group has significant exposure to individual customers. As at 31 December 2022, 95.57% and 97.65% of the total trade receivables were due from the Group’s largest customer and the five largest customers respectively within the Group (31 December 2021: 93.20% and 94.70%).
For other receivables, management makes periodic collective assessment as well as individual assessment on the recoverability of other receivables based on historical settlement records and forward-looking information. The management believes that there is no material credit risk inherent in the Group’s outstanding balance of other receivable.

(ii)
Impairment of financial assets
The Group has three types of financial assets that are subject to the expected credit loss model:

•
Trade receivables for sales of goods and from the providing services,

•
Other financial assets carried at amortized cost, and

•
Debt instruments carried at FVOCI.
While cash and cash equivalents, time deposits with banks and bills receivable are also subject to the impairment requirements of IFRS 9, the identified impairment loss was immaterial.

Trade receivables

The Group applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables (including trade receivables with related parties) and financial assets at fair value through other comprehensive income.

To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due.

The expected credit loss rates are based on the payment profiles of sales over a period of 36 months before 31 December 2021 and 31 December 2022 respectively and the corresponding historical credit losses experienced within this period. The historical loss rates are adjusted to reflect current and forward-looking information on macroeconomic factors affecting the ability of the customers to settle the receivables
.

Impairment losses on trade receivables are presented as provision of impairment losses on financial assets within operating (loss) / profit. Subsequent recoveries of amounts previously written off are credited against the same line item.

Other financial assets at amortized cost

Other financial assets at amortized cost include other receivables.

As at 31 December 2021 and 31 December 2022, the internal credit rating of other receivables was all performing. The Group has assessed that the expected credit losses for these receivables are not material under the 12 months expected losses method.

Management considered that there was no significant increase in credit risk for other receivables including receivables from related parties by taking into account of their past history of making payments when due and current ability to pay, and thus the impairment provision recognized during the period was limited to 12 months expected losses.

The (reversal)/provision for loss allowance was recognized in the statements of profit or loss in reversal/(provision) of impairment losses on financial assets.

Trade and other receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan with the Group, and a failure to make contractual payments for a period of greater than 120 days past due.

Impairment losses on trade and other receivables are presented as (provision)/ reversal of impairment losses within operating profit. Subsequent recoveries of amounts previously written off are credited against the same line item.

Debt instruments carried at FVOCI

Debt instruments carried at FVOCI include trade receivables and bills receivable with a business model which is achieved both by collecting contractual cash flows and selling of these assets. The loss allowance for debt instruments is recognized in the statements of profit or loss and reduces the fair value loss otherwise recognized in OCI.

As at 31 December 2021 and 31 December 2022, no loss allowance was provided for financial assets at FVOCI.

(iii)

Provision of impairment losses on financial assets recognized in the consolidated statements of profit or loss

During the year, the following (losses) /recoveries were recognized in provision of impairment losses on financial assets in relation to impaired financial assets:

   2021
RMB’000    2022
RMB’000

Impairment losses


- provision in loss allowance for trade receivables
   (1,354 )    (778 )

- provision in loss allowance for other receivables
   (1 )    (4,727 )

Impairment losses reversed
   —      139





Provision of impairment losses on financial assets
   (1,355 )    (5,366 )





(iv)
Financial assets at fair value through profit or loss

The Group is also exposed to credit risk in relation to investments such as derivative financial instruments, which are measured at fair value through profit or loss. The maximum exposure at the end of the reporting period is the carrying amount of these investments.

(d)
Liquidity risk

Cash flow forecast is performed by the operating entities of the Group and aggregated by Group finance. Group finance monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities from major financial institutions so that the Group does not breach borrowing limits or covenants on any of its borrowing facilities to meet the short-term and long-term liquidity requirements.
The liquidity of the Group is primarily dependent on its ability to maintain adequate cash inflow from operations, the renewal of its short-term bank loans and its ability to obtain adequate external financing to support its working capital and meet its debt obligation when they become due. As at 31 December 2022, the Group had credit facilities with several PRC financial institutions which provided the Group to draw down to RMB 9,200,000 thousand, within which amounted to RMB 6,950,000 thousand were unused. Management assessed that all the facilities could be renewed upon the expiration dates.
Surplus cash held by the operating entities over and above balance required for working capital management is transferred to the Group treasury. As at 31 December 2022, the Group held cash and cash equivalents of RMB 889,413 thousand (31 December 2021: RMB 5,112,010 thousand) (note 23), time deposits with banks - current of RMB 3,108,919 thousand (31 December 2021: RMB 7,386,607 thousand) (note 24) and trade receivables (including trade receivables with related parties and those carried at fair value through other comprehensive income (“FVOCI”) of RMB 2,957,771 thousand (31 December 2021: RMB 1,568,800 thousand), that are expected to readily generate cash inflows for managing liquidity risk.

The table below analyzes the Group’s financial liabilities into relevant maturity groupings based on the remaining period at the consolidated statements of financial position date to the contractual maturity date. The amounts disclosed in the table are the contractual undiscounted cash flows.



As at 31 December 2021



Contractual maturities of financial liabilities



Less than 1 year
RMB’000



Between
1 and 2 years
RMB’000



Between
2 and 5 years
RMB’000



Over
5 years
RMB’000



Total
RMB’000



Carrying
amount

Non-derivatives













Borrowings
   1,578,817    7,665    704,914    —      2,291,396

2,259,800

Lease liabilities
   3,814    730    814    —      5,358

4,613

Bills payables
   562,593    —      —      —      562,593

562,593

Trade payables
   1,527,706    —      —      —      1,527,706

1,527,706

Other payables
   1,003,860    —      —      —      1,003,860

1,003,860

Amounts due to related parties excluded non-financial liabilities
   4,910,255    —      —      —      4,910,255

4,910,255











   9,587,045    8,395    705,728    —      10,301,168

10,268,827













Derivatives


Derivative financial liabilities
   23,804    —      —      —      23,804

23,804















As at 31 December 2022



Contractual maturities of financial liabilities



Less than 1 year



Between
1 and 2 years



Between
2 and 5 years



Over
5 years



Total



Carrying
amount



RMB’000



RMB’000



RMB’000



RMB’000



RMB’000

Non-derivatives













Borrowings
   1,570,282    704,914    —      —      2,275,196

2,250,000

Lease liabilities
   9,395    7,531    655    —      17,581

16,251

Bills payables
   24,951    —      —      —      24,951

24,951

Trade payables
   1,818,453    —      —      —      1,818,453

1,818,453

Other payables
   1,083,130    —      —      —      1,083,130

1,083,130

Amounts due to related parties excluded
non-financial
liabilities
   7,877,323    —      —      —      7,877,323

7,877,323













   12,383,534    712,445    655    —      13,096,634

13,070,108













Derivatives


Derivative financial liabilities
   —      —      —      —      —

—













3.2
Capital management

The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern, so that it can continue to provide returns for shareholders and benefits for other stakeholders, by pricing products and services commensurately with the level of risk and by securing access to finance at a reasonable cost.
The Group actively and regularly reviews and manages its capital structure to maintain a balance between the higher shareholder returns that might be possible with higher levels of borrowings and the advantages and security afforded by a sound capital position, and makes adjustments to the capital structure in light of changes in economic conditions.
The Group monitors its capital structure on the basis of an adjusted net
debt-to-capital
ratio. For this purpose, adjusted net debt is defined as total debt (which includes interest-bearing loans and borrowings, and lease liabilities) plus unaccrued proposed dividends, less cash and cash equivalents. Adjusted capital comprises all components of equity, other than amounts recognized in equity relating to cash flow hedges,less unaccrued proposed dividends.

The Group’s adjusted net
debt-to-capital
ratio at 31 December 2022 was as follows:

   Note    2022
RMB’000

Current liabilities:


Borrowings
   26    1,550,000

Lease liabilities
   15    8,738



      1,558,738

Non-current
liabilities:


Borrowings
   26    700,000

Lease liabilities
   15    7,513



Total Debt
      2,266,251

Less: Cash and cash equivalents
   23    (889,413 )



Adjusted net debt
      1,376,838



Total equity
      26,355,363

Less: Hedging reserve
      —



Adjusted capital
      26,355,363



Adjusted net
debt-to-capital
ratio
      5 %



As cash and cash equivalents exceed total borrowings and short-term bonds, which was resulted primarily from profitability, there was no net debt as at 31 December 2021.

3.3
Fair value estimation

The table below analyzes the Group’s financial instruments carried at fair value as at 31 December 2021 and 2022 by the level of the inputs to valuation techniques used to measure fair value. Such inputs are categorized into three levels within a fair value hierarchy as follows:

•
The fair value of financial instruments traded in active markets (such as publicly traded derivatives and equity securities) is based on quoted market prices at the end of the reporting period. The quoted market price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.

•
The fair value of financial instruments that are not traded in an active market (for example, over–the–counter derivatives) is determined using valuation techniques that maximize the use of observable market data and rely as little as possible on entity- specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is in

cluded in level 2.

•
If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3. This is the case for unlisted equity securities.

   As at 31 December 2021

   Note Level 1    Level 2    Level 3    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Recurring fair value measurements


Financial assets


Financial assets measured at fair value through profit or loss


- Commodity swaps contracts
   3.1(a) —      32,791    —      32,791

Financial assets at fair value through other comprehensive income


- Trade and bills receivable
   25 —      1,072,690    —      1,072,690

- Equity investments
   25 —      —      5,000    5,000

- Commodity swaps contracts
   3.1(a) —      48,614    —      48,614









   —      1,154,095    5,000    1,159,095









Financial liabilities


Financial liabilities measured at fair value through profit or loss


- Commodity swaps contracts
   —      23,804    —      23,804









   —      23,804    —      23,804









Amounts due to related parties – measured at fair value through profit or loss (FVPL)


—



1,388,286



—



1,388,286









   As at 31 December 2022

   Note Level 1    Level 2    Level 3    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Recurring fair value measurements


Financial assets


Financial assets measured at fair value through other comprehensive income


- Trade and bills receivable
   25 —      582,354    —      582,354

- Equity investments
   25 —      —      5,000    5,000









   —      582,354    5,000    587,354









Valuation techniques and inputs used in Level 2 fair value measurements
The fair value of commodity swaps contract is the estimated amount that the Group would receive or pay to terminate the swap at the end of the reporting period, taking into account the current interest rates and the current creditworthiness of the swap counterparties.
The fair value of trade and bills receivable is estimated as the present value of the future cash flows, discounted at the market interest rates at the balance sheet date.
The fair value of amounts due to related parties is the estimated amount that the Group would settle the liability by returning certain quantity of crude oil at the end of the reporting period, referring to market price of the related crude oil. As at 31 December 2022, if market price of crude oil had risen/fallen by 10% while all other variables had been held constant, the Group’s net loss would have increased / decreased by approximately RMB nil (2021: RMB 89,787 thousand decreased / increased in net profit ).
During the year ended 31 December 2022, there were no transfers between Level 1 and Level 2, or transfers into or out of Level 3. The Group’s policy is to recognize transfers between levels of fair value hierarchy as at the end of the reporting period in which they occur.
Financial assets and financial liabilities not measured at fair value mainly represent trade receivables, other receivables, amounts due from related parties excluded prepayments, trade payables, amounts due to related parties, other payables (except for the staff salaries and welfare payables and taxes payables), borrowings and short-term bonds. The carrying amounts of these financial assets and liabilities not measured at fair value are a reasonable approximation of their fair value.

The following table presents the changes in level 3 items for the year ended 31 December 2022:

   Equity
investments
RMB’000    Structured
deposits
RMB’000    Total
RMB’000

As at 31 December 2020
   5,000    —      5,000

Acquisitions
   —      8,150,000    8,150,000

Disposals
   —      (8,247,921 )    (8,247,921 )

Fair value change
   —      97,921    97,921







As at 31 December 2021
   5,000    —      5,000







Acquisitions
   —      1,000,000    1,000,000

Disposals
   —      (1,011,124 )    (1,011,124 )

Fair value change
   —      11,124    11,124







As at 31 December 2022
   5,000    —      5,000

v3.23.1

Critical accounting judgement and estimates
12 Months Ended

Dec. 31, 2022

CriticalAccountingEstimatesAndAssumptionsAbstract [Abstract]

Critical accounting judgement and estimates

4
Critical accounting judgement and estimates

4.1
Critical accounting judgements in applying the Group’s accounting policies
In the process of applying the Group’s accounting policies, management has made the following accounting judgement:

(a)
Classification of financial assets
The classification depends on the Group’s business model for managing the financial assets and the contractual terms of the cash flows. The Group determines the business model for managing financial assets at the level of the financial asset portfolio. The factors considered include the way to evaluate and report the performance of financial assets to key management personnel, the risks affecting the performance of financial assets and their management methods, and the way for relevant business management personnel to obtain remuneration, etc.

When evaluating whether the contractual cash flow of financial assets is consistent with the basic lending arrangements, the Group has the following main judgments: whether the time distribution or amount of the principal may change in the duration due to prepayment and other reasons; whether the interest only includes the time value of money, credit risk, other basic lending risks and the consideration of cost and profit. For example, does the amount of prepayment only reflect the outstanding principal and the interest based on the outstanding principal, as well as the reasonable compensation paid for the early termination of the contract.

4.2
Sources of estimation uncertainty
Significant sources of estimation uncertainty are as follows:

(a)

Net realizable value (“NRV”) of inventories
As described in note 2.14, inventories are valued at the lower of cost and net realizable value. The net realizable value is determined based on the estimated selling prices in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale. These estimates are based on the current market condition and historical experience of selling products of similar nature. It could change significantly as a result of competitor actions in response to changes in market conditions.

Management reassesses these estimations at the end of each reporting period to ensure inventory is measured at the lower of cost and net realizable value.

(b)
Impairments for
non-current
assets
As discussed in note 2.12, at the end of each reporting period, the Group estimates the recoverable amount of an asset or a cash-generating unit (“CGU”) (a portion of which related to certain production facilities), at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses. If circumstances indicate that the carrying amount of the asset or CGU may not be recoverable, the asset or CGU may be considered “impaired”, and an impairment loss may be recognized.
The recoverable amount of assets or CGUs is the higher of the fair value less costs of disposal and value in use. As the fair value of certain assets or CGUs may not be publicly available, the Group uses all readily available information in determining an amount that is a reasonable approximation of recoverable amount, including estimates based on reasonable and supportable assumptions for projections of product sales and operating costs and discount rate. In particular, in determining the value in use of the Group’s specific CGUs, significant judgements are required on the accounting estimates which are based on the assumptions relating to product sales growth rates, related costs growth rates and discount rate applied.

(c)

Useful life and residual value of property, plant and equipment
Property, plant and equipment, are depreciated on a straight-line basis over the estimated useful lives of the assets, after taking into account the estimated residual value. Management reviews the estimated useful lives and estimated residual value of the assets annually in order to determine the amount of depreciation expense to be recorded during any reporting period. The useful lives are based on the Group’s historical experience with similar assets, taking into account anticipated technological changes. The depreciation expense for future periods is adjusted if there are significant changes from previous estimates.

v3.23.1

Segment Information and Revenue
12 Months Ended

Dec. 31, 2022

Disclosure of operating segments [abstract]

Segment information

5
Segment information and revenue

5.1
Segment information
The Group manages its business by divisions, which are organized by business lines. In view of the fact that the Company and its subsidiaries operate substantially all in the PRC, no geographical segment information is presented.
In a manner consistent with the way in which information is reported internally to the Group’s chief operating decision maker, Board of Directors, for the purposes of resource allocation and performance assessment, the Group has identified the following five reportable segments. No operating segments have been aggregated to form the following reportable segments.

Segment results, assets and liabilities include items directly attributable to a segment as well as those that can be allocated on a reasonable basis. Unallocated items mainly comprise interests in associates and joint ventures, deferred tax assets, cash and cash equivalents, time deposits, and incomes relating to these assets (such as share of net profits/(losses) of associates and joint ventures accounted for using the equity method and interest income), derivative financial assets, borrowings, short-term bonds and interest expenses, derivative financial liabilities, and deferred tax liabilities.

The Group principally operates in five operating segments: synthetic fibres, resins and plastics, intermediate petrochemicals, petroleum products and trading of petrochemical products. Synthetic fibres, resins and plastics, intermediate petrochemicals and petroleum products are produced through intermediate steps from the principal raw material of crude oil. The specific products of each segment are as follows:

(i)
The petroleum products segment is equipped with crude oil refinery facilities used to produce qualified refined gasoline, fuel, diesel oil, heavy oil and liquefied petroleum gas, and provide raw materials for the Group’s downstream petrochemical processing facilities.

(ii)
The intermediate petrochemicals segment primarily produces
p-xylene,
benzene and ethylene oxide. The intermediate petrochemicals produced by the Group are both served as raw materials in the production of other petrochemicals, resins, plastics and synthetic fibres, and sold to external customers.

(iii)
The resins and plastics segment produces primarily polyester chips, polyethylene resins, polypropylene resins and PVA granules. The polyester chips are used to produce polyester fibres, coating and containers. Polyethylene resins and plastics are used to produce insulated cable, mulching films and moulded products such as housewares and toys. Polypropylene resins are used for films, sheets and moulded products such as housewares, toys, consumer electronics and automobile parts.

(iv)
The synthetic fibres segment produces primarily polyester, acrylic fibres and carbon fibres, which are mainly used in the textile and apparel industries.

(v)
The trading of petrochemical products segment is primarily engaged in importing and exporting of petrochemical products. The products are sourced from international and domestic suppliers.

(vi)
Other operating segments represent the operating segments that do not meet the quantitative threshold for determining reportable segments. These include investment property leasing, service provision and a variety of other commercial activities.

2020
   Petroleum
products
RMB’000 Intermediate
petrochemicals
RMB’000 Resins and
plastics
RMB’000 Synthetic fibres
RMB’000 Trading of
petrochemical
products
RMB’000 Others
RMB’000 Total
RMB’000

Total segment revenue
   49,711,547 19,777,574 9,576,944 1,480,576 12,023,744 1,583,236 94,153,621

Inter segment revenue
   (6,631,343 ) (11,526,322 ) (101,057 ) —   (438,634 ) (832,690 ) (19,530,046 )



Revenue from external customers
   43,080,204 8,251,252 9,475,887 1,480,576 11,585,110 750,546 74,623,575



Timing of revenue recognition


- At a point in time
   43,080,204 8,251,252 9,475,887 1,480,576 11,583,709 750,546 74,622,174

- Over time
   —   —   —   —   1,401 —   1,401



   43,080,204 8,251,252 9,475,887 1,480,576 11,585,110 750,546 74,623,575



Segment result – (loss)/profit from operations
   (2,198,705 ) 581,597 1,262,029 (364,211 ) 42,039 211,015 (466,236 )



2021
   Petroleum
products
RMB’000 Intermediate
petrochemicals
RMB’000 Resins and
plastics
RMB’000 Synthetic fibres
RMB’000 Trading of
petrochemical
products
RMB’000 Others
RMB’000 Total
RMB’000

Total segment revenue
   65,528,687 26,454,844 10,176,285 1,381,443 12,972,922 1,625,705 118,139,886

Inter segment revenue
   (10,454,529 ) (15,619,770 ) (170,255 ) (445 ) (1,912,789 ) (783,606 ) (28,941,394 )



Revenue from external customers
   55,074,158 10,835,074 10,006,030 1,380,998 11,060,133 842,099 89,198,492



Timing of revenue recognition


- At a point in time
   55,074,158 10,835,074 10,006,030 1,380,998 11,020,323 842,099 89,158,682

- Over time
   —   —   —   —   39,810 —   39,810



   55,074,158 10,835,074 10,006,030 1,380,998 11,060,133 842,099 89,198,492



Segment result – profit/(loss) from operations
   2,967,030 (635,155 ) 52,215 (854,077 ) 43,729 (141,510 ) 1,432,232



2022
   Petroleum
products
RMB’000 Intermediate
petrochemicals
RMB’000 Resins and
plastics
RMB’000 Synthetic fibres
RMB’000 Trading of
petrochemical
products
RMB’000 Others
RMB’000 Total
RMB’000

Total segment revenue
   62,729,318 26,112,700 7,416,830 413,981 12,938,663 1,641,243 111,252,735

Inter segment revenue
   (11,575,451 ) (15,536,795
)
(71,778 ) (98 ) (922,077 ) (703,380 ) (28,809,579 )



Revenue from external customers
   51,153,867 10,575,905 7,345,052 413,883 12,016,586 937,863 82,443,156



Timing of revenue recognition


- At a point in time
   51,153,867 10,575,905 7,345,052 413,883 11,917,827 937,863 82,344,397

- Over time
   —   —   —   —   98,759 —   98,759



   51,153,867 10,575,905 7,345,052 413,883 12,016,586 937,863 82,443,156



Segment result – profit/(loss) from operations
   972 (1,456,647 ) (1,252,524 ) (1,015,255 ) 12,838 (132,750 ) (3,843,366 )



   2020
RMB’000    2021
RMB’000    2022
RMB’000

Segment result – (loss)/profit from operations


Petroleum products
   (2,198,705 )    2,967,030    972

Intermediate petrochemicals
   581,597    (635,155 )    (1,456,647 )

Resins and plastics
   1,262,029    52,215    (1,252,524 )

Synthetic fibres
   (364,211 )    (854,077 )    (1,015,255 )

Trading of petrochemical products
   42,039    43,729    12,838

Others
   211,015    (141,510 )    (132,750 )







(Loss)/profit from operations
   (466,236 )    1,432,232    (3,843,366 )

Finance income – net
   332,274    414,569    443,328

Share of profit/(loss) of investments accounted for using the equity method
   724,740    874,285    (173,616 )







Profit/(loss) before taxation
   590,778    2,721,086    (3,573,654 )







Other profit and loss disclosures

   2020 2021 2022

   Depreciation
and
amortization Impairment
loss and
credit loss Inventory

write-down
Depreciation
and
amortization Impairment
loss and
credit loss Inventory

write-down
Depreciation
and
amortization Impairment
loss and
credit loss Inventory

write-down

   RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000

Petroleum products
   (917,637 ) —   (138,537 ) (975,492 ) (94,420 ) (782 ) (928,687 ) —   (37,900 )

Intermediate petrochemicals
   (465,425 ) (55,204 ) (15,418 ) (523,484 ) (297,632 ) (136,694 ) (414,999 ) (215,355 ) (248,518 )

Resins and plastics
   (138,204 ) —   (26,382 ) (86,183 ) (61,242 ) (168 ) (106,845 ) (25,102 ) (134,138 )

Synthetic fibres
   (78,030 ) 88,550 (39,657 ) (132,091 ) (135,683 ) (13,239 ) (140,885 ) (51,160 ) (104,713 )

Trading of petrochemical products
   (19,938 ) —   (788 ) (39,125 ) —   —   (35,345 ) —   —

Others
   (207,905 ) —   (106 ) (209,333 ) (28,392 ) —   (186,537 ) (9 ) —



   (1,827,139 ) 33,346 (220,888 ) (1,965,708 ) (617,369 ) (150,883 ) (1,813,298 ) (291,626 ) (525,269 )





As at 31 December



2021

Total assets
RMB’000



2022

Total assets
RMB’000

Allocated assets





Petroleum products

13,317,338

16,021,111

Intermediate petrochemicals

3,781,785

3,803,989

Resins and plastics

1,395,867

1,359,796

Synthetic fibres

1,919,194

2,734,193

Trading of petrochemical products

1,348,751

1,391,104

Others

2,700,327

2,765,693

Allocated assets

24,463,262

28,075,886

Unallocated assets

Investments accounted for using the equity method

4,088,888

3,504,393

Cash and cash equivalents

5,112,010

889,413

Time deposits with banks

12,968,042

6,498,478

Deferred tax assets

184,143

991,850

Derivative financial assets

81,405

—

Value added tax recoverable

13,322

1,057,463

Others

9,517

119,234

Unallocated assets

22,457,327

13,060,831

Total assets

46,920,589

41,136,717

   As at 31 December


2021
Total liabilities
RMB’000
   2022
Total liabilities
RMB’000

Allocated liabilities


Petroleum products
   9,749,806    8,159,960

Intermediate petrochemicals
   1,257,436    801,787

Resins and plastics
   1,327,587    1,309,344

Synthetic fibres
   490,211    531,455

Trading of petrochemical products
   1,257,750    1,370,346

Others
   112,876    251,328





Allocated liabilities
   14,195,666    12,424,220





Unallocated liabilities


Borrowings
   2,259,800    2,250,000

Deferred tax liabilities
   33,344    30,895

Derivative financial liabilities
   23,804    —

Others
   30,577    76,239





Unallocated liabilities
   2,347,525    2,357,134





Total liabilities
   16,543,191    14,781,354





   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Additions to property, plant and equipment, construction in progress,
right-of-use
assets, other
non-current
assets


Petroleum products
   779,392    708,342    544,806

Intermediate petrochemicals
   278,788    1,306,813    1,029,771

Resins and plastics
   139,212    44,495    54,220

Synthetic fibres
   496,125    1,748,868    1,573,781

Trading of petrochemical products
   378,292    71,917    16,603

Others
   222,080    234,023    235,406







   2,293,889    4,114,458    3,454,587







5.2
Revenue

The Group’s revenue from external customers are substantially all within Mainland China in 2020, 2021 and 2022. As at 31 December 2021 and 31 December 2022, assets are also substantially all within Mainland China.

Revenue of approximately RMB 52,190,120
thousand (2020: RMB38,651,385 thousand, 2021: RMB
59,766,489 thousand) are derived from a single customer. These revenues are attributable to the petroleum products and other segments .
Details of concentrations of credit risk arising from these customers are set out in note 3.1(c).

v3.23.1

Other Operating Income
12 Months Ended

Dec. 31, 2022

Other operating income [abstract]

Other operating income

6
Other operating income

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Government grants (a)
   61,296    35,944    33,055

Rental income from investment properties (note 17)
   81,608    81,923    75,159

Others
   5,772    7,438    2,427







   148,676    125,305    110,641







(a)
Government grants
Grants related to R&D, other tax refund and subsidies are included in the government grants line item. There are no unfulfilled conditions or other contingencies attaching to these grants.

v3.23.1

Other Operating Expenses
12 Months Ended

Dec. 31, 2022

Other operating expenses [abstract]

Other operating expenses

7
Other operating
expenses



2020



2021



2022



RMB’000



RMB’000



RMB’000

Cost related to lease of investment properties
   (15,625 )    (13,439 )    (12,037 )

Others
   (9,061 )    (31,273 )    (13,738 )







   (24,686 )    (44,712 )    (25,775 )

v3.23.1

Other Gains/(losses) - net
12 Months Ended

Dec. 31, 2022

Other gains/(losses) - net [abstract]

Other gains(losses) - net

8

Other gains/(losses) – net

   2020 2021 2022

   RMB’000 RMB’000 RMB’000

Net (losses) / gains on disposal of property, plant and equipment and other long-term assets
   (1,212 ) 48,671 (26,767 )

Gains from structured deposits (note a)
   114,283 97,921 11,124

Net losses on foreign exchange option contracts
   (376 ) (151 ) —

Net gains on foreign exchange forward contracts
   —   —   7,583

Net gains/(losses) on commodity swaps contracts not qualified for hedging accounting
   —   18,997 (35,434 )

Losses from disposal of a subsidiary
   —   —   —

Impairment losses for investment in an associate
   —   (28,392 ) —

Net foreign exchange gains / (losses)
   12,248 (1,861 ) 21,969

Losses on sale of FVOCI
   (9,513 ) (4,685 ) (3,148 )

Gains from entrusted loan receivables
   —   —   2,704

Net losses on disposal of inventories
   —   (19 ) (819 )



   115,430 130,481 (22,788 )



(a)
Gains from structured deposits
Structured deposits are financial products issued by banks, return of which are linked to the performance of the embedded index, like foreign exchange rate, interest rate and etc..

(b)
The effect of “6.18” No.1 ethylene glycol plant explosion accident
On 18 June 2022, a fire broke out in No.1 ethylene glycol plant of the intermediate petrochemicals segment of the Company, causing a fire on surrounding individual pipelines. Net losses due to the fire, including writing off of damaged fixed assets and inventories in the amount of RMB7,676 thousand and RMB819
thousand respectively, have been recorded in Other

gains/(losses)

- net, and compensation to casualties in the amount of RMB
1,010
thousand have been recorded in other operating expenses (2020 and 2021:
Nil).

v3.23.1

Finance Income and Expenses
12 Months Ended

Dec. 31, 2022

Finance income and expenses [abstract]

Finance income and expenses

9
Finance income and expenses

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Interest income from time deposits with maturity more than 3 months
   339,595    424,696    410,652

Interest income from time deposits with maturity less than 3 months
   83,812    71,402    124,468

Others
   7,821    12,657    6,710







Finance income
   431,228    508,755    541,830







Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss
   (101,732 )    (106,827 )    (122,638 )

Less: interest expense capitalized into construction in progress
   8,292    12,641    24,136







Net interest expenses
   (93,440 )    (94,186 )    (98,502 )

Net foreign exchange losses
   (5,514 )    —      —







Finance expenses
   (98,954 )    (94,186 )    (98,502 )







Finance income – net
   332,274    414,569    443,328

v3.23.1

Expense by Nature
12 Months Ended

Dec. 31, 2022

Expenses by nature [abstract]

Expense by nature

10
Expense by nature

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Cost of raw materials
   42,082,307    54,457,558    55,997,717

Cost of trading products
   11,467,420    10,929,127    11,910,488

Employee benefit expenses (note 11)
   3,143,219    3,456,765    3,545,720

Depreciation and amortization:


Property, plant and equipment (note 16)
   1,553,039    1,621,459    1,494,176

Investment properties (note 17)
   15,184    15,325    15,323

Other
non-current
assets (note 14)
   226,263    294,617    270,881

Right-of-use
assets (note 15)
   32,653    34,307    32,918

Repairs and maintenance expenses
   1,060,624    1,587,955    1,513,812

Changes of work in progress and finished goods
   862,652    (235,402 )    (78,255 )

Transportation costs
   274,002    238,405    193,144

Inventory write-down (note 21)
   220,888    150,883    525,269

External processing fee
   215,467    213,691    192,288

Commission expense (note 3
2
)
   104,598    110,552    90,341

Impairment loss of property, plant and equipment (note 16)
   87,570    587,622    286,260

Impairment loss of investments accounted for using equity method (note 20)
   —      28,392    —

Auditors’ remuneration – audit services
   7,800    6,837    6,837

Auditors’ remuneration –
non-audit
services
   —      129    129

Expenses relating to short - term leases
   3,731    6,938    14,774

v3.23.1

Employee Benefit Expenses
12 Months Ended

Dec. 31, 2022

Classes of employee benefits expense [abstract]

Employee benefit expenses

11
Employee benefit expenses

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Wages and salaries
   2,009,645    2,142,959    2,139,472

Social welfare costs
   714,484    861,375    921,971

Others
   419,090    452,431    484,277







Total employee benefit expense
   3,143,219    3,456,765    3,545,720







(a)

Employees of the Group’s subsidiaries in the PRC are required to participate in a defined contribution retirement scheme administered and operated by the local municipal government. The Group’s subsidiaries in the PRC contribute funds which are calculated on certain percentages of the average employee salary as stipulated by the local municipal government to the scheme to fund the retirement benefits of the employees.

In addition, the Group provides a supplementary retirement plan for its staff at rates not exceeding 8% of the salaries. The Group has no other material obligation for the payment of pension benefits associated with these plans beyond the annual contributions described above.

For the year ended 31 December 2022, the Group’s total contributions to defined contribution retirement plans was RMB 463,204 thousand.

(2020: RMB 342,073 thousand, 2021: RMB
431,818 thousand)

(c)
As at 31 December 2020, 31 December 2021 and 31 December 2022, there was
no material outstanding contribution to the above defined contribution retirement plans.

v3.23.1

Income Tax Benefits /(Expenses)
12 Months Ended

Dec. 31, 2022

Income tax [abstract]

Income tax benefits /(expenses)

12

Income tax benefits /(expenses)

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Current income tax
   (37,027 )    (590,668 )    (66,649 )

Deferred taxation
   102,647    (53,812 )    798,003







Income tax benefits / (expenses)
   65,620    (644,480 )    731,354







A reconciliation of the expected income tax calculated at the applicable tax rate and profit / (loss) before taxation, with the actual income tax is as follows:



Years ended 31 December



2020



2021



2022



RMB’000



RMB’000



RMB’000

Profit / (loss) before income tax
   590,778    2,721,086    (3,573,654 )







Expected PRC income tax at the statutory tax rate of 25%
   (147,695 )    (680,272 )    893,414

Tax effect of share of net profits / (losses) of investments accounted for using the equity method
   178,685    214,750    (46,787 )

Tax effect of other
non-taxable
income
   54,379    10,782    9,890

Tax effect of additional deductions for R&D expenses
   11,863    12,168    17,779

Tax effect of
non-deductible
loss, expenses and costs
   (51,543 )    (185,945 )    (67,330 )

True up for final settlement of enterprise income taxes in respect of previous years
   9,188    —      (54,017 )

Tax losses for which no deferred income tax asset was recognized
   (2,821 )    (21,225 )    (24,948 )

Utilization of previously unrecognized tax losses
   13,564    157    3,353

Tax effect of additional deduction for purchasing environmental protection equipment
   —      12,446    —

Derecognition of previously recognized tax losses
   —      (7,341 )    —







Actual income tax benefits / (expenses)
   65,620    (644,480 )    731,354







The provision for PRC income tax is calculated at the rate of
25
% (2020 and 2021:

25
%) on the estimated taxable income of the year ended
31 December 2022 determined in accordance with relevant income tax rules and
regul
ations. The Group did
not car
ry out business overseas and therefore does not incur overseas income taxes.

(a)

Current taxation in the consolidated statements of financial position represents:


2021
RMB’000
   2022
RMB’000

At the beginning of the year
   19,425    258,466

Provision for current income tax for the year
   590,668    66,649

Payment during the year
   (351,627 )    (376,765 )





At the end of the year
   258,466    (51,650 )

Representing


Income tax
   258,466    2,754

-Payable
   —      (54,404 )

-Prepaid
   258,466    (51,650 )





(b)
Movements in deferred tax assets and liabilities are as follows:

   Balance as at 1
January 2021
RMB’000
Credited/
(Charged) to
profit or
loss
RMB’000
   Credited/
(Charged) to
reserves
RMB’000    Balance as at
31 December
2021
RMB’000

Deferred tax assets:


Impairment for bad and doubtful debts and provision for inventories
   57,326    (977 )    —      56,349

Provision for impairment losses in property, plant and equipment and construction in progress
   226,435    131,776    —      358,211

Tax losses
   87,799    (87,799 )    —      —

Accruals and others
   130,986    (48,808 )    —      82,178









   502,546    (5,808 )    —      496,738









Deferred tax liabilities:


Difference in depreciation
   (283,739 )    (46,332 )    —      (330,071 )

Capitalization of borrowing costs
   (2,043 )    575    —      (1,468 )

Derivative financial instruments
   —      (2,247 )    (12,153 )    (14,400 )









   (285,782 )    (48,004 )    (12,153 )    (345,939 )









Deferred tax assets – net
   252,121    (55,825 )    (12,153 )    184,143

Deferred tax liabilities – net
   (35,357 )    2,013    —      (33,344 )

   Balance as at 1
January 2022
RMB’000
Credited/
(Charged) to
profit
or loss
RMB’000
   Credited/
(Charged) to
reserves
RMB’000    Balance as at
31 December
2022
RMB’000

Deferred tax assets:


Impairment for bad and doubtful debts and provision for inventories
   56,349    71,761    —      128,110

Provision for impairment losses in property, plant and equipment and construction in progress
   358,211    70,499    —      428,710

Tax losses

—
   872,648    —      872,648

Accruals and others
   82,178    (55,873 )    —      26,305









   496,738    959,035    —      1,455,773









Deferred tax liabilities:


Difference in depreciation
   (330,071 )    (163,492 )    —      (493,563 )

Capitalization of borrowing costs
   (1,468 )    213    —      (1,255 )

Derivative financial instruments
   (14,400 )    2,247    12,153    —









   (345,939 )    (161,032 )    12,153    (494,818 )









Deferred tax assets – net
   184,143    795,554    12,153    991,850

Deferred tax liabilities – net
   (33,344 )    2,449    —      (30,895 )

The Group recognizes deferred tax assets only to the extent that it is probable that future taxable income will be available against which the assets can be utilized. Based on the level of historical taxable income and projections for future taxable income over the periods which the deferred tax assets will be utilized, management believes that it is probable the Group will realize the benefits of these temporary differences for which deferred tax assets have been recognized.

(c)
Deferred tax assets not recognized:

As at 31 December 2022, certain subsidiaries of the Company did not recognize the deferred tax assets in respect of the impairment losses
on
property, plant and equipment amounting to RMB29,856 thousand (31 December 2021: RMB29,969 thousand), because it was not probable that the related tax benefit would be realized.

As at 31 December 2022, certain subsidiaries of the Company did not recognize the deferred tax assets in respect of tax losses of RMB 393,896 thousand (31 December 2021: RMB350,574 thousand) carried forward for PRC income tax purpose because it was not probable that the related tax benefit would be realized.

Tax losses carried
forw
ard that are not recognized as deferred tax assets will expire in the following years:

   2021    2022

   RMB’000    RMB’000

2022
   65,331    —

2023
   66,965    65,585

2024
   91,901    91,901

2025
   41,475    41,475

2026
   84,902    95,144

2027
   —      99,791





   350,574    393,896

v3.23.1

Earnings/(losses) Per Share
12 Months Ended

Dec. 31, 2022

Earnings per share [abstract]

Earnings/(losses) per share

13

Earnings/(losses) per share

(a)

Basic earnings/(losses) per share

Basic earnings/(losses) per share is calculated by dividing the profit/(loss) attributable to equity shareholders of the Company by the weighted average number of ordinary shares in issue during the year.



2020



2021



2022



RMB’000



RMB’000



RMB’000

Net profit/(loss) attributable to equity shareholders of the Company
   645,072    2,073,431    (2,846,156 )

Weighted average number of ordinary shares in issue (thousand of shares)
   10,823,814    10,823,814    10,819,622

Basic earnings/(losses) per share (RMB per share)
   RMB 0.060    RMB 0.192    RMB(0.263 )







Weighted average number of ordinary shares (thousand of shares)



2020



2021



2022

Issued ordinary shares at 1 January



10,823,814



10,823,814



10,823,814

Effect of shares repurchased (note 30)



—



—



(4,192

)







Weighted average number of ordinary shares at 31 December



10,823,814



   10,823,814



  10,819,622







(b)

Diluted earnings/(losses) per share

There were no dilutive potential ordinary shares for the years ended 31 December 2020, 2021 and 2022, therefore diluted earnings/(losses) per share is the same as basic earnings/(losses) per share.

v3.23.1

Other Non-current Assets
12 Months Ended

Dec. 31, 2022

Other non-current assets [abstract]

Other non-current assets

14
Other
non-current
assets

   Intangible
assets    Long-term
prepaid
expense    Investment
deposits    Total

   RMB’000    RMB’000    RMB’000    RMB’000

As at 1 January 2021


Cost
   85,908    1,069,157    —      1,155,065

Accumulated amortization
   (71,139 )    (658,967 )    —      (730,106 )









Net book amount
   14,769    410,190    —      424,959









Year ended 31 December 2021


Opening net book amount
   14,769    410,190    —      424,959

Additions
   —      657,465    —      657,465

Charge for the year
   (2,925 )    (291,692 )    —      (294,617 )









Closing net book amount
   11,844    775,963    —      787,807









As at 31 December 2021


Cost
   85,908    1,726,622    —      1,812,530

Accumulated amortization
   (74,064 )    (950,659 )    —      (1,024,723 )









Net book amount
   11,844    775,963    —      787,807









Year ended 31 December 2022


Opening net book amount
   11,844    775,963    —      787,807

Additions
   —      268,474    50,000    318,474

Charge for the year
   (2,924 )    (267,957 )    —      (270,881 )









Closing net book amount
   8,920    776,480    50,000    835,400









As at 31 December 2022


Cost
   85,908    1,995,096    50,000    2,131,004

Accumulated amortization
   (76,988 )    (1,218,616 )    —      (1,295,604 )









Net book amount
   8,920    776,480    50,000    835,400









For the year ended 31 December 2022, the amortization of intangible assets and long-term prepaid expense of RMB 270,881
thousand (2020: RMB226,263 thousand, 2021:
RMB294,617 thousand) has been charged in Cost of sales.

v3.23.1

Leases
12 Months Ended

Dec. 31, 2022

Disclosure of quantitative information about leases for lessee [abstract]

Leases

15

Leases

(a)

Amounts recognized in the consolidated statements of financial position

The consolidated statements of financial position shows the following amounts relating to leases:

As at 31 December

   202
1
   202
2

   RMB’000    RMB’000

Right-of-use
assets


Land use rights
   380,764    363,720

Buildings
   3,288    14,540

Equipment
   625    373

Others
   966    1,172





   385,643    379,805





Lease liabilities


Current
   3,229    8,738

Non-current
   1,384    7,513





   4,613    16,251





For the year ended 31 December 2022, additions to the
right-of-use
assets were RMB27,275
thousand (2020: RMB 109,238 thousand, including 102,283 thousand generated by the acquisition of a subsidiary, 2021: RMB
9,534 thousand). At 31 December 2022, the lease liabilities were repayable as follows:

   2022

   RMB’000

Within 1 year
   8,738

After 1 year but within 2 years
   6,945

After 2 years but within 5 years
   568



   16,251



(b)

Amounts recognized in the consolidated statement
s
of profit or loss

The consolidated statements of profit or loss shows the following amounts relating to leases:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Depreciation charge of
right-of-use
assets


Land use rights
   (15,965 )    (17,044 )    (17,044 )

Buildings
   (15,481 )    (15,677 )    (14,089 )

Equipment
   (449 )    (399 )    (547 )

Others
   (758 )    (1,187 )    (1,238 )







   (32,653 )    (34,307 )    (32,918 )







Interest expense (included in Finance expenses)
   (887 )    (537 )    (1,039 )

Expense relating to short-term leases (included in Cost of sales)
   (3,731 )    (6,938 )    (14,774 )

The total cash outflow for leases in 2022 was RMB27,843
thousand (2020: RMB20,204 thousand, 2021: RMB
24,482 thousand).

v3.23.1

Property, Plant and Equipment
12 Months Ended

Dec. 31, 2022

Property, plant and equipment [abstract]

Property, plant and equipment

16
Property, plant and equipment

   Buildings    Plant and
machinery    Vehicles and
other
equipment    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Cost:


At 1 January 2021
   3,481,210    42,742,330    1,958,220    48,181,760

Additions
   —      161,118    15,646    176,764

Transferred from construction in progress (note 18)
   130,947    1,476,065    92,962    1,699,974

Reclassification
   267,662    (275,880 )    8,218    —

Disposals
   (4,717 )    (737,634 )    (62,782 )    (805,133 )

Transferred from investment properties (note 17)
   1,164    —      —      1,164

Transferred to construction in progress (note 18)
   (2,091 )    (1,260 )    (15,404 )    (18,755 )

Transferred to investment properties (note 17)
   (83 )    (7 )    —      (90 )









At 31 December 2021 and 1 January 2022
   3,874,092    43,364,732    1,996,860    49,235,684

Additions
   132    187,460    39,934    227,526

Transferred from construction in progress (note 18)
   609,303    1,768,395    90,219    2,467,917

Reclassification
   9,088    (47,399 )    38,311    —

Disposals
   (2,596 )    (393,686 )    (51,813 )    (448,095 )

Transferred from investment properties (note 17)
   47    —      —      47

Others
   1,208    —      —      1,208









At 31 December 2022
   4,491,274    44,879,502    2,113,511    51,484,287









Accumulated depreciation:


At 1 January 2021
   (2,396,564 )    (31,700,912 )    (1,457,854 )    (35,555,330 )

Charge for the year
   (88,234 )    (1,419,669 )    (113,556 )    (1,621,459 )

Reclassification
   (214,041 )    216,706    (2,665 )    —

Written back on disposals
   3,652    626,865    55,709    686,226

Transferred from investment properties (note 17)
   (1,088 )    —      —      (1,088 )

Transfer to construction in progress (note 18)
   46    735    5,642    6,423

Transferred to investment properties (note 17)
   80    7    —      87









At 31 December 2021 and 1 January 2022
   (2,696,149 )    (32,276,268 )    (1,512,724 )    (36,485,141 )

Charge for the year
   (95,661 )    (1,270,423 )    (128,092 )    (1,494,176 )

Reclassification
   (787 )    6,340    (5,553 )    —

Written back on disposals
   2,469    344,469    50,036    396,974

Transferred from investment properties (note 17)
   (45 )    —      —      (45 )









At 31 December 2022
   (2,790,173 )    (33,195,882 )    (1,596,333 )    (37,582,388 )









   Buildings    Plant and
machinery    Vehicles
and other
equipment    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Impairment losses:


At 1 January 2021
   (53,792 )    (850,967 )    (8,649 )    (913,408 )

Charge for the year
   (793 )    (586,147 )    (682 )    (587,622 )

Written back on disposals
   —      60,018    501    60,519

Reclassification
   (26,133 )    26,270    (137 )    —









At 31 December 2021 and 1 January 2022
   (80,718 )    (1,350,826 )    (8,967 )    (1,440,511 )

Charge for the year
   (984 )    (283,624 )    (1,652 )    (286,260 )

Written back on disposals
   —      4,264    112    4,376

Reclassification
   (2,146 )    2,202    (56 )    —









At 31 December 2022
   (83,848 )    (1,627,984 )    (10,563 )    (1,722,395 )









Net book value:


At 31 December 2022
   1,617,253    10,055,636    506,615    12,179,504









At 31 December 2021
   1,097,225    9,737,638    475,169    11,310,032









(i)
The Group recognized impairment loss on property, plant and equipment in relation to certain production facilities of RMB 212,410 thousand for the year ended 31 December 2022. Due to deteriorating market conditions, the increasing production cost is not expected to be covered by the estimated selling price of the products, the Group identified an impairment indicator for property, plant and equipment in relation to certain production facilities, including No.1 ethylene glycol plant and No.2 ethylene glycol plant under intermediate petrochemicals segment, and performed an impairment assessment of these assets based on their estimated recoverable amounts, as a result the carrying amount of these assets were written down to their recoverable amount of RMB 265,377 thousand.
The recoverable amounts of above production facilities are estimated using the present value of future cash flows based on the financial budgets approved by management covering a five-year period. Forecasted cash flows are developed using several key assumptions, including the product sales growth rates, related costs growth rates (“forecasted growth rates”) and discount rate. The forecasted growth rates are based on past business performance and market participants’ expectations for market development, which are consistent with the forecasts included in industry reports. The discount rate used is a
pre-tax
ratio of 9% and reflects specific risks relating to the Group.

(ii)
During the year ended 31 December 2022, a number of production facilities were idle or obsolete. The Group does not expect to have future economic benefits recoverable from the use of those production facilities. There is no alternative use of those production facilities which is specifically designed. The recoverable amounts of property, plant and equipment related to those production facilities are estimated to be their residual value. As a result, impairment loss of RMB49,230 thousand under synthetic fibres segment and RMB24,620 thousand under resins and plastics segment was made against the carrying amounts of those assets.
As a result of these assessments, an impairment loss of RMB286,260 thousand on property, plant and equipment was recognized in “cost of sales” for the year ended 31 December 2022.
For the year ended 31 December 2021, impairment loss of RMB 587,622 thousand on property, plant and equipment was recognized in Cost of sales for the excess of carrying amount over its recoverable amount.
For the year ended 31 December 2020, impairment loss of RMB 87,570 thousands has been recognized in Cost of sales for the excess of carrying amount over its recoverable amount.

v3.23.1

Investment Properties
12 Months Ended

Dec. 31, 2022

Disclosure of detailed information about investment property [abstract]

Investment properties

17
Investment properties

   RMB’000

Cost:


As at 1 January 2021
   627,488

Transferred from property plant and equipment (note 16)
   90

Transferred to property plant and equipment (note 16)
   (1,164 )



At 31 December 2021 and 1 January 2022
   626,414



Transferred to property plant and equipment (note 16)
   (47 )



At 31 December 2022
   626,367



Accumulated depreciation:


At 1 January 2021
   (259,902 )

Charge for the year
   (15,325 )

Transferred from property plant and equipment (note 16)
   (87 )

Transferred to property plant and equipment (note 16)
   1,088



At 31 December 2021 and 1 January 2022
   (274,226 )



Charge for the year
   (15,323 )

Transferred from property plant and equipment (note 16)
   —

Transferred to property plant and equipment (note 16)
   45



At 31 December 2022
   (289,504 )



Net book value:


At 31 December 2022
   336,863



At 31 December 2021
   352,188



As at 31 December 2022, the Group has no contractual obligations for future repairs and maintenance (31 December 2020 and 31 December 2021: Nil).
Investment properties represent certain floors of an office building leased to other entities including related parties.

a.
The fair value of the investment properties of the Group as at 31 December 2022 was estimated by the directors to be approximately RMB 1,236,686 thousand by reference to market values of similar properties in the nearby area (31 December 2021: RMB 1,217,987 thousand). This fair value estimation was at level 3 of fair value hierarchy by using market observable inputs. The investment properties have not been valued by external independent appraisers.

b.
Rental income of RMB
75,159
thousand was recognized in other operating income by the Group for the year ended 31 December 2022 (2020: RMB81,608 thousand, 2021: RMB
81,923
thousand).

c.
Leasing arrangements
The investment properties are leased out under operating leases. The leases typically run for an initial period of 1 to 3 years, with an option to renew the lease after that date at which time all terms are renegotiated. Lease payments are usually renegotiated every year to reflect market rentals.

Undiscounted lease payments under
non-cancellable
operating leases in place at the reporting date will be receivable by the Group in future periods as follows :



2021



2022



RMB’000



RMB’000

Within 1 year
   49,420    52,138

Between 1 and 2 years
   39,137    6,638

Above 2 years
   —    6,522





   88,557    65,298

v3.23.1

Construction in Progress
12 Months Ended

Dec. 31, 2022

Construction in progress [abstract]

Construction in progress

18

Construction in progress

   202
1
   202
2

   RMB’000    RMB’000

As at 1 January
   1,710,124    3,293,177

Additions
   3,270,695    2,927,950

Disposal
   —    (4,749 )

Transferred to property plant and equipment (note 16)
   (1,699,974 )    (2,467,917 )

Transferred from property plant and equipment (note 16)
   12,332    —





As at 31 December
   3,293,177    3,748,461





As at 31 December 2022, the impairment loss in construction in progress was RMB24,486
thousand (31 December 2020: RMB24,486 thousand, 31 December 2021: RMB
24,486 thousand).
For the year ended 31 December 2022, the group had no impairment write-off due to the disposal of construction in progress (2020: RMB 10,175 thousand, 2021: Nil).

For the year ended 31 December 2022, the Group capitalized borrowing costs amounting to RMB24,136
thousand (2021: RMB
12,641 thousand) on qualifying assets. Borrowing costs were capitalized at the weighted average rate of its borrowings of 1.78
% (2020: 2.79%, 2021:
2.85%).

v3.23.1

Subsidiaries
12 Months Ended

Dec. 31, 2022

Disclosure of subsidiaries [abstract]

Subsidiaries

19

Subsidiaries

The following list contains only the particulars of subsidiaries which principally affected the results, assets or liabilities of the Group. The class of shares held is ordinary unless otherwise stated.







Proportion of ownership interest



Name of company



Place of
incorporation
and business



Particulars of paid-
up capital ’000



Group’s
effective
interest



Held by
the Company



Held by a
subsidiary



Principal activity

Shanghai Petrochemical Investment Development Company Limited
(“Toufa”)    Mainland
China    RMB1,000,000    100.00    100.00    —      Investment
management

China Jinshan Associated Trading Corporation (“Jinmao”)    Mainland
China    RMB      25,000    67.33    67.33    —      Import and
export of
petrochemical
products and
equipment

Shanghai Jinchang Engineering Plastics Company Limited (“Jinchang”)    Mainland
China    USD        9,154    74.25    —      74.25    Production of
polypropylene
compound
products

Shanghai Golden Phillips Petrochemical Company Limited (“Jinfei”)    Mainland
China    RMB   415,623    100.00    —      100.00    Production of
polyethylene
products

Shanghai Jinshan Trading Corporation (“JMGJ”)    Mainland
China    RMB   100,000    67.33    —      67.33    Import and
export of
petrochemical
products

Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd.
(“Jinlian”)    Mainland
China    RMB   400,000    100.00    —      100.00    Trading of
petrochemical
products

a. On 30 June 2020, one of the Company’s subsidiaries, Toufa acquired
100
% share of Zhejiang Zhonghang Oil Petrochemical Storage and Transportation Co., Ltd., renamed as Jinlian, from China Aviation Oil Group Logistics Co., Ltd., with the total purchase consideration of RMB
340,369
thousand.

v3.23.1

Investments Accounted for Using the Equity Method
12 Months Ended

Dec. 31, 2022

Investments accounted for using equity method [abstract]

Investments accounted for using the equity method

20

Investments accounted for using the equity method
The amounts recognized in the consolidated statements of financial position are as follows:



As at 31 December



2021



2022



RMB’000



RMB’000

Associates

– Share of net assets
   3,812,845    3,027,632

Joint ventures


– Share of net assets
   276,043    476,761





As at 31 December
   4,088,888    3,504,393





The amounts recognized in the share of net profits / (losses) of associates and joint ventures accounted for using the equity method are as follows:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Associates
   678,077    825,132    (188,549 )

Joint ventures
   46,663    49,153    14,933

   724,740    874,285    (173,616 )





(a)

Investment in associates



2021



2022



RMB’000



RMB’000

As at 1 January
   5,146,160    3,812,845

Additions (note i)
   26,000    96,672

Decrease caused by associate’s capital reduction (note ii)
   (1,460,258 )    —

Share of net profits / (losses)
   825,132    (188,549 )

Other comprehensive income
   16,639    (23,771 )

Cash dividends distribution
   (712,436 )    (669,565 )

Impairment (note iii)
   (28,392 )    —





As at 31 December
   3,812,845    3,027,632





Set out below are the material associates of the Group as at 31 December 2022. The associates as
listed
below have share capital consisting solely of ordinary shares, which are held directly by the Group; the country of incorporation or registration is also their principal place of business.

The following list contains only the particulars of material associates, all of which
are
unlisted
corporate
entities whose quoted market price is not available:









Proportion of ownership interest

Name of company



Form of
business
structure



Place of
incorporation
and business



Particulars of paid-
up capital ‘000



Group’s
effective
interest

Held by the
Company

Held by a
subsidiary

Principal activity

Shanghai Secco Petrochemical Company
Limited (“Shanghai Secco”) (note ii)
   Incorporated    Mainland
China    RMB 3,115,180    20.00 % 20.00 % —   Manufacturing
and
distribution of
chemical
products

Shanghai Chemical Industry Park
Development Company Limited
(“Chemical Industry”)    Incorporated    Mainland
China    RMB 2,372,439    38.26 % 38.26 % —   Planning,
development
and operation
of the
Chemical
Industry Park
in Shanghai,
PRC

Shanghai Jinsen Hydrocarbon Resins
Company Limited (“Jinsen”)    Incorporated    Mainland
China    RMB    193,695    40.00 % —   40.00 % Production of
resins
products

Shanghai Azbil Automation Company
Limited (“Azbil”)    Incorporated    Mainland
China    RMB      24,440    40.00 % —   40.00 % Service and
maintenance
of building
automation
systems and
products

Shanghai Shidian Energy Company Limited
(“Shidian Energy”) (note i)
   Incorporated    Mainland
China    RMB 1,000,000    40.00 % —   40.00 % Electric power
supply
There are no contingent liabilities relating to the Group’s
interest
in the associates.

i.
Pursuant to the articles of association of Shidian Energy in August 2019, Toufa agreed to make a capital contribution of
RMB
400,000 thousand to acquire 40% share of Shidian Energy. In 2022, Toufa contributed RMB80,000 thousand to Shidian Energy and the total investment amounted to RMB 400,000
thousand as at 31 December 2022 (31 December 202
0
: RMB 320,000 thousand, 31 December 2021:
RMB
320,000 thousand).

ii.
According to the resolution of the Board of Directors on 9 July 2021, the Company, Sinopec Corp., and Sinopec Shanghai Gaoqiao Petrochemical Company Limited (“Gaoqiao Company”) approved to reduce their
paid-in
capital in Shanghai Secco, an associate of the Company, by a total amount of RMB 7,300,811,000 in proportion to their shareholding ratios of 20%, 30% and 50% respectively. Among them, the Company reduced its investment cost in Shanghai Secco by approximately RMB 1,460,258 thousand and the Company has received the amount of the capital reduction in December 2021.

iii.
During the year ended 31 December 2021, the directors of the Company reviewed the carrying value of the Group’s associate and joint ventures. The entire carrying amount of the interests in an associate is tested for impairment in accordance with IAS 36 Impairment of Assets as a single asset by comparing its recoverable amount with its carrying amount. Since the recoverable amount of investment in an associate Jinsen is lower when compared with its carrying amount, impairment loss of RMB 28,392 thousand is recognized during the year ended 31 December 2021. The recoverable amount of the investment in an associate was based on its fair value less costs to sell. The fair value was estimated with reference to the transaction price of a recent share transaction of the associate.
All of the above associates are accounted for using the equity method in the consolidated financial statements.

Summarized financial information of the material associates, adjusted for any differences in accounting policies, and reconciled to the carrying amounts in the consolidated financial statements, are disclosed below:

Summarized financial information for material associates
Set out below are the summarized financial information for the above associates.

Summarized statements of financial position for material associates

As at 31 December 2021
   Shanghai Secco
RMB’000
Chemical Industry
RMB’000
Jinsen
RMB’000 Azbil
RMB’000 Shidian Energy
RMB’000

Current


– Current assets
   6,066,119 4,133,397 63,192 274,697 804,470

– Current liabilities
   (5,433,872 ) (1,789,223 ) (10,476 ) (111,472 ) (34,565 )

Non-current


–
Non-current
assets
   5,735,360 4,431,463 58,737 15,698 121,051

–
Non-current
liabilities
   (66 ) (619,306 ) —   (7,506 ) (15,827 )



Net assets
   6,367,541 6,156,331 111,453 171,417 875,129



Group’s effective interest
   20.00 % 38.26 % 40.00 % 40.00 % 40.00 %

Group’s share of net assets
   1,273,508 2,355,412 44,581 68,567 350,052

Unrealized upstream and downstream transaction
   (3,157 ) — —   —   (15,979 )

Unentitled portion (note i)
   —   (331,826 ) —   —   —

Impairment loss
   —   — (28,392 ) —   —



Carrying value
   1,270,351 2,023,586 16,189 68,567 334,073



As at 31 December 2022
   Shanghai Secco
RMB’000 Chemical Industry
RMB’000 Jinsen
RMB’000 Azbil
RMB’000 Shidian Energy
RMB’000

Current


– Current assets
   4,941,394 4,327,622 49,810 276,707 950,614

– Current liabilities
   (8,977,030 ) (1,765,771 ) (17,905 ) (125,216 ) (38,133 )

Non-current


–
Non-current
assets
   5,683,409 4,480,448 50,360 12,338 166,068

–
Non-current
liabilities
   (1 ) (651,729 ) —   (5,518 ) (35,355 )



Net assets
   1,647,772 6,390,570 82,265 158,311 1,043,194



Group’s effective interest
   20.00 % 38.26 % 40.00 % 40.00 % 40.00 %

Group’s share of net assets
   329,554 2,445,032 32,906 63,324 417,278

Unrealized upstream and downstream transaction
   4,342 —   —   —   (12,615 )

Unentitled portion (note i)
   —   (329,890 ) —   —   —

Impairment loss
   —   —   (28,392 ) —   —



Carrying value
   333,896 2,115,142 4,514 63,324 404,663



Note i: Unentitled portion represented the earnings from sales of the lands injected by Government in Chemical Industry that cannot be shared by other shareholders.

Summarized statements of comprehensive income for material
associates

   Shanghai Secco    Chemical
Industry Jinsen Azbil    Shidian Energy

2020    RMB’000    RMB’000 RMB’000 RMB’000    RMB’000

Revenue
   21,626,059    1,683,096 187,580 340,905    472,640

Post-tax
profit/(loss) from continuing operations
   2,412,802    404,117 (8,232 ) 48,264    36,696

Other comprehensive income
   —      (30,089 ) —   —      —

Total comprehensive income
   2,412,802    374,028 (8,232 ) 48,264    36,696

Dividend received from the associate
   473,600    32,522 —   9,200    —

2021
   Shanghai Secco
Chemical
Industry
Jinsen Azbil    Shidian Energy

   RMB’000 RMB’000 RMB’000 RMB’000    RMB’000

Revenue
   29,723,223 1,709,110 165,499 427,378    489,490

Post-tax
profit/(loss) from continuing operations
   3,125,904 396,761 (16,657 ) 61,711    33,269

Other comprehensive income
   —   43,488 —   —      —





Total comprehensive income
   3,125,904 440,249 (16,657 ) 61,711    33,269





Dividend received from the associate
   634,341 52,225 —   19,200    —





2022
   Shanghai Secco Chemical
Industry Jinsen Azbil    Shidian Energy

   RMB’000 RMB’000 RMB’000 RMB’000    RMB’000

Revenue
   24,096,829 1,806,888 119,098 384,655    508,704

Post-tax
(loss)/profit from continuing operations
   (1,947,579 ) 441,369 (29,188 ) 46,894    28,065

Other comprehensive income
   —   (62,130 ) —   —      —





Total comprehensive income
   (1,947,579 ) 379,239 (29,188 ) 46,894    28,065





Dividend received from the associate
   554,438 55,477 —   24,000    24,000





Aggregate information of associates that are not individually material:

   2021    2022

   RMB’000    RMB’000

Aggregate carrying value of investments at 31 December
   100,079    106,093

Aggregate amounts of the Group’s share of those associates:


Profit for the year
   5,655    876



Total comprehensive income
   5,655    876



Dividend received from the associate
   6,670    11,650

(b)
Investment in joint ventures

   2021    2022

   RMB’000    RMB’000

As at 1 January
   241,674    276,043

Addition (note i)
   50,000    200,000

Share of profit
   49,153    14,933

Cash dividends distribution
   (64,784 )    (14,215 )



As at 31 December
   276,043    476,761





Details of the Group’s interest in the joint venture, which is accounted for using the equity method in the consolidated financial statements, are as follows:

The following list contains only the particulars of material joint ventures, all of the Group’s joint ventures are unlisted corporate entities whose quoted market price is not available:

Name of joint venture



Form of
business
structure



Place of
incorporation
and business



Particulars of
paid-up
capital ’000



Proportion of ownership interest

Principal activity



Group’s
effective
interest

Held by
the
Company



Held by a
subsidiary

Linde-SPC
Gases Company Limited (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)

Incorporated    Mainland China    USD     32,000    50.00 % —      50.00 % Production and sales
of industrial gases

Shanghai Petrochemical Pressure Vessel Testing Center (“JYJC”)
Incorporated    Mainland China    RMB    10,000    50.00 % —      50.00 %
Providing
inspection and
testing service

Shanghai Petrochemical Yangu Gas
Development Company Limited
(“Yangu Gas”) Incorporated    Mainland China    USD     10,560    50.00 % —      50.00 % Production and sales
of industrial gases

Shanghai Jinshan Baling New Materials
Co., Ltd. (“Baling Materials”) (note i)
(“Linde”), formerly known as
“BOC-SPC Gases Company Limited”) Incorporated    Mainland China    RMB  500,000    50.00 % —      50.00 %

Production and sales
of new styrene
thermoplastic
elastomer materials

i.
In September 2021, Sinopec Baling Petrochemical Co., Ltd and the Company jointly established Baling
Materials
, the Company agreed to make cash contribution of RMB 400,000 thousand to acquire 50% share of Baling Materials. In 2022, the Group made new investment of RMB 200,000 thousand into Barling Materials. As at 31 December 2022, the Company has made a
paid-up
capital contribution of RMB 250,000 thousand.

Summarized financial information for joint ventures

Set out below are the summarized financial information for joint ventures which are accounted for using the equity method.

Summarized statements of financial position for joint ventures

As at 31 December 2021



Linde
RMB’000



JYJC
RMB’000



Yangu Gas
RMB’000



Baling Materials
RMB’000

Current


Cash and cash equivalents
   226,860 16,914 72,916 6,062

Other current assets (excluding cash)
   74,652 5,065 11,149 28,418



Total current assets
   301,512 21,979 84,065 34,480

Total current liabilities
   (62,356 ) (3,356 ) (3,262 ) —



Non-current


Total
non-current
assets
   109,366 1,577 19,034 65,520

Total
non-current
liabilities
   (16,303 ) —   —   —



Net assets
   332,219 20,200 99,837 100,000



Group’s effective interest
   50% 50% 50% 50%

Interest in joint ventures
   166,110 10,100 49,919 50,000

Unrealized downstream transactions
   (86 ) —   —   —



Carrying value
   166,024 10,100 49,919 50,000



As at 31 December 2022



Linde



JYJC



Yangu
Gas



Baling Materials



RMB’000



RMB’000



RMB’000



RMB’000

Current


Cash and cash equivalents
   237,902 11,482 62,639 13,948

Other current assets (excluding cash)
   73,026 9,167 6,423 60,243



Total current assets
   310,928 20,649 69,062 74,191

Total current liabilities
   (32,670 ) (2,437 ) (2,392 ) (153,952 )



Non-current


Total
non-current
assets
   92,325 1,478 13,765 626,761

Total
non-current
liabilities
   (17,016 ) —   —   (47,000 )



Net assets
   353,567 19,690 80,435 500,000



Group’s effective interest
   50% 50% 50% 50%

Interest in joint ventures
   176,784 9,845 40,218 250,000

Unrealized downstream transactions
   (86 ) —   —   —



Carrying value
   176,698 9,845 40,218 250,000



Summarized statements of comprehensive income for joint ventures

The information above reflects the amounts presented in the financial statements of the joint ventures (and not the Group’s share of those amounts) adjusted for differences in accounting policies between the Group and the joint ventures.

2020

   Linde    JYJC    Yangu Gas

   RMB’000    RMB’000    RMB’000

Revenue
   420,160    21,674    58,463

Depreciation and amortization
   (45,756 )    (350 )    (8,313 )

Interest income
   2,246    304    1,483

Interest expense
   —      —      —

Profit from continuing operations
   108,677    2,279    1,830

Income tax expenses
   (26,290 )    (177 )    —

Post-tax
profit from continuing operations
   82,387    2,102    1,830

Other comprehensive income
   —      —      —







Total comprehensive income
   82,387    2,102    1,830







Dividend received from joint venture
   38,234    1,049    1,000







2021



Linde



JYJC



Yangu Gas



Baling Materials



RMB’000



RMB’000



RMB’000



RMB’000

Revenue



428,971



27,190



60,222



—

Depreciation and amortization



(44,307

)



(386

)



(5,162

)



—

Interest income



3,489



304



1,516



—

Profit from continuing operations



116,768



2,250



4,144



—

Income tax (expenses)/benefits



(29,316

)



1,125



—



—

Post-tax profit from continuing operations



87,452



3,375



4,144



—

Other comprehensive income



—



—



—



—









Total comprehensive income



87,452



3,375



4,144



—









Dividend received from joint venture



63,044



940



800



—









Summarized statements of comprehensive income for joint
ventures
(continued)

2022



Linde



JYJC



Yangu Gas



Baling Materials



RMB’000



RMB’000



RMB’000



RMB’000

Revenue



375,795



25,129



26,091



—

Depreciation and amortization



(20,902

)



(341

)



(8,061

)



—

Interest income



4,799



351



1,029



—

Profit/ (loss) from continuing operations



58,338



1,996



(15,802

)



—

Income tax expenses



(14,590

)



(76

)



—



—

Post-tax profit/ (loss) from continuing operations



43,748



1,920



(15,802

)



—

Other comprehensive income



—



—



—



—









Total comprehensive income



43,748



1,920



(15,802

)



—









Dividend received from joint venture



11,200



1,215



1,800



—









(c)

For the year ended December 31, 2022, equity method investments held by the Company in aggregate have met the significance criteria as defined under Rule 4-08(g) of Regulation S-X. Shanghai Secco was deemed a significant equity investee for the fiscal years ended December 31, 2020 and a non-significant equity investee for the fiscal years ended December 31, 2021 and December 31, 2022 under Rule 3-09 of Regulation S-X. As such, the financial statements of Shanghai Secco required by Rule 3-09 of Regulation S-X are provided as Exhibit 99.1 to this Annual Report on Form 20-F. Financial information for the Company’s equity method investments other than Shanghai Secco are summarized as a group as follow:



2020



2021



2022



RMB’000



RMB’000



RMB’000

Revenue



4,548,574



4,863,742



3,759,076

Gross profit



825,799



828,183



670,678

Profit from continuing operations



753,799



798,867



670,678

Profit after taxation



593,211



586,612



512,758

Profit after taxation attributable to the Group



243,953



240,882



208,401



As of 31 December 2022



2021



2022



RMB’000



RMB’
000

Current assets



6,083,530



6,436,238

Non-current assets



5,000,852



5,909,304

Current liabilities



(2,086,793

)



(2,185,434

)

Non-current liabilities



(707,374

)



(978,325

)

Non-controlling interests



1,508,175



1,578,714

v3.23.1

Inventories
12 Months Ended

Dec. 31, 2022

Classes of current inventories [abstract]

Inventories

21

Inventories

(a)

Inventories in the consolidated statements of financial position comprise:

As at 31 December 2021

As at 31 December 2022

Gross carrying
amount

Provision for
diminution
in value of
inventories

Carrying amount

Gross carrying
amount

Provision for
diminution
in value of
inventories

Carrying amount

RMB’000

RMB’000

RMB’000

RMB’000

RMB’000

RMB’000

Raw materials
4,391,555 (13,406 ) 4,378,149 5,700,215 (26,491 ) 5,673,724

Work in progress
795,791 (105,450 ) 690,341 756,007 (237,959 ) 518,048

Finished goods
709,990 (45,950 ) 664,040 1,096,623 (182,035 ) 914,588

Spare parts and consumables
249,456 (58,461 ) 190,995 246,161 (58,461 ) 187,700

6,146,792 (223,267 ) 5,923,525 7,799,006 (504,946 ) 7,294,060

(b)
The analysis of the amount of inventories recognized as expenses and included in profit or loss is as follows:

The cost of inventories recognized in Cost of sales amounted to RMB72,419,098
thousand for the year ended 31 December 2022 (2020: RMB53,622,798 thousand, 2021: RMB
70,704,868 thousand) which excluded an inventory provision of RMB 525,269
thousand (2020: RMB220,888 thousand, 2021: RMB
150,883 thousand).

For the year ended 31 December 2022, the Group sold certain finished goods and utilized certain spare parts and consumables which were previously provided for. The related provision of RMB243,590
thousand was reversed and included in cost of sales in the consolidated statement of profit or loss (2020: RMB147,817 thousand, 2021: RMB
156,149 thousand).

v3.23.1

Trade And Other Receivables
12 Months Ended

Dec. 31, 2022

Text Block [Abstract]

Trade and other receivables

22
Trade and other receivables



As at 31
December 2021



As at 31 December 2022



RMB’000



RMB’000

Trade receivables
   79,413    72,110

Less: loss allowance
   (1,988 )    (2,759 )





   77,425    69,351

Amounts due from related parties excluded prepayments and
bills receivable (*)
   1,153,111    2,583,289

Less: loss allowance (*)
   —      (2,802 )





Total trade receivables
   1,230,536    2,649,838





Other receivables
   47,737    109,440

Less: loss allowance
   (140 )    (1,933 )





   47,597    107,507





Financial assets measured at amortized cost
   1,278,133    2,757,345





Amounts due from related parties - prepayments (*)
   34,220    58,496

Amounts due from related parties - bills receivables (*) (note 25)
   25,000    —





   1,337,353    2,815,841





Amounts due from related parties (summary of *)
   1,212,331    2,638,983

All of the trade and other receivables are expected to be recovered or recognized as expenses within one year.

Amounts due from related parties mainly represent trade-related balances, unsecured in nature and bear no interest.

The aging analysis based on invoice date of trade receivables and amounts due from related parties excluded prepayments and bills receivable (net of allowance for doubtful debts) is as follows:



As at 31
December 2021



As at 31 December 2022



RMB’000



RMB’000

Within one year
   1,230,360    2,649,673

Over one year but within two years
   27    165

Over two years
   149    —





   1,230,536    2,649,838

Movements in the loss allowance account in respect of trade and other receivables during the period is as follows:



Years ended 31 December



2021



2022



RMB’000



RMB’000

Balance at 1 January
   773    2,128

Impairment losses recognized during the year
   1,355    5,366

Balance at 31 December
   2,128    7,494

As at 31 December 2021 and 31 December 2022, no trade receivable was pledged as collateral.

Sale to third parties is generally on cash basis or on letter of credit. Subject to negotiation, credit is generally only available for major customers
with well-established trading records.

v3.23.1

Cash and cash equivalents
12 Months Ended

Dec. 31, 2022

Cash and cash equivalents [abstract]

Cash and cash equivalents

23
Cash and cash equivalents

(a)
Cash and cash equivalents comprise:

   As at    As at

   31 December 2021    31 December 2022

   RMB’000    RMB’000

Cash deposits with a related party (note i)
   3,243    —

Cash at bank and on hand
   5,108,767    889,413





Cash and cash equivalents in the consolidated statements of financial position
   5,112,010    889,413





i.
Cash deposits with a related party were cash deposits at Sinopec Finance Company Limited (“Sinopec Finance”).

(b)

Cash generated from / (used in) cash

Reconciliation of profit/(loss)
before
taxation to cash generated from
operations



2020



2021



2022



RMB’000



RMB’000



RMB’000

Profit/(loss) before taxation
   590,778    2,721,086    (3,573,654 )

Adjustments items:


Interest income from time deposits with maturity more than 3 months
   (339,505 )    (424,696 )    (410,652 )

Share of (profits)/losses of investments accounted for using the equity method
   (724,740 )    (874,285 )    173,616

Net losses/(gains) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges
   376    (18,846 )    27,851

Gains from structured deposits
   (114,283 )    (97,921 )    (11,124 )

Gains from entrusted loan receivables
   —      —      (2,704 )

Losses on sale of FVOCI
   9,513    4,685    3,148

Interest expense
   64,169    94,186    98,502

Foreign exchange losses/(gains)
   5,514    1,861    (15,320 )

Depreciation of property, plant and equipment
   1,553,039    1,621,459    1,494,176

Depreciation of investment property
   15,184    15,325    15,323

Depreciation of
right-of-use
assets
   32,653    34,307    32,918

Amortization of other
non-current
assets
   226,263    294,617    270,881

Impairment loss on property, plant and equipment
   87,570    587,622    286,260

Impairment loss on investment accounted for using the equity method
   —      28,392    —







Losses / (gains) on disposal of property, plant and equipment and other long-term
assets-net
   1,212    (48,671 )    26,767







Profit/(loss) on operation before change of working capital
   1,407,743    3,939,121    (1,584,012 )

Decrease/(increase) in inventories
   2,865,687    (2,034,779 )    (1,370,535 )

Decrease in operation receivables
   308,333    49,586    511,325

Decrease in operation payables
   (1,008,800 )    (70,235 )    (4,673,853 )

(Decrease)/increase in balances to related parties – net
   (1,577,876 )    2,527,960    156,341







Cash generated from/(used in) operations
   1,995,087    4,411,653    (6,960,734 )







(c)
Reconciliation of liabilities arising from financing activities

   Borrowings    Lease
liabilities    Short-term
bonds    Total

   RMB’000    RMB’000    RMB’000    RMB’000

As at 31 December 2020 and 1 January 2021
   1,548,000    12,471    3,017,811    4,578,282

Changes from financing cash flows:


Proceeds from new bank loans
   14,163,132    —      —      14,163,132

Repayment of bank loans
   (13,451,332 )    —      —      (13,451,332 )

Proceeds from short-term bonds
   —      —      5,998,899    5,998,899

Repayments of short-term bonds
   —      —      (9,000,000 )    (9,000,000 )

Principal elements of lease payments
   —      (17,544 )    —      (17,544 )









Total changes from financing cash flows
   711,800    (17,544 )    (3,001,101 )    (2,306,845 )

Other changes:


Addition of lease liabilities
   —      9,686    —      9,686

Issuance costs on short-term bonds
   —      —      1,101    1,101

Interest expense
   —      —      28,340    28,340

Others
   —      —      (46,151 )    (46,151 )









Total other changes
   —      9,686    (16,710 )    (7,024 )

As at 31 December 2021 and 1 January 2022
   2,259,800    4,613    —      2,264,413









Changes from financing cash flows:


Proceeds from new bank loans
   19,485,000    —      —      19,485,000

Repayment of bank loans
   (19,494,800 )    —      —      (19,494,800 )

Proceeds from short-term bonds
   —      —      5,000,000    5,000,000

Repayments of short-term bonds
   —      —      (5,000,000 )    (5,000,000 )

Principal elements of lease payments
   —      (13,069 )    —      (13,069 )









Total changes from financing cash flows
   (9,800 )    (13,069 )    —      (22,869 )









Other changes:


Addition of lease liabilities
   —      24,707    —      24,707









Total other changes
   —      24,707    —      24,707









As at 31 December 2022
   2,250,000    16,251    —      2,266,251









(d)
Total cash outflow for leases

Amounts included in the consolidated statements of cash flows for leases comprise the following:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Within operating cash flows
   (4,618 )    (6,938 )    (14,774 )

Within financing cash flows
   (15,586 )    (17,544 )    (13,069 )

   (20,204 )    (24,482 )    (27,843 )

These amounts relate to the following:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Lease rentals paid
   (20,204 )    (24,482 )    (27,843 )

v3.23.1

Time Deposits With Banks
12 Months Ended

Dec. 31, 2022

Debt instruments held [abstract]

Time deposits with banks

24
Time deposits with banks



As at 31 December



2021



2022



RMB’000



RMB’000

T
ime deposits with maturity less than one year

   7,386,607    3,108,919

Time deposits with maturity more than one year
   5,581,435    3,389,559

   12,968,042    6,498,478

As at 31 December 2022, interest rates of time deposits with maturity less than one year ranged from 3.85% to 4.13% per annum (31 December 2021: 3.40% to 3.50% per annum), which were presented as current assets. Time deposits with maturity of more than one year were time deposits of three or five years with the interest rates from 3.55% to 4.20% per annum, which were presented as
non-current
assets in the consolidated statement of financial position (31 December 2021: 3.45% to 4.20% per annum).

v3.23.1

Financial Assets at Fair Value Through Other Comprehensive Income
12 Months Ended

Dec. 31, 2022

Financial assets at fair value through other comprehensive income [abstract]

Financial assets at fair value through other comprehensive income

25
Financial assets at fair value through other comprehensive income

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Trade and bills receivable (i)


- Amounts due from related parties (note 22)
   25,000    —

- Others
   1,047,690    582,354





   1,072,690    582,354

Equity investments
   5,000    5,000





   1,077,690    587,354





(i)

As at 31 December 2021 and 2022, certain trade receivables and bills receivable were classified as
financial
assets at FVOCI, as the Group’s business model is achieved both by collecting contractual cash flows and selling of these assets.

(ii)
As at 31 December 2022, the Group discounted certain bank acceptance bills to banks for cash proceeds and endorsed certain bank acceptance bills to suppliers on a full recourse basis for settling trade payables of the same amount. The Group has derecognized these bills receivable and the payables to suppliers in their entirety. These derecognized bank acceptance bills had a maturity date less than twelve months from the end of the reporting period. In the opinion of the directors, the Group has transferred substantially all the risks and rewards of ownership of these bills to its suppliers, and the Group has limited exposure in respect of the settlement obligation of these bills receivable under the relevant PRC rules and regulations should the issuing banks fail to settle the bills on maturity date. The Group considered the issuing banks of the bills are of good credit rating and the
non-settlement
of these bills by the issuing banks on maturity is not probable.

As at 31 December 2022, the Group’s maximum exposure to loss and undiscounted cash outflow, which is the same as the amounts payable by the Group to banks or suppliers in respect of the discounted bills and endorsed bills, should the issuing banks fail to settle the bills on maturity date, amounted to RMB 196,667 thousand and RMB 178,369 thousand respectively.

v3.23.1

Borrowings
12 Months Ended

Dec. 31, 2022

Borrowings [abstract]

Borrowings

26
Borrowings

   As at 31
December 2021    As at 31
December 2022

   RMB’000    RMB’000

Credit loans due within one year


- Short term bank loan
   1,559,800    1,550,000

Credit loans due over one year but within three years


- Long-term borrowing from a related party (note 3
2
(c))
   700,000    700,000





   2,259,800    2,250,000





(a)
The analysis of the repayment schedule of borrowings are as follows:

   2021    2022

   RMB’000    RMB’000

Within 1 year or on demand
   1,559,800    1,550,000

Over one year but within two years
   —      700,000

Over two years but within three years
   700,000    —





   2,259,800    2,250,000





The weighted average interest rate for the Group’s short-term bank loan was 2.35
% as at 31 December 2022 (2020: 2.79%, 2021:
2.74%). The interest rate of the Group’s long-term borrowings was 1.08
% as at 31 December 2022 (2020: Nil, 2021:
1.08%).

As at 31 December 2021 and 31 December 2022, no borrowings were secured by property, plant and equipment .

v3.23.1

Trade and Other Payables
12 Months Ended

Dec. 31, 2022

Trade and other payables [abstract]

Trade and other payables

27
Trade and other payables



As at 31 December



2021



2022



RMB’000



RMB’000

Trade payables
   1,527,706    1,818,453

Bills payable
   562,593    24,951

Amounts due to related parties exclude advances received (*)
   4,910,255    7,877,323





   7,000,554    9,720,727





Dividends payable
   30,577    31,631

Construction payable
   487,283    831,422

Accrued expenses
   400,391    143,299

Other liabilities
   87,144    76,778





   1,005,395    1,083,130





Financial liabilities measured at amortized cost
   8,005,949    10,803,857

Amounts due to related parties – advances received (*)
   6,275    10,486

Amounts due to related parties – measured at fair value through profit or loss (FVPL) (*) (note i)
   1,388,286    —





   9,400,510    10,814,343





Total amount due to related parties (summary of *)
   6,304,816    7,887,809

All trade and other payables (including amounts due to related parties) are expected to be
settled
or recognized as income within one year or are repayable on demand.
(i) Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.
As at 31 December 2021 and 31 December 2022, all trade and other payables of the Group were
non-interest
bearing, and their fair value, approximated their carrying amounts due to their short maturities.
Majority of amount due to related parties were trade payable for purchasing crude oil from related parties .

As at 31 December 2021 and 31 December 2022, the ageing analysis of the trade payables (including amounts due to related parties of trading in nature) and bills payable based on invoice date were as follows:

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Within one year
   6,990,653    9,708,441

Over one year within two years
   9,527    2,524

Over two years
   374    9,762





   7,000,554    9,720,727

v3.23.1

Contract Liabilities
12 Months Ended

Dec. 31, 2022

Contract liabilities [abstract]

Contract liabilities

28
Contract liabilities

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Contract liabilities
   424,607    372,760

The contract liabilities of the Group are advance for goods from customers. Related performance obligations are expected to be satisfied and revenue is recognized within one year. Revenue amounted to RMB
424,607
thousand has been recognized in the current year relates to carried-forward contract liabilities (2020: RMB 579,750 thousand, 2021: RMB
495,404
thousand).

v3.23.1

Deferred Income
12 Months Ended

Dec. 31, 2022

Accruals and deferred income including contract liabilities [abstract]

Deferred income

29
Deferred income


2021

2022

   RMB’000    RMB’000

As at 1 January
   13,433    12,720

Additions
   —      34,623

Amortization
   (713 )    (2,735 )





As at 31 December
   12,720    44,608

v3.23.1

Share Capital
12 Months Ended

Dec. 31, 2022

Disclosure of classes of share capital [abstract]

Share capital

30

Share capital

(i)

Issued share captial


Number of
shares

Amount

   ’000    RMB’000

As at 31 December 2021, 1 January 2022 and 31 December 2022


Registered, issued and fully paid:


Ordinary A shares listed in PRC
   7,328,814    7,328,814

Foreign invested H shares listed overseas
   3,495,000    3,495,000





Total
   10,823,814    10,823,814





(ii)

Purchase of own shares

During the year, the Company repurchased its own ordinary shares on the Stock Exchange of Hong Kong Limited as follows:

Month/year



Number of
shares
repurchased



Highest
price paid
per share



Lowest
price
paid per
share



Aggregate
price paid





HKD



HKD



RMB’000









October 2022



4,956,000



1.10



1.03



4,883

November 2022



15,866,000



1.26



1.04



16,299

December 2022



3,706,000



1.39



1.25



4,507











24,528,000







25,689









The Company repurchased 24,528,000 H shares for an aggregate consideration of RMB 25,689 thousand. In February 2023, the Company has completed the cancellation procedures for all the repurchased own shares.

v3.23.1

Reserves
12 Months Ended

Dec. 31, 2022

Disclosure of reserves within equity [abstract]

Reserves

31
Reserves

   Legal
surplus    Capital
surplus    Surplus
reserve    Other
reserve
Hedging
reserve
Share
premium    Safety
production
fund    Treasury
shares Retained
earnings Total

   (note(a))    (note(b))    (note(c))    (note(d)) (note 3.1(a)) (note(e))    (note(f))    (note 30(ii)) (note(g))

   RMB’000    RMB’000    RMB’000    RMB’000 RMB’000 RMB’000    RMB’000    RMB’000 RMB’000 RMB’000

Balance at 1 January 2021
   4,072,476    13,739    101,355    6,326 —   106,846    145,597    —   13,927,837 18,374,176

Total comprehensive income for the year attributable to shareholders of the Company
   —      —      —      16,639 125,159 —      —      —   2,073,431 2,215,229

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —   (88,699 ) —      —      —   —   (88,699 )

Dividends declared and approved in respect of previous year
   —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Transfer to legal surplus
   2,498,808    —      —      —   —   —      —      —   (2,498,808 ) —

Appropriation of safety production fund
   —      —      —      —   —   —      40,729    —   (40,729) —

Balance at 31 December 2021 and 1 January 2022
   6,571,284    13,739    101,355    22,965 36,460 106,846    186,326    —   12,379,350 19,418,325













Total comprehensive income for the year attributable to shareholders of the Company
   —      —      —      (23,771 ) 201,519 —      —      —   (2,846,156 ) (2,668,408 )

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —   (237,979 ) —      —      —   —   (237,979 )

Dividends declared and approved in respect of previous year
   —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Purchase of own shares
   —      —      —      —   —   —      —      (25,689 ) —   (25,689 )

Appropriation of safety production fund
   —      —      —      —   —   —      54,092    —   (54,092 ) —













Balance at 31 December 2022
   6,571,284    13,739    101,355    (806 ) —   106,846    240,418    (25,689 ) 8,396,721 15,403,868













Notes:

(a) Under PRC rules and regulations, the Company and its PRC subsidiaries are required to set aside 10% of the net income determined in accordance with the PRC accounting rules and regulations to a legal surplus reserve. The transfer to this reserve must be made before distribution of any dividend to shareholders.

The legal surplus reserve is
non-distributable
other than in liquidation and can be used to make good of previous years’ losses, if any, and may be utilized for business expansion or converted into ordinary shares by the issuance of new shares to shareholders in proportion to
their
existing shareholdings or by increasing the par value of the shares currently held by the shareholders, provided that the balance after such issuance is not less than 25% of the registered capital.

In accordance with PRC rules and regulations, the Company has set aside RMB6,571,284 thousand of legal surplus as of 31 December 2022.

(b) This reserve represents gifts or grants received from China Petrochemical Corporation, the ultimate parent company and which are required to be included in this reserve fund by PRC regulations.

(c) The transfer to this reserve from the retained profits is subject to the approval by shareholders at general meetings. Its usage is similar to that of the legal surplus reserve.

(d) Other reserve comprises share of post-acquisition movements in other comprehensive income from associates and joint ventures using the equity methods of accounting with a corresponding adjustment to the carrying amount of the investment.

(e) The application of the share premium account is governed by Sections 167 and 168 of the PRC Company Law.

(f) According to the relevant PRC regulations, the Group is required to transfer an amount to specific reserve for the safety production fund based on the turnover of certain refining and chemicals products. This reserve represents unutilized safety production fund.

(g) According to the Company’s Articles of Association, the reserve available for distribution is the lower of the amount determined under China Accounting Standards for Business Enterprises and the amount determined under IFRS.

v3.23.1

Related-Party Transactions
12 Months Ended

Dec. 31, 2022

Disclosure of transactions between related parties [abstract]

Related-party transactions

32

Related-party transactions

The following is a list of the Group’s major related parties:

Names of related parties    Relationship with the Company

China International United Petroleum & Chemicals Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Chemical Sales Company Limited
Subsidiary of the ultimate parent company

Sinopec Chemical Commercial Holding Company Limited
Subsidiary of the ultimate parent company

Petro-cyberworks Information Technology Co., Ltd.
Subsidiary of the ultimate parent company

Lianhua (Ningbo) International Logistics Co., Ltd.
Subsidiary of the ultimate parent company

Zhongke (Guangdong) Refining & Chemical Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Marketing Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Fuel Oil Sales Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Lubricant Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Yangzi Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Beijing) Company Limited
Subsidiary of the ultimate parent company

Sinopec Catalysts Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Shanghai) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Beijing Research Institute of Chemical Industry
Subsidiary of the ultimate parent company

China Petrochemical International (Ningbo) Co., Ltd.
Subsidiary of the ultimate parent company

Zhoushan Shihua Crude Oil Terminal Co., Ltd.
Subsidiary of the ultimate parent company

Dalian Sinopec Material Equip Company
Subsidiary of the ultimate parent company

Sinopec Material & Equipment (East China) Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Nanjing) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Honeywell (Tianjin) Company Limited
Subsidiary of the ultimate parent company

China Petrochemical International (Wuhan) Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical Refinery Sales Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Tianjin) Co., Ltd.
Subsidiary of the ultimate parent company

Ningbo East sea Line fan Technology Company Limited
Subsidiary of the ultimate parent company

Sinopec Petroleum & Chemical Scientific Research Institute Dadi Company

Subsidiary of the ultimate parent company

Sinopec Shanghai Research Institute of Petrochemical Technology
Subsidiary of the ultimate parent company

Sinopec Lubricating Oil Shanghai Research Institute Company Limited
Subsidiary of the ultimate parent company

Dalian Furuipu Technology Co., Ltd.
Subsidiary of the ultimate parent company

Nantong Donghai Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

China Petroleum and Chemical Corporation Qingdao Security Engineering Research Institute

Subsidiary of the ultimate parent company

Sinopec (Shanghai) Energy Trade Co., Ltd.
Subsidiary of the ultimate parent company

Storage and Transportation Installation Company of Ningbo Engineering Company Limited

Subsidiary of the ultimate parent company

Sinopec Chemical Commercial Holding (Hong Kong) Company Limited

Subsidiary of the ultimate parent company

Sinopec Yizheng Chemical Fibre Limited Liability Company
Subsidiary of the ultimate parent company

Fujian Gulei Petrochemical Company Limited
Subsidiary of the ultimate parent company

Sinopec China East Chemical Sales Co., Ltd.
Subsidiary of the ultimate parent company

Names of related parties    Relationship with the Company

Unipec Singapore
Subsidiary of the ultimate parent company

China Yanshan United Foreign Trade Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Chemical Commercial Holding (Wuhan) Company Limited
Subsidiary of the ultimate parent company

Nanjing Yangzi Petrol-chemical Industry Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Baling Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

Shengli Oil Field Exploration and Development Research Institute
Subsidiary of the ultimate parent company

Shanghai Lide Catalyst Co., Ltd.
Subsidiary of the ultimate parent company

Ypc-gpro
(Nanjing) Rubber Co., Ltd.
Subsidiary of the ultimate parent company

Fujian Refining & Petrochemical Company Limited
Subsidiary of the ultimate parent company

Sinopec Dalian (Fushun) Research Institute of Petroleum and Petrochemicals
Subsidiary of the ultimate parent company

Sinopec Jianghan Salt Chemical Hubei Co., Ltd.
Subsidiary of the ultimate parent company

Yipaike Business Factoring Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Great Wall Energy and Chemical (Ningxia) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec (Shenzhen)
E-Commerce
Company Limited
Subsidiary of the ultimate parent company

Sinopec Research Institute of Safety Engineering
Subsidiary of the ultimate parent company

Ningbo Minggang Gas Company Limited
Subsidiary of the ultimate parent company

Sinopec Zhongyuan Petrol-Chemical Industry Co., Ltd.
Subsidiary of the ultimate parent company

Epec
E-commerce
Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Oil Refining and Marketing (Shanghai) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Chemical Sales (Guangdong) Co., Ltd.
Subsidiary of the ultimate parent company

Unipec (Qingdao) International Logistics Company Limited
Subsidiary of the ultimate parent company

     Names of related parties    Relationship with the Company

Qingdao Zhonghua Sunshine Management System Certification Center
Subsidiary of the ultimate parent company

Zhejiang Baling Hengyi Caprolactam Limited Company
Joint venture of the ultimate parent company

Shanghai Sinopec Mitsui Chemicals, Co., Ltd
.

Joint venture of the ultimate parent company

Basf-ypc
Company Limited
Joint venture of the ultimate parent company

Shanghai Changshi Shipping Co., Ltd.
Associate of the ultimate parent company

Shanghai KSD Bulk Solids Engineering Co., Ltd.
Associate of the ultimate parent company

Basf
Gao-Qiao
Performance Chemicals (Shanghai) Company Limited
Associate of the ultimate parent company

Sinopec Chemical Commercial Holding (Singapore) Pte. Ltd
.

Subsidiary of the immediate parent company

Sinopec Finance Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Chemical Commercial Holding Company Limited
Subsidiary of the immediate parent company

Sinopec Nanjing Chemical Research Institute Co., Ltd.
Subsidiary of the immediate parent company

China Economy Phulishing House Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Publishing House Co., Ltd.
Subsidiary of the immediate parent company

Sinopec International Travel Service Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Assets Management Co., Ltd.
Subsidiary of the immediate parent company

Ningbo Engineering Company of Sinopec
Subsidiary of the immediate parent company

Sinopec Shared Service Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Petroleum Engineering Geophysics Ltd.
Subsidiary of the immediate parent company

Sinopec Baichuan Economic and Trade Company
Subsidiary of the immediate parent company

Sinopec Group Jiangsu Petroleum Exploration Bureau Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Newspaper Office
Subsidiary of the immediate parent company

Sinopec Energy Saving Technology Service Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Group Economic and Technology Research Institute Co., Ltd.
Subsidiary of the immediate parent company

Names of related parties    Relationship with the Company

Beijing Petro-Chemical Construction Consulting Co., Ltd.
Subsidiary of the immediate parent company

China Economicbooks Co., Ltd.
Subsidiary of the immediate parent company

Petrol-Chemical Industry Management Cadre College
Subsidiary of the immediate parent company

Sinopec Engineering Quality Supervision Terminal
Subsidiary of the immediate parent company

Sinopec Group Shanghai Training Center Ltd.
Subsidiary of the immediate parent company

Sinopec Beijing Yanshan Petrochemical Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Zhongyuan Petroleum Exploration Bureau Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Shengli Petroleum Administration Co., Ltd.
Subsidiary of the immediate parent company

The Fourth Construction Company of Sinopec
Subsidiary of the immediate parent company

Sinopec Tending Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Shanghai Engineering Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Engineering Incorporation
Subsidiary of the immediate parent company

Sinopec Engineering Quality Monitoring Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Engineering(Group)Co.,Ltd.
Subsidiary of the immediate parent company

National Petrochemical Project Risk Assessment Technology Center
Subsidiary of the immediate parent company

The Tenth Construction Company of Sinopec
Subsidiary of the immediate parent company

The Fifth Construction Company of Sinopec
Subsidiary of the immediate parent company

Shanghai Petrochemical Machinery Manufacturing Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Nanjing Engineering Company Limited
Subsidiary of the immediate parent company

Sinopec Luoyang Engineering Company Limited
Subsidiary of the immediate parent company

Jiangsu Jinling Opta Polymer Company Limited
Subsidiary of the immediate parent company

Shanghai Petro-Chemical Haidi Administration Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Sichuan Uinylon Works
Subsidiary of the immediate parent company

China Petrochemical Corp. Nanjing Chemistry Industrial Co., Ltd.

Subsidiary of the immediate parent company

Names of related parties    Relationship with the Company

Sinopec Group International Petroleum Exploration And Production Limited

Subsidiary of the immediate parent company

Sinopec Consulting Company Limited
Subsidiary of the immediate parent company

China Petrochemical Corp. Engineering Ration Management Station
Subsidiary of the immediate parent company

Beijing Victory Hotel Company Limited
Subsidiary of the immediate parent company

Maoming Shihua Dongcheng Chemical Co., Ltd.
Subsidiary of the immediate parent company

Yihua Tory Polyester Film Company Limited
Joint venture of the immediate parent company

China Sinopec Pipeline Storage and Transportation Co., Ltd.
Associate of the immediate parent

Yihua Bonar Yarns and Fabrics Co., Ltd.
Associate of the immediate parent

Unipec Singapore
Subsidiary of the immediate parent company

Unipec America, Inc
Subsidiary of the immediate parent company

Sinopec Japan Company Limited
Subsidiary of the immediate parent company

Rizhao Shihua Crude Oil Terminal Co., Ltd.
Joint venture of the ultimate parent company

Sinopec Europe Company Limited
Subsidiary of the immediate parent company

Sinopec Chemical Commercial Holding (North America), Inc.
Subsidiary of the immediate parent company

Sinopec International (Australia) Pty. Ltd.
Subsidiary of the immediate parent company

Sinopec Easy Joy sales CO., Ltd.
Subsidiary of the immediate parent company

Sinopec National Petrochemical Project Risk Assessment Technology Center Co., Ltd.

Subsidiary of the immediate parent company

Sinopec International (Russia) Pty. Ltd.
Subsidiary of the immediate parent company

Sinopec Jianghan Petroleum Administration Co., Ltd.
Subsidiary of the ulitimate parent company

Sinopec America Company Limited
Subsidiary of the ulitimate parent company

Sinopec (Beijing) Chemical Research Institute Co., Ltd.
Subsidiary of the ulitimate parent company

Sinopec-Sk(Wuhan)Petrochemical
Co., Ltd.
Subsidiary of the ulitimate parent company

Shanghai Petroleum&Natural Gas General Co., Ltd.
Associate of the ultimate parent company

Beijing Heyuan Jingyi Hotel Co., Ltd.
Subsidiary of the ulitimate parent company

Sinopec Henan Oilfield Training Center
Subsidiary of the ulitimate parent company

Sinopec Jiangsu Petroleum Exploration Bureau Co., Ltd. Training Center

Subsidiary of the ulitimate parent company

Sinopec Capital Co., Ltd.
Subsidiary of the ulitimate parent company

The following is a summary of significant balances and transactions between the Group and its related
parties
except for the dividends payable as disclosed in note 33.

(a)
Most of the transactions undertaken by the Group during the year ended 31 December 2022 have been affected on such terms as determined by Sinopec Corp. and relevant PRC authorities.

Sinopec Corp. negotiates and agrees with the terms of crude oil supply with suppliers on a group basis, which is then allocated among its subsidiaries, including the Group, on a discretionary basis. Sinopec Corp. also owns a widespread petroleum products sales network and possesses a fairly high market share in the domestic petroleum products market, which is subject to extensive regulation by the PRC government.

The Group has entered into a mutual product supply and sales services framework agreement with Sinopec Corp. Pursuant to the agreement, Sinopec Corp. provides the Company with crude oil, other petrochemical raw materials and agent services. On the other hand, the Group provides Sinopec Corp. with petroleum products, petrochemical products and property leasing services.

The pricing policy for these services and products provided under the agreement is as follows:

•
if there are applicable State (central and local government) tariffs, the pricing shall follow the State tariffs;

•
if there are no State tariffs, but there are applicable State guidance prices, the pricing shall follow the State’s guidance prices; or

•
if there are no State tariffs or State’s guidance prices, the pricing shall be determined in accordance with the prevailing market prices (including any bidding prices).

Transactions between the Group and Sinopec Corp, its subsidiaries and joint ventures during the years ended 31 December 2020, 2021 and 2022 were as follows :

   2020
RMB’000    2021
RMB’000    2022
RMB’000

Sales of petroleum products
   39,879,549    47,201,755    44,392,225

Sales other than petroleum products
   6,790,568    9,439,546    8,194,827

Purchases of crude oil
   27,934,926    35,371,820    46,790,433

Purchases other than crude oil
   9,937,862    9,008,147    7,544,094

Commission expense
   104,598    110,552    90,341

Rental income
   32,829    34,475    34,088

(b)

Other transactions between the Group and Sinopec Group and its subsidiaries, associates and joint ventures of the Group during the years ended 31 December 2020, 2021 and 2022 were as follows:

   2020
RMB’000    2021
RMB’000    2022
RMB’000

Sales of goods and service fee income


- Sinopec Group and its subsidiaries
   14,870    36,683    19,450

- Associates and joint ventures of the Group
   2,019,997    4,248,658    3,171,835







   2,034,867    4,285,341    3,191,285







Purchases


- Sinopec Group and its subsidiaries
   832,617    2,830,256    1,870,287

- Associates and joint ventures of the Group
   3,648,664    4,425,698    2,411,552







   4,481,281    7,255,954    4,281,839







Insurance premium expenses


- Sinopec Group and its subsidiaries
   107,495    108,850    109,597







Addition to
right-of-use
assets


- Sinopec Group and its subsidiaries
   2,267    1,388    20,023

Interest expense of lease liabilities


- Sinopec Group and its subsidiaries
   205    247    787

- Joint ventures of the Group
   8    24    17





   213    271    804

Interest expens
e

- Sinopec Finance
   —



2,835



7,665

Interest income


- Sinopec Finance
   2,088    824    213

- Joint ventures of the Group
   —      —      2,704

   2,088    824    2,917

Construction and installation cost


- Sinopec Group and its subsidiaries
   233,591    785,216    812,516

Rental income


- Associates and joint ventures of the Group
   15,577    14,930    14,032

- Sinopec Group and its subsidiaries
   464    464    427





   16,041    15,394    14,459

Long-term borrowings


- Sinopec Finance
   —      700,000    —







The directors of the Company are of the opinion that the transactions with Sinopec Corp., its subsidiaries and joint ventures, Sinopec Group and its subsidiaries, associates and joint ventures of the Group as disclosed in notes 3
2
(a) and 3
2
(b) were conducted in the ordinary course of business, on normal commercial terms and in accordance with the agreements governing such transactions.

(c)
The relevant amounts due from/to Sinopec Corp., its subsidiaries and joint ventures, Sinopec Group and its subsidiaries, associates and joint ventures of the Group, arising from purchases, sales and other transactions as disclosed in notes 3
2
(a) and 3
2
(b), are summarized as follows:



As at 31 December 2021



As at 31 December 2022



RMB’000



RMB’000

Amounts due from related parties





- Sinopec Corp., its subsidiaries and joint ventures
   1,184,117    2,593,908

- Associates and joint ventures of the Group
   28,214    45,075





   1,212,331    2,638,983





Amounts due to related parties


- Sinopec Corp., its subsidiaries and joint ventures
   4,475,992    6,569,219

- Sinopec Group and its subsidiaries
   1,672,439    1,232,589

- Associates and joint ventures of the Group
   156,385    86,001





   6,304,816    7,887,809





Lease liabilities


- Sinopec Group and its subsidiaries
   992    12,714

- Joint ventures of the Group
   435    290





   1,427    13,004





Cash deposits, maturing within three months


- Sinopec Finance (note d)
   3,243    —





Long-term borrowings


- Sinopec Finance
   700,000    700,000





(d)
As at 31 December 2021, cash deposits at Sinopec Finance were charged at an interest rate of
0.35
% per
annum.

Except for cash deposits at Sinopec Finance and long-term borrowings from Sinopec Finance, the balances with related parties as above are unsecured, interest-free and repayable on demand.

(e)
Key management personnel compensation, post-employment benefit plans and share options
Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the Group, directly or indirectly, including directors and supervisors of the Group. The key personnel compensations are as follows:



Years ended 31 December



2020



2021



2022



RMB’000



RMB’000



RMB’000

Short-term employee benefits
   9,859    11,866    13,667

Post-employment benefits
   441    551    639







   10,300    12,417    14,306







(f)
Transactions with other state-owned entities in the PRC
The Group is a state-controlled enterprise and operates in an economic regime currently dominated by entities directly or indirectly
controlled
by the PRC government (collectively referred to as “state-controlled entities”) through its government authorities, agencies, affiliations and other organizations.
Apart from transactions with related parties, the Group has transactions with other state-controlled entities which include, but are not limited to, the following:

•
sales and purchases of goods and ancillary materials;

•
rendering and receiving services;

•
lease of assets, purchase of property, plant and equipment;

•
placing deposits and obtaining finance; and

•
use of public utilities
These transactions are conducted in the ordinary course of the Group’s business on terms comparable to those with other entities that are not state controlled. The Group has established its procurement policies, pricing strategy and approval process for purchases and sales of products and services which do not depend on whether the counterparties are state-controlled entities or not.

(g)
Commitments with related parties

(i)
Construction and installation cost

   As at
31 December 2021
RMB’000    As at
31 December 2022
RMB’000

Sinopec Group and its subsidiaries
   775,007    930,665

(h)
Investment commitments with related parties

   As at
31 December 2021
RMB’000    As at
31 December 2022
RMB’000

Capital contribution to Shanghai Secco (i)
   111,263    111,263

Capital contribution to Shanghai Shidian Energy Company


Limited (“Shidian Energy”) (ii)
   80,000    —

Capital contribution to Baling Materials (iii)
   350,000    150,000





   541,263    261,263





(i)
Pursuant to the resolution of the 18th meeting of the 7th term of Board of Directors on 5 December 2013, the Group was approved to make a capital contribution of USD 30,017,000 (RMB 182,804 thousand equivalent) to Shanghai Secco, an associate of the Group. As at 31 December 2022, the Company has contributed RMB 71,541 thousand to Shanghai Secco.
According to the approval by Shanghai Municipal Commission of Commerce as issued on 19 October 2015, the rest of the capital contribution to Shanghai Secco should be within 50 years starting from its registration date.

(ii)
Pursuant to the articles of association of Shidian Energy in August
2019
, Toufa agreed to make a capital contribution of RMB 400,000 thousand to acquire 40% share of Shidian Energy. As at 31 December 2022, Toufa has fully contributed RMB 400,000 thousand to Shidian Energy.

(iii)
Sinopec Baling Petrochemical Co., Ltd and the Company jointly established Baling Materials on 7 September 2021, each with a cash contribution of RMB 400,000 thousand. As at 31 December 2022, the Company has made a
paid-up
capital contribution of RMB 250,000 thousand.

Except for the above disclosed in notes 32 (g) and 32 (h), the Group had no other material commitments with related parties as at 31 December 2022, which are contracted, but not included in the financial statements.

v3.23.1

Dividend
12 Months Ended

Dec. 31, 2022

Dividend [abstract]

Dividend

33
Dividend

(a)
Dividends payable to equity shareholders of the Company attributable to the year:


2021

RMB’000
2022

RMB’000

No final dividend proposed after the end of the reporting period
(2021: RMB 0.10 per ordinary share)
   1,082,381    —





The final dividend proposed after the end of the reporting period has not been recognized as a liability at the end of the reporting period.

(b)
Dividends payable to equity shareholders of the Company attributable to the previous financial year, approved and paid during the year

   2021
RMB’000    2022
RMB’000

Final dividend in respect of the previous financial year, approved and paid during the year, of RMB 0.10 per share (2021: RMB 0.10)    1,082,381    1,082,381

v3.23.1

Commitments
12 Months Ended

Dec. 31, 2022

Commitments [abstract]

Commitments

34
Commitments

Capital commitments outstanding at 31 December 2022 not provided for in the financial statements were as follows:

   As at 31
December 2021
RMB’000    As at 31
December 2022
RMB’000

Property, plant and equipment contracted for
   1,176,168    1,783,781

v3.23.1

Statements of Financial Position and Equity Movement of the Company
12 Months Ended

Dec. 31, 2022

Balance sheet and reserve movement of the Company [abstract]

Statements of financial position and equity movement of the Company

35

Statements of financial position and equity movement of the Company



As at 31 December 2021



As at 31 December 2022



RMB’000



RMB’000

Non-current
assets





Property, plant and equipment
   10,914,990    11,823,562

Investment properties
   381,540    365,147

Right-of-use
assets
   275,924    274,926

Construction in progress
   3,201,111    3,647,200

Investments in subsidiaries
   2,048,328    2,048,328

Investments accounted for using the equity method
   3,299,050    2,654,151

Time deposits with banks
   5,381,149    3,139,559

Deferred tax assets
   178,084    986,830

Other
non-current
assets
   769,492    821,397





   26,449,668    25,761,100





Current assets


Derivative financial instruments
   81,405    —

Inventories
   5,726,264    7,043,613

Trade receivables
   149    —

Other receivables
   8,276    88,839

Amounts due from related parties
   1,116,553    2,526,598

Prepayments
   13,790    10,711

Value added tax recoverable
   —    1,045,002

Financial assets at fair value through other
comprehensive income (FVOCI)

   615,689    127,558

Time deposits with banks
   7,386,605    3,108,916

Cash and cash equivalents
   4,927,519    671,538





   19,876,250    14,622,775





Current liabilities


Trade and other payables
   2,389,508    2,217,580

Contract liabilities
   376,834    289,407

Amounts due to related parties
   7,423,883    8,809,690

Staff salaries and welfares payable
   253,800    307,190

Borrowings
   1,500,000    1,500,000

Lease liabilities
   1,604    7,172

Derivative financial instruments
   23,804    —

Income tax payable
   249,332    —

Current tax liabilities
   3,843,541    913,231





   16,062,306    14,044,270





Net current assets
   3,813,944    578,505







As at 31 December 2021



As at 31 December 2022



RMB’000



RMB’000

Total assets less current liabilities
   30,263,612    26,339,605





Non-current
liabilities


Interest-bearing borrowings
   700,000    700,000

Lease liabilities
   399    6,481

Deferred income
   12,720    44,494





   713,119    750,975











NET ASSETS
   29,550,493    25,588,630





CAPITAL AND RESERVES


Share capital
   10,823,814    10,823,814

Reserves
   18,726,679    14,764,816





TOTAL EQUITY
   29,550,493    25,588,630





Approved and authorized for issue by the Board of Directors on 26 April 2023.



)





)



Wan Tao



)





)





)



Directors



)



Du Jun



)





)





)



(a)

Movements in components of equity of the Company

   Share
capital
RMB’000
Legal
surplus
RMB’000
   Capital
surplus
RMB’000    Surplus
reserve
RMB’000    Other
reserve
RMB’000
Hedging
reserve
RMB’000
Share
premium
RMB’000    Safety
production
fund
RMB’000    Treasury
reserve
RMB’000 Retained
earnings
RMB’000 Total
RMB’000

Balance at 1 January 2021
   10,823,814    4,072,476    4,180    101,355    6,326 —   106,846    145,597    —   13,260,897 28,521,491

Total comprehensive income for the year
   —      —      —      —      16,639 125,159 —      —      —   2,058,284 2,200,082

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —      —   (88,699 ) —      —      —   —   (88,699 )

Dividends declared and approved in respect of previous year
   —      —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Transfer to legal surplus
   —      2,498,808    —      —      —   —   —      —      —   (2,498,808 ) —

Appropriation of safety production fund
   —      —      —      —      —   —   —      32,310    —   (32,310 ) —















Balance at 31 December 2021 and 1 January 2022
   10,823,814    6,571,284    4,180    101,355    22,965 36,460 106,846    177,907    —   11,705,682 29,550,493















Total comprehensive income for the year
   —      —      —      —      (23,771 ) 201,519 —      —      —   (2,793,562 ) (2,615,814 )

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —      —   (237,979 ) —      —      —   —   (237,979 )

Dividends declared and approved in respect of previous year
   —      —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Purchase of own shares
   —      —      —      —      —   —   —      —      (25,689 ) —   (25,689 )

Appropriation of safety production fund
   —      —      —      —      —   —   —      61,782    —   (61,782 ) —















Balance at 31 December 2022
   10,823,814    6,571,284    4,180    101,355    (806 ) —   106,846    239,689    (25,689 ) 7,767,957 25,588,630

v3.23.1

Comparative Figures
12 Months Ended

Dec. 31, 2022

Disclosure of comparative information prepared under previous GAAP [abstract]

Comparative figures

36

Comparative figures
Certain comparative figures, as disclosed below, have been adjusted to conform to current year’s presentation. Value added tax recoverable in the amount of RMB
13,322
thousand as of December 31, 2021, which was previously included in prepayments, and has been reclassified as value added tax recoverable and separately presented on the consolidated balance sheet as of December 31, 2021.

v3.23.1

Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022
12 Months Ended

Dec. 31, 2022

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Abstract]

Possible impact of amendments, new standards and interpretations issued but not yet effective for the year ended 31 December 2022

37

Possible impact of amendments, new standards and interpretations issued but not yet effective for the year ended 31 December 2022
Up to the date of issue of these financial statements, the IASB has issued a number of amendments, new standards and interpretations, which are not yet effective for the year ended 31 December 2022 and which have not been adopted in these financial statements. These developments include the following which may be relevant to the Group.


Effective for
accounting periods
beginning on or
after

IFRS 17, Insurance contracts
   1 January 2023

Amendments to IAS 1, Presentation of financial statements: Classification of liabilities as current or
non-current
   1 January 2023

Amendments to IAS 1, Presentation of financial statements and IFRS Practice Statement 2, Making materiality judgements: Disclosure of accounting policies
   1 January 2023

Amendments to IAS 8, Accounting policies, changes in accounting estimates and errors: Definition of accounting estimates
   1 January 2023

Amendments to IAS 12, Income taxes: Deferred tax related to assets and liabilities arising from a single transaction
   1 January 2023

The Group is in the process of making an assessment of what the impact of these amendments, new standards and interpretations are expected to be in the period of initial application. So far, the Group has concluded that the adoption of them is unlikely to have a significant impact on the consolidated financial statements.

v3.23.1

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2022

Summary of significant accounting policies [abstract]

Basis of preparation

2.1
Statement of compliance and basis of preparation

(a)
Statement of compliance

These financial statements have been prepared in accordance with all applicable International Financial Reporting Standards (IFRSs), which collective term includes all applicable individual International Financial Reporting Standards, International Accounting Standards (IASs) and related Interpretations, promulgated by the International Accounting Standards Board (IASB) Significant accounting policies adopted by the Group are disclosed below.

The IASB has issued certain amendments to IFRSs that are first effective or available for early adoption for the current accounting period of the Group. Note 2.1 (c) provides information on any changes in accounting policies resulting from initial application of these developments to the extent that they are relevant to the Group for the current accounting period reflected in these financial statements.

(b)
Basis of preparation

The consolidated financial statements for the year ended 31 December 2022 comprise the Company and its subsidiaries (together referred to as the “Group”) and the Group’s interest in associates and a joint ventures.

The measurement basis used in the preparation of the financial statements is the historical cost basis except for certain financial assets and liabilities measured at fair value, including:

•
derivative financial instruments (see note 2.13); and

•
investment in debt and equity securities (see note 2.11).

The preparation of financial statements in conformity with IFRSs requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Judgements made by management in the application of IFRSs that have significant effect on the financial statements and major sources of estimation uncertainty are discussed in note 4.

(c)

Changes in accounting policies
The Group has applied the following amendments to IFRSs issued by the IASB to these financial statements for the current accounting period:

•
Amendments to IAS 16, Property, plant and equipment: Proceeds before intended use

•
Amendments to IAS 37, Provisions, contingent liabilities and contingent assets: Onerous contracts —
cost of fulfilling a contract

•
Amendments to IFRSs, Annual Improvements to IFRS Standards 2018-2020

•
Amendments to IFRS 3, Reference to the Conceptual Framework
None of these developments have had a material effect on how the Group’s results and financial position for the current or prior periods have been prepared or presented. The Group has not applied any new standard or interpretation that is not yet effective for the current accounting period.

Subsidiaries

2.2
Subsidiaries

2.2.1
Consolidation
Subsidiaries are all entities over which the Group has control. The Group controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.
Inter-company transactions, balances and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group.
Non-controlling
interests in the results and equity of subsidiaries are shown separately in the consolidated statements of financial position, consolidated statements of profit or loss, statements of comprehensive income and changes in equity respectively.

(a)

Business combinations
The acquisition method of accounting is used to account for all business combinations by the Group, regardless of whether equity instruments or other assets are acquired. The consideration transferred for the acquisition of a subsidiary comprises the:

•
fair values of the assets transferred;

•
liabilities incurred to the former owners of the acquired business;

•
equity interests issued by the Group;

•
fair value of any asset or liability resulting from a contingent consideration arrangement, and

•
fair value of any
pre-existing
equity interest in the subsidiary.
Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured initially at their fair values at the acquisition date. The Group recognizes any
non-controlling
interest in the acquired entity on an
acquisition-by-acquisition
basis either at fair value or at the
non-controlling
interest’s proportionate share of the acquired entity’s net identifiable assets.
Acquisition-related costs are expensed as incurred.
The excess of the:

•
consideration transferred

•
amount of any
non-controlling
interest in the acquired entity, and

•
acquisition-date fair value of any previous equity interest in the acquired entity

Over the fair value of the net identifiable assets acquired is recorded as goodwill. If those amounts are less than the fair value of the net identifiable assets of the business acquired, the difference is recognized directly in the statements of profit or loss as a bargain purchase.
Where settlement of any part of cash consideration is deferred, the amounts payable in the future are discounted to their present value as at the date of exchange. The discount rate used is the Group’s incremental borrowing rate, being the rate at which a similar borrowing could be obtained from an independent financier under comparable terms and conditions.
If the business combination is achieved in stages, the acquirer’s previously held equity interest in the acquiree is remeasured to fair value at the acquisition date. Any gains or losses arising from such remeasurement are recognized in the statements of profit or loss.

(b)
Changes in ownership interests
The Group treats transactions with
non-controlling
interests that do not result in loss of control as transactions with equity
owners
of the Group. A change in ownership interest results in an adjustment between the carrying amounts of the controlling and
non-controlling
interests to reflect their relative interests in the subsidiary. Any difference between the amount of the adjustment to
non-controlling
interests and any consideration paid or received is recognized in a separate reserve within equity attributable to owners of the Group.
When the Group ceases to consolidate or equity account for an investment because of a loss of control, joint control or significant influence, any retained interest in the entity is remeasured to its fair value, with the change in carrying amount recognized in the statements of profit or loss. This fair value becomes the initial carrying amount for the purposes of subsequently accounting for the retained interest as an associate, joint venture or financial asset. In addition, any amounts previously recognized in other comprehensive income in respect of that entity are accounted for as if the Group had directly disposed of the related assets or liabilities. This means that amounts previously recognized in other comprehensive income are reclassified to profit or loss.

2.2.2
Separate financial statements
Investments in subsidiaries are accounted for at cost less impairment. Cost includes direct attributable costs of investment. The results of subsidiaries are accounted for by the Company on the basis of dividend received and receivable.
Investments in joint ventures and associates are accounted for using the equity method of accounting.

Associates

2.3
Associates
Associates are all entities over which the Group has significant
influence
but not control or joint control. Investments in associates are accounted for using the equity method of accounting. Under the equity method, the investment is initially recognized at cost, and the carrying amount is increased or decreased to recognize the investor’s share of the profit or loss of the investee after the date of acquisition. The Group’s investments in associates include goodwill identified on acquisition. Upon the acquisition of the ownership interest in an associate, any difference between the cost of the associate and the Group’s share of the net fair value of the associate’s identifiable assets and liabilities is accounted for as goodwill.
The Group’s share of post-acquisition profit or loss is recognized in the statements of profit or loss, and its share of post-acquisition movements in other comprehensive income is recognized in other comprehensive income with a corresponding adjustment to the carrying amount of the investment. When the Group’s share of losses in an associate equals or exceeds its interest in the associate, including any other unsecured receivables, the Group does not recognize further losses, unless it has incurred legal or constructive obligations or made payments on behalf of the associate.
The Group determines at each reporting date whether there is any objective evidence that the investment in the associate is impaired. If this is the case, the Group calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value and recognizes the amount in the statements of profit or loss.
Profits and losses resulting from upstream and downstream transactions between the Group and its associates are recognized in the Group’s financial statements only to the extent of unrelated investor’s interests in the associates. Unrealized losses are eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of associates have been changed where necessary to ensure consistency with the policies adopted by the Group.
Gain or loss on dilution of equity interest in associates are recognized in the statements of profit or
loss
.

Joint arrangements

2.4
Joint arrangements
Under IFRS 11 ‘Joint Arrangements’ investments in joint arrangements are classified as either joint operations or joint ventures. The classification depends on the contractual rights and obligations of each investor, rather than the legal structure of the joint arrangement. The Group has assessed the nature of its joint arrangements and determined them to be joint ventures. Joint ventures are accounted for using the equity method.
Under the equity method of accounting, interests in joint ventures are initially recognized at cost and adjusted thereafter to recognize the Group’s share of the post-acquisition profits or losses and movements in other comprehensive income. The Group’s investments in joint ventures include goodwill identified on acquisition. Upon the acquisition of the ownership interest in a joint venture, any difference between the cost of the joint venture and the Group’s share of the net fair value of the joint venture’s identifiable assets and liabilities is accounted for as goodwill. When the Group’s share of losses in a joint venture equals or exceeds its interests in the joint ventures, including any other unsecured receivables, the Group does not recognize further losses, unless it has incurred obligations or made payments on behalf of the joint ventures.
Unrealized gains on transactions between the Group and its joint ventures are eliminated to the extent of the Group’s interest in the joint ventures. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Accounting policies of the joint ventures have been changed where necessary to ensure consistency with the policies adopted by the Group.
The carrying amount of equity-accounted investments is tested for impairment in accordance with the policy described in note 2.12.

Segment reporting

2.5
Segment reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Board of Directors that makes strategic decisions.

Foreign currency translation

2.6
Foreign currency translation
(a)

Functional and presentation currency
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic environment in which the entity operates (“the functional currency”).
The consolidated financial statements are presented in RMB, which is the Company’s functional and the Group’s presentation currency.
(b) Transactions and balances

Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates, are generally recognized in the statements of profit or loss. They are deferred in equity if they relate to qualifying cash flow hedges and qualifying net investment hedges.

Property, plant and equipment

2.7
Property, plant and equipment
Property, plant and equipment is stated at historical cost less depreciation and impairment losses. Historical cost includes expenditure that is directly attributable to the acquisition of the items.

Items may be produced while bringing an item of property, plant and equipment to the location and condition necessary for it to be capable of operating in the manner intended by management. The proceeds from selling any such items and the related costs are recognized in profit or loss.
Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognized. All other repairs and maintenance are charged to the statements of profit or loss during the financial period in which they are incurred.

Depreciation on property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:

- Buildings
   12 to 40 years

- Plant and machinery
   5 to 20 years

- Vehicles and other equipment
   4 to 20 years

The assets’ residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period.
An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated recoverable amount (note 2.12 (b)).

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognized within Other gains/(losses) - net in the statements of profit or loss.

Construction in progress

2.8
Construction in progress

Construction in progress represents buildings, various plant and equipment under construction and pending installation, and is stated at cost less government grants that compensate the Company for the cost of construction, and impairment losses. Cost comprises direct costs of construction as well as interest charges, and foreign exchange differences on related borrowed funds to the extent that they are regarded as an adjustment to interest charges, during the period of construction. Construction in progress is transferred to property, plant and equipment when the asset is substantially ready for its intended use. No depreciation is provided in respect of construction in progress.

Investment properties

2.9
Investment properties

Investment properties are properties which are owned either to earn rental income and/or for capital appreciation.

Investment properties are stated in the statements of financial position at cost less accumulated depreciation and impairment losses (note 2.12(b)). Depreciation is provided over their estimated useful lives on a straight-line basis, after taking into account their estimated residual values.

Estimated useful lives of the Group’s investment properties are
30-40
years.

Other non-current assets

2.10
Other
non-current
assets

Other non-current assets mainly represent intangible assets and long-term prepaid expense, which are amortized on a straight-line basis over the following periods:

Intangible assets - patents
   2 to 28 years

Long-term prepaid expense - catalyst
   1.5 to 10 years

Long-term prepaid expense - leasehold improvement
   3 to 27 years

Other investments in debt and equity securities

2.11
Other investments in debt and equity securities

The Group’s policies for investments in debt and equity securities, other than investments in subsidiaries, associates and joint ventures, are set out below.

Investments in debt and equity securities are recognized/derecognized on the date the Group commits to purchase/sell the investment. The investments are initially stated at fair value plus directly attributable transaction costs, except for those investments measured at fair value through profit or loss (FVPL) for which transaction costs are recognized directly in profit or loss. For an explanation of how the Group determines fair value of financial instruments, see note 3.3. These investments are subsequently accounted for as follows, depending on their classification.

(a)
Investments other than equity investments

Non-equity
investments held by the Group are classified into one of the following measurement categories:

•
amortized cost, if the investment is held for the collection of contractual cash flows which represent solely payments of principal and interest. Interest income from the investment is calculated using the effective interest method (see note 2.27).

•
fair value through other comprehensive income (FVOCI) - recycling, if the contractual cash flows of the investment comprise solely payments of principal and interest and the investment is held within a business model whose objective is achieved by both the collection of contractual cash flows and sale. Changes in fair value are recognized in other comprehensive income, except for the recognition in profit or loss of expected credit losses, interest income (calculated using the effective interest method) and foreign exchange gains and losses. When the investment is derecognized, the amount accumulated in other
comprehensive
income is recycled from equity to profit or loss.

•
fair value through profit or loss (FVPL) if the investment does not meet the criteria for being measured at amortized cost or FVOCI (recycling). Changes in the fair value of the investment (including interest) are recognized in profit or loss.

(b)
Equity investments

An investment in equity securities is classified as FVPL unless the equity investment is not held for trading purposes and on initial recognition of the investment the Group makes an irrevocable election to designate the investment at FVOCI
(non-recycling)
such that subsequent changes in fair value are recognized in other comprehensive income. Such elections are made on an
instrument-by-instrument
basis, but may only be made if the investment meets the definition of equity from the issuer’s perspective. Where such an election is made, the amount accumulated in other comprehensive income remains in the fair value reserve
(non-recycling)
until the investment is disposed of. At the time of disposal, the amount accumulated in the fair value reserve
(non-recycling)
is transferred to retained earnings. It is not recycled through profit or loss. Dividends from an investment in equity securities, irrespective of whether classified as at FVPL or FVOCI, are recognized in profit or loss as other income in accordance with the policy set out in note 2.28.

Credit losses and impairment of assets

2.12
Credit losses and impairment of assets

(a)
Credit losses from financial instruments

The Group recognizes a loss allowance for expected credit losses (ECLs) on the following items:

•
financial assets measured at amortized cost (including cash and cash equivalents, time deposits with banks, trade receivables and other receivables); and

•
debt securities measured at FVOCI (recycling);

Other financial assets measured at fair value, including equity securities designated at FVOCI
(non-recycling)
and derivative financial assets, are not subject to the ECL assessment.
Measurement of ECLs
ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of all expected cash shortfalls (i.e. the difference between the cash flows due to the Group in accordance with the contract and the cash flows that the Group expects to receive).
The expected cash shortfalls are discounted using the following discount rates where the effect of discounting is material:

•
fixed-rate financial assets, trade and other receivables: effective interest rate determined at initial recognition or an approximation thereof;

•
variable-rate financial assets: current effective interest rate.
The maximum period considered when estimating ECLs is the maximum contractual period over which the Group is exposed to credit risk. In measuring ECLs, the Group takes into account reasonable and supportable information that is available without undue cost or effort. This includes information about past events, current conditions and forecasts of future economic conditions.
ECLs are measured on either of the following bases:

•
12-month
ECLs: these are losses that are expected to result from possible default events within the 12 months after the reporting date; and

•
lifetime ECLs: these are losses that are expected to result from all possible default events over the expected lives of the items to which the ECL model applies.
Loss allowances for trade receivables are always measured at an amount equal to lifetime ECLs. ECLs on these financial assets are estimated using a provision matrix based on the Group’s historical credit loss experience, adjusted for factors that are specific to the debtors and an assessment of both the current and forecast general economic conditions at the reporting date.
For all other financial instruments, the Group recognizes a loss allowance equal to
12-month
ECLs unless there has been a significant increase in credit risk of the financial instrument since initial recognition, in which case the loss allowance is measured at an amount equal to lifetime ECLs.

Significant increases in credit risk
In assessing whether the credit risk of a financial instrument has increased significantly
since
initial recognition, the Group compares the risk of default occurring on the financial instrument assessed at the reporting date with that assessed at the date of initial recognition.
In making this reassessment, the Group considers that a default event occurs when (i) the borrower is unlikely to pay its credit obligations to the Group in full, without recourse by the Group to actions such as realizing security (if any is held); or (ii) the financial asset is 90 days past due.
The Group considers both quantitative and qualitative information that is reasonable and supportable, including historical experience and forward-looking information that is available without undue cost or effort.
In particular, the following information is taken into account when assessing whether credit risk has increased significantly since initial recognition:

•
failure to make payments of principal or interest on their contractually due dates;

•
an actual or expected significant deterioration in a financial instrument’s external or internal credit rating (if available);

•
an actual or expected significant deterioration in the operating results of the debtor; and

•
existing or forecast changes in the technological, market, economic or legal environment that have a significant adverse effect on the debtor’s ability to meet its obligation to the Group.
Depending on the nature of the financial instruments, the assessment of a significant increase in credit risk is performed on either an individual basis or a collective basis. When the assessment is performed on a collective basis, the financial instruments are grouped based on shared credit risk characteristics, such as past due status and credit risk ratings.
ECLs are remeasured at each reporting date to reflect changes in the financial instrument’s credit risk since initial recognition. Any change in the ECL amount is recognized as an impairment gain or loss in profit or loss. The Group recognizes an impairment gain or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for investments in debt securities that are measured at FVOCI (recycling), for which the loss allowance is recognized in other comprehensive income and accumulated in the fair value reserve (recycling).

Basis of calculation of interest income
Interest income recognized in accordance with note 2.27 is calculated based on the gross carrying amount of the financial asset unless the financial asset is credit-impaired, in which case interest income is calculated based on the amortized cost (i.e. the gross carrying amount less loss allowance) of the financial asset.
At each reporting date, the Group assesses whether a financial asset is credit-impaired. A financial asset is credit-impaired when one or more events that have a detrimental impact on the estimated future cash flows of the financial asset have occurred.
Evidence that a financial asset is credit-impaired includes the following observable events:

•
significant financial difficulties of the debtor;

•
a breach of contract, such as a default or past due event;

•
it is becoming probable that the borrower will enter into bankruptcy or other financial reorganization;

•
significant changes in the technological, market, economic or legal environment that have an adverse effect on the debtor; or

•
the disappearance of an active market for a security because of financial difficulties of the issuer.
Write-off
policy
The gross carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery. This is generally the case when the Group determines that the debtor does not have assets or sources of income that could generate sufficient cash flows to repay the amounts subject to the
write-off.

Subsequent recoveries of an asset that was previously written off are recognized as a reversal of impairment in profit or loss in the period in which the recovery occurs.

(b)
Impairment of other
non-current
assets

Internal and external sources of information are reviewed at the end of each reporting period to identify indications
that
the following assets may be impaired or, except in the case of goodwill, an impairment loss previously recognized no longer exists or may have decreased:

•
property, plant and equipment;

•
right-of-use
assets;

•
investment properties;

•
construction in progress

•
other
non-current
assets; and

•
investments in subsidiaries, associates and joint ventures in the Company’s statements of financial position.
At the end of each reporting period, if any indication of impairment exists, the Company estimates the recoverable amount of an asset, or a cash- generating unit, at the higher of its fair value less costs of disposal and its value in use, to determine the impairment losses.

•
Calculation of recoverable amount
The recoverable amount of an asset is the greater of its fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash fl ows are discounted to their present value using a
pre-tax
discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. Where an asset does not generate cash inflows largely independent of those from other assets, the recoverable amount is determined for the smallest group of assets that generates cash inflows independently (i.e. a cash-generating unit). A portion of the carrying amount of a corporate asset (for example, head office building) is allocated to an individual cash-generating unit if the allocation can be done on a reasonable and consistent basis, or to the smallest group of cash-generating units if otherwise.

•
Recognition of impairment losses
An impairment loss is recognized in profit or loss if the carrying amount of an asset, or the cash-generating unit to which it belongs, exceeds its recoverable amount. Impairment losses recognized in respect of cash-generating units are allocated first to reduce the carrying amount of any goodwill allocated to the cash-generating unit (or group of units) and then, to reduce the carrying amount of the other assets in the unit (or group of units) on a pro rata basis, except that the carrying value of an asset will not be reduced below its individual fair value less costs of disposal (if measurable) or value in use (if determinable).

•
Reversals of impairment losses
An impairment loss is reversed if there has been a favourable change in the estimates used to determine the recoverable amount.
A reversal of an impairment loss is limited to the asset’s carrying amount that would have been determined had no impairment loss been recognized in prior years.

Reversals of impairment losses are credited to profit or loss in the year in which the reversals are recognized.

Derivative and hedging activities

2.13

Derivative and hedging activities
Derivatives are initially recognized at fair value on the date a derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. The accounting for subsequent changes in fair value depends on whether the derivative is designated as a hedging instrument and, if so, the nature of the item being hedged. The Group designates certain derivatives as hedges of a particular risk associated with the cash flows of recognized assets and liabilities and highly probable forecast transactions (cash flow hedges).
At inception of the hedge relationship, the Group documents the economic relationship between hedging instruments and hedged items, including whether changes in the cash flows of the hedging instruments are expected to offset changes in the cash flows of hedged items. The Group documents its risk management objective and strategy for undertaking its hedge transactions.
The fair values of derivative financial instruments designated in hedge relationships are disclosed in note 3.1(a). Movements in the hedging reserve in shareholders’ equity are shown in note 3
1
. The full fair value of a hedging derivative is classified as a
non-current
asset or liability when the remaining maturity of the hedged item is more than 12 months; it is classified as a current asset or liability when the remaining maturity of the hedged item is less than 12 months. Trading derivatives are classified as a current asset or liability.
Cash flow hedges that qualify for hedge accounting

The effective portion of changes in the fair value of derivatives that are designated and qualify as cash flow hedges is recognized in the cash flow hedge reserve within equity. The gain or loss relating to the ineffective portion is recognized immediately in the statements of profit or loss, within Other gains/(losses) – net.
When swap contracts are used to hedge forecast transactions the Group may designate the full change in fair value of the swap contract as the hedging instrument. The gains or losses relating to the effective portion of the change in fair value of the entire swap contract are recognized in the cash flow hedge reserve within equity.

Amounts accumulated in equity are reclassified in the periods when the hedged item affects the statements of profit or loss as follows:
Where the hedged item subsequently results in the recognition of a
non-financial
asset (such as inventory), the deferred hedging gains and losses are included within the initial cost of the asset. The deferred amounts are ultimately recognized in the statements of profit or loss as the hedged item affects profit or loss (for example through cost of sales).

When a hedging instrument expires, or is sold or terminated, or when a hedge no longer meets the criteria for hedge accounting, any cumulative deferred gain or loss and deferred costs of hedging in equity at that time remains in equity until the forecast transaction occurs, resulting in the recognition of a
non-financial
asset such as inventory. When the forecast transaction is no longer expected to occur, the cumulative gain or loss and deferred costs of hedging that were reported in equity are immediately reclassified to Other gains/(losses) - net.
Derivatives that do not qualify for hedge accounting

Certain derivative instruments do not qualify for hedge accounting. Changes in the fair value of any derivative instrument that does not qualify for hedge accounting are recognized immediately in the statements of profit or loss and are included in Other gains/(losses) - net.

Inventories

2.14

Inventories
Inventories are valued at the lower of cost and net realizable value. Cost is determined using the weighted average cost method. The cost of finished goods and work in progress comprises raw materials, direct labor, other direct costs and related production overheads (based on normal operating capacity). It excludes borrowing costs. The net realizable value is determined based on the estimated selling price in the ordinary course of business less the estimated costs to completion, and other costs necessary to make the sale.

Contract liabilities

2.15

Contract liabilities
A contract liability is recognized when the customer pays
non-refundable
consideration before the Group recognizes the related revenue (see note 2.26). A contract liability would also be recognized if the Group has an unconditional right to receive
non-refundable
consideration before the Group recognizes the related revenue. In such cases, a corresponding receivable would also be recognized (see note 2.16).
When the contract includes a significant financing component, the contract balance includes interest accrued under the effective interest method (see note 2.27).

Trade and other receivables

2.16

Trade and other receivables
A receivable is recognized when the Group has an unconditional right to receive consideration. A right to receive consideration is unconditional if only the passage of time is required before payment of that consideration is due. If revenue has been recognized before the Group has an unconditional right to receive consideration, the amount is presented as a contract asset.
Trade receivables that do not contain a significant financing component are initially measured at their transaction price.
Receivables are subsequently stated at amortized cost using the effective interest method less allowance for credit losses (see note 2.12(a)).

Cash and cash equivalents

2.17

Cash and cash equivalents
In the consolidated cash flow statements, cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value, and bank overdrafts. Bank overdrafts are presented within borrowings in current liabilities in the statements of financial position. Cash and cash equivalents are assessed for expected credit losses (ECL) in accordance with the policy set out in note 2.12(a).

Share capital

2.18

Share capital
Ordinary shares are classified as equity.
Incremental costs directly attributable to the issue of new shares are shown in equity as a deduction, net of tax, from the proceeds.

Safety production fund

2.19

Safety production fund
Under China’s law and regulation, the Group is required to accrue safety production fund at a certain percentage of the sales of dangerous goods. The fund is earmarked for improving the safety of production. The fund is accrued from retained earnings to other reserves and converted back to retained earnings when used.

Trade and other payables

2.20

Trade and other payables
Trade and other payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade and other payables are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as
non-current
liabilities.
Trade and other payables generally are financial liabilities and are recognized initially at fair value plus transaction costs and subsequently measured at amortized cost unless the effect of discounting would be immaterial, in which case they are stated at invoice amounts.

Borrowings

2.21

Borrowings
Borrowings are initially recognized at fair value, net of transaction costs incurred. Borrowings are subsequently measured at amortized cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognized in the statements of profit or loss over the period of the borrowings using the effective interest method.
Fees paid on the establishment of loan facilities are recognized as transaction costs of the loan to the extent that it is probable that some or all of the facility will be drawn down. In this case, the fee is deferred until the draw-down occurs. To the extent there is no evidence that it is probable that some or all of the facility will be drawn down, the fee is capitalized as a
pre-payment
for liquidity services and amortized over the period of the facility to which it relates.
Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the liability for at least 12 months after the end of the reporting period.

Borrowing costs

2.22

Borrowings costs
General and specific borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.
Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalization.
Other borrowing costs are expensed in the period in which they are incurred.

Current and deferred income tax

2.23

Current and deferred income tax
The tax expense for the period comprises current and deferred tax. Tax is recognized in the statements of profit or loss, except to the extent that it relates to items recognized in other comprehensive income or directly in equity. In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively.

(a)

Current income tax
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the statements of financial position date in the countries where the Company’s subsidiaries, associates and joint ventures operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.

(b)
Deferred income tax

Inside basis differences

Deferred income tax is recognized, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. However, deferred tax liabilities are not recognized if they arise from the initial recognition of goodwill, the deferred income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the statements of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled.

Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.

Outside basis differences

Deferred income tax liabilities are provided on taxable temporary differences arising from investments in subsidiaries, associates and joint arrangements, except for deferred income tax liability where the timing of the reversal of the temporary difference is controlled by the Group and it is probable that the temporary difference will not reverse in the foreseeable future. Generally, the Group is unable to control the reversal of the temporary difference for associates. Only when there is an agreement in place that gives the Group the ability to control the reversal of the temporary difference in the foreseeable future, deferred tax liability in relation to taxable temporary differences arising from the associate’s undistributed profits is not recognized.

Deferred income tax assets are recognized on deductible temporary differences arising from investments in subsidiaries, associates and joint arrangements only to the extent that it is probable the temporary difference will reverse in the future and there is sufficient taxable profit available against which the temporary difference can be utilized.

(c)

Offsetting

Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities and when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.

Employee benefits

2.24

Employee benefits

(a)
Short-term employee benefits

Salaries, annual bonuses, paid annual leave and the cost of
non-monetary
benefits are accrued in the year in which the associated services are rendered by employees. Where payment or settlement is deferred and the effect would be material, these amounts are stated at their present values.

(b)
Pension obligations

The PRC employees of the Group are covered by various PRC government-sponsored defined-contribution pension plans under which the employees are entitled to a monthly pension based on certain formulas. The relevant government agencies are responsible for the pension liability to these employees when they retire. The Group contributes on a monthly basis to these pension plans for the employees which are determined at a certain percentage of their salaries. Under these plans, the Group has no obligation for post-retirement benefits beyond the contribution made. Contributions to these plans are expensed as incurred and contributions paid to the defined contribution pension plans for a staff are not available to reduce the Group’s future obligations to such defined-contribution pension plans even if the staff leaves the Group.

(c)

Termination benefits

Termination benefits are payable when employment is terminated by the Group before the normal retirement date, or whenever an employee accepts voluntary redundancy in exchange for these benefits. The Group recognizes termination benefits at the earlier of the following dates: (a) when the Group can no longer withdraw the offer of those benefits; and (b) when the entity recognizes costs for a restructuring that is within the scope of IAS 37 and involves the payment of terminations benefits. In the case of an offer made to encourage voluntary redundancy, the termination benefits are measured based on the number of employees expected to accept the offer. Benefits falling due more than 12 months after the end of the reporting period are discounted to present value.

Provisions and contingent liabilities

2.25

Provisions and contingent liabilities

Provisions for environmental restoration, restructuring costs and legal claims are recognized when: the Group has a present legal or constructive obligation as a result of past events; it is probable that an outflow of resources will be required to settle the obligation; and the amount has been reliably estimated. Restructuring provisions comprise lease termination penalties and employee termination payments. Provisions are not recognized for future operating losses.

Where there are a number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class of obligations as a whole. A provision is recognized even if the likelihood of an outflow with respect to any one item included in the same class of obligations may be small.

Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a
pre-tax
rate that reflects current market assessments of the time value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognized as interest expense.

Where it is not probable that an outflow of economic benefits will be required, or the amount cannot be estimated reliably, the obligation is disclosed as a contingent liability, unless the probability of outflow of economic benefits is remote. Possible obligations, whose existence will only be confirmed by the occurrence or
non-occurrence
of one or more future events are also disclosed as contingent liabilities unless the probability of outflow of economic benefits is remote.

Revenue recognition

2.26

Revenue recognition

(a)

Sales of petroleum and chemical products

The Group manufactures and sells petroleum and chemical products. Sales are recognized when control of the products has transferred, being when the products are delivered to or accepted by the customer. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the customer, and either the customer has accepted the products in accordance with the sales contract, or the Group has objective evidence that all criteria for acceptance have been satisfied. Advance from customers but goods not yet delivered is recorded as contract liabilities and is recognized as revenue when a customer obtains control over the relevant goods.

Revenue excludes value added tax and is after deduction of any estimated trade discounts.

The Group has elected to apply the practical expedient that contract costs incurred related to contracts with an amortization period of less than one year have been expensed as incurred. The Group also applies the practical expedient in paragraph 121 of IFRS 15 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

(b)
Overseas shipping services

The Group arranges overseas shipping services for the customer and revenue is recognized over time and based on the actual shipping service provided to the end of the reporting period as a proportion of the total services to be provided, because the customer receives and uses the benefits simultaneously. This is determined based on the actual passages of time (days) relative to the total expected shipping days.

Interest income

2.27
Interest income

Interest income from financial assets at FVPL is included in Other gains/(losses) - net, see note 8 below. Interest income on financial assets at amortized cost and financial assets at FVOCI calculated using the effective interest method is recognized in the consolidated statements of profit or loss as part of other income.

Interest income is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for financial assets that subsequently become credit-impaired. For credit-impaired financial assets the effective interest rate is applied to the net carrying amount of the financial asset (after deduction of the loss allowance).

Interest income is presented as Finance income where it is earned from financial assets that are held for cash management purposes, see note 9 below.

Dividend income

2.28
Dividend income

Dividend income is recognized when the right to receive payment is established.

Government grants

2.29
Government grants

Grants from the government are recognized at their fair value where there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions.

Government grants relating to costs are deferred and recognized in the statements of profit or loss over the period necessary to match them with the costs that they are intended to compensate.

Grants that compensate the Group for the cost of an asset are deducted from the carrying amount of the asset and consequently are effectively recognized in the statements of profit or loss over the useful life of the asset by way of reduced depreciation expense.

Leases

2.30
Leases

The Group leases various land, buildings, equipment, vehicles and others. Rental contracts of buildings, equipment, vehicles and others are typically made for fixed periods of 1 to 30 years. Rental contracts of land use rights are typically made for fixed periods of 30 to 50 years. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions.

Leases are recognized as a
right-of-use
asset and a corresponding liability at the date at which the leased asset is available for use by the Group.

Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the following lease payments:

•
fixed payments (including
in-substance
fixed payments), less any lease incentives receivable,

•
variable lease payment that are based on an index or a rate, initially measured using the index or rate as at the commencement date,

•
amounts expected to be payable by the Group under residual value guarantees,

•
the exercise price of a purchase option if the Group is reasonably certain to exercise that option, and

•
payments of penalties for terminating the lease, if the lease term reflects the Group exercising that option.
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for leases in the Group, the lessee’s incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the funds necessary to obtain an asset of similar value to the
right-of-use
asset in a similar economic environment with similar terms, security and conditions.
To determine the incremental borrowing rate, the Group:

•
where possible, uses recent third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing conditions since third party financing was received

•
uses a
build-up
approach that starts with a risk-free interest rate adjusted for credit risk for leases held by the Group, which does not have recent third party financing, and

•
makes adjustments specific to the lease, e.g., term, country, currency and security.
Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic rate of interest on the remaining balance of the liability for each period.

Right-of-use
assets are measured at cost comprising the following:

•

the amount of the initial measurement of lease liability,

•

any lease payments made at or before the commencement date less any lease incentives received,

•

any initial direct costs, and

•

restoration costs.

Right-of-use
assets are generally depreciated over the shorter of the asset’s useful life and the lease term on a straight - line basis, as follows:

Land use rights

20 - 50 years

Buildings
   2 - 8 years

Equipment
   2 - 3 years

Others
   2 - 4 years

Payments associated with short-term leases of equipment and vehicles are recognized on a straight-line basis as an expense in the statements of profit or loss. Short-term leases are leases with a lease term of 12 months or less. A single discount rate was applied to the portfolio of the leases with reasonably similar characteristics.
Lease income from operating leases where the Group is a lessor is recognized as income on a straight-line basis over the lease term. Initial direct costs incurred in obtaining an operating lease are added to the carrying amount of the underlying asset and recognized as expense over the lease term on the same basis as lease income. The respective leased assets are included in the statement
s
of financial position based on their nature.

Dividend distribution

2.31
Dividend distribution
Dividend distribution to the Company’s shareholders is recognized as a liability in the Group’s financial statements in the period in which the dividends are approved by the Company’s shareholders.

Research and development costs

2.32
Research and development costs
Research and development costs comprise all costs that are directly attributable to research and development activities or that can be allocated on a reasonable basis to such activities. Research and development costs are recognized as intangible assets when the following criteria are met:

•
it is technically feasible to complete the research and development project so that it will be available for use or sale;

•
management intends to complete the research and development project, and use or sell it;

•
it can be demonstrated how the research and development project will generate economic benefits;

•
there are adequate technical, financial and other resources to complete the development and the ability to use or sell the research and development project; and

•
the expenditure attributable to the research and development project during its development phase can be reliably measured.
Other research and development expenditures that do not meet these criteria are recognized as an expense as incurred. Research and development costs previously recognized as an expense are not recognized as an asset in a subsequent period.

Related parties

2.33
Related parties

(a)
A person, or a close member of that person’s family, is related to the Group if that person:

(i)
has control or joint control over the Group;

(ii)
has significant influence over the Group; or

(iii)
is a member of the key management personnel of the Group or the Group’s parent.

(b)
An entity is related to the Group if any of the following conditions applies:

(iv)
The entity and the Group are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others).

(v)
One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member).

(vi)
Both entities are joint ventures of the same third party.

(vii)
One entity is a joint venture of a third entity and the other entity is an associate of the third entity.

(viii)
The entity is a post-employment benefit plan for the benefit of employees of either the Group or an entity related to the Group. (ix) The entity is controlled or jointly controlled by a person identified in (i).

(x)
A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity).

(xi)
The entity, or any member of a Group of which it is a part, provides key management personnel services to the Group or to the Group’s parent.

Close members of the family of a person are those family members who may be expected to influence, or be influenced by, that person in their dealings with the entity.

Rounding of amounts

2.34
Rounding of amounts

All amounts disclosed in the consolidated financial statements and notes have been rounded off to the nearest thousand currency units unless otherwise stated.

v3.23.1

Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2022

Summary of Significant Accounting Policies [Line Items]

Summary of estimated useful lives of property, plant and equipment

Depreciation on property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:

- Buildings
   12 to 40 years

- Plant and machinery
   5 to 20 years

- Vehicles and other equipment
   4 to 20 years

Summary of estimated useful lives of other non-current assets
Other non-current assets mainly represent intangible assets and long-term prepaid expense, which are amortized on a straight-line basis over the following periods:

Intangible assets - patents
   2 to 28 years

Long-term prepaid expense - catalyst
   1.5 to 10 years

Long-term prepaid expense - leasehold improvement
   3 to 27 years

Previously stated [member]

Summary of Significant Accounting Policies [Line Items]

Summary of estimated useful lives of other non-current assets
Right-of-use
assets are generally depreciated over the shorter of the asset’s useful life and the lease term on a straight - line basis, as follows:

Land use rights

20 - 50 years

Buildings
   2 - 8 years

Equipment
   2 - 3 years

Others
   2 - 4 years

v3.23.1

Financial Risk Management (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of nature and extent of risks arising from financial instruments [abstract]

Derivative financial instruments

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Current derivative financial instrument assets


Commodity swaps contracts applied hedge accounting
   48,614    —

Commodity swaps contracts at fair value through profit or loss
   32,791    —





Total derivative financial assets
   81,405    —





Current derivative financial instrument liabilities


Commodity swaps contracts at fair value through profit or loss
   (23,804 )    —





Total derivative financial liabilities
   (23,804 )    —





Reconciliation of hedging reserve in respect of commodity price risk and effectiveness of hedging relationships


Pre-tax
   Tax effect
Post-tax

   amount
RMB’000    RMB’000    amount
RMB’000

Balance at 1 January 2022
   48,613    (12,153 )    36,460

Effective portion of the cash flow hedge recognized in other comprehensive income
   375,701    (93,925 )    281,776

Amounts reclassified to profit or loss
   (107,009 )    26,752    (80,257 )

Reclassified to inventory
   (317,305 )    79,326    (237,979 )







Balance at 31 December 2022
   —      —      —







Reconciliation of hedging reserves in statement of profit or loss

   2021    2022

   RMB’000    RMB’000

Net gains/(losses) on commodity swaps contracts not qualifying as hedges included in other gains / (losses) - net
   18,997    (35,434 )

Net gains on foreign exchange forward contracts not qualifying as hedges included in other gains / (losses) - net
   —      7,583

Net losses on foreign exchange option contracts not qualifying as hedges included in other gains / (losses) - net
   (151 )    —





Total
   18,846    (27,851 )





The aggregate net foreign exchange (losses) / gains recognized in the consolidated statements of profit or loss

The aggregate net foreign exchange (losses) / gains recognized in the consolidated statements of profit or loss were:

   2021    2022

   RMB’000    RMB’000

Net foreign exchange (losses)/gains included in Other gains/(losses) - net (note 8)
   (1,861 )    21,969

Schedule of interest rate financial instruments



2021



2022



RMB’000



RMB’000

Fixed rate:


Time deposits with maturity less than one year
   7,350,000    3,000,000

Time deposits with maturity more than one year
   5,500,000    3,300,000

Borrowings
   (1,500,000 )    (1,550,000 )

Lease liabilities
   (4,613 )    (16,251 )





   11,345,387    4,733,749





Variable rate:


Cash and cash equivalents
   5,112,010    889,413

Borrowings
   (759,800 )    (700,000 )





   4,352,210    189,413





Net provision of impairment losses on financial assets recognized in income statement

   2021
RMB’000    2022
RMB’000

Impairment losses


- provision in loss allowance for trade receivables
   (1,354 )    (778 )

- provision in loss allowance for other receivables
   (1 )    (4,727 )

Impairment losses reversed
   —      139





Provision of impairment losses on financial assets
   (1,355 )    (5,366 )





Maturity analysis for financial liabilities



As at 31 December 2021



Contractual maturities of financial liabilities



Less than 1 year
RMB’000



Between
1 and 2 years
RMB’000



Between
2 and 5 years
RMB’000



Over
5 years
RMB’000



Total
RMB’000



Carrying
amount

Non-derivatives













Borrowings
   1,578,817    7,665    704,914    —      2,291,396

2,259,800

Lease liabilities
   3,814    730    814    —      5,358

4,613

Bills payables
   562,593    —      —      —      562,593

562,593

Trade payables
   1,527,706    —      —      —      1,527,706

1,527,706

Other payables
   1,003,860    —      —      —      1,003,860

1,003,860

Amounts due to related parties excluded non-financial liabilities
   4,910,255    —      —      —      4,910,255

4,910,255











   9,587,045    8,395    705,728    —      10,301,168

10,268,827













Derivatives


Derivative financial liabilities
   23,804    —      —      —      23,804

23,804















As at 31 December 2022



Contractual maturities of financial liabilities



Less than 1 year



Between
1 and 2 years



Between
2 and 5 years



Over
5 years



Total



Carrying
amount



RMB’000



RMB’000



RMB’000



RMB’000



RMB’000

Non-derivatives













Borrowings
   1,570,282    704,914    —      —      2,275,196

2,250,000

Lease liabilities
   9,395    7,531    655    —      17,581

16,251

Bills payables
   24,951    —      —      —      24,951

24,951

Trade payables
   1,818,453    —      —      —      1,818,453

1,818,453

Other payables
   1,083,130    —      —      —      1,083,130

1,083,130

Amounts due to related parties excluded
non-financial
liabilities
   7,877,323    —      —      —      7,877,323

7,877,323













   12,383,534    712,445    655    —      13,096,634

13,070,108













Derivatives


Derivative financial liabilities
   —      —      —      —      —

—













Schedule of detailed information of adjusted net debt to capital ratio explanatory

   Note    2022
RMB’000

Current liabilities:


Borrowings
   26    1,550,000

Lease liabilities
   15    8,738



      1,558,738

Non-current
liabilities:


Borrowings
   26    700,000

Lease liabilities
   15    7,513



Total Debt
      2,266,251

Less: Cash and cash equivalents
   23    (889,413 )



Adjusted net debt
      1,376,838



Total equity
      26,355,363

Less: Hedging reserve
      —



Adjusted capital
      26,355,363



Adjusted net
debt-to-capital
ratio
      5 %



Recurring fair value measurements

   As at 31 December 2021

   Note Level 1    Level 2    Level 3    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Recurring fair value measurements


Financial assets


Financial assets measured at fair value through profit or loss


- Commodity swaps contracts
   3.1(a) —      32,791    —      32,791

Financial assets at fair value through other comprehensive income


- Trade and bills receivable
   25 —      1,072,690    —      1,072,690

- Equity investments
   25 —      —      5,000    5,000

- Commodity swaps contracts
   3.1(a) —      48,614    —      48,614









   —      1,154,095    5,000    1,159,095









Financial liabilities


Financial liabilities measured at fair value through profit or loss


- Commodity swaps contracts
   —      23,804    —      23,804









   —      23,804    —      23,804









Amounts due to related parties – measured at fair value through profit or loss (FVPL)


—



1,388,286



—



1,388,286









   As at 31 December 2022

   Note Level 1    Level 2    Level 3    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Recurring fair value measurements


Financial assets


Financial assets measured at fair value through other comprehensive income


- Trade and bills receivable
   25 —      582,354    —      582,354

- Equity investments
   25 —      —      5,000    5,000









   —      582,354    5,000    587,354









Changes in level 3 items

   Equity
investments
RMB’000    Structured
deposits
RMB’000    Total
RMB’000

As at 31 December 2020
   5,000    —      5,000

Acquisitions
   —      8,150,000    8,150,000

Disposals
   —      (8,247,921 )    (8,247,921 )

Fair value change
   —      97,921    97,921







As at 31 December 2021
   5,000    —      5,000







Acquisitions
   —      1,000,000    1,000,000

Disposals
   —      (1,011,124 )    (1,011,124 )

Fair value change
   —      11,124    11,124







As at 31 December 2022
   5,000    —      5,000

v3.23.1

Segment Information and Revenue (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of operating segments [abstract]

Segment information

2020
   Petroleum
products
RMB’000 Intermediate
petrochemicals
RMB’000 Resins and
plastics
RMB’000 Synthetic fibres
RMB’000 Trading of
petrochemical
products
RMB’000 Others
RMB’000 Total
RMB’000

Total segment revenue
   49,711,547 19,777,574 9,576,944 1,480,576 12,023,744 1,583,236 94,153,621

Inter segment revenue
   (6,631,343 ) (11,526,322 ) (101,057 ) —   (438,634 ) (832,690 ) (19,530,046 )



Revenue from external customers
   43,080,204 8,251,252 9,475,887 1,480,576 11,585,110 750,546 74,623,575



Timing of revenue recognition


- At a point in time
   43,080,204 8,251,252 9,475,887 1,480,576 11,583,709 750,546 74,622,174

- Over time
   —   —   —   —   1,401 —   1,401



   43,080,204 8,251,252 9,475,887 1,480,576 11,585,110 750,546 74,623,575



Segment result – (loss)/profit from operations
   (2,198,705 ) 581,597 1,262,029 (364,211 ) 42,039 211,015 (466,236 )



2021
   Petroleum
products
RMB’000 Intermediate
petrochemicals
RMB’000 Resins and
plastics
RMB’000 Synthetic fibres
RMB’000 Trading of
petrochemical
products
RMB’000 Others
RMB’000 Total
RMB’000

Total segment revenue
   65,528,687 26,454,844 10,176,285 1,381,443 12,972,922 1,625,705 118,139,886

Inter segment revenue
   (10,454,529 ) (15,619,770 ) (170,255 ) (445 ) (1,912,789 ) (783,606 ) (28,941,394 )



Revenue from external customers
   55,074,158 10,835,074 10,006,030 1,380,998 11,060,133 842,099 89,198,492



Timing of revenue recognition


- At a point in time
   55,074,158 10,835,074 10,006,030 1,380,998 11,020,323 842,099 89,158,682

- Over time
   —   —   —   —   39,810 —   39,810



   55,074,158 10,835,074 10,006,030 1,380,998 11,060,133 842,099 89,198,492



Segment result – profit/(loss) from operations
   2,967,030 (635,155 ) 52,215 (854,077 ) 43,729 (141,510 ) 1,432,232



2022
   Petroleum
products
RMB’000 Intermediate
petrochemicals
RMB’000 Resins and
plastics
RMB’000 Synthetic fibres
RMB’000 Trading of
petrochemical
products
RMB’000 Others
RMB’000 Total
RMB’000

Total segment revenue
   62,729,318 26,112,700 7,416,830 413,981 12,938,663 1,641,243 111,252,735

Inter segment revenue
   (11,575,451 ) (15,536,795
)
(71,778 ) (98 ) (922,077 ) (703,380 ) (28,809,579 )



Revenue from external customers
   51,153,867 10,575,905 7,345,052 413,883 12,016,586 937,863 82,443,156



Timing of revenue recognition


- At a point in time
   51,153,867 10,575,905 7,345,052 413,883 11,917,827 937,863 82,344,397

- Over time
   —   —   —   —   98,759 —   98,759



   51,153,867 10,575,905 7,345,052 413,883 12,016,586 937,863 82,443,156



Segment result – profit/(loss) from operations
   972 (1,456,647 ) (1,252,524 ) (1,015,255 ) 12,838 (132,750 ) (3,843,366 )



   2020
RMB’000    2021
RMB’000    2022
RMB’000

Segment result – (loss)/profit from operations


Petroleum products
   (2,198,705 )    2,967,030    972

Intermediate petrochemicals
   581,597    (635,155 )    (1,456,647 )

Resins and plastics
   1,262,029    52,215    (1,252,524 )

Synthetic fibres
   (364,211 )    (854,077 )    (1,015,255 )

Trading of petrochemical products
   42,039    43,729    12,838

Others
   211,015    (141,510 )    (132,750 )







(Loss)/profit from operations
   (466,236 )    1,432,232    (3,843,366 )

Finance income – net
   332,274    414,569    443,328

Share of profit/(loss) of investments accounted for using the equity method
   724,740    874,285    (173,616 )







Profit/(loss) before taxation
   590,778    2,721,086    (3,573,654 )







Other profit and loss disclosures

   2020 2021 2022

   Depreciation
and
amortization Impairment
loss and
credit loss Inventory

write-down
Depreciation
and
amortization Impairment
loss and
credit loss Inventory

write-down
Depreciation
and
amortization Impairment
loss and
credit loss Inventory

write-down

   RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000

Petroleum products
   (917,637 ) —   (138,537 ) (975,492 ) (94,420 ) (782 ) (928,687 ) —   (37,900 )

Intermediate petrochemicals
   (465,425 ) (55,204 ) (15,418 ) (523,484 ) (297,632 ) (136,694 ) (414,999 ) (215,355 ) (248,518 )

Resins and plastics
   (138,204 ) —   (26,382 ) (86,183 ) (61,242 ) (168 ) (106,845 ) (25,102 ) (134,138 )

Synthetic fibres
   (78,030 ) 88,550 (39,657 ) (132,091 ) (135,683 ) (13,239 ) (140,885 ) (51,160 ) (104,713 )

Trading of petrochemical products
   (19,938 ) —   (788 ) (39,125 ) —   —   (35,345 ) —   —

Others
   (207,905 ) —   (106 ) (209,333 ) (28,392 ) —   (186,537 ) (9 ) —



   (1,827,139 ) 33,346 (220,888 ) (1,965,708 ) (617,369 ) (150,883 ) (1,813,298 ) (291,626 ) (525,269 )





As at 31 December



2021

Total assets
RMB’000



2022

Total assets
RMB’000

Allocated assets





Petroleum products

13,317,338

16,021,111

Intermediate petrochemicals

3,781,785

3,803,989

Resins and plastics

1,395,867

1,359,796

Synthetic fibres

1,919,194

2,734,193

Trading of petrochemical products

1,348,751

1,391,104

Others

2,700,327

2,765,693

Allocated assets

24,463,262

28,075,886

Unallocated assets

Investments accounted for using the equity method

4,088,888

3,504,393

Cash and cash equivalents

5,112,010

889,413

Time deposits with banks

12,968,042

6,498,478

Deferred tax assets

184,143

991,850

Derivative financial assets

81,405

—

Value added tax recoverable

13,322

1,057,463

Others

9,517

119,234

Unallocated assets

22,457,327

13,060,831

Total assets

46,920,589

41,136,717

   As at 31 December


2021
Total liabilities
RMB’000
   2022
Total liabilities
RMB’000

Allocated liabilities


Petroleum products
   9,749,806    8,159,960

Intermediate petrochemicals
   1,257,436    801,787

Resins and plastics
   1,327,587    1,309,344

Synthetic fibres
   490,211    531,455

Trading of petrochemical products
   1,257,750    1,370,346

Others
   112,876    251,328





Allocated liabilities
   14,195,666    12,424,220





Unallocated liabilities


Borrowings
   2,259,800    2,250,000

Deferred tax liabilities
   33,344    30,895

Derivative financial liabilities
   23,804    —

Others
   30,577    76,239





Unallocated liabilities
   2,347,525    2,357,134





Total liabilities
   16,543,191    14,781,354





   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Additions to property, plant and equipment, construction in progress,
right-of-use
assets, other
non-current
assets


Petroleum products
   779,392    708,342    544,806

Intermediate petrochemicals
   278,788    1,306,813    1,029,771

Resins and plastics
   139,212    44,495    54,220

Synthetic fibres
   496,125    1,748,868    1,573,781

Trading of petrochemical products
   378,292    71,917    16,603

Others
   222,080    234,023    235,406







   2,293,889    4,114,458    3,454,587

v3.23.1

Other Operating Income (Tables)
12 Months Ended

Dec. 31, 2022

Other operating income [abstract]

Other operating income

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Government grants (a)
   61,296    35,944    33,055

Rental income from investment properties (note 17)
   81,608    81,923    75,159

Others
   5,772    7,438    2,427







   148,676    125,305    110,641







(a)
Government grants
Grants related to R&D, other tax refund and subsidies are included in the government grants line item. There are no unfulfilled conditions or other contingencies attaching to these grants.

v3.23.1

Other Operating Expenses (Tables)
12 Months Ended

Dec. 31, 2022

Other operating expenses [abstract]

Other operating expenses



2020



2021



2022



RMB’000



RMB’000



RMB’000

Cost related to lease of investment properties
   (15,625 )    (13,439 )    (12,037 )

Others
   (9,061 )    (31,273 )    (13,738 )







   (24,686 )    (44,712 )    (25,775 )

v3.23.1

Other gains(losses) - net (Tables)
12 Months Ended

Dec. 31, 2022

Other gains/(losses) - net [abstract]

Other gains(losses) - net

   2020 2021 2022

   RMB’000 RMB’000 RMB’000

Net (losses) / gains on disposal of property, plant and equipment and other long-term assets
   (1,212 ) 48,671 (26,767 )

Gains from structured deposits (note a)
   114,283 97,921 11,124

Net losses on foreign exchange option contracts
   (376 ) (151 ) —

Net gains on foreign exchange forward contracts
   —   —   7,583

Net gains/(losses) on commodity swaps contracts not qualified for hedging accounting
   —   18,997 (35,434 )

Losses from disposal of a subsidiary
   —   —   —

Impairment losses for investment in an associate
   —   (28,392 ) —

Net foreign exchange gains / (losses)
   12,248 (1,861 ) 21,969

Losses on sale of FVOCI
   (9,513 ) (4,685 ) (3,148 )

Gains from entrusted loan receivables
   —   —   2,704

Net losses on disposal of inventories
   —   (19 ) (819 )



   115,430 130,481 (22,788 )

v3.23.1

Finance Income and Expenses (Tables)
12 Months Ended

Dec. 31, 2022

Finance income and expenses [abstract]

Finance income and expenses

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Interest income from time deposits with maturity more than 3 months
   339,595    424,696    410,652

Interest income from time deposits with maturity less than 3 months
   83,812    71,402    124,468

Others
   7,821    12,657    6,710







Finance income
   431,228    508,755    541,830







Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss
   (101,732 )    (106,827 )    (122,638 )

Less: interest expense capitalized into construction in progress
   8,292    12,641    24,136







Net interest expenses
   (93,440 )    (94,186 )    (98,502 )

Net foreign exchange losses
   (5,514 )    —      —







Finance expenses
   (98,954 )    (94,186 )    (98,502 )







Finance income – net
   332,274    414,569    443,328

v3.23.1

Expense by Nature (Tables)
12 Months Ended

Dec. 31, 2022

Expenses by nature [abstract]

Expense by nature

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Cost of raw materials
   42,082,307    54,457,558    55,997,717

Cost of trading products
   11,467,420    10,929,127    11,910,488

Employee benefit expenses (note 11)
   3,143,219    3,456,765    3,545,720

Depreciation and amortization:


Property, plant and equipment (note 16)
   1,553,039    1,621,459    1,494,176

Investment properties (note 17)
   15,184    15,325    15,323

Other
non-current
assets (note 14)
   226,263    294,617    270,881

Right-of-use
assets (note 15)
   32,653    34,307    32,918

Repairs and maintenance expenses
   1,060,624    1,587,955    1,513,812

Changes of work in progress and finished goods
   862,652    (235,402 )    (78,255 )

Transportation costs
   274,002    238,405    193,144

Inventory write-down (note 21)
   220,888    150,883    525,269

External processing fee
   215,467    213,691    192,288

Commission expense (note 3
2
)
   104,598    110,552    90,341

Impairment loss of property, plant and equipment (note 16)
   87,570    587,622    286,260

Impairment loss of investments accounted for using equity method (note 20)
   —      28,392    —

Auditors’ remuneration – audit services
   7,800    6,837    6,837

Auditors’ remuneration –
non-audit
services
   —      129    129

Expenses relating to short - term leases
   3,731    6,938    14,774

v3.23.1

Employee Benefit Expenses (Tables)
12 Months Ended

Dec. 31, 2022

Classes of employee benefits expense [abstract]

Employee benefit expenses

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Wages and salaries
   2,009,645    2,142,959    2,139,472

Social welfare costs
   714,484    861,375    921,971

Others
   419,090    452,431    484,277







Total employee benefit expense
   3,143,219    3,456,765    3,545,720







(a)

Employees of the Group’s subsidiaries in the PRC are required to participate in a defined contribution retirement scheme administered and operated by the local municipal government. The Group’s subsidiaries in the PRC contribute funds which are calculated on certain percentages of the average employee salary as stipulated by the local municipal government to the scheme to fund the retirement benefits of the employees.

v3.23.1

Income Tax Benefits /(Expenses) (Tables)
12 Months Ended

Dec. 31, 2022

Income tax [abstract]

Summary of major components of income tax expense

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Current income tax
   (37,027 )    (590,668 )    (66,649 )

Deferred taxation
   102,647    (53,812 )    798,003







Income tax benefits / (expenses)
   65,620    (644,480 )    731,354







Summary of reconciliation of expected income tax and actual income tax



Years ended 31 December



2020



2021



2022



RMB’000



RMB’000



RMB’000

Profit / (loss) before income tax
   590,778    2,721,086    (3,573,654 )







Expected PRC income tax at the statutory tax rate of 25%
   (147,695 )    (680,272 )    893,414

Tax effect of share of net profits / (losses) of investments accounted for using the equity method
   178,685    214,750    (46,787 )

Tax effect of other
non-taxable
income
   54,379    10,782    9,890

Tax effect of additional deductions for R&D expenses
   11,863    12,168    17,779

Tax effect of
non-deductible
loss, expenses and costs
   (51,543 )    (185,945 )    (67,330 )

True up for final settlement of enterprise income taxes in respect of previous years
   9,188    —      (54,017 )

Tax losses for which no deferred income tax asset was recognized
   (2,821 )    (21,225 )    (24,948 )

Utilization of previously unrecognized tax losses
   13,564    157    3,353

Tax effect of additional deduction for purchasing environmental protection equipment
   —      12,446    —

Derecognition of previously recognized tax losses
   —      (7,341 )    —







Actual income tax benefits / (expenses)
   65,620    (644,480 )    731,354







Summary of current taxation in the consolidated statement of financial position


2021
RMB’000
   2022
RMB’000

At the beginning of the year
   19,425    258,466

Provision for current income tax for the year
   590,668    66,649

Payment during the year
   (351,627 )    (376,765 )





At the end of the year
   258,466    (51,650 )

Representing


Income tax
   258,466    2,754

-Payable
   —      (54,404 )

-Prepaid
   258,466    (51,650 )





Summary of movements in deferred tax assets and liabilities

   Balance as at 1
January 2021
RMB’000
Credited/
(Charged) to
profit or
loss
RMB’000
   Credited/
(Charged) to
reserves
RMB’000    Balance as at
31 December
2021
RMB’000

Deferred tax assets:


Impairment for bad and doubtful debts and provision for inventories
   57,326    (977 )    —      56,349

Provision for impairment losses in property, plant and equipment and construction in progress
   226,435    131,776    —      358,211

Tax losses
   87,799    (87,799 )    —      —

Accruals and others
   130,986    (48,808 )    —      82,178









   502,546    (5,808 )    —      496,738









Deferred tax liabilities:


Difference in depreciation
   (283,739 )    (46,332 )    —      (330,071 )

Capitalization of borrowing costs
   (2,043 )    575    —      (1,468 )

Derivative financial instruments
   —      (2,247 )    (12,153 )    (14,400 )









   (285,782 )    (48,004 )    (12,153 )    (345,939 )









Deferred tax assets – net
   252,121    (55,825 )    (12,153 )    184,143

Deferred tax liabilities – net
   (35,357 )    2,013    —      (33,344 )

   Balance as at 1
January 2022
RMB’000
Credited/
(Charged) to
profit
or loss
RMB’000
   Credited/
(Charged) to
reserves
RMB’000    Balance as at
31 December
2022
RMB’000

Deferred tax assets:


Impairment for bad and doubtful debts and provision for inventories
   56,349    71,761    —      128,110

Provision for impairment losses in property, plant and equipment and construction in progress
   358,211    70,499    —      428,710

Tax losses

—
   872,648    —      872,648

Accruals and others
   82,178    (55,873 )    —      26,305









   496,738    959,035    —      1,455,773









Deferred tax liabilities:


Difference in depreciation
   (330,071 )    (163,492 )    —      (493,563 )

Capitalization of borrowing costs
   (1,468 )    213    —      (1,255 )

Derivative financial instruments
   (14,400 )    2,247    12,153    —









   (345,939 )    (161,032 )    12,153    (494,818 )









Deferred tax assets – net
   184,143    795,554    12,153    991,850

Deferred tax liabilities – net
   (33,344 )    2,449    —      (30,895 )

Summary of tax losses carried forward and not recognised as deferred tax assets

   2021    2022

   RMB’000    RMB’000

2022
   65,331    —

2023
   66,965    65,585

2024
   91,901    91,901

2025
   41,475    41,475

2026
   84,902    95,144

2027
   —      99,791





   350,574    393,896

v3.23.1

Earnings/(losses) Per Share (Tables)
12 Months Ended

Dec. 31, 2022

Earnings per share [abstract]

Summary of earnings/(losses) per share, basic
Basic earnings/(losses) per share is calculated by dividing the profit/(loss) attributable to equity shareholders of the Company by the weighted average number of ordinary shares in issue during the year.



2020



2021



2022



RMB’000



RMB’000



RMB’000

Net profit/(loss) attributable to equity shareholders of the Company
   645,072    2,073,431    (2,846,156 )

Weighted average number of ordinary shares in issue (thousand of shares)
   10,823,814    10,823,814    10,819,622

Basic earnings/(losses) per share (RMB per share)
   RMB 0.060    RMB 0.192    RMB(0.263 )







Summary of weighted average number of ordinary shares

Weighted average number of ordinary shares (thousand of shares)



2020



2021



2022

Issued ordinary shares at 1 January



10,823,814



10,823,814



10,823,814

Effect of shares repurchased (note 30)



—



—



(4,192

)







Weighted average number of ordinary shares at 31 December



10,823,814



   10,823,814



  10,819,622

v3.23.1

Other Non-current Assets (Tables)
12 Months Ended

Dec. 31, 2022

Other non-current assets [abstract]

Summary of other non-current assets

   Intangible
assets    Long-term
prepaid
expense    Investment
deposits    Total

   RMB’000    RMB’000    RMB’000    RMB’000

As at 1 January 2021


Cost
   85,908    1,069,157    —      1,155,065

Accumulated amortization
   (71,139 )    (658,967 )    —      (730,106 )









Net book amount
   14,769    410,190    —      424,959









Year ended 31 December 2021


Opening net book amount
   14,769    410,190    —      424,959

Additions
   —      657,465    —      657,465

Charge for the year
   (2,925 )    (291,692 )    —      (294,617 )









Closing net book amount
   11,844    775,963    —      787,807









As at 31 December 2021


Cost
   85,908    1,726,622    —      1,812,530

Accumulated amortization
   (74,064 )    (950,659 )    —      (1,024,723 )









Net book amount
   11,844    775,963    —      787,807









Year ended 31 December 2022


Opening net book amount
   11,844    775,963    —      787,807

Additions
   —      268,474    50,000    318,474

Charge for the year
   (2,924 )    (267,957 )    —      (270,881 )









Closing net book amount
   8,920    776,480    50,000    835,400









As at 31 December 2022


Cost
   85,908    1,995,096    50,000    2,131,004

Accumulated amortization
   (76,988 )    (1,218,616 )    —      (1,295,604 )









Net book amount
   8,920    776,480    50,000    835,400

v3.23.1

Leases (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of quantitative information about leases for lessee [abstract]

Disclosure of Balance sheet amounts relating to leases

As at 31 December

   202
1
   202
2

   RMB’000    RMB’000

Right-of-use
assets


Land use rights
   380,764    363,720

Buildings
   3,288    14,540

Equipment
   625    373

Others
   966    1,172





   385,643    379,805





Lease liabilities


Current
   3,229    8,738

Non-current
   1,384    7,513





   4,613    16,251





Disclosure of Maturity analysis for lease liabilities At 31 December 2022, the lease liabilities were repayable as follows:

   2022

   RMB’000

Within 1 year
   8,738

After 1 year but within 2 years
   6,945

After 2 years but within 5 years
   568



   16,251



Disclosure of Income statement amounts relating to leases

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Depreciation charge of
right-of-use
assets


Land use rights
   (15,965 )    (17,044 )    (17,044 )

Buildings
   (15,481 )    (15,677 )    (14,089 )

Equipment
   (449 )    (399 )    (547 )

Others
   (758 )    (1,187 )    (1,238 )







   (32,653 )    (34,307 )    (32,918 )







Interest expense (included in Finance expenses)
   (887 )    (537 )    (1,039 )

Expense relating to short-term leases (included in Cost of sales)
   (3,731 )    (6,938 )    (14,774 )

v3.23.1

Property, Plant and Equipment (Tables)
12 Months Ended

Dec. 31, 2022

Property, plant and equipment [abstract]

Summary of property, plant and equipment

   Buildings    Plant and
machinery    Vehicles and
other
equipment    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Cost:


At 1 January 2021
   3,481,210    42,742,330    1,958,220    48,181,760

Additions
   —      161,118    15,646    176,764

Transferred from construction in progress (note 18)
   130,947    1,476,065    92,962    1,699,974

Reclassification
   267,662    (275,880 )    8,218    —

Disposals
   (4,717 )    (737,634 )    (62,782 )    (805,133 )

Transferred from investment properties (note 17)
   1,164    —      —      1,164

Transferred to construction in progress (note 18)
   (2,091 )    (1,260 )    (15,404 )    (18,755 )

Transferred to investment properties (note 17)
   (83 )    (7 )    —      (90 )









At 31 December 2021 and 1 January 2022
   3,874,092    43,364,732    1,996,860    49,235,684

Additions
   132    187,460    39,934    227,526

Transferred from construction in progress (note 18)
   609,303    1,768,395    90,219    2,467,917

Reclassification
   9,088    (47,399 )    38,311    —

Disposals
   (2,596 )    (393,686 )    (51,813 )    (448,095 )

Transferred from investment properties (note 17)
   47    —      —      47

Others
   1,208    —      —      1,208









At 31 December 2022
   4,491,274    44,879,502    2,113,511    51,484,287









Accumulated depreciation:


At 1 January 2021
   (2,396,564 )    (31,700,912 )    (1,457,854 )    (35,555,330 )

Charge for the year
   (88,234 )    (1,419,669 )    (113,556 )    (1,621,459 )

Reclassification
   (214,041 )    216,706    (2,665 )    —

Written back on disposals
   3,652    626,865    55,709    686,226

Transferred from investment properties (note 17)
   (1,088 )    —      —      (1,088 )

Transfer to construction in progress (note 18)
   46    735    5,642    6,423

Transferred to investment properties (note 17)
   80    7    —      87









At 31 December 2021 and 1 January 2022
   (2,696,149 )    (32,276,268 )    (1,512,724 )    (36,485,141 )

Charge for the year
   (95,661 )    (1,270,423 )    (128,092 )    (1,494,176 )

Reclassification
   (787 )    6,340    (5,553 )    —

Written back on disposals
   2,469    344,469    50,036    396,974

Transferred from investment properties (note 17)
   (45 )    —      —      (45 )









At 31 December 2022
   (2,790,173 )    (33,195,882 )    (1,596,333 )    (37,582,388 )









   Buildings    Plant and
machinery    Vehicles
and other
equipment    Total

   RMB’000    RMB’000    RMB’000    RMB’000

Impairment losses:


At 1 January 2021
   (53,792 )    (850,967 )    (8,649 )    (913,408 )

Charge for the year
   (793 )    (586,147 )    (682 )    (587,622 )

Written back on disposals
   —      60,018    501    60,519

Reclassification
   (26,133 )    26,270    (137 )    —









At 31 December 2021 and 1 January 2022
   (80,718 )    (1,350,826 )    (8,967 )    (1,440,511 )

Charge for the year
   (984 )    (283,624 )    (1,652 )    (286,260 )

Written back on disposals
   —      4,264    112    4,376

Reclassification
   (2,146 )    2,202    (56 )    —









At 31 December 2022
   (83,848 )    (1,627,984 )    (10,563 )    (1,722,395 )









Net book value:


At 31 December 2022
   1,617,253    10,055,636    506,615    12,179,504









At 31 December 2021
   1,097,225    9,737,638    475,169    11,310,032

v3.23.1

Investment Properties (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of detailed information about investment property [abstract]

Summary of investment properties

   RMB’000

Cost:


As at 1 January 2021
   627,488

Transferred from property plant and equipment (note 16)
   90

Transferred to property plant and equipment (note 16)
   (1,164 )



At 31 December 2021 and 1 January 2022
   626,414



Transferred to property plant and equipment (note 16)
   (47 )



At 31 December 2022
   626,367



Accumulated depreciation:


At 1 January 2021
   (259,902 )

Charge for the year
   (15,325 )

Transferred from property plant and equipment (note 16)
   (87 )

Transferred to property plant and equipment (note 16)
   1,088



At 31 December 2021 and 1 January 2022
   (274,226 )



Charge for the year
   (15,323 )

Transferred from property plant and equipment (note 16)
   —

Transferred to property plant and equipment (note 16)
   45



At 31 December 2022
   (289,504 )



Net book value:


At 31 December 2022
   336,863



At 31 December 2021
   352,188



Disclosure of maturity analysis of operating lease payments
Undiscounted lease payments under
non-cancellable
operating leases in place at the reporting date will be receivable by the Group in future periods as follows :



2021



2022



RMB’000



RMB’000

Within 1 year
   49,420    52,138

Between 1 and 2 years
   39,137    6,638

Above 2 years
   —    6,522





   88,557    65,298

v3.23.1

Construction in Progress (Tables)
12 Months Ended

Dec. 31, 2022

Construction in progress [abstract]

Construction in progress

   202
1
   202
2

   RMB’000    RMB’000

As at 1 January
   1,710,124    3,293,177

Additions
   3,270,695    2,927,950

Disposal
   —    (4,749 )

Transferred to property plant and equipment (note 16)
   (1,699,974 )    (2,467,917 )

Transferred from property plant and equipment (note 16)
   12,332    —





As at 31 December
   3,293,177    3,748,461

v3.23.1

Subsidiaries (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of subsidiaries [abstract]

Summary of major subsidiaries
The following list contains only the particulars of subsidiaries which principally affected the results, assets or liabilities of the Group. The class of shares held is ordinary unless otherwise stated.







Proportion of ownership interest



Name of company



Place of
incorporation
and business



Particulars of paid-
up capital ’000



Group’s
effective
interest



Held by
the Company



Held by a
subsidiary



Principal activity

Shanghai Petrochemical Investment Development Company Limited
(“Toufa”)    Mainland
China    RMB1,000,000    100.00    100.00    —      Investment
management

China Jinshan Associated Trading Corporation (“Jinmao”)    Mainland
China    RMB      25,000    67.33    67.33    —      Import and
export of
petrochemical
products and
equipment

Shanghai Jinchang Engineering Plastics Company Limited (“Jinchang”)    Mainland
China    USD        9,154    74.25    —      74.25    Production of
polypropylene
compound
products

Shanghai Golden Phillips Petrochemical Company Limited (“Jinfei”)    Mainland
China    RMB   415,623    100.00    —      100.00    Production of
polyethylene
products

Shanghai Jinshan Trading Corporation (“JMGJ”)    Mainland
China    RMB   100,000    67.33    —      67.33    Import and
export of
petrochemical
products

Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd.
(“Jinlian”)    Mainland
China    RMB   400,000    100.00    —      100.00    Trading of
petrochemical
products

v3.23.1

Investments Accounted for Using the Equity Method (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of significant investments in associates and joint ventures [line items]

Summary of amounts recognized in balance sheet



As at 31 December



2021



2022



RMB’000



RMB’000

Associates

– Share of net assets
   3,812,845    3,027,632

Joint ventures


– Share of net assets
   276,043    476,761





As at 31 December
   4,088,888    3,504,393





Summary of amounts recognized in share of profit/ losses of investments accounted for using the equity method

The amounts recognized in the share of net profits / (losses) of associates and joint ventures accounted for using the equity method are as follows:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Associates
   678,077    825,132    (188,549 )

Joint ventures
   46,663    49,153    14,933

   724,740    874,285    (173,616 )





Financial information for the Company's equity method investments other than Shanghai Secco are summarized

(c)

For the year ended December 31, 2022, equity method investments held by the Company in aggregate have met the significance criteria as defined under Rule 4-08(g) of Regulation S-X. Shanghai Secco was deemed a significant equity investee for the fiscal years ended December 31, 2020 and a non-significant equity investee for the fiscal years ended December 31, 2021 and December 31, 2022 under Rule 3-09 of Regulation S-X. As such, the financial statements of Shanghai Secco required by Rule 3-09 of Regulation S-X are provided as Exhibit 99.1 to this Annual Report on Form 20-F. Financial information for the Company’s equity method investments other than Shanghai Secco are summarized as a group as follow:



2020



2021



2022



RMB’000



RMB’000



RMB’000

Revenue



4,548,574



4,863,742



3,759,076

Gross profit



825,799



828,183



670,678

Profit from continuing operations



753,799



798,867



670,678

Profit after taxation



593,211



586,612



512,758

Profit after taxation attributable to the Group



243,953



240,882



208,401



As of 31 December 2022



2021



2022



RMB’000



RMB’
000

Current assets



6,083,530



6,436,238

Non-current assets



5,000,852



5,909,304

Current liabilities



(2,086,793

)



(2,185,434

)

Non-current liabilities



(707,374

)



(978,325

)

Non-controlling interests



1,508,175



1,578,714

Joint ventures [member]

Disclosure of significant investments in associates and joint ventures [line items]

Summary of investments in associates/joint ventures

   2021    2022

   RMB’000    RMB’000

As at 1 January
   241,674    276,043

Addition (note i)
   50,000    200,000

Share of profit
   49,153    14,933

Cash dividends distribution
   (64,784 )    (14,215 )



As at 31 December
   276,043    476,761





Summary of principal activities of material associates/joint ventures
The following list contains only the particulars of material joint ventures, all of the Group’s joint ventures are unlisted corporate entities whose quoted market price is not available:

Name of joint venture



Form of
business
structure



Place of
incorporation
and business



Particulars of
paid-up
capital ’000



Proportion of ownership interest

Principal activity



Group’s
effective
interest

Held by
the
Company



Held by a
subsidiary

Linde-SPC
Gases Company Limited (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)

Incorporated    Mainland China    USD     32,000    50.00 % —      50.00 % Production and sales
of industrial gases

Shanghai Petrochemical Pressure Vessel Testing Center (“JYJC”)
Incorporated    Mainland China    RMB    10,000    50.00 % —      50.00 %
Providing
inspection and
testing service

Shanghai Petrochemical Yangu Gas
Development Company Limited
(“Yangu Gas”) Incorporated    Mainland China    USD     10,560    50.00 % —      50.00 % Production and sales
of industrial gases

Shanghai Jinshan Baling New Materials
Co., Ltd. (“Baling Materials”) (note i)
(“Linde”), formerly known as
“BOC-SPC Gases Company Limited”) Incorporated    Mainland China    RMB  500,000    50.00 % —      50.00 %

Production and sales
of new styrene
thermoplastic
elastomer materials

Summarized statement of financial position
As at 31 December 2021



Linde
RMB’000



JYJC
RMB’000



Yangu Gas
RMB’000



Baling Materials
RMB’000

Current


Cash and cash equivalents
   226,860 16,914 72,916 6,062

Other current assets (excluding cash)
   74,652 5,065 11,149 28,418



Total current assets
   301,512 21,979 84,065 34,480

Total current liabilities
   (62,356 ) (3,356 ) (3,262 ) —



Non-current


Total
non-current
assets
   109,366 1,577 19,034 65,520

Total
non-current
liabilities
   (16,303 ) —   —   —



Net assets
   332,219 20,200 99,837 100,000



Group’s effective interest
   50% 50% 50% 50%

Interest in joint ventures
   166,110 10,100 49,919 50,000

Unrealized downstream transactions
   (86 ) —   —   —



Carrying value
   166,024 10,100 49,919 50,000



As at 31 December 2022



Linde



JYJC



Yangu
Gas



Baling Materials



RMB’000



RMB’000



RMB’000



RMB’000

Current


Cash and cash equivalents
   237,902 11,482 62,639 13,948

Other current assets (excluding cash)
   73,026 9,167 6,423 60,243



Total current assets
   310,928 20,649 69,062 74,191

Total current liabilities
   (32,670 ) (2,437 ) (2,392 ) (153,952 )



Non-current


Total
non-current
assets
   92,325 1,478 13,765 626,761

Total
non-current
liabilities
   (17,016 ) —   —   (47,000 )



Net assets
   353,567 19,690 80,435 500,000



Group’s effective interest
   50% 50% 50% 50%

Interest in joint ventures
   176,784 9,845 40,218 250,000

Unrealized downstream transactions
   (86 ) —   —   —



Carrying value
   176,698 9,845 40,218 250,000



Summarized statement of comprehensive income

Summarized statements of comprehensive income for joint ventures

The information above reflects the amounts presented in the financial statements of the joint ventures (and not the Group’s share of those amounts) adjusted for differences in accounting policies between the Group and the joint ventures.

2020

   Linde    JYJC    Yangu Gas

   RMB’000    RMB’000    RMB’000

Revenue
   420,160    21,674    58,463

Depreciation and amortization
   (45,756 )    (350 )    (8,313 )

Interest income
   2,246    304    1,483

Interest expense
   —      —      —

Profit from continuing operations
   108,677    2,279    1,830

Income tax expenses
   (26,290 )    (177 )    —

Post-tax
profit from continuing operations
   82,387    2,102    1,830

Other comprehensive income
   —      —      —







Total comprehensive income
   82,387    2,102    1,830







Dividend received from joint venture
   38,234    1,049    1,000







2021



Linde



JYJC



Yangu Gas



Baling Materials



RMB’000



RMB’000



RMB’000



RMB’000

Revenue



428,971



27,190



60,222



—

Depreciation and amortization



(44,307

)



(386

)



(5,162

)



—

Interest income



3,489



304



1,516



—

Profit from continuing operations



116,768



2,250



4,144



—

Income tax (expenses)/benefits



(29,316

)



1,125



—



—

Post-tax profit from continuing operations



87,452



3,375



4,144



—

Other comprehensive income



—



—



—



—









Total comprehensive income



87,452



3,375



4,144



—









Dividend received from joint venture



63,044



940



800



—









Summarized statements of comprehensive income for joint
ventures
(continued)

2022



Linde



JYJC



Yangu Gas



Baling Materials



RMB’000



RMB’000



RMB’000



RMB’000

Revenue



375,795



25,129



26,091



—

Depreciation and amortization



(20,902

)



(341

)



(8,061

)



—

Interest income



4,799



351



1,029



—

Profit/ (loss) from continuing operations



58,338



1,996



(15,802

)



—

Income tax expenses



(14,590

)



(76

)



—



—

Post-tax profit/ (loss) from continuing operations



43,748



1,920



(15,802

)



—

Other comprehensive income



—



—



—



—









Total comprehensive income



43,748



1,920



(15,802

)



—









Dividend received from joint venture



11,200



1,215



1,800



—









Associates [member]

Disclosure of significant investments in associates and joint ventures [line items]

Summary of investments in associates/joint ventures



2021



2022



RMB’000



RMB’000

As at 1 January
   5,146,160    3,812,845

Additions (note i)
   26,000    96,672

Decrease caused by associate’s capital reduction (note ii)
   (1,460,258 )    —

Share of net profits / (losses)
   825,132    (188,549 )

Other comprehensive income
   16,639    (23,771 )

Cash dividends distribution
   (712,436 )    (669,565 )

Impairment (note iii)
   (28,392 )    —





As at 31 December
   3,812,845    3,027,632





Summarized financial information for associates/joint ventures

Aggregate information of associates that are not individually material:

   2021    2022

   RMB’000    RMB’000

Aggregate carrying value of investments at 31 December
   100,079    106,093

Aggregate amounts of the Group’s share of those associates:


Profit for the year
   5,655    876



Total comprehensive income
   5,655    876



Dividend received from the associate
   6,670    11,650

Material associates [member]

Disclosure of significant investments in associates and joint ventures [line items]

Summary of principal activities of material associates/joint ventures
The following list contains only the particulars of material associates, all of which
are
unlisted
corporate
entities whose quoted market price is not available:









Proportion of ownership interest

Name of company



Form of
business
structure



Place of
incorporation
and business



Particulars of paid-
up capital ‘000



Group’s
effective
interest

Held by the
Company

Held by a
subsidiary

Principal activity

Shanghai Secco Petrochemical Company
Limited (“Shanghai Secco”) (note ii)
   Incorporated    Mainland
China    RMB 3,115,180    20.00 % 20.00 % —   Manufacturing
and
distribution of
chemical
products

Shanghai Chemical Industry Park
Development Company Limited
(“Chemical Industry”)    Incorporated    Mainland
China    RMB 2,372,439    38.26 % 38.26 % —   Planning,
development
and operation
of the
Chemical
Industry Park
in Shanghai,
PRC

Shanghai Jinsen Hydrocarbon Resins
Company Limited (“Jinsen”)    Incorporated    Mainland
China    RMB    193,695    40.00 % —   40.00 % Production of
resins
products

Shanghai Azbil Automation Company
Limited (“Azbil”)    Incorporated    Mainland
China    RMB      24,440    40.00 % —   40.00 % Service and
maintenance
of building
automation
systems and
products

Shanghai Shidian Energy Company Limited
(“Shidian Energy”) (note i)
   Incorporated    Mainland
China    RMB 1,000,000    40.00 % —   40.00 % Electric power
supply
There are no contingent liabilities relating to the Group’s
interest
in the associates.

Summarized statement of financial position
Summarized statements of financial position for material associates

As at 31 December 2021
   Shanghai Secco
RMB’000
Chemical Industry
RMB’000
Jinsen
RMB’000 Azbil
RMB’000 Shidian Energy
RMB’000

Current


– Current assets
   6,066,119 4,133,397 63,192 274,697 804,470

– Current liabilities
   (5,433,872 ) (1,789,223 ) (10,476 ) (111,472 ) (34,565 )

Non-current


–
Non-current
assets
   5,735,360 4,431,463 58,737 15,698 121,051

–
Non-current
liabilities
   (66 ) (619,306 ) —   (7,506 ) (15,827 )



Net assets
   6,367,541 6,156,331 111,453 171,417 875,129



Group’s effective interest
   20.00 % 38.26 % 40.00 % 40.00 % 40.00 %

Group’s share of net assets
   1,273,508 2,355,412 44,581 68,567 350,052

Unrealized upstream and downstream transaction
   (3,157 ) — —   —   (15,979 )

Unentitled portion (note i)
   —   (331,826 ) —   —   —

Impairment loss
   —   — (28,392 ) —   —



Carrying value
   1,270,351 2,023,586 16,189 68,567 334,073



As at 31 December 2022
   Shanghai Secco
RMB’000 Chemical Industry
RMB’000 Jinsen
RMB’000 Azbil
RMB’000 Shidian Energy
RMB’000

Current


– Current assets
   4,941,394 4,327,622 49,810 276,707 950,614

– Current liabilities
   (8,977,030 ) (1,765,771 ) (17,905 ) (125,216 ) (38,133 )

Non-current


–
Non-current
assets
   5,683,409 4,480,448 50,360 12,338 166,068

–
Non-current
liabilities
   (1 ) (651,729 ) —   (5,518 ) (35,355 )



Net assets
   1,647,772 6,390,570 82,265 158,311 1,043,194



Group’s effective interest
   20.00 % 38.26 % 40.00 % 40.00 % 40.00 %

Group’s share of net assets
   329,554 2,445,032 32,906 63,324 417,278

Unrealized upstream and downstream transaction
   4,342 —   —   —   (12,615 )

Unentitled portion (note i)
   —   (329,890 ) —   —   —

Impairment loss
   —   —   (28,392 ) —   —



Carrying value
   333,896 2,115,142 4,514 63,324 404,663



Summarized statement of comprehensive income

Summarized statements of comprehensive income for material
associates

   Shanghai Secco    Chemical
Industry Jinsen Azbil    Shidian Energy

2020    RMB’000    RMB’000 RMB’000 RMB’000    RMB’000

Revenue
   21,626,059    1,683,096 187,580 340,905    472,640

Post-tax
profit/(loss) from continuing operations
   2,412,802    404,117 (8,232 ) 48,264    36,696

Other comprehensive income
   —      (30,089 ) —   —      —

Total comprehensive income
   2,412,802    374,028 (8,232 ) 48,264    36,696

Dividend received from the associate
   473,600    32,522 —   9,200    —

2021
   Shanghai Secco
Chemical
Industry
Jinsen Azbil    Shidian Energy

   RMB’000 RMB’000 RMB’000 RMB’000    RMB’000

Revenue
   29,723,223 1,709,110 165,499 427,378    489,490

Post-tax
profit/(loss) from continuing operations
   3,125,904 396,761 (16,657 ) 61,711    33,269

Other comprehensive income
   —   43,488 —   —      —





Total comprehensive income
   3,125,904 440,249 (16,657 ) 61,711    33,269





Dividend received from the associate
   634,341 52,225 —   19,200    —





2022
   Shanghai Secco Chemical
Industry Jinsen Azbil    Shidian Energy

   RMB’000 RMB’000 RMB’000 RMB’000    RMB’000

Revenue
   24,096,829 1,806,888 119,098 384,655    508,704

Post-tax
(loss)/profit from continuing operations
   (1,947,579 ) 441,369 (29,188 ) 46,894    28,065

Other comprehensive income
   —   (62,130 ) —   —      —





Total comprehensive income
   (1,947,579 ) 379,239 (29,188 ) 46,894    28,065





Dividend received from the associate
   554,438 55,477 —   24,000    24,000

v3.23.1

Inventories (Tables)
12 Months Ended

Dec. 31, 2022

Classes of current inventories [abstract]

Inventories

(a)

Inventories in the consolidated statements of financial position comprise:

As at 31 December 2021

As at 31 December 2022

Gross carrying
amount

Provision for
diminution
in value of
inventories

Carrying amount

Gross carrying
amount

Provision for
diminution
in value of
inventories

Carrying amount

RMB’000

RMB’000

RMB’000

RMB’000

RMB’000

RMB’000

Raw materials
4,391,555 (13,406 ) 4,378,149 5,700,215 (26,491 ) 5,673,724

Work in progress
795,791 (105,450 ) 690,341 756,007 (237,959 ) 518,048

Finished goods
709,990 (45,950 ) 664,040 1,096,623 (182,035 ) 914,588

Spare parts and consumables
249,456 (58,461 ) 190,995 246,161 (58,461 ) 187,700

6,146,792 (223,267 ) 5,923,525 7,799,006 (504,946 ) 7,294,060

v3.23.1

Trade And Other Receivables (Tables)
12 Months Ended

Dec. 31, 2022

Trade and other receivables [abstract]

Disclosure of Component of Trade and Other Receivables Explanatory



As at 31
December 2021



As at 31 December 2022



RMB’000



RMB’000

Trade receivables
   79,413    72,110

Less: loss allowance
   (1,988 )    (2,759 )





   77,425    69,351

Amounts due from related parties excluded prepayments and
bills receivable (*)
   1,153,111    2,583,289

Less: loss allowance (*)
   —      (2,802 )





Total trade receivables
   1,230,536    2,649,838





Other receivables
   47,737    109,440

Less: loss allowance
   (140 )    (1,933 )





   47,597    107,507





Financial assets measured at amortized cost
   1,278,133    2,757,345





Amounts due from related parties - prepayments (*)
   34,220    58,496

Amounts due from related parties - bills receivables (*) (note 25)
   25,000    —





   1,337,353    2,815,841





Amounts due from related parties (summary of *)
   1,212,331    2,638,983

Disclosure of Aging Analysis in Trade and Other Receivables Explanatory
The aging analysis based on invoice date of trade receivables and amounts due from related parties excluded prepayments and bills receivable (net of allowance for doubtful debts) is as follows:



As at 31
December 2021



As at 31 December 2022



RMB’000



RMB’000

Within one year
   1,230,360    2,649,673

Over one year but within two years
   27    165

Over two years
   149    —





   1,230,536    2,649,838

Schedule of Movements in the Loss Allowance AccountIng Respect of Trade and Other Receivables Explanatory
Movements in the loss allowance account in respect of trade and other receivables during the period is as follows:



Years ended 31 December



2021



2022



RMB’000



RMB’000

Balance at 1 January
   773    2,128

Impairment losses recognized during the year
   1,355    5,366

Balance at 31 December
   2,128    7,494

v3.23.1

Cash and cash equivalents (Tables)
12 Months Ended

Dec. 31, 2022

Cash and cash equivalents [abstract]

Summary of Cash and cash equivalents

   As at    As at

   31 December 2021    31 December 2022

   RMB’000    RMB’000

Cash deposits with a related party (note i)
   3,243    —

Cash at bank and on hand
   5,108,767    889,413





Cash and cash equivalents in the consolidated statements of financial position
   5,112,010    889,413





i.
Cash deposits with a related party were cash deposits at Sinopec Finance Company Limited (“Sinopec Finance”).

Reconciliation of profit before taxation to cash used in operation
Reconciliation of profit/(loss)
before
taxation to cash generated from
operations



2020



2021



2022



RMB’000



RMB’000



RMB’000

Profit/(loss) before taxation
   590,778    2,721,086    (3,573,654 )

Adjustments items:


Interest income from time deposits with maturity more than 3 months
   (339,505 )    (424,696 )    (410,652 )

Share of (profits)/losses of investments accounted for using the equity method
   (724,740 )    (874,285 )    173,616

Net losses/(gains) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges
   376    (18,846 )    27,851

Gains from structured deposits
   (114,283 )    (97,921 )    (11,124 )

Gains from entrusted loan receivables
   —      —      (2,704 )

Losses on sale of FVOCI
   9,513    4,685    3,148

Interest expense
   64,169    94,186    98,502

Foreign exchange losses/(gains)
   5,514    1,861    (15,320 )

Depreciation of property, plant and equipment
   1,553,039    1,621,459    1,494,176

Depreciation of investment property
   15,184    15,325    15,323

Depreciation of
right-of-use
assets
   32,653    34,307    32,918

Amortization of other
non-current
assets
   226,263    294,617    270,881

Impairment loss on property, plant and equipment
   87,570    587,622    286,260

Impairment loss on investment accounted for using the equity method
   —      28,392    —







Losses / (gains) on disposal of property, plant and equipment and other long-term
assets-net
   1,212    (48,671 )    26,767







Profit/(loss) on operation before change of working capital
   1,407,743    3,939,121    (1,584,012 )

Decrease/(increase) in inventories
   2,865,687    (2,034,779 )    (1,370,535 )

Decrease in operation receivables
   308,333    49,586    511,325

Decrease in operation payables
   (1,008,800 )    (70,235 )    (4,673,853 )

(Decrease)/increase in balances to related parties – net
   (1,577,876 )    2,527,960    156,341







Cash generated from/(used in) operations
   1,995,087    4,411,653    (6,960,734 )







Reconciliation of liabilities arising from financing activities

(c)
Reconciliation of liabilities arising from financing activities

   Borrowings    Lease
liabilities    Short-term
bonds    Total

   RMB’000    RMB’000    RMB’000    RMB’000

As at 31 December 2020 and 1 January 2021
   1,548,000    12,471    3,017,811    4,578,282

Changes from financing cash flows:


Proceeds from new bank loans
   14,163,132    —      —      14,163,132

Repayment of bank loans
   (13,451,332 )    —      —      (13,451,332 )

Proceeds from short-term bonds
   —      —      5,998,899    5,998,899

Repayments of short-term bonds
   —      —      (9,000,000 )    (9,000,000 )

Principal elements of lease payments
   —      (17,544 )    —      (17,544 )









Total changes from financing cash flows
   711,800    (17,544 )    (3,001,101 )    (2,306,845 )

Other changes:


Addition of lease liabilities
   —      9,686    —      9,686

Issuance costs on short-term bonds
   —      —      1,101    1,101

Interest expense
   —      —      28,340    28,340

Others
   —      —      (46,151 )    (46,151 )









Total other changes
   —      9,686    (16,710 )    (7,024 )

As at 31 December 2021 and 1 January 2022
   2,259,800    4,613    —      2,264,413









Changes from financing cash flows:


Proceeds from new bank loans
   19,485,000    —      —      19,485,000

Repayment of bank loans
   (19,494,800 )    —      —      (19,494,800 )

Proceeds from short-term bonds
   —      —      5,000,000    5,000,000

Repayments of short-term bonds
   —      —      (5,000,000 )    (5,000,000 )

Principal elements of lease payments
   —      (13,069 )    —      (13,069 )









Total changes from financing cash flows
   (9,800 )    (13,069 )    —      (22,869 )









Other changes:


Addition of lease liabilities
   —      24,707    —      24,707









Total other changes
   —      24,707    —      24,707









As at 31 December 2022
   2,250,000    16,251    —      2,266,251









Summary of Cash flow Statement for Leases

Amounts included in the consolidated statements of cash flows for leases comprise the following:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Within operating cash flows
   (4,618 )    (6,938 )    (14,774 )

Within financing cash flows
   (15,586 )    (17,544 )    (13,069 )

   (20,204 )    (24,482 )    (27,843 )

Summary of Lease Rentals
These amounts relate to the following:

   2020    2021    2022

   RMB’000    RMB’000    RMB’000

Lease rentals paid
   (20,204 )    (24,482 )    (27,843 )

v3.23.1

Time Deposits With Banks (Tables)
12 Months Ended

Dec. 31, 2022

Time Deposits With Banks [Abstract]

Summary Of Time Deposits With Banks



As at 31 December



2021



2022



RMB’000



RMB’000

T
ime deposits with maturity less than one year

   7,386,607    3,108,919

Time deposits with maturity more than one year
   5,581,435    3,389,559

   12,968,042    6,498,478

v3.23.1

Financial Assets At Fair Value Through Other Comprehensive Income (Tables)
12 Months Ended

Dec. 31, 2022

Financial assets at fair value through other comprehensive income [abstract]

Financial assets at fair value through other comprehensive income

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Trade and bills receivable (i)


- Amounts due from related parties (note 22)
   25,000    —

- Others
   1,047,690    582,354





   1,072,690    582,354

Equity investments
   5,000    5,000





   1,077,690    587,354





(i)

As at 31 December 2021 and 2022, certain trade receivables and bills receivable were classified as
financial
assets at FVOCI, as the Group’s business model is achieved both by collecting contractual cash flows and selling of these assets.

(ii)
As at 31 December 2022, the Group discounted certain bank acceptance bills to banks for cash proceeds and endorsed certain bank acceptance bills to suppliers on a full recourse basis for settling trade payables of the same amount. The Group has derecognized these bills receivable and the payables to suppliers in their entirety. These derecognized bank acceptance bills had a maturity date less than twelve months from the end of the reporting period. In the opinion of the directors, the Group has transferred substantially all the risks and rewards of ownership of these bills to its suppliers, and the Group has limited exposure in respect of the settlement obligation of these bills receivable under the relevant PRC rules and regulations should the issuing banks fail to settle the bills on maturity date. The Group considered the issuing banks of the bills are of good credit rating and the
non-settlement
of these bills by the issuing banks on maturity is not probable.

v3.23.1

Borrowings (Tables)
12 Months Ended

Dec. 31, 2022

Borrowings [abstract]

Summary of borrowings

   As at 31
December 2021    As at 31
December 2022

   RMB’000    RMB’000

Credit loans due within one year


- Short term bank loan
   1,559,800    1,550,000

Credit loans due over one year but within three years


- Long-term borrowing from a related party (note 3
2
(c))
   700,000    700,000





   2,259,800    2,250,000





Summary of analysis of the repayment schedule of borrowings

   2021    2022

   RMB’000    RMB’000

Within 1 year or on demand
   1,559,800    1,550,000

Over one year but within two years
   —      700,000

Over two years but within three years
   700,000    —





   2,259,800    2,250,000

v3.23.1

Trade and Other Payables (Tables)
12 Months Ended

Dec. 31, 2022

Trade and other payables [abstract]

Disclosure of summary of trade and other payables



As at 31 December



2021



2022



RMB’000



RMB’000

Trade payables
   1,527,706    1,818,453

Bills payable
   562,593    24,951

Amounts due to related parties exclude advances received (*)
   4,910,255    7,877,323





   7,000,554    9,720,727





Dividends payable
   30,577    31,631

Construction payable
   487,283    831,422

Accrued expenses
   400,391    143,299

Other liabilities
   87,144    76,778





   1,005,395    1,083,130





Financial liabilities measured at amortized cost
   8,005,949    10,803,857

Amounts due to related parties – advances received (*)
   6,275    10,486

Amounts due to related parties – measured at fair value through profit or loss (FVPL) (*) (note i)
   1,388,286    —





   9,400,510    10,814,343





Total amount due to related parties (summary of *)
   6,304,816    7,887,809

All trade and other payables (including amounts due to related parties) are expected to be
settled
or recognized as income within one year or are repayable on demand.
(i) Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.

Disclosure of summary of aging analysis of trade payables

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Within one year
   6,990,653    9,708,441

Over one year within two years
   9,527    2,524

Over two years
   374    9,762





   7,000,554    9,720,727

v3.23.1

Contract Liabilities (Tables)
12 Months Ended

Dec. 31, 2022

Contract liabilities [abstract]

Disclosure of detailed information about contracts liabilities [Text Block]

   As at 31 December

   2021    2022

   RMB’000    RMB’000

Contract liabilities
   424,607    372,760

v3.23.1

Deferred Income (Tables)
12 Months Ended

Dec. 31, 2022

Accruals and deferred income including contract liabilities [abstract]

Deferred income


2021

2022

   RMB’000    RMB’000

As at 1 January
   13,433    12,720

Additions
   —      34,623

Amortization
   (713 )    (2,735 )





As at 31 December
   12,720    44,608

v3.23.1

Share Capital (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of classes of share capital [abstract]

Share capital


Number of
shares

Amount

   ’000    RMB’000

As at 31 December 2021, 1 January 2022 and 31 December 2022


Registered, issued and fully paid:


Ordinary A shares listed in PRC
   7,328,814    7,328,814

Foreign invested H shares listed overseas
   3,495,000    3,495,000





Total
   10,823,814    10,823,814





Purchase of own shares
During the year, the Company repurchased its own ordinary shares on the Stock Exchange of Hong Kong Limited as follows:

Month/year



Number of
shares
repurchased



Highest
price paid
per share



Lowest
price
paid per
share



Aggregate
price paid





HKD



HKD



RMB’000









October 2022



4,956,000



1.10



1.03



4,883

November 2022



15,866,000



1.26



1.04



16,299

December 2022



3,706,000



1.39



1.25



4,507











24,528,000







25,689

v3.23.1

Reserves (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of reserves within equity [abstract]

Reserves

   Legal
surplus    Capital
surplus    Surplus
reserve    Other
reserve
Hedging
reserve
Share
premium    Safety
production
fund    Treasury
shares Retained
earnings Total

   (note(a))    (note(b))    (note(c))    (note(d)) (note 3.1(a)) (note(e))    (note(f))    (note 30(ii)) (note(g))

   RMB’000    RMB’000    RMB’000    RMB’000 RMB’000 RMB’000    RMB’000    RMB’000 RMB’000 RMB’000

Balance at 1 January 2021
   4,072,476    13,739    101,355    6,326 —   106,846    145,597    —   13,927,837 18,374,176

Total comprehensive income for the year attributable to shareholders of the Company
   —      —      —      16,639 125,159 —      —      —   2,073,431 2,215,229

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —   (88,699 ) —      —      —   —   (88,699 )

Dividends declared and approved in respect of previous year
   —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Transfer to legal surplus
   2,498,808    —      —      —   —   —      —      —   (2,498,808 ) —

Appropriation of safety production fund
   —      —      —      —   —   —      40,729    —   (40,729) —

Balance at 31 December 2021 and 1 January 2022
   6,571,284    13,739    101,355    22,965 36,460 106,846    186,326    —   12,379,350 19,418,325













Total comprehensive income for the year attributable to shareholders of the Company
   —      —      —      (23,771 ) 201,519 —      —      —   (2,846,156 ) (2,668,408 )

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —   (237,979 ) —      —      —   —   (237,979 )

Dividends declared and approved in respect of previous year
   —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Purchase of own shares
   —      —      —      —   —   —      —      (25,689 ) —   (25,689 )

Appropriation of safety production fund
   —      —      —      —   —   —      54,092    —   (54,092 ) —













Balance at 31 December 2022
   6,571,284    13,739    101,355    (806 ) —   106,846    240,418    (25,689 ) 8,396,721 15,403,868













Notes:

(a) Under PRC rules and regulations, the Company and its PRC subsidiaries are required to set aside 10% of the net income determined in accordance with the PRC accounting rules and regulations to a legal surplus reserve. The transfer to this reserve must be made before distribution of any dividend to shareholders.

The legal surplus reserve is
non-distributable
other than in liquidation and can be used to make good of previous years’ losses, if any, and may be utilized for business expansion or converted into ordinary shares by the issuance of new shares to shareholders in proportion to
their
existing shareholdings or by increasing the par value of the shares currently held by the shareholders, provided that the balance after such issuance is not less than 25% of the registered capital.

In accordance with PRC rules and regulations, the Company has set aside RMB6,571,284 thousand of legal surplus as of 31 December 2022.

(b) This reserve represents gifts or grants received from China Petrochemical Corporation, the ultimate parent company and which are required to be included in this reserve fund by PRC regulations.

(c) The transfer to this reserve from the retained profits is subject to the approval by shareholders at general meetings. Its usage is similar to that of the legal surplus reserve.

(d) Other reserve comprises share of post-acquisition movements in other comprehensive income from associates and joint ventures using the equity methods of accounting with a corresponding adjustment to the carrying amount of the investment.

(e) The application of the share premium account is governed by Sections 167 and 168 of the PRC Company Law.

(f) According to the relevant PRC regulations, the Group is required to transfer an amount to specific reserve for the safety production fund based on the turnover of certain refining and chemicals products. This reserve represents unutilized safety production fund.

(g) According to the Company’s Articles of Association, the reserve available for distribution is the lower of the amount determined under China Accounting Standards for Business Enterprises and the amount determined under IFRS.

v3.23.1

Related-Party Transactions (Tables)
12 Months Ended

Dec. 31, 2022

Disclosure of transactions between related parties [abstract]

Summary of major related parties

The following is a list of the Group’s major related parties:

Names of related parties    Relationship with the Company

China International United Petroleum & Chemicals Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Chemical Sales Company Limited
Subsidiary of the ultimate parent company

Sinopec Chemical Commercial Holding Company Limited
Subsidiary of the ultimate parent company

Petro-cyberworks Information Technology Co., Ltd.
Subsidiary of the ultimate parent company

Lianhua (Ningbo) International Logistics Co., Ltd.
Subsidiary of the ultimate parent company

Zhongke (Guangdong) Refining & Chemical Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Marketing Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Fuel Oil Sales Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Lubricant Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Yangzi Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Beijing) Company Limited
Subsidiary of the ultimate parent company

Sinopec Catalysts Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Shanghai) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Beijing Research Institute of Chemical Industry
Subsidiary of the ultimate parent company

China Petrochemical International (Ningbo) Co., Ltd.
Subsidiary of the ultimate parent company

Zhoushan Shihua Crude Oil Terminal Co., Ltd.
Subsidiary of the ultimate parent company

Dalian Sinopec Material Equip Company
Subsidiary of the ultimate parent company

Sinopec Material & Equipment (East China) Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Nanjing) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Honeywell (Tianjin) Company Limited
Subsidiary of the ultimate parent company

China Petrochemical International (Wuhan) Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical Refinery Sales Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Shanghai Gaoqiao Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

China Petrochemical International (Tianjin) Co., Ltd.
Subsidiary of the ultimate parent company

Ningbo East sea Line fan Technology Company Limited
Subsidiary of the ultimate parent company

Sinopec Petroleum & Chemical Scientific Research Institute Dadi Company

Subsidiary of the ultimate parent company

Sinopec Shanghai Research Institute of Petrochemical Technology
Subsidiary of the ultimate parent company

Sinopec Lubricating Oil Shanghai Research Institute Company Limited
Subsidiary of the ultimate parent company

Dalian Furuipu Technology Co., Ltd.
Subsidiary of the ultimate parent company

Nantong Donghai Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

China Petroleum and Chemical Corporation Qingdao Security Engineering Research Institute

Subsidiary of the ultimate parent company

Sinopec (Shanghai) Energy Trade Co., Ltd.
Subsidiary of the ultimate parent company

Storage and Transportation Installation Company of Ningbo Engineering Company Limited

Subsidiary of the ultimate parent company

Sinopec Chemical Commercial Holding (Hong Kong) Company Limited

Subsidiary of the ultimate parent company

Sinopec Yizheng Chemical Fibre Limited Liability Company
Subsidiary of the ultimate parent company

Fujian Gulei Petrochemical Company Limited
Subsidiary of the ultimate parent company

Sinopec China East Chemical Sales Co., Ltd.
Subsidiary of the ultimate parent company

Names of related parties    Relationship with the Company

Unipec Singapore
Subsidiary of the ultimate parent company

China Yanshan United Foreign Trade Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Chemical Commercial Holding (Wuhan) Company Limited
Subsidiary of the ultimate parent company

Nanjing Yangzi Petrol-chemical Industry Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Baling Petrochemical Co., Ltd.
Subsidiary of the ultimate parent company

Shengli Oil Field Exploration and Development Research Institute
Subsidiary of the ultimate parent company

Shanghai Lide Catalyst Co., Ltd.
Subsidiary of the ultimate parent company

Ypc-gpro
(Nanjing) Rubber Co., Ltd.
Subsidiary of the ultimate parent company

Fujian Refining & Petrochemical Company Limited
Subsidiary of the ultimate parent company

Sinopec Dalian (Fushun) Research Institute of Petroleum and Petrochemicals
Subsidiary of the ultimate parent company

Sinopec Jianghan Salt Chemical Hubei Co., Ltd.
Subsidiary of the ultimate parent company

Yipaike Business Factoring Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Great Wall Energy and Chemical (Ningxia) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec (Shenzhen)
E-Commerce
Company Limited
Subsidiary of the ultimate parent company

Sinopec Research Institute of Safety Engineering
Subsidiary of the ultimate parent company

Ningbo Minggang Gas Company Limited
Subsidiary of the ultimate parent company

Sinopec Zhongyuan Petrol-Chemical Industry Co., Ltd.
Subsidiary of the ultimate parent company

Epec
E-commerce
Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Oil Refining and Marketing (Shanghai) Co., Ltd.
Subsidiary of the ultimate parent company

Sinopec Chemical Sales (Guangdong) Co., Ltd.
Subsidiary of the ultimate parent company

Unipec (Qingdao) International Logistics Company Limited
Subsidiary of the ultimate parent company

     Names of related parties    Relationship with the Company

Qingdao Zhonghua Sunshine Management System Certification Center
Subsidiary of the ultimate parent company

Zhejiang Baling Hengyi Caprolactam Limited Company
Joint venture of the ultimate parent company

Shanghai Sinopec Mitsui Chemicals, Co., Ltd
.

Joint venture of the ultimate parent company

Basf-ypc
Company Limited
Joint venture of the ultimate parent company

Shanghai Changshi Shipping Co., Ltd.
Associate of the ultimate parent company

Shanghai KSD Bulk Solids Engineering Co., Ltd.
Associate of the ultimate parent company

Basf
Gao-Qiao
Performance Chemicals (Shanghai) Company Limited
Associate of the ultimate parent company

Sinopec Chemical Commercial Holding (Singapore) Pte. Ltd
.

Subsidiary of the immediate parent company

Sinopec Finance Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Chemical Commercial Holding Company Limited
Subsidiary of the immediate parent company

Sinopec Nanjing Chemical Research Institute Co., Ltd.
Subsidiary of the immediate parent company

China Economy Phulishing House Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Publishing House Co., Ltd.
Subsidiary of the immediate parent company

Sinopec International Travel Service Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Assets Management Co., Ltd.
Subsidiary of the immediate parent company

Ningbo Engineering Company of Sinopec
Subsidiary of the immediate parent company

Sinopec Shared Service Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Petroleum Engineering Geophysics Ltd.
Subsidiary of the immediate parent company

Sinopec Baichuan Economic and Trade Company
Subsidiary of the immediate parent company

Sinopec Group Jiangsu Petroleum Exploration Bureau Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Newspaper Office
Subsidiary of the immediate parent company

Sinopec Energy Saving Technology Service Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Group Economic and Technology Research Institute Co., Ltd.
Subsidiary of the immediate parent company

Names of related parties    Relationship with the Company

Beijing Petro-Chemical Construction Consulting Co., Ltd.
Subsidiary of the immediate parent company

China Economicbooks Co., Ltd.
Subsidiary of the immediate parent company

Petrol-Chemical Industry Management Cadre College
Subsidiary of the immediate parent company

Sinopec Engineering Quality Supervision Terminal
Subsidiary of the immediate parent company

Sinopec Group Shanghai Training Center Ltd.
Subsidiary of the immediate parent company

Sinopec Beijing Yanshan Petrochemical Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Zhongyuan Petroleum Exploration Bureau Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Shengli Petroleum Administration Co., Ltd.
Subsidiary of the immediate parent company

The Fourth Construction Company of Sinopec
Subsidiary of the immediate parent company

Sinopec Tending Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Shanghai Engineering Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Engineering Incorporation
Subsidiary of the immediate parent company

Sinopec Engineering Quality Monitoring Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Engineering(Group)Co.,Ltd.
Subsidiary of the immediate parent company

National Petrochemical Project Risk Assessment Technology Center
Subsidiary of the immediate parent company

The Tenth Construction Company of Sinopec
Subsidiary of the immediate parent company

The Fifth Construction Company of Sinopec
Subsidiary of the immediate parent company

Shanghai Petrochemical Machinery Manufacturing Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Nanjing Engineering Company Limited
Subsidiary of the immediate parent company

Sinopec Luoyang Engineering Company Limited
Subsidiary of the immediate parent company

Jiangsu Jinling Opta Polymer Company Limited
Subsidiary of the immediate parent company

Shanghai Petro-Chemical Haidi Administration Co., Ltd.
Subsidiary of the immediate parent company

Sinopec Sichuan Uinylon Works
Subsidiary of the immediate parent company

China Petrochemical Corp. Nanjing Chemistry Industrial Co., Ltd.

Subsidiary of the immediate parent company

Names of related parties    Relationship with the Company

Sinopec Group International Petroleum Exploration And Production Limited

Subsidiary of the immediate parent company

Sinopec Consulting Company Limited
Subsidiary of the immediate parent company

China Petrochemical Corp. Engineering Ration Management Station
Subsidiary of the immediate parent company

Beijing Victory Hotel Company Limited
Subsidiary of the immediate parent company

Maoming Shihua Dongcheng Chemical Co., Ltd.
Subsidiary of the immediate parent company

Yihua Tory Polyester Film Company Limited
Joint venture of the immediate parent company

China Sinopec Pipeline Storage and Transportation Co., Ltd.
Associate of the immediate parent

Yihua Bonar Yarns and Fabrics Co., Ltd.
Associate of the immediate parent

Unipec Singapore
Subsidiary of the immediate parent company

Unipec America, Inc
Subsidiary of the immediate parent company

Sinopec Japan Company Limited
Subsidiary of the immediate parent company

Rizhao Shihua Crude Oil Terminal Co., Ltd.
Joint venture of the ultimate parent company

Sinopec Europe Company Limited
Subsidiary of the immediate parent company

Sinopec Chemical Commercial Holding (North America), Inc.
Subsidiary of the immediate parent company

Sinopec International (Australia) Pty. Ltd.
Subsidiary of the immediate parent company

Sinopec Easy Joy sales CO., Ltd.
Subsidiary of the immediate parent company

Sinopec National Petrochemical Project Risk Assessment Technology Center Co., Ltd.

Subsidiary of the immediate parent company

Sinopec International (Russia) Pty. Ltd.
Subsidiary of the immediate parent company

Sinopec Jianghan Petroleum Administration Co., Ltd.
Subsidiary of the ulitimate parent company

Sinopec America Company Limited
Subsidiary of the ulitimate parent company

Sinopec (Beijing) Chemical Research Institute Co., Ltd.
Subsidiary of the ulitimate parent company

Sinopec-Sk(Wuhan)Petrochemical
Co., Ltd.
Subsidiary of the ulitimate parent company

Shanghai Petroleum&Natural Gas General Co., Ltd.
Associate of the ultimate parent company

Beijing Heyuan Jingyi Hotel Co., Ltd.
Subsidiary of the ulitimate parent company

Sinopec Henan Oilfield Training Center
Subsidiary of the ulitimate parent company

Sinopec Jiangsu Petroleum Exploration Bureau Co., Ltd. Training Center

Subsidiary of the ulitimate parent company

Sinopec Capital Co., Ltd.
Subsidiary of the ulitimate parent company

Transactions between the Group and Sinopec Corp., its subsidiaries and joint ventures

Transactions between the Group and Sinopec Corp, its subsidiaries and joint ventures during the years ended 31 December 2020, 2021 and 2022 were as follows :

   2020
RMB’000    2021
RMB’000    2022
RMB’000

Sales of petroleum products
   39,879,549    47,201,755    44,392,225

Sales other than petroleum products
   6,790,568    9,439,546    8,194,827

Purchases of crude oil
   27,934,926    35,371,820    46,790,433

Purchases other than crude oil
   9,937,862    9,008,147    7,544,094

Commission expense
   104,598    110,552    90,341

Rental income
   32,829    34,475    34,088

Other transactions between the Group and Sinopec Group and its subsidiaries, associates and joint ventures of the Group

   2020
RMB’000    2021
RMB’000    2022
RMB’000

Sales of goods and service fee income


- Sinopec Group and its subsidiaries
   14,870    36,683    19,450

- Associates and joint ventures of the Group
   2,019,997    4,248,658    3,171,835







   2,034,867    4,285,341    3,191,285







Purchases


- Sinopec Group and its subsidiaries
   832,617    2,830,256    1,870,287

- Associates and joint ventures of the Group
   3,648,664    4,425,698    2,411,552







   4,481,281    7,255,954    4,281,839







Insurance premium expenses


- Sinopec Group and its subsidiaries
   107,495    108,850    109,597







Addition to
right-of-use
assets


- Sinopec Group and its subsidiaries
   2,267    1,388    20,023

Interest expense of lease liabilities


- Sinopec Group and its subsidiaries
   205    247    787

- Joint ventures of the Group
   8    24    17





   213    271    804

Interest expens
e

- Sinopec Finance
   —



2,835



7,665

Interest income


- Sinopec Finance
   2,088    824    213

- Joint ventures of the Group
   —      —      2,704

   2,088    824    2,917

Construction and installation cost


- Sinopec Group and its subsidiaries
   233,591    785,216    812,516

Rental income


- Associates and joint ventures of the Group
   15,577    14,930    14,032

- Sinopec Group and its subsidiaries
   464    464    427





   16,041    15,394    14,459

Long-term borrowings


- Sinopec Finance
   —      700,000    —







Summary of amounts due from/to related parties



As at 31 December 2021



As at 31 December 2022



RMB’000



RMB’000

Amounts due from related parties





- Sinopec Corp., its subsidiaries and joint ventures
   1,184,117    2,593,908

- Associates and joint ventures of the Group
   28,214    45,075





   1,212,331    2,638,983





Amounts due to related parties


- Sinopec Corp., its subsidiaries and joint ventures
   4,475,992    6,569,219

- Sinopec Group and its subsidiaries
   1,672,439    1,232,589

- Associates and joint ventures of the Group
   156,385    86,001





   6,304,816    7,887,809





Lease liabilities


- Sinopec Group and its subsidiaries
   992    12,714

- Joint ventures of the Group
   435    290





   1,427    13,004





Cash deposits, maturing within three months


- Sinopec Finance (note d)
   3,243    —





Long-term borrowings


- Sinopec Finance
   700,000    700,000





Summary of key personnel compensations



Years ended 31 December



2020



2021



2022



RMB’000



RMB’000



RMB’000

Short-term employee benefits
   9,859    11,866    13,667

Post-employment benefits
   441    551    639







   10,300    12,417    14,306







Commitments with related parties

   As at
31 December 2021
RMB’000    As at
31 December 2022
RMB’000

Sinopec Group and its subsidiaries
   775,007    930,665

Investment commitments with related parties

   As at
31 December 2021
RMB’000    As at
31 December 2022
RMB’000

Capital contribution to Shanghai Secco (i)
   111,263    111,263

Capital contribution to Shanghai Shidian Energy Company


Limited (“Shidian Energy”) (ii)
   80,000    —

Capital contribution to Baling Materials (iii)
   350,000    150,000





   541,263    261,263





(i)
Pursuant to the resolution of the 18th meeting of the 7th term of Board of Directors on 5 December 2013, the Group was approved to make a capital contribution of USD 30,017,000 (RMB 182,804 thousand equivalent) to Shanghai Secco, an associate of the Group. As at 31 December 2022, the Company has contributed RMB 71,541 thousand to Shanghai Secco.
According to the approval by Shanghai Municipal Commission of Commerce as issued on 19 October 2015, the rest of the capital contribution to Shanghai Secco should be within 50 years starting from its registration date.

(ii)
Pursuant to the articles of association of Shidian Energy in August
2019
, Toufa agreed to make a capital contribution of RMB 400,000 thousand to acquire 40% share of Shidian Energy. As at 31 December 2022, Toufa has fully contributed RMB 400,000 thousand to Shidian Energy.

(iii)
Sinopec Baling Petrochemical Co., Ltd and the Company jointly established Baling Materials on 7 September 2021, each with a cash contribution of RMB 400,000 thousand. As at 31 December 2022, the Company has made a
paid-up
capital contribution of RMB 250,000 thousand.

v3.23.1

Dividend (Tables)
12 Months Ended

Dec. 31, 2022

Dividend [abstract]

Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year

(a)
Dividends payable to equity shareholders of the Company attributable to the year:


2021

RMB’000
2022

RMB’000

No final dividend proposed after the end of the reporting period
(2021: RMB 0.10 per ordinary share)
   1,082,381    —





Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year

(b)
Dividends payable to equity shareholders of the Company attributable to the previous financial year, approved and paid during the year

   2021
RMB’000    2022
RMB’000

Final dividend in respect of the previous financial year, approved and paid during the year, of RMB 0.10 per share (2021: RMB 0.10)    1,082,381    1,082,381

v3.23.1

Commitments (Tables)
12 Months Ended

Dec. 31, 2022

Commitments [abstract]

Capital Commitments
Capital commitments outstanding at 31 December 2022 not provided for in the financial statements were as follows:

   As at 31
December 2021
RMB’000    As at 31
December 2022
RMB’000

Property, plant and equipment contracted for
   1,176,168    1,783,781

v3.23.1

Statements of Financial Position and Equity Movement of the Company (Tables)
12 Months Ended

Dec. 31, 2022

Balance sheet and reserve movement of the Company [abstract]

Statements of financial position of the Company



As at 31 December 2021



As at 31 December 2022



RMB’000



RMB’000

Non-current
assets





Property, plant and equipment
   10,914,990    11,823,562

Investment properties
   381,540    365,147

Right-of-use
assets
   275,924    274,926

Construction in progress
   3,201,111    3,647,200

Investments in subsidiaries
   2,048,328    2,048,328

Investments accounted for using the equity method
   3,299,050    2,654,151

Time deposits with banks
   5,381,149    3,139,559

Deferred tax assets
   178,084    986,830

Other
non-current
assets
   769,492    821,397





   26,449,668    25,761,100





Current assets


Derivative financial instruments
   81,405    —

Inventories
   5,726,264    7,043,613

Trade receivables
   149    —

Other receivables
   8,276    88,839

Amounts due from related parties
   1,116,553    2,526,598

Prepayments
   13,790    10,711

Value added tax recoverable
   —    1,045,002

Financial assets at fair value through other
comprehensive income (FVOCI)

   615,689    127,558

Time deposits with banks
   7,386,605    3,108,916

Cash and cash equivalents
   4,927,519    671,538





   19,876,250    14,622,775





Current liabilities


Trade and other payables
   2,389,508    2,217,580

Contract liabilities
   376,834    289,407

Amounts due to related parties
   7,423,883    8,809,690

Staff salaries and welfares payable
   253,800    307,190

Borrowings
   1,500,000    1,500,000

Lease liabilities
   1,604    7,172

Derivative financial instruments
   23,804    —

Income tax payable
   249,332    —

Current tax liabilities
   3,843,541    913,231





   16,062,306    14,044,270





Net current assets
   3,813,944    578,505







As at 31 December 2021



As at 31 December 2022



RMB’000



RMB’000

Total assets less current liabilities
   30,263,612    26,339,605





Non-current
liabilities


Interest-bearing borrowings
   700,000    700,000

Lease liabilities
   399    6,481

Deferred income
   12,720    44,494





   713,119    750,975











NET ASSETS
   29,550,493    25,588,630





CAPITAL AND RESERVES


Share capital
   10,823,814    10,823,814

Reserves
   18,726,679    14,764,816





TOTAL EQUITY
   29,550,493    25,588,630





Statements of equity movement of the Company

   Share
capital
RMB’000
Legal
surplus
RMB’000
   Capital
surplus
RMB’000    Surplus
reserve
RMB’000    Other
reserve
RMB’000
Hedging
reserve
RMB’000
Share
premium
RMB’000    Safety
production
fund
RMB’000    Treasury
reserve
RMB’000 Retained
earnings
RMB’000 Total
RMB’000

Balance at 1 January 2021
   10,823,814    4,072,476    4,180    101,355    6,326 —   106,846    145,597    —   13,260,897 28,521,491

Total comprehensive income for the year
   —      —      —      —      16,639 125,159 —      —      —   2,058,284 2,200,082

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —      —   (88,699 ) —      —      —   —   (88,699 )

Dividends declared and approved in respect of previous year
   —      —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Transfer to legal surplus
   —      2,498,808    —      —      —   —   —      —      —   (2,498,808 ) —

Appropriation of safety production fund
   —      —      —      —      —   —   —      32,310    —   (32,310 ) —















Balance at 31 December 2021 and 1 January 2022
   10,823,814    6,571,284    4,180    101,355    22,965 36,460 106,846    177,907    —   11,705,682 29,550,493















Total comprehensive income for the year
   —      —      —      —      (23,771 ) 201,519 —      —      —   (2,793,562 ) (2,615,814 )

Amounts transferred from hedging reserve to initial carrying amount of hedged items
   —      —      —      —      —   (237,979 ) —      —      —   —   (237,979 )

Dividends declared and approved in respect of previous year
   —      —      —      —      —   —   —      —      —   (1,082,381 ) (1,082,381 )

Purchase of own shares
   —      —      —      —      —   —   —      —      (25,689 ) —   (25,689 )

Appropriation of safety production fund
   —      —      —      —      —   —   —      61,782    —   (61,782 ) —















Balance at 31 December 2022
   10,823,814    6,571,284    4,180    101,355    (806 ) —   106,846    239,689    (25,689 ) 7,767,957 25,588,630

v3.23.1

Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022 (Tables)
12 Months Ended

Dec. 31, 2022

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Abstract]

Summary of Number of Amendments, New Standards and Interpretations Which are Not Yet Effective


Effective for
accounting periods
beginning on or
after

IFRS 17, Insurance contracts
   1 January 2023

Amendments to IAS 1, Presentation of financial statements: Classification of liabilities as current or
non-current
   1 January 2023

Amendments to IAS 1, Presentation of financial statements and IFRS Practice Statement 2, Making materiality judgements: Disclosure of accounting policies
   1 January 2023

Amendments to IAS 8, Accounting policies, changes in accounting estimates and errors: Definition of accounting estimates
   1 January 2023

Amendments to IAS 12, Income taxes: Deferred tax related to assets and liabilities arising from a single transaction
   1 January 2023

v3.23.1

General Information (Reorganisation) (Details) - CNY (¥)
¥ in Thousands

Feb. 25, 2000

Jan. 12, 2018

Sep. 27, 2017

Nov. 08, 1993

General information [line items]

Capital registered ¥ 9,637 ¥ 14,177 ¥ 4,000,000

China Petrochemical Corporation ("Sinopec Group") [member] | Sinopec Shanghai Petrochemical Company Limited ("the Company") [member] | China Petroleum & Chemical Corporation ("Sinopec Corp.") [member]

General information [line items]

State-owned legal shares transferred 4,000,000,000

Percentage of issued share capital, state-owned legal shares transferred 55.56%

v3.23.1

General Information (The Fifteenth Meeting of the Seventh Term of Board of Directors) (Details) - shares
shares in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

General information [line items]

Total shares of the Company 10,823,814 10,823,814 10,823,814

Sinopec Shanghai Petrochemical Company Limited ("the Company") [member]

General information [line items]

Total shares of the Company 10,823,814

v3.23.1

Summary of Significant Accounting Policies (Property, Plant and Equipment) (Details)
12 Months Ended

Dec. 31, 2022

Buildings [member]

Disclosure of detailed information about property, plant and equipment [line items]

Estimated useful lives of property, plant and equipment 12 to 40 years

Plant and machinery [member]

Disclosure of detailed information about property, plant and equipment [line items]

Estimated useful lives of property, plant and equipment 5 to 20 years

Vehicles and other equipment [member]

Disclosure of detailed information about property, plant and equipment [line items]

Estimated useful lives of property, plant and equipment 4 to 20 years

v3.23.1

Summary of Significant Accounting Policies (Investment Properties) (Details)
12 Months Ended

Dec. 31, 2022

Disclosure of detailed information about investment property [abstract]

Estimated useful lives of investment properties 30-40 years

v3.23.1

Summary of Significant Accounting Policies (Other Non-current Assets) (Details)
12 Months Ended

Dec. 31, 2022

Intangible assets - patents

Disclosure of information about other non-current assets [line items]

Estimated useful lives of other non-current assets 2 to 28 years

Long-term prepaid expense - catalyst

Disclosure of information about other non-current assets [line items]

Estimated useful lives of other non-current assets 1.5 to 10 years

Long-term prepaid expense - leasehold improvement

Disclosure of information about other non-current assets [line items]

Estimated useful lives of other non-current assets 3 to 27 years

v3.23.1

Summary of Significant Accounting Policies (Leases) (Details)
12 Months Ended

Dec. 31, 2022

Land use rights [member]

Disclosure of quantitative information about right-of-use assets [line items]

Estimated useful lives of right-of-use assets 20 - 50 years

Buildings [member]

Disclosure of quantitative information about right-of-use assets [line items]

Estimated useful lives of right-of-use assets 2 - 8 years

Equipment [member]

Disclosure of quantitative information about right-of-use assets [line items]

Estimated useful lives of right-of-use assets 2 - 3 years

Others [member]

Disclosure of quantitative information about right-of-use assets [line items]

Estimated useful lives of right-of-use assets 2 - 4 years

v3.23.1

Financial Risk Management (Financial Risk Factors, Derivatives, Derivative Financial Instruments) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of nature and extent of risks arising from financial instruments [line items]

Total derivative financial assets ¥ 0 ¥ 81,405

Total derivative financial liabilities 0 23,804

Current derivative financial instrument assets [member]

Disclosure of nature and extent of risks arising from financial instruments [line items]

Commodity swaps contracts applied hedge accounting 0 48,614

Commodity swaps contracts at fair value through profit or loss 0 32,791

Total derivative financial assets 0 81,405

Current derivative financial instrument liabilities [member]

Disclosure of nature and extent of risks arising from financial instruments [line items]

Commodity swaps contracts at fair value through profit or loss 0 (23,804)

Total derivative financial liabilities ¥ 0 ¥ (23,804)

v3.23.1

Financial Risk Management (Reconciliation of Hedging Reserve in Respect of Commodity Price Risk and Effectiveness of Hedging Relationships) (Details) - Swap contract [member]
¥ in Thousands
12 Months Ended

Dec. 31, 2022

CNY (¥)

Disclosure of nature and extent of risks arising from financial instruments [line items]

Beginning balance - Pre-tax amount ¥ 48,613

Effective portion of the cash flow hedge recognized in other comprehensive income 375,701

Amounts reclassified to profit or loss (107,009)

Reclassified to inventory (317,305)

Ending balance - Pre-tax amount 0

Beginning balance - Tax effect (12,153)

Effective portion of the cash flow hedge recognized in other comprehensive income (93,925)

Amounts reclassified to profit or loss 26,752

Reclassified to inventory 79,326

Ending balance - Tax effect 0

Beginning balance - Post-tax 36,460

Effective portion of the cash flow hedge recognized in other comprehensive income 281,776

Amounts reclassified to profit or loss (80,257)

Reclassified to inventory (237,979)

Ending balance - Post-tax ¥ 0

v3.23.1

Financial Risk Management (Financial Risk Factors, Derivatives, Reconciliation of Hedging Reserves in Statement of Profit or Loss) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of financial assets [line items]

Net gains/(losses) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges ¥ (27,851) ¥ 18,846 ¥ (376)

Commodity Swap Contracts [Member]

Disclosure of financial assets [line items]

Net gains/(losses) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges (35,434) 18,997

Foreign Exchange Forward [Member]

Disclosure of financial assets [line items]

Net gains/(losses) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges 7,583 0

Foreign Exchange Option Contract [Member]

Disclosure of financial assets [line items]

Net gains/(losses) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges ¥ 0 ¥ (151)

v3.23.1

Financial Risk Management (Financial Risk Factors, Foreign Exchange Risk , Foreign Exchange Risk) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of nature and extent of risks arising from financial instruments [abstract]

Net foreign exchange (losses)/gains included in Other gains/(losses) - net ¥ 21,969 ¥ (1,861) ¥ 12,248

v3.23.1

Financial Risk Management (Financial Risk Factors, Schedule of Interest Rate Financial Instruments) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Disclosure of financial instruments by type of interest rate [line items]

Cash and cash equivalents ¥ 889,413 ¥ 5,112,010 ¥ 6,916,408 ¥ 7,449,699

Borrowings (2,250,000) (2,259,800)

Lease liabilities (16,251) (4,613)

Not later than one year [member]

Disclosure of financial instruments by type of interest rate [line items]

Borrowings (1,550,000) (1,559,800)

Fixed interest rate [member]

Disclosure of financial instruments by type of interest rate [line items]

Borrowings (1,550,000) (1,500,000)

Lease liabilities (16,251) (4,613)

Financial instruments fixed interest rate bearing value 4,733,749 11,345,387

Fixed interest rate [member] | Not later than one year [member]

Disclosure of financial instruments by type of interest rate [line items]

Time deposits with maturity less than one year 3,000,000 7,350,000

Fixed interest rate [member] | Later than one year [member]

Disclosure of financial instruments by type of interest rate [line items]

Time deposits with maturity more than one year 3,300,000 5,500,000

Floating interest rate [member]

Disclosure of financial instruments by type of interest rate [line items]

Cash and cash equivalents 889,413 5,112,010

Borrowings (700,000) (759,800)

Financial instruments variable interest rate bearing value ¥ 189,413 ¥ 4,352,210

v3.23.1

Financial Risk Management (Financial Risk Factors, Net Provision of Impairment Losses on Financial Assets Recognized in Income Statement) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of nature and extent of risks arising from financial instruments [abstract]

Impairment losses - provision in loss allowance for trade receivables ¥ (778) ¥ (1,354)

Impairment losses - provision in loss allowance for other receivables (4,727) (1)

Impairment losses reversed 139 0

Provision of impairment losses on financial assets ¥ (5,366) ¥ (1,355) ¥ 120,916

v3.23.1

Financial Risk Management (Schedule of Detailed Information of Adjusted Net Debt to Capital Ratio Explanatory) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Disclosure Of Detailed Information Of Adjusted Net Debt To Capital Ratio [Abstract]

Borrowings ¥ 1,550,000 ¥ 1,559,800

Lease liabilities 8,738 3,229

Current liabilities 1,558,738

Borrowings 700,000 700,000

Lease liabilities 7,513 1,384

Total Debt 2,266,251

Less: Cash and cash equivalents (889,413) (5,112,010) ¥ (6,916,408) ¥ (7,449,699)

Adjusted net debt 1,376,838

Total equity 26,355,363 ¥ 30,377,398 ¥ 29,334,975 ¥ 29,993,848

Less: Hedging reserve 0

Adjusted capital ¥ 26,355,363

Adjusted net debt-to-capital ratio 5.00%

v3.23.1

Financial Risk Management (Fair Value Estimation, Changes in level 3 items) (Details) - Level 3 of fair value hierarchy [member] - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Financial instruments, fair value measurement [line items]

Beginning Balance ¥ 5,000 ¥ 5,000

Acquisitions 1,000,000 8,150,000

Disposals (1,011,124) (8,247,921)

Fair value change 11,124 97,921

Ending Balance 5,000 5,000

Equity investments [member]

Financial instruments, fair value measurement [line items]

Beginning Balance 5,000 5,000

Acquisitions 0 0

Disposals 0 0

Fair value change 0 0

Ending Balance 5,000 5,000

Structured deposits [member]

Financial instruments, fair value measurement [line items]

Beginning Balance 0 0

Acquisitions 1,000,000 8,150,000

Disposals (1,011,124) (8,247,921)

Fair value change 11,124 97,921

Ending Balance ¥ 0 ¥ 0

v3.23.1

Segment information and revenue (Other Profit and Loss Disclosures) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of operating segments [line items]

Depreciation and amortisation ¥ (1,813,298) ¥ (1,965,708) ¥ (1,827,139)

Impairment loss (291,626) (617,369) 33,346

Inventory write-down (525,269) (150,883) (220,888)

Petroleum products [member]

Disclosure of operating segments [line items]

Depreciation and amortisation (928,687) (975,492) (917,637)

Impairment loss 0 (94,420) 0

Inventory write-down (37,900) (782) (138,537)

Intermediate petrochemicals [member]

Disclosure of operating segments [line items]

Depreciation and amortisation (414,999) (523,484) (465,425)

Impairment loss (215,355) (297,632) (55,204)

Inventory write-down (248,518) (136,694) (15,418)

Resins and plastics [member]

Disclosure of operating segments [line items]

Depreciation and amortisation (106,845) (86,183) (138,204)

Impairment loss (25,102) (61,242) 0

Inventory write-down (134,138) (168) (26,382)

Synthetic fibers [member]

Disclosure of operating segments [line items]

Depreciation and amortisation (140,885) (132,091) (78,030)

Impairment loss (51,160) (135,683) 88,550

Inventory write-down (104,713) (13,239) (39,657)

Trading of petrochemical products [member]

Disclosure of operating segments [line items]

Depreciation and amortisation (35,345) (39,125) (19,938)

Impairment loss 0 0 0

Inventory write-down 0 0 (788)

Others [member]

Disclosure of operating segments [line items]

Depreciation and amortisation (186,537) (209,333) (207,905)

Impairment loss (9) (28,392) 0

Inventory write-down ¥ 0 ¥ 0 ¥ (106)

v3.23.1

Segment information and revenue (Entity-wide information) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of operating segments [line items]

Revenue derived from a single customer ¥ 82,443,156 ¥ 89,198,492 ¥ 74,623,575

Single customer [member]

Disclosure of operating segments [line items]

Revenue derived from a single customer ¥ 52,190,120 ¥ 59,766,489 ¥ 38,651,385

v3.23.1

Other Operating Income (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Other operating income [abstract]

Government grants ¥ 33,055 ¥ 35,944 ¥ 61,296

Rental income from investment properties 75,159 81,923 81,608

Others 2,427 7,438 5,772

Other operating income ¥ 110,641 ¥ 125,305 ¥ 148,676

v3.23.1

Other Operating Expenses (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Other operating expenses [abstract]

Cost related to lease of investment properties ¥ (12,037) ¥ (13,439) ¥ (15,625)

Others (13,738) (31,273) (9,061)

Other operating expenses ¥ (25,775) ¥ (44,712) ¥ (24,686)

v3.23.1

Other Gains/(Losses) - Net (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Other gains/(losses) - net [abstract]

Net (losses) / gains on disposal of property, plant and equipment and other long-term assets ¥ (26,767) ¥ 48,671 ¥ (1,212)

Gains from structured deposits ^[1] 11,124 97,921 114,283

Net losses on foreign exchange option contracts 0 (151) (376)

Net gains on foreign exchange forward contracts 7,583 0 0

Net gains/(losses) on commodity swaps contracts not qualified for hedging accounting (35,434) 18,997 0

Losses from disposal of a subsidiary 0 0 0

Impairment losses for investment in an associate 0 (28,392) 0

Net foreign exchange gains / (losses) 21,969 (1,861) 12,248

Losses on sale of FVOCI (3,148) (4,685) (9,513)

Gains from entrusted loan receivables 2,704 0 0

Net losses on disposal of inventories (819) (19) 0

Other gains/(losses) – net ¥ (22,788) ¥ 130,481 ¥ 115,430

[1] Structured deposits are financial products issued by banks, return of which are linked to the performance of the embedded index, like foreign exchange rate, interest rate and etc..

v3.23.1

Other Gains/(Losses) - Net (Parenthetical) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Other Gains Net [Line Items]

Write off of fixed assets ¥ 7,676

Write off of inventory 819

Compensation to casualties ¥ 1,010 ¥ 0 ¥ 0

v3.23.1

Finance Income and Expenses (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Finance Income and Expenses [Line Items]

Others ¥ 6,710 ¥ 12,657 ¥ 7,821

Finance income 541,830 508,755 431,228

Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss (122,638) (106,827) (101,732)

Less: interest expense capitalized into construction in progress 24,136 12,641 8,292

Net interest expense (98,502) (94,186) (93,440)

Net foreign exchange loss 0 0 (5,514)

Finance expenses (98,502) (94,186) (98,954)

Finance income – net 443,328 414,569 332,274

Later than three months [member]

Finance Income and Expenses [Line Items]

Interest income from time deposits 410,652 424,696 339,595

Not later than three months [member]

Finance Income and Expenses [Line Items]

Interest income from time deposits ¥ 124,468 ¥ 71,402 ¥ 83,812

v3.23.1

Expense by Nature (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of attribution of expenses by nature to their function [line items]

Cost of raw material ¥ 55,997,717 ¥ 54,457,558 ¥ 42,082,307

Cost of trading products 11,910,488 10,929,127 11,467,420

Employee benefit expenses 3,545,720 3,456,765 3,143,219

Depreciation and amortization: Property, plant and equipment (note 16) 1,494,176 1,621,459 1,553,039

Depreciation and amortization: Investment properties (note 17) 15,323 15,325 15,184

Depreciation and amortization: Other non-current assets (note 14) 270,881 294,617 226,263

Depreciation and amortization: Right-of-use assets (note 15) 32,918 34,307 32,653

Repairs and maintenance expenses 1,513,812 1,587,955 1,060,624

Changes of work in progress and finished goods (78,255) (235,402) 862,652

Transportation costs 193,144 238,405 274,002

Inventory write-down 525,269 150,883 220,888

External processing fee 192,288 213,691 215,467

Commission expense 90,341 110,552 104,598

Impairment loss of property, plant and equipment (note 16) 286,260 587,622 87,570

Impairment loss of investments accounted for using equity method (note 20) 0 28,392 0

Auditors' remuneration - audit services 6,837 6,837 7,800

Auditors' remuneration – non-audit services 129 129 0

Expenses relating to short-term leases ¥ 14,774 ¥ 6,938 ¥ 3,731

v3.23.1

Employee Benefit Expenses (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Classes of employee benefits expense [abstract]

Wages and salaries ¥ 2,139,472 ¥ 2,142,959 ¥ 2,009,645

Social welfare costs 921,971 861,375 714,484

Others 484,277 452,431 419,090

Total employee benefit expense ¥ 3,545,720 3,456,765 3,143,219

Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan. 8.00%

Contributions to defined contribution retirement plans ¥ 463,204 431,818 342,073

Defined contribution retirement plans outstanding contribution ¥ 0 ¥ 0 ¥ 0

v3.23.1

Income Tax Benefits /(Expenses) Major Components of Income Tax (Expense)/Benefits (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Major components of tax expense (income) [abstract]

Current income tax ¥ (66,649) ¥ (590,668) ¥ (37,027)

Deferred taxation 798,003 (53,812) 102,647

Income tax benefits / (expenses) ¥ 731,354 ¥ (644,480) ¥ 65,620

v3.23.1

Income Tax Benefits /(Expenses) (Reconciliation of Income Tax) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Reconciliation of accounting profit multiplied by applicable tax rates [abstract]

Profit / (loss) before income tax ¥ (3,573,654) ¥ 2,721,086 ¥ 590,778

Expected PRC income tax at the statutory tax rate of 25% 893,414 (680,272) (147,695)

Tax effect of share of net profits / (losses) of investments accounted for using the equity method (46,787) 214,750 178,685

Tax effect of other non-taxable income 9,890 10,782 54,379

Tax effect of additional deductions for R&D expenses 17,779 12,168 11,863

Tax effect of non-deductible loss, expenses and costs (67,330) (185,945) (51,543)

True up for final settlement of enterprise income taxes in respect of previous years (54,017) 0 9,188

Tax losses for which no deferred income tax asset was recognized (24,948) (21,225) (2,821)

Utilization of previously unrecognized tax losses 3,353 157 13,564

Tax effect of additional deduction for purchasing environmental protection equipment 0 12,446 0

Derecognition of previously recognized tax losses 0 (7,341) 0

Income tax benefits / (expenses) ¥ 731,354 ¥ (644,480) ¥ 65,620

PRC income tax rate 25.00% 25.00% 25.00%

v3.23.1

Income Tax Benefits /(Expenses) (Summary of Current Taxation in the Consolidated Statements) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Major components of tax expense (income) [abstract]

At beginning of the year ¥ 258,466 ¥ 19,425

Provision for current income tax for the year 66,649 590,668 ¥ 37,027

Payment during the year (376,765) (351,627)

At the end of the year (51,650) 258,466 19,425

Income tax 2,754 258,466

Payable (54,404) 0

Prepaid ¥ (51,650) ¥ 258,466 ¥ 19,425

v3.23.1

Earnings/(losses) Per Share (Summary of Earnings/(losses) Per Share, Basic) (Details) - CNY (¥)
¥ / shares in Units, ¥ in Thousands, shares in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Basic earnings per share [abstract]

Net (loss)/profit attributable to equity shareholders of the Company ¥ (2,846,156) ¥ 2,073,431 ¥ 645,072

Weighted average number of ordinary shares in issue (thousands of shares) 10,819,622 10,823,814 10,823,814

Basic earnings/(losses) per share (RMB per share) ¥ (0.263) ¥ 0.192 ¥ 0.06

v3.23.1

Earnings/(losses) Per Share (Weighted Average Number of Ordinary Shares) (Details) - shares
shares in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Basic earnings per share [abstract]

Issued ordinary shares at 1 January 10,823,814 10,823,814 10,823,814

Effect of shares repurchased (4,192) 0 0

Weighted average number of ordinary shares at 31 December 10,819,622 10,823,814 10,823,814

v3.23.1

Other Non-current Assets (Narrative) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Intangible Assets Other Than Goodwill And Long Term Prepaid Expense [Member]

Disclosure of information about other non-current assets [line items]

Amortization charged in cost of sales ¥ 270,881 ¥ 294,617 ¥ 226,263

v3.23.1

Leases - (Statements of Financial Position Relating to Leases) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Right-of-use assets

Right-of-use assets ¥ 379,805 ¥ 385,643

Lease liabilities

Current 8,738 3,229

Non-current 7,513 1,384

Lease liabilities 16,251 4,613

Additions to right-of-use assets 27,275 9,534 ¥ 109,238

Right-of-use assets generated by the acquisition of a subsidiary 102,283

Land use rights [member]

Right-of-use assets

Right-of-use assets 363,720 380,764

Buildings [member]

Right-of-use assets

Right-of-use assets 14,540 3,288

Equipment [member]

Right-of-use assets

Right-of-use assets 373 625

Others [member]

Right-of-use assets

Right-of-use assets ¥ 1,172 ¥ 966

v3.23.1

Lease - (Maturity Analysis for Lease Liabilities) (Detail)
¥ in Thousands

Dec. 31, 2022

CNY (¥)

Disclosure of maturity analysis for non-derivative financial liabilities [line items]

Gross lease liabilities ¥ 16,251

Within 1 year [member]

Disclosure of maturity analysis for non-derivative financial liabilities [line items]

Gross lease liabilities 8,738

After 1 year but within 2 years [member]

Disclosure of maturity analysis for non-derivative financial liabilities [line items]

Gross lease liabilities 6,945

After 2 years but within 5 years [member]

Disclosure of maturity analysis for non-derivative financial liabilities [line items]

Gross lease liabilities ¥ 568

v3.23.1

Leases - (Statements of Profit Loss Amount Relating to Leases) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Income statement amount relating to leases [line items]

Depreciation of right-of-use assets ¥ (32,918) ¥ (34,307) ¥ (32,653)

Interest expense (included in Finance expenses) (1,039) (537) (887)

Expense relating to short-term leases (included in Cost of sales) (14,774) (6,938) (3,731)

Total cash outflow for leases 27,843 24,482 20,204

Land use rights [member]

Income statement amount relating to leases [line items]

Depreciation of right-of-use assets (17,044) (17,044) (15,965)

Buildings [member]

Income statement amount relating to leases [line items]

Depreciation of right-of-use assets (14,089) (15,677) (15,481)

Equipment [member]

Income statement amount relating to leases [line items]

Depreciation of right-of-use assets (547) (399) (449)

Others [member]

Income statement amount relating to leases [line items]

Depreciation of right-of-use assets ¥ (1,238) ¥ (1,187) ¥ (758)

v3.23.1

Property, Plant and Equipment (Narrative) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of detailed information about property, plant and equipment [line items]

Impairment loss ¥ 286,260 ¥ 587,622 ¥ 87,570

Certain production facilities [Member]

Disclosure of detailed information about property, plant and equipment [line items]

Recoverable amount of asset ¥ 265,377

Pre tax discount rate 9.00%

Impairment loss ¥ 212,410

Resins and plastics [member] | Idle or obsolete production technology facilities [member]

Disclosure of detailed information about property, plant and equipment [line items]

Impairment loss 24,620

Synthetic fibres [member] | Idle or obsolete production technology facilities [member]

Disclosure of detailed information about property, plant and equipment [line items]

Impairment loss ¥ 49,230

v3.23.1

Investment Properties (Movement in Net Book Amount) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of detailed information about investment property [line items]

Opening net book amount ¥ 352,188

Charge for the year (15,323) ¥ (15,325) ¥ (15,184)

Closing net book amount 336,863 352,188

Cost [member]

Disclosure of detailed information about investment property [line items]

Opening net book amount 626,414 627,488

Transferred from property plant and equipment 90

Transferred to property plant and equipment (47) (1,164)

Closing net book amount 626,367 626,414 627,488

Accumulated depreciation [member]

Disclosure of detailed information about investment property [line items]

Opening net book amount (274,226) (259,902)

Transferred from property plant and equipment 0 (87)

Transferred to property plant and equipment 45 1,088

Charge for the year (15,323) (15,325)

Closing net book amount ¥ (289,504) ¥ (274,226) ¥ (259,902)

v3.23.1

Construction in Progress (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Construction in progress [line items]

As at 1 January ¥ 3,293,177

As at 31 December 3,748,461 ¥ 3,293,177

Construction in progress [member]

Construction in progress [line items]

As at 1 January 3,293,177 1,710,124

Additions 2,927,950 3,270,695

Disposal (4,749) 0

Transferred to property plant and equipment (2,467,917) (1,699,974)

Transferred from property plant and equipment 0 12,332

As at 31 December 3,748,461 3,293,177 ¥ 1,710,124

Impairment loss in construction in progress 24,486 24,486 24,486

Impairment write-off due to the disposal of construction in progress 0 0 ¥ 10,175

Capitalized borrowing costs ¥ 24,136 ¥ 12,641

Weighted average rate of capitalized borrowing costs 1.78% 2.85% 2.79%

v3.23.1

Subsidiaries (Acquisition of Jinlian) (Details) - Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd. ("Jinlian") [member] - CNY (¥)
¥ in Thousands
12 Months Ended

Jun. 30, 2020

Dec. 31, 2022

Disclosure of subsidiaries [line items]

Percentage of equity held by the subsidiary 100.00%

Shanghai Petrochemical Investment Development Company Limited ("Toufa") [member]

Disclosure of subsidiaries [line items]

Percentage of equity held by the subsidiary 100.00%

Purchase consideration ¥ 340,369

v3.23.1

Investments Accounted for Using the Equity Method (Investments Recognized in Balance Sheet) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of significant investments in associates and joint ventures [line items]

Share of net assets ¥ 3,504,393 ¥ 4,088,888

Joint ventures [member]

Disclosure of significant investments in associates and joint ventures [line items]

Share of net assets 476,761 276,043

Associates [member]

Disclosure of significant investments in associates and joint ventures [line items]

Share of net assets ¥ 3,027,632 ¥ 3,812,845

v3.23.1

Investments Accounted for Using the Equity Method (Investments Recognized in Share of Profit/(Loss)) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]

Associates ¥ (188,549) ¥ 825,132 ¥ 678,077

Joint ventures 14,933 49,153 46,663

Total ¥ (173,616) ¥ 874,285 ¥ 724,740

v3.23.1

Investments Accounted for Using the Equity Method (Investment in Associates) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of associates [line items]

Share of net profits / (losses) ¥ (188,549) ¥ 825,132 ¥ 678,077

Associates [member]

Disclosure of associates [line items]

As at 1 January 3,812,845 5,146,160

Additions 96,672 26,000

Decrease caused by associate's capital reduction 0 (1,460,258)

Share of net profits / (losses) (188,549) 825,132

Other comprehensive income (23,771) 16,639

Cash dividends distribution (669,565) (712,436)

Impairment 0 (28,392)

As at 31 December ¥ 3,027,632 ¥ 3,812,845 ¥ 5,146,160

v3.23.1

Investments Accounted for Using the Equity Method (Summarized Balance Sheet for Material Associates) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Current

Current assets ¥ 15,765,882 ¥ 20,932,276

Current liabilities (13,998,338) (15,795,743)

Non-current

Non-current assets 25,370,835 25,988,313

Non-current liabilities (783,016) (747,448)

Shanghai Secco [member]

Current

Current assets 4,941,394 6,066,119

Current liabilities (8,977,030) (5,433,872)

Non-current

Non-current assets 5,683,409 5,735,360

Non-current liabilities (1) (66)

Net assets ¥ 1,647,772 ¥ 6,367,541

Proportion of ownership interest in associate 20.00% 20.00%

Interest in associates and joint ventures ¥ 329,554 ¥ 1,273,508

Adjustments for unrealized upstream and downstream transaction 4,342 (3,157)

Adjustments for earnings not shared by other shareholders 0 0

Impairment Loss On Investment In Associates 0 0

Investments in associates accounted for using equity method 333,896 1,270,351

Chemical Industry [member]

Current

Current assets 4,327,622 4,133,397

Current liabilities (1,765,771) (1,789,223)

Non-current

Non-current assets 4,480,448 4,431,463

Non-current liabilities (651,729) (619,306)

Net assets ¥ 6,390,570 ¥ 6,156,331

Proportion of ownership interest in associate 38.26% 38.26%

Interest in associates and joint ventures ¥ 2,445,032 ¥ 2,355,412

Adjustments for unrealized upstream and downstream transaction 0 0

Adjustments for earnings not shared by other shareholders (329,890) (331,826)

Impairment Loss On Investment In Associates 0 0

Investments in associates accounted for using equity method 2,115,142 2,023,586

Jinsen [member]

Current

Current assets 49,810 63,192

Current liabilities (17,905) (10,476)

Non-current

Non-current assets 50,360 58,737

Non-current liabilities 0 0

Net assets ¥ 82,265 ¥ 111,453

Proportion of ownership interest in associate 40.00% 40.00%

Interest in associates and joint ventures ¥ 32,906 ¥ 44,581

Adjustments for unrealized upstream and downstream transaction 0 0

Adjustments for earnings not shared by other shareholders 0 0

Impairment Loss On Investment In Associates (28,392) (28,392)

Investments in associates accounted for using equity method 4,514 16,189

Azbil [member]

Current

Current assets 276,707 274,697

Current liabilities (125,216) (111,472)

Non-current

Non-current assets 12,338 15,698

Non-current liabilities (5,518) (7,506)

Net assets ¥ 158,311 ¥ 171,417

Proportion of ownership interest in associate 40.00% 40.00%

Interest in associates and joint ventures ¥ 63,324 ¥ 68,567

Adjustments for unrealized upstream and downstream transaction 0 0

Adjustments for earnings not shared by other shareholders 0 0

Impairment Loss On Investment In Associates 0 0

Investments in associates accounted for using equity method 63,324 68,567

Shidian Energy [member]

Current

Current assets 950,614 804,470

Current liabilities (38,133) (34,565)

Non-current

Non-current assets 166,068 121,051

Non-current liabilities (35,355) (15,827)

Net assets ¥ 1,043,194 ¥ 875,129

Proportion of ownership interest in associate 40.00% 40.00%

Interest in associates and joint ventures ¥ 417,278 ¥ 350,052

Adjustments for unrealized upstream and downstream transaction (12,615) (15,979)

Adjustments for earnings not shared by other shareholders 0 0

Impairment Loss On Investment In Associates 0 0

Investments in associates accounted for using equity method ¥ 404,663 ¥ 334,073

v3.23.1

Investments Accounted for Using the Equity Method (Summarized Financial Information for Other Associates) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Aggregate amounts of the group's share of:

Profit for the year ¥ (2,842,300) ¥ 2,076,606 ¥ 656,398

Total comprehensive income (2,664,552) 2,218,404 ¥ 644,886

Other associates [member]

Disclosure of associates [line items]

Aggregate carrying value of investments at 31 December 106,093 100,079

Aggregate amounts of the group's share of:

Profit for the year 876 5,655

Total comprehensive income 876 5,655

Dividend received from the associate ¥ 11,650 ¥ 6,670

v3.23.1

Investments Accounted for Using the Equity Method (Investment in Joint Ventures) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of joint ventures [line items]

Share of profit ¥ 14,933 ¥ 49,153 ¥ 46,663

Joint ventures [member]

Disclosure of joint ventures [line items]

As at 1 January 276,043 241,674

Addition (note i) 200,000 50,000

Share of profit 14,933 49,153

Cash dividends distribution (14,215) (64,784)

As at 31 December ¥ 476,761 ¥ 276,043 ¥ 241,674

v3.23.1

Investments Accounted for Using the Equity Method (Financial Information For The Company's Equity Method Investments Other Than Shanghai Secco Are Summarized) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure Of Investments Accounted For Using The Equity Method Have Met The Significance Criteria Under The Rule 408(G) Of Regulation SX [Line Items]

Revenue ¥ 82,443,156 ¥ 89,198,492 ¥ 74,623,575

Gross profit (3,611,377) 1,590,756 (340,249)

Profit after taxation (2,842,300) 2,076,606 656,398

Profit after taxation attributable to the Group (2,846,156) 2,073,431 645,072

Current assets 15,765,882 20,932,276

Non-current assets 25,370,835 25,988,313

Current liabilities 13,998,338 15,795,743

Non-current liabilities 783,016 747,448

Non-controlling interests 127,681 135,259

Investments accounted for using equity method [member]

Disclosure Of Investments Accounted For Using The Equity Method Have Met The Significance Criteria Under The Rule 408(G) Of Regulation SX [Line Items]

Revenue 3,759,076 4,863,742 4,548,574

Gross profit 670,678 828,183 825,799

Profit from continuing operations 670,678 798,867 753,799

Profit after taxation 512,758 586,612 593,211

Profit after taxation attributable to the Group 208,401 240,882 ¥ 243,953

Current assets 6,436,238 6,083,530

Non-current assets 5,909,304 5,000,852

Current liabilities (2,185,434) (2,086,793)

Non-current liabilities (978,325) (707,374)

Non-controlling interests ¥ 1,578,714 ¥ 1,508,175

v3.23.1

Inventories (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of detailed information about inventories [line items]

Raw materials ¥ 5,673,724 ¥ 4,378,149

Work in progress 518,048 690,341

Finished goods 914,588 664,040

Spare parts and consumables 187,700 190,995

Inventories 7,294,060 5,923,525

Gross carrying amount [member]

Disclosure of detailed information about inventories [line items]

Raw materials 5,700,215 4,391,555

Work in progress 756,007 795,791

Finished goods 1,096,623 709,990

Spare parts and consumables 246,161 249,456

Inventories 7,799,006 6,146,792

Provision for declines in the value of inventories [member]

Disclosure of detailed information about inventories [line items]

Raw materials (26,491) 13,406

Work in progress (237,959) (105,450)

Finished goods (182,035) (45,950)

Spare parts and consumables (58,461) (58,461)

Inventories ¥ 504,946 ¥ 223,267

v3.23.1

Inventories (Narrative) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Classes of current inventories [abstract]

Cost of inventories recognized in Cost of Sales ¥ 72,419,098 ¥ 70,704,868 ¥ 53,622,798

Inventory provision excluded in cost of sales 525,269 150,883 220,888

Reversal of inventory write-down ¥ 243,590 ¥ 156,149 ¥ 147,817

v3.23.1

Trade And Other Receivable - Summary Of Movements In The Loss Allowance AccountIng Respect Of Trade And Other Receivables Explanatory (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Movements in the loss allowance account in respect of trade and other receivables

Balance at 1 January ¥ 2,128 ¥ 773

Impairment losses recognized during the year 5,366 1,355

Balance at 31 December ¥ 7,494 ¥ 2,128

v3.23.1

Trade And Other Receivables - Summary Of Component Of Trade And Other Receivables Explanatory (Detail) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Trade receivables ¥ 72,110 ¥ 79,413

Less: loss allowance (7,494) (2,128) ¥ (773)

Current trade receivables 69,351 77,425

Amounts due from related parties excluded prepayments and bills receivable 2,583,289 1,153,111

Less: loss allowance (2,802) 0

Total trade receivables 2,649,838 1,230,536

Other receivables 109,440 47,737

Less: loss allowance (107,507) (47,597)

Other receivables net 107,507 47,597

Amounts due from related parties - prepayments 58,496 34,220

Amounts due from related parties - bills receivables (note 25) 0 25,000

Trade and other current receivables 2,815,841 1,337,353

Amounts due from related parties 2,638,983 1,212,331

Trade receivables [member]

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Less: loss allowance (2,759) (1,988)

Other Current Receivables [Member]

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Less: loss allowance (1,933) (140)

Trade And Other Current Receivables And Amounts Due From Related Parties Net Of Prepayments And Bills Receivable [Member]

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Financial assets measured at amortized cost ¥ 2,757,345 ¥ 1,278,133

v3.23.1

Trade And Other Receivable - Summary Of Aging Analysis In Trade And Other Receivables Explanatory (Detail) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Trade receivables and amounts due from related parties net Of prepayments and bills receivable ¥ 2,649,838 ¥ 1,230,536

Within one year [member]

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Trade receivables and amounts due from related parties net Of prepayments and bills receivable 2,649,673 1,230,360

Over one year but within two years [member]

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Trade receivables and amounts due from related parties net Of prepayments and bills receivable 165 27

Over two years [member]

Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]

Trade receivables and amounts due from related parties net Of prepayments and bills receivable ¥ 0 ¥ 149

v3.23.1

Cash and cash equivalents (Cash and cash equivalents) (Detail) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Cash and cash equivalents [abstract]

Cash deposits with a related party ^[1] ¥ 0 ¥ 3,243

Cash at bank and on hand 889,413 5,108,767

Cash and cash equivalents in the consolidated statements of financial position ¥ 889,413 ¥ 5,112,010 ¥ 6,916,408 ¥ 7,449,699

[1] Cash deposits with a related party were cash deposits at Sinopec Finance Company Limited (“Sinopec Finance”).

v3.23.1

Cash and cash equivalents (Reconciliation of Profit/(loss) before Taxation to Cash Used in Operation) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Cash flows from (used in) operating activities [abstract]

Profit/(loss) before taxation ¥ (3,573,654) ¥ 2,721,086 ¥ 590,778

Adjustment items:

Interest income from time deposits with maturity more than 3 months (410,652) (424,696) (339,505)

Share of (profits)/losses of investments accounted for using the equity method 173,616 (874,285) (724,740)

Net losses/(gains) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges 27,851 (18,846) 376

Gains from structured deposits ^[1] (11,124) (97,921) (114,283)

Gains from entrusted loan receivables (2,704) 0 0

Losses on sale of FVOCI 3,148 4,685 9,513

Interest expense 98,502 94,186 64,169

Foreign exchange losses/(gains) (15,320) 1,861 5,514

Depreciation of property, plant and equipment 1,494,176 1,621,459 1,553,039

Depreciation of investment property 15,323 15,325 15,184

Depreciation of right-of-use assets 32,918 34,307 32,653

Amortization of other non-current assets 270,881 294,617 226,263

Impairment loss on property, plant and equipment 286,260 587,622 87,570

Losses / (gains) on disposal of property, plant and equipment and other long-term assets-net 26,767 (48,671) 1,212

Impairment loss on investment accounted for using the equity method 0 28,392 0

Profit/(loss) on operation before change of working capital (1,584,012) 3,939,121 1,407,743

Decrease/(increase) in inventories (1,370,535) (2,034,779) 2,865,687

Decrease in operation receivables 511,325 49,586 308,333

Decrease in operation payables (4,673,853) (70,235) (1,008,800)

(Decrease)/increase in balances to related parties – net 156,341 2,527,960 (1,577,876)

Cash generated from/(used in) operations ¥ (6,960,734) ¥ 4,411,653 ¥ 1,995,087

[1] Structured deposits are financial products issued by banks, return of which are linked to the performance of the embedded index, like foreign exchange rate, interest rate and etc..

v3.23.1

Cash and cash equivalents -Summary of Cash flow Statements for Leases (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Text Block [Abstract]

Within operating cash flows ¥ (14,774) ¥ (6,938) ¥ (4,618)

Within financing cash flows (13,069) (17,544) (15,586)

Total ¥ (27,843) ¥ (24,482) ¥ (20,204)

v3.23.1

Cash and cash equivalents - Summary of Lease Rentals (Detail) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Cash and cash equivalents [abstract]

Lease rentals paid ¥ (27,843) ¥ (24,482) ¥ (20,204)

v3.23.1

Time Deposits With Banks - Summary Of Time Deposits With Banks (Detail) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Time deposits with banks [abstract]

Time deposits with maturity less than one year ¥ 3,108,919 ¥ 7,386,607

Time deposits with maturity more than one year 3,389,559 5,581,435

Time deposits with banks ¥ 6,498,478 ¥ 12,968,042

v3.23.1

Time Deposits With Banks - Additional Information (Details)

Dec. 31, 2022

Dec. 31, 2021

Less than one year [member] | Bottom of range [member]

Disclosure In Entirety Of Time Deposits Held With Banks [Line Items]

Interest rate on time deposits with banks 3.85% 3.40%

Less than one year [member] | Top of range [member]

Disclosure In Entirety Of Time Deposits Held With Banks [Line Items]

Interest rate on time deposits with banks 4.13% 3.50%

More than three or five years [member] | Bottom of range [member]

Disclosure In Entirety Of Time Deposits Held With Banks [Line Items]

Interest rate on time deposits with banks 3.55% 3.45%

More than three or five years [member] | Top of range [member]

Disclosure In Entirety Of Time Deposits Held With Banks [Line Items]

Interest rate on time deposits with banks 4.20% 4.20%

v3.23.1

Financial Assets At Fair Value Through Other Comprehensive Income - Additional Information (Detail)
¥ in Thousands

Dec. 31, 2022

CNY (¥)

Discounted Bills [Member]

Statement [Line Items]

Gross undiscounted cash flows discounted and endorsed bills ¥ 196,667

Endorsed Bills [Member]

Statement [Line Items]

Gross undiscounted cash flows discounted and endorsed bills ¥ 178,369

v3.23.1

Financial Assets At Fair Value Through Other Comprehensive Income - Summary Of Financial Assets at Fair Value Through Other Comprehensive Income (Detail) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of financial assets [line items]

Trade and bill receivable ¥ 582,354 ¥ 1,047,690

Total financial assets at fair value through other comprehensive income 5,000 5,000

At fair value [member]

Disclosure of financial assets [line items]

Trade and bill receivable ^[1] 0 25,000

- Amounts due from related parties (note 22) 582,354 1,047,690

- Others 582,354 1,072,690

Total financial assets at fair value through other comprehensive income 5,000 5,000

Equity investments ¥ 587,354 ¥ 1,077,690

[1] As at 31 December 2021 and 2022, certain trade receivables and bills receivable were classified as financial assets at FVOCI, as the Group’s business model is achieved both by collecting contractual cash flows and selling of these assets.

v3.23.1

Borrowings - Summary of Borrowings (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Borrowings [abstract]

Credit loans due within one year - Short term bank loan ¥ 1,550,000 ¥ 1,559,800

Credit loans due over one year but within three years - Long-term borrowing from a related party (note 32(c)) 700,000 700,000

Borrowings ¥ 2,250,000 ¥ 2,259,800

v3.23.1

Borrowings - Summary of Analysis of the Repayment Schedule of Borrowings (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure In Tabular Form Of Repayment Schedule Of Borrowings [Line Items]

Borrowings ¥ 2,250,000 ¥ 2,259,800

Within 1 year or on demand [member]

Disclosure In Tabular Form Of Repayment Schedule Of Borrowings [Line Items]

Borrowings 1,550,000 1,559,800

Over one year but within two years [member]

Disclosure In Tabular Form Of Repayment Schedule Of Borrowings [Line Items]

Borrowings 700,000 0

Over two years but within three years [member]

Disclosure In Tabular Form Of Repayment Schedule Of Borrowings [Line Items]

Borrowings ¥ 0 ¥ 700,000

v3.23.1

Borrowings - Additional Information (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of detailed information about borrowings [line items]

Borrowings secured by property, plant and equipment ¥ 0 ¥ 0

Long-term borrowings [member] | Weighted average [member]

Disclosure of detailed information about borrowings [line items]

Weighted average interest rate for the Group's borrowings 1.08% 1.08% 0.00%

Short Term Bank Borrowings [Member] | Weighted average [member]

Disclosure of detailed information about borrowings [line items]

Weighted average interest rate for the Group's borrowings 2.35% 2.74% 2.79%

v3.23.1

Trade and Other Payables - Summary of Trade and Other Payables (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Trade and other payables [abstract]

Trade payables ¥ 1,818,453 ¥ 1,527,706

Bills payable 24,951 562,593

Amounts due to related parties exclude advances received ^[1] 7,877,323 4,910,255

Subtotal 9,720,727 7,000,554

Dividends payable 31,631 30,577

Construction payable 831,422 487,283

Accrued expenses 143,299 400,391

Other liabilities 76,778 87,144

Subtotal of other payables 1,083,130 1,005,395

Financial liabilities measured at amortized cost 10,803,857 8,005,949

Amounts due to related parties – advances received ^[1] 10,486 6,275

Amounts due to related parties – measured at fair value through profit or loss (FVPL) ^[1] 0 1,388,286

Sub Total 10,814,343 9,400,510

Total amount due to related parties ^[1] ¥ 7,887,809 ¥ 6,304,816

[1] Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.

v3.23.1

Trade and Other Payables - Summary of Aging Analysis of Trade Payables (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

TradeAndOtherPayables [Line Items]

Trade payables (including amounts due to related parties of trading in nature) ¥ 9,720,727 ¥ 7,000,554

Within 1 year [member]

TradeAndOtherPayables [Line Items]

Trade payables (including amounts due to related parties of trading in nature) 9,708,441 6,990,653

Between one and two years [member]

TradeAndOtherPayables [Line Items]

Trade payables (including amounts due to related parties of trading in nature) 2,524 9,527

Over two years [member]

TradeAndOtherPayables [Line Items]

Trade payables (including amounts due to related parties of trading in nature) ¥ 9,762 ¥ 374

v3.23.1

Contract Liabilities (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Contract liabilities [abstract]

Contract liabilities ¥ 372,760 ¥ 424,607

Carried-forward contract liabilities recognized in current year ¥ 424,607 ¥ 495,404 ¥ 579,750

v3.23.1

Deferred Income (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Accruals and deferred income including contract liabilities [abstract]

As at 1 January ¥ 12,720 ¥ 13,433

Additions 34,623 0

Amortization (2,735) (713)

As at 31 December ¥ 44,608 ¥ 12,720

v3.23.1

Share Capital (Details) - CNY (¥)
¥ in Thousands, shares in Thousands

Dec. 31, 2022

Jan. 01, 2022

Dec. 31, 2021

Disclosure of classes of share capital [line items]

As at 31 December ¥ 10,823,814 ¥ 10,823,814

Ordinary A shares listed in PRC [member]

Disclosure of classes of share capital [line items]

As at 31 December 7,328,814 7,328,814 7,328,814

As at 31 December ¥ 7,328,814 ¥ 7,328,814 ¥ 7,328,814

Foreign invested H shares listed overseas [member]

Disclosure of classes of share capital [line items]

As at 31 December 3,495,000 3,495,000 3,495,000

As at 31 December ¥ 10,823,814 ¥ 3,495,000 ¥ 3,495,000

Total [member]

Disclosure of classes of share capital [line items]

As at 31 December 10,823,814 10,823,814 10,823,814

As at 31 December ¥ 3,495,000 ¥ 10,823,814 ¥ 10,823,814

v3.23.1

Share capital - Purchase of own shares (Details) - 12 months ended Dec. 31, 2022
¥ in Thousands

CNY (¥)

shares

$ / shares

Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]

Number of shares repurchased | shares 24,528,000

Aggregate price paid | ¥ ¥ 25,689

October Two Thousand And Twenty Two [Member]

Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]

Number of shares repurchased | shares 4,956,000

Highest price paid per share $ 1.1

Lowest price paid per share 1.03

Aggregate price paid | ¥ ¥ 4,883

November Two Thousand And Twenty Two [Member]

Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]

Number of shares repurchased | shares 15,866,000

Highest price paid per share 1.26

Lowest price paid per share 1.04

Aggregate price paid | ¥ ¥ 16,299

December Two Thousand And Twenty Two [Member]

Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]

Number of shares repurchased | shares 3,706,000

Highest price paid per share 1.39

Lowest price paid per share $ 1.25

Aggregate price paid | ¥ ¥ 4,507

v3.23.1

Share capital - Additional Information (Details)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

CNY (¥)

shares

Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]

Stock shares repurchased during the period shares | shares 24,528,000

Purchase of treasury shares | ¥ ¥ 25,689

HSBC-X HONG KONG [Member]

Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]

Stock shares repurchased during the period shares | shares 24,528,000

Purchase of treasury shares | ¥ ¥ 25,689

v3.23.1

Reserves - Additional Information (Details)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

CNY (¥)

Disclosure of reserves within equity [line items]

Percentage of net income to be transferred to legal surplus reserve 10.00%

Legal reserve as a percentage of registered capital after issuance or conversion into ordinary shares if any 25.00%

Legal surplus ¥ 6,571,284

v3.23.1

Related-Party Transactions (Transactions between the Group and Sinopec Corp., Its Subsidiaries and Joint Ventures) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of transactions between related parties [line items]

Commission expense ¥ 90,341 ¥ 110,552 ¥ 104,598

Sinopec Corp., its subsidiaries and joint ventures [member]

Disclosure of transactions between related parties [line items]

Sales of petroleum products 44,392,225 47,201,755 39,879,549

Sales other than petroleum products 8,194,827 9,439,546 6,790,568

Purchases of crude oil 46,790,433 35,371,820 27,934,926

Purchases other than crude oil 7,544,094 9,008,147 9,937,862

Commission expense 90,341 110,552 104,598

Rental income ¥ 34,088 ¥ 34,475 ¥ 32,829

v3.23.1

Related-Party Transactions (Other Transactions between the Group and Sinopec Group and Its Subsidiaries, Associates and Joint Ventures of the Group) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of transactions between related parties [line items]

Additions to right-of-use assets ¥ 27,275 ¥ 9,534 ¥ 109,238

Interest expense of lease liabilities 1,039 537 887

Interest expense 98,502 94,186 93,440

The group and Sinopec group and subsidiaries associates and joint ventures of the group [member]

Disclosure of transactions between related parties [line items]

Sales of goods and service fee income 3,191,285 4,285,341 2,034,867

Purchase 4,281,839 7,255,954 4,481,281

Interest expense of lease liabilities 804 271 213

Interest income 2,917 824 2,088

Rental income 14,459 15,394 16,041

Sinopec Group and its subsidiaries [member]

Disclosure of transactions between related parties [line items]

Sales of goods and service fee income 19,450 36,683 14,870

Purchase 1,870,287 2,830,256 832,617

Insurance premiums expenses 109,597 108,850 107,495

Additions to right-of-use assets 20,023 1,388 2,267

Interest expense of lease liabilities 787 247 205

Construction and installation cost 812,516 785,216 233,591

Rental income 427 464 464

Associates and joint ventures of the Group [member]

Disclosure of transactions between related parties [line items]

Sales of goods and service fee income 3,171,835 4,248,658 2,019,997

Purchase 2,411,552 4,425,698 3,648,664

Rental income 14,032 14,930 15,577

Joint ventures of the Group [member]

Disclosure of transactions between related parties [line items]

Interest expense of lease liabilities 17 24 8

Interest income 2,704 0 0

Sinopec Finance [member]

Disclosure of transactions between related parties [line items]

Interest income 213 824 2,088

Interest expense 7,665 2,835 0

Long-term borrowings ¥ 0 ¥ 700,000 ¥ 0

v3.23.1

Related-Party Transactions (Relevant Amounts Due from/to Related Parties) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of transactions between related parties [line items]

Amounts due from related parties ¥ 2,638,983 ¥ 1,212,331

Amounts due to related parties ^[1] 7,887,809 6,304,816

Lease liabilities 16,251 4,613

Cash deposits, maturing within 3 months ^[2] 0 3,243

Long-term borrowings 700,000 700,000

The group and Sinopec group and subsidiaries associates and joint ventures of the group [member]

Disclosure of transactions between related parties [line items]

Amounts due from related parties 2,638,983 1,212,331

Amounts due to related parties 7,887,809 6,304,816

Lease liabilities 13,004 1,427

Sinopec Corp., its subsidiaries and joint ventures [member]

Disclosure of transactions between related parties [line items]

Amounts due from related parties 2,593,908 1,184,117

Amounts due to related parties 6,569,219 4,475,992

Associates and joint ventures of the Group [member]

Disclosure of transactions between related parties [line items]

Amounts due from related parties 45,075 28,214

Amounts due to related parties 86,001 156,385

Sinopec Group and its subsidiaries [member]

Disclosure of transactions between related parties [line items]

Amounts due to related parties 1,232,589 1,672,439

Lease liabilities 12,714 992

Joint ventures of the Group [member]

Disclosure of transactions between related parties [line items]

Lease liabilities 290 435

Sinopec Finance [member]

Disclosure of transactions between related parties [line items]

Cash deposits, maturing within 3 months 0 3,243

Long-term borrowings ¥ 700,000 ¥ 700,000

Cash deposits interest rate 0.35%

[1] Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.

[2] Cash deposits with a related party were cash deposits at Sinopec Finance Company Limited (“Sinopec Finance”).

v3.23.1

Related-Party Transactions (Key Personnel Compensations) (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Disclosure of transactions between related parties [abstract]

Short-term employee benefits ¥ 13,667 ¥ 11,866 ¥ 9,859

Post-employment benefits 639 551 441

Total ¥ 14,306 ¥ 12,417 ¥ 10,300

v3.23.1

Related-Party Transactions (Commitments with Related Parties) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Sinopec Group and its subsidiaries [member]

Disclosure of transactions between related parties [line items]

Construction and installation cost ¥ 930,665 ¥ 775,007

v3.23.1

Related-Party Transactions (Investment Commitments with Related Parties) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of transactions between related parties [line items]

Capital contribution to related parties ¥ 261,263 ¥ 541,263

Shanghai Secco Petrochemical Company Limited [member]

Disclosure of transactions between related parties [line items]

Capital contribution to related parties ^[1] 111,263 111,263

Shanghai Shidian Energy Company Limited Shidian Energy [member]

Disclosure of transactions between related parties [line items]

Capital contribution to related parties ^[2] 0 80,000

Baling Materials [Member]

Disclosure of transactions between related parties [line items]

Capital contribution to related parties ^[3] ¥ 150,000 ¥ 350,000

[1] Pursuant to the resolution of the 18th meeting of the 7th term of Board of Directors on 5 December 2013, the Group was approved to make a capital contribution of USD 30,017,000 (RMB 182,804 thousand equivalent) to Shanghai Secco, an associate of the Group. As at 31 December 2022, the Company has contributed RMB 71,541 thousand to Shanghai Secco.

[2] Pursuant to the articles of association of Shidian Energy in August 2019, Toufa agreed to make a capital contribution of RMB 400,000 thousand to acquire 40% share of Shidian Energy. As at 31 December 2022, Toufa has fully contributed RMB 400,000 thousand to Shidian Energy.

[3] Sinopec Baling Petrochemical Co., Ltd and the Company jointly established Baling Materials on 7 September 2021, each with a cash contribution of RMB 400,000 thousand. As at 31 December 2022, the Company has made a paid-up capital contribution of RMB 250,000 thousand.

v3.23.1

Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dividend [abstract]

Final dividend proposed after the end of the reporting period of RMB 0.10 per ordinary share (2020: RMB 0.10 per ordinary share) ¥ 0 ¥ 1,082,381

v3.23.1

Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year (Parenthetical) (Details) - ¥ / shares
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dividend [abstract]

Dividend per share proposed after the reporting period but not recognized as distribution to owners ¥ 0 ¥ 0.1

v3.23.1

Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year (Details) - CNY (¥)
¥ in Thousands
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dividend [abstract]

Dividends recognised as distributions to owners of parent, relating to prior years ¥ 1,082,381 ¥ 1,082,381

v3.23.1

Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year (Parenthetical) (Details) - ¥ / shares
12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dividend [abstract]

Dividend per share of previous financial years recognized as distribution to owners ¥ 0.1 ¥ 0.1

v3.23.1

Commitments (Capital Commitments) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Property, plant and equipment [abstract]

Property, plant and equipment contracted for ¥ 1,783,781 ¥ 1,176,168

v3.23.1

Statements of Financial Position and Equity Movement of the Company (Balance Sheet) (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Dec. 31, 2019

Non-current assets

Property, plant and equipment ¥ 12,179,504 ¥ 11,310,032

Investment properties 336,863 352,188

Right-of-use assets 379,805 385,643

Construction in progress 3,748,461 3,293,177

Investments accounted for using the equity method 3,504,393 4,088,888

Time deposits with banks 3,389,559 5,581,435

Other non-current assets 835,400 787,807

Non-current assets 25,370,835 25,988,313

Current assets

Derivative financial instruments 0 81,405

Inventories 7,294,060 5,923,525

Trade receivables 69,351 77,425

Other receivables 107,507 47,597

Amounts due from related parties 2,638,983 1,212,331

Prepayments 17,832 30,364

Value added tax recoverable 1,057,463 13,322

Financial assets at fair value through other comprehensive income (FVOCI) 582,354 1,047,690

Time deposits with banks 3,108,919 7,386,607

Cash and cash equivalents 889,413 5,112,010 ¥ 6,916,408 ¥ 7,449,699

Current assets 15,765,882 20,932,276

Current liabilities

Trade and other payables 2,926,534 3,095,694

Contract liabilities 372,760 424,607

Amounts due to related parties ^[1] 7,887,809 6,304,816

Staff salaries and welfares payable 317,891 260,096

Borrowings 1,550,000 1,559,800

Lease liabilities 8,738 3,229

Derivative financial instruments 0 23,804

Income tax payable 2,754 258,466

Current tax liabilities 931,852 3,865,231

Current liabilities 13,998,338 15,795,743

Non-current liabilities

Lease liabilities 7,513 1,384

Deferred income 44,608 12,720 ¥ 13,433

Non-current liabilities 783,016 747,448

CAPITAL AND RESERVES

Share capital 10,823,814 10,823,814

Reserves 15,403,868 19,418,325

Equity attributable to owners of the Company 26,227,682 30,242,139

The Company [member]

Non-current assets

Property, plant and equipment 11,823,562 10,914,990

Investment properties 365,147 381,540

Right-of-use assets 274,926 275,924

Construction in progress 3,647,200 3,201,111

Investments in subsidiaries 2,048,328 2,048,328

Investments accounted for using the equity method 2,654,151 3,299,050

Time deposits with banks 3,139,559 5,381,149

Deferred tax assets 986,830 178,084

Other non-current assets 821,397 769,492

Non-current assets 25,761,100 26,449,668

Current assets

Derivative financial instruments 0 81,405

Inventories 7,043,613 5,726,264

Trade receivables 0 149

Other receivables 88,839 8,276

Amounts due from related parties 2,526,598 1,116,553

Prepayments 10,711 13,790

Value added tax recoverable 1,045,002 0

Financial assets at fair value through other comprehensive income (FVOCI) 127,558 615,689

Time deposits with banks 3,108,916 7,386,605

Cash and cash equivalents 671,538 4,927,519

Current assets 14,622,775 19,876,250

Current liabilities

Trade and other payables 2,217,580 2,389,508

Contract liabilities 289,407 376,834

Amounts due to related parties 8,809,690 7,423,883

Staff salaries and welfares payable 307,190 253,800

Borrowings 1,500,000 1,500,000

Lease liabilities 7,172 1,604

Derivative financial instruments 0 23,804

Income tax payable 0 249,332

Current tax liabilities 913,231 3,843,541

Current liabilities 14,044,270 16,062,306

Total assets less current liabilities 26,339,605 30,263,612

Net current assets 578,505 3,813,944

Non-current liabilities

Interest-bearing borrowings 700,000 700,000

Lease liabilities 6,481 399

Deferred income 44,494 12,720

Non-current liabilities 750,975 713,119

NET ASSETS 25,588,630 29,550,493

CAPITAL AND RESERVES

Share capital 10,823,814 10,823,814

Reserves 14,764,816 18,726,679

Equity attributable to owners of the Company ¥ 25,588,630 ¥ 29,550,493

[1] Amounts due to related parties – measured at FVPL represents the obligation that the Company needs to return the crude oil to its related party with maturity of less than 1 year, which is measured at fair value through profit or loss.

v3.23.1

Comparative figures - Additional Information (Details) - CNY (¥)
¥ in Thousands

Dec. 31, 2022

Dec. 31, 2021

Disclosure of comparative information prepared under previous GAAP [abstract]

Current value added tax receivables ¥ 1,057,463 ¥ 13,322

v3.23.1

Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022 - Summary of Number of Amendments, New Standards and Interpretations Which are Not Yet Effective (Detail)
12 Months Ended

Dec. 31, 2022

IFRS 17, Insurance contracts [Member]

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Line Items]

Effective Date From Which Reporting Standard Is Applicable Jan. 01, 2023

Amendments to IAS 12, Deferred Tax related to Assets and Liabilities arising from a Single Transaction [Member]

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Line Items]

Effective Date From Which Reporting Standard Is Applicable Jan. 01, 2023

Amendments to IAS 1, Presentation of financial statements: Classification of liabilities as current or non-current [Member]

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Line Items]

Effective Date From Which Reporting Standard Is Applicable Jan. 01, 2023

Amendments to IAS 1, Presentation of financial statements and IFRS Practice Statement 2, Making materiality judgements: Disclosure of accounting policies [Member]

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Line Items]

Effective Date From Which Reporting Standard Is Applicable Jan. 01, 2023

Amendments to IAS 8, Accounting policies, changes in accounting estimates and errors: Definition of accounting estimates [Member]

Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Line Items]

Effective Date From Which Reporting Standard Is Applicable Jan. 01, 2023

{
 "instance": {
  "d474415d20f.htm": {
   "axisCustom": 7,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 45,
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 2509
   },
   "contextCount": 902,
   "dts": {
    "calculationLink": {
     "local": [
      "shi-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "shi-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d474415d20f.htm"
     ]
    },
    "labelLink": {
     "local": [
      "shi-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "shi-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "shi-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 1148,
   "entityCount": 1,
   "hidden": {
    "http://SinopecShanghai.com/20221231": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 5
   },
   "keyCustom": 248,
   "keyStandard": 363,
   "memberCustom": 226,
   "memberStandard": 65,
   "nsprefix": "shi",
   "nsuri": "http://SinopecShanghai.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "1001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://SinopecShanghai.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1010 - Disclosure - Segment Information and Revenue",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenue",
     "shortName": "Segment Information and Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:AdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsLeasePrepaymentsAndOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1100 - Disclosure - Segment information and revenue (Additions to Property, Plant and Equipment, Construction in Progress, Right-of-Use Assets and Other Non-current Assets) (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
     "shortName": "Segment information and revenue (Additions to Property, Plant and Equipment, Construction in Progress, Right-of-Use Assets and Other Non-current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:AdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsLeasePrepaymentsAndOtherAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1101 - Disclosure - Segment information and revenue (Entity-wide information) (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails",
     "shortName": "Segment information and revenue (Entity-wide information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_SingleCustomerMemberifrsfullMajorCustomersAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherOperatingIncomeComponentsExplanatory",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1102 - Disclosure - Other Operating Income (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails",
     "shortName": "Other Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherOperatingIncomeComponentsExplanatory",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherOperatingExpenseComponentsExplanatory",
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DirectOperatingExpenseFromInvestmentProperty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1103 - Disclosure - Other Operating Expenses (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://SinopecShanghai.com/role/OtherOperatingExpensesDetails",
     "shortName": "Other Operating Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherOperatingExpenseComponentsExplanatory",
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DirectOperatingExpenseFromInvestmentProperty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfNetOtherGainsComponentsTextBlock",
       "shi:DisclosureOfNetOtherGainsLossesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:NetGainsLossesOnDisposalOfPropertyPlantAndEquipmentAndOtherLongTermAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1104 - Disclosure - Other Gains/(Losses) - Net (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails",
     "shortName": "Other Gains/(Losses) - Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfNetOtherGainsComponentsTextBlock",
       "shi:DisclosureOfNetOtherGainsLossesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:NetGainsLossesOnDisposalOfPropertyPlantAndEquipmentAndOtherLongTermAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "shi:DisclosureOfNetOtherGainsLossesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:WriteOffOfFixedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1105 - Disclosure - Other Gains/(Losses) - Net (Parenthetical) (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails",
     "shortName": "Other Gains/(Losses) - Net (Parenthetical) (Details)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "shi:DisclosureOfNetOtherGainsLossesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:WriteOffOfFixedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfFinanceIncomeAndExpensesExplanatory",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherFinanceIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1106 - Disclosure - Finance Income and Expenses (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails",
     "shortName": "Finance Income and Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfFinanceIncomeAndExpensesExplanatory",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherFinanceIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfExpenseByNatureExplanatory",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterialsAndConsumablesUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1107 - Disclosure - Expense by Nature (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
     "shortName": "Expense by Nature (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfExpenseByNatureExplanatory",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterialsAndConsumablesUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEmployeeBenefitExpenseExplanatory",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1108 - Disclosure - Employee Benefit Expenses (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails",
     "shortName": "Employee Benefit Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEmployeeBenefitExpenseExplanatory",
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WagesAndSalaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorComponentsOfIncomeTaxExpenseIncomeExplanatoryTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1109 - Disclosure - Income Tax Benefits /(Expenses) Major Components of Income Tax (Expense)/Benefits (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMajorComponentsOfIncomeTaxExpenseBenefitsDetails",
     "shortName": "Income Tax Benefits /(Expenses) Major Components of Income Tax (Expense)/Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorComponentsOfIncomeTaxExpenseIncomeExplanatoryTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1011 - Disclosure - Other Operating Income",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://SinopecShanghai.com/role/OtherOperatingIncome",
     "shortName": "Other Operating Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossBeforeTax",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1110 - Disclosure - Income Tax Benefits /(Expenses) (Reconciliation of Income Tax) (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails",
     "shortName": "Income Tax Benefits /(Expenses) (Reconciliation of Income Tax) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfExpectedIncomeTaxAndActualIncomeTaxExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:TaxExpenseIncomeAtApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDetailedInformationAboutCurrentTaxationExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:IncomeTaxPrepaid",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1111 - Disclosure - Income Tax Benefits /(Expenses) (Summary of Current Taxation in the Consolidated Statements) (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesSummaryOfCurrentTaxationInTheConsolidatedStatementsDetails",
     "shortName": "Income Tax Benefits /(Expenses) (Summary of Current Taxation in the Consolidated Statements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDetailedInformationAboutCurrentTaxationExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMovementsInDeferredTaxAssetsAndLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021_DeferredTaxAssetsMemberifrsfullAssetsAndLiabilitiesAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1112 - Disclosure - Income Tax Benefits /(Expenses) (Movements in Deferred Tax Assets and Liabilities) (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Tax Benefits /(Expenses) (Movements in Deferred Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMovementsInDeferredTaxAssetsAndLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2020_DeferredTaxAssetsMemberifrsfullAssetsAndLiabilitiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfTaxLossesCarriedForwardAndNotRecognisedAsDeferredTaxAssetsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1113 - Disclosure - Income Tax Benefits /(Expenses) (Deferred Tax Assets Not Recognized) (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
     "shortName": "Income Tax Benefits /(Expenses) (Deferred Tax Assets Not Recognized) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfTaxLossesCarriedForwardAndNotRecognisedAsDeferredTaxAssetsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1114 - Disclosure - Earnings/(losses) Per Share (Summary of Earnings/(losses) Per Share, Basic) (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://SinopecShanghai.com/role/EarningsLossesPerShareSummaryOfEarningsLossesPerShareBasicDetails",
     "shortName": "Earnings/(losses) Per Share (Summary of Earnings/(losses) Per Share, Basic) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfWeightedAverageNumberOfSharesBasicExplanatory",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1115 - Disclosure - Earnings/(losses) Per Share (Weighted Average Number of Ordinary Shares) (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://SinopecShanghai.com/role/EarningsLossesPerShareWeightedAverageNumberOfOrdinarySharesDetails",
     "shortName": "Earnings/(losses) Per Share (Weighted Average Number of Ordinary Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfWeightedAverageNumberOfSharesBasicExplanatory",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "shi:SharesRepurchasedDuringThePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherNoncurrentAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1116 - Disclosure - Other Non-current Assets (Details)",
     "menuCat": "Details",
     "order": "116",
     "role": "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
     "shortName": "Other Non-current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherAssetsNoncurrentExplanatory",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_OtherIntangibleAssetsMemberifrsfullClassesOfAssetsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:OtherNoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherNoncurrentAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1117 - Disclosure - Other Non-current Assets (Movement in Net Book Amount) (Details)",
     "menuCat": "Details",
     "order": "117",
     "role": "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails",
     "shortName": "Other Non-current Assets (Movement in Net Book Amount) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherAssetsNoncurrentExplanatory",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_OtherIntangibleAssetsMemberifrsfullClassesOfAssetsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsToNoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_IntangibleAssetsOtherThanGoodwillAndLongTermPrepaidExpenseMemberifrsfullClassesOfAssetsAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:AmortisationExpenseChargedToCostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1118 - Disclosure - Other Non-current Assets (Narrative) (Details)",
     "menuCat": "Details",
     "order": "118",
     "role": "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails",
     "shortName": "Other Non-current Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_IntangibleAssetsOtherThanGoodwillAndLongTermPrepaidExpenseMemberifrsfullClassesOfAssetsAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:AmortisationExpenseChargedToCostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1119 - Disclosure - Leases - (Statements of Financial Position Relating to Leases) (Details)",
     "menuCat": "Details",
     "order": "119",
     "role": "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
     "shortName": "Leases - (Statements of Financial Position Relating to Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "lang": null,
      "name": "shi:RightofuseAssetsAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1012 - Disclosure - Other Operating Expenses",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://SinopecShanghai.com/role/OtherOperatingExpenses",
     "shortName": "Other Operating Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1120 - Disclosure - Lease - (Maturity Analysis for Lease Liabilities) (Detail)",
     "menuCat": "Details",
     "order": "120",
     "role": "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail",
     "shortName": "Lease - (Maturity Analysis for Lease Liabilities) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GrossLeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfExpenseByNatureExplanatory",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationRightofuseAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1121 - Disclosure - Leases - (Statements of Profit Loss Amount Relating to Leases) (Details)",
     "menuCat": "Details",
     "order": "121",
     "role": "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
     "shortName": "Leases - (Statements of Profit Loss Amount Relating to Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfIncomeStatementAmountsRelatedToLeasesExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "shi:ExpenseRelatingToShortTermLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1122 - Disclosure - Property, Plant and Equipment (Movement in Net Book Amount) (Details)",
     "menuCat": "Details",
     "order": "122",
     "role": "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
     "shortName": "Property, Plant and Equipment (Movement in Net Book Amount) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfExpenseByNatureExplanatory",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1123 - Disclosure - Property, Plant and Equipment (Narrative) (Details)",
     "menuCat": "Details",
     "order": "123",
     "role": "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
     "shortName": "Property, Plant and Equipment (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_CertainProductionFacilitiesMemberifrsfullSegmentsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:RecoverableAmountOfAssetOrCashgeneratingUnit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InvestmentProperty",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1124 - Disclosure - Investment Properties (Movement in Net Book Amount) (Details)",
     "menuCat": "Details",
     "order": "124",
     "role": "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
     "shortName": "Investment Properties (Movement in Net Book Amount) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory",
       "ifrs-full:DisclosureOfInvestmentPropertyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2021To12_31_2021_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:IncreaseDecreaseInInvestmentPropertyResultingFromTransfersFromPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InvestmentProperty",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1125 - Disclosure - Investment Properties (Narrative) (Details)",
     "menuCat": "Details",
     "order": "125",
     "role": "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
     "shortName": "Investment Properties (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_BottomOfRangeMemberifrsfullRangeAxis",
      "decimals": null,
      "lang": "en-US",
      "name": "shi:LeasedInvestmentPropertiesLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1126 - Disclosure - Investment Properties (Minimum Lease Payments Receivable on Leases of Investment Properties) (Details)",
     "menuCat": "Details",
     "order": "126",
     "role": "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails",
     "shortName": "Investment Properties (Minimum Lease Payments Receivable on Leases of Investment Properties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ConstructionInProgress",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1127 - Disclosure - Construction in Progress (Details)",
     "menuCat": "Details",
     "order": "127",
     "role": "http://SinopecShanghai.com/role/ConstructionInProgressDetails",
     "shortName": "Construction in Progress (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfConstructionInProgressExplanatory",
       "shi:ConstructionInProgressExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ConstructionInProgressMemberifrsfullClassesOfAssetsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsToNoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ShanghaiPetrochemicalInvestmentDevelopmentCompanyLimitedMemberifrsfullSignificantInvestmentsInSubsidiariesAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NameOfSubsidiary",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1128 - Disclosure - Subsidiaries (Major Subsidiaries of the Group) (Details)",
     "menuCat": "Details",
     "order": "128",
     "role": "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails",
     "shortName": "Subsidiaries (Major Subsidiaries of the Group) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ShanghaiPetrochemicalInvestmentDevelopmentCompanyLimitedMemberifrsfullSignificantInvestmentsInSubsidiariesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:PaidUpCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ZhejiangJinlianPetrochemicalStorageandTransportationCoLtdMemberifrsfullSignificantInvestmentsInSubsidiariesAxis",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1129 - Disclosure - Subsidiaries (Acquisition of Jinlian) (Details)",
     "menuCat": "Details",
     "order": "129",
     "role": "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
     "shortName": "Subsidiaries (Acquisition of Jinlian) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P06_30_2020To06_30_2020_ShanghaiPetrochemicalInvestmentDevelopmentCompanyLimitedMemberdeiLegalEntityAxis_ZhejiangJinlianPetrochemicalStorageandTransportationCoLtdMemberifrsfullSignificantInvestmentsInSubsidiariesAxis",
      "decimals": "2",
      "lang": null,
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfNetOtherGainsLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1013 - Disclosure - Other Gains/(losses) - net",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://SinopecShanghai.com/role/OtherGainsLossesNet",
     "shortName": "Other Gains/(losses) - net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfNetOtherGainsLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1130 - Disclosure - Investments Accounted for Using the Equity Method (Investments Recognized in Balance Sheet) (Details)",
     "menuCat": "Details",
     "order": "130",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Investments Recognized in Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInBalanceSheetExplanatory",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_JointVenturesMemberifrsfullJointVenturesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R131": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInShareOfProfitLossExplanatory",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1131 - Disclosure - Investments Accounted for Using the Equity Method (Investments Recognized in Share of Profit/(Loss)) (Details)",
     "menuCat": "Details",
     "order": "131",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInShareOfProfitLossDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Investments Recognized in Share of Profit/(Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R132": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInShareOfProfitLossExplanatory",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1132 - Disclosure - Investments Accounted for Using the Equity Method (Investment in Associates) (Details)",
     "menuCat": "Details",
     "order": "132",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Investment in Associates) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsInAssociatesAndJointVenturesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_AssociatesMemberifrsfullSignificantInvestmentsInAssociatesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:InvestmentAdditionInAssociates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R133": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCapitalCommitmentsExplanatory",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ContractualCapitalCommitments",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1133 - Disclosure - Investments Accounted for Using the Equity Method (Principal Activities of Material Associates) (Details)",
     "menuCat": "Details",
     "order": "133",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Principal Activities of Material Associates) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfNatureOfInvestmentsAccountedUsingEquityMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ShanghaiSeccoPetrochemicalCompanyLimitedMemberifrsfullSignificantInvestmentsInAssociatesAxis",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:NameOfAssociate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R134": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1134 - Disclosure - Investments Accounted for Using the Equity Method (Summarized Balance Sheet for Material Associates) (Details)",
     "menuCat": "Details",
     "order": "134",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Summarized Balance Sheet for Material Associates) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_ShanghaiSeccoPetrochemicalCompanyLimitedMemberifrsfullSignificantInvestmentsInAssociatesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R135": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1135 - Disclosure - Investments Accounted for Using the Equity Method (Summarized Statements of Comprehensive Income for Material Associates) (Details)",
     "menuCat": "Details",
     "order": "135",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Summarized Statements of Comprehensive Income for Material Associates) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ShanghaiSeccoPetrochemicalCompanyLimitedMemberifrsfullSignificantInvestmentsInAssociatesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R136": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1136 - Disclosure - Investments Accounted for Using the Equity Method (Summarized Financial Information for Other Associates) (Details)",
     "menuCat": "Details",
     "order": "136",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Summarized Financial Information for Other Associates) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsAccountedForUsingTheEquityMethodNotIndividuallyMaterialTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullSignificantInvestmentsInAssociatesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R137": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInShareOfProfitLossExplanatory",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1137 - Disclosure - Investments Accounted for Using the Equity Method (Investment in Joint Ventures) (Details)",
     "menuCat": "Details",
     "order": "137",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Investment in Joint Ventures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsInAssociatesAndJointVenturesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_JointVenturesMemberifrsfullJointVenturesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:InvestmentAdditionInJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R138": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1138 - Disclosure - Investments Accounted for Using the Equity Method (Principal Activities in Joint Ventures) (Details)",
     "menuCat": "Details",
     "order": "138",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Principal Activities in Joint Ventures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfNatureOfInvestmentsAccountedUsingEquityMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ShanghaiPetrochemicalPressureVesselTestingCenterMemberifrsfullJointVenturesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:PaidUpCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R139": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1139 - Disclosure - Investments Accounted for Using the Equity Method (Summarized Balance Sheet for Joint Ventures) (Details)",
     "menuCat": "Details",
     "order": "139",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Summarized Balance Sheet for Joint Ventures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfSummarizedStatementOfFinancialPositionOfInvestmentsAccountedUsingEquityMethodTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_ShanghaiPetrochemicalPressureVesselTestingCenterMemberifrsfullJointVenturesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1014 - Disclosure - Finance Income and Expenses",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://SinopecShanghai.com/role/FinanceIncomeAndExpenses",
     "shortName": "Finance Income and Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R140": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1140 - Disclosure - Investments Accounted for Using the Equity Method (Summarized Statements of Comprehensive Income for Joint Ventures) (Details)",
     "menuCat": "Details",
     "order": "140",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Summarized Statements of Comprehensive Income for Joint Ventures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ShanghaiPetrochemicalPressureVesselTestingCenterMemberifrsfullJointVenturesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R141": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1141 - Disclosure - Investments Accounted for Using the Equity Method (Financial Information For The Company's Equity Method Investments Other Than Shanghai Secco Are Summarized) (Details)",
     "menuCat": "Details",
     "order": "141",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
     "shortName": "Investments Accounted for Using the Equity Method (Financial Information For The Company's Equity Method Investments Other Than Shanghai Secco Are Summarized) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_InvestmentsAccountedForUsingEquityMethodMemberifrsfullClassesOfAssetsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R142": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInventoriesComponentsExplanatory",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1142 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "142",
     "role": "http://SinopecShanghai.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInventoriesComponentsExplanatory",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R143": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:CostOfInventoriesRecognisedInCostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1143 - Disclosure - Inventories (Narrative) (Details)",
     "menuCat": "Details",
     "order": "143",
     "role": "http://SinopecShanghai.com/role/InventoriesNarrativeDetails",
     "shortName": "Inventories (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:CostOfInventoriesRecognisedInCostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R144": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:ScheduleOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1144 - Disclosure - Trade And Other Receivable - Summary Of Movements In The Loss Allowance AccountIng Respect Of Trade And Other Receivables Explanatory (Detail)",
     "menuCat": "Details",
     "order": "144",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryDetail",
     "shortName": "Trade And Other Receivable - Summary Of Movements In The Loss Allowance AccountIng Respect Of Trade And Other Receivables Explanatory (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:ScheduleOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R145": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:CurrentTradeReceivablesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1145 - Disclosure - Trade And Other Receivables - Summary Of Component Of Trade And Other Receivables Explanatory (Detail)",
     "menuCat": "Details",
     "order": "145",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail",
     "shortName": "Trade And Other Receivables - Summary Of Component Of Trade And Other Receivables Explanatory (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:CurrentTradeReceivablesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R146": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:TradeReceivablesAndAmountsDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivable",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1146 - Disclosure - Trade And Other Receivable - Summary Of Aging  Analysis In Trade And Other Receivables Explanatory (Detail)",
     "menuCat": "Details",
     "order": "146",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail",
     "shortName": "Trade And Other Receivable - Summary Of Aging  Analysis In Trade And Other Receivables Explanatory (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_NotLaterThanOneYearMemberifrsfullMaturityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:TradeReceivablesAndAmountsDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R147": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCashAndCashEquivalentsComponentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1147 - Disclosure - Cash and cash equivalents (Cash and cash equivalents) (Detail)",
     "menuCat": "Details",
     "order": "147",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalentsCashAndCashEquivalentsDetail",
     "shortName": "Cash and cash equivalents (Cash and cash equivalents) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCashAndCashEquivalentsComponentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R148": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossBeforeTax",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1148 - Disclosure - Cash and cash equivalents (Reconciliation of Profit/(loss) before Taxation to Cash Used in Operation) (Details)",
     "menuCat": "Details",
     "order": "148",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
     "shortName": "Cash and cash equivalents (Reconciliation of Profit/(loss) before Taxation to Cash Used in Operation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfReconciliationOfProfitBeforeIncomeTaxToCashUsedInOperationExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "shi:AdjustmentsForInterestIncomeFromTimeDepositsWithMaturityMoreThanThreeMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R149": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1149 - Disclosure - Cash and cash equivalents - Reconciliation of liabilities arising from financing activities (Detail)",
     "menuCat": "Details",
     "order": "149",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
     "shortName": "Cash and cash equivalents - Reconciliation of liabilities arising from financing activities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1015 - Disclosure - Expense by Nature",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://SinopecShanghai.com/role/ExpenseByNature",
     "shortName": "Expense by Nature",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R150": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDetailedInformationOfTotalCashOutflowForLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:PaymentsOfLeaseLiabilitiesClassifiedAsOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1150 - Disclosure - Cash and cash equivalents -Summary of Cash flow Statements for Leases (Detail)",
     "menuCat": "Details",
     "order": "150",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail",
     "shortName": "Cash and cash equivalents -Summary of Cash flow Statements for Leases (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDetailedInformationOfTotalCashOutflowForLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:PaymentsOfLeaseLiabilitiesClassifiedAsOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R151": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashOutflowForLeases",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1151 - Disclosure - Cash and cash equivalents - Summary of Lease Rentals (Detail)",
     "menuCat": "Details",
     "order": "151",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfLeaseRentalsDetail",
     "shortName": "Cash and cash equivalents - Summary of Lease Rentals (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R152": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1152 - Disclosure - Time Deposits With Banks - Summary Of Time Deposits With Banks (Detail)",
     "menuCat": "Details",
     "order": "152",
     "role": "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail",
     "shortName": "Time Deposits With Banks - Summary Of Time Deposits With Banks (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:TimeDepositsWithBanksTableTextBlock",
       "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "shi:TimeDepositsWithBanks",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R153": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_BottomOfRangeMemberifrsfullRangeAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:BorrowingsInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1153 - Disclosure - Time Deposits With Banks - Additional Information (Details)",
     "menuCat": "Details",
     "order": "153",
     "role": "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails",
     "shortName": "Time Deposits With Banks - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_BottomOfRangeMemberifrsfullRangeAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "ifrs-full:BorrowingsInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R154": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_DiscountedBillsMemberSHIBillsOfExchangeAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:GrossUndiscountedCashFlowsDiscountedAndEndorsedBills",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1154 - Disclosure - Financial Assets At Fair Value Through Other Comprehensive Income - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "154",
     "role": "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail",
     "shortName": "Financial Assets At Fair Value Through Other Comprehensive Income - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_DiscountedBillsMemberSHIBillsOfExchangeAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:GrossUndiscountedCashFlowsDiscountedAndEndorsedBills",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R155": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1155 - Disclosure - Financial Assets At Fair Value Through Other Comprehensive Income - Summary Of Financial Assets at Fair Value Through Other Comprehensive Income (Detail)",
     "menuCat": "Details",
     "order": "155",
     "role": "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
     "shortName": "Financial Assets At Fair Value Through Other Comprehensive Income - Summary Of Financial Assets at Fair Value Through Other Comprehensive Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_AtFairValueMemberifrsfullMeasurementAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R156": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShorttermBorrowings",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1156 - Disclosure - Borrowings - Summary of Borrowings (Details)",
     "menuCat": "Details",
     "order": "156",
     "role": "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails",
     "shortName": "Borrowings - Summary of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R157": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1157 - Disclosure - Borrowings - Summary of Analysis of the Repayment Schedule of Borrowings (Details)",
     "menuCat": "Details",
     "order": "157",
     "role": "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
     "shortName": "Borrowings - Summary of Analysis of the Repayment Schedule of Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfRepaymentScheduleOfBorrowings",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R158": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:SecuredBankLoansReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1158 - Disclosure - Borrowings - Additional Information (Details)",
     "menuCat": "Details",
     "order": "158",
     "role": "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails",
     "shortName": "Borrowings - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:SecuredBankLoansReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R159": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1159 - Disclosure - Trade and Other Payables - Summary of Trade and Other Payables (Details)",
     "menuCat": "Details",
     "order": "159",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails",
     "shortName": "Trade and Other Payables - Summary of Trade and Other Payables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentDividendPayables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1016 - Disclosure - Employee Benefit Expenses",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://SinopecShanghai.com/role/EmployeeBenefitExpenses",
     "shortName": "Employee Benefit Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R160": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:TradePayablesBillsPayableAndAmountsDueToRelatedParties",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1160 - Disclosure - Trade and Other Payables - Summary of Aging Analysis of Trade Payables (Details)",
     "menuCat": "Details",
     "order": "160",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails",
     "shortName": "Trade and Other Payables - Summary of Aging Analysis of Trade Payables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMaturityAnalysisOfTradePayablesExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_NotLaterThanOneYearMemberifrsfullMaturityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:TradePayablesBillsPayableAndAmountsDueToRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R161": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentContractLiabilities",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1161 - Disclosure - Contract Liabilities (Details)",
     "menuCat": "Details",
     "order": "161",
     "role": "http://SinopecShanghai.com/role/ContractLiabilitiesDetails",
     "shortName": "Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ContractualAmountsToBeExchangedInDerivativeFinancialInstrumentForWhichGrossCashFlowsAreExchanged",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R162": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDeferredIncomeMovementExplanatory",
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1162 - Disclosure - Deferred Income (Details)",
     "menuCat": "Details",
     "order": "162",
     "role": "http://SinopecShanghai.com/role/DeferredIncomeDetails",
     "shortName": "Deferred Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDeferredIncomeMovementExplanatory",
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "shi:AdditionsToDeferredIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R163": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1163 - Disclosure - Share Capital (Details)",
     "menuCat": "Details",
     "order": "163",
     "role": "http://SinopecShanghai.com/role/ShareCapitalDetails",
     "shortName": "Share Capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:NumberOfSharesIssuedAndFullyPaid",
       "ifrs-full:NumberOfSharesIssuedAndFullyPaid",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_OrdinaryASharesListedInPRCMemberifrsfullComponentsOfEquityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssuedAndFullyPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R164": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodExplanatory",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "shi:StockSharesRepurchasedDuringThePeriodShares",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1164 - Disclosure - Share capital - Purchase of own shares (Details)",
     "menuCat": "Details",
     "order": "164",
     "role": "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails",
     "shortName": "Share capital - Purchase of own shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodExplanatory",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_OctoberTwoThousandAndTwentyTwoMemberSHIRepurchasePeriodAxis",
      "decimals": "0",
      "lang": null,
      "name": "shi:StockSharesRepurchasedDuringThePeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R165": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodExplanatory",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "shi:StockSharesRepurchasedDuringThePeriodShares",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1165 - Disclosure - Share capital - Additional Information (Details)",
     "menuCat": "Details",
     "order": "165",
     "role": "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails",
     "shortName": "Share capital - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_HSXASHIStockExchangeAxis",
      "decimals": "INF",
      "lang": null,
      "name": "shi:StockSharesRepurchasedDuringThePeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R166": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:Reserves",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1166 - Disclosure - Reserves (Details)",
     "menuCat": "Details",
     "order": "166",
     "role": "http://SinopecShanghai.com/role/ReservesDetails",
     "shortName": "Reserves (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfReserveExplanatory",
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_StatutoryReserveMemberifrsfullComponentsOfEquityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R167": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "shi:PercentageOfNetIncomeToBeTransferredToLegalSurplusReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1167 - Disclosure - Reserves - Additional Information (Details)",
     "menuCat": "Details",
     "order": "167",
     "role": "http://SinopecShanghai.com/role/ReservesAdditionalInformationDetails",
     "shortName": "Reserves - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "shi:PercentageOfNetIncomeToBeTransferredToLegalSurplusReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R168": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorRelatedParties",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ChinaInternationalUnitedPetroleumAndChemicalCompanyLimitedMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfNatureOfRelatedPartyRelationship",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1168 - Disclosure - Related-Party Transactions (List of Major Related Parties) (Details)",
     "menuCat": "Details",
     "order": "168",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails",
     "shortName": "Related-Party Transactions (List of Major Related Parties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfMajorRelatedParties",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ChinaInternationalUnitedPetroleumAndChemicalCompanyLimitedMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfNatureOfRelatedPartyRelationship",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R169": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfExpenseByNatureExplanatory",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FeeAndCommissionExpense",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1169 - Disclosure - Related-Party Transactions (Transactions between the Group and Sinopec Corp., Its Subsidiaries and Joint Ventures) (Details)",
     "menuCat": "Details",
     "order": "169",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails",
     "shortName": "Related-Party Transactions (Transactions between the Group and Sinopec Corp., Its Subsidiaries and Joint Ventures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfTransactionsWithUltimateParentCompanySubsidiariesAndJointVenturesOfUltimateParentCompany",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_SinopecCorpWithSubsidiariesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:RevenueFromSaleOfPetroleumAndPetrochemicalProducts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1017 - Disclosure - Income Tax Benefits /(Expenses)",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpenses",
     "shortName": "Income Tax Benefits /(Expenses)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R170": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1170 - Disclosure - Related-Party Transactions (Other Transactions between the Group and Sinopec Group and Its Subsidiaries, Associates and Joint Ventures of the Group) (Details)",
     "menuCat": "Details",
     "order": "170",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
     "shortName": "Related-Party Transactions (Other Transactions between the Group and Sinopec Group and Its Subsidiaries, Associates and Joint Ventures of the Group) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfOtherTransactionsWithAssociatesAndJointVenturesUltimateParentCompanySubsidiariesOfUltimateParentCompany",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_TheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:RevenueFromSalesOfGoodsAndServiceFeeRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R171": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1171 - Disclosure - Related-Party Transactions (Relevant Amounts Due from/to Related Parties) (Details)",
     "menuCat": "Details",
     "order": "171",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
     "shortName": "Related-Party Transactions (Relevant Amounts Due from/to Related Parties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfRelevantAmountsDueFromToRelatedParties",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_TheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:TradeAndOtherCurrentReceivablesDueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R172": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfKeyPersonnelCompensations",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1172 - Disclosure - Related-Party Transactions (Key Personnel Compensations) (Details)",
     "menuCat": "Details",
     "order": "172",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsKeyPersonnelCompensationsDetails",
     "shortName": "Related-Party Transactions (Key Personnel Compensations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfKeyPersonnelCompensations",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R173": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCommitmentsWithRelatedParties",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_SinopecGroupAndSubsidiariesMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:ConstructionAndInstallationCostCommitmentsRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1173 - Disclosure - Related-Party Transactions (Commitments with Related Parties) (Details)",
     "menuCat": "Details",
     "order": "173",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails",
     "shortName": "Related-Party Transactions (Commitments with Related Parties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCommitmentsWithRelatedParties",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_SinopecGroupAndSubsidiariesMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:ConstructionAndInstallationCostCommitmentsRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R174": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentCommitmentsWithRelatedParties",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:CapitalcontributiontoRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1174 - Disclosure - Related-Party Transactions (Investment Commitments with Related Parties) (Details)",
     "menuCat": "Details",
     "order": "174",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
     "shortName": "Related-Party Transactions (Investment Commitments with Related Parties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentCommitmentsWithRelatedParties",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:CapitalcontributiontoRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R175": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCapitalCommitmentsExplanatory",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ContractualCapitalCommitments",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1175 - Disclosure - Related-Party Transactions (Investment Commitments with Related Parties, Narrative) (Details)",
     "menuCat": "Details",
     "order": "175",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
     "shortName": "Related-Party Transactions (Investment Commitments with Related Parties, Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfInvestmentCommitmentsWithRelatedParties",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P12_31_2021To12_31_2021_ShanghaiPetrochemicalInvestmentDevelopmentCompanyLimitedMemberdeiLegalEntityAxis_ShanghaiShidianEnergyCompanyLimitedShidianEnergyMemberifrsfullSignificantInvestmentsInAssociatesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R176": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
       "ifrs-full:DisclosureOfDividendsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1176 - Disclosure - Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year (Details)",
     "menuCat": "Details",
     "order": "176",
     "role": "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToTheYearDetails",
     "shortName": "Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
       "ifrs-full:DisclosureOfDividendsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R177": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
       "ifrs-full:DisclosureOfDividendsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1177 - Disclosure - Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year (Parenthetical) (Details)",
     "menuCat": "Details",
     "order": "177",
     "role": "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToTheYearParentheticalDetails",
     "shortName": "Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year (Parenthetical) (Details)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
       "ifrs-full:DisclosureOfDividendsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY_per_Share",
      "xsiNil": "false"
     }
    },
    "R178": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureDetailsOfDividendToShareholdersApprovedInThePreviousYearAndPaidInTheCurrentYearTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1178 - Disclosure - Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year (Details)",
     "menuCat": "Details",
     "order": "178",
     "role": "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToThePreviousFinancialYearDetails",
     "shortName": "Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R179": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureDetailsOfDividendToShareholdersApprovedInThePreviousYearAndPaidInTheCurrentYearTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1179 - Disclosure - Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year (Parenthetical) (Details)",
     "menuCat": "Details",
     "order": "179",
     "role": "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToThePreviousFinancialYearParentheticalDetails",
     "shortName": "Dividend - Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year (Parenthetical) (Details)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureDetailsOfDividendToShareholdersApprovedInThePreviousYearAndPaidInTheCurrentYearTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY_per_Share",
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1018 - Disclosure - Earnings/(losses) Per Share",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://SinopecShanghai.com/role/EarningsLossesPerShare",
     "shortName": "Earnings/(losses) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R180": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfCapitalCommitmentsExplanatory",
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ContractualCapitalCommitments",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1180 - Disclosure - Commitments (Capital Commitments) (Details)",
     "menuCat": "Details",
     "order": "180",
     "role": "http://SinopecShanghai.com/role/CommitmentsCapitalCommitmentsDetails",
     "shortName": "Commitments (Capital Commitments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R181": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1181 - Disclosure - Statements of Financial Position and Equity Movement of the Company (Balance Sheet) (Details)",
     "menuCat": "Details",
     "order": "181",
     "role": "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
     "shortName": "Statements of Financial Position and Equity Movement of the Company (Balance Sheet) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfBalanceSheetOfParentCompanyOnlyExplanatory",
       "shi:DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_ParentMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R182": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:Reserves",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1182 - Disclosure - Statements of Financial Position and Equity Movement of the Company (Reserve Movement) (Details)",
     "menuCat": "Details",
     "order": "182",
     "role": "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails",
     "shortName": "Statements of Financial Position and Equity Movement of the Company (Reserve Movement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfReserveMovementOfParentCompanyOnlyExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_ClassesOfShareCapitalMemberifrsfullComponentsOfEquityAxis_ParentMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:IncreaseDecreaseThroughUtilisationOfSafetyProductionFund",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R183": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentValueAddedTaxReceivables",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1183 - Disclosure - Comparative figures - Additional Information (Details)",
     "menuCat": "Details",
     "order": "183",
     "role": "http://SinopecShanghai.com/role/ComparativeFiguresAdditionalInformationDetails",
     "shortName": "Comparative figures - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R184": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfPossibleImpactOfAmendmentsOfNewAccountingStandardsAndIssuedButNotYetEffective",
       "shi:PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_IfrsSeventeenInsuranceContractsMemberSHIReportingStandardDetailsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:EffectiveDateFromWhichReportingStandardIsApplicable",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1184 - Disclosure - Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022 - Summary of Number of Amendments, New Standards and Interpretations Which are Not Yet Effective (Detail)",
     "menuCat": "Details",
     "order": "184",
     "role": "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail",
     "shortName": "Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022 - Summary of Number of Amendments, New Standards and Interpretations Which are Not Yet Effective (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfPossibleImpactOfAmendmentsOfNewAccountingStandardsAndIssuedButNotYetEffective",
       "shi:PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_IfrsSeventeenInsuranceContractsMemberSHIReportingStandardDetailsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:EffectiveDateFromWhichReportingStandardIsApplicable",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1019 - Disclosure - Other Non-current Assets",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://SinopecShanghai.com/role/OtherNonCurrentAssets",
     "shortName": "Other Non-current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002 - Statement - Consolidated statements of profit or loss and other comprehensive income",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
     "shortName": "Consolidated statements of profit or loss and other comprehensive income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:TaxExpenseOtherThanIncomeTaxExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1020 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://SinopecShanghai.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1021 - Disclosure - Property, Plant and Equipment",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://SinopecShanghai.com/role/PropertyPlantAndEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1022 - Disclosure - Investment Properties",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://SinopecShanghai.com/role/InvestmentProperties",
     "shortName": "Investment Properties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentPropertyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:ConstructionInProgressExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1023 - Disclosure - Construction in Progress",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://SinopecShanghai.com/role/ConstructionInProgress",
     "shortName": "Construction in Progress",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:ConstructionInProgressExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1024 - Disclosure - Subsidiaries",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://SinopecShanghai.com/role/Subsidiaries",
     "shortName": "Subsidiaries",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1025 - Disclosure - Investments Accounted for Using the Equity Method",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethod",
     "shortName": "Investments Accounted for Using the Equity Method",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1026 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://SinopecShanghai.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1027 - Disclosure - Trade And Other Receivables",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherReceivables",
     "shortName": "Trade And Other Receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1028 - Disclosure - Cash and cash equivalents",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalents",
     "shortName": "Cash and cash equivalents",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1029 - Disclosure - Time Deposits With Banks",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://SinopecShanghai.com/role/TimeDepositsWithBanks",
     "shortName": "Time Deposits With Banks",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003 - Statement - Consolidated statements of financial position",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
     "shortName": "Consolidated statements of financial position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:DeferredTaxAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1030 - Disclosure - Financial Assets at Fair Value Through Other Comprehensive Income",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "shortName": "Financial Assets at Fair Value Through Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1031 - Disclosure - Borrowings",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://SinopecShanghai.com/role/Borrowings",
     "shortName": "Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1032 - Disclosure - Trade and Other Payables",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherPayables",
     "shortName": "Trade and Other Payables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1033 - Disclosure - Contract Liabilities",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://SinopecShanghai.com/role/ContractLiabilities",
     "shortName": "Contract Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1034 - Disclosure - Deferred Income",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://SinopecShanghai.com/role/DeferredIncome",
     "shortName": "Deferred Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1035 - Disclosure - Share Capital",
     "menuCat": "Notes",
     "order": "35",
     "role": "http://SinopecShanghai.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1036 - Disclosure - Reserves",
     "menuCat": "Notes",
     "order": "36",
     "role": "http://SinopecShanghai.com/role/Reserves",
     "shortName": "Reserves",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1037 - Disclosure - Related-Party Transactions",
     "menuCat": "Notes",
     "order": "37",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactions",
     "shortName": "Related-Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDividendsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1038 - Disclosure - Dividend",
     "menuCat": "Notes",
     "order": "38",
     "role": "http://SinopecShanghai.com/role/Dividend",
     "shortName": "Dividend",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDividendsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1039 - Disclosure - Commitments",
     "menuCat": "Notes",
     "order": "39",
     "role": "http://SinopecShanghai.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2019",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004 - Statement - Consolidated Statements of Changes in Equity",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2019_IssuedCapitalMemberifrsfullComponentsOfEquityAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1040 - Disclosure - Statements of Financial Position and Equity Movement of the Company",
     "menuCat": "Notes",
     "order": "40",
     "role": "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompany",
     "shortName": "Statements of Financial Position and Equity Movement of the Company",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfComparativeInformationPreparedUnderPreviousGAAPExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1041 - Disclosure - Comparative Figures",
     "menuCat": "Notes",
     "order": "41",
     "role": "http://SinopecShanghai.com/role/ComparativeFigures",
     "shortName": "Comparative Figures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfComparativeInformationPreparedUnderPreviousGAAPExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1042 - Disclosure - Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022",
     "menuCat": "Notes",
     "order": "42",
     "role": "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022",
     "shortName": "Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1043 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "43",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1044 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1045 - Disclosure - Financial Risk Management (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementTables",
     "shortName": "Financial Risk Management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1046 - Disclosure - Segment Information and Revenue (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueTables",
     "shortName": "Segment Information and Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfOtherOperatingIncomeComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1047 - Disclosure - Other Operating Income (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://SinopecShanghai.com/role/OtherOperatingIncomeTables",
     "shortName": "Other Operating Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfOtherOperatingIncomeComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfOtherOperatingExpenseComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1048 - Disclosure - Other Operating Expenses (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://SinopecShanghai.com/role/OtherOperatingExpensesTables",
     "shortName": "Other Operating Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfOtherOperatingExpenseComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "shi:DisclosureOfNetOtherGainsLossesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfNetOtherGainsComponentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1049 - Disclosure - Other gains(losses) - net (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://SinopecShanghai.com/role/OtherGainsLossesNetTables",
     "shortName": "Other gains(losses) - net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "shi:DisclosureOfNetOtherGainsLossesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfNetOtherGainsComponentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashFlowsFromUsedInOperations",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005 - Statement - Consolidated Statements of Cash Flow",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow",
     "shortName": "Consolidated Statements of Cash Flow",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:InterestPaidClassifiedAsOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfFinanceIncomeAndExpensesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1050 - Disclosure - Finance Income and Expenses (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesTables",
     "shortName": "Finance Income and Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfFinanceIncomeAndExpensesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfExpenseByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1051 - Disclosure - Expense by Nature (Tables)",
     "menuCat": "Tables",
     "order": "51",
     "role": "http://SinopecShanghai.com/role/ExpenseByNatureTables",
     "shortName": "Expense by Nature (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfExpenseByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfEmployeeBenefitExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1052 - Disclosure - Employee Benefit Expenses  (Tables)",
     "menuCat": "Tables",
     "order": "52",
     "role": "http://SinopecShanghai.com/role/EmployeeBenefitExpensesTables",
     "shortName": "Employee Benefit Expenses  (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfEmployeeBenefitExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfMajorComponentsOfIncomeTaxExpenseIncomeExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1053 - Disclosure - Income Tax Benefits /(Expenses) (Tables)",
     "menuCat": "Tables",
     "order": "53",
     "role": "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesTables",
     "shortName": "Income Tax Benefits /(Expenses) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfMajorComponentsOfIncomeTaxExpenseIncomeExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfEarningsPerShareBasicExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1054 - Disclosure - Earnings/(losses) Per Share (Tables)",
     "menuCat": "Tables",
     "order": "54",
     "role": "http://SinopecShanghai.com/role/EarningsLossesPerShareTables",
     "shortName": "Earnings/(losses) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfEarningsPerShareBasicExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfOtherAssetsNoncurrentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1055 - Disclosure - Other Non-current Assets (Tables)",
     "menuCat": "Tables",
     "order": "55",
     "role": "http://SinopecShanghai.com/role/OtherNonCurrentAssetsTables",
     "shortName": "Other Non-current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfOtherAssetsNoncurrentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfBalanceSheetAmountsRelatedToLeasesExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1056 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "56",
     "role": "http://SinopecShanghai.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfBalanceSheetAmountsRelatedToLeasesExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1057 - Disclosure - Property, Plant and Equipment (Tables)",
     "menuCat": "Tables",
     "order": "57",
     "role": "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentPropertyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1058 - Disclosure - Investment Properties (Tables)",
     "menuCat": "Tables",
     "order": "58",
     "role": "http://SinopecShanghai.com/role/InvestmentPropertiesTables",
     "shortName": "Investment Properties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentPropertyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "shi:ConstructionInProgressExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfConstructionInProgressExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1059 - Disclosure - Construction in Progress (Tables)",
     "menuCat": "Tables",
     "order": "59",
     "role": "http://SinopecShanghai.com/role/ConstructionInProgressTables",
     "shortName": "Construction in Progress (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "shi:ConstructionInProgressExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfConstructionInProgressExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1006 - Disclosure - General Information",
     "menuCat": "Notes",
     "order": "6",
     "role": "http://SinopecShanghai.com/role/GeneralInformation",
     "shortName": "General Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfMajorSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1060 - Disclosure - Subsidiaries (Tables)",
     "menuCat": "Tables",
     "order": "60",
     "role": "http://SinopecShanghai.com/role/SubsidiariesTables",
     "shortName": "Subsidiaries (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfMajorSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInBalanceSheetExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1061 - Disclosure - Investments Accounted for Using the Equity Method (Tables)",
     "menuCat": "Tables",
     "order": "61",
     "role": "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables",
     "shortName": "Investments Accounted for Using the Equity Method (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInBalanceSheetExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfInventoriesComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1062 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "62",
     "role": "http://SinopecShanghai.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfInventoriesComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1063 - Disclosure - Trade And Other Receivables (Tables)",
     "menuCat": "Tables",
     "order": "63",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherReceivablesTables",
     "shortName": "Trade And Other Receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfCashAndCashEquivalentsComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1064 - Disclosure - Cash and cash equivalents (Tables)",
     "menuCat": "Tables",
     "order": "64",
     "role": "http://SinopecShanghai.com/role/CashAndCashEquivalentsTables",
     "shortName": "Cash and cash equivalents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfCashAndCashEquivalentsComponentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:TimeDepositsWithBanksTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1065 - Disclosure - Time Deposits With Banks (Tables)",
     "menuCat": "Tables",
     "order": "65",
     "role": "http://SinopecShanghai.com/role/TimeDepositsWithBanksTables",
     "shortName": "Time Deposits With Banks (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "shi:DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:TimeDepositsWithBanksTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1066 - Disclosure - Financial Assets At Fair Value Through Other Comprehensive Income (Tables)",
     "menuCat": "Tables",
     "order": "66",
     "role": "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeTables",
     "shortName": "Financial Assets At Fair Value Through Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1067 - Disclosure - Borrowings (Tables)",
     "menuCat": "Tables",
     "order": "67",
     "role": "http://SinopecShanghai.com/role/BorrowingsTables",
     "shortName": "Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1068 - Disclosure - Trade and Other Payables (Tables)",
     "menuCat": "Tables",
     "order": "68",
     "role": "http://SinopecShanghai.com/role/TradeAndOtherPayablesTables",
     "shortName": "Trade and Other Payables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfDetailedInformationAboutContractsLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1069 - Disclosure - Contract Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "69",
     "role": "http://SinopecShanghai.com/role/ContractLiabilitiesTables",
     "shortName": "Contract Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfDetailedInformationAboutContractsLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1007 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfDeferredIncomeMovementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1070 - Disclosure - Deferred Income (Tables)",
     "menuCat": "Tables",
     "order": "70",
     "role": "http://SinopecShanghai.com/role/DeferredIncomeTables",
     "shortName": "Deferred Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfDeferredIncomeExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfDeferredIncomeMovementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1071 - Disclosure - Share Capital (Tables)",
     "menuCat": "Tables",
     "order": "71",
     "role": "http://SinopecShanghai.com/role/ShareCapitalTables",
     "shortName": "Share Capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfShareCapitalExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfReserveExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1072 - Disclosure - Reserves (Tables)",
     "menuCat": "Tables",
     "order": "72",
     "role": "http://SinopecShanghai.com/role/ReservesTables",
     "shortName": "Reserves (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfReserveExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfMajorRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1073 - Disclosure - Related-Party Transactions (Tables)",
     "menuCat": "Tables",
     "order": "73",
     "role": "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables",
     "shortName": "Related-Party Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfMajorRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfDividendsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1074 - Disclosure - Dividend (Tables)",
     "menuCat": "Tables",
     "order": "74",
     "role": "http://SinopecShanghai.com/role/DividendTables",
     "shortName": "Dividend (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfDividendsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfCapitalCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1075 - Disclosure - Commitments (Tables)",
     "menuCat": "Tables",
     "order": "75",
     "role": "http://SinopecShanghai.com/role/CommitmentsTables",
     "shortName": "Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCommitmentsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfCapitalCommitmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "shi:DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfBalanceSheetOfParentCompanyOnlyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1076 - Disclosure - Statements of Financial Position and Equity Movement of the Company (Tables)",
     "menuCat": "Tables",
     "order": "76",
     "role": "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyTables",
     "shortName": "Statements of Financial Position and Equity Movement of the Company (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "shi:DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureOfBalanceSheetOfParentCompanyOnlyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "shi:PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureInTabularFormOfPossibleImpactOfAmendmentsOfNewAccountingStandardsAndIssuedButNotYetEffective",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1077 - Disclosure - Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022 (Tables)",
     "menuCat": "Tables",
     "order": "77",
     "role": "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022Tables",
     "shortName": "Possible Impact of Amendments, New Standards and Interpretations Issued But Not Yet Effective for the Year Ended 31 December 2022 (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "shi:PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DisclosureInTabularFormOfPossibleImpactOfAmendmentsOfNewAccountingStandardsAndIssuedButNotYetEffective",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn01_12_2018",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:RegisteredCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1078 - Disclosure - General Information (Reorganisation) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
     "shortName": "General Information (Reorganisation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn01_12_2018",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:RegisteredCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureInTabularFormOfWeightedAverageNumberOfSharesBasicExplanatory",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1079 - Disclosure - General Information (The Fifteenth Meeting of the Seventh Term of Board of Directors) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails",
     "shortName": "General Information (The Fifteenth Meeting of the Seventh Term of Board of Directors) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_ParentMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1008 - Disclosure - Financial Risk Management",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagement",
     "shortName": "Financial Risk Management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_BuildingsMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1080 - Disclosure - Summary of Significant Accounting Policies (Property, Plant and Equipment) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies (Property, Plant and Equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_BuildingsMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfUsefulLifeInvestmentPropertyCostModel",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1081 - Disclosure - Summary of Significant Accounting Policies (Investment Properties) (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesInvestmentPropertiesDetails",
     "shortName": "Summary of Significant Accounting Policies (Investment Properties) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfUsefulLifeInvestmentPropertyCostModel",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEstimatedUsefulLivesOfOtherNonCurrentAssets",
       "shi:DescriptionOfAccountingPolicyForOtherNonCurrentAssetsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_IntangibleAssetsOtherThanGoodwillMemberifrsfullClassesOfAssetsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:UsefulLivesOrAmortisationRatesOtherNonCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1082 - Disclosure - Summary of Significant Accounting Policies (Other Non-current Assets) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails",
     "shortName": "Summary of Significant Accounting Policies (Other Non-current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEstimatedUsefulLivesOfOtherNonCurrentAssets",
       "shi:DescriptionOfAccountingPolicyForOtherNonCurrentAssetsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_IntangibleAssetsOtherThanGoodwillMemberifrsfullClassesOfAssetsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:UsefulLivesOrAmortisationRatesOtherNonCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEstimatedUsefulLivesOfOtherNonCurrentAssets",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_LandUseRightsMemberifrsfullClassesOfAssetsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DescriptionOfUsefulLivesRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1083 - Disclosure - Summary of Significant Accounting Policies (Leases) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails",
     "shortName": "Summary of Significant Accounting Policies (Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "shi:DisclosureOfEstimatedUsefulLivesOfOtherNonCurrentAssets",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_LandUseRightsMemberifrsfullClassesOfAssetsAxis",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "shi:DescriptionOfUsefulLivesRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1084 - Disclosure - Financial Risk Management (Financial Risk Factors, Narrative) (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "2",
      "lang": null,
      "name": "shi:IncreaseDecreasePercentageInMarketPriceOfCrudeOil",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentDerivativeFinancialAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1085 - Disclosure - Financial Risk Management (Financial Risk Factors, Derivatives, Derivative Financial Instruments) (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Derivatives, Derivative Financial Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_CurrentDerivativeFinancialInstrumentAssetsMemberifrsfullClassesOfFinancialInstrumentsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:DerivativeFinancialAssetsHeldForHedging",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfHedgingInstrumentsExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021_SwapContractMemberifrsfullClassesOfFinancialAssetsAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:HedgingInstrumentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1086 - Disclosure - Financial Risk Management (Reconciliation of Hedging Reserve in Respect of Commodity Price Risk and Effectiveness of Hedging Relationships) (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails",
     "shortName": "Financial Risk Management (Reconciliation of Hedging Reserve in Respect of Commodity Price Risk and Effectiveness of Hedging Relationships) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfHedgingInstrumentsExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021_SwapContractMemberifrsfullClassesOfFinancialAssetsAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:HedgingInstrumentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfHedgingReservesExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1087 - Disclosure - Financial Risk Management (Financial Risk Factors, Derivatives, Reconciliation of Hedging Reserves in Statement of Profit or Loss) (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Derivatives, Reconciliation of Hedging Reserves in Statement of Profit or Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfHedgingReservesExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_CommoditySwapContractsMemberifrsfullClassesOfFinancialAssetsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfForeignExchangeGainsLossesExplanatoryTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInOtherGains",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1088 - Disclosure - Financial Risk Management (Financial Risk Factors, Foreign Exchange Risk , Foreign Exchange Risk) (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsForeignExchangeRiskForeignExchangeRiskDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Foreign Exchange Risk , Foreign Exchange Risk) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1089 - Disclosure - Financial Risk Management (Financial Risk Factors, Schedule of Interest Rate Financial Instruments) (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Schedule of Interest Rate Financial Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_FixedInterestRateMemberifrsfullTypesOfInterestRatesAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1009 - Disclosure - Critical accounting judgement and estimates",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://SinopecShanghai.com/role/CriticalAccountingJudgementAndEstimates",
     "shortName": "Critical accounting judgement and estimates",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:ImpairmentLossesMovementInLossAllowanceForTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1090 - Disclosure - Financial Risk Management (Financial Risk Factors, Net Provision of Impairment Losses on Financial Assets Recognized in Income Statement) (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Net Provision of Impairment Losses on Financial Assets Recognized in Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "shi:ImpairmentLossesMovementInLossAllowanceForTradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ifrs-full:DisclosureOfBorrowingsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1091 - Disclosure - Financial Risk Management (Financial Risk Factors, Maturity Analysis for Financial Liabilities) (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
     "shortName": "Financial Risk Management (Financial Risk Factors, Maturity Analysis for Financial Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_LiquidityRiskMemberifrsfullTypesOfRisksAxis_UndiscountedCashFlowMemberifrsfullMeasurementAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Borrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShorttermBorrowings",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1092 - Disclosure - Financial Risk Management (Schedule of Detailed Information of Adjusted Net Debt to Capital Ratio Explanatory) (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails",
     "shortName": "Financial Risk Management (Schedule of Detailed Information of Adjusted Net Debt to Capital Ratio Explanatory) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentFinancialLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1093 - Disclosure - Financial Risk Management (Fair Value Estimation, Recurring Fair Value Measurements) (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
     "shortName": "Financial Risk Management (Fair Value Estimation, Recurring Fair Value Measurements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_RecurringFairValueMeasurementMemberifrsfullMeasurementAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfChangesInLevelThreeItemsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2021_Level3OfFairValueHierarchyMemberifrsfullLevelsOfFairValueHierarchyAxis",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1094 - Disclosure - Financial Risk Management (Fair Value Estimation, Changes in level 3 items) (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
     "shortName": "Financial Risk Management (Fair Value Estimation, Changes in level 3 items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "shi:DisclosureOfChangesInLevelThreeItemsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_Level3OfFairValueHierarchyMemberifrsfullLevelsOfFairValueHierarchyAxis",
      "decimals": "-3",
      "lang": null,
      "name": "shi:IncreaseDecreaseOfFinancialAssetsDueToAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1095 - Disclosure - Segment information and revenue (Revenue) (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
     "shortName": "Segment information and revenue (Revenue) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022_RevenueRecognizedAtAPointInTimeMemberSHITimingOfRevenueRecognitionAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossFromOperatingActivities",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1096 - Disclosure - Segment information and revenue (Segment Result - Profit/(Loss) from Operations) (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails",
     "shortName": "Segment information and revenue (Segment Result - Profit/(Loss) from Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DepreciationAndAmortisationExpense",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1097 - Disclosure - Segment information and revenue (Other Profit and Loss Disclosures) (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
     "shortName": "Segment information and revenue (Other Profit and Loss Disclosures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "P01_01_2022To12_31_2022",
      "decimals": "-3",
      "lang": null,
      "name": "shi:ImpairmentLossIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1098 - Disclosure - Segment information and revenue (Assets) (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
     "shortName": "Segment information and revenue (Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ShorttermBorrowings",
      "reportCount": 1,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1099 - Disclosure - Segment information and revenue (Liabilities) (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
     "shortName": "Segment information and revenue (Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d474415d20f.htm",
      "contextRef": "PAsOn12_31_2022_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:OtherLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_CNY",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 298,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AdrMember": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Receipt (or American Depositary Share, ADS).",
        "label": "ADR [Member]",
        "terseLabel": "American Depositary Shares [member]"
       }
      }
     },
     "localname": "AdrMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelFaxNumber": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fax Number of contact personnel.",
        "label": "Contact Personnel Fax Number"
       }
      }
     },
     "localname": "ContactPersonnelFaxNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [member]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal entity [axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "exch_HSXA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HSBC-X HONG KONG [Member]"
       }
      }
     },
     "localname": "HSXA",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AccrualsAndDeferredIncomeIncludingContractLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accruals and deferred income including contract liabilities [abstract]",
        "verboseLabel": "Deferred income [abstract]"
       }
      }
     },
     "localname": "AccrualsAndDeferredIncomeIncludingContractLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "auth_ref": [
      "r77",
      "r367",
      "r375",
      "r378",
      "r379"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]",
        "terseLabel": "Accumulated amortization [member]",
        "verboseLabel": "Accumulated depreciation [member]"
       }
      }
     },
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AccumulatedImpairmentMember": {
     "auth_ref": [
      "r205",
      "r220",
      "r316",
      "r336",
      "r340",
      "r367",
      "r375",
      "r378",
      "r379"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated impairment [member]",
        "verboseLabel": "Impairment losses [member]"
       }
      }
     },
     "localname": "AccumulatedImpairmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "verboseLabel": "Purchase consideration"
       }
      }
     },
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsToNoncurrentAssets": {
     "auth_ref": [
      "r247",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Financial instruments, class [member]; Non-current assets; Types of insurance contracts [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions to non-current assets other than financial instruments, deferred tax assets, net defined benefit assets, and rights arising under insurance contracts",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsToNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions to right-of-use assets",
        "terseLabel": "Additions to right-of-use assets"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForAmortisationExpense": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for amortisation expense",
        "verboseLabel": "Amortization of other non-current assets"
       }
      }
     },
     "localname": "AdjustmentsForAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForAmountsTransferredToInitialCarryingAmountOfHedgedItems": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts removed from equity and included in the initial cost or other carrying amount of a non-financial asset (liability) whose acquisition or incurrence was a hedged, highly probable forecast transaction, net of tax. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts removed from equity and included in carrying amount of non-financial asset (liability) whose acquisition or incurrence was hedged highly probable forecast transaction, net of tax",
        "negatedLabel": "Amounts transferred from hedging reserve to initial carrying amount of hedged items"
       }
      }
     },
     "localname": "AdjustmentsForAmountsTransferredToInitialCarryingAmountOfHedgedItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments of tax expense (income) recognised in the period for current tax of prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for current tax of prior periods",
        "negatedLabel": "True up for final settlement of enterprise income taxes in respect of previous years"
       }
      }
     },
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "verboseLabel": "Decrease/(increase) in inventories"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade and other receivables",
        "verboseLabel": "Decrease in operation receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment",
        "negatedLabel": "Losses / (gains) on disposal of property, plant and equipment and other long-term assets-net"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gains (losses) on changes in the fair value of derivatives to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: At fair value [member]; Derivatives [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gains (losses) on change in fair value of derivatives",
        "negatedLabel": "Net losses/(gains) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges",
        "verboseLabel": "Net gains/(losses) on foreign exchange option contracts and commodity swaps contracts not qualifying as hedges"
       }
      }
     },
     "localname": "AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment",
        "terseLabel": "Impairment loss on property, plant and equipment"
       }
      }
     },
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "terseLabel": "Decrease in operation payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForInterestExpense": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "AdjustmentsForInterestExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustment items:"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for undistributed profits of investments accounted for using the equity method to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Investments accounted for using equity method; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for undistributed profits of investments accounted for using equity method",
        "negatedTerseLabel": "Share of (profits)/losses of investments accounted for using the equity method"
       }
      }
     },
     "localname": "AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "auth_ref": [
      "r308",
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for unrealised foreign exchange losses (gains)",
        "terseLabel": "Foreign exchange losses/(gains)"
       }
      }
     },
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember": {
     "auth_ref": [
      "r160",
      "r274",
      "r279"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the aggregation of associates that are individually immaterial. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated individually immaterial associates [member]",
        "terseLabel": "Other associates [member]"
       }
      }
     },
     "localname": "AggregatedIndividuallyImmaterialAssociatesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AggregatedMeasurementMember": {
     "auth_ref": [
      "r121",
      "r129",
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated measurement [member]"
       }
      }
     },
     "localname": "AggregatedMeasurementMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r28",
      "r186",
      "r198",
      "r199",
      "r210",
      "r260",
      "r261",
      "r263",
      "r269",
      "r297",
      "r318",
      "r323"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails",
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "auth_ref": [
      "r79",
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "All levels of fair value hierarchy [member]"
       }
      }
     },
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllOtherSegmentsMember": {
     "auth_ref": [
      "r185",
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for business activities and operating segments that are not reportable."
       }
      },
      "en-us": {
       "role": {
        "label": "All other segments [member]",
        "terseLabel": "Others [member]",
        "verboseLabel": "Other Segments [member]"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Allowance account for credit losses of financial assets",
        "negatedLabel": "Less: loss allowance",
        "periodEndLabel": "Balance at 31 December",
        "periodStartLabel": "Balance at 1 January"
       }
      }
     },
     "localname": "AllowanceAccountForCreditLossesOfFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryDetail",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmortisationExpense": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation expense",
        "negatedLabel": "Charge for the year"
       }
      }
     },
     "localname": "AmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "PRC income tax rate"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r24",
      "r179",
      "r180",
      "r181",
      "r245",
      "r250"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssetsAndLiabilitiesAxis": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets and liabilities [axis]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssetsAndLiabilitiesMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Assets and liabilities [member]",
        "verboseLabel": "Deferred tax assets and liabilities [member]"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AssetsLessCurrentLiabilities": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of current liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets less current liabilities",
        "terseLabel": "Total assets less current liabilities"
       }
      }
     },
     "localname": "AssetsLessCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssociatesMember": {
     "auth_ref": [
      "r94",
      "r103",
      "r106",
      "r178",
      "r273",
      "r278"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entities over which the investor has significant influence."
       }
      },
      "en-us": {
       "role": {
        "label": "Associates [member]"
       }
      }
     },
     "localname": "AssociatesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AtFairValueMember": {
     "auth_ref": [
      "r121",
      "r129",
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      },
      "en-us": {
       "role": {
        "label": "At fair value [member]",
        "terseLabel": "Fair value [member]"
       }
      }
     },
     "localname": "AtFairValueMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AuditorsRemunerationForAuditServices": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for auditing services."
       }
      },
      "en-us": {
       "role": {
        "label": "Auditor's remuneration for audit services",
        "terseLabel": "Auditors' remuneration - audit services"
       }
      }
     },
     "localname": "AuditorsRemunerationForAuditServices",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AuditorsRemunerationForOtherServices": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable to the entity's auditors for services that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Auditor's remuneration for other services",
        "terseLabel": "Auditors' remuneration \u2013\u00a0non-audit\u00a0services"
       }
      }
     },
     "localname": "AuditorsRemunerationForOtherServices",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r107",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic earnings/(losses) per share",
        "verboseLabel": "Basic earnings/(losses) per share (RMB per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/EarningsLossesPerShareSummaryOfEarningsLossesPerShareBasicDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per share [abstract]"
       }
      }
     },
     "localname": "BasicEarningsPerShareAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingCostsCapitalised": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowing costs capitalised",
        "terseLabel": "Capitalized borrowing costs"
       }
      }
     },
     "localname": "BorrowingCostsCapitalised",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Borrowings": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings",
        "negatedLabel": "Borrowings",
        "terseLabel": "Borrowings",
        "totalLabel": "Borrowings"
       }
      }
     },
     "localname": "Borrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings [abstract]"
       }
      }
     },
     "localname": "BorrowingsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      }
     },
     "localname": "BorrowingsByNameAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameMember": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [member]"
       }
      }
     },
     "localname": "BorrowingsByNameMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BorrowingsInterestRate": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings, interest rate",
        "terseLabel": "Interest rate on time deposits with banks",
        "verboseLabel": "Weighted average interest rate for the Group's borrowings"
       }
      }
     },
     "localname": "BorrowingsInterestRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r183",
      "r202",
      "r263",
      "r312",
      "r313",
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "terseLabel": "Buildings [member]"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CapitalReserveMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing capital reserves."
       }
      },
      "en-us": {
       "role": {
        "label": "Capital reserve [member]",
        "terseLabel": "Capital surplus [member]"
       }
      }
     },
     "localname": "CapitalReserveMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average of interest and other costs that an entity incurs in connection with the borrowing of funds applicable to the borrowings of the entity that are outstanding during the period, other than borrowings made specifically for the purpose of obtaining a qualifying asset. [Refer: Weighted average [member]; Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Capitalisation rate of borrowing costs eligible for capitalisation",
        "terseLabel": "Weighted average rate of capitalized borrowing costs"
       }
      }
     },
     "localname": "CapitalisationRateOfBorrowingCostsEligibleForCapitalisation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r68",
      "r74",
      "r118",
      "r119",
      "r123",
      "r125",
      "r127",
      "r129",
      "r130",
      "r205",
      "r220",
      "r221",
      "r390",
      "r392"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/InventoriesDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r74",
      "r119",
      "r123",
      "r127",
      "r129",
      "r205",
      "r220",
      "r221",
      "r336",
      "r339"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount [member]",
        "terseLabel": "Net book amount [member]"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/InventoriesDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Cash": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash",
        "terseLabel": "Cash at bank and on hand"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsCashAndCashEquivalentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r18",
      "r139",
      "r169"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 40.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "negatedLabel": "Less: Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of the year",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the year",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents in the consolidated statements of financial position",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsCashAndCashEquivalentsDetail",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r131",
      "r141"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 28.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash generated from / (used in) financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r131",
      "r141"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash (used in) / generated from investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r131",
      "r141"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 24.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash generated from / (used in) operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "auth_ref": [
      "r305",
      "r308"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 27.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations",
        "terseLabel": "Cash generated from / (used in) operations",
        "totalLabel": "Cash generated from/(used in) operations"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": {
     "auth_ref": [
      "r308",
      "r384"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations before changes in working capital",
        "totalLabel": "Profit/(loss) on operation before change of working capital"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashOutflowForLeases": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash outflow for leases",
        "negatedLabel": "Lease rentals paid",
        "negatedTotalLabel": "Total",
        "terseLabel": "Total cash outflow for leases"
       }
      }
     },
     "localname": "CashOutflowForLeases",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail",
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfLeaseRentalsDetail",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInExposureToRisk": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of changes in the exposure to risks arising from financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of changes in exposure to risk",
        "terseLabel": "Description of change in foreign exchange risk/interest rate risk with all other variables held constant"
       }
      }
     },
     "localname": "ChangesInExposureToRisk",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress": {
     "auth_ref": [
      "r55",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in inventories of finished goods and work in progress. [Refer: Inventories; Current finished goods; Current work in progress]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in inventories of finished goods and work in progress",
        "terseLabel": "Changes of work in progress and finished goods"
       }
      }
     },
     "localname": "ChangesInInventoriesOfFinishedGoodsAndWorkInProgress",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r111",
      "r114",
      "r182",
      "r196"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails",
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r111",
      "r182",
      "r196"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails",
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of employee benefits expense [abstract]"
       }
      }
     },
     "localname": "ClassesOfEmployeeBenefitsExpenseAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r228",
      "r229",
      "r259",
      "r270",
      "r271",
      "r272"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "auth_ref": [
      "r220",
      "r222",
      "r224",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]",
        "verboseLabel": "Current derivative financial instrument [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "auth_ref": [
      "r220",
      "r222",
      "r224",
      "r225"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments, class [member]",
        "verboseLabel": "Current derivative financial instrument [member]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of current inventories [abstract]"
       }
      }
     },
     "localname": "ClassesOfInventoriesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital [member]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/ShareCapitalDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r2",
      "r39",
      "r146",
      "r149",
      "r165",
      "r311"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeAlternate1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Total comprehensive income for the year",
        "label": "Comprehensive income",
        "terseLabel": "Total comprehensive income",
        "totalLabel": "Total comprehensive income for the year",
        "verboseLabel": "Total comprehensive income for the year"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income attributable to [abstract]",
        "verboseLabel": "Attributable to:"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r2",
      "r42"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeAlternate1": {
       "order": 23.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r2",
      "r43"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeAlternate1": {
       "order": 22.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "terseLabel": "Equity shareholders of the Company",
        "verboseLabel": "Total comprehensive income for the year attributable to shareholders of the Company"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/ReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ConstructionInProgress": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 26.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure capitalised during the construction of non-current assets that are not yet available for use. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Construction in progress",
        "periodEndLabel": "As at 31 December",
        "periodStartLabel": "As at 1 January",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgress",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ConstructionInProgressMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Construction in progress [member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContractLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities [abstract]"
       }
      }
     },
     "localname": "ContractLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ContractualAmountsToBeExchangedInDerivativeFinancialInstrumentForWhichGrossCashFlowsAreExchanged": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to contractual amounts to be exchanged in a derivative financial instrument for which gross cash flows are exchanged. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contractual amounts to be exchanged in derivative financial instrument for which gross cash flows are exchanged",
        "terseLabel": "Carried-forward contract liabilities recognized in current year"
       }
      }
     },
     "localname": "ContractualAmountsToBeExchangedInDerivativeFinancialInstrumentForWhichGrossCashFlowsAreExchanged",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContractualCapitalCommitments": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Capital contribution to related parties",
        "label": "Contractual capital commitments",
        "terseLabel": "Commitement to invest in associate",
        "verboseLabel": "Property, plant and equipment contracted for"
       }
      }
     },
     "localname": "ContractualCapitalCommitments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CommitmentsCapitalCommitmentsDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfMerchandiseSold": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of merchandise that was sold during the period and recognised as an expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of merchandise sold",
        "terseLabel": "Cost of trading products"
       }
      }
     },
     "localname": "CostOfMerchandiseSold",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r0",
      "r55"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 5.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrencyRiskMember": {
     "auth_ref": [
      "r236",
      "r264",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency risk [member]",
        "verboseLabel": "Foreign exchange risk [member]"
       }
      }
     },
     "localname": "CurrencyRiskMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r29",
      "r161",
      "r311"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 32.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "terseLabel": "Current assets",
        "totalLabel": "Current assets",
        "verboseLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets [abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentAssetsLiabilities": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets less the amount of current liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets (liabilities)",
        "terseLabel": "Net current assets"
       }
      }
     },
     "localname": "CurrentAssetsLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentContractLiabilities": {
     "auth_ref": [
      "r184"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 16.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract liabilities",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "CurrentContractLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/ContractLiabilitiesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialAssets": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 35.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Derivative financial instruments",
        "label": "Current derivative financial assets",
        "presentationGuidance": "Derivative financial assets",
        "terseLabel": "Derivative financial instruments",
        "verboseLabel": "Total derivative financial assets"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 15.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial liabilities",
        "presentationGuidance": "Total derivative financial liabilities",
        "terseLabel": "Derivative financial liabilities",
        "verboseLabel": "Derivative financial instruments"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDividendPayables": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current dividend payables. [Refer: Dividend payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current dividend payables",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "CurrentDividendPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialAssetsAtAmortisedCost": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets measured at amortised cost. [Refer: Financial assets at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial assets at amortised cost",
        "terseLabel": "Financial assets measured at amortized cost"
       }
      }
     },
     "localname": "CurrentFinancialAssetsAtAmortisedCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 34.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Financial assets at fair value through other comprehensive income (FVOCI)",
        "label": "Current financial assets at fair value through other comprehensive income",
        "presentationGuidance": "Trade and bill receivable",
        "terseLabel": "Trade and bill receivables",
        "verboseLabel": "Financial assets at fair value through other comprehensive income"
       }
      }
     },
     "localname": "CurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets measured at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial assets at fair value through profit or loss",
        "positiveLabel": "Commodity swaps contracts",
        "presentationGuidance": "Commodity swaps contracts at fair value through profit or loss"
       }
      }
     },
     "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial liabilities",
        "totalLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentFinancialLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialLiabilitiesAtAmortisedCost": {
     "auth_ref": [
      "r234",
      "r286"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 8.0,
       "parentTag": "shi_CurrentFinancialLiabilitiesAtAmortisedCostsAdvancesDueToRelatedPartiesAndDueToRelatedPartiesMeasuredAtFairValueThroughProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities measured at amortised cost. [Refer: Financial liabilities at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial liabilities at amortised cost",
        "terseLabel": "Financial liabilities measured at amortized cost"
       }
      }
     },
     "localname": "CurrentFinancialLiabilitiesAtAmortisedCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities measured at fair value through profit or loss. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Commodity swaps contracts",
        "label": "Current financial liabilities at fair value through profit or loss",
        "negatedLabel": "Commodity swaps contracts at fair value through profit or loss"
       }
      }
     },
     "localname": "CurrentFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 14.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r30",
      "r163",
      "r311"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 12.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "negatedLabel": "Current liabilities",
        "negatedTotalLabel": "Total current liabilities",
        "totalLabel": "Current liabilities",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities [abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentPrepayments": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 38.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current prepayments. [Refer: Prepayments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepayments",
        "terseLabel": "Prepayments"
       }
      }
     },
     "localname": "CurrentPrepayments",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "negatedLabel": "Current income tax",
        "terseLabel": "Provision for current income tax for the year"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMajorComponentsOfIncomeTaxExpenseBenefitsDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesSummaryOfCurrentTaxationInTheConsolidatedStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilities": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 21.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "CurrentTaxLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 19.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax liabilities, current",
        "terseLabel": "Current tax liabilities"
       }
      }
     },
     "localname": "CurrentTaxLiabilitiesCurrent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r290",
      "r291"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 36.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Trade receivables",
        "verboseLabel": "Current trade receivables"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "auth_ref": [
      "r361"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 42.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current value added tax receivables",
        "terseLabel": "Value added tax recoverable"
       }
      }
     },
     "localname": "CurrentValueAddedTaxReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ComparativeFiguresAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DebtInstrumentsHeldAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instruments held [abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsHeldAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DebtSecurities": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of instruments issued by the entity that represent indebtedness."
       }
      },
      "en-us": {
       "role": {
        "label": "Debt instruments issued",
        "totalLabel": "Total Debt"
       }
      }
     },
     "localname": "DebtSecurities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deductible temporary differences for which no deferred tax asset is recognised",
        "terseLabel": "Deferred tax assets not recognized in respect of temporary differences"
       }
      }
     },
     "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r21",
      "r25",
      "r63"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 28.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income)",
        "negatedLabel": "Deferred taxation"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMajorComponentsOfIncomeTaxExpenseBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income) recognised in profit or loss",
        "terseLabel": "Credited/ (charged) to profit or loss"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r21",
      "r25",
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liability (asset)",
        "periodEndLabel": "Balance at 31 December",
        "periodStartLabel": "Balance at 1 January"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAsset",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax related to items credited (charged) directly to equity. [Refer: Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax relating to items credited (charged) directly to equity",
        "terseLabel": "Credited/ (Charged) to reserves"
       }
      }
     },
     "localname": "DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepositsFromBanks": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deposit liabilities from banks held by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Deposits from banks",
        "terseLabel": "Time deposits with banks"
       }
      }
     },
     "localname": "DepositsFromBanks",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r1",
      "r55",
      "r170",
      "r242",
      "r252",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortisation expense",
        "negatedLabel": "Depreciation and amortization",
        "negatedTerseLabel": "Depreciation and amortisation"
       }
      }
     },
     "localname": "DepreciationAndAmortisationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationInvestmentProperty": {
     "auth_ref": [
      "r123",
      "r126"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation recognised on investment property. [Refer: Depreciation and amortisation expense; Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, investment property",
        "negatedLabel": "Charge for the year",
        "terseLabel": "Depreciation of investment property",
        "verboseLabel": "Depreciation and amortization: Investment properties (note 17)"
       }
      }
     },
     "localname": "DepreciationInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r73",
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "negatedLabel": "Charge for the year",
        "terseLabel": "Depreciation of property, plant and equipment",
        "verboseLabel": "Depreciation and amortization: Property, plant and equipment (note 16)"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Depreciation and amortization: Right-of-use assets (note 15)",
        "label": "Depreciation, right-of-use assets",
        "negatedLabel": "Depreciation of right-of-use assets",
        "verboseLabel": "Depreciation of right-of-use assets"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialAssetsHeldForHedging": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of derivative financial assets held for hedging. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial assets held for hedging",
        "verboseLabel": "Commodity swaps contracts applied hedge accounting"
       }
      }
     },
     "localname": "DerivativeFinancialAssetsHeldForHedging",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingCostsExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for interest and other costs that the entity incurs in connection with the borrowing of funds.\nEffective 2023-01-01: The description of the entity's material accounting policy information for interest and other costs that the entity incurs in connection with the borrowing of funds."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for borrowing costs [text block]",
        "terseLabel": "Borrowing costs"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBorrowingCostsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for borrowings. [Refer: Borrowings]\nEffective 2023-01-01: The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for borrowings [text block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBorrowingsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForConstructionInProgressExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for construction in progress. [Refer: Construction in progress]\nEffective 2023-01-01: The description of the entity's material accounting policy information for construction in progress. [Refer: Construction in progress]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for construction in progress [text block]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForConstructionInProgressExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for derivative financial instruments and hedging. [Refer: Financial instruments, class [member]; Derivatives [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Financial instruments, class [member]; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for derivative financial instruments and hedging [text block]",
        "terseLabel": "Derivative and hedging activities"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.\nEffective 2023-01-01: The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for foreign currency translation.\nEffective 2023-01-01: The description of the entity's material accounting policy information for foreign currency translation."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for foreign currency translation [text block]",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for government grants [text block]",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for income tax.\nEffective 2023-01-01: The description of the entity's material accounting policy information for income tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for income tax [text block]",
        "terseLabel": "Current and deferred income tax"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for income and expense arising from interest.\nEffective 2023-01-01: The description of the entity's material accounting policy information for income and expense arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for interest income and expense [text block]",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for investments in associates. [Refer: Associates [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for investments in associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for investment in associates [text block]",
        "terseLabel": "Associates"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInvestmentInAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for investment property. [Refer: Investment property]\nEffective 2023-01-01: The description of the entity's material accounting policy information for investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for investment property [text block]",
        "terseLabel": "Investment properties"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInvestmentsInJointVentures": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for investments in joint ventures. [Refer: Joint ventures [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for investments in joint ventures. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for investments in joint ventures [text block]",
        "terseLabel": "Joint arrangements"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForInvestmentsInJointVentures",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for issued capital. [Refer: Issued capital]\nEffective 2023-01-01: The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for issued capital [text block]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.\nEffective 2023-01-01: The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]\nEffective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for provisions. [Refer: Provisions]\nEffective 2023-01-01: The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions and contingent liabilities"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]\nEffective 2023-01-01: The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]\nEffective 2023-01-01: The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for segment reporting.\nEffective 2023-01-01: The description of the entity's material accounting policy information for segment reporting."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for segment reporting [text block]",
        "terseLabel": "Segment reporting"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for subsidiaries. [Refer: Subsidiaries [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for subsidiaries [text block]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSubsidiariesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for trade and other payables. [Refer: Trade and other payables]\nEffective 2023-01-01: The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for trade and other payables [text block]",
        "terseLabel": "Trade and other payables"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for trade and other receivables. [Refer: Trade and other receivables]\nEffective 2023-01-01: The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for trade and other receivables [text block]",
        "terseLabel": "Trade and other receivables"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory": {
     "auth_ref": [
      "r388",
      "r389"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for transactions with related parties. [Refer: Related parties [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for transactions with related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for transactions with related parties [text block]",
        "terseLabel": "Related parties"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "auth_ref": [
      "r116",
      "r117"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Discount rate applied to cash flow projections",
        "terseLabel": "Pre tax discount rate"
       }
      }
     },
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the nature of the entity's operations and principal activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of nature of entity's operations and principal activities",
        "terseLabel": "Principal activities",
        "verboseLabel": "Principal activity"
       }
      }
     },
     "localname": "DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfNatureOfRelatedPartyRelationship": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the nature of the related party relationships. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of nature of related party relationship",
        "terseLabel": "Relationship with the Company"
       }
      }
     },
     "localname": "DescriptionOfNatureOfRelatedPartyRelationship",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfUsefulLifeInvestmentPropertyCostModel": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Description of useful life used for investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of useful life, investment property, cost model",
        "terseLabel": "Estimated useful lives of investment properties"
       }
      }
     },
     "localname": "DescriptionOfUsefulLifeInvestmentPropertyCostModel",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesInvestmentPropertiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of useful life, property, plant and equipment",
        "terseLabel": "Estimated useful lives of property, plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfUsefulLifePropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r107",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted earnings/(losses) per share"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DirectOperatingExpenseFromInvestmentProperty": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of direct operating expenses (including repairs and maintenance) arising from investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Direct operating expense from investment property",
        "negatedLabel": "Cost related to lease of investment properties"
       }
      }
     },
     "localname": "DirectOperatingExpenseFromInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "verboseLabel": "Critical accounting judgement and estimates"
       }
      }
     },
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CriticalAccountingJudgementAndEstimates"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [line items]"
       }
      }
     },
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": {
     "auth_ref": [
      "r354",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of attribution of expenses by nature to their function [table]"
       }
      }
     },
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of preparation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of borrowings [text block]",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "DisclosureOfBorrowingsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Borrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [abstract]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      }
     },
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of commitments [text block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of comparative information prepared under previous GAAP [abstract]"
       }
      }
     },
     "localname": "DisclosureOfComparativeInformationPreparedUnderPreviousGAAPAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfComparativeInformationPreparedUnderPreviousGAAPExplanatory": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure, in the entity's first IFRS financial statements, of comparative information prepared under previous GAAP."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of comparative information prepared under previous GAAP [text block]",
        "terseLabel": "Comparative figures"
       }
      }
     },
     "localname": "DisclosureOfComparativeInformationPreparedUnderPreviousGAAPExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ComparativeFigures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDeferredIncomeExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of deferred income. [Refer: Deferred income including contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of deferred income [text block]",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DisclosureOfDeferredIncomeExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/DeferredIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of derivative financial instruments [text block]",
        "terseLabel": "Derivative financial instruments"
       }
      }
     },
     "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [text block]",
        "verboseLabel": "Summary of borrowings"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about investment property. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about investment property [text block]",
        "terseLabel": "Summary of investment properties"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Summary of property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDividendsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of dividends. Dividends are distributions of profits to holders of equity investments in proportion to their holdings of a particular class of capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of dividends [text block]",
        "terseLabel": "Dividend"
       }
      }
     },
     "localname": "DisclosureOfDividendsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Dividend"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block]",
        "terseLabel": "Employee benefit expenses"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of expenses by nature [text block]",
        "terseLabel": "Expense by nature"
       }
      }
     },
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNature"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [abstract]",
        "terseLabel": "Financial assets"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of liabilities [abstract]",
        "terseLabel": "Finanical liabilities"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value of financial instruments [text block]",
        "terseLabel": "Recurring fair value measurements"
       }
      }
     },
     "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of finance income (cost) [text block]",
        "terseLabel": "Finance income and expenses"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [abstract]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateExplanatory": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of financial instruments by type of interest rate. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [text block]",
        "terseLabel": "Schedule of interest rate financial instruments"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial instruments, by type of interest rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments by type of interest rate [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial instruments [text block]",
        "verboseLabel": "Financial assets at fair value through other comprehensive income"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [abstract]"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [line items]"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial risk management [text block]",
        "terseLabel": "Financial risk management"
       }
      }
     },
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "General information"
       }
      }
     },
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of impairment loss and the reversal of impairment loss. [Refer: Impairment loss; Reversal of impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of impairment loss and reversal of impairment loss [text block]",
        "verboseLabel": "Net provision of impairment losses on financial assets recognized in income statement"
       }
      }
     },
     "localname": "DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "Income tax benefits /(expenses)"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisclosureOfInventoriesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInvestmentPropertyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about investment property [abstract]"
       }
      }
     },
     "localname": "DisclosureOfInvestmentPropertyAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for investment property."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of investment property [text block]",
        "terseLabel": "Investment properties"
       }
      }
     },
     "localname": "DisclosureOfInvestmentPropertyExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentProperties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInvestmentPropertyLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about investment property [line items]",
        "verboseLabel": "Disclosure of detailed information about investment properties [line items]"
       }
      }
     },
     "localname": "DisclosureOfInvestmentPropertyLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInvestmentPropertyTable": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of investment property."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about investment property [table]",
        "verboseLabel": "Disclosure of detailed information about investment properties [table]"
       }
      }
     },
     "localname": "DisclosureOfInvestmentPropertyTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of investments accounted for using equity method [text block]",
        "terseLabel": "Investments accounted for using the equity method"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethod"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of joint ventures [abstract]"
       }
      }
     },
     "localname": "DisclosureOfJointVenturesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfJointVenturesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of joint ventures [line items]"
       }
      }
     },
     "localname": "DisclosureOfJointVenturesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfJointVenturesTable": {
     "auth_ref": [
      "r103",
      "r106",
      "r177"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to joint ventures."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of joint ventures [table]"
       }
      }
     },
     "localname": "DisclosureOfJointVenturesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DisclosureOfLeasesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfLiquidityRiskExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of liquidity risk. [Refer: Liquidity risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of liquidity risk [text block]",
        "terseLabel": "Maturity analysis for financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfLiquidityRiskExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMajorCustomersTable": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the entity's major customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of major customers [table]"
       }
      }
     },
     "localname": "DisclosureOfMajorCustomersTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for derivative financial liabilities [abstract]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [abstract]",
        "terseLabel": "Non-derivatives"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [line items]",
        "terseLabel": "Disclosure of maturity analysis for non-derivative financial liabilities [line items]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis for non-derivative financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [line items]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [table]",
        "terseLabel": "Disclosure of maturity analysis of operating lease payments [table]"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": {
     "auth_ref": [
      "r217",
      "r218"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of nature and extent of risks arising from financial instruments [table]"
       }
      }
     },
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [text block]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [line items]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other non-current assets [text block]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherOperatingExpenseExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other operating expense. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other operating expense [text block]",
        "terseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingExpenseExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other operating income [text block]",
        "terseLabel": "Other operating income"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about leases for lessee [abstract]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [abstract]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [line items]",
        "terseLabel": "Balance sheet amount relating to lease [line items]",
        "verboseLabel": "Income statement amount relating to leases [line items]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to right-of-use assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [table]"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]",
        "terseLabel": "Reconciliation of liabilities arising from financing activities"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Related-party transactions"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of reserves within equity. [Refer: Other reserves [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reserves within equity [text block]",
        "terseLabel": "Reserves"
       }
      }
     },
     "localname": "DisclosureOfReservesAndOtherEquityInterestExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Reserves"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfReservesWithinEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reserves within equity [abstract]"
       }
      }
     },
     "localname": "DisclosureOfReservesWithinEquityAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReservesWithinEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reserves within equity [line items]"
       }
      }
     },
     "localname": "DisclosureOfReservesWithinEquityLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReservesWithinEquityTable": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to reserves within equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reserves within equity [table]"
       }
      }
     },
     "localname": "DisclosureOfReservesWithinEquityTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "auth_ref": [
      "r187",
      "r188"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue from contracts with customers [text block]",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ContractLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of associates [abstract]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of associates [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": {
     "auth_ref": [
      "r103",
      "r106",
      "r178"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to associates."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of associates [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [abstract]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r103",
      "r106",
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/Subsidiaries"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "auth_ref": [
      "r103",
      "r106",
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Summary of significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]",
        "terseLabel": "Movements in deferred tax assets and liabilities [line items]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      }
     },
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other payables [text block]",
        "terseLabel": "Trade and other payables"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "terseLabel": "Trade and other receivables"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [abstract]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, property, plant and equipment",
        "negatedLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalsPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaid": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to owners",
        "negatedLabel": "Dividends proposed and approved"
       }
      }
     },
     "localname": "DividendsPaid",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 32.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to equity holders of the parent, classified as financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to equity holders of parent, classified as financing activities",
        "negatedLabel": "Dividends paid to the Company's shareholders"
       }
      }
     },
     "localname": "DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 33.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests, classified as financing activities",
        "negatedLabel": "Dividends paid by subsidiaries to non-controlling interests"
       }
      }
     },
     "localname": "DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners": {
     "auth_ref": [
      "r9",
      "r56"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends proposed or declared after the reporting period but before financial statements are authorised for issue. Such dividends are not recognised as a liability at the end of the reporting period because no obligation exists at that time."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Final dividend proposed after the end of the reporting period of RMB 0.10 per ordinary share (2020: RMB 0.10 per ordinary share)",
        "label": "Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners"
       }
      }
     },
     "localname": "DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToTheYearDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount, per share, of dividends proposed or declared before financial statements were authorised for issue but not recognised as distribution to owners."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Dividend per share proposed after the reporting period but not recognized as distribution to owners",
        "label": "Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share"
       }
      }
     },
     "localname": "DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToTheYearParentheticalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DividendsReceivedFromAssociatesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow representing dividends received from associates, classified as investing activities. [Refer: Associates [member]; Dividends received]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends received from associates, classified as investing activities",
        "terseLabel": "Dividend received from the associate"
       }
      }
     },
     "localname": "DividendsReceivedFromAssociatesClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow representing dividends received from investments that are accounted for using the equity method, classified as investing activities. [Refer: Investments accounted for using equity method; Dividends received]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends received from investments accounted for using equity method, classified as investing activities",
        "terseLabel": "Dividends received from joint ventures and associates"
       }
      }
     },
     "localname": "DividendsReceivedFromInvestmentsAccountedForUsingEquityMethodClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsReceivedFromJointVenturesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow representing dividends received from joint ventures, classified as investing activities. [Refer: Joint ventures [member]; Dividends received]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends received from joint ventures, classified as investing activities",
        "terseLabel": "Dividend received from joint venture"
       }
      }
     },
     "localname": "DividendsReceivedFromJointVenturesClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to non-controlling interests",
        "negatedLabel": "Dividends paid by subsidiaries to non-controlling interests"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends relating to prior years, recognised as distributions to owners of the parent. [Refer: Parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to owners of parent, relating to prior years",
        "terseLabel": "Dividends declared and approved in respect of previous year"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToThePreviousFinancialYearDetails",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToOwnersPerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount, per share, of dividends recognised as distributions to owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to owners per share",
        "verboseLabel": "Dividend per share of previous financial years recognized as distribution to owners"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToOwnersPerShare",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/DividendSummaryOfDividendsPayableToEquityShareholdersOfTheCompanyAttributableToThePreviousFinancialYearParentheticalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Earnings per share [text block]",
        "terseLabel": "Earnings/(losses) per share"
       }
      }
     },
     "localname": "EarningsPerShareExplanatory",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EarningsLossesPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r133",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Exchange (losses) / gains on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EliminationOfIntersegmentAmountsMember": {
     "auth_ref": [
      "r329",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the elimination of intersegment amounts in the reconciliations of total segment amounts to amounts recognised in the entity's financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Elimination of intersegment amounts [member]",
        "terseLabel": "Inter - segment revenue [member]"
       }
      }
     },
     "localname": "EliminationOfIntersegmentAmountsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "auth_ref": [
      "r1",
      "r55",
      "r287"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "totalLabel": "Total employee benefit expense",
        "verboseLabel": "Employee benefit expenses"
       }
      }
     },
     "localname": "EmployeeBenefitsExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails",
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForAssociatesMember": {
     "auth_ref": [
      "r103",
      "r106",
      "r178",
      "r275",
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for associates [member]"
       }
      }
     },
     "localname": "EntitysTotalForAssociatesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForJointVenturesMember": {
     "auth_ref": [
      "r103",
      "r106",
      "r177",
      "r275",
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for joint ventures [member]"
       }
      }
     },
     "localname": "EntitysTotalForJointVenturesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for segment consolidation items [member]",
        "terseLabel": "Revenue from external customer [member]"
       }
      }
     },
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "auth_ref": [
      "r103",
      "r106",
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for subsidiaries [member]"
       }
      }
     },
     "localname": "EntitysTotalForSubsidiariesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r24",
      "r33",
      "r145",
      "r148",
      "r179",
      "r180",
      "r181"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": 4.0,
       "parentTag": "shi_AdjustedCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total equity and liabilities"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities [abstract]",
        "terseLabel": "Equity and liabilities",
        "verboseLabel": "CAPITAL AND RESERVES"
       }
      }
     },
     "localname": "EquityAndLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "totalLabel": "Equity attributable to owners of the Company"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]",
        "terseLabel": "Total [member]"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityInvestmentsMember": {
     "auth_ref": [
      "r317",
      "r326"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for investments in equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity investments [member]"
       }
      }
     },
     "localname": "EquityInvestmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]",
        "verboseLabel": "Total equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/ShareCapitalDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ExpenseByNatureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses by nature [abstract]"
       }
      }
     },
     "localname": "ExpenseByNatureAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease."
       }
      },
      "en-us": {
       "role": {
        "label": "Expense relating to short-term leases for which recognition exemption has been used",
        "terseLabel": "Expenses relating to short-term leases"
       }
      }
     },
     "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r207",
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in equity instruments designated at fair value through other comprehensive income",
        "verboseLabel": "Equity investments"
       }
      }
     },
     "localname": "FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FeeAndCommissionExpense": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to fees and commissions."
       }
      },
      "en-us": {
       "role": {
        "label": "Fee and commission expense",
        "terseLabel": "Commission expense",
        "verboseLabel": "Commission expense"
       }
      }
     },
     "localname": "FeeAndCommissionExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 16.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      },
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "Finance expenses",
        "negatedTotalLabel": "Finance expenses"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 15.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "totalLabel": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 14.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "terseLabel": "Finance income \u2013 net",
        "totalLabel": "Finance income \u2013 net"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r215",
      "r220",
      "r221",
      "r224",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "verboseLabel": "Total finanical assets"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial assets at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at fair value through other comprehensive income",
        "verboseLabel": "- Others"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets at fair value through other comprehensive income [abstract]"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r228",
      "r229",
      "r259",
      "r270",
      "r271",
      "r272"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FixedInterestRateMember": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Fixed interest rate [member]"
       }
      }
     },
     "localname": "FixedInterestRateMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FloatingInterestRateMember": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Floating interest rate [member]"
       }
      }
     },
     "localname": "FloatingInterestRateMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GainsLossesRecognisedWhenControlInSubsidiaryIsLost": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in association with the loss of control over a subsidiary, which are attributable to the former controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) recognised when control of subsidiary is lost",
        "verboseLabel": "Losses from disposal of a subsidiary"
       }
      }
     },
     "localname": "GainsLossesRecognisedWhenControlInSubsidiaryIsLost",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 11.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains on change in fair value of derivatives",
        "terseLabel": "Net gains on foreign exchange forward contracts"
       }
      }
     },
     "localname": "GainsOnChangeInFairValueOfDerivatives",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r68",
      "r118",
      "r125",
      "r130",
      "r205",
      "r221",
      "r224",
      "r316",
      "r390",
      "r392"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Cost [member]",
        "verboseLabel": "Carrying amount [member]"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/InventoriesDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "auth_ref": [
      "r197",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross lease liabilities",
        "terseLabel": "Gross lease liabilities"
       }
      }
     },
     "localname": "GrossLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross (loss)/profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_HedgingInstrumentAssets": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a hedging instrument, recognised as an asset. [Refer: Hedging instruments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Hedging instrument, assets",
        "periodEndLabel": "Ending balance - Pre-tax amount",
        "periodStartLabel": "Beginning balance - Pre-tax amount"
       }
      }
     },
     "localname": "HedgingInstrumentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_HedgingInstrumentsMember": {
     "auth_ref": [
      "r209",
      "r212"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Hedging instruments [member]",
        "verboseLabel": "Hedging reserve [member]"
       }
      }
     },
     "localname": "HedgingInstrumentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ImpairmentLossOnFinancialAssets": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 10.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      },
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss on financial assets",
        "negatedLabel": "Reversal/(provision) of impairment losses on financial assets",
        "negatedTotalLabel": "Provision of impairment losses on financial assets"
       }
      }
     },
     "localname": "ImpairmentLossOnFinancialAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss. [Refer: Impairment loss; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss",
        "verboseLabel": "Impairment loss of investments accounted for using equity method (note 20)"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": {
     "auth_ref": [
      "r54",
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, property, plant and equipment",
        "terseLabel": "Impairment loss",
        "verboseLabel": "Impairment loss of property, plant and equipment (note 16)"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in profit or loss for trade receivables. [Refer: Impairment loss recognised in profit or loss; Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, trade receivables",
        "terseLabel": "Impairment losses recognized during the year"
       }
      }
     },
     "localname": "ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r47",
      "r57",
      "r60",
      "r61",
      "r99",
      "r173",
      "r244"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      },
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedLabel": "Income tax benefits/(expenses)",
        "negatedTerseLabel": "Income tax expenses",
        "negatedTotalLabel": "Income tax benefits / (expenses)"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMajorComponentsOfIncomeTaxExpenseBenefitsDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome": {
     "auth_ref": [
      "r49",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to cash flow hedges included in other comprehensive income",
        "terseLabel": "Effective portion of the cash flow hedge recognized in other comprehensive income"
       }
      }
     },
     "localname": "IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income that will be reclassified to profit or loss",
        "terseLabel": "Amounts reclassified to profit or loss"
       }
      }
     },
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r136",
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as financing activities. [Refer: Income taxes paid (refund)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as financing activities",
        "negatedLabel": "Payment during the year"
       }
      }
     },
     "localname": "IncomeTaxesPaidRefundClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesSummaryOfCurrentTaxationInTheConsolidatedStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r136",
      "r300"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 25.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as operating activities",
        "negatedLabel": "Income tax paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the appropriation of retained earnings. [Refer: Retained earnings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through appropriation of retained earnings, equity",
        "terseLabel": "Transfer to other reserves"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughAppropriationOfRetainedEarnings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through financing cash flows, liabilities arising from financing activities",
        "totalLabel": "Total changes from financing cash flows"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 8.0,
       "parentTag": "shi_IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through other changes, liabilities arising from financing activities",
        "negatedLabel": "Others"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through other changes, property, plant and equipment",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherChangesPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers from construction in progress, property, plant and equipment",
        "terseLabel": "Transferred from construction in progress"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment": {
     "auth_ref": [
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from (to) investment property. [Refer: Property, plant and equipment; Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers from (to) investment property, property, plant and equipment",
        "terseLabel": "Transferred to investment properties"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InsuranceExpense": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from purchased insurance."
       }
      },
      "en-us": {
       "role": {
        "label": "Insurance expense",
        "terseLabel": "Insurance premiums expenses"
       }
      }
     },
     "localname": "InsuranceExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r120",
      "r299",
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]",
        "verboseLabel": "Intangible assets - patents"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestCostsCapitalised": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_InterestExpense",
       "weight": -1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest costs capitalised",
        "terseLabel": "Less: interest expense capitalized into construction in progress"
       }
      }
     },
     "localname": "InterestCostsCapitalised",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpense": {
     "auth_ref": [
      "r172",
      "r241",
      "r252"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense",
        "negatedLabel": "Interest expense",
        "negatedTotalLabel": "Net interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r191"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "negatedLabel": "Interest expense (included in Finance expenses)",
        "verboseLabel": "Interest expense of lease liabilities"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestIncomeOnDeposits": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest income on deposits. [Refer: Interest income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income on deposits",
        "terseLabel": "Interest income from time deposits"
       }
      }
     },
     "localname": "InterestIncomeOnDeposits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 26.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRateRiskMember": {
     "auth_ref": [
      "r236",
      "r264",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate risk [member]",
        "verboseLabel": "Cash flow and fair value interest rate risk [member]"
       }
      }
     },
     "localname": "InterestRateRiskMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestRateTypesMember": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate types [member]"
       }
      }
     },
     "localname": "InterestRateTypesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r16",
      "r83",
      "r290"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 33.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InventoriesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r15",
      "r175",
      "r246"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 27.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments accounted for using equity method",
        "terseLabel": "Share of net assets",
        "verboseLabel": "Investments accounted for using the equity method"
       }
      }
     },
     "localname": "InvestmentAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentProperty": {
     "auth_ref": [
      "r14",
      "r123",
      "r127"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 25.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business."
       }
      },
      "en-us": {
       "role": {
        "label": "Investment property",
        "periodEndLabel": "Closing net book amount",
        "periodStartLabel": "Opening net book amount",
        "terseLabel": "Estimated fair value of the investment properties",
        "verboseLabel": "Investment properties"
       }
      }
     },
     "localname": "InvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments accounted for using equity method [abstract]"
       }
      }
     },
     "localname": "InvestmentsAccountedForUsingEquityMethodAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_InvestmentsAccountedForUsingEquityMethodMember": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments accounted for using equity method [member]"
       }
      }
     },
     "localname": "InvestmentsAccountedForUsingEquityMethodMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in associates accounted for using equity method",
        "periodEndLabel": "As at 31 December",
        "periodStartLabel": "As at 1 January",
        "terseLabel": "Investment in associates using equity method of accounting",
        "verboseLabel": "Aggregate carrying value of investments at 31 December"
       }
      }
     },
     "localname": "InvestmentsInAssociatesAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in joint ventures accounted for using the equity method. [Refer: Joint ventures [member]; Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in joint ventures accounted for using equity method",
        "periodEndLabel": "As at 31 December",
        "periodStartLabel": "As at 1 January",
        "totalLabel": "Carrying value"
       }
      }
     },
     "localname": "InvestmentsInJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInSubsidiaries": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries in an entity's separate financial statements. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in subsidiaries reported in separate financial statements",
        "terseLabel": "Investments in subsidiaries"
       }
      }
     },
     "localname": "InvestmentsInSubsidiaries",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital",
        "verboseLabel": "As at 31 December"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/ShareCapitalDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital [member]",
        "verboseLabel": "Total [member]"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_JointVenturesAxis": {
     "auth_ref": [
      "r103",
      "r106",
      "r177",
      "r275",
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Joint ventures [axis]"
       }
      }
     },
     "localname": "JointVenturesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_JointVenturesMember": {
     "auth_ref": [
      "r103",
      "r106",
      "r177",
      "r273",
      "r278"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for joint arrangements whereby the parties that have joint control of the arrangement have rights to the net assets of the arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Joint ventures [member]"
       }
      }
     },
     "localname": "JointVenturesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsKeyPersonnelCompensationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, post-employment benefits",
        "terseLabel": "Post-employment benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsKeyPersonnelCompensationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, short-term employee benefits",
        "verboseLabel": "Short-term employee benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsKeyPersonnelCompensationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r198",
      "r199",
      "r269",
      "r318",
      "r322",
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than five years [member]",
        "terseLabel": "2027 [member]"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r198",
      "r199",
      "r269",
      "r318",
      "r325",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than four years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than four years and not later than five years [member]",
        "terseLabel": "2026 [member]"
       }
      }
     },
     "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "auth_ref": [
      "r198",
      "r199",
      "r269",
      "r318",
      "r325",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "After 1 year but within 2 years [member]",
        "disclosureGuidance": "2023 [member]",
        "label": "Later than one year and not later than two years [member]",
        "presentationGuidance": "Over one year but within two years [member]",
        "terseLabel": "Over one year but within two years [member]",
        "verboseLabel": "Between one and two years [member]"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails",
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearMember": {
     "auth_ref": [
      "r27",
      "r335",
      "r338"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year [member]"
       }
      }
     },
     "localname": "LaterThanOneYearMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeMonthsMember": {
     "auth_ref": [
      "r316",
      "r324",
      "r391"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three months [member]"
       }
      }
     },
     "localname": "LaterThanThreeMonthsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r318",
      "r321",
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three years and not later than five years [member]",
        "terseLabel": "More than three or five years [member]"
       }
      }
     },
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": {
     "auth_ref": [
      "r198",
      "r199",
      "r269",
      "r318",
      "r325",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than four years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three years and not later than four years [member]",
        "terseLabel": "2025 [member]"
       }
      }
     },
     "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanTwoYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than two years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than two years and not later than five years [member]",
        "verboseLabel": "After 2 years but within 5 years [member]"
       }
      }
     },
     "localname": "LaterThanTwoYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": {
     "auth_ref": [
      "r198",
      "r199",
      "r269",
      "r318",
      "r325",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than two years and not later than three years."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Over two years [member]",
        "label": "Later than two years and not later than three years [member]",
        "terseLabel": "2024 [member]",
        "verboseLabel": "Over two years but within three years [member]"
       }
      }
     },
     "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "negatedLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities [abstract]",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "auth_ref": [
      "r306",
      "r309"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities [member]",
        "terseLabel": "Lease liabilities [member]"
       }
      }
     },
     "localname": "LeaseLiabilitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LegalFormOfEntity": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Information about the legal structure under which the entity operates."
       }
      },
      "en-us": {
       "role": {
        "label": "Legal form of entity"
       }
      }
     },
     "localname": "LegalFormOfEntity",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "auth_ref": [
      "r79",
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 1 of fair value hierarchy [member]"
       }
      }
     },
     "localname": "Level1OfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]"
       }
      }
     },
     "localname": "Level2OfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]"
       }
      }
     },
     "localname": "Level3OfFairValueHierarchyMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "auth_ref": [
      "r79",
      "r180"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      }
     },
     "localname": "LevelsOfFairValueHierarchyAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r24",
      "r179",
      "r180",
      "r181",
      "r245",
      "r251"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 6.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Begining balance"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [member]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiquidityRiskMember": {
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r315"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liquidity risk [member]"
       }
      }
     },
     "localname": "LiquidityRiskMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LongtermBorrowings": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 11.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Long-term borrowings",
        "label": "Non-current portion of non-current borrowings",
        "terseLabel": "Borrowings",
        "verboseLabel": "Credit loans due over one year but within three years - Long-term borrowing from a related party (note 32(c))"
       }
      }
     },
     "localname": "LongtermBorrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermBorrowingsMember": {
     "auth_ref": [
      "r306",
      "r309"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for long-term borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Long-term borrowings [member]"
       }
      }
     },
     "localname": "LongtermBorrowingsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LongtermDeposits": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 30.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail": {
       "order": 2.0,
       "parentTag": "shi_TimeDepositsWithBanks",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Time deposits with maturity more than one year",
        "label": "Long-term deposits",
        "terseLabel": "Time deposits with banks"
       }
      }
     },
     "localname": "LongtermDeposits",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Losses on change in fair value of derivatives",
        "negatedLabel": "Net losses on foreign exchange option contracts"
       }
      }
     },
     "localname": "LossesOnChangeInFairValueOfDerivatives",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major components of tax expense (income) [abstract]"
       }
      }
     },
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r28",
      "r186",
      "r198",
      "r199",
      "r210",
      "r227",
      "r260",
      "r261",
      "r263",
      "r269",
      "r297",
      "r318"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]",
        "terseLabel": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails",
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MeasurementAxis": {
     "auth_ref": [
      "r121",
      "r129",
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Measurement [axis]"
       }
      }
     },
     "localname": "MeasurementAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating expense",
        "negatedLabel": "Others"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MiscellaneousOtherOperatingIncome": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating income. [Refer: Other operating income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating income",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "MiscellaneousOtherOperatingIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MiscellaneousOtherReservesMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing miscellaneous reserves that the entity does not separately disclose in the same statement or note. [Refer: Other reserves [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Miscellaneous other reserves [member]",
        "terseLabel": "Other reserve [member]"
       }
      }
     },
     "localname": "MiscellaneousOtherReservesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NameOfAssociate": {
     "auth_ref": [
      "r101",
      "r104",
      "r158"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The name of an associate. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Name of associate",
        "terseLabel": "Name of entity"
       }
      }
     },
     "localname": "NameOfAssociate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NameOfJointVenture": {
     "auth_ref": [
      "r101",
      "r104",
      "r158"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The name of a joint venture. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Name of joint venture",
        "terseLabel": "Name of entity"
       }
      }
     },
     "localname": "NameOfJointVenture",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NameOfSubsidiary": {
     "auth_ref": [
      "r101",
      "r104",
      "r151",
      "r156"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Name of subsidiary",
        "terseLabel": "Name of company"
       }
      }
     },
     "localname": "NameOfSubsidiary",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NetAssetsLiabilities": {
     "auth_ref": [
      "r310",
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets (liabilities)",
        "terseLabel": "Net assets",
        "verboseLabel": "NET ASSETS"
       }
      }
     },
     "localname": "NetAssetsLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetDebt": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of net debt of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Net debt",
        "terseLabel": "Adjusted net debt"
       }
      }
     },
     "localname": "NetDebt",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net deferred tax assets",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "NetDeferredTaxAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "auth_ref": [
      "r359",
      "r373"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_FinanceCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "negatedLabel": "Net foreign exchange loss"
       }
      }
     },
     "localname": "NetForeignExchangeLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r22",
      "r150",
      "r154"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]",
        "terseLabel": "Non-controlling interests [member]"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r29",
      "r162",
      "r311"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 22.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Non-current assets",
        "label": "Non-current assets",
        "totalLabel": "Non-current assets",
        "verboseLabel": "Total non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities": {
     "auth_ref": [
      "r360",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current deferred income other than non-current contract liabilities. [Refer: Deferred income other than contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current deferred income other than non-current contract liabilities",
        "periodEndLabel": "As at 31 December",
        "periodStartLabel": "As at 1 January",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "NoncurrentDeferredIncomeOtherThanNoncurrentContractLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/DeferredIncomeDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 29.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial assets at fair value through other comprehensive income",
        "totalLabel": "Total financial assets at fair value through other comprehensive income",
        "verboseLabel": "Financial assets at fair value through other comprehensive income"
       }
      }
     },
     "localname": "NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 8.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_DebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r30",
      "r164",
      "r311"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 7.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "negatedLabel": "Non-current liabilities",
        "terseLabel": "Non-current liabilities",
        "totalLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities [abstract]",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-derivative financial liabilities, undiscounted cash flows",
        "terseLabel": "Total non-derivatives"
       }
      }
     },
     "localname": "NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r26",
      "r198",
      "r199",
      "r269",
      "r318",
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Less than one year [member]",
        "disclosureGuidance": "Within one year [member]",
        "label": "Not later than one year [member]",
        "presentationGuidance": "Within 1 year or on demand [member]",
        "terseLabel": "2022 [member]",
        "verboseLabel": "Within 1 year [member]"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails",
      "http://SinopecShanghai.com/role/LeaseMaturityAnalysisForLeaseLiabilitiesDetail",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotLaterThanThreeMonthsMember": {
     "auth_ref": [
      "r335",
      "r337",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than three months."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than three months [member]"
       }
      }
     },
     "localname": "NotLaterThanThreeMonthsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Total shares of the Company",
        "verboseLabel": "Issued ordinary shares at 1 January"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EarningsLossesPerShareWeightedAverageNumberOfOrdinarySharesDetails",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssuedAndFullyPaid": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity, for which full payment has been received."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued and fully paid",
        "terseLabel": "As at 31 December"
       }
      }
     },
     "localname": "NumberOfSharesIssuedAndFullyPaid",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OperatingSegmentsMember": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating segments [member]",
        "terseLabel": "Total segment revenue [member]",
        "verboseLabel": "Allocated amounts [member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAssets": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets",
        "verboseLabel": "Others"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherAssetsMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for assets that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets [member]",
        "terseLabel": "Others [member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 12.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire interests in joint ventures (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other cash payments to acquire interests in joint ventures, classified as investing activities",
        "negatedLabel": "Payment for set up of a joint venture",
        "terseLabel": "Other cash payments to acquire interests In joint ventures classified as investing activities"
       }
      }
     },
     "localname": "OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r5",
      "r38",
      "r50",
      "r168"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 18.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income for the year, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income [abstract]",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTaxCashFlowHedges": {
     "auth_ref": [
      "r31",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income, before tax]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, before tax, cash flow hedges",
        "terseLabel": "Effective portion of the cash flow hedge recognized in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeBeforeTaxCashFlowHedges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges": {
     "auth_ref": [
      "r31",
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, cash flow hedges",
        "terseLabel": "Effective portion of the cash flow hedge recognized in other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxCashFlowHedges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxChangeInValueOfForwardElementsOfForwardContracts": {
     "auth_ref": [
      "r31",
      "r50"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 20.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to change in value of forward elements of forward contracts. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income, net of tax, change in value of forward elements of forward contracts",
        "terseLabel": "Cash flow hedges: net movement in hedging reserve"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeNetOfTaxChangeInValueOfForwardElementsOfForwardContracts",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentAssets": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current assets",
        "terseLabel": "Other current assets (excluding cash)"
       }
      }
     },
     "localname": "OtherCurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentPayables": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other current payables",
        "totalLabel": "Subtotal of other payables"
       }
      }
     },
     "localname": "OtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 37.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "negatedLabel": "Less: loss allowance",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherEmployeeExpense": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of employee expenses that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other employee expense",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherEmployeeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherExpenseByFunction": {
     "auth_ref": [
      "r55",
      "r98",
      "r288"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 12.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses."
       }
      },
      "en-us": {
       "role": {
        "label": "Other expense, by function",
        "negatedLabel": "Other operating expenses",
        "negatedTotalLabel": "Other operating expenses"
       }
      }
     },
     "localname": "OtherExpenseByFunction",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/OtherOperatingExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherFinanceIncome": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other finance income",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherFinanceIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherGainsLosses": {
     "auth_ref": [
      "r352",
      "r353"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 13.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other gains (losses)",
        "terseLabel": "Other gains/(losses) - net",
        "totalLabel": "Other gains/(losses) \u2013 net"
       }
      }
     },
     "localname": "OtherGainsLosses",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIncome": {
     "auth_ref": [
      "r97",
      "r287",
      "r288"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 11.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other income",
        "terseLabel": "Other operating income",
        "totalLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets [member]",
        "terseLabel": "Intangible assets [member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherLiabilities": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 31.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "periodEndLabel": "Closing net book amount",
        "periodStartLabel": "Opening net book amount",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPayables": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other payables"
       }
      }
     },
     "localname": "OtherPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherReservesMember": {
     "auth_ref": [
      "r6",
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. It also represents the standard value for the 'Reserves within equity' axis if no other member is used. [Refer: Retained earnings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other reserves [member]",
        "terseLabel": "Other reserves [member]"
       }
      }
     },
     "localname": "OtherReservesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ParentMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an entity that controls one or more entities."
       }
      },
      "en-us": {
       "role": {
        "label": "Parent [member]",
        "terseLabel": "The Company [member]",
        "verboseLabel": "Sinopec Shanghai Petrochemical Company Limited (\"the Company\") [member]"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 4.0,
       "parentTag": "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashOutflowForLeases",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 34.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Principal elements of lease payments",
        "negatedTerseLabel": "Within financing cash flows"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods."
       }
      },
      "en-us": {
       "role": {
        "label": "Post-employment benefit expense, defined contribution plans",
        "verboseLabel": "Contributions to defined contribution retirement plans"
       }
      }
     },
     "localname": "PostemploymentBenefitExpenseDefinedContributionPlans",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PreviouslyStatedMember": {
     "auth_ref": [
      "r3",
      "r142",
      "r143",
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the information previously stated in the financial statements (ie before retrospective application or retrospective restatement)."
       }
      },
      "en-us": {
       "role": {
        "label": "Previously stated [member]"
       }
      }
     },
     "localname": "PreviouslyStatedMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r302"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from sales of property, plant and equipment, classified as investing activities",
        "terseLabel": "Net proceeds from disposal of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r37",
      "r132",
      "r146",
      "r149",
      "r245",
      "r249",
      "r311",
      "r331",
      "r333"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 21.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeAlternate1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Profit after taxation",
        "label": "Profit (loss)",
        "presentationGuidance": "(Loss)/profit for the year",
        "terseLabel": "Profit/(loss) for the year",
        "totalLabel": "Profit/(loss) for the year",
        "verboseLabel": "Profit for the year"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) [abstract]",
        "verboseLabel": "Segment result \u2013 (loss)/profit from operations"
       }
      }
     },
     "localname": "ProfitLossAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to [abstract]",
        "terseLabel": "Profit/(loss) attributable to:"
       }
      }
     },
     "localname": "ProfitLossAttributableToAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r40",
      "r153"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeAlternate1": {
       "order": 25.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncomeAlternate1": {
       "order": 24.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Net (loss)/profit attributable to equity shareholders of the Company",
        "label": "Profit (loss), attributable to owners of parent",
        "presentationGuidance": "Profit after taxation attributable to the Group",
        "terseLabel": "Equity shareholders of the Company"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/EarningsLossesPerShareSummaryOfEarningsLossesPerShareBasicDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r206",
      "r287",
      "r288",
      "r327",
      "r328"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Profit / (loss) before income tax",
        "label": "Profit (loss) before tax",
        "presentationGuidance": "Profit/(loss) before taxation",
        "terseLabel": "Profit/(loss) before taxation",
        "totalLabel": "Profit/(loss) before taxation",
        "verboseLabel": "Profit/ (loss) from continuing operations"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromContinuingOperations": {
     "auth_ref": [
      "r37",
      "r167",
      "r245",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Profit from continuing operations",
        "label": "Profit (loss) from continuing operations",
        "terseLabel": "Post-tax (loss)/profit from continuing operations",
        "verboseLabel": "Post-tax profit/ (loss) from continuing operations"
       }
      }
     },
     "localname": "ProfitLossFromContinuingOperations",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r298",
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "terseLabel": "Profit/(loss) from operations",
        "totalLabel": "(Loss) / profit from operations",
        "verboseLabel": "(loss)/profit from operations"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r13",
      "r74"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 23.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "periodEndLabel": "Closing net book amount",
        "periodStartLabel": "Opening net book amount",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r75",
      "r299",
      "r314"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]",
        "terseLabel": "Total [member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInAssociate": {
     "auth_ref": [
      "r102",
      "r105",
      "r159"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in associate",
        "terseLabel": "Percentage of ownership interest"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInAssociate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "auth_ref": [
      "r102",
      "r105",
      "r159"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in joint venture",
        "terseLabel": "Percentage of ownership interest",
        "verboseLabel": "Group's effective interest"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r102",
      "r105",
      "r157"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Percentage of equity held by the subsidiary",
        "verboseLabel": "Proportion of ownership interest Group's effective interest"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interests held by non-controlling interests",
        "verboseLabel": "Proportion of ownership interest Held by the Company"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PurchaseOfInterestsInAssociates": {
     "auth_ref": [
      "r380"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 10.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of interests in associates. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of interests in associates",
        "negatedLabel": "Payment for set up of an associate",
        "terseLabel": "Payment to acquire interests in associates"
       }
      }
     },
     "localname": "PurchaseOfInterestsInAssociates",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of interests in investments accounted for using equity method",
        "terseLabel": "Capital contribution paid to related parties"
       }
      }
     },
     "localname": "PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 13.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Payment for the purchase of property, plant and equipment and construction in progress"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfTreasuryShares": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Purchase of treasury shares",
        "label": "Purchase of treasury shares",
        "negatedLabel": "Purchase of own shares",
        "terseLabel": "Purchase of own shares",
        "verboseLabel": "Aggregate price paid"
       }
      }
     },
     "localname": "PurchaseOfTreasuryShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r183",
      "r202",
      "r263",
      "r312",
      "r313",
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r183",
      "r202",
      "r263",
      "r312",
      "r313",
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RawMaterials": {
     "auth_ref": [
      "r292",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current raw materials",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "RawMaterials",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RawMaterialsAndConsumablesUsed": {
     "auth_ref": [
      "r55",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]"
       }
      },
      "en-us": {
       "role": {
        "label": "Raw materials and consumables used",
        "terseLabel": "Cost of raw material"
       }
      }
     },
     "localname": "RawMaterialsAndConsumablesUsed",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax": {
     "auth_ref": [
      "r53",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to cash flow hedges, before tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reclassification adjustments on cash flow hedges, before tax",
        "terseLabel": "Amounts reclassified to profit or loss"
       }
      }
     },
     "localname": "ReclassificationAdjustmentsOnCashFlowHedgesBeforeTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax": {
     "auth_ref": [
      "r53",
      "r213",
      "r214",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to cash flow hedges, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reclassification adjustments on cash flow hedges, net of tax",
        "terseLabel": "Amounts reclassified to profit or loss"
       }
      }
     },
     "localname": "ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of accounting profit multiplied by applicable tax rates [abstract]"
       }
      }
     },
     "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Movements in the loss allowance account in respect of trade and other receivables"
       }
      }
     },
     "localname": "ReconciliationOfChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in deferred tax liability (asset) [abstract]"
       }
      }
     },
     "localname": "ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RecoverableAmountOfAssetOrCashgeneratingUnit": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The higher of an asset\u2019s (or cash-generating unit\u2019s) fair value less costs of disposal and its value in use. [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Recoverable amount of asset or cash-generating unit",
        "terseLabel": "Recoverable amount of asset"
       }
      }
     },
     "localname": "RecoverableAmountOfAssetOrCashgeneratingUnit",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RecurringFairValueMeasurementMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for fair value measurements which other IFRSs require or permit in the statement of financial position at the end of each reporting period. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Recurring fair value measurement [member]",
        "terseLabel": "Recurring fair value measurements [member]"
       }
      }
     },
     "localname": "RecurringFairValueMeasurementMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ReductionOfIssuedCapital": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reduction of issued capital",
        "verboseLabel": "Reduction of issued capital"
       }
      }
     },
     "localname": "ReductionOfIssuedCapital",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RentalIncome": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income recognised from rental activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Rental income"
       }
      }
     },
     "localname": "RentalIncome",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RentalIncomeFromInvestmentProperty": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of rental income arising from investment property recognised in profit or loss. [Refer: Investment property]"
       }
      },
      "en-us": {
       "role": {
        "label": "Rental income from investment property",
        "terseLabel": "Rental income",
        "verboseLabel": "Rental income from investment properties"
       }
      }
     },
     "localname": "RentalIncomeFromInvestmentProperty",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RepairsAndMaintenanceExpense": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts."
       }
      },
      "en-us": {
       "role": {
        "label": "Repairs and maintenance expense",
        "verboseLabel": "Repairs and maintenance expenses"
       }
      }
     },
     "localname": "RepairsAndMaintenanceExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfCashFlowHedges": {
     "auth_ref": [
      "r258",
      "r362"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": 5.0,
       "parentTag": "shi_AdjustedCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of cash flow hedges",
        "terseLabel": "Less: Hedging reserve"
       }
      }
     },
     "localname": "ReserveOfCashFlowHedges",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfDiscretionaryParticipationFeaturesMember": {
     "auth_ref": [
      "r277",
      "r281",
      "r334"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from discretionary participation features. Discretionary participation features are contractual rights to receive, as a supplement to guaranteed benefits, additional benefits: (a) that are likely to be a significant portion of the total contractual benefits; (b) whose amount or timing is contractually at the discretion of the issuer; and (c) that are contractually based on: (i) the performance of a specified pool of contracts or a specified type of contract; (ii) realised and/or unrealised investment returns on a specified pool of assets held by the issuer; or (iii) the profit or loss of the company, fund or other entity that issues the contract."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of discretionary participation features [member]",
        "terseLabel": "Surplus reserve [member]"
       }
      }
     },
     "localname": "ReserveOfDiscretionaryParticipationFeaturesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RestatedMember": {
     "auth_ref": [
      "r3",
      "r142",
      "r143",
      "r144",
      "r262",
      "r358"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the information currently stated in the financial statements. It also represents the standard value for the 'Retrospective application and retrospective restatement' and 'Departure from requirement of IFRS' axes if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Currently stated [member]"
       }
      }
     },
     "localname": "RestatedMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r6",
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Retained earnings [member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis": {
     "auth_ref": [
      "r3",
      "r142",
      "r143",
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Retrospective application and retrospective restatement [axis]"
       }
      }
     },
     "localname": "RetrospectiveApplicationAndRetrospectiveRestatementAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r44",
      "r166",
      "r206",
      "r239",
      "r248",
      "r254",
      "r255",
      "r256",
      "r287",
      "r288",
      "r311"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 7.0,
       "parentTag": "shi_NetSales",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Revenue",
        "label": "Revenue",
        "terseLabel": "Segment revenue",
        "verboseLabel": "Revenue derived from a single customer"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "auth_ref": [
      "r372"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income from government grants",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "RevenueFromGovernmentGrants",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromInterest": {
     "auth_ref": [
      "r171",
      "r240",
      "r252",
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest income"
       }
      }
     },
     "localname": "RevenueFromInterest",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromSaleOfPetroleumAndPetrochemicalProducts": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of petroleum and petrochemical products. [Refer: Current petroleum and petrochemical products; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from sale of petroleum and petrochemical products",
        "terseLabel": "Sales of petroleum products"
       }
      }
     },
     "localname": "RevenueFromSaleOfPetroleumAndPetrochemicalProducts",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReversalOfImpairmentLoss": {
     "auth_ref": [
      "r113",
      "r114"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_ImpairmentLossOnFinancialAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as an increase of the carrying amount of an asset or cash-generating unit to its recoverable amount when an impairment loss had been previously recognised. [Refer: Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reversal of impairment loss",
        "terseLabel": "Impairment losses reversed"
       }
      }
     },
     "localname": "ReversalOfImpairmentLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReversalOfInventoryWritedown": {
     "auth_ref": [
      "r54",
      "r84"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a reduction in the amount of inventories recognised as an expense due to the reversal of any write-down of inventories resulting from an increase in net realisable value. [Refer: Inventories; Inventory write-down]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reversal of inventory write-down"
       }
      }
     },
     "localname": "ReversalOfInventoryWritedown",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 24.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SecuredBankLoansReceived": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of loans received from banks that have been secured by collateral. [Refer: Loans received]"
       }
      },
      "en-us": {
       "role": {
        "label": "Secured bank loans received",
        "terseLabel": "Borrowings secured by property, plant and equipment"
       }
      }
     },
     "localname": "SecuredBankLoansReceived",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]"
       }
      }
     },
     "localname": "SegmentConsolidationItemsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r114",
      "r185",
      "r245",
      "r296",
      "r332"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r114",
      "r185",
      "r253",
      "r296",
      "r332"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [member]"
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 9.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "negatedLabel": "Selling and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r50",
      "r174",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the other comprehensive income of associates and joint ventures accounted for using the equity method, net of tax. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method, net of tax",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 19.0,
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax."
       }
      },
      "en-us": {
       "role": {
        "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, net of tax",
        "verboseLabel": "Share of other comprehensive income of associates accounted for using the equity method"
       }
      }
     },
     "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates accounted for using equity method",
        "terseLabel": "Associates",
        "verboseLabel": "Share of net profits / (losses)"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInShareOfProfitLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r46",
      "r243",
      "r252",
      "r274"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 17.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method",
        "terseLabel": "Share of net profits/(losses) of associates and joint ventures accounted for using the equity method",
        "totalLabel": "Total",
        "verboseLabel": "Share of profit/(loss) of investments accounted for using the equity method"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInShareOfProfitLossDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of joint ventures accounted for using the equity method. [Refer: Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of joint ventures accounted for using equity method",
        "terseLabel": "Joint ventures",
        "verboseLabel": "Share of profit"
       }
      }
     },
     "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInShareOfProfitLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremiumMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium [member]"
       }
      }
     },
     "localname": "SharePremiumMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShorttermBorrowings": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 13.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Credit loans due within one year - Short term bank loan",
        "label": "Current borrowings",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ShorttermBorrowings",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfBorrowingsDetails",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermBorrowingsMember": {
     "auth_ref": [
      "r306",
      "r309"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for short-term borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term borrowings [member]",
        "terseLabel": "Borrowings [member]"
       }
      }
     },
     "localname": "ShorttermBorrowingsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term deposits, classified as cash equivalents",
        "terseLabel": "Cash deposits with a related party",
        "verboseLabel": "Cash deposits, maturing within 3 months"
       }
      }
     },
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsCashAndCashEquivalentsDetail",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 41.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail": {
       "order": 1.0,
       "parentTag": "shi_TimeDepositsWithBanks",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "definitionGuidance": "Time deposits with maturity less than one year",
        "label": "Short-term deposits, not classified as cash equivalents",
        "terseLabel": "Time deposits with banks"
       }
      }
     },
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SignificantInvestmentsInAssociatesAxis": {
     "auth_ref": [
      "r103",
      "r106",
      "r178",
      "r275",
      "r280"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Associates [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInAssociatesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "auth_ref": [
      "r103",
      "r106",
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SocialSecurityContributions": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Social security contributions",
        "terseLabel": "Social welfare costs"
       }
      }
     },
     "localname": "SocialSecurityContributions",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatutoryReserve": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing reserves created based on legal requirements."
       }
      },
      "en-us": {
       "role": {
        "label": "Statutory reserve",
        "terseLabel": "Legal surplus"
       }
      }
     },
     "localname": "StatutoryReserve",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_StatutoryReserveMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves created based on legal requirements."
       }
      },
      "en-us": {
       "role": {
        "label": "Statutory reserve [member]",
        "terseLabel": "Legal surplus [member]"
       }
      }
     },
     "localname": "StatutoryReserveMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SwapContractMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a derivative financial instrument that involves the exchange of cash flow streams between the parties of the contract over a specified period. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Swap contract [member]"
       }
      }
     },
     "localname": "SwapContractMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)",
        "negatedLabel": "Tax effect of non-deductible loss, expenses and costs"
       }
      }
     },
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of revenues exempt from taxation",
        "terseLabel": "Tax effect of other non-taxable income"
       }
      }
     },
     "localname": "TaxEffectOfRevenuesExemptFromTaxation2011",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 4.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax effect of tax losses",
        "negatedLabel": "Tax losses for which no deferred income tax asset was recognized"
       }
      }
     },
     "localname": "TaxEffectOfTaxLosses",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income) at applicable tax rate",
        "negatedLabel": "Expected PRC income tax at the statutory tax rate of 25%"
       }
      }
     },
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseOtherThanIncomeTaxExpense": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 8.0,
       "parentTag": "shi_NetSales",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense exclusive of income tax expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense other than income tax expense",
        "negatedLabel": "Taxes and surcharges"
       }
      }
     },
     "localname": "TaxExpenseOtherThanIncomeTaxExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [member]"
       }
      }
     },
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails",
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r183",
      "r202",
      "r263",
      "r312",
      "r313",
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails",
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 17.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current payables",
        "terseLabel": "Trade and other payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 18.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current payables to related parties",
        "terseLabel": "Amounts due to related parties",
        "verboseLabel": "Total amount due to related parties"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "auth_ref": [
      "r17",
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other current receivables",
        "terseLabel": "Trade and other current receivables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivables",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 39.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current receivables due from related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current receivables due from related parties",
        "terseLabel": "Amounts due from related parties"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivablesDueFromRelatedParties",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other payables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherPayablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherPayablesToRelatedParties": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 1.0,
       "parentTag": "shi_TradePayablesBillsPayableAndAmountsDueToRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of payables due to related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payables to related parties",
        "terseLabel": "Amounts due to related parties excluded\u00a0non-financial\u00a0liabilities",
        "verboseLabel": "Amounts due to related parties exclude advances received"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToRelatedParties",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 2.0,
       "parentTag": "shi_TradePayablesBillsPayableAndAmountsDueToRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      },
      "en-us": {
       "role": {
        "label": "Trade payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAbstract",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeReceivablesMember": {
     "auth_ref": [
      "r219",
      "r223",
      "r316",
      "r357"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables [member]",
        "terseLabel": "Trade receivables [member]"
       }
      }
     },
     "localname": "TradeReceivablesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TransportationExpense": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from transportation services."
       }
      },
      "en-us": {
       "role": {
        "label": "Transportation expense",
        "terseLabel": "Transportation costs"
       }
      }
     },
     "localname": "TransportationExpense",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasurySharesMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [member]",
        "terseLabel": "Treasury reserve [member]"
       }
      }
     },
     "localname": "TreasurySharesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      }
     },
     "localname": "TypesOfInterestRatesAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksAxis": {
     "auth_ref": [
      "r208",
      "r217",
      "r218",
      "r264",
      "r265",
      "r266",
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      }
     },
     "localname": "TypesOfRisksAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksMember": {
     "auth_ref": [
      "r208",
      "r217",
      "r218",
      "r264",
      "r265",
      "r266",
      "r268"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Risks [member]"
       }
      }
     },
     "localname": "TypesOfRisksMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UnallocatedAmountsMember": {
     "auth_ref": [
      "r329",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items that have not been allocated to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Unallocated amounts [member]"
       }
      }
     },
     "localname": "UnallocatedAmountsMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Undiscounted operating lease payments to be received",
        "terseLabel": "Undiscounted operating lease payments to be received"
       }
      }
     },
     "localname": "UndiscountedOperatingLeasePaymentsToBeReceived",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses for which no deferred tax asset recognised",
        "terseLabel": "Deferred tax assets not recognized in respect of unused tax losses carried forward"
       }
      }
     },
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      },
      "en-us": {
       "role": {
        "label": "Unused tax losses [member]",
        "verboseLabel": "Unused tax losses carried forward [member]"
       }
      }
     },
     "localname": "UnusedTaxLossesMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r370"
     ],
     "calculation": {
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_EmployeeBenefitsExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageMember": {
     "auth_ref": [
      "r183",
      "r263",
      "r312",
      "r313",
      "r387"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an average in which each quantity to be averaged is assigned a weight that determines the relative effect of each quantity on the average."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average [member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Weighted average number of ordinary shares in issue (thousands of shares)",
        "verboseLabel": "Weighted average number of ordinary shares at 31 December"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/EarningsLossesPerShareSummaryOfEarningsLossesPerShareBasicDetails",
      "http://SinopecShanghai.com/role/EarningsLossesPerShareWeightedAverageNumberOfOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_WritedownsReversalsOfInventories": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised resulting from the write-down of inventories to net realisable value or reversals of those write-downs. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Write-downs (reversals of write-downs) of inventories",
        "negatedLabel": "Inventory write-down",
        "terseLabel": "Inventory write-down",
        "verboseLabel": "Inventory provision excluded in cost of sales"
       }
      }
     },
     "localname": "WritedownsReversalsOfInventories",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails",
      "http://SinopecShanghai.com/role/InventoriesNarrativeDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ASharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A shares [member]",
        "label": "A shares [member]"
       }
      }
     },
     "localname": "ASharesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AccrualsAndOthersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accruals and others.",
        "label": "Accruals and Others [Member]"
       }
      }
     },
     "localname": "AccrualsAndOthersMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AccumulatedImpairmentLossInConstructionInProgress": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated impairment loss in construction in progress",
        "label": "Accumulated impairment loss in construction in progress",
        "terseLabel": "Impairment loss in construction in progress"
       }
      }
     },
     "localname": "AccumulatedImpairmentLossInConstructionInProgress",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AcquisitionOfASubsidiaryNetOfCashAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 16.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of a subsidiary, net of cash acquired.",
        "label": "Acquisition Of A Subsidiary Net Of Cash Acquired",
        "negatedLabel": "Acquisition of a subsidiary, net of cash acquired"
       }
      }
     },
     "localname": "AcquisitionOfASubsidiaryNetOfCashAcquired",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdditionOfLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 5.0,
       "parentTag": "shi_IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in addition of liabilities arising from financing activities resulting from financing cash flows.",
        "label": "Addition of lease liabilities",
        "verboseLabel": "Addition of lease liabilities"
       }
      }
     },
     "localname": "AdditionOfLeaseLiabilities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdditionsToDeferredIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions to deferred income",
        "label": "Additions"
       }
      }
     },
     "localname": "AdditionsToDeferredIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/DeferredIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsLeasePrepaymentsAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions to property, plant and equipment, construction in progress, right-of-use assets, lease prepayments and other assets",
        "label": "Additions to property, plant and equipment, construction in progress, right-of-use assets, lease prepayments and other assets",
        "verboseLabel": "Additions to property, plant and equipment, construction in progress, right-of-use assets and other non-current assets"
       }
      }
     },
     "localname": "AdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsLeasePrepaymentsAndOtherAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsLeasePrepaymentsAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions to property, plant and equipment, construction in progress, right-of-use assets, lease prepayments and other assets [abstact]",
        "label": "Additions to property, plant and equipment, construction in progress, right-of-use assets, lease prepayments and other assets [abstact]",
        "terseLabel": "Additions to property, plant and equipment, construction in progress, right-of-use assets and other non-current assets"
       }
      }
     },
     "localname": "AdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsLeasePrepaymentsAndOtherAssetsAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_AdjustedCapital": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted capital.",
        "label": "Adjusted Capital",
        "totalLabel": "Adjusted capital"
       }
      }
     },
     "localname": "AdjustedCapital",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustedNetDebtToCapitalRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted net debt to capital ratio.",
        "label": "Adjusted Net Debt To Capital Ratio",
        "terseLabel": "Adjusted net\u00a0debt-to-capital\u00a0ratio"
       }
      }
     },
     "localname": "AdjustedNetDebtToCapitalRatio",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementScheduleOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_AdjustmentForGainsLossesOnEntrustedLoanReceivables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for gains losses on entrusted loan receivables.",
        "label": "Adjustment For Gains Losses On Entrusted Loan Receivables",
        "negatedLabel": "Gains from entrusted loan receivables"
       }
      }
     },
     "localname": "AdjustmentForGainsLossesOnEntrustedLoanReceivables",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustmentForImpairmentLossOnInvestmentAccountedForUsingTheEquityMethodAndGainsLossesOnDisposalOfPropertyPlantAndEquipmentAndOtherLongTermAssetsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for impairment loss on investment accounted for using the equity method and gains losses on disposal of property plant and equipment and other long term assets net.",
        "label": "Adjustment For Impairment Loss On Investment Accounted For Using The Equity Method And Gains Losses On Disposal Of Property Plant And Equipment And Other Long Term Assets Net",
        "verboseLabel": "Impairment loss on investment accounted for using the equity method"
       }
      }
     },
     "localname": "AdjustmentForImpairmentLossOnInvestmentAccountedForUsingTheEquityMethodAndGainsLossesOnDisposalOfPropertyPlantAndEquipmentAndOtherLongTermAssetsNet",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustmentsForDecreaseIncreaseInBalancesToRelatedPartiesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in balances to related parties, net",
        "label": "Adjustments for decrease (increase) in balances to related parties, net",
        "terseLabel": "(Decrease)/increase in balances to related parties \u2013 net"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInBalancesToRelatedPartiesNet",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustmentsForEarningsNotSharedByOtherShareholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the earnings from sales of the lands injected by Government in Chemical Industry cannot be shared by other shareholders",
        "label": "Adjustments for earnings not shared by other shareholders"
       }
      }
     },
     "localname": "AdjustmentsForEarningsNotSharedByOtherShareholders",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustmentsForGainLossOnDisposalOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments For Gain Loss On Disposal Of Financial Assets At Fair Value Through Other Comprehensive Income",
        "label": "Adjustments For Gain Loss On Disposal Of Financial Assets At Fair Value Through Other Comprehensive Income",
        "terseLabel": "Losses on sale of FVOCI"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustmentsForInterestIncomeFromTimeDepositsWithMaturityMoreThanThreeMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments For Interest Income From Time Deposits With Maturity More Than Three Months.",
        "label": "Adjustments For Interest Income From Time Deposits With Maturity More Than Three Months",
        "negatedLabel": "Interest income from time deposits with maturity more than 3 months"
       }
      }
     },
     "localname": "AdjustmentsForInterestIncomeFromTimeDepositsWithMaturityMoreThanThreeMonths",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AdjustmentsForUnrealisedUpstreamAndDownstreamTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for unrealised upstream and downstream transaction",
        "label": "Adjustments for unrealized upstream and downstream transaction",
        "negatedTerseLabel": "Unrealised downstream transactions"
       }
      }
     },
     "localname": "AdjustmentsForUnrealisedUpstreamAndDownstreamTransaction",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AggregatedIndividuallyMaterialAssociatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the aggregation of associates that are individually material.",
        "label": "Aggregated individually material associates [member]",
        "terseLabel": "Material associates [member]"
       }
      }
     },
     "localname": "AggregatedIndividuallyMaterialAssociatesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AllowanceAccountForCreditLossesOfFinancialAssetsFromRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance account for credit losses of financial assets from related parties",
        "label": "Allowance Account For Credit Losses Of Financial Assets From Related Parties",
        "terseLabel": "Less: loss allowance"
       }
      }
     },
     "localname": "AllowanceAccountForCreditLossesOfFinancialAssetsFromRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmendmentsToIasEightAccountingPoliciesChangesInAccountingEstimatesAndErrorsDefinitionOfAccountingEstimatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendments to IAS eight accounting policies changes in accounting estimates and errors definition of accounting estimates.",
        "label": "Amendments To IAS Eight Accounting Policies Changes In Accounting Estimates And Errors Definition Of Accounting Estimates [Member]",
        "terseLabel": "Amendments to IAS 8, Accounting policies, changes in accounting estimates and errors: Definition of accounting estimates [Member]"
       }
      }
     },
     "localname": "AmendmentsToIasEightAccountingPoliciesChangesInAccountingEstimatesAndErrorsDefinitionOfAccountingEstimatesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AmendmentsToIasOnePresentationOfFinancialStatementsAndIfrsPracticeStatementTwoMakingMaterialityJudgementsDisclosureOfAccountingPoliciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendments to IAS one presentation of financial statements and IFRS practice statement two making materiality judgements disclosure of accounting policies.",
        "label": "Amendments To IAS One Presentation Of Financial Statements And IFRS Practice Statement Two Making Materiality Judgements Disclosure Of Accounting Policies [Member]",
        "terseLabel": "Amendments to IAS 1, Presentation of financial statements and IFRS Practice Statement 2, Making materiality judgements: Disclosure of accounting policies [Member]"
       }
      }
     },
     "localname": "AmendmentsToIasOnePresentationOfFinancialStatementsAndIfrsPracticeStatementTwoMakingMaterialityJudgementsDisclosureOfAccountingPoliciesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AmendmentsToIasOnePresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendments to IAS 1 presentation of financial statements classification of liabilities as current or non current.",
        "label": "Amendments To IAS One Presentation Of Financial Statements Classification Of Liabilities As Current Or Non Current [Member]",
        "terseLabel": "Amendments to IAS 1, Presentation of financial statements: Classification of liabilities as current or non-current [Member]"
       }
      }
     },
     "localname": "AmendmentsToIasOnePresentationOfFinancialStatementsClassificationOfLiabilitiesAsCurrentOrNonCurrentMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AmendmentsToIasTwelveDeferredTaxRelatedToAssetsAndLiabilitiesArisingFromASingleTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendments to IAS twelve deferred tax related to assets and liabilities arising from a single transaction.",
        "label": "Amendments to IAS Twelve Deferred Tax related to Assets and Liabilities arising from a Single Transaction [Member]",
        "terseLabel": "Amendments to IAS 12, Deferred Tax related to Assets and Liabilities arising from a Single Transaction [Member]"
       }
      }
     },
     "localname": "AmendmentsToIasTwelveDeferredTaxRelatedToAssetsAndLiabilitiesArisingFromASingleTransactionMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_AmortisationExpenseChargedToCostOfSales": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization expense charged to cost of sales",
        "label": "Amortization expense charged to cost of sales",
        "terseLabel": "Amortization charged in cost of sales"
       }
      }
     },
     "localname": "AmortisationExpenseChargedToCostOfSales",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmortizationOfGovernmentGrantsRelatingToPurchaseOfPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of government grants relating to purchase of property plant and equipment",
        "label": "Amortization of government grants relating to purchase of property plant and equipment",
        "negatedLabel": "Amortization"
       }
      }
     },
     "localname": "AmortizationOfGovernmentGrantsRelatingToPurchaseOfPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/DeferredIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmountDueFromRelatedPartiesAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from related parties at fair value through other comprehensive income.",
        "label": "Amount Due From Related Parties At Fair Value Through Other Comprehensive Income",
        "verboseLabel": "- Amounts due from related parties (note 22)"
       }
      }
     },
     "localname": "AmountDueFromRelatedPartiesAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeSummaryOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmountOfImpairmentWriteOffDueToTheDisposalOfConstructionInProgress": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment write-off due to the disposal of construction in progress.",
        "label": "Impairment write-off due to the disposal of construction in progress"
       }
      }
     },
     "localname": "AmountOfImpairmentWriteOffDueToTheDisposalOfConstructionInProgress",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmountsDueFromRelatedPartiesBillsReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from related parties bills receivables current.",
        "label": "Amounts Due From Related Parties Bills Receivables Current",
        "terseLabel": "Amounts due from related parties - bills receivables (note 25)"
       }
      }
     },
     "localname": "AmountsDueFromRelatedPartiesBillsReceivablesCurrent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmountsDueFromRelatedPartiesPrepaymentsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from related parties prepayments current.",
        "label": "Amounts Due From Related Parties Prepayments Current",
        "terseLabel": "Amounts due from related parties - prepayments"
       }
      }
     },
     "localname": "AmountsDueFromRelatedPartiesPrepaymentsCurrent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AmountsIncludedInTheCashFlowStatementForLleasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts included in the cash flow statement for leases.",
        "label": "Amounts Included in the Cash Flow Statement for Lleases [Abstract]"
       }
      }
     },
     "localname": "AmountsIncludedInTheCashFlowStatementForLleasesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_AmountsTransferredFromHedgingReserveToInitialCarryingAmountOfHedgedItems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts transferred from hedging reserve to initial carrying amount of hedged Items.",
        "label": "Amounts Transferred From Hedging Reserve To Initial Carrying Amount Of Hedged Items",
        "terseLabel": "Amounts transferred from hedging reserve to initial carrying amount of hedged items"
       }
      }
     },
     "localname": "AmountsTransferredFromHedgingReserveToInitialCarryingAmountOfHedgedItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_AssetsAndLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and liabilities, current [abstract]",
        "label": "Assets and liabilities, current [abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesCurrentAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_AssetsAndLiabilitiesNonCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and liabilities, non-current [abstract]",
        "label": "Assets and liabilities, non-current [abstract]",
        "terseLabel": "Non-current"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesNonCurrentAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_AssociatesAndJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Associates and joint ventures [member]",
        "label": "Associates and joint ventures [member]",
        "terseLabel": "Associates and joint ventures of the Group [member]"
       }
      }
     },
     "localname": "AssociatesAndJointVenturesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BASFYpcCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BASF-YPC Company Limited [member]",
        "label": "BASF-YPC Company Limited [member]"
       }
      }
     },
     "localname": "BASFYpcCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BalanceSheetAndReserveMovementOfParentCompanyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance sheet and reserve movement of parent company [abstract]",
        "label": "Balance sheet and reserve movement of the Company [abstract]"
       }
      }
     },
     "localname": "BalanceSheetAndReserveMovementOfParentCompanyAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_BalingMaterialsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Baling materials.",
        "label": "Baling Materials [Member]"
       }
      }
     },
     "localname": "BalingMaterialsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BasfGaoQiaoPerformanceChemicalsShanghaiCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BASF Gao-Qiao Performance Chemicals(Shanghai) Company Limited [member]",
        "label": "BASF GaoQiao Performance ChemicalsShanghai Company Limited [member]",
        "terseLabel": "BASF Gao-Qiao Performance Chemicals (Shanghai) Company Limited [member]"
       }
      }
     },
     "localname": "BasfGaoQiaoPerformanceChemicalsShanghaiCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BasicAndDilutedEarningPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basic And Diluted Earning Per Share",
        "label": "Basic And Diluted Earning Per Share [Abstract]",
        "verboseLabel": "Earnings/(losses) per share attributable to equity shareholders of the Company for the year (expressed in RMB per share)"
       }
      }
     },
     "localname": "BasicAndDilutedEarningPerShareAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_BasisPointsOfInterestRatesRisenFallenForSensitivityAnalysisOfFinancialRisk": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis points of interest rates risen (fallen) for sensitivity analysis of financial risk",
        "label": "Basis points of interest rates risen (fallen) for sensitivity analysis of financial risk",
        "terseLabel": "Interest rates on the floating rate borrowings risen/(fallen) basis points"
       }
      }
     },
     "localname": "BasisPointsOfInterestRatesRisenFallenForSensitivityAnalysisOfFinancialRisk",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_BeijingHeyuanJingyiHotelCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beijing Heyuan Jingyi Hotel Company Limited [Member]",
        "label": "Beijing Heyuan Jingyi Hotel Company Limited [Member]"
       }
      }
     },
     "localname": "BeijingHeyuanJingyiHotelCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BeijingPetrochemicalConstructionConsultingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beijing petro-chemical construction consulting compant limited.",
        "label": "Beijing PetroChemical Construction Consulting Company Limited [Member]"
       }
      }
     },
     "localname": "BeijingPetrochemicalConstructionConsultingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BeijingVictoryHotelCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beijing Victory Hotel Company Limited [member]",
        "label": "Beijing Victory Hotel Company Limited [member]"
       }
      }
     },
     "localname": "BeijingVictoryHotelCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BillsOfExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bills of exchange.",
        "label": "Bills Of Exchange [Axis]"
       }
      }
     },
     "localname": "BillsOfExchangeAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_BillsOfExchangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bills Of Exchange [Member]"
       }
      }
     },
     "localname": "BillsOfExchangeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_BillsPayables": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 3.0,
       "parentTag": "shi_TradePayablesBillsPayableAndAmountsDueToRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of bills payables.",
        "label": "Bills payables",
        "terseLabel": "Bills payable"
       }
      }
     },
     "localname": "BillsPayables",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_BorrowingsDrawn": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings drawn.",
        "label": "Borrowings Drawn",
        "terseLabel": "Borrowings drawn"
       }
      }
     },
     "localname": "BorrowingsDrawn",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CapitalcontributiontoRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of capital contribution to related parties for which the entity has entered into a contract.",
        "label": "Capital contribution to related parties"
       }
      }
     },
     "localname": "CapitalcontributiontoRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CapitalizationOfBorrowingCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalization of borrowing costs [member]",
        "label": "Capitalization of borrowing costs [Member]"
       }
      }
     },
     "localname": "CapitalizationOfBorrowingCostsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_CashDepositsInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate on cash deposits.",
        "label": "Cash deposits interest rate"
       }
      }
     },
     "localname": "CashDepositsInterestRate",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_CashDividendDistributionFromInvestmentsAccountedForUsingEquityMethod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash dividend distribution from investments accounted for using equity method",
        "label": "Cash dividend distribution from investments accounted for using equity method",
        "negatedLabel": "Cash dividends distribution"
       }
      }
     },
     "localname": "CashDividendDistributionFromInvestmentsAccountedForUsingEquityMethod",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentForInvestmentDepositsClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 21.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment for investment deposits classified as investing activities.",
        "label": "Cash Payment For Investment Deposits Classified As Investing Activities",
        "negatedLabel": "Cash payment for investment deposits"
       }
      }
     },
     "localname": "CashPaymentForInvestmentDepositsClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentForInvestmentInEntrustedLoansClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 19.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment for investment in entrusted loans classified as investing activities.",
        "label": "Cash Payment For Investment In Entrusted Loans Classified As Investing Activities",
        "negatedLabel": "Cash payment for investment in entrusted loans"
       }
      }
     },
     "localname": "CashPaymentForInvestmentInEntrustedLoansClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentForInvestmentInStructuredDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 15.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment for investment in structured deposits.",
        "label": "Cash Payment For Investment In Structured Deposits",
        "negatedLabel": "Cash payment for investment in structured deposits"
       }
      }
     },
     "localname": "CashPaymentForInvestmentInStructuredDeposits",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentForShareRepurchases": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 36.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment for share repurchases.",
        "label": "Cash Payment For Share Repurchases",
        "negatedLabel": "Payment for repurchase of shares"
       }
      }
     },
     "localname": "CashPaymentForShareRepurchases",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentOfTimeDepositsAboveOneYearClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment of time deposits above one year, classified as investing activities",
        "label": "Cash payment for time deposits above one year",
        "negatedLabel": "Cash payment for investment in time deposits with maturity less than one year"
       }
      }
     },
     "localname": "CashPaymentOfTimeDepositsAboveOneYearClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentOfTimeDepositsWithinOneYearClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment of time deposits within one year, classified as investing activities",
        "label": "Cash payment for time deposits within one year",
        "negatedLabel": "Cash payment for investment in time deposits with maturity more than one year"
       }
      }
     },
     "localname": "CashPaymentOfTimeDepositsWithinOneYearClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashPaymentsToAcquireInterestInAssociatesAndJointVenture": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 22.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to acquire interest in associates and joint venture.",
        "label": "Cash Payments To Acquire Interest In Associates And Joint Venture",
        "negatedLabel": "Payment for investment in associates and a joint venture"
       }
      }
     },
     "localname": "CashPaymentsToAcquireInterestInAssociatesAndJointVenture",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashReceivedForInvestmentInEntrustedLoansClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 20.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for investment in entrusted loans classified as investing activities.",
        "label": "Cash Received For Investment In Entrusted Loans Classified As Investing Activities",
        "terseLabel": "Cash received from investment in entrusted loans"
       }
      }
     },
     "localname": "CashReceivedForInvestmentInEntrustedLoansClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashReceivedFromMaturityOfStructuredDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 14.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from maturity of structured deposits.",
        "label": "Cash Received From Maturity Of Structured Deposits",
        "terseLabel": "Cash received from maturity of structured deposits"
       }
      }
     },
     "localname": "CashReceivedFromMaturityOfStructuredDeposits",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashReceivedFromTimeDepositsClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from time deposits, classified as investing activities",
        "label": "Cash received from time deposits, classified as investing activities",
        "terseLabel": "Cash received from time deposits with maturity less than one year"
       }
      }
     },
     "localname": "CashReceivedFromTimeDepositsClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CashReceivedFromTimeDepositsMoreThanOneYearClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 18.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from time deposits more than one year classified as investing activities.",
        "label": "Cash Received From Time Deposits More Than One Year Classified As Investing Activities",
        "terseLabel": "Cash received from time deposits with maturity more than one year"
       }
      }
     },
     "localname": "CashReceivedFromTimeDepositsMoreThanOneYearClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CertainProductionFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain production facilities.",
        "label": "Certain production facilities [Member]"
       }
      }
     },
     "localname": "CertainProductionFacilitiesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaEconomicbooksCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Economicbooks Company Limited [member]",
        "label": "China Economicbooks Company Limited [member]",
        "terseLabel": "China Economicbooks Co., Ltd. [member]"
       }
      }
     },
     "localname": "ChinaEconomicbooksCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaEconomyPhulishingHouseCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China economy publishing house company limited.",
        "label": "China Economy Phulishing House Company Limited [Member]"
       }
      }
     },
     "localname": "ChinaEconomyPhulishingHouseCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaInternationalUnitedPetroleumAndChemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China International United Petroleum and Chemical Company Limited [member]",
        "label": "China International United Petroleum and Chemical Company Limited [member]"
       }
      }
     },
     "localname": "ChinaInternationalUnitedPetroleumAndChemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaJinshanAssociatedTradingCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Jinshan Associated Trading Corporation [member]",
        "label": "China Jinshan Associated Trading Corporation [member]",
        "verboseLabel": "China Jinshan Associated Trading Corporation (\"Jinmao\") [member]"
       }
      }
     },
     "localname": "ChinaJinshanAssociatedTradingCorporationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalCorpEngineeringRationManagementStationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical Corp. Engineering Ration Management Station [member]",
        "label": "China Petrochemical Corp. Engineering Ration Management Station [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalCorpEngineeringRationManagementStationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalCorpNanjingChemicalIndustryCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China petrochemical corp nanjing chemical industry company limited.",
        "label": "China Petrochemical Corp Nanjing Chemical Industry Company Limited [Member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalCorpNanjingChemicalIndustryCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical Corporation (\"Sinopec Group\") [member]",
        "label": "China Petrochemical Corporation [member]",
        "verboseLabel": "China Petrochemical Corporation (\"Sinopec Group\") [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalCorporationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalBeijingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical International Beijing Company Limited [member]",
        "label": "China Petrochemical International Beijing Company Limited [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalBeijingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China petrochemical international company limited.",
        "label": "China Petrochemical International Company Limited [Member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalNanjingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical International Nanjing Company Limited [member]",
        "label": "China Petrochemical International (Nanjing) Company Limited [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalNanjingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalNingboCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical International Ningbo Company Limited [member]",
        "label": "China Petrochemical International Ningbo Company Limited [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalNingboCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalShanghaiCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical International Shanghai Company Limited [member]",
        "label": "China Petrochemical International Shanghai Company Limited [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalShanghaiCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalTianjinCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical International Tianjin Company Limited [member]",
        "label": "China Petrochemical International Tianjin Company Limited [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalTianjinCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalInternationalWuhanCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petrochemical International Wuhan Company Limited [member]",
        "label": "China Petrochemical International Wuhan Company Limited [member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalInternationalWuhanCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetrochemicalRefinerySalesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China petrochemical refinery sales company limited.",
        "label": "China Petrochemical Refinery Sales Company Limited [Member]"
       }
      }
     },
     "localname": "ChinaPetrochemicalRefinerySalesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetroleumAndChemicalCorporationQingdaoSecurityEngineeringAndResearchInstituteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China petroleum and chemical corporation qingdao security engineering and research institute.",
        "label": "China Petroleum And Chemical Corporation Qingdao Security Engineering And Research Institute [Member]"
       }
      }
     },
     "localname": "ChinaPetroleumAndChemicalCorporationQingdaoSecurityEngineeringAndResearchInstituteMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaPetroleumChemicalCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Petroleum &amp; Chemical Corporation [member]",
        "label": "China Petroleum &amp; Chemical Corporation [member]",
        "verboseLabel": "China Petroleum &amp; Chemical Corporation (\"Sinopec Corp.\") [member]"
       }
      }
     },
     "localname": "ChinaPetroleumChemicalCorporationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaSinopecPipelineStorageAndTransportationCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China sinopec pipeline storage and transportation company limited.",
        "label": "China Sinopec Pipeline Storage And Transportation Company Limited [Member]"
       }
      }
     },
     "localname": "ChinaSinopecPipelineStorageAndTransportationCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ChinaYanshanUnitedForeignTradeCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "China Yanshan United Foreign Trade Company Limited [member]",
        "label": "China Yanshan United Foreign Trade Company Limited [member]",
        "terseLabel": "China Yanshan United Foreign Trade Co., Ltd. [member]"
       }
      }
     },
     "localname": "ChinaYanshanUnitedForeignTradeCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_CommitmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments [abstract]",
        "label": "Commitments [abstract]"
       }
      }
     },
     "localname": "CommitmentsAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_CommoditySwapContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commodity swap contracts.",
        "label": "Commodity Swap Contracts [Member]"
       }
      }
     },
     "localname": "CommoditySwapContractsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_CompensationToCasualties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation to casualties.",
        "label": "Compensation To Casualties",
        "terseLabel": "Compensation to casualties"
       }
      }
     },
     "localname": "CompensationToCasualties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ConstructionAndInstallationCostCommitmentsRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction and installation cost commitments, related party transactions",
        "label": "Construction and installation cost commitments, related party transactions",
        "terseLabel": "Construction and installation cost"
       }
      }
     },
     "localname": "ConstructionAndInstallationCostCommitmentsRelatedPartyTransactions",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ConstructionAndInstallationCostRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction and installation cost, related party transactions",
        "label": "Construction and installation cost, related party transactions",
        "terseLabel": "Construction and installation cost"
       }
      }
     },
     "localname": "ConstructionAndInstallationCostRelatedPartyTransactions",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ConstructionInProgressExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction in progress [text block]",
        "label": "Construction in progress [text block]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgress"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_ConstructionInProgressLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Construction in progress [line items]"
       }
      }
     },
     "localname": "ConstructionInProgressLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_ConstructionInProgressTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction in progress [table]",
        "label": "Construction in progress [table]"
       }
      }
     },
     "localname": "ConstructionInProgressTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_ConstructionPayable": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherCurrentPayables",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction payable",
        "label": "Construction payable",
        "terseLabel": "Construction payable"
       }
      }
     },
     "localname": "ConstructionPayable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CostOfInventoriesRecognisedInCostOfSales": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventories recognised in cost of sales.",
        "label": "Cost of inventories recognised in cost of sales",
        "terseLabel": "Cost of inventories recognized in Cost of Sales"
       }
      }
     },
     "localname": "CostOfInventoriesRecognisedInCostOfSales",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CriticalaccountingestimatesandassumptionsabstractAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CriticalAccountingEstimatesAndAssumptionsAbstract.",
        "label": "CriticalAccountingEstimatesAndAssumptionsAbstract [Abstract]"
       }
      }
     },
     "localname": "CriticalaccountingestimatesandassumptionsabstractAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_CurrentAdvancesPayableToRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 9.0,
       "parentTag": "shi_CurrentFinancialLiabilitiesAtAmortisedCostsAdvancesDueToRelatedPartiesAndDueToRelatedPartiesMeasuredAtFairValueThroughProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Advances Payable To Related Parties.",
        "label": "Current Advances Payable To Related Parties",
        "terseLabel": "Amounts due to related parties \u2013 advances received"
       }
      }
     },
     "localname": "CurrentAdvancesPayableToRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CurrentDerivativeFinancialInstrumentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current derivative financial instrument assets [member]",
        "label": "Current derivative financial instrument assets [member]"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialInstrumentAssetsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_CurrentDerivativeFinancialInstrumentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current derivative financial instrument liabilities [member]",
        "label": "Current derivative financial instrument liabilities [member]"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialInstrumentLiabilitiesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_CurrentFinancialLiabilitiesAtAmortisedCostsAdvancesDueToRelatedPartiesAndDueToRelatedPartiesMeasuredAtFairValueThroughProfitOrLoss": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Financial Liabilities At Amortised Costs Advances Due To Related Parties And Due To Related Parties Measured At Fair Value Through Profit Or Loss.",
        "label": "Current Financial Liabilities At Amortised Costs Advances Due To Related Parties And Due To Related Parties Measured At Fair Value Through Profit Or Loss",
        "totalLabel": "Sub Total"
       }
      }
     },
     "localname": "CurrentFinancialLiabilitiesAtAmortisedCostsAdvancesDueToRelatedPartiesAndDueToRelatedPartiesMeasuredAtFairValueThroughProfitOrLoss",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_CurrentTradeReceivablesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current trade receivables, gross",
        "label": "Current trade receivables, gross",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "CurrentTradeReceivablesGross",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DalianFuruipuTechnologyCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dalian furuipu technology company limited.",
        "label": "Dalian Furuipu Technology Company Limited [Member]"
       }
      }
     },
     "localname": "DalianFuruipuTechnologyCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DalianSinopecMaterialEquipCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dalian sinopec material equip company.",
        "label": "Dalian Sinopec Material Equip Company [Member]"
       }
      }
     },
     "localname": "DalianSinopecMaterialEquipCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument unused borrowing capacity amount.",
        "label": "Debt Instrument Unused Borrowing Capacity Amount",
        "terseLabel": "Debt instrument unused borrowing capacity amount"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DecemberTwoThousandAndTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December two thousand and twenty two.",
        "label": "December Two Thousand And Twenty Two [Member]"
       }
      }
     },
     "localname": "DecemberTwoThousandAndTwentyTwoMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DecreaseCausedByAssociatesCapitalReductionInvestmentInAssociates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease caused by associates capital reduction investment in associates.",
        "label": "Decrease Caused By Associates Capital Reduction Investment In Associates",
        "terseLabel": "Decrease caused by associate's capital reduction",
        "verboseLabel": "Decrease caused by associates capital reduction investment in associates"
       }
      }
     },
     "localname": "DecreaseCausedByAssociatesCapitalReductionInvestmentInAssociates",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DecreaseInConstructionWorkInProgressDisposal": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in construction work in progress disposal.",
        "label": "Decrease In Construction Work In Progress Disposal",
        "terseLabel": "Disposal"
       }
      }
     },
     "localname": "DecreaseInConstructionWorkInProgressDisposal",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DecreaseThroughTransfersToConstructionInProgressPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease Through Transfers To Construction In Progress Property Plant And Equipment.",
        "label": "Decrease Through Transfers To Construction In Progress Property Plant And Equipment",
        "terseLabel": "Transferred to construction in progres"
       }
      }
     },
     "localname": "DecreaseThroughTransfersToConstructionInProgressPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DeferredIncomeNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 10.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred income classified as non-current.",
        "label": "Deferred income, non-current",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredIncomeNoncurrent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DeferredTaxAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets [member]",
        "label": "Deferred tax assets [member]"
       }
      }
     },
     "localname": "DeferredTaxAssetsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DeferredTaxAssetsNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets - net [member]",
        "label": "Deferred tax assets - net [member]"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DeferredTaxLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities [member]",
        "label": "Deferred tax liabilities [member]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DeferredTaxLiabilitiesNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities - net [member]",
        "label": "Deferred tax liabilities - net [member]",
        "verboseLabel": "Deferred tax liabilities - net [member]"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DeferredTaxLiabilitiesOfSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 9.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred tax liabilities, net of deferred tax assets.",
        "label": "Deferred tax liabilities of subsidiaries",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOfSubsidiaries",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan Maximum Annual Contributions Per Employee Percent",
        "terseLabel": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_DefinedContributionRetirementPlansOutstandingContribution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution retirement plans outstanding contribution.",
        "label": "Defined Contribution Retirement Plans Outstanding Contribution",
        "terseLabel": "Defined contribution retirement plans outstanding contribution"
       }
      }
     },
     "localname": "DefinedContributionRetirementPlansOutstandingContribution",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DepreciationOtherNonCurrentAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation other noncurrent assets.",
        "label": "Depreciation Other Non Current Assets",
        "terseLabel": "Depreciation and amortization: Other non-current assets (note 14)"
       }
      }
     },
     "localname": "DepreciationOtherNonCurrentAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_DerivativeFinancialInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative financial instruments.",
        "label": "Derivative Financial Instruments [Member]",
        "terseLabel": "Derivative financial instruments [member]"
       }
      }
     },
     "localname": "DerivativeFinancialInstrumentsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DescriptionOfAccountingPolicyForContractLiabilitiesExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for Contract liabilities explanatory.",
        "label": "Description of accounting policy for Contract liabilities explanatory [Policy Text Block]",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForContractLiabilitiesExplanatoryPolicyTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForCreditLossesAndImpairmentOfAssetsExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy forCredit losses and impairment of assets explanatory.",
        "label": "Description of accounting policy for Credit losses and impairment of assets explanatory [Policy Text Block]",
        "terseLabel": "Credit losses and impairment of assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForCreditLossesAndImpairmentOfAssetsExplanatoryPolicyTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForDividendDistribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for dividend distribution.",
        "label": "Description of accounting policy for dividend distribution [text block]",
        "terseLabel": "Dividend distribution"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForDividendDistribution",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForDividendIncome": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for dividend income.",
        "label": "Description of accounting policy for dividend income [text block]",
        "terseLabel": "Dividend income"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForDividendIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForOtherInvestmentsInDebtAndEquitySecuritiesExplanatoryPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of accounting policy for Other investments in debt and equity securities explanatory.",
        "label": "Description of accounting policy for Other investments in debt and equity securities explanatory [Policy Text Block]",
        "terseLabel": "Other investments in debt and equity securities"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForOtherInvestmentsInDebtAndEquitySecuritiesExplanatoryPolicyTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForOtherNonCurrentAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for lease prepayments and other non-current assets.",
        "label": "Description of accounting policy for lease prepayments and other non-current assets [text block]",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForOtherNonCurrentAssetsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForRoundingOfAmountsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for rounding of amounts.",
        "label": "Description of accounting policy for rounding of amounts [text block]",
        "terseLabel": "Rounding of amounts"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRoundingOfAmountsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfAccountingPolicyForSafetyProductionFund": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for safety production fund.",
        "label": "Description of accounting policy for safety production fund [text block]",
        "terseLabel": "Safety production fund"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForSafetyProductionFund",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DescriptionOfChangeInNetProfitLoss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of change in net profit (loss)",
        "label": "Description of change in net profit (loss)",
        "terseLabel": "Description of change in net profit"
       }
      }
     },
     "localname": "DescriptionOfChangeInNetProfitLoss",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DescriptionOfUsefulLivesRightofuseAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of useful life for right-of-use assets.",
        "label": "Description of useful lif, right-of-use assets",
        "verboseLabel": "Estimated useful lives of right-of-use assets"
       }
      }
     },
     "localname": "DescriptionOfUsefulLivesRightofuseAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DifferenceInDepreciationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference in depreciation [member]",
        "label": "Difference in depreciation [member]"
       }
      }
     },
     "localname": "DifferenceInDepreciationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DisclosureDetailsOfDividendToShareholdersApprovedInThePreviousYearAndPaidInTheCurrentYearTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure details of dividend to shareholders approved In the previous year and paid In the current year.",
        "label": "Disclosure Details Of Dividend To Shareholders Approved In The Previous Year And Paid In The Current Year [Table Text Block]",
        "terseLabel": "Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Previous Financial Year"
       }
      }
     },
     "localname": "DisclosureDetailsOfDividendToShareholdersApprovedInThePreviousYearAndPaidInTheCurrentYearTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/DividendTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureInEntiretyOfTimeDepositsHeldWithBanksLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in entirety of time deposits held with banks.",
        "label": "Disclosure In Entirety Of Time Deposits Held With Banks [Line Items]"
       }
      }
     },
     "localname": "DisclosureInEntiretyOfTimeDepositsHeldWithBanksLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureInEntiretyOfTimeDepositsHeldWithBanksTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in entirety of time deposits held with banks.",
        "label": "Disclosure In Entirety Of Time Deposits Held With Banks [Table]"
       }
      }
     },
     "localname": "DisclosureInEntiretyOfTimeDepositsHeldWithBanksTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in entirety of time deposits held with banks.",
        "label": "Disclosure In Entirety Of Time Deposits Held With Banks [Text Block]",
        "terseLabel": "Time deposits with banks"
       }
      }
     },
     "localname": "DisclosureInEntiretyOfTimeDepositsHeldWithBanksTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TimeDepositsWithBanks"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In tabular form of dividend payable to equity holders of the company attributable to the year.",
        "label": "Disclosure In Tabular Form Of Dividend Payable To Equity Holders Of The Company Attributable To The Year [Text Block]",
        "verboseLabel": "Summary of Dividends Payable to Equity Shareholders of the Company Attributable to the Year"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfDividendPayableToEquityHoldersOfTheCompanyAttributableToTheYearTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/DividendTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureInTabularFormOfPossibleImpactOfAmendmentsOfNewAccountingStandardsAndIssuedButNotYetEffective": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of possible impact of amendments of new accounting standards and issued but not yet effective.",
        "label": "Disclosure In Tabular Form Of Possible Impact of Amendments Of New Accounting Standards And Issued But Not Yet Effective",
        "terseLabel": "Summary of Number of Amendments, New Standards and Interpretations Which are Not Yet Effective"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfPossibleImpactOfAmendmentsOfNewAccountingStandardsAndIssuedButNotYetEffective",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureInTabularFormOfRepaymentScheduleOfBorrowings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Repayment Schedule Of Borrowings.",
        "label": "Disclosure In Tabular Form Of Repayment Schedule Of Borrowings",
        "terseLabel": "Summary of analysis of the repayment schedule of borrowings"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfRepaymentScheduleOfBorrowings",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureInTabularFormOfRepaymentScheduleOfBorrowingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Repayment Schedule Of Borrowings.",
        "label": "Disclosure In Tabular Form Of Repayment Schedule Of Borrowings [Line Items]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfRepaymentScheduleOfBorrowingsLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureInTabularFormOfRepaymentScheduleOfBorrowingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure In Tabular Form Of Repayment Schedule Of Borrowings.",
        "label": "Disclosure In Tabular Form Of Repayment Schedule Of Borrowings [Table]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfRepaymentScheduleOfBorrowingsTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsSummaryOfAnalysisOfTheRepaymentScheduleOfBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of shares repurchased during the period [Text block].",
        "label": "Disclosure In Tabular Form Of Shares Repurchased During The Period Explanatory",
        "terseLabel": "Purchase of own shares"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of shares repurchased during the period [Line items].",
        "label": "Disclosure In Tabular Form Of Shares Repurchased During The Period [Line Items]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of shares repurchased during the period [Table].",
        "label": "Disclosure In Tabular Form Of Shares Repurchased During The Period [Table]"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfSharesRepurchasedDuringThePeriodTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureInTabularFormOfWeightedAverageNumberOfSharesBasicExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of weighted average number of shares basic explanatory.",
        "label": "Disclosure In Tabular Form Of Weighted Average Number Of Shares Basic Explanatory",
        "terseLabel": "Summary of weighted average number of ordinary shares"
       }
      }
     },
     "localname": "DisclosureInTabularFormOfWeightedAverageNumberOfSharesBasicExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/EarningsLossesPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of aging analysis in trade and other receivables explanatory.",
        "label": "Disclosure Of Aging Analysis In Trade And Other Receivables Explanatory [Table Text Block]",
        "terseLabel": "Disclosure of Aging Analysis in Trade and Other Receivables Explanatory"
       }
      }
     },
     "localname": "DisclosureOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfBalanceSheetAmountsRelatedToLeasesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of balance sheet amounts related to leases [text block]",
        "label": "Disclosure of balance sheet amounts related to leases Explanatory [Text Block]",
        "terseLabel": "Disclosure of Balance sheet amounts relating to leases"
       }
      }
     },
     "localname": "DisclosureOfBalanceSheetAmountsRelatedToLeasesExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfBalanceSheetOfParentCompanyOnlyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of balance sheet of parent company only [text block]",
        "label": "Disclosure of balance sheet of parent company only [text block]",
        "terseLabel": "Statements of financial position of the Company"
       }
      }
     },
     "localname": "DisclosureOfBalanceSheetOfParentCompanyOnlyExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfCapitalCommitmentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of capital commitments [text block]",
        "label": "Disclosure of capital commitments [text block]",
        "terseLabel": "Capital Commitments"
       }
      }
     },
     "localname": "DisclosureOfCapitalCommitmentsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfCashAndCashEquivalentsComponentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents components.",
        "label": "Disclosure of cash and cash equivalents components [text block]",
        "terseLabel": "Summary of Cash and cash equivalents"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsComponentsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfChangesInLevelThreeItemsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of changes in Level 3 items.",
        "label": "Disclosure of changes in Level 3 items [text block]",
        "terseLabel": "Changes in level 3 items"
       }
      }
     },
     "localname": "DisclosureOfChangesInLevelThreeItemsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfCommitmentsWithRelatedParties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of commitments with related parties",
        "label": "Disclosure of commitments with related parties [text block]",
        "terseLabel": "Commitments with related parties"
       }
      }
     },
     "localname": "DisclosureOfCommitmentsWithRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of component of trade And other receivables explanatory.",
        "label": "Disclosure Of Component Of Trade And Other Receivables Explanatory [Table Text Block]",
        "terseLabel": "Disclosure of Component of Trade and Other Receivables Explanatory"
       }
      }
     },
     "localname": "DisclosureOfComponentOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfComponentOfTradeAndOtherReceivablesLineItemsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "disclosure of component of trade and other receivables line items.",
        "label": "Disclosure Of Component Of Trade And Other Receivables Line Items [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfComponentOfTradeAndOtherReceivablesLineItemsLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfComponentOfTradeAndOtherReceivablesTableTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of component of trade and other receivables table.",
        "label": "Disclosure Of Component Of Trade And Other Receivables Table [Table]"
       }
      }
     },
     "localname": "DisclosureOfComponentOfTradeAndOtherReceivablesTableTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfConstructionInProgressAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of construction in progress [abstract]",
        "label": "Construction in progress [abstract]"
       }
      }
     },
     "localname": "DisclosureOfConstructionInProgressAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfConstructionInProgressExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of tables of construction in progress.",
        "label": "Disclosure of construction in progress [text block]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "DisclosureOfConstructionInProgressExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfDeferredIncomeMovementExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of deferred income movement.",
        "label": "Disclosure of deferred income movement [text block]",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DisclosureOfDeferredIncomeMovementExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/DeferredIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfDeferredTaxAssetsNotRecognizedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of deferred tax assets not recognized [abstract]",
        "label": "Disclosure of deferred tax assets not recognized [abstract]"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxAssetsNotRecognizedAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfDeferredTaxAssetsNotRecognizedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of deferred tax assets not recognized [line items]",
        "label": "Disclosure of deferred tax assets not recognized [line items]"
       }
      }
     },
     "localname": "DisclosureOfDeferredTaxAssetsNotRecognizedLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfDetailedInformationAboutContractsLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about contracts liabilities.",
        "label": "Disclosure of detailed information about contracts liabilities [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutContractsLiabilitiesTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ContractLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfDetailedInformationAboutCurrentTaxationExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Detailed Information About Current Taxation Explanatory.",
        "label": "Disclosure of Detailed Information About Current Taxation Explanatory [Table Text Block]",
        "terseLabel": "Summary of current taxation in the consolidated statement of financial position"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutCurrentTaxationExplanatoryTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfDetailedInformationAboutInventoriesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about inventories [line items]",
        "label": "Disclosure of detailed information about inventories [line items]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutInventoriesLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfDetailedInformationAboutInventoriesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about inventories [table]",
        "label": "Disclosure of detailed information about inventories [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutInventoriesTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfDetailedInformationAboutMaturityAnalysisForLeaseLiabilitiesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about maturity analysis for lease liabilities explanatory",
        "label": "Disclosure Of Detailed Information About Maturity Analysis For Lease Liabilities Explanatory [Text Block]",
        "terseLabel": "Disclosure of Maturity analysis for lease liabilities"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutMaturityAnalysisForLeaseLiabilitiesExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfDetailedInformationOfAdjustedNetDebtToCapitalRatioAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information of adjusted net debt to capital ratio.",
        "label": "Disclosure Of Detailed Information Of Adjusted Net Debt To Capital Ratio [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationOfAdjustedNetDebtToCapitalRatioAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information of adjusted net debt to capital ratio explanatory.",
        "label": "Disclosure Of Detailed Information Of Adjusted Net Debt To Capital Ratio Explanatory",
        "terseLabel": "Schedule of detailed information of adjusted net debt to capital ratio explanatory"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationOfAdjustedNetDebtToCapitalRatioExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfDetailedInformationOfTotalCashOutflowForLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information of total cash outflow for leases.",
        "label": "Disclosure Of Detailed Information Of Total Cash Outflow For Leases [Table Text Block]",
        "terseLabel": "Summary of Cash flow Statement for Leases"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationOfTotalCashOutflowForLeasesTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfEarningsPerShareBasicExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of earnings per share, basic.",
        "label": "Disclosure of earnings per share, basic [text block]",
        "terseLabel": "Summary of earnings/(losses) per share, basic"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareBasicExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/EarningsLossesPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfEmployeeBenefitExpenseExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of employee benefit expense [text block]",
        "label": "Disclosure of employee benefit expense [text block]",
        "terseLabel": "Employee benefit expenses"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitExpenseExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/EmployeeBenefitExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfEstimatedUsefulLivesOfOtherNonCurrentAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's estimated useful lives of other non-current assets.",
        "label": "Disclosure of estimated useful lives of other non-current assets [text block]",
        "terseLabel": "Summary of estimated useful lives of other non-current assets"
       }
      }
     },
     "localname": "DisclosureOfEstimatedUsefulLivesOfOtherNonCurrentAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's estimated useful lives of property, plant and equipment.",
        "label": "Disclosure of estimated useful lives of property, plant and equipment [text block]",
        "verboseLabel": "Summary of estimated useful lives of property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfExpectedIncomeTaxAndActualIncomeTaxExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of expected income tax and actual income tax [text block]",
        "label": "Disclosure of reconciliation of expected income tax and actual income tax [text block]",
        "terseLabel": "Summary of reconciliation of expected income tax and actual income tax"
       }
      }
     },
     "localname": "DisclosureOfExpectedIncomeTaxAndActualIncomeTaxExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfExpenseByNatureExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of expense by nature [text block]",
        "label": "Disclosure of expense by nature [text block]",
        "terseLabel": "Expense by nature"
       }
      }
     },
     "localname": "DisclosureOfExpenseByNatureExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfFinanceIncomeAndExpensesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of finance income and expenses.",
        "label": "Disclosure of finance income and expenses [text block]",
        "terseLabel": "Finance income and expenses"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeAndExpensesExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of financial assets at fair value through other comprehensive income.",
        "label": "Disclosure of financial assets at fair value through other comprehensive income [text block]",
        "terseLabel": "Financial assets at fair value through other comprehensive income"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of financial information of parent company only [text block]",
        "label": "Disclosure of financial information of parent company only [text block]",
        "terseLabel": "Statements of financial position and equity movement of the Company"
       }
      }
     },
     "localname": "DisclosureOfFinancialInformationOfParentCompanyOnlyExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompany"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfForeignExchangeGainsLossesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of aggregate net foreign exchange gains/(losses) recognized in the income statement.",
        "label": "Disclosure of foreign exchange gains/(losses) [text block] [Text Block]",
        "terseLabel": "The aggregate net foreign exchange (losses) / gains recognized in the consolidated statements of profit or loss"
       }
      }
     },
     "localname": "DisclosureOfForeignExchangeGainsLossesExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfHedgingInstrumentsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of reconciliation of hedging reserves in cash flow.",
        "label": "Disclosure of hedging instrument [text block] [Text Block]",
        "terseLabel": "Reconciliation of hedging reserve in respect of commodity price risk and effectiveness of hedging relationships"
       }
      }
     },
     "localname": "DisclosureOfHedgingInstrumentsExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfHedgingReservesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of reconciliation of hedging reserves in statement of profit or loss.",
        "label": "Disclosure of hedging reserves [text block] [Text Block]",
        "terseLabel": "Reconciliation of hedging reserves in statement of profit or loss"
       }
      }
     },
     "localname": "DisclosureOfHedgingReservesExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfIncomeStatementAmountsRelatedToLeasesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of income statement amounts related to leases [text block]",
        "label": "Disclosure of income statement amounts related to leases Explanatory [Text Block]",
        "terseLabel": "Disclosure of Income statement amounts relating to leases"
       }
      }
     },
     "localname": "DisclosureOfIncomeStatementAmountsRelatedToLeasesExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInformationAboutOtherNonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about other other non-current assets [abstract]",
        "label": "Other non-current assets [abstract]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutOtherNonCurrentAssetsAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfInformationAboutOtherNonCurrentAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.",
        "label": "Disclosure of information about other non-current assets [line items]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutOtherNonCurrentAssetsLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfInformationAboutOtherNonCurrentAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to information of other non-current assets.",
        "label": "Disclosure of information about other non-current assets [table]"
       }
      }
     },
     "localname": "DisclosureOfInformationAboutOtherNonCurrentAssetsTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfInventoriesComponentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of inventories components.",
        "label": "Disclosure of inventories components [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DisclosureOfInventoriesComponentsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInvestmentCommitmentsWithRelatedParties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investment commitments with related parties",
        "label": "Disclosure of investment commitments with related parties [text block]",
        "terseLabel": "Investment commitments with related parties"
       }
      }
     },
     "localname": "DisclosureOfInvestmentCommitmentsWithRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInBalanceSheetExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments accounted for using equity method recognised in balance sheet [text block]",
        "label": "Disclosure of investments accounted for using equity method recognised in balance sheet [text block]",
        "terseLabel": "Summary of amounts recognized in balance sheet"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInBalanceSheetExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInShareOfProfitLossExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments accounted for using equity method recognised in share of profit/(loss) [text block]",
        "label": "Disclosure of investments accounted for using equity method recognised in share of profit/(loss) [text block]",
        "terseLabel": "Summary of amounts recognized in share of profit/ losses of investments accounted for using the equity method"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodRecognisedInShareOfProfitLossExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments accounted for using the equity method have met the significance criteria under the rule 4-08(g) of regulation s-x explanatory.",
        "label": "Disclosure Of Investments Accounted For Using The Equity Method have met the significance criteria under the Rule 408(g) of Regulation SX Explanatory",
        "terseLabel": "Financial information for the Company's equity method investments other than Shanghai Secco are summarized"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments accounted for using the equity method have met the significance criteria under the rule 4-08(g) of regulation s-x.",
        "label": "Disclosure Of Investments Accounted For Using The Equity Method Have Met The Significance Criteria Under The Rule 408(G) Of Regulation SX [Line Items]"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments accounted for using the equity method have met the significance criteria under the rule 4-08(g) of regulation s-x.",
        "label": "Disclosure Of Investments Accounted For Using The Equity Method Have Met The Significance Criteria Under The Rule 408(G) Of Regulation SX [Table]"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingTheEquityMethodHaveMetTheSignificanceCriteriaUnderTheRule408GOfRegulationSxTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodFinancialInformationForTheCompanySEquityMethodInvestmentsOtherThanShanghaiSeccoAreSummarizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfInvestmentsAccountedForUsingTheEquityMethodNotIndividuallyMaterialTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments accounted for using the equity method not individually material.",
        "label": "Disclosure Of Investments Accounted For Using The Equity Method Not Individually Material [Table Text Block]",
        "terseLabel": "Summarized financial information for associates/joint ventures"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsAccountedForUsingTheEquityMethodNotIndividuallyMaterialTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfInvestmentsInAssociatesAndJointVenturesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of investments in associates and joint ventures [text block]",
        "label": "Disclosure of investments in associates and joint ventures [text block]",
        "terseLabel": "Summary of investments in associates/joint ventures"
       }
      }
     },
     "localname": "DisclosureOfInvestmentsInAssociatesAndJointVenturesExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfKeyPersonnelCompensations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of key personnel compensations",
        "label": "Disclosure of key personnel compensations [text block]",
        "terseLabel": "Summary of key personnel compensations"
       }
      }
     },
     "localname": "DisclosureOfKeyPersonnelCompensations",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfMajorComponentsOfIncomeTaxExpenseIncomeExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of major components of income tax expense (benefit).",
        "label": "Disclosure of major components of income tax expense (income) [text block] [Text Block]",
        "terseLabel": "Summary of major components of income tax expense"
       }
      }
     },
     "localname": "DisclosureOfMajorComponentsOfIncomeTaxExpenseIncomeExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfMajorRelatedParties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of major related parties",
        "label": "Disclosure of major related parties [text block]",
        "terseLabel": "Summary of major related parties"
       }
      }
     },
     "localname": "DisclosureOfMajorRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfMajorSubsidiariesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of major subsidiaries.",
        "label": "Disclosure of major subsidiaries [text block]",
        "terseLabel": "Summary of major subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfMajorSubsidiariesExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfMaturityAnalysisOfTradePayablesExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Maturity Analysis Of Trade Payables Explanatory.",
        "label": "Disclosure Of Maturity Analysis Of Trade Payables Explanatory [Text Block]",
        "verboseLabel": "Disclosure of summary of aging analysis of trade payables"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfTradePayablesExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfMovementsInDeferredTaxAssetsAndLiabilitiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of movements in deferred tax assets and liabilities [text block]",
        "label": "Disclosure of movements in deferred tax assets and liabilities [text block]",
        "terseLabel": "Summary of movements in deferred tax assets and liabilities"
       }
      }
     },
     "localname": "DisclosureOfMovementsInDeferredTaxAssetsAndLiabilitiesExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfNatureOfInvestmentsAccountedUsingEquityMethodTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of nature of investments accounted using equity method.",
        "label": "Disclosure of nature of investments accounted using equity method [Text Block]",
        "terseLabel": "Summary of principal activities of material associates/joint ventures"
       }
      }
     },
     "localname": "DisclosureOfNatureOfInvestmentsAccountedUsingEquityMethodTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfNetOtherGainsComponentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of net other gains components.",
        "label": "Disclosure of net other gains components [Text Block]",
        "terseLabel": "Other gains(losses) - net"
       }
      }
     },
     "localname": "DisclosureOfNetOtherGainsComponentsTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfNetOtherGainsLossesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other gains(losses) - net.",
        "label": "Disclosure of net other gains(losses) [Text Block]",
        "terseLabel": "Other gains(losses) - net"
       }
      }
     },
     "localname": "DisclosureOfNetOtherGainsLossesTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfOtherAssetsNoncurrentExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other non-current assets.",
        "label": "Disclosure of other assets, non-current",
        "terseLabel": "Summary of other non-current assets"
       }
      }
     },
     "localname": "DisclosureOfOtherAssetsNoncurrentExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfOtherOperatingExpenseComponentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other operating expense components.",
        "label": "Disclosure of other operating expense components [text block]",
        "terseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingExpenseComponentsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfOtherOperatingIncomeComponentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of other operating income components.",
        "label": "Disclosure of other operating income components [text block]",
        "terseLabel": "Other operating income"
       }
      }
     },
     "localname": "DisclosureOfOtherOperatingIncomeComponentsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherOperatingIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfOtherTransactionsWithAssociatesAndJointVenturesUltimateParentCompanySubsidiariesOfUltimateParentCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of other transactions with associates and joint ventures, ultimate parent company, subsidiaries of ultimate parent company.",
        "label": "Disclosure of other transactions with associates and joint ventures, ultimate parent company, subsidiaries of ultimate parent company [text block]",
        "terseLabel": "Other transactions between the Group and Sinopec Group and its subsidiaries, associates and joint ventures of the Group"
       }
      }
     },
     "localname": "DisclosureOfOtherTransactionsWithAssociatesAndJointVenturesUltimateParentCompanySubsidiariesOfUltimateParentCompany",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfReconciliationOfProfitBeforeIncomeTaxToCashUsedInOperationExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reconciliation of profit before income tax to cash used in operation [text block].",
        "label": "Disclosure of reconciliation of profit before income tax to cash used in operation explanatory [Text Block]",
        "terseLabel": "Reconciliation of profit before taxation to cash used in operation"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfProfitBeforeIncomeTaxToCashUsedInOperationExplanatoryTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfRelevantAmountsDueFromToRelatedParties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of relevant amounts due from/to related parties",
        "label": "Disclosure of relevant amounts due from/to related parties [text block]",
        "terseLabel": "Summary of amounts due from/to related parties"
       }
      }
     },
     "localname": "DisclosureOfRelevantAmountsDueFromToRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfReserveExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reserve [text block]",
        "label": "Disclosure of reserve [text block]",
        "terseLabel": "Reserves"
       }
      }
     },
     "localname": "DisclosureOfReserveExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfReserveMovementOfParentCompanyOnlyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reserve movement of parent company only [text block]",
        "label": "Disclosure of reserve movement of parent company only [text block]",
        "terseLabel": "Statements of equity movement of the Company"
       }
      }
     },
     "localname": "DisclosureOfReserveMovementOfParentCompanyOnlyExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfShareCapitalExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of share capital.",
        "label": "Disclosure of share capital [text block]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfSignificantInvestmentsInAssociatesAndJointVenturesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of significant investments in associates and joint ventures [line items]",
        "label": "Disclosure of significant investments in associates and joint ventures [line items]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesAndJointVenturesLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfSignificantInvestmentsInAssociatesAndJointVenturesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of significant investments in associates and joint ventures [table]",
        "label": "Disclosure of significant investments in associates and joint ventures [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesAndJointVenturesTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentsRecognizedInBalanceSheetDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_DisclosureOfSummarizedStatementOfComprehensiveIncomeOfInvestmentsAccountedUsingEquityMethodTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of summarized statement of comprehensive income of investments accounted using equity method.",
        "label": "Disclosure of Summarized Statement of Comprehensive Income of Investments Accounted using Equity Method [Table Text Block]",
        "terseLabel": "Summarized statement of comprehensive income"
       }
      }
     },
     "localname": "DisclosureOfSummarizedStatementOfComprehensiveIncomeOfInvestmentsAccountedUsingEquityMethodTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfSummarizedStatementOfFinancialPositionOfInvestmentsAccountedUsingEquityMethodTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of summarized statement of financial position of investments accounted using equity method.",
        "label": "Disclosure of Summarized Statement of Financial Position of Investments Accounted using Equity Method [Table Text Block]",
        "terseLabel": "Summarized statement of financial position"
       }
      }
     },
     "localname": "DisclosureOfSummarizedStatementOfFinancialPositionOfInvestmentsAccountedUsingEquityMethodTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfTaxLossesCarriedForwardAndNotRecognisedAsDeferredTaxAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of tax losses carried forward and not recognised as deferred tax assets [text block]",
        "label": "Disclosure of tax losses carried forward and not recognised as deferred tax assets [text block]",
        "terseLabel": "Summary of tax losses carried forward and not recognised as deferred tax assets"
       }
      }
     },
     "localname": "DisclosureOfTaxLossesCarriedForwardAndNotRecognisedAsDeferredTaxAssetsExplanatory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of trade and other payables explanatory.",
        "label": "Disclosure Of Trade And Other Payables Explanatory1 [Text Block]",
        "verboseLabel": "Disclosure of summary of trade and other payables"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory1TextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DisclosureOfTransactionsWithUltimateParentCompanySubsidiariesAndJointVenturesOfUltimateParentCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of transactions with ultimate parent company, subsidiaries and joint ventures of ultimate parent company.",
        "label": "Disclosure of transactions with ultimate parent company, subsidiaries and joint ventures of ultimate parent company [text block]",
        "terseLabel": "Transactions between the Group and Sinopec Corp., its subsidiaries and joint ventures"
       }
      }
     },
     "localname": "DisclosureOfTransactionsWithUltimateParentCompanySubsidiariesAndJointVenturesOfUltimateParentCompany",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_DiscountedBillsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discounted Bills [Member]",
        "terseLabel": "Discounted Bills [Member]"
       }
      }
     },
     "localname": "DiscountedBillsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_DividendAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend [abstract]",
        "label": "Dividend [abstract]"
       }
      }
     },
     "localname": "DividendAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_DueToRelatedPartiesAtFairValueThroughProfitLoss": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": 10.0,
       "parentTag": "shi_CurrentFinancialLiabilitiesAtAmortisedCostsAdvancesDueToRelatedPartiesAndDueToRelatedPartiesMeasuredAtFairValueThroughProfitOrLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due to related parties at fair value through profit loss.",
        "label": "Due To Related Parties At Fair Value Through Profit Loss",
        "terseLabel": "Amounts due to related parties \u2013 measured at fair value through profit or loss (FVPL)"
       }
      }
     },
     "localname": "DueToRelatedPartiesAtFairValueThroughProfitLoss",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_EffectiveDateFromWhichReportingStandardIsApplicable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective date from which reporting standard is applicable.",
        "label": "Effective Date From Which Reporting Standard Is Applicable"
       }
      }
     },
     "localname": "EffectiveDateFromWhichReportingStandardIsApplicable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "shi_EndorsedBillsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Endorsed Bills [Member]",
        "terseLabel": "Endorsed Bills [Member]"
       }
      }
     },
     "localname": "EndorsedBillsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_EpecECommerceCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Epec e commerce company limited.",
        "label": "Epec E Commerce Company Limited [Member]"
       }
      }
     },
     "localname": "EpecECommerceCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment [member]",
        "label": "Equipment [member]",
        "terseLabel": "Equipment [member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_EquityInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of equity investments.",
        "label": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestments",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_EstimatedIncreaseDecreaseInNetProfitDueToSensitivityAnalysisOfFinancialRisk": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated increase (decrease) in net profit due to sensitivity analysis of financial risk",
        "label": "Estimated increase (decrease) in net profit due to sensitivity analysis of financial risk",
        "terseLabel": "Estimated change in net profit due to sensitivity analysis"
       }
      }
     },
     "localname": "EstimatedIncreaseDecreaseInNetProfitDueToSensitivityAnalysisOfFinancialRisk",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_EventAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event.",
        "label": "Event [Axis]"
       }
      }
     },
     "localname": "EventAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_EventMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event.",
        "label": "Event [Member]"
       }
      }
     },
     "localname": "EventMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ExpenseRelatingToShortTermLeases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expense relating to short-term leases",
        "label": "Expense relating to short-term leases",
        "terseLabel": "Expense relating to short-term leases (included in Cost of sales)"
       }
      }
     },
     "localname": "ExpenseRelatingToShortTermLeases",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ExpirationPeriodOfCapitalContributionPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration period of capital contribution plan",
        "label": "Expiration period of capital contribution plan"
       }
      }
     },
     "localname": "ExpirationPeriodOfCapitalContributionPlan",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "shi_ExternalProcessingFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External processing fee",
        "label": "External processing fee"
       }
      }
     },
     "localname": "ExternalProcessingFee",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ExpenseByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_FinanceIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance income and expenses [abstract]",
        "label": "Finance income and expenses [abstract]"
       }
      }
     },
     "localname": "FinanceIncomeAndExpensesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_FinanceIncomeAndExpensesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance income And expenses.",
        "label": "Finance Income And Expenses [Line Items]",
        "terseLabel": "Finance Income and Expenses [Line Items]"
       }
      }
     },
     "localname": "FinanceIncomeAndExpensesLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_FinanceIncomeAndExpensesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance income and expenses.",
        "label": "Finance Income And Expenses [Table]"
       }
      }
     },
     "localname": "FinanceIncomeAndExpensesTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_FinancialInstrumentsFairValueMeasurementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instruments, fair value measurement [abstract]",
        "label": "Finanical instruments, fair value measurement [abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsFairValueMeasurementAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_FinancialInstrumentsFairValueMeasurementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instruments, fair value measurement [line items]",
        "label": "Financial instruments, fair value measurement [line items]"
       }
      }
     },
     "localname": "FinancialInstrumentsFairValueMeasurementLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_FinancialInstrumentsFairValueMeasurementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instruments, fair value measurement [table]",
        "label": "Financial instruments, fair value measurement [table]"
       }
      }
     },
     "localname": "FinancialInstrumentsFairValueMeasurementTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationRecurringFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_FinancialInstrumentsFixedInterestRateBearingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instruments fixed interest rate bearing value.",
        "label": "Financial Instruments Fixed Interest Rate Bearing Value",
        "terseLabel": "Financial instruments fixed interest rate bearing value"
       }
      }
     },
     "localname": "FinancialInstrumentsFixedInterestRateBearingValue",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_FinancialInstrumentsVariableInterestRateBearingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instruments variable interest rate bearing value.",
        "label": "Financial Instruments Variable Interest Rate Bearing Value",
        "terseLabel": "Financial instruments variable interest rate bearing value"
       }
      }
     },
     "localname": "FinancialInstrumentsVariableInterestRateBearingValue",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_FinishedGoodsInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A classification of current inventories representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business.",
        "label": "Finished goods, inventory",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "FinishedGoodsInventory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_FiveLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five largest customer.",
        "label": "Five Largest Customer [Member]"
       }
      }
     },
     "localname": "FiveLargestCustomerMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward [Member]"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ForeignExchangeOptionContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange option contract.",
        "label": "Foreign Exchange Option Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeOptionContractMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsDerivativesReconciliationOfHedgingReservesInStatementOfProfitOrLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ForeignInvestedHSharesListedOverseasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for foreign invested H shares listed overseas.",
        "label": "Foreign invested H shares listed overseas [member]"
       }
      }
     },
     "localname": "ForeignInvestedHSharesListedOverseasMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_FujianGuleiPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fujian Gulei Petrochemical Company Limited [member]",
        "label": "Fujian Gulei Petrochemical Company Limited [member]"
       }
      }
     },
     "localname": "FujianGuleiPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_FujianRefiningPetrochemicalCompanyLimitedFREPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fujian Refining Petrochemical Company Limited FREP [member]",
        "label": "Fujian Refining and Petrochemical Company Limited FREP [member]",
        "terseLabel": "Fujian Refining &amp; Petrochemical Company Limited (FREP) [member]"
       }
      }
     },
     "localname": "FujianRefiningPetrochemicalCompanyLimitedFREPMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_GainLossesFromEntrustedLoanReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 10.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain losses from entrusted loan receivables.",
        "label": "Gain Losses From Entrusted Loan Receivables",
        "terseLabel": "Gains from entrusted loan receivables"
       }
      }
     },
     "localname": "GainLossesFromEntrustedLoanReceivables",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_GainsLossesFromStructuredDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gains (losses) from structured deposits.",
        "label": "Gains (losses) from structured deposits",
        "negatedLabel": "Gains from structured deposits",
        "terseLabel": "Gains from structured deposits"
       }
      }
     },
     "localname": "GainsLossesFromStructuredDeposits",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfProfitLossBeforeTaxationToCashUsedInOperationDetails",
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInOtherGains": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 6.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of exchange differences recognised in other gains.",
        "label": "Foreign exchange gain (loss) recognized in other gains",
        "terseLabel": "Net foreign exchange gains / (losses)",
        "verboseLabel": "Net foreign exchange (losses)/gains included in Other gains/(losses) - net"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInOtherGains",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsForeignExchangeRiskForeignExchangeRiskDetails",
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_GaoqiaoCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gaoqiao company.",
        "label": "Gaoqiao Company [Member]"
       }
      }
     },
     "localname": "GaoqiaoCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_GeneralInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General information [Abstract]",
        "label": "General information [abstract]"
       }
      }
     },
     "localname": "GeneralInformationAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_GeneralInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General information [line items]",
        "label": "General information [line items]"
       }
      }
     },
     "localname": "GeneralInformationLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_GeneralInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General information [table]",
        "label": "General information [table]"
       }
      }
     },
     "localname": "GeneralInformationTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails",
      "http://SinopecShanghai.com/role/GeneralInformationTheFifteenthMeetingOfTheSeventhTermOfBoardOfDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_GrossUndiscountedCashFlowsDiscountedAndEndorsedBills": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross undiscounted cash flows discounted and endorsed bills.",
        "label": "Gross Undiscounted Cash Flows Discounted And Endorsed Bills",
        "verboseLabel": "Gross undiscounted cash flows discounted and endorsed bills"
       }
      }
     },
     "localname": "GrossUndiscountedCashFlowsDiscountedAndEndorsedBills",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_GroupsShareOfOtherAssociatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group's share of other associates [abstract]",
        "label": "Group's share of other associates [abstract]",
        "terseLabel": "Aggregate amounts of the group's share of:"
       }
      }
     },
     "localname": "GroupsShareOfOtherAssociatesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedFinancialInformationForOtherAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_HSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "H shares [member]",
        "label": "H shares [member]"
       }
      }
     },
     "localname": "HSharesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_HedgingInstrumentAssetsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedging instrument assets net.",
        "label": "Hedging Instrument Assets Net",
        "periodEndLabel": "Ending balance - Post-tax",
        "periodStartLabel": "Beginning balance - Post-tax"
       }
      }
     },
     "localname": "HedgingInstrumentAssetsNet",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_HedgingInstrumentAssetsReclassifiedToCostOfInventoryNetOfTaxNotIncludedInOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedging instrument assets reclassified to cost of inventory net of tax not included in other comprehensive income.",
        "label": "Hedging Instrument Assets Reclassified To Cost Of Inventory Net Of Tax Not Included In Other Comprehensive Income",
        "negatedLabel": "Reclassified to inventory"
       }
      }
     },
     "localname": "HedgingInstrumentAssetsReclassifiedToCostOfInventoryNetOfTaxNotIncludedInOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_HedgingInstrumentAssetsReclassifiedToCostOfInventoryNotIncludedInOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of hedging instrument assets reclassified to cost of inventory, not included in other comprehensive income",
        "label": "Hedging instrument assets reclassified to cost of inventory, not included in other comprehensive income",
        "negatedLabel": "Reclassified to inventory"
       }
      }
     },
     "localname": "HedgingInstrumentAssetsReclassifiedToCostOfInventoryNotIncludedInOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_HedgingInstrumentAssetsTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedging instrument assets tax.",
        "label": "Hedging Instrument Assets Tax",
        "periodEndLabel": "Ending balance - Tax effect",
        "periodStartLabel": "Beginning balance - Tax effect"
       }
      }
     },
     "localname": "HedgingInstrumentAssetsTax",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_HighestPricePerSharePaidSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Highest price per share paid shares repurchased.",
        "label": "Highest Price Per Share Paid Shares Repurchased",
        "terseLabel": "Highest price paid per share"
       }
      }
     },
     "localname": "HighestPricePerSharePaidSharesRepurchased",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "shi_IdleOrObsoleteProductionTechnologyFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Idle or Obsolete Production Technology Facilities [Member]",
        "terseLabel": "Idle or obsolete production technology facilities [member]"
       }
      }
     },
     "localname": "IdleOrObsoleteProductionTechnologyFacilitiesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_IfrsSeventeenInsuranceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IFRS seventeen insurance contracts.",
        "label": "IFRS Seventeen Insurance Contracts [Member]",
        "terseLabel": "IFRS 17, Insurance contracts [Member]"
       }
      }
     },
     "localname": "IfrsSeventeenInsuranceContractsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ImpairmentForBadAndDoubtfulDebtsAndProvisionForInventoriesAndPayrollPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment for bad and doubtful debts and provision for inventories and payroll payables [member]",
        "label": "Impairment for bad and doubtful debts and provision for inventories and payroll payables [member]",
        "terseLabel": "Impairment for bad and doubtful debts and provision for inventories [member]"
       }
      }
     },
     "localname": "ImpairmentForBadAndDoubtfulDebtsAndProvisionForInventoriesAndPayrollPayablesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ImpairmentLossIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Loss Income.",
        "label": "Impairment Loss Income",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "ImpairmentLossIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ImpairmentLossOnInvestmentInAssociates": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment loss on investment in associates.",
        "label": "Impairment Loss On Investment In Associates",
        "negatedLabel": "Impairment Loss On Investment In Associates",
        "terseLabel": "Impairment",
        "verboseLabel": "Impairment loss on investment in associates"
       }
      }
     },
     "localname": "ImpairmentLossOnInvestmentInAssociates",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ImpairmentLossesForInvestmentInAnAssociate": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment losses for investment in an associate.",
        "label": "Impairment losses for Investment In an Associate",
        "negatedLabel": "Impairment losses for investment in an associate"
       }
      }
     },
     "localname": "ImpairmentLossesForInvestmentInAnAssociate",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ImpairmentLossesMovementInLossAllowanceForTradeReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_ImpairmentLossOnFinancialAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment losses, movement in loss allowance for trade receivables.",
        "label": "Impairment losses, movement in loss allowance for trade receivables",
        "negatedLabel": "Impairment losses - provision in loss allowance for trade receivables"
       }
      }
     },
     "localname": "ImpairmentLossesMovementInLossAllowanceForTradeReceivables",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ImpairmentLossesOnPropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment losses on property, plant and equipment [member]",
        "label": "Impairment losses on property, plant and equipment [member]"
       }
      }
     },
     "localname": "ImpairmentLossesOnPropertyPlantAndEquipmentMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesDeferredTaxAssetsNotRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ImpairmentLossesProvisionInLossAllowanceForOtherReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_ImpairmentLossOnFinancialAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment losses provision in loss allowance for other receivables.",
        "label": "Impairment Losses Provision In Loss Allowance For Other Receivables",
        "negatedLabel": "Impairment losses - provision in loss allowance for other receivables"
       }
      }
     },
     "localname": "ImpairmentLossesProvisionInLossAllowanceForOtherReceivables",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNetProvisionOfImpairmentLossesOnFinancialAssetsRecognizedInIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncomeStatementLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income statement location.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_IncomeStatementLocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income statement location.",
        "label": "Income Statement Location [Member]"
       }
      }
     },
     "localname": "IncomeStatementLocationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_IncomeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax.",
        "label": "Income tax"
       }
      }
     },
     "localname": "IncomeTax",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesSummaryOfCurrentTaxationInTheConsolidatedStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncomeTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax [abstract]",
        "label": "Income tax [abstract]"
       }
      }
     },
     "localname": "IncomeTaxAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_IncomeTaxPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax payable.",
        "label": "Income Tax Payable",
        "terseLabel": "Payable"
       }
      }
     },
     "localname": "IncomeTaxPayable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesSummaryOfCurrentTaxationInTheConsolidatedStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncomeTaxPrepaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax prepaid.",
        "label": "Income Tax Prepaid",
        "periodEndLabel": "At the end of the year",
        "periodStartLabel": "At beginning of the year",
        "terseLabel": "Prepaid"
       }
      }
     },
     "localname": "IncomeTaxPrepaid",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesSummaryOfCurrentTaxationInTheConsolidatedStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncomeTaxRelatingToHedgingInstrumentsReclassifiedToInventoryOfOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax relating to hedging instruments reclassified to inventory of other comprehensive income.",
        "label": "Income Tax Relating To Hedging Instruments Reclassified To Inventory Of Other Comprehensive Income",
        "terseLabel": "Reclassified to inventory"
       }
      }
     },
     "localname": "IncomeTaxRelatingToHedgingInstrumentsReclassifiedToInventoryOfOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementReconciliationOfHedgingReserveInRespectOfCommodityPriceRiskAndEffectivenessOfHedgingRelationshipsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseInInvestmentPropertyResultingFromTransfersFromPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in investment property resulting from transfers from property, plant and equipment.",
        "label": "Increase (decrease) in investment property resulting from transfers from property, plant and equipment",
        "terseLabel": "Transferred from property plant and equipment"
       }
      }
     },
     "localname": "IncreaseDecreaseInInvestmentPropertyResultingFromTransfersFromPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseInInvestmentPropertyResultingFromTransfersToPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in investment property resulting from transfers to property, plant and equipment.",
        "label": "Increase (decrease) in investment property resulting from transfers to property, plant and equipment",
        "terseLabel": "Transferred to property plant and equipment"
       }
      }
     },
     "localname": "IncreaseDecreaseInInvestmentPropertyResultingFromTransfersToPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseInNetProfitLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in net profit loss.",
        "label": "Increase Decrease In Net Profit Loss",
        "terseLabel": "Increase decrease in net profit loss"
       }
      }
     },
     "localname": "IncreaseDecreaseInNetProfitLoss",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseOfFinancialAssetsDueToAcquisitions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase/decrease of financial assets due to acquisitions.",
        "label": "Increase (decrease) of financial assets due to acquisitions",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "IncreaseDecreaseOfFinancialAssetsDueToAcquisitions",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseOfFinancialAssetsDueToDisposals": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase/decrease of financial assets due to disposals.",
        "label": "Increase (decrease) of financial assets due to disposals",
        "negatedLabel": "Disposals"
       }
      }
     },
     "localname": "IncreaseDecreaseOfFinancialAssetsDueToDisposals",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseOfFinancialAssetsDueToFairValueChanges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase/decrease of financial assets due to acquisitions fair value changes.",
        "label": "Increase (decrease) of financial assets due to fair value changes",
        "terseLabel": "Fair value change"
       }
      }
     },
     "localname": "IncreaseDecreaseOfFinancialAssetsDueToFairValueChanges",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreasePercentageInMarketPriceOfCrudeOil": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease percentage in market price of crude oil.",
        "label": "Increase Decrease Percentage In Market Price Of Crude Oil",
        "terseLabel": "Increase decrease percentage in market price of crude oil"
       }
      }
     },
     "localname": "IncreaseDecreasePercentageInMarketPriceOfCrudeOil",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease Through Changes Other Than From Financing Cash Flows Liabilities Arising From Financing Activities",
        "label": "Increase Decrease Through Changes Other Than From Financing Cash Flows Liabilities Arising From Financing Activities",
        "totalLabel": "Total other changes"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease Through Changes Other Than From Financing Cash Flows Liabilities Arising From Financing Activities",
        "label": "Increase Decrease Through Changes Other Than From Financing Cash Flows Liabilities Arising From Financing Activities [Abstract]",
        "terseLabel": "Other changes:"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivitiesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities",
        "label": "Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities [Abstract]",
        "terseLabel": "Changes from financing cash flows:"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivitiesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_IncreaseDecreaseThroughTransfersFromInvestmentPropertyPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from investment property",
        "label": "The increase (decrease) in property, plant and equipment resulting from transfers from investment property",
        "terseLabel": "Transferred from investment properties"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersFromInvestmentPropertyPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseThroughTransfersFromPropertyPlantAndEquipmentConstructionInProgress": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease through transfers from property plant and equipment construction in progress.",
        "label": "Increase Decrease Through Transfers From Property Plant And Equipment Construction In Progress",
        "terseLabel": "Transferred from property plant and equipment"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersFromPropertyPlantAndEquipmentConstructionInProgress",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseThroughTransfersToPropertyPlantAndEquipmentConstructionInProgress": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) through transfers to property, plant and equipment, construction in progress.",
        "label": "Increase (decrease) through transfers to property, plant and equipment, construction in progress",
        "terseLabel": "Transferred to property plant and equipment"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersToPropertyPlantAndEquipmentConstructionInProgress",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConstructionInProgressDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IncreaseDecreaseThroughUtilisationOfSafetyProductionFund": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) through utilisation of safety production fund",
        "label": "Increase (decrease) through utilisation of safety production fund",
        "terseLabel": "Appropriation of safety production fund"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughUtilisationOfSafetyProductionFund",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IntangibleAssetsOtherThanGoodwillAndLongTermPrepaidExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets other than goodwill and long term prepaid expense.",
        "label": "Intangible Assets Other Than Goodwill And Long Term Prepaid Expense [Member]",
        "terseLabel": "Intangible Assets Other Than Goodwill And Long Term Prepaid Expense [Member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillAndLongTermPrepaidExpenseMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_InterestAndFinanceChargesPaidPayableForLeaseLiabilitiesAndFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_InterestExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss.",
        "label": "Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss",
        "negatedLabel": "Interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss"
       }
      }
     },
     "localname": "InterestAndFinanceChargesPaidPayableForLeaseLiabilitiesAndFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinanceIncomeAndExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestBearingBorrowingsNonCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest bearing borrowings non current.",
        "label": "Interest Bearing Borrowings Non Current",
        "terseLabel": "Interest-bearing borrowings"
       }
      }
     },
     "localname": "InterestBearingBorrowingsNonCurrent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestExpenseOnLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 7.0,
       "parentTag": "shi_IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense On Liabilities Arising From Financing Activities",
        "label": "Interest Expense On Liabilities Arising From Financing Activities",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseOnLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestInAssociatesAndJointVentures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest in associates and joint ventures",
        "label": "Interest in associates and joint ventures",
        "verboseLabel": "Interest in joint ventures"
       }
      }
     },
     "localname": "InterestInAssociatesAndJointVentures",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestReceivedFromBanksExcludedStructuredDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from interest received from banks excluded structured deposits, classified as investing activities.",
        "label": "Interest Received From Banks Excluded Structured Deposits",
        "verboseLabel": "Interest received from banks excluded structured deposits"
       }
      }
     },
     "localname": "InterestReceivedFromBanksExcludedStructuredDeposits",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestReceivedFromEntrustedLoans": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 17.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest received from entrusted loans.",
        "label": "Interest Received From Entrusted Loans",
        "terseLabel": "Interest received from entrusted loans"
       }
      }
     },
     "localname": "InterestReceivedFromEntrustedLoans",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestReceivedFromRelatedPartiesClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest received from related parties, classified as investing activities",
        "label": "Interest received from related parties, classified as investing activities",
        "terseLabel": "Interest received from related parties"
       }
      }
     },
     "localname": "InterestReceivedFromRelatedPartiesClassifiedAsInvestingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InterestReceivedFromStructuredDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from interest received from structured deposits, classified as investing activities.",
        "label": "Interest received from structured deposits"
       }
      }
     },
     "localname": "InterestReceivedFromStructuredDeposits",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_IntermediatePetrochemicalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intermediate petrochemicals [member]",
        "label": "Intermediate petrochemicals [member]"
       }
      }
     },
     "localname": "IntermediatePetrochemicalsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_InvestmentAdditionInAssociates": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of additions to Investment in associates.",
        "label": "Investment addition in associates",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "InvestmentAdditionInAssociates",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInAssociatesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InvestmentAdditionInJointVentures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment addition in joint ventures.",
        "label": "Investment Addition In Joint Ventures",
        "terseLabel": "Addition (note i)"
       }
      }
     },
     "localname": "InvestmentAdditionInJointVentures",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodInvestmentInJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_InvestmentDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment deposits.",
        "label": "Investment Deposits [Member]",
        "terseLabel": "Investment Deposits [Member]"
       }
      }
     },
     "localname": "InvestmentDepositsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_IssuanceCostsOnShortTermBondsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 6.0,
       "parentTag": "shi_IncreaseDecreaseThroughChangesOtherThanFromFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance Costs On Short Term Bonds Liabilities Arising From Financing Activities",
        "label": "Issuance Costs On Short Term Bonds Liabilities Arising From Financing Activities",
        "terseLabel": "Issuance costs on short-term bonds"
       }
      }
     },
     "localname": "IssuanceCostsOnShortTermBondsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_JiangsuJinlingOptaPolymerCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jiangsu Jinling Opta Polymer Company Limited [member]",
        "label": "Jiangsu Jinling Opta Polymer Company Limited [member]"
       }
      }
     },
     "localname": "JiangsuJinlingOptaPolymerCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_JointVenturesOfTheGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint ventures of the Group [member]",
        "label": "Joint ventures of the Group [member]"
       }
      }
     },
     "localname": "JointVenturesOfTheGroupMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LandUseRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for land use rights.",
        "label": "Land use rights [member]",
        "terseLabel": "Land use rights [member]"
       }
      }
     },
     "localname": "LandUseRightsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/LeasesStatementsOfProfitLossAmountRelatingToLeasesDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesLeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LaterThanTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Later than two years [member]",
        "label": "Later than two years [member]",
        "terseLabel": "Over two years [member]"
       }
      }
     },
     "localname": "LaterThanTwoYearsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LeasedInvestmentPropertiesLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leased investment properties, Lease term.",
        "label": "Leased Investment Properties Lease Term",
        "terseLabel": "Leased investment properties, Lease term"
       }
      }
     },
     "localname": "LeasedInvestmentPropertiesLeaseTerm",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "shi_LegalReserveAsAPercentageOfRegisteredCapitalAfterIssuanceAfterConversionIntoOrdinarySharesIfAny": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal reserve as a percentage of registered capital after issuance after conversion into ordinary shares if any.",
        "label": "Legal Reserve As A Percentage Of Registered Capital After Issuance After Conversion Into Ordinary Shares If Any",
        "terseLabel": "Legal reserve as a percentage of registered capital after issuance or conversion into ordinary shares if any"
       }
      }
     },
     "localname": "LegalReserveAsAPercentageOfRegisteredCapitalAfterIssuanceAfterConversionIntoOrdinarySharesIfAny",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_LianhuaNingboInternationalLogisticsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lianhua ningbo international logistics limited.",
        "label": "Lianhua (Ningbo) International Logistics Limited [Member]"
       }
      }
     },
     "localname": "LianhuaNingboInternationalLogisticsLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LindeSpcGasesCompanyLimitedFormerlyKnownAsbocspcGasesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Linde SPC gases company limited formerly known as BOCSPC gases company limited.",
        "label": "Linde SPC Gases Company Limited Formerly Known AsBOCSPC Gases Company Limited [Member]",
        "terseLabel": "Linde [Member]"
       }
      }
     },
     "localname": "LindeSpcGasesCompanyLimitedFormerlyKnownAsbocspcGasesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LineOfCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility.",
        "label": "Line Of Credit Facility [Member]",
        "terseLabel": "Line of Credit Facility [member]"
       }
      }
     },
     "localname": "LineOfCreditFacilityMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location.",
        "label": "Location [Axis]"
       }
      }
     },
     "localname": "LocationAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_LocationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location.",
        "label": "Location [Member]"
       }
      }
     },
     "localname": "LocationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LongTermPrepaidExpenseInLeaseholdImprovementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term prepaid expense in leasehold improvement.",
        "label": "Long Term Prepaid Expense In Leasehold Improvement [Member]",
        "verboseLabel": "Long-term prepaid expense - leasehold improvement"
       }
      }
     },
     "localname": "LongTermPrepaidExpenseInLeaseholdImprovementMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LongTermPrepaidExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for long-term prepaid expense.",
        "label": "Long-term prepaid expense [member]"
       }
      }
     },
     "localname": "LongTermPrepaidExpenseMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_LossesOnSaleOfAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gain/losses on sale of assets measured at fair value through other comprehensive income",
        "label": "Losses on sale of assets measured at FVOCI",
        "negatedLabel": "Losses on sale of FVOCI"
       }
      }
     },
     "localname": "LossesOnSaleOfAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_LowestPricePerSharePaidSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lowest price per share paid shares repurchased.",
        "label": "Lowest Price Per Share Paid Shares Repurchased",
        "terseLabel": "Lowest price paid per share"
       }
      }
     },
     "localname": "LowestPricePerSharePaidSharesRepurchased",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "shi_MaomingShihuaDongchengChemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maoming shihua dongcheng chemical company limited.",
        "label": "Maoming Shihua Dongcheng Chemical Company Limited [Member]"
       }
      }
     },
     "localname": "MaomingShihuaDongchengChemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_MaturityPeriodOfCommodityContractsEntered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity period of commodity contracts entered.",
        "label": "Maturity Period Of Commodity Contracts Entered",
        "terseLabel": "Maturity period of cash flow hedge"
       }
      }
     },
     "localname": "MaturityPeriodOfCommodityContractsEntered",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "shi_MinimumLeasePaymentsReceivableOnInvestmentPropertiesLeasesAboveTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum lease payments receivable on investment properties leases above two years [member]",
        "label": "Minimum lease payments receivable on investment properties leases above two years [member]",
        "terseLabel": "Above 2 years [member]"
       }
      }
     },
     "localname": "MinimumLeasePaymentsReceivableOnInvestmentPropertiesLeasesAboveTwoYearsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentPropertiesMinimumLeasePaymentsReceivableOnLeasesOfInvestmentPropertiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NanjingYangzhiPetrochemicalIndutryCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nanjing yangzhi petrochemical indutry company limited.",
        "label": "Nanjing Yangzhi Petrochemical Indutry Company Limited [Member]"
       }
      }
     },
     "localname": "NanjingYangzhiPetrochemicalIndutryCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NantongDonghaiPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nantong donghai petrochemical company limited.",
        "label": "Nantong Donghai Petrochemical Company Limited [Member]"
       }
      }
     },
     "localname": "NantongDonghaiPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NationalPetrochemicalProjectRiskAssessmentTechnologyCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "National Petrochemical Project Risk Assessment Technology Center [member]",
        "label": "National Petrochemical Project Risk Assessment Technology Center [member]"
       }
      }
     },
     "localname": "NationalPetrochemicalProjectRiskAssessmentTechnologyCenterMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NetGainsLossesOnCommoditySwapsContractsNotQualifiedForHedgingAccounting": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 7.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net gains (losses) on commodity swaps contracts not qualified for hedging accounting.",
        "label": "Net Gains Losses on Commodity Swaps Contracts Not Qualified for Hedging Accounting",
        "terseLabel": "Net gains/(losses) on commodity swaps contracts not qualified for hedging accounting"
       }
      }
     },
     "localname": "NetGainsLossesOnCommoditySwapsContractsNotQualifiedForHedgingAccounting",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_NetGainsLossesOnDisposalOfPropertyPlantAndEquipmentAndOtherLongTermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net gains losses on disposal of property plant and equipment and other long term assets.",
        "label": "Net Gains Losses on Disposal of Property Plant and Equipment and Other Long Term Assets",
        "verboseLabel": "Net (losses) / gains on disposal of property, plant and equipment and other long-term assets"
       }
      }
     },
     "localname": "NetGainsLossesOnDisposalOfPropertyPlantAndEquipmentAndOtherLongTermAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_NetLossesOnDisposalOfInventory": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_OtherGainsLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net losses on disposal of inventory.",
        "label": "Net Losses on Disposal of Inventory",
        "negatedLabel": "Net losses on disposal of inventories"
       }
      }
     },
     "localname": "NetLossesOnDisposalOfInventory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_NetSales": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome": {
       "order": 6.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Sales",
        "label": "Net sales",
        "totalLabel": "Net sales"
       }
      }
     },
     "localname": "NetSales",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfProfitOrLossAndOtherComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_NingboEastseaLinefanTechnologyCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NingboEastsea Linefan Technology Company Limited [member]",
        "label": "Ningbo Eastsea Linefan Technology Company Limited [member]"
       }
      }
     },
     "localname": "NingboEastseaLinefanTechnologyCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NingboEngineeringCompanyOfSinopecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ningbo engineering company of sinopec.",
        "label": "Ningbo Engineering Company of Sinopec [Member]"
       }
      }
     },
     "localname": "NingboEngineeringCompanyOfSinopecMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NingboMinggangGasCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ningbo Minggang Gas Company Limited [member]",
        "label": "Ningbo Minggang Gas Company Limited [member]"
       }
      }
     },
     "localname": "NingboMinggangGasCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NonCurrentBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current borrowings.",
        "label": "Non Current Borrowings",
        "terseLabel": "Long-term borrowings"
       }
      }
     },
     "localname": "NonCurrentBorrowings",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_NovemberTwoThousandAndTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November two thousand and twenty two.",
        "label": "November Two Thousand And Twenty Two [Member]"
       }
      }
     },
     "localname": "NovemberTwoThousandAndTwentyTwoMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_NumberOfCustomersAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers.",
        "label": "Number Of Customers [Axis]"
       }
      }
     },
     "localname": "NumberOfCustomersAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_NumberOfCustomersDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers.",
        "label": "Number Of Customers [Domain]"
       }
      }
     },
     "localname": "NumberOfCustomersDomain",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_OctoberTwoThousandAndTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October two thousand and twenty two.",
        "label": "October Two Thousand And Twenty Two [Member]"
       }
      }
     },
     "localname": "OctoberTwoThousandAndTwentyTwoMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_OneLargestCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One largest customer.",
        "label": "One Largest Customer [Member]"
       }
      }
     },
     "localname": "OneLargestCustomerMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_OrdinaryASharesListedInPRCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for ordinary A shares listed in PRC.",
        "label": "Ordinary A shares listed in PRC [member]"
       }
      }
     },
     "localname": "OrdinaryASharesListedInPRCMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_OtherCurrentReceivablesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross amount of current other receivables.",
        "label": "Other current receivables, gross",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivablesGross",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_OtherCurrentReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other current receivables.",
        "label": "Other Current Receivables [Member]",
        "terseLabel": "Other Current Receivables [Member]"
       }
      }
     },
     "localname": "OtherCurrentReceivablesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_OtherCurrentReceivablesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other current receivables net.",
        "label": "Other Current Receivables Net",
        "terseLabel": "Other receivables net"
       }
      }
     },
     "localname": "OtherCurrentReceivablesNet",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_OtherGainsLossesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other gains(losses) - net [abstract].",
        "label": "Other gains/(losses) - net [abstract]"
       }
      }
     },
     "localname": "OtherGainsLossesNetAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_OtherGainsNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other gains net.",
        "label": "Other Gains Net [Line Items]"
       }
      }
     },
     "localname": "OtherGainsNetLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_OtherLossesgainsNetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other gains net.",
        "label": "Other (losses)gains net [Table]"
       }
      }
     },
     "localname": "OtherLossesgainsNetTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the amount of other non-current assets.",
        "label": "Other non-current assets [member]",
        "terseLabel": "Total [member]"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/OtherNonCurrentAssetsMovementInNetBookAmountDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_OtherOperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other operating expenses [abstract]",
        "label": "Other operating expenses [abstract]"
       }
      }
     },
     "localname": "OtherOperatingExpensesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_OtherOperatingIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other operating income [abstract]",
        "label": "Other operating income [abstract]"
       }
      }
     },
     "localname": "OtherOperatingIncomeAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_PaidUpCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paid up capital.",
        "label": "Paid Up Capital",
        "terseLabel": "Paid up capital",
        "verboseLabel": "Particulars of paid-up capital"
       }
      }
     },
     "localname": "PaidUpCapital",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_PaymentsForSaleOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 23.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payment for sale of financial assets at fair value through other comprehensive income, classified as investing activities",
        "label": "Payments for sale of financial assets at fair value through other comprehensive income",
        "negatedLabel": "Payment for sales of financial assets at fair value through other comprehensive income"
       }
      }
     },
     "localname": "PaymentsForSaleOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_PaymentsOfLeaseLiabilitiesClassifiedAsOperatingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashOutflowForLeases",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Of Lease Liabilities Classified As Operating Activities",
        "label": "Payments Of Lease Liabilities Classified As Operating Activities",
        "negatedLabel": "Within operating cash flows"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsOperatingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsSummaryOfCashFlowStatementsForLeasesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_PercentageOfIssuedShareCapitalStateOwnedLegalSharesTransferred": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of issued share capital represented by state-owned legal shares transferred.",
        "label": "Percentage of issued share capital, state-owned legal shares transferred"
       }
      }
     },
     "localname": "PercentageOfIssuedShareCapitalStateOwnedLegalSharesTransferred",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_PercentageOfNetIncomeToBeTransferredToLegalSurplusReserve": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of net income to be transferred to legal surplus reserve.",
        "label": "Percentage Of Net Income To Be Transferred To Legal Surplus Reserve",
        "terseLabel": "Percentage of net income to be transferred to legal surplus reserve"
       }
      }
     },
     "localname": "PercentageOfNetIncomeToBeTransferredToLegalSurplusReserve",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_PercentageOfOwnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of ownership interest acquired.",
        "label": "Percentage of Ownership Interest Acquired",
        "terseLabel": "Percentage of ownership interest acquired"
       }
      }
     },
     "localname": "PercentageOfOwnershipInterestAcquired",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_PercentageOfTradeReceivablesDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of trade receivables due.",
        "label": "Percentage Of Trade Receivables Due",
        "terseLabel": "Percentage of trade receivables due"
       }
      }
     },
     "localname": "PercentageOfTradeReceivablesDue",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_PetroCyberworksInformationTechnologyCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Petro-Cyber Works Information Technology Company Limited [member]",
        "label": "Petro-CyberWorks Information Technology Company Limited [member]"
       }
      }
     },
     "localname": "PetroCyberworksInformationTechnologyCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_PetrolChemicalIndustryManagementCadreCollegeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Petrol-chemical industry management cadre college.",
        "label": "Petrol Chemical Industry Management Cadre College [Member]"
       }
      }
     },
     "localname": "PetrolChemicalIndustryManagementCadreCollegeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_PetroleumProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Petroleum products [member]",
        "label": "Petroleum products [member]"
       }
      }
     },
     "localname": "PetroleumProductsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_PlaceOfIncorporationAndBusinessOfSubsidiary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Place of incorporation and business of subsidiary.",
        "label": "Place Of Incorporation And Business Of Subsidiary",
        "terseLabel": "Place of incorporation and business"
       }
      }
     },
     "localname": "PlaceOfIncorporationAndBusinessOfSubsidiary",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_PlantAndMachineryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable plant and machinery and similar structures for use in operations. [Refer: Property, plant and equipment]",
        "label": "Plant and machinery [member]",
        "terseLabel": "Plant and machinery [member]"
       }
      }
     },
     "localname": "PlantAndMachineryMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Possible impact of amendments new accounting standards and interpretations issued but not yet effective.",
        "label": "Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective",
        "terseLabel": "Possible impact of amendments, new standards and interpretations issued but not yet effective for the year ended 31 December 2022"
       }
      }
     },
     "localname": "PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffective",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffectiveAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Possible impact of amendments new accounting standards and interpretations issued but not yet effective.",
        "label": "Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Abstract]"
       }
      }
     },
     "localname": "PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffectiveAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffectiveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Possible impact of amendments new accounting standards and interpretations issued but not yet effective.",
        "label": "Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Line Items]"
       }
      }
     },
     "localname": "PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffectiveLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffectiveTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Possible impact of amendments new accounting standards and interpretations issued but not yet effective.",
        "label": "Possible Impact Of Amendments New Accounting Standards And Interpretations Issued But Not Yet Effective [Table]"
       }
      }
     },
     "localname": "PossibleImpactOfAmendmentsNewAccountingStandardsAndInterpretationsIssuedButNotYetEffectiveTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_PrepaidExpenseNonCurrentCatalystMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expense non current catalyst.",
        "label": "Prepaid Expense Non Current Catalyst [Member]",
        "terseLabel": "Long-term prepaid expense - catalyst"
       }
      }
     },
     "localname": "PrepaidExpenseNonCurrentCatalystMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_PrincipalPlaceOfBusinessOrCountryOfIncorporationOfAssociatesAndJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal place of business or country of incorporation of associates and joint ventures.",
        "label": "Principal place of business or country of incorporation of associates and joint ventures.",
        "terseLabel": "Place of business/country of incorporation"
       }
      }
     },
     "localname": "PrincipalPlaceOfBusinessOrCountryOfIncorporationOfAssociatesAndJointVentures",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_ProceedsFromBorrowingsFromBanksClassifiedAsFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": -1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 29.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from borrowings from banks, classified as financing activities",
        "label": "Proceeds from borrowings from banks, classified as financing activities",
        "terseLabel": "Proceeds from borrowings",
        "verboseLabel": "Proceeds from new bank loans"
       }
      }
     },
     "localname": "ProceedsFromBorrowingsFromBanksClassifiedAsFinancingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ProceedsFromCapitalReductionOfAnAssociate": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 11.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from capital reduction of an associate.",
        "label": "Proceeds From Capital Reduction Of An Associate",
        "verboseLabel": "Proceeds from capital reduction of an associate"
       }
      }
     },
     "localname": "ProceedsFromCapitalReductionOfAnAssociate",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ProceedsFromSalesOrMaturityOfFinancialInstrumentClassifiedAsInvestingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlowAlternate3": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash (outflow) / inflow from sales or maturity of financial instrument, classified as investing activity.",
        "label": "Proceeds from sales or maturity of financial instrument, classified as investing activity",
        "terseLabel": "(Payments)/proceeds from settlement of derivative financial instruments"
       }
      }
     },
     "localname": "ProceedsFromSalesOrMaturityOfFinancialInstrumentClassifiedAsInvestingActivity",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ProceedsFromShortTermBonds": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": -1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 30.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from short-term bonds.",
        "label": "Proceeds from short-term bonds",
        "terseLabel": "Proceeds from short-term bonds"
       }
      }
     },
     "localname": "ProceedsFromShortTermBonds",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ProportionOfOwnershipInterestsHeldByASubsidiary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proportion of ownership interests held by a subsidiary.",
        "label": "Proportion Of Ownership Interests Held By A Subsidiary",
        "terseLabel": "Held by the Company",
        "verboseLabel": "Proportion of ownership interest Held by a subsidiary"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestsHeldByASubsidiary",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_ProvisionForDeclinesInValueOfInventoriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for declines in value of inventories [member]",
        "label": "Provision for declines in value of inventories [member]",
        "terseLabel": "Provision for declines in the value of inventories [member]"
       }
      }
     },
     "localname": "ProvisionForDeclinesInValueOfInventoriesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ProvisionForImpairmentLossesInFixedAssetsConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for impairment losses in fixed assets, construction in progress [member]",
        "label": "Provision for impairment losses in fixed assets, construction in progress [member]",
        "terseLabel": "Provision for impairment losses in property, plant and equipment and construction in progress [member]"
       }
      }
     },
     "localname": "ProvisionForImpairmentLossesInFixedAssetsConstructionInProgressMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_PurchaseRelatedPartyTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase related party transaction",
        "label": "Purchase related party transaction",
        "terseLabel": "Purchase"
       }
      }
     },
     "localname": "PurchaseRelatedPartyTransaction",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_PurchasesOfCrudeOil": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of crude oil",
        "label": "Purchases of crude oil"
       }
      }
     },
     "localname": "PurchasesOfCrudeOil",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_PurchasesOtherThanCrudeOil": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases other than crude oil",
        "label": "Purchases other than crude oil"
       }
      }
     },
     "localname": "PurchasesOtherThanCrudeOil",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_QingdaoZhonghuaSunshineManagementSystemCertificationCentreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qingdao zhonghua sunshine management system certification centre.",
        "label": "Qingdao Zhonghua Sunshine Management System Certification Centre [Member]"
       }
      }
     },
     "localname": "QingdaoZhonghuaSunshineManagementSystemCertificationCentreMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_RateOfForeignCurrenciesAgainstReportingCurrencyWeakenedStrengthenedForSensitivityAnalysisOfFinancialRisk": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of foreign currencies against reporting currency weakened (strengthened) for sensitivity analysis of financial risk",
        "label": "Rate of foreign currencies against reporting currency weakened (strengthened) for sensitivity analysis of financial risk",
        "terseLabel": "Foreign currencies weakened/strengthened rate against RMB"
       }
      }
     },
     "localname": "RateOfForeignCurrenciesAgainstReportingCurrencyWeakenedStrengthenedForSensitivityAnalysisOfFinancialRisk",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shi_ReclassificationAdjustmentsOnPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification adjustments on property, plant and equipment",
        "label": "Reclassification adjustments on property, plant and equipment",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "ReclassificationAdjustmentsOnPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_RegisteredCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered capital",
        "label": "Registered capital",
        "terseLabel": "Capital registered"
       }
      }
     },
     "localname": "RegisteredCapital",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_RepaymentsOfBorrowingsToBanksClassifiedAsFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
       "weight": 1.0
      },
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 31.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of borrowings to banks, classified as financing activities",
        "label": "Repayments of borrowings to banks, classified as financing activities",
        "negatedLabel": "Repayment of bank loans",
        "negatedTerseLabel": "Repayments of borrowings"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsToBanksClassifiedAsFinancingActivities",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_RepaymentsOfShorttermBonds": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow": {
       "order": 35.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of short-term bonds.",
        "label": "Repayments Of ShortTerm Bonds",
        "negatedLabel": "Repayments of short-term bonds"
       }
      }
     },
     "localname": "RepaymentsOfShorttermBonds",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ReportingStandardDetailsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reporting standard details.",
        "label": "Reporting Standard Details [Axis]"
       }
      }
     },
     "localname": "ReportingStandardDetailsAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_ReportingStandardDetailsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reporting standard details.",
        "label": "Reporting Standard Details [Member]"
       }
      }
     },
     "localname": "ReportingStandardDetailsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PossibleImpactOfAmendmentsNewStandardsAndInterpretationsIssuedButNotYetEffectiveForTheYearEnded31December2022SummaryOfNumberOfAmendmentsNewStandardsAndInterpretationsWhichAreNotYetEffectiveDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_RepurchasePeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase period [Axis].",
        "label": "Repurchase Period [Axis]"
       }
      }
     },
     "localname": "RepurchasePeriodAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_RepurchasePeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase period.",
        "label": "Repurchase Period [Member]"
       }
      }
     },
     "localname": "RepurchasePeriodMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_Reserves": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserves",
        "label": "Reserves",
        "periodEndLabel": "Balance at 31 December",
        "periodStartLabel": "Balance at 1 January",
        "terseLabel": "Reserves"
       }
      }
     },
     "localname": "Reserves",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_ReservesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserves [member]",
        "label": "Reserves [member]",
        "terseLabel": "Total [member]"
       }
      }
     },
     "localname": "ReservesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ResinsAndPlasticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Resins and plastics [member]",
        "label": "Resins and plastics [member]"
       }
      }
     },
     "localname": "ResinsAndPlasticsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_RevenueFromSaleOfOtherThanPetroleumAndPetrochemicalProducts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of other than petroleum and petrochemical products.",
        "label": "Revenue from sale of other than petroleum and petrochemical products",
        "terseLabel": "Sales other than petroleum products"
       }
      }
     },
     "localname": "RevenueFromSaleOfOtherThanPetroleumAndPetrochemicalProducts",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_RevenueFromSalesOfGoodsAndServiceFeeRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sales of goods and service fee, related party transactions",
        "label": "Revenue from sales of goods and service fee, related party transactions",
        "terseLabel": "Sales of goods and service fee income"
       }
      }
     },
     "localname": "RevenueFromSalesOfGoodsAndServiceFeeRelatedPartyTransactions",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_RevenueRecognizedAtAPointInTimeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognized at a point in time [member]",
        "label": "Revenue recognized at a point in time [member]",
        "terseLabel": "At a point in time [member]"
       }
      }
     },
     "localname": "RevenueRecognizedAtAPointInTimeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_RevenueRecognizedOverTimeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognized over time [member]",
        "label": "Revenue recognized over time [member]",
        "terseLabel": "Over time [member]"
       }
      }
     },
     "localname": "RevenueRecognizedOverTimeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_RightOfUseAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-use assets [abstract]",
        "label": "Right-of-use Assets [abstract]",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetsAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_RightofuseAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of assets as of acquisition date that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.",
        "label": "Right-of-use assets as of acquisition date",
        "terseLabel": "Right-of-use assets generated by the acquisition of a subsidiary"
       }
      }
     },
     "localname": "RightofuseAssetsAsOfAcquisitionDate",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/LeasesStatementsOfFinancialPositionRelatingToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_RizhaoShihuaCrudeOilTerminalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rizhao Shihua Crude Oil Terminal Company Limited [member]",
        "label": "Rizhao Shihua Crude Oil Terminal Company Limited [member]",
        "terseLabel": "Rizhao Shihua Crude Oil Terminal Co., Ltd. [member]"
       }
      }
     },
     "localname": "RizhaoShihuaCrudeOilTerminalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SafetyProductionFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Safety production fund [member]",
        "label": "Safety production fund [member]"
       }
      }
     },
     "localname": "SafetyProductionFundMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ScheduleOfCashOutflowForLeasesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash outflow for leases explanatory.",
        "label": "Schedule Of Cash Outflow For Leases Explanatory [Table Text Block]",
        "terseLabel": "Summary of Lease Rentals"
       }
      }
     },
     "localname": "ScheduleOfCashOutflowForLeasesExplanatoryTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_ScheduleOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of movements in the loss allowance accounting respect of trade and other receivables explanatory.",
        "label": "Schedule Of Movements In The Loss Allowance AccountIng Respect Of Trade And Other Receivables Explanatory [Table Text Block]",
        "terseLabel": "Schedule of Movements in the Loss Allowance AccountIng Respect of Trade and Other Receivables Explanatory"
       }
      }
     },
     "localname": "ScheduleOfMovementsInTheLossAllowanceAccountingRespectOfTradeAndOtherReceivablesExplanatoryTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_ShanghaiAzbilAutomationCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Azbil Automation Company Limited [member]",
        "label": "Shanghai Azbil Automation Company Limited [member]",
        "terseLabel": "Azbil [member]",
        "verboseLabel": "Shanghai Azbil Automation Company Limited (\"Azbil\") [member]"
       }
      }
     },
     "localname": "ShanghaiAzbilAutomationCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiChangshiShippingLimitedCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Changshi Shipping Limited Company [member]",
        "label": "Shanghai Changshi Shipping Limited Company [member]",
        "terseLabel": "Shanghai Changshi Shipping Co., Ltd. [member]"
       }
      }
     },
     "localname": "ShanghaiChangshiShippingLimitedCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiChemicalIndustryParkDevelopmentCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Chemical Industry Park Development Company Limited [member]",
        "label": "Shanghai Chemical Industry Park Development Company Limited [member]",
        "terseLabel": "Chemical Industry [member]",
        "verboseLabel": "Shanghai Chemical Industry Park Development Company Limited (\"Chemical Industry\") [member]"
       }
      }
     },
     "localname": "ShanghaiChemicalIndustryParkDevelopmentCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiGoldenPhillipsPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Golden Phillips Petrochemical Company Limited [member]",
        "label": "Shanghai Golden Phillips Petrochemical Company Limited [member]",
        "verboseLabel": "Shanghai Golden Phillips Petrochemical Company Limited (\"Jinfei\") [member]"
       }
      }
     },
     "localname": "ShanghaiGoldenPhillipsPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiJinchangEngineeringPlasticsCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Jinchang Engineering Plastics Company Limited [member]",
        "label": "Shanghai Jinchang Engineering Plastics Company Limited [member]",
        "verboseLabel": "Shanghai Jinchang Engineering Plastics Company Limited (\"Jinchang\") [member]"
       }
      }
     },
     "localname": "ShanghaiJinchangEngineeringPlasticsCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiJinsenHydrocarbonResinsCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Jinsen Hydrocarbon Resins Company Limited [member]",
        "label": "Shanghai Jinsen Hydrocarbon Resins Company Limited [member]",
        "terseLabel": "Jinsen [member]",
        "verboseLabel": "Shanghai Jinsen Hydrocarbon Resins Company Limited (\"Jinsen\") [member]"
       }
      }
     },
     "localname": "ShanghaiJinsenHydrocarbonResinsCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiJinshanBalingNewMaterialsCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai jinshan baling new materials co Ltd.",
        "label": "Shanghai Jinshan Baling New Materials Co Ltd [Member]",
        "terseLabel": "Baling Materials [Member]",
        "verboseLabel": "Shanghai Jinshan Baling New Materials Co., Ltd. (\"Baling Materials\") (note i) (\"Linde\"), formerly known as \"BOC-SPC Gases Company Limited\")"
       }
      }
     },
     "localname": "ShanghaiJinshanBalingNewMaterialsCoLtdMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiJinshanTradingCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Jinshan Trading Corporation [member]",
        "label": "Shanghai Jinshan Trading Corporation [member]",
        "verboseLabel": "Shanghai Jinshan Trading Corporation (\"JMGJ\") [member]"
       }
      }
     },
     "localname": "ShanghaiJinshanTradingCorporationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiKsdBulkSolidsEngineeringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai KSD Bulk Solids Engineering Company Limited [member]",
        "label": "Shanghai KSD Bulk Solids Engineering Company Limited [member]"
       }
      }
     },
     "localname": "ShanghaiKsdBulkSolidsEngineeringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiLideCatalystCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai lide catalyst company limited.",
        "label": "Shanghai Lide Catalyst Company Limited [Member]"
       }
      }
     },
     "localname": "ShanghaiLideCatalystCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiPetrochemicalHaidiAdministrationCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai petrochemical haidi administration company limited.",
        "label": "Shanghai Petrochemical Haidi Administration Company Limited [Member]"
       }
      }
     },
     "localname": "ShanghaiPetrochemicalHaidiAdministrationCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiPetrochemicalInvestmentDevelopmentCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Petrochemical Investment Development Company Limited [member]",
        "label": "Shanghai Petrochemical Investment Development Company Limited [member]",
        "terseLabel": "Toufa [member]",
        "verboseLabel": "Shanghai Petrochemical Investment Development Company Limited (\"Toufa\") [member]"
       }
      }
     },
     "localname": "ShanghaiPetrochemicalInvestmentDevelopmentCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiPetrochemicalMachineryManufactureCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Petrochemical Machinery Manufacture Company Limited.",
        "label": "Shanghai Petrochemical Machinery Manufacture Company Limited [Member]"
       }
      }
     },
     "localname": "ShanghaiPetrochemicalMachineryManufactureCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiPetrochemicalPressureVesselTestingCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Petrochemical Pressure Vessel Testing Center [member]",
        "label": "Shanghai Petrochemical Pressure Vessel Testing Center [member]",
        "terseLabel": "Shanghai Petrochemical Pressure Vessel Testing Center (\"JYJC\") [member]",
        "verboseLabel": "JYJC [member]"
       }
      }
     },
     "localname": "ShanghaiPetrochemicalPressureVesselTestingCenterMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiPetrochemicalYanguGasDevelopmentCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Petrochemical Yangu Gas Development Company Limited [member]",
        "label": "Shanghai Petrochemical Yangu Gas Development Company Limited [member]",
        "terseLabel": "Yangu Gas [member]",
        "verboseLabel": "Shanghai Petrochemical Yangu Gas Development Company Limited (\"Yangu Gas\") [member]"
       }
      }
     },
     "localname": "ShanghaiPetrochemicalYanguGasDevelopmentCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiPetroleumNaturalGasGeneralCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Petroleum &amp; Natural Gas General Company Limited [member]",
        "label": "Shanghai Petroleum Natural Gas General Company Limited [Member]"
       }
      }
     },
     "localname": "ShanghaiPetroleumNaturalGasGeneralCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiSeccoPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Secco Petrochemical Company Limited [member]",
        "label": "Shanghai Secco Petrochemical Company Limited [member]",
        "terseLabel": "Shanghai Secco [member]",
        "verboseLabel": "Shanghai Secco Petrochemical Company Limited (\"Shanghai Secco\") [member]"
       }
      }
     },
     "localname": "ShanghaiSeccoPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesInJointVenturesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiShidianEnergyCompanyLimitedShidianEnergyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai Shidian Energy Company Limited [member]",
        "label": "Shanghai Shidian Energy Company Limited Shidian Energy [member]",
        "terseLabel": "Shanghai Shidian Energy Company Limited (\"Shidian Energy\") [member]",
        "verboseLabel": "Shidian Energy [member]"
       }
      }
     },
     "localname": "ShanghaiShidianEnergyCompanyLimitedShidianEnergyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedBalanceSheetForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodSummarizedStatementsOfComprehensiveIncomeForMaterialAssociatesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShanghaiSinopecMitsuiChemicalsCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shanghai sinopec mitsui chemicals company limited.",
        "label": "Shanghai Sinopec Mitsui Chemicals Company Limited [Member]"
       }
      }
     },
     "localname": "ShanghaiSinopecMitsuiChemicalsCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShareOfNetAssetsOfAssociatesAndJointVenturesAccountedForUsingEquityMethodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of net assets of associates and joint ventures accounted for using equity method [abstract]",
        "label": "Investments recognized in balance sheet [abstract]"
       }
      }
     },
     "localname": "ShareOfNetAssetsOfAssociatesAndJointVenturesAccountedForUsingEquityMethodAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_ShareholdersOfLegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders of legal entity [axis]",
        "label": "Shareholders of legal entity [axis]"
       }
      }
     },
     "localname": "ShareholdersOfLegalEntityAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_ShareholdersOfLegalEntityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders of legal entity [member]",
        "label": "Shareholders of legal entity [member]"
       }
      }
     },
     "localname": "ShareholdersOfLegalEntityMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SharesRepurchasedDuringThePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares repurchased during the period .",
        "label": "Shares Repurchased During The Period",
        "terseLabel": "Effect of shares repurchased"
       }
      }
     },
     "localname": "SharesRepurchasedDuringThePeriod",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/EarningsLossesPerShareWeightedAverageNumberOfOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "shi_ShengliOilFieldExplorationAndDevelopmentResearchInstituteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ShengliOil Field Exploration And Development Research Institute [member]",
        "label": "Shengli Oil Field Exploration And Development Research Institute [member]"
       }
      }
     },
     "localname": "ShengliOilFieldExplorationAndDevelopmentResearchInstituteMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShortTermBankBorrowingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Bank Borrowings.",
        "label": "Short Term Bank Borrowings [Member]"
       }
      }
     },
     "localname": "ShortTermBankBorrowingsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ShortTermBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term bonds [member]",
        "label": "Short-term bonds [member]",
        "terseLabel": "Short-term bonds [member]"
       }
      }
     },
     "localname": "ShortTermBondsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SingleCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single customer [member]",
        "label": "Single customer [member]"
       }
      }
     },
     "localname": "SingleCustomerMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueEntityWideInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecAmericaCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec america company limited.",
        "label": "Sinopec America Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecAmericaCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecAssetsManagementCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec assets management company limited.",
        "label": "Sinopec Assets Management Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecAssetsManagementCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecBaichuanEconomicAndTradeCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "sinopec baichuan economic and trade company.",
        "label": "Sinopec Baichuan Economic And Trade Company [Member]"
       }
      }
     },
     "localname": "SinopecBaichuanEconomicAndTradeCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecBalingPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Baling Petrochemical Company Limited [member]",
        "label": "Sinopec Baling Petrochemical Company Limited [member]",
        "terseLabel": "Sinopec Baling Petrochemical Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecBalingPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsInvestmentCommitmentsWithRelatedPartiesNarrativeDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecBeijingChemicalResearchInstituteCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec (Beijing) chemical research institute company limited.",
        "label": "Sinopec (Beijing) Chemical Research Institute Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecBeijingChemicalResearchInstituteCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecBeijingResearchInstituteOfChemicalIndustryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Beijing Research Institute of Chemical Industry [member]",
        "label": "Sinopec Beijing Research Institute of Chemical Industry [member]"
       }
      }
     },
     "localname": "SinopecBeijingResearchInstituteOfChemicalIndustryMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecBeijingYanshanPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Beijing Yanshan Petrochemical Company Limited [member]",
        "label": "Sinopec Beijing Yanshan Petrochemical Company Limited [member]",
        "terseLabel": "Sinopec Beijing Yanshan Petrochemical Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecBeijingYanshanPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecCapitalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Capital Company Limited [member]",
        "label": "Sinopec Capital Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecCapitalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecCatalystCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Catalyst Company Limited [member]",
        "label": "Sinopec Catalyst Company Limited [member]"
       }
      }
     },
     "localname": "SinopecCatalystCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalCommercialHoldingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Chemical Commercial Holding Company Limited [member]",
        "label": "Sinopec Chemical Commercial Holding Company Limited [member]"
       }
      }
     },
     "localname": "SinopecChemicalCommercialHoldingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalCommercialHoldingCompanyLimitedTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec chemical commercial holding company limited.",
        "label": "Sinopec Chemical Commercial Holding Company Limited two [Member]",
        "terseLabel": "Sinopec Chemical Commercial Holding Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecChemicalCommercialHoldingCompanyLimitedTwoMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalCommercialHoldingHongKongCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Chemical Commercial Holding (Hong Kong) Company Limited [member]",
        "label": "Sinopec Chemical Commercial Holding (Hong Kong) Company Limited [member]"
       }
      }
     },
     "localname": "SinopecChemicalCommercialHoldingHongKongCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalCommercialHoldingSingaporePteLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec chemical commercial holding singapore pte limited.",
        "label": "Sinopec Chemical Commercial Holding Singapore Pte Limited [Member]"
       }
      }
     },
     "localname": "SinopecChemicalCommercialHoldingSingaporePteLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalCommercialHoldingWuhanCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec chemical commercial holding wuhan company limited.",
        "label": "Sinopec Chemical Commercial Holding Wuhan Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecChemicalCommercialHoldingWuhanCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalCommericalHoldingNorthAmericaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec chemical commerical holding north america inc.",
        "label": "Sinopec Chemical Commerical Holding North America Inc [Member]"
       }
      }
     },
     "localname": "SinopecChemicalCommericalHoldingNorthAmericaIncMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalSalesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec chemical sales company limited.",
        "label": "Sinopec Chemical Sales Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecChemicalSalesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChemicalSalesGuangdongCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Chemical Sales Guangdong Company Limited [member]",
        "label": "Sinopec Chemical Sales Guangdong Company Limited [member]",
        "terseLabel": "Sinopec Chemical Sales (Guangdong) Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecChemicalSalesGuangdongCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecChinaEastChemicalSalesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec china east chemical sales company limited.",
        "label": "Sinopec China East Chemical Sales Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecChinaEastChemicalSalesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecConsultingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Consulting Company Limited [member]",
        "label": "Sinopec Consulting Company Limited [member]"
       }
      }
     },
     "localname": "SinopecConsultingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecCorpWithSubsidiariesAndJointVenturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Corp., with subsidiaries and joint ventures [member]",
        "label": "Sinopec Corp., with subsidiaries and joint ventures [member]",
        "terseLabel": "Sinopec Corp., its subsidiaries and joint ventures [member]"
       }
      }
     },
     "localname": "SinopecCorpWithSubsidiariesAndJointVenturesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsTransactionsBetweenTheGroupAndSinopecCorpItsSubsidiariesAndJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecDalianFushunResearchInstituteOfPetroleumAndPetrochemicalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Dalian Fushun Research Institute of Petroleum and Petrochemicals [member]",
        "label": "Sinopec Dalian Fushun Research Institute of Petroleum and Petrochemicals [member]",
        "terseLabel": "Sinopec Dalian (Fushun) Research Institute of Petroleum and Petrochemicals [member]"
       }
      }
     },
     "localname": "SinopecDalianFushunResearchInstituteOfPetroleumAndPetrochemicalsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEasyJoySalesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Easy Joy sales company limited [Member]",
        "label": "Sinopec Easy Joy sales company limited [Member]"
       }
      }
     },
     "localname": "SinopecEasyJoySalesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEnergySavingTechnologyServiceCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Energy Saving Technology Service Company limited [member]",
        "label": "Sinopec Energy Saving Technology Service Company Limited [member]"
       }
      }
     },
     "localname": "SinopecEnergySavingTechnologyServiceCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEngineeringGroupCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Engineering(Group) Company Limited [Member]",
        "label": "Sinopec Engineering(Group) Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecEngineeringGroupCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEngineeringIncorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Engineering Incorporation [member]",
        "label": "Sinopec Engineering Incorporation [member]"
       }
      }
     },
     "localname": "SinopecEngineeringIncorporationMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEngineeringQualityMonitoringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec engineering quality monitoring company limited.",
        "label": "Sinopec Engineering Quality Monitoring Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecEngineeringQualityMonitoringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEngineeringQualitySupervisionTerminalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec engineering quality supervision terminal.",
        "label": "Sinopec Engineering Quality Supervision Terminal [Member]"
       }
      }
     },
     "localname": "SinopecEngineeringQualitySupervisionTerminalMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecEuropeCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Europe Company Limited [member]",
        "label": "Sinopec Europe Company Limited [member]"
       }
      }
     },
     "localname": "SinopecEuropeCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecFinanceCompanyLimited1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Finance co., ltd.",
        "label": "Sinopec Finance Company Limited 1 [Member]",
        "terseLabel": "Sinopec Finance Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecFinanceCompanyLimited1Member",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecFinanceCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Finance Company Limited [member]",
        "label": "Sinopec Finance Company Limited [member]",
        "terseLabel": "Sinopec Finance [member]"
       }
      }
     },
     "localname": "SinopecFinanceCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecFuelOilSalesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Fuel Oil Sales Company Limited [member]",
        "label": "Sinopec Fuel Oil Sales Company Limited [member]",
        "terseLabel": "Sinopec Fuel Oil Sales Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecFuelOilSalesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecGreatWallEnergyAndChemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec great wall energy and chemical company limited.",
        "label": "Sinopec Great Wall Energy And Chemical Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecGreatWallEnergyAndChemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecGroupAndSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Group and subsidiaries [member]",
        "label": "Sinopec Group and subsidiaries [member]",
        "terseLabel": "Sinopec Group and its subsidiaries [member]"
       }
      }
     },
     "localname": "SinopecGroupAndSubsidiariesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsCommitmentsWithRelatedPartiesDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecGroupEconomicandTechnologyResearchInstituteCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Group Economic and Technology Research Institute Company Limited [member]",
        "label": "Sinopec Group Economic and Technology Research Institute Company Limited [member]",
        "terseLabel": "Sinopec Group Economic and Technology Research Institute Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecGroupEconomicandTechnologyResearchInstituteCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecGroupInternationalPetroleumExplorationAndProductionLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec group international petroleum exploration and production limited.",
        "label": "Sinopec Group International Petroleum Exploration And Production Limited [Member]"
       }
      }
     },
     "localname": "SinopecGroupInternationalPetroleumExplorationAndProductionLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecGroupJiangsuPetroleumExplorationBureauCo.LtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec group jiangsu petroleum exploration bureau co., ltd.",
        "label": "Sinopec Group Jiangsu Petroleum Exploration Bureau Co., Ltd [Member]"
       }
      }
     },
     "localname": "SinopecGroupJiangsuPetroleumExplorationBureauCo.LtdMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecGroupShanghaiTrainingCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Group Shanghai Training Center [member]",
        "label": "Sinopec Group Shanghai Training Center [member]"
       }
      }
     },
     "localname": "SinopecGroupShanghaiTrainingCenterMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecHenanOilfieldTrainingCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Henan Oilfield Training Center [Member]",
        "label": "Sinopec Henan Oilfield Training Center [Member]"
       }
      }
     },
     "localname": "SinopecHenanOilfieldTrainingCenterMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecHoneywellTianjinCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec HoneywellTianjin Company Limited [member]",
        "label": "Sinopec Honeywell Tianjin Company Limited [member]",
        "terseLabel": "Sinopec Honeywell(Tianjin) Company Limited [member]"
       }
      }
     },
     "localname": "SinopecHoneywellTianjinCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecInternationalAustrailiaPtyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec chemical commerical holding north america inc.",
        "label": "Sinopec International Austrailia Pty Limited [Member]"
       }
      }
     },
     "localname": "SinopecInternationalAustrailiaPtyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecInternationalRussiaPrivateLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec international (Russia) private limited.",
        "label": "Sinopec International (Russia) Private Limited [Member]"
       }
      }
     },
     "localname": "SinopecInternationalRussiaPrivateLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecInternationalTravelServiceCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec International Travel Service Company Limited [member]",
        "label": "Sinopec International Travel Service Company Limited [member]"
       }
      }
     },
     "localname": "SinopecInternationalTravelServiceCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecJapanCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Japan Company Limited [member]",
        "label": "Sinopec Japan Company Limited [member]"
       }
      }
     },
     "localname": "SinopecJapanCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecJianghanPetroleumAdministrationCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec jianghan petroleum administration company limited.",
        "label": "Sinopec Jianghan Petroleum Administration Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecJianghanPetroleumAdministrationCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecJianghanSaltChemicalHubeiCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec jianghan salt chemical hubei company limited.",
        "label": "Sinopec Jianghan Salt Chemical Hubei Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecJianghanSaltChemicalHubeiCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecJiangsuPetroleumExplorationBureauCompanyLimitedTrainingCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Jiangsu Petroleum Exploration Bureau Company Limited Training Center [member]",
        "label": "Sinopec Jiangsu Petroleum Exploration Bureau Company Limited Training Center [Member]"
       }
      }
     },
     "localname": "SinopecJiangsuPetroleumExplorationBureauCompanyLimitedTrainingCenterMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecLubricantCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec lubricant company limited.",
        "label": "Sinopec Lubricant Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecLubricantCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecLubricatingOilShanghaiResearchInstituteCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Lubricating OilShanghai Research Institute Company Limited [member]",
        "label": "Sinopec Lubricating Oil Shanghai Research Institute Company Limited [member]"
       }
      }
     },
     "localname": "SinopecLubricatingOilShanghaiResearchInstituteCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecLuoyangEngineeringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Luoyang Engineering Company Limited [member]",
        "label": "Sinopec Luoyang Engineering Company Limited [member]"
       }
      }
     },
     "localname": "SinopecLuoyangEngineeringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecMarketingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec marketing company limited.",
        "label": "Sinopec Marketing Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecMarketingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecMaterialsEquipmentEastChinaCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec MaterialsEquipment East China Company Limited [member]",
        "label": "Sinopec Materials and Equipment East China Company Limited [member]",
        "terseLabel": "Sinopec Materials &amp; Equipment (East China) Company Limited [member]"
       }
      }
     },
     "localname": "SinopecMaterialsEquipmentEastChinaCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecNanjingChemicalResearchInstituteCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Nanjing Chemical Research Institute Company Limited [Member]",
        "label": "Sinopec Nanjing Chemical Research Institute Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecNanjingChemicalResearchInstituteCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecNanjingEngineeringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Nanjing Engineering Company Limited [member]",
        "label": "Sinopec Nanjing Engineering Company Limited [member]"
       }
      }
     },
     "localname": "SinopecNanjingEngineeringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecNationalPetrochemicalProjectRiskAssessmentTechnologyCenterCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec national petrochemical project risk assessment technology center company limited.",
        "label": "Sinopec National Petrochemical Project Risk Assessment Technology Center company limited [Member]"
       }
      }
     },
     "localname": "SinopecNationalPetrochemicalProjectRiskAssessmentTechnologyCenterCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecNewspaperOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec newspaper office.",
        "label": "Sinopec Newspaper Office [Member]"
       }
      }
     },
     "localname": "SinopecNewspaperOfficeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecOilRefiningAndMarketingShanghaiCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec oil refining and marketing (shnaghai company limited.",
        "label": "Sinopec Oil Refining and Marketing (Shanghai) Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecOilRefiningAndMarketingShanghaiCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecPetroleumAndChemicalSceintificResearchInstituteDadiCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec petroleum and chemical sceintific research institute dadi company.",
        "label": "Sinopec Petroleum And Chemical Sceintific Research Institute Dadi Company [Member]"
       }
      }
     },
     "localname": "SinopecPetroleumAndChemicalSceintificResearchInstituteDadiCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecPetroleumEngineeringGeophysicsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Petroleum Engineering Geophysics Limited [member]",
        "label": "Sinopec Petroleum Engineering Geophysics Limited [member]",
        "terseLabel": "Sinopec Petroleum Engineering Geophysics Ltd. [member]"
       }
      }
     },
     "localname": "SinopecPetroleumEngineeringGeophysicsLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecPublishingHouseCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec publishing house company limited.",
        "label": "Sinopec Publishing House Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecPublishingHouseCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecResearchInstituteOfSafetyEngineeringMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec research institute of safety engineering.",
        "label": "Sinopec Research Institute of Safety Engineering [Member]"
       }
      }
     },
     "localname": "SinopecResearchInstituteOfSafetyEngineeringMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecShanghaiEnergyTradeCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec shanghai energy trade company limited.",
        "label": "Sinopec Shanghai Energy Trade Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecShanghaiEnergyTradeCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecShanghaiEngineeringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Shanghai Engineering Company Limited [member]",
        "label": "Sinopec Shanghai Engineering Company Limited [member]"
       }
      }
     },
     "localname": "SinopecShanghaiEngineeringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecShanghaiGaoqiaoPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec ShanghaiGaoqiaoPetrochemical Company Limited [member]",
        "label": "Sinopec Shanghai Gaoqiao Petrochemical Company Limited [member]"
       }
      }
     },
     "localname": "SinopecShanghaiGaoqiaoPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecShanghaiResearchInstituteOfPetrochemicalTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Shanghai Research Institute?of?Petrochemical Technology [member]",
        "label": "Sinopec Shanghai Research Institute of Petrochemical Technology [member]"
       }
      }
     },
     "localname": "SinopecShanghaiResearchInstituteOfPetrochemicalTechnologyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecSharedServicesCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Shared Services Company Limited [member]",
        "label": "Sinopec Shared Services Company Limited [member]"
       }
      }
     },
     "localname": "SinopecSharedServicesCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecShengliPetroleumAdministrationCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Shengli Petroleum Administration Company Limited [member]",
        "label": "Sinopec Shengli Petroleum Administration Company Limited [member]",
        "terseLabel": "Sinopec Shengli Petroleum Administration Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecShengliPetroleumAdministrationCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecShenzhenECommerceCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Shenzhen ECommerce Company Limited [member]",
        "label": "Sinopec Shenzhen E-Commerce Company Limited [member]",
        "terseLabel": "Sinopec (Shenzhen) E-Commerce Company Limited [member]"
       }
      }
     },
     "localname": "SinopecShenzhenECommerceCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecSichuanUninylonWorksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec sichuan uninylon works.",
        "label": "Sinopec Sichuan Uninylon Works [Member]"
       }
      }
     },
     "localname": "SinopecSichuanUninylonWorksMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecTendingCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Tending Company Limited.",
        "label": "Sinopec Tending Company Limited [Member]"
       }
      }
     },
     "localname": "SinopecTendingCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecYangziPetrochemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Yangzi Petrochemical Company Limited [member]",
        "label": "Sinopec Yangzi Petrochemical Company Limited [member]"
       }
      }
     },
     "localname": "SinopecYangziPetrochemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecYizhengChemicalFibreCompanyLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Yizheng Chemical Fibre Company Limited liability company.",
        "label": "Sinopec Yizheng Chemical Fibre Company Limited Liability Company [Member]"
       }
      }
     },
     "localname": "SinopecYizhengChemicalFibreCompanyLimitedLiabilityCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecZhongyuanPetrolChemicalIndustryCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec Zhongyuan Petrol-Chemical Industry Company Limited [member]",
        "label": "Sinopec Zhongyuan Petrol-Chemical Industry Company Limited [member]",
        "terseLabel": "Sinopec Zhongyuan Petrol-Chemical Industry Co., Ltd. [member]"
       }
      }
     },
     "localname": "SinopecZhongyuanPetrolChemicalIndustryCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecZhongyuanPetroleumExplorationBureauCo.LtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec zhongyuan petroleum exploration bureau co., ltd.",
        "label": "Sinopec Zhongyuan Petroleum Exploration Bureau Co., Ltd [Member]"
       }
      }
     },
     "localname": "SinopecZhongyuanPetroleumExplorationBureauCo.LtdMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopeccorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SinopecCorp.",
        "label": "SinopecCorp [Member]"
       }
      }
     },
     "localname": "SinopeccorpMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SinopecskWuhanPetrochemicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sinopec-Sk (Wuhan) petrochemical.",
        "label": "SinopecSk (Wuhan) Petrochemical [Member]"
       }
      }
     },
     "localname": "SinopecskWuhanPetrochemicalMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SparePartsAndConsumables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of spare parts and consumables. [Refer: Inventories]",
        "label": "Spare parts and consumables"
       }
      }
     },
     "localname": "SparePartsAndConsumables",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_StaffSalariesAndWelfaresPayable": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition": {
       "order": 20.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Staff salaries and welfares payable",
        "label": "Staff salaries and welfares payable",
        "terseLabel": "Staff salaries and welfares payable"
       }
      }
     },
     "localname": "StaffSalariesAndWelfaresPayable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ConsolidatedStatementsOfFinancialPosition",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_StateOwnedLegalSharesTransferred": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State-owned legal shares transferred",
        "label": "State-owned legal shares transferred"
       }
      }
     },
     "localname": "StateOwnedLegalSharesTransferred",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/GeneralInformationReorganisationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "shi_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_StatementOfBalanceSheetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement of balance sheet [line items]",
        "label": "Statement of balance sheet [line items]"
       }
      }
     },
     "localname": "StatementOfBalanceSheetLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_StatementOfBalanceSheetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule disclosing information related to balance sheet.",
        "label": "Statement of balance sheet [table]"
       }
      }
     },
     "localname": "StatementOfBalanceSheetTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statement.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/CashAndCashEquivalentsReconciliationOfLiabilitiesArisingFromFinancingActivitiesDetail",
      "http://SinopecShanghai.com/role/FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_StockExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Exchange [Axis].",
        "label": "Stock Exchange [Axis]"
       }
      }
     },
     "localname": "StockExchangeAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_StockExchangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock exchange.",
        "label": "Stock Exchange [Member]"
       }
      }
     },
     "localname": "StockExchangeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_StockSharesRepurchasedDuringThePeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock shares repurchased during the period shares.",
        "label": "Stock Shares Repurchased During The Period Shares",
        "terseLabel": "Number of shares repurchased",
        "verboseLabel": "Stock shares repurchased during the period shares"
       }
      }
     },
     "localname": "StockSharesRepurchasedDuringThePeriodShares",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ShareCapitalAdditionalInformationDetails",
      "http://SinopecShanghai.com/role/ShareCapitalPurchaseOfOwnSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "shi_StorageAndTransportationInstallationCompanyOfNingboEngineeringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Storage And Transportation Installation Company of Ningbo Engineering Company Limited [member]",
        "label": "Storage And Transportation Installation Company of Ningbo Engineering Company Limited [member]"
       }
      }
     },
     "localname": "StorageAndTransportationInstallationCompanyOfNingboEngineeringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_StructuredDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structured deposits [member]",
        "label": "Structured deposits [member]"
       }
      }
     },
     "localname": "StructuredDepositsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFairValueEstimationChangesInLevel3ItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_SummaryOfSignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies [abstract]",
        "label": "Summary of significant accounting policies [abstract]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Policies [Line Items]",
        "label": "Summary of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Significant Accounting Policies [Table]",
        "label": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_SyntheticFibresMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Synthetic fibres [member]",
        "label": "Synthetic fibres [member]",
        "terseLabel": "Synthetic fibers [member]"
       }
      }
     },
     "localname": "SyntheticFibresMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentNarrativeDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossOfPriorPeriodUsedToReduceIncomeTaxExpense": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of benefit arising from a previously unrecognised tax loss of a prior period that is used to reduce income tax expense.",
        "label": "Tax benefit arising from previously unrecognised tax loss of prior period used to reduce income tax expense",
        "terseLabel": "Utilization of previously unrecognized tax losses"
       }
      }
     },
     "localname": "TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossOfPriorPeriodUsedToReduceIncomeTaxExpense",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TaxEffectOfAdditionalDeductionsForPurchasingEnvironmentalProtectionEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax effect of additional deductions for purchasing environmental protection equipment.",
        "label": "Tax Effect of Additional Deductions for Purchasing Environmental Protection Equipment",
        "terseLabel": "Tax effect of additional deduction for purchasing environmental protection equipment"
       }
      }
     },
     "localname": "TaxEffectOfAdditionalDeductionsForPurchasingEnvironmentalProtectionEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TaxEffectOfAdditionalDeductionsForResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 8.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Effect of Additional Deductions for Research And Development Expense.",
        "label": "Tax Effect of Additional Deductions for Research And Development Expense",
        "terseLabel": "Tax\u00a0effect of additional\u00a0deductions for R&amp;D expenses"
       }
      }
     },
     "localname": "TaxEffectOfAdditionalDeductionsForResearchAndDevelopmentExpense",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TaxEffectOfDerecognitionOfPreviouslyRecognizedTaxLosses": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax effect of derecognition of previously recognized tax losses.",
        "label": "Tax Effect of Derecognition of Previously Recognized Tax Losses",
        "negatedLabel": "Derecognition of previously recognized tax losses"
       }
      }
     },
     "localname": "TaxEffectOfDerecognitionOfPreviouslyRecognizedTaxLosses",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TaxEffectOfShareOfProfitLossOfInvestmentAccountedForUsingEquityMethod": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails": {
       "order": 9.0,
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit (loss) of investments accounted for using equity method.",
        "label": "Tax effect of share of profit (loss) of investment accounted for using equity method",
        "terseLabel": "Tax effect of share of net profits / (losses) of investments accounted for using the equity method"
       }
      }
     },
     "localname": "TaxEffectOfShareOfProfitLossOfInvestmentAccountedForUsingEquityMethod",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesReconciliationOfIncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TaxLossesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax losses [member]",
        "label": "Tax losses [member]"
       }
      }
     },
     "localname": "TaxLossesMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/IncomeTaxBenefitsExpensesMovementsInDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Text block.",
        "label": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_TheCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company.",
        "label": "The Company [Member]"
       }
      }
     },
     "localname": "TheCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TheFifthConstructionCompanyOfSinopecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Fifth Construction Company of Sinopec [member]",
        "label": "The Fifth Construction Company of Sinopec [member]"
       }
      }
     },
     "localname": "TheFifthConstructionCompanyOfSinopecMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TheFourthConstructionCompanyOfSinopecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Fourth Construction Company of Sinopec [member]",
        "label": "The Fourth Construction Company of Sinopec [member]"
       }
      }
     },
     "localname": "TheFourthConstructionCompanyOfSinopecMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The group and Sinopec group and subsidiaries associates and joint ventures of the group [member]",
        "label": "The group and Sinopec group and subsidiaries associates and joint ventures of the group [member]"
       }
      }
     },
     "localname": "TheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsOtherTransactionsBetweenTheGroupAndSinopecGroupAndItsSubsidiariesAssociatesAndJointVenturesOfTheGroupDetails",
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsRelevantAmountsDueFromToRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TheTenthConstructionCompanyOfSinopecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tenth Construction Company of Sinopec [member]",
        "label": "The Tenth Construction Company of Sinopec [member]"
       }
      }
     },
     "localname": "TheTenthConstructionCompanyOfSinopecMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TimeDepositsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time deposits current.",
        "label": "Time Deposits Current",
        "terseLabel": "Time deposits with maturity less than one year"
       }
      }
     },
     "localname": "TimeDepositsCurrent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails",
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TimeDepositsNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time deposits noncurrent.",
        "label": "Time Deposits Noncurrent",
        "terseLabel": "Time deposits with maturity more than one year"
       }
      }
     },
     "localname": "TimeDepositsNoncurrent",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsScheduleOfInterestRateFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TimeDepositsWithBanks": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time deposits with banks.",
        "label": "Time Deposits With Banks",
        "totalLabel": "Time deposits with banks"
       }
      }
     },
     "localname": "TimeDepositsWithBanks",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksSummaryOfTimeDepositsWithBanksDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TimeDepositsWithBanksAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time Deposits With Banks [Abstract]",
        "label": "Time Deposits With Banks [Abstract]"
       }
      }
     },
     "localname": "TimeDepositsWithBanksAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_TimeDepositsWithBanksTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time deposits with banks",
        "label": "Time Deposits With Banks [Table Text Block]",
        "terseLabel": "Summary Of Time Deposits With Banks"
       }
      }
     },
     "localname": "TimeDepositsWithBanksTableTextBlock",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TimeDepositsWithBanksTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "shi_TimeDepositsWithFinancialInstitutionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Time deposits with financial institutions [abstract]",
        "label": "Time deposits with banks [abstract]"
       }
      }
     },
     "localname": "TimeDepositsWithFinancialInstitutionsAbstract",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "xbrltype": "stringItemType"
    },
    "shi_TimingOfRevenueRecognitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of revenue recognition [axis]",
        "label": "Timing of revenue recognition [axis]"
       }
      }
     },
     "localname": "TimingOfRevenueRecognitionAxis",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_TimingOfRevenueRecognitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of revenue recognition [member]",
        "label": "Timing of revenue recognition [member]"
       }
      }
     },
     "localname": "TimingOfRevenueRecognitionMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TradeAndOtherCurrentReceivablesAndAmountsDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade and other current receivables and amounts due from related parties net of prepayments and bills receivable.",
        "label": "Trade And Other Current Receivables And Amounts Due From Related Parties Net Of Prepayments And Bills Receivable [Member]",
        "terseLabel": "Trade And Other Current Receivables And Amounts Due From Related Parties Net Of Prepayments And Bills Receivable [Member]"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivablesAndAmountsDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivableMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TradeAndOtherCurrentReceivablesDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade and other current receivables due from related parties net of prepayments and bills receivable.",
        "label": "Trade And Other Current Receivables Due From Related Parties Net Of Prepayments And Bills Receivable",
        "terseLabel": "Amounts due from related parties excluded prepayments and bills receivable"
       }
      }
     },
     "localname": "TradeAndOtherCurrentReceivablesDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TradeAndOtherPayablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade and other payables [table]",
        "label": "Trade and other payables [table]"
       }
      }
     },
     "localname": "TradeAndOtherPayablesTable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_TradePayablesBillsPayableAndAmountsDueToRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of trade payables, bills payable and amounts due to related parties.",
        "label": "Trade payables, bills payable and amounts due to related parties",
        "totalLabel": "Subtotal",
        "verboseLabel": "Trade payables (including amounts due to related parties of trading in nature)"
       }
      }
     },
     "localname": "TradePayablesBillsPayableAndAmountsDueToRelatedParties",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails",
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TradeReceivablesAndAmountsDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade receivables and amounts due from related parties net of prepayments and bills receivable.",
        "label": "Trade Receivables And Amounts Due From Related Parties Net Of Prepayments And Bills Receivable",
        "terseLabel": "Total trade receivables",
        "verboseLabel": "Trade receivables and amounts due from related parties net Of prepayments and bills receivable"
       }
      }
     },
     "localname": "TradeReceivablesAndAmountsDueFromRelatedPartiesNetOfPrepaymentsAndBillsReceivable",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherReceivableSummaryOfAgingAnalysisInTradeAndOtherReceivablesExplanatoryDetail",
      "http://SinopecShanghai.com/role/TradeAndOtherReceivablesSummaryOfComponentOfTradeAndOtherReceivablesExplanatoryDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TradeReceivablesIncludingTradeReceivablesWithRelatedPartiesAndTradeReceivablesAtFairValueThroughOtherComprehensiveIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of trade receivables including trade receivables with related parties and those carried at FVOCI.",
        "label": "Trade receivables including trade receivables with related parties and trade receivables at fair value through other comprehensive income",
        "terseLabel": "Trade receivables (including trade receivables with related parties and those carried at FVOCI)"
       }
      }
     },
     "localname": "TradeReceivablesIncludingTradeReceivablesWithRelatedPartiesAndTradeReceivablesAtFairValueThroughOtherComprehensiveIncome",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_TradeandotherpayablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TradeAndOtherPayables.",
        "label": "TradeAndOtherPayables [Line Items]"
       }
      }
     },
     "localname": "TradeandotherpayablesLineItems",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/TradeAndOtherPayablesSummaryOfAgingAnalysisOfTradePayablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_TradingOfPetrochemicalProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading of petrochemical products [member]",
        "label": "Trading of petrochemical products [member]"
       }
      }
     },
     "localname": "TradingOfPetrochemicalProductsMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAdditionsToPropertyPlantAndEquipmentConstructionInProgressRightOfUseAssetsAndOtherNonCurrentAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueAssetsDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueLiabilitiesDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueOtherProfitAndLossDisclosuresDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueRevenueDetails",
      "http://SinopecShanghai.com/role/SegmentInformationAndRevenueSegmentResultProfitLossFromOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_TransferToLegalSurplus": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfer to legal surplus.",
        "label": "Transfer To Legal Surplus",
        "terseLabel": "Transfer to legal surplus"
       }
      }
     },
     "localname": "TransferToLegalSurplus",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/ReservesDetails",
      "http://SinopecShanghai.com/role/StatementsOfFinancialPositionAndEquityMovementOfTheCompanyReserveMovementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_UndiscountedCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted cash flow [member]",
        "label": "Undiscounted cash flow [member]"
       }
      }
     },
     "localname": "UndiscountedCashFlowMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/FinancialRiskManagementFinancialRiskFactorsMaturityAnalysisForFinancialLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_UnipecAmericaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unipec America Inc [member]",
        "label": "Unipec America Inc [member]",
        "terseLabel": "Unipec America, Inc [member]"
       }
      }
     },
     "localname": "UnipecAmericaIncMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_UnipecQingdaoInternationalLogisticsCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unipec Qingdao International Logistics Company Limited [member]",
        "label": "Unipec Qingdao International Logistics Company Limited [member]",
        "terseLabel": "Unipec (Qingdao) International Logistics Company Limited [member]"
       }
      }
     },
     "localname": "UnipecQingdaoInternationalLogisticsCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_UnipecSingaporeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unipec Singapore [member]",
        "label": "Unipec Singapore [member]"
       }
      }
     },
     "localname": "UnipecSingaporeMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_UnipecSingaporeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unipec singapore.",
        "label": "Unipec Singapore [Member]"
       }
      }
     },
     "localname": "UnipecSingaporeOneMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_UsefulLivesOrAmortisationRatesOtherNonCurrentAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The useful lives or amortisation rates of other non-current assets.",
        "label": "Useful lives or amortisation rates, other non-current assets",
        "terseLabel": "Estimated useful lives of other non-current assets"
       }
      }
     },
     "localname": "UsefulLivesOrAmortisationRatesOtherNonCurrentAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "shi_VehiclesAndOtherEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable vehicles and other equipment and similar structures for use in operations. [Refer: Property, plant and equipment]",
        "label": "Vehicles and other equipment [member]",
        "verboseLabel": "Vehicles and other equipment [member]"
       }
      }
     },
     "localname": "VehiclesAndOtherEquipmentMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails",
      "http://SinopecShanghai.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_WorkInProgressInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A classification of current inventories representing the amount of assets currently in production, which require further processes to be converted into finished goods or services.",
        "label": "Work in progress, inventory",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "WorkInProgressInventory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_WriteOffOfFixedAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write off of fixed assets.",
        "label": "Write Off Of Fixed Assets",
        "terseLabel": "Write off of fixed assets"
       }
      }
     },
     "localname": "WriteOffOfFixedAssets",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_WriteOffOfInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write off of inventory.",
        "label": "Write Off Of Inventory",
        "terseLabel": "Write off of inventory"
       }
      }
     },
     "localname": "WriteOffOfInventory",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/OtherGainsLossesNetParentheticalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_WrittenBackOnDisposalsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written Back on Disposals Property Plant And Equipment.",
        "label": "Written Back on Disposals Property Plant And Equipment",
        "terseLabel": "Written back on disposals"
       }
      }
     },
     "localname": "WrittenBackOnDisposalsPropertyPlantAndEquipment",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/PropertyPlantAndEquipmentMovementInNetBookAmountDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shi_YihuaBonarYarnsAndFabricsCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yihua bonar yarns and fabrics company limited.",
        "label": "Yihua Bonar Yarns And Fabrics Company Limited [Member]"
       }
      }
     },
     "localname": "YihuaBonarYarnsAndFabricsCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_YihuaToryPolyesterFilmCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yihua Tory Polyester Film Company Limited [member]",
        "label": "Yihua Tory Polyester Film Company Limited [member]"
       }
      }
     },
     "localname": "YihuaToryPolyesterFilmCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_YipaikeBusinessFactoringCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yipaike business factoring company limited.",
        "label": "Yipaike Business Factoring Company Limited [Member]"
       }
      }
     },
     "localname": "YipaikeBusinessFactoringCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_YpcGproNanjingRubberCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "YPC Gpro nanjing rubber company limited.",
        "label": "YPC Gpro Nanjing Rubber Company Limited [Member]"
       }
      }
     },
     "localname": "YpcGproNanjingRubberCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ZhejiangBalingHengyiCaprolactamLimitedCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zhejiang Baling Hengyi Caprolactam Limited Company [member]",
        "label": "Zhejiang Baling Hengyi Caprolactam Limited Company [member]"
       }
      }
     },
     "localname": "ZhejiangBalingHengyiCaprolactamLimitedCompanyMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ZhejiangJinlianPetrochemicalStorageandTransportationCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd. [member]",
        "label": "Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd. [member]",
        "verboseLabel": "Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd. (\"Jinlian\") [member]"
       }
      }
     },
     "localname": "ZhejiangJinlianPetrochemicalStorageandTransportationCoLtdMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/SubsidiariesAcquisitionOfJinlianDetails",
      "http://SinopecShanghai.com/role/SubsidiariesMajorSubsidiariesOfTheGroupDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ZhongkeGuangdongRefiningAndChemicalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zhongke guangdong refining and chemical company limited.",
        "label": "Zhongke Guangdong Refining And Chemical Company Limited [Member]"
       }
      }
     },
     "localname": "ZhongkeGuangdongRefiningAndChemicalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shi_ZhoushanShihuaCrudeOilTerminalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZhoushanShihua Crude Oil Terminal Company Limited [member]",
        "label": "Zhoushan Shihua Crude Oil Terminal Company Limited [member]"
       }
      }
     },
     "localname": "ZhoushanShihuaCrudeOilTerminalCompanyLimitedMember",
     "nsuri": "http://SinopecShanghai.com/20221231",
     "presentation": [
      "http://SinopecShanghai.com/role/RelatedPartyTransactionsListOfMajorRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://SinopecShanghai.com/role/InvestmentsAccountedForUsingTheEquityMethodPrincipalActivitiesOfMaterialAssociatesDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r1": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r10": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r100": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "138",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_138_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r110": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_126_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "129",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_129_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r120": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "75",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_75_f_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS40_g74-79__IAS40_g74-79_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r130": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r140": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_f_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "29",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_29_c_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "8",
   "Paragraph": "49",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_49_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r150": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2022-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_21_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r160": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "21",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_21_c_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Clause": "ix",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Clause": "vi",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Clause": "viii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r170": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B16",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B16_c&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B16&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r180": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFR15_g110-129_IFRS15_g110-129_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS15_g105-109__IFRS15_g105-109_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r190": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r20": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r200": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS16_g51-60__IFRS16_g51-60_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS16_g47-50__IFRS16_g47-50_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "11A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_11A_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r210": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24A_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24C",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24C_b_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "24E",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_24E_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_33_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r220": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Clause": "iii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r230": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA__IFRS07_APPA_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A__IFRS07_g3-5A_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r240": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r250": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS08_g20-24__IFRS08_g20-24_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "6.5.11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_6.5.11&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r260": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r270": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "34",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_34_b&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39J_a&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39J_b&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r280": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39J&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "IG22",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_IG22_f&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_23_d&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_23_e&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_f&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r288": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r289": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r29": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r290": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r291": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r292": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r293": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r294": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r295": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_80_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r296": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r297": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r298": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r299": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r3": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r30": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r300": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r301": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r302": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r303": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r304": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r305": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r306": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r307": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r308": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r309": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r31": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r310": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "IG63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r311": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r312": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r313": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r314": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r315": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r316": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r317": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r318": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r319": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r32": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r320": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11D",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11D_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r321": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r322": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r323": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r324": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r325": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r326": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG40B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r327": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r328": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r329": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r33": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r330": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "IG4",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r331": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r332": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r333": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r334": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_108&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r335": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r336": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r337": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r338": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r339": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r340": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r341": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r342": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r343": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r344": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-3",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r345": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r346": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r347": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r348": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r349": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r350": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r351": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r352": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r354": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r355": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r356": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r357": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r358": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "20",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_20_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r359": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r360": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r361": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r362": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r363": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r364": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r365": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r368": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r369": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "5",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r370": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r371": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r372": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r373": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r374": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r375": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r376": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r377": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "75",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_75_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r378": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r379": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r38": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r380": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r381": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r382": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r383": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r384": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r385": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r386": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r387": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r388": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Effective 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r389": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Note": "Expiry date 2023-01-01",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r39": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r390": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r391": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "IssueDate": "2022-03-24",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r40": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "90",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_90&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r50": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "92",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_92&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "13",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_13&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r60": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS12_g79-88__IAS12_g79-88_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Clause": "i",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_107&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r70": {
   "Clause": "ii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Clause": "ix",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_ix&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Clause": "v",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_v&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Clause": "vii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS16_g73-79__IAS16_g73-79_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r80": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "19",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS19_g2-7__IAS19_g2-7_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_f&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "2",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "23",
   "Paragraph": "26",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=23&code=ifrs-tx-2022-en-r&anchor=para_26_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "23",
   "Paragraph": "26",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=23&code=ifrs-tx-2022-en-r&anchor=para_26_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "137",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_137_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r90": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19_a&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19_d&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS24_g13-24__IAS24_g13-24_TI",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Clause": "iv",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Clause": "vii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_vii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Clause": "viii",
   "IssueDate": "2022-03-24",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2022-03-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}

Cover Page - shares	12 Months Ended
Cover Page - shares	Dec. 31, 2022	Dec. 31, 2021
Document Information [Line Items]
Document Type	20-F
Amendment Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Document Transition Report	false
Document Shell Company Report	false
Entity Registrant Name	Sinopec Shanghai Petrochemical Company Limited
Entity Central Index Key	0000908732
Entity Address, Country	CN
Entity Address, Address Line One	No. 48 Jinyi Road, Jinshan District, Shanghai, PRC 200540
Entity Address, City or Town	Shanghai
Entity Address, Postal Zip Code	200540
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Accounting Standard	International Financial Reporting Standards
Entity Shell Company	false
Entity File Number	1-12158
Auditor Name	KPMG Huazhen LLP	PricewaterhouseCoopers Zhong Tian LLP
Auditor Firm ID	1186	1424
Auditor Location	Shanghai, China	Shanghai, the People’s Republic of China
Entity Incorporation, State or Country Code	F4
Business Contact [Member]
Document Information [Line Items]
Entity Address, Country	CN
Entity Address, Address Line One	No. 48 Jinyi Road, Jinshan District, Shanghai, 200540
Entity Address, City or Town	Shanghai
Entity Address, Postal Zip Code	200540
Contact Personnel Name	Mr. Wan Tao
City Area Code	+86
Local Phone Number	57943143
Contact Personnel Fax Number	57940050
American Depositary Shares [member]
Document Information [Line Items]
Title of 12(b) Security	American Depositary Shares, each representing 100 H Shares, par value RMB1.00 per Share
No Trading Symbol Flag	true
H shares [member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	3,495,000,000
A shares [member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	7,328,813,500

Consolidated statements of profit or loss and other comprehensive income - CNY (¥) ¥ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of comprehensive income [abstract]
Revenue	¥ 82,443,156	¥ 89,198,492	¥ 74,623,575
Taxes and surcharges	(9,788,593)	(13,309,688)	(13,062,710)
Net sales	72,654,563	75,888,804	61,560,865
Cost of sales	(76,265,940)	(74,298,048)	(61,901,114)
Gross (loss)/profit	(3,611,377)	1,590,756	(340,249)
Selling and administrative expenses	(288,701)	(368,243)	(486,323)
Reversal/(provision) of impairment losses on financial assets	(5,366)	(1,355)	120,916
Other operating income	110,641	125,305	148,676
Other operating expenses	(25,775)	(44,712)	(24,686)
Other gains/(losses) - net	(22,788)	130,481	115,430
(Loss) / profit from operations	(3,843,366)	1,432,232	(466,236)
Finance income	541,830	508,755	431,228
Finance expenses	(98,502)	(94,186)	(98,954)
Finance income – net	443,328	414,569	332,274
Share of net profits/(losses) of associates and joint ventures accounted for using the equity method	(173,616)	874,285	724,740
Profit/(loss) before taxation	(3,573,654)	2,721,086	590,778
Income tax benefits/(expenses)	731,354	(644,480)	65,620
Profit/(loss) for the year	(2,842,300)	2,076,606	656,398
Profit/(loss) attributable to:
Equity shareholders of the Company	(2,846,156)	2,073,431	645,072
Non-controlling interests	3,856	3,175	11,326
Profit/(loss) for the year	¥ (2,842,300)	¥ 2,076,606	¥ 656,398
Earnings/(losses) per share attributable to equity shareholders of the Company for the year (expressed in RMB per share)
Basic earnings/(losses) per share	¥ (0.263)	¥ 0.192	¥ 0.06
Diluted earnings/(losses) per share	¥ (0.263)	¥ 0.192	¥ 0.06
Profit/(loss) for the year	¥ (2,842,300)	¥ 2,076,606	¥ 656,398
Other comprehensive income
Share of other comprehensive income of associates accounted for using the equity method	(23,771)	16,639	(11,512)
Cash flow hedges: net movement in hedging reserve	201,519	125,159	0
Other comprehensive income for the year, net of tax	177,748	141,798	(11,512)
Total comprehensive income for the year	(2,664,552)	2,218,404	644,886
Attributable to:
Equity shareholders of the Company	(2,668,408)	2,215,229	633,560
Non-controlling interests	3,856	3,175	11,326
Total comprehensive income for the year	¥ (2,664,552)	¥ 2,218,404	¥ 644,886

Consolidated Statements of Changes in Equity - CNY (¥) ¥ in Thousands	Total	Share capital [member]	Other reserves [member]	Retained earnings [member]	Total [member]	Non-controlling interests [member]
Beginning Balance at Dec. 31, 2019	¥ 29,993,848	¥ 10,823,814	¥ 4,369,391	¥ 14,670,083	¥ 29,863,288	¥ 130,560
(Loss)/profit for the year	656,398	0	0	645,072	645,072	11,326
Other comprehensive income	(11,512)	0	(11,512)	0	(11,512)	0
Total comprehensive income for the year	644,886	0	(11,512)	645,072	633,560	11,326
Dividends proposed and approved	(1,298,858)	0	0	(1,298,858)	(1,298,858)	0
Dividends paid by subsidiaries to non-controlling interests	(4,901)	0	0	0	0	(4,901)
Appropriation of safety production fund	0	0	88,460	(88,460)	0	0
Ending Balance at Dec. 31, 2020	29,334,975	10,823,814	4,446,339	13,927,837	29,197,990	136,985
(Loss)/profit for the year	2,076,606	0	0	2,073,431	2,073,431	3,175
Other comprehensive income	141,798	0	141,798	0	141,798	0
Total comprehensive income for the year	2,218,404	0	141,798	2,073,431	2,215,229	3,175
Transfer to other reserves	0	0	2,498,808	(2,498,808)	0	0
Amounts transferred from hedging reserve to initial carrying amount of hedged items	(88,699)	0	(88,699)	0	(88,699)	0
Dividends proposed and approved	(1,082,381)	0	0	(1,082,381)	(1,082,381)	0
Dividends paid by subsidiaries to non-controlling interests	(4,901)	0	0	0	0	(4,901)
Appropriation of safety production fund	0	0	40,729	(40,729)	0	0
Ending Balance at Dec. 31, 2021	30,377,398	10,823,814	7,038,975	12,379,350	30,242,139	135,259
(Loss)/profit for the year	(2,842,300)	0	0	(2,846,156)	(2,846,156)	3,856
Other comprehensive income	177,748	0	177,748	0	177,748	0
Total comprehensive income for the year	(2,664,552)	0	177,748	(2,846,156)	(2,668,408)	3,856
Amounts transferred from hedging reserve to initial carrying amount of hedged items	(237,979)	0	(237,979)	0	(237,979)	0
Dividends proposed and approved	(1,082,381)	0	0	(1,082,381)	(1,082,381)	0
Dividends paid by subsidiaries to non-controlling interests	(11,434)	0	0	0	0	(11,434)
Purchase of own shares	(25,689)	0	(25,689)	0	(25,689)	0
Appropriation of safety production fund	0	0	54,092	(54,092)	0	0
Ending Balance at Dec. 31, 2022	¥ 26,355,363	¥ 10,823,814	¥ 7,007,147	¥ 8,396,721	¥ 26,227,682	¥ 127,681

General Information (Reorganisation) (Details) - CNY (¥) ¥ in Thousands	Feb. 25, 2000	Jan. 12, 2018	Sep. 27, 2017	Nov. 08, 1993
General information [line items]
Capital registered		¥ 9,637	¥ 14,177	¥ 4,000,000
China Petrochemical Corporation ("Sinopec Group") [member] \| Sinopec Shanghai Petrochemical Company Limited ("the Company") [member] \| China Petroleum & Chemical Corporation ("Sinopec Corp.") [member]
General information [line items]
State-owned legal shares transferred	4,000,000,000
Percentage of issued share capital, state-owned legal shares transferred	55.56%

General Information (The Fifteenth Meeting of the Seventh Term of Board of Directors) (Details) - shares shares in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
General information [line items]
Total shares of the Company	10,823,814	10,823,814	10,823,814
Sinopec Shanghai Petrochemical Company Limited ("the Company") [member]
General information [line items]
Total shares of the Company	10,823,814

Summary of Significant Accounting Policies (Property, Plant and Equipment) (Details)	12 Months Ended
	Dec. 31, 2022
Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful lives of property, plant and equipment	12 to 40 years
Plant and machinery [member]
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful lives of property, plant and equipment	5 to 20 years
Vehicles and other equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Estimated useful lives of property, plant and equipment	4 to 20 years

Summary of Significant Accounting Policies (Investment Properties) (Details)	12 Months Ended
	Dec. 31, 2022
Disclosure of detailed information about investment property [abstract]
Estimated useful lives of investment properties	30-40 years

Summary of Significant Accounting Policies (Other Non-current Assets) (Details)	12 Months Ended
	Dec. 31, 2022
Intangible assets - patents
Disclosure of information about other non-current assets [line items]
Estimated useful lives of other non-current assets	2 to 28 years
Long-term prepaid expense - catalyst
Disclosure of information about other non-current assets [line items]
Estimated useful lives of other non-current assets	1.5 to 10 years
Long-term prepaid expense - leasehold improvement
Disclosure of information about other non-current assets [line items]
Estimated useful lives of other non-current assets	3 to 27 years

Summary of Significant Accounting Policies (Leases) (Details)	12 Months Ended
	Dec. 31, 2022
Land use rights [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated useful lives of right-of-use assets	20 - 50 years
Buildings [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated useful lives of right-of-use assets	2 - 8 years
Equipment [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated useful lives of right-of-use assets	2 - 3 years
Others [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated useful lives of right-of-use assets	2 - 4 years

Financial Risk Management (Financial Risk Factors, Derivatives, Derivative Financial Instruments) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Disclosure of nature and extent of risks arising from financial instruments [line items]
Total derivative financial assets	¥ 0	¥ 81,405
Total derivative financial liabilities	0	23,804
Current derivative financial instrument assets [member]
Disclosure of nature and extent of risks arising from financial instruments [line items]
Commodity swaps contracts applied hedge accounting	0	48,614
Commodity swaps contracts at fair value through profit or loss	0	32,791
Total derivative financial assets	0	81,405
Current derivative financial instrument liabilities [member]
Disclosure of nature and extent of risks arising from financial instruments [line items]
Commodity swaps contracts at fair value through profit or loss	0	(23,804)
Total derivative financial liabilities	¥ 0	¥ (23,804)

Financial Risk Management (Reconciliation of Hedging Reserve in Respect of Commodity Price Risk and Effectiveness of Hedging Relationships) (Details) - Swap contract [member] ¥ in Thousands	12 Months Ended
	Dec. 31, 2022 CNY (¥)
Disclosure of nature and extent of risks arising from financial instruments [line items]
Beginning balance - Pre-tax amount	¥ 48,613
Effective portion of the cash flow hedge recognized in other comprehensive income	375,701
Amounts reclassified to profit or loss	(107,009)
Reclassified to inventory	(317,305)
Ending balance - Pre-tax amount	0
Beginning balance - Tax effect	(12,153)
Effective portion of the cash flow hedge recognized in other comprehensive income	(93,925)
Amounts reclassified to profit or loss	26,752
Reclassified to inventory	79,326
Ending balance - Tax effect	0
Beginning balance - Post-tax	36,460
Effective portion of the cash flow hedge recognized in other comprehensive income	281,776
Amounts reclassified to profit or loss	(80,257)
Reclassified to inventory	(237,979)
Ending balance - Post-tax	¥ 0

Financial Risk Management (Financial Risk Factors, Schedule of Interest Rate Financial Instruments) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of financial instruments by type of interest rate [line items]
Cash and cash equivalents	¥ 889,413	¥ 5,112,010	¥ 6,916,408	¥ 7,449,699
Borrowings	(2,250,000)	(2,259,800)
Lease liabilities	(16,251)	(4,613)
Not later than one year [member]
Disclosure of financial instruments by type of interest rate [line items]
Borrowings	(1,550,000)	(1,559,800)
Fixed interest rate [member]
Disclosure of financial instruments by type of interest rate [line items]
Borrowings	(1,550,000)	(1,500,000)
Lease liabilities	(16,251)	(4,613)
Financial instruments fixed interest rate bearing value	4,733,749	11,345,387
Fixed interest rate [member] \| Not later than one year [member]
Disclosure of financial instruments by type of interest rate [line items]
Time deposits with maturity less than one year	3,000,000	7,350,000
Fixed interest rate [member] \| Later than one year [member]
Disclosure of financial instruments by type of interest rate [line items]
Time deposits with maturity more than one year	3,300,000	5,500,000
Floating interest rate [member]
Disclosure of financial instruments by type of interest rate [line items]
Cash and cash equivalents	889,413	5,112,010
Borrowings	(700,000)	(759,800)
Financial instruments variable interest rate bearing value	¥ 189,413	¥ 4,352,210

Financial Risk Management (Schedule of Detailed Information of Adjusted Net Debt to Capital Ratio Explanatory) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Detailed Information Of Adjusted Net Debt To Capital Ratio [Abstract]
Borrowings	¥ 1,550,000	¥ 1,559,800
Lease liabilities	8,738	3,229
Current liabilities	1,558,738
Borrowings	700,000	700,000
Lease liabilities	7,513	1,384
Total Debt	2,266,251
Less: Cash and cash equivalents	(889,413)	(5,112,010)	¥ (6,916,408)	¥ (7,449,699)
Adjusted net debt	1,376,838
Total equity	26,355,363	¥ 30,377,398	¥ 29,334,975	¥ 29,993,848
Less: Hedging reserve	0
Adjusted capital	¥ 26,355,363
Adjusted net debt-to-capital ratio	5.00%

Financial Risk Management (Fair Value Estimation, Changes in level 3 items) (Details) - Level 3 of fair value hierarchy [member] - CNY (¥) ¥ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Financial instruments, fair value measurement [line items]
Beginning Balance	¥ 5,000	¥ 5,000
Acquisitions	1,000,000	8,150,000
Disposals	(1,011,124)	(8,247,921)
Fair value change	11,124	97,921
Ending Balance	5,000	5,000
Equity investments [member]
Financial instruments, fair value measurement [line items]
Beginning Balance	5,000	5,000
Acquisitions	0	0
Disposals	0	0
Fair value change	0	0
Ending Balance	5,000	5,000
Structured deposits [member]
Financial instruments, fair value measurement [line items]
Beginning Balance	0	0
Acquisitions	1,000,000	8,150,000
Disposals	(1,011,124)	(8,247,921)
Fair value change	11,124	97,921
Ending Balance	¥ 0	¥ 0

Segment information and revenue (Assets) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of operating segments [line items]
Investments accounted for using the equity method	¥ 3,504,393	¥ 4,088,888
Cash and cash equivalents	889,413	5,112,010	¥ 6,916,408	¥ 7,449,699
Derivative financial assets	0	81,405
Value added tax recoverable	1,057,463	13,322
Assets	41,136,717	46,920,589
Allocated amounts [member]
Disclosure of operating segments [line items]
Assets	28,075,886	24,463,262
Allocated amounts [member] \| Synthetic fibers [member]
Disclosure of operating segments [line items]
Assets	2,734,193	1,919,194
Allocated amounts [member] \| Resins and plastics [member]
Disclosure of operating segments [line items]
Assets	1,359,796	1,395,867
Allocated amounts [member] \| Intermediate petrochemicals [member]
Disclosure of operating segments [line items]
Assets	3,803,989	3,781,785
Allocated amounts [member] \| Petroleum products [member]
Disclosure of operating segments [line items]
Assets	16,021,111	13,317,338
Allocated amounts [member] \| Trading of petrochemical products [member]
Disclosure of operating segments [line items]
Assets	1,391,104	1,348,751
Allocated amounts [member] \| Others [member]
Disclosure of operating segments [line items]
Assets	2,765,693	2,700,327
Unallocated amounts [member]
Disclosure of operating segments [line items]
Investments accounted for using the equity method	3,504,393	4,088,888
Cash and cash equivalents	889,413	5,112,010
Time deposits with banks	6,498,478	12,968,042
Deferred tax assets	991,850	184,143
Derivative financial assets	0	81,405
Value added tax recoverable	1,057,463	13,322
Others	119,234	9,517
Assets	¥ 13,060,831	¥ 22,457,327

Other Operating Income (Details) - CNY (¥) ¥ in Thousands	12 Months Ended
Other Operating Income (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other operating income [abstract]
Government grants	¥ 33,055	¥ 35,944	¥ 61,296
Rental income from investment properties	75,159	81,923	81,608
Others	2,427	7,438	5,772
Other operating income	¥ 110,641	¥ 125,305	¥ 148,676

Other Operating Expenses (Details) - CNY (¥) ¥ in Thousands	12 Months Ended
Other Operating Expenses (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Other operating expenses [abstract]
Cost related to lease of investment properties	¥ (12,037)	¥ (13,439)	¥ (15,625)
Others	(13,738)	(31,273)	(9,061)
Other operating expenses	¥ (25,775)	¥ (44,712)	¥ (24,686)

Expense by Nature (Details) - CNY (¥) ¥ in Thousands	12 Months Ended
Expense by Nature (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disclosure of attribution of expenses by nature to their function [line items]
Cost of raw material	¥ 55,997,717	¥ 54,457,558	¥ 42,082,307
Cost of trading products	11,910,488	10,929,127	11,467,420
Employee benefit expenses	3,545,720	3,456,765	3,143,219
Depreciation and amortization: Property, plant and equipment (note 16)	1,494,176	1,621,459	1,553,039
Depreciation and amortization: Investment properties (note 17)	15,323	15,325	15,184
Depreciation and amortization: Other non-current assets (note 14)	270,881	294,617	226,263
Depreciation and amortization: Right-of-use assets (note 15)	32,918	34,307	32,653
Repairs and maintenance expenses	1,513,812	1,587,955	1,060,624
Changes of work in progress and finished goods	(78,255)	(235,402)	862,652
Transportation costs	193,144	238,405	274,002
Inventory write-down	525,269	150,883	220,888
External processing fee	192,288	213,691	215,467
Commission expense	90,341	110,552	104,598
Impairment loss of property, plant and equipment (note 16)	286,260	587,622	87,570
Impairment loss of investments accounted for using equity method (note 20)	0	28,392	0
Auditors' remuneration - audit services	6,837	6,837	7,800
Auditors' remuneration – non-audit services	129	129	0
Expenses relating to short-term leases	¥ 14,774	¥ 6,938	¥ 3,731

Income Tax Benefits /(Expenses) (Movements in Deferred Tax Assets and Liabilities) (Details) - CNY (¥) ¥ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	¥ 496,738	¥ 502,546
Credited/ (charged) to profit or loss	959,035	(5,808)
Balance at 31 December	1,455,773	496,738
Deferred tax assets [member] \| Impairment for bad and doubtful debts and provision for inventories [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	56,349	57,326
Credited/ (charged) to profit or loss	71,761	(977)
Balance at 31 December	128,110	56,349
Deferred tax assets [member] \| Provision for impairment losses in property, plant and equipment and construction in progress [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	358,211	226,435
Credited/ (charged) to profit or loss	70,499	131,776
Balance at 31 December	428,710	358,211
Deferred tax assets [member] \| Tax losses [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	0	87,799
Credited/ (charged) to profit or loss	872,648	(87,799)
Balance at 31 December	872,648	0
Deferred tax assets [member] \| Accruals and Others [Member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	82,178	130,986
Credited/ (charged) to profit or loss	(55,873)	(48,808)
Balance at 31 December	26,305	82,178
Deferred tax liabilities [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	(345,939)	(285,782)
Credited/ (charged) to profit or loss	(161,032)	(48,004)
Credited/ (Charged) to reserves	12,153	(12,153)
Balance at 31 December	(494,818)	(345,939)
Deferred tax liabilities [member] \| Difference in depreciation [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	(330,071)	(283,739)
Credited/ (charged) to profit or loss	(163,492)	(46,332)
Balance at 31 December	(493,563)	(330,071)
Deferred tax liabilities [member] \| Capitalization of borrowing costs [Member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	(1,468)	(2,043)
Credited/ (charged) to profit or loss	213	575
Balance at 31 December	(1,255)	(1,468)
Deferred tax liabilities [member] \| Derivative financial instruments [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	(14,400)
Credited/ (charged) to profit or loss	2,247	(2,247)
Credited/ (Charged) to reserves	12,153	(12,153)
Balance at 31 December	0	(14,400)
Deferred tax assets - net [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	184,143	252,121
Credited/ (charged) to profit or loss	795,554	(55,825)
Credited/ (Charged) to reserves	12,153	(12,153)
Balance at 31 December	991,850	184,143
Deferred tax liabilities - net [member]
Movements in deferred tax assets and liabilities [line items]
Balance at 1 January	(33,344)	(35,357)
Credited/ (charged) to profit or loss	2,449	2,013
Balance at 31 December	¥ (30,895)	¥ (33,344)

Income Tax Benefits /(Expenses) (Deferred Tax Assets Not Recognized) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	¥ 393,896	¥ 350,574
2022 [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	0	65,331
2023 [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	65,585	66,965
2024 [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	91,901	91,901
2025 [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	41,475	41,475
2026 [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	95,144	84,902
2027 [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of unused tax losses carried forward	99,791	0
Impairment losses on property, plant and equipment [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of temporary differences	29,856	29,969
Unused tax losses carried forward [member]
Disclosure of deferred tax assets not recognized [line items]
Deferred tax assets not recognized in respect of temporary differences	¥ 393,896	¥ 350,574

Other Non-current Assets (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disclosure of information about other non-current assets [line items]
Other non-current assets	¥ 835,400	¥ 787,807
Intangible assets [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	8,920	11,844	¥ 14,769
Intangible assets [member] \| Cost [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	85,908	85,908	85,908
Intangible assets [member] \| Accumulated amortization [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	(76,988)	(74,064)	(71,139)
Long-term prepaid expense [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	776,480	775,963	410,190
Long-term prepaid expense [member] \| Cost [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	1,995,096	1,726,622	1,069,157
Long-term prepaid expense [member] \| Accumulated amortization [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	(1,218,616)	(950,659)	(658,967)
Investment Deposits [Member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	50,000
Investment Deposits [Member] \| Cost [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	50,000
Total [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	835,400	787,807	424,959
Total [member] \| Cost [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	2,131,004	1,812,530	1,155,065
Total [member] \| Accumulated amortization [member]
Disclosure of information about other non-current assets [line items]
Other non-current assets	¥ (1,295,604)	¥ (1,024,723)	¥ (730,106)

Lease - (Maturity Analysis for Lease Liabilities) (Detail) ¥ in Thousands	Dec. 31, 2022 CNY (¥)
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Gross lease liabilities	¥ 16,251
Within 1 year [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Gross lease liabilities	8,738
After 1 year but within 2 years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Gross lease liabilities	6,945
After 2 years but within 5 years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Gross lease liabilities	¥ 568

Investment Properties (Minimum Lease Payments Receivable on Leases of Investment Properties) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Disclosure of maturity analysis of operating lease payments [line items]
Undiscounted operating lease payments to be received	¥ 65,298	¥ 88,557
Within 1 year [member]
Disclosure of maturity analysis of operating lease payments [line items]
Undiscounted operating lease payments to be received	52,138	49,420
Between one and two years [member]
Disclosure of maturity analysis of operating lease payments [line items]
Undiscounted operating lease payments to be received	6,638	39,137
Above 2 years [member]
Disclosure of maturity analysis of operating lease payments [line items]
Undiscounted operating lease payments to be received	¥ 6,522	¥ 0

Construction in Progress (Details) - CNY (¥) ¥ in Thousands	12 Months Ended
Construction in Progress (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Construction in progress [line items]
As at 1 January	¥ 3,293,177
As at 31 December	3,748,461	¥ 3,293,177
Construction in progress [member]
Construction in progress [line items]
As at 1 January	3,293,177	1,710,124
Additions	2,927,950	3,270,695
Disposal	(4,749)	0
Transferred to property plant and equipment	(2,467,917)	(1,699,974)
Transferred from property plant and equipment	0	12,332
As at 31 December	3,748,461	3,293,177	¥ 1,710,124
Impairment loss in construction in progress	24,486	24,486	24,486
Impairment write-off due to the disposal of construction in progress	0	0	¥ 10,175
Capitalized borrowing costs	¥ 24,136	¥ 12,641
Weighted average rate of capitalized borrowing costs	1.78%	2.85%	2.79%

Subsidiaries (Major Subsidiaries of the Group) (Details) - 12 months ended Dec. 31, 2022 ¥ in Thousands, $ in Thousands	CNY (¥)	USD ($)
Shanghai Petrochemical Investment Development Company Limited ("Toufa") [member]
Disclosure of subsidiaries [line items]
Name of company	Shanghai Petrochemical Investment Development Company Limited(“Toufa”)	Shanghai Petrochemical Investment Development Company Limited(“Toufa”)
Place of incorporation and business	MainlandChina	MainlandChina
Particulars of paid-up capital	¥ 1,000,000
Proportion of ownership interest Group's effective interest	100.00%	100.00%
Proportion of ownership interest Held by the Company	100.00%	100.00%
Principal activity	Investment management	Investment management
China Jinshan Associated Trading Corporation ("Jinmao") [member]
Disclosure of subsidiaries [line items]
Name of company	China Jinshan Associated Trading Corporation (“Jinmao”)	China Jinshan Associated Trading Corporation (“Jinmao”)
Place of incorporation and business	MainlandChina	MainlandChina
Particulars of paid-up capital	¥ 25,000
Proportion of ownership interest Group's effective interest	67.33%	67.33%
Proportion of ownership interest Held by the Company	67.33%	67.33%
Principal activity	Import and export of petrochemical products and equipment	Import and export of petrochemical products and equipment
Shanghai Jinchang Engineering Plastics Company Limited ("Jinchang") [member]
Disclosure of subsidiaries [line items]
Name of company	Shanghai Jinchang Engineering Plastics Company Limited (“Jinchang”)	Shanghai Jinchang Engineering Plastics Company Limited (“Jinchang”)
Place of incorporation and business	MainlandChina	MainlandChina
Particulars of paid-up capital \| $		$ 9,154
Proportion of ownership interest Group's effective interest	74.25%	74.25%
Proportion of ownership interest Held by a subsidiary	74.25%	74.25%
Principal activity	Production of polypropylene compound products	Production of polypropylene compound products
Shanghai Golden Phillips Petrochemical Company Limited ("Jinfei") [member]
Disclosure of subsidiaries [line items]
Name of company	Shanghai Golden Phillips Petrochemical Company Limited (“Jinfei”)	Shanghai Golden Phillips Petrochemical Company Limited (“Jinfei”)
Place of incorporation and business	MainlandChina	MainlandChina
Particulars of paid-up capital	¥ 415,623
Proportion of ownership interest Group's effective interest	100.00%	100.00%
Proportion of ownership interest Held by a subsidiary	100.00%	100.00%
Principal activity	Production of polyethylene products	Production of polyethylene products
Shanghai Jinshan Trading Corporation ("JMGJ") [member]
Disclosure of subsidiaries [line items]
Name of company	Shanghai Jinshan Trading Corporation (“JMGJ”)	Shanghai Jinshan Trading Corporation (“JMGJ”)
Place of incorporation and business	MainlandChina	MainlandChina
Particulars of paid-up capital	¥ 100,000
Proportion of ownership interest Group's effective interest	67.33%	67.33%
Proportion of ownership interest Held by a subsidiary	67.33%	67.33%
Principal activity	Import and export of petrochemical products	Import and export of petrochemical products
Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd. ("Jinlian") [member]
Disclosure of subsidiaries [line items]
Name of company	Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd.(“Jinlian”)	Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd.(“Jinlian”)
Place of incorporation and business	MainlandChina	MainlandChina
Particulars of paid-up capital	¥ 400,000
Proportion of ownership interest Group's effective interest	100.00%	100.00%
Proportion of ownership interest Held by a subsidiary	100.00%	100.00%
Principal activity	Trading of petrochemical products	Trading of petrochemical products

Subsidiaries (Acquisition of Jinlian) (Details) - Zhejiang Jinlian Petrochemical Storage and Transportation Co., Ltd. ("Jinlian") [member] - CNY (¥) ¥ in Thousands		12 Months Ended
	Jun. 30, 2020	Dec. 31, 2022
Disclosure of subsidiaries [line items]
Percentage of equity held by the subsidiary		100.00%
Shanghai Petrochemical Investment Development Company Limited ("Toufa") [member]
Disclosure of subsidiaries [line items]
Percentage of equity held by the subsidiary	100.00%
Purchase consideration	¥ 340,369

Investments Accounted for Using the Equity Method (Investments Recognized in Balance Sheet) (Details) - CNY (¥) ¥ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Disclosure of significant investments in associates and joint ventures [line items]
Share of net assets	¥ 3,504,393	¥ 4,088,888
Joint ventures [member]
Disclosure of significant investments in associates and joint ventures [line items]
Share of net assets	476,761	276,043
Associates [member]
Disclosure of significant investments in associates and joint ventures [line items]
Share of net assets	¥ 3,027,632	¥ 3,812,845

Investments Accounted for Using the Equity Method (Principal Activities of Material Associates) (Details) ¥ in Thousands			1 Months Ended	12 Months Ended
	Jul. 09, 2021 CNY (¥)	Aug. 31, 2019 CNY (¥)	Aug. 31, 2019 CNY (¥)	Dec. 31, 2022 CNY (¥)	Dec. 31, 2021 CNY (¥)	Dec. 31, 2020 CNY (¥)	Dec. 05, 2013 CNY (¥)	Dec. 05, 2013 USD ($)
Disclosure of associates [line items]
Commitement to invest in associate				¥ 1,783,781	¥ 1,176,168
Payment to acquire interests in associates				¥ 0	¥ 26,000	¥ 27,603
Shanghai Secco Petrochemical Company Limited ("Shanghai Secco") [member]
Disclosure of associates [line items]
Name of entity				Shanghai Secco Petrochemical Company Limited (“Shanghai Secco”)
Place of business/country of incorporation				MainlandChina
Percentage of ownership interest				20.00%	20.00%
Principal activities				Manufacturing and distribution of chemical products
Paid Up Capital				¥ 3,115,180
Proportion Of Ownership Interests Held By A Subsidiary				0.00%
Legal form of entity				Incorporated
Reduction of issued capital	¥ 7,300,811,000
Decrease caused by associates capital reduction investment in associates					¥ 1,460,258
Impairment loss on investment in associates				¥ 0	0
Investment in associates using equity method of accounting				¥ 333,896	¥ 1,270,351
Shanghai Secco Petrochemical Company Limited ("Shanghai Secco") [member] \| The Company [Member]
Disclosure of associates [line items]
Percentage of ownership interest	20.00%
Shanghai Secco Petrochemical Company Limited ("Shanghai Secco") [member] \| SinopecCorp [Member]
Disclosure of associates [line items]
Percentage of ownership interest	30.00%
Shanghai Secco Petrochemical Company Limited ("Shanghai Secco") [member] \| Gaoqiao Company [Member]
Disclosure of associates [line items]
Percentage of ownership interest	50.00%
Shanghai Secco Petrochemical Company Limited ("Shanghai Secco") [member] \| The Company [member]
Disclosure of associates [line items]
Percentage of ownership interest				20.00%
Commitement to invest in associate				¥ 71,541			¥ 182,804	$ 30,017,000
Shanghai Chemical Industry Park Development Company Limited ("Chemical Industry") [member]
Disclosure of associates [line items]
Name of entity				Shanghai Chemical Industry Park Development Company Limited (“Chemical Industry”)
Place of business/country of incorporation				MainlandChina
Percentage of ownership interest				38.26%	38.26%
Principal activities				Planning, development and operation of the Chemical Industry Park in Shanghai, PRC
Paid Up Capital				¥ 2,372,439
Proportion Of Ownership Interests Held By A Subsidiary				0.00%
Legal form of entity				Incorporated
Impairment loss on investment in associates				¥ 0	¥ 0
Investment in associates using equity method of accounting				¥ 2,115,142	¥ 2,023,586
Shanghai Chemical Industry Park Development Company Limited ("Chemical Industry") [member] \| The Company [member]
Disclosure of associates [line items]
Percentage of ownership interest				38.26%
Shanghai Jinsen Hydrocarbon Resins Company Limited ("Jinsen") [member]
Disclosure of associates [line items]
Name of entity				Shanghai Jinsen Hydrocarbon ResinsCompany Limited (“Jinsen”)
Place of business/country of incorporation				MainlandChina
Percentage of ownership interest				40.00%	40.00%
Principal activities				Production of resins products
Paid Up Capital				¥ 193,695
Proportion Of Ownership Interests Held By A Subsidiary				40.00%
Legal form of entity				Incorporated
Impairment loss on investment in associates				¥ 28,392	¥ 28,392
Investment in associates using equity method of accounting				¥ 4,514	¥ 16,189
Shanghai Jinsen Hydrocarbon Resins Company Limited ("Jinsen") [member] \| The Company [member]
Disclosure of associates [line items]
Percentage of ownership interest				0.00%
Shanghai Azbil Automation Company Limited ("Azbil") [member]
Disclosure of associates [line items]
Name of entity				Shanghai Azbil Automation CompanyLimited (“Azbil”)
Place of business/country of incorporation				MainlandChina
Percentage of ownership interest				40.00%	40.00%
Principal activities				Service and maintenance of building automation systems and products
Paid Up Capital				¥ 24,440
Proportion Of Ownership Interests Held By A Subsidiary				40.00%
Legal form of entity				Incorporated
Impairment loss on investment in associates				¥ 0	¥ 0
Investment in associates using equity method of accounting				¥ 63,324	¥ 68,567
Shanghai Azbil Automation Company Limited ("Azbil") [member] \| The Company [member]
Disclosure of associates [line items]
Percentage of ownership interest				0.00%
Shanghai Shidian Energy Company Limited ("Shidian Energy") [member]
Disclosure of associates [line items]
Name of entity				Shanghai Shidian Energy Company Limited (“Shidian Energy”)
Place of business/country of incorporation				MainlandChina
Percentage of ownership interest				40.00%	40.00%
Principal activities				Electric power supply
Paid Up Capital				¥ 1,000,000
Proportion Of Ownership Interests Held By A Subsidiary				40.00%
Legal form of entity				Incorporated
Impairment loss on investment in associates				¥ 0	¥ 0
Investment in associates using equity method of accounting				¥ 404,663	334,073
Shanghai Shidian Energy Company Limited ("Shidian Energy") [member] \| The Company [member]
Disclosure of associates [line items]
Percentage of ownership interest				0.00%
Shanghai Shidian Energy Company Limited ("Shidian Energy") [member] \| Toufa [member]
Disclosure of associates [line items]
Percentage of ownership interest		40.00%
Percentage of ownership interest acquired			40.00%
Commitement to invest in associate		¥ 400,000	¥ 400,000
Payment to acquire interests in associates				¥ 80,000
Investment in associates using equity method of accounting				¥ 400,000	¥ 320,000	¥ 320,000

Investments Accounted for Using the Equity Method (Summarized Balance Sheet for Material Associates) (Details) - CNY (¥) ¥ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Current
Current assets	¥ 15,765,882	¥ 20,932,276
Current liabilities	(13,998,338)	(15,795,743)
Non-current
Non-current assets	25,370,835	25,988,313
Non-current liabilities	(783,016)	(747,448)
Shanghai Secco [member]
Current
Current assets	4,941,394	6,066,119
Current liabilities	(8,977,030)	(5,433,872)
Non-current
Non-current assets	5,683,409	5,735,360
Non-current liabilities	(1)	(66)
Net assets	¥ 1,647,772	¥ 6,367,541
Proportion of ownership interest in associate	20.00%	20.00%
Interest in associates and joint ventures	¥ 329,554	¥ 1,273,508
Adjustments for unrealized upstream and downstream transaction	4,342	(3,157)
Adjustments for earnings not shared by other shareholders	0	0
Impairment Loss On Investment In Associates	0	0
Investments in associates accounted for using equity method	333,896	1,270,351
Chemical Industry [member]
Current
Current assets	4,327,622	4,133,397
Current liabilities	(1,765,771)	(1,789,223)
Non-current
Non-current assets	4,480,448	4,431,463
Non-current liabilities	(651,729)	(619,306)
Net assets	¥ 6,390,570	¥ 6,156,331
Proportion of ownership interest in associate	38.26%	38.26%
Interest in associates and joint ventures	¥ 2,445,032	¥ 2,355,412
Adjustments for unrealized upstream and downstream transaction	0	0
Adjustments for earnings not shared by other shareholders	(329,890)	(331,826)
Impairment Loss On Investment In Associates	0	0
Investments in associates accounted for using equity method	2,115,142	2,023,586
Jinsen [member]
Current
Current assets	49,810	63,192
Current liabilities	(17,905)	(10,476)
Non-current
Non-current assets	50,360	58,737
Non-current liabilities	0	0
Net assets	¥ 82,265	¥ 111,453
Proportion of ownership interest in associate	40.00%	40.00%
Interest in associates and joint ventures	¥ 32,906	¥ 44,581
Adjustments for unrealized upstream and downstream transaction	0	0
Adjustments for earnings not shared by other shareholders	0	0
Impairment Loss On Investment In Associates	(28,392)	(28,392)
Investments in associates accounted for using equity method	4,514	16,189
Azbil [member]
Current
Current assets	276,707	274,697
Current liabilities	(125,216)	(111,472)
Non-current
Non-current assets	12,338	15,698
Non-current liabilities	(5,518)	(7,506)
Net assets	¥ 158,311	¥ 171,417
Proportion of ownership interest in associate	40.00%	40.00%
Interest in associates and joint ventures	¥ 63,324	¥ 68,567
Adjustments for unrealized upstream and downstream transaction	0	0
Adjustments for earnings not shared by other shareholders	0	0
Impairment Loss On Investment In Associates	0	0
Investments in associates accounted for using equity method	63,324	68,567
Shidian Energy [member]
Current
Current assets	950,614	804,470
Current liabilities	(38,133)	(34,565)
Non-current
Non-current assets	166,068	121,051
Non-current liabilities	(35,355)	(15,827)
Net assets	¥ 1,043,194	¥ 875,129
Proportion of ownership interest in associate	40.00%	40.00%
Interest in associates and joint ventures	¥ 417,278	¥ 350,052
Adjustments for unrealized upstream and downstream transaction	(12,615)	(15,979)
Adjustments for earnings not shared by other shareholders	0	0
Impairment Loss On Investment In Associates	0	0
Investments in associates accounted for using equity method	¥ 404,663	¥ 334,073

Investments Accounted for Using the Equity Method (Principal Activities in Joint Ventures) (Details) ¥ in Thousands, $ in Thousands	1 Months Ended	12 Months Ended
	Sep. 30, 2021 CNY (¥)	Dec. 31, 2022 CNY (¥)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 CNY (¥)	Dec. 31, 2020 CNY (¥)
Disclosure of joint ventures [line items]
Other cash payments to acquire interests In joint ventures classified as investing activities		¥ 0		¥ 50,000	¥ 0
Shanghai Petrochemical Pressure Vessel Testing Center ("JYJC") [member]
Disclosure of joint ventures [line items]
Name of entity		Shanghai Petrochemical Pressure Vessel Testing Center (“JYJC”)	Shanghai Petrochemical Pressure Vessel Testing Center (“JYJC”)
Place of business/country of incorporation		Mainland China	Mainland China
Percentage of ownership interest		50.00%	50.00%	50.00%
Principal activities		Providing inspection and testing service	Providing inspection and testing service
Legal form of entity		Incorporated	Incorporated
Paid up capital		¥ 10,000
Held by the Company		50.00%	50.00%
Shanghai Petrochemical Pressure Vessel Testing Center ("JYJC") [member] \| The Company [member]
Disclosure of joint ventures [line items]
Percentage of ownership interest		0.00%	0.00%
Shanghai Petrochemical Yangu Gas Development Company Limited ("Yangu Gas") [member]
Disclosure of joint ventures [line items]
Name of entity		Shanghai Petrochemical Yangu Gas Development Company Limited (“Yangu Gas”)	Shanghai Petrochemical Yangu Gas Development Company Limited (“Yangu Gas”)
Place of business/country of incorporation		Mainland China	Mainland China
Percentage of ownership interest		50.00%	50.00%	50.00%
Principal activities		Production and sales of industrial gases	Production and sales of industrial gases
Legal form of entity		Incorporated	Incorporated
Paid up capital \| $			$ 10,560
Held by the Company		50.00%	50.00%
Shanghai Petrochemical Yangu Gas Development Company Limited ("Yangu Gas") [member] \| The Company [member]
Disclosure of joint ventures [line items]
Percentage of ownership interest		0.00%	0.00%
Linde SPC Gases Company Limited Formerly Known AsBOCSPC Gases Company Limited [Member]
Disclosure of joint ventures [line items]
Name of entity		Linde-SPC Gases Company Limited (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)	Linde-SPC Gases Company Limited (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)
Place of business/country of incorporation		Mainland China	Mainland China
Percentage of ownership interest		50.00%	50.00%	50.00%
Principal activities		Production and sales of industrial gases	Production and sales of industrial gases
Legal form of entity		Incorporated	Incorporated
Paid up capital \| $			$ 32,000
Held by the Company		50.00%	50.00%
Linde SPC Gases Company Limited Formerly Known AsBOCSPC Gases Company Limited [Member] \| The Company [member]
Disclosure of joint ventures [line items]
Percentage of ownership interest		0.00%	0.00%
Shanghai Jinshan Baling New Materials Co., Ltd. ("Baling Materials") (note i) ("Linde"), formerly known as "BOC-SPC Gases Company Limited")
Disclosure of joint ventures [line items]
Name of entity		Shanghai Jinshan Baling New Materials Co., Ltd. (“Baling Materials”) (note i) (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)	Shanghai Jinshan Baling New Materials Co., Ltd. (“Baling Materials”) (note i) (“Linde”), formerly known as “BOC-SPC Gases Company Limited”)
Place of business/country of incorporation		Mainland China	Mainland China
Percentage of ownership interest	50.00%	50.00%	50.00%	50.00%
Principal activities		Production and sales of new styrene thermoplastic elastomer materials	Production and sales of new styrene thermoplastic elastomer materials
Legal form of entity		Incorporated	Incorporated
Paid up capital		¥ 500,000
Held by the Company		50.00%	50.00%
Other cash payments to acquire interests In joint ventures classified as investing activities	¥ 400,000	¥ 200,000
Shanghai Jinshan Baling New Materials Co., Ltd. ("Baling Materials") (note i) ("Linde"), formerly known as "BOC-SPC Gases Company Limited") \| The Company [member]
Disclosure of joint ventures [line items]
Percentage of ownership interest		0.00%	0.00%
Shanghai Secco Petrochemical Company Limited [member]
Disclosure of joint ventures [line items]
Paid up capital		¥ 250,000